Go to the Table of Contents

Results from the 2016 National Survey on Drug Use and Health:
Detailed Tables



Acknowledgments

These tables were prepared by the Center for Behavioral Health Statistics and Quality (CBHSQ), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS), and by RTI International, a registered trademark and a trade name of Research Triangle Institute, Research Triangle Park, North Carolina. Work by RTI was performed under Contract No. HHSS283201300001C. Contributors and reviewers at RTI listed alphabetically include Kevin T. Adams, Tricia Adams, Jeremy Aldworth, Katherine J. Asman, Stephanie N. Barnett, Ellen Bishop, Michael R. Bradshaw, Kristen Brown, Lisa A. Carpenter, Pinliang (Patrick) Chen, Chuchun Chien, Devon S. Cribb, Lanting Dai, Teresa R. Davis, Susan L. Edwards, Glynis S. Ewing, Barbara J. Felts, Misty S. Foster, Peter A. Frechtel, Julia M. Gable, Gina M. Geercken, Harper Gordek, Paxton S. Gorsage, Rebecca K. Granger, Wafa Handley, Rachel M. Harter, Erica L. Hirsch, David Hunter (Project Director), Phillip S. Kott, Larry A. Kroutil, Jeffrey S. Laufenberg, Philip K. Lee, Dan Liao, Nicole Mack, Peilan Chen Martin, Dexter McNutt, Andrew S. Moore, Kayla J. Nowak, Lisa E. Packer, Michael R. Pemberton, Jeremy D. Porter, Rosanna S. Quiroz, Jessica L. Roycroft, Jill W. Ruppenkamp, Ana Saravia, Neeraja S. Sathe, Jennifer H. Schoden, Kathryn E. Spagnola, Jiantong (Jean) Wang, Lauren K. Warren, Matthew J. Westlake, and Carol L. Woodell. Contributors at SAMHSA listed alphabetically include Rebecca Ahrnsbrak, Jonaki Bose, Barbara Forsyth, Sarra L. Hedden, Joel Kennet, Rachel N. Lipari, Grace E. Medley, Eunice Park-Lee, Kathryn Piscopo, Peter Tice (Project Officer), and Matthew R. Williams. At RTI, Farrah Bullock Mann and Brenda K. Porter formatted the tables; Amber M. Rohloff and Richard S. Straw provided editorial assistance; and Teresa F. Bass, Debbie F. Bond, Kimberly H. Cone, Daniel Occoquan, Pamela Couch Prevatt, and Pamela G. Tuck provided web conversion and/or document production support.

Table of Contents

Introduction

List of Tables Containing Prevalence Estimates and Sample Sizes - Table Types A, B, and N (If Applicable)

Illicit Drug Use Tables – 1.1 to 1.116
Tobacco Product and Alcohol Use Tables – 2.1 to 2.57
Risk and Protective Factor Tables – 3.1 to 3.33
Incidence Tables – 4.1 to 4.13
Substance Use Disorder and Treatment Tables – 5.1 to 5.54
Miscellaneous Tables – 6.1 to 6.90
Trend Tables – 7.1 to 7.40
Adult Mental Health Tables – 8.1 to 8.85
Youth Mental Health Tables – 9.1 to 9.15
Adult Mental Health Trend Tables – 10.1 to 10.41
Youth Mental Health Trend Tables – 11.1 to 11.6
Sample Size and Population Tables – 12.1 to 12.9

List of Tables Containing Standard Errors and P Values - Table Types C, D, and P (If Applicable)

Illicit Drug Use Tables – 1.1 to 1.116
Tobacco Product and Alcohol Use Tables – 2.1 to 2.57
Risk and Protective Factor Tables – 3.1 to 3.33
Incidence Tables – 4.1 to 4.13
Substance Use Disorder and Treatment Tables – 5.1 to 5.54
Miscellaneous Tables – 6.1 to 6.90
Trend Tables – 7.1 to 7.40
Adult Mental Health Tables – 8.1 to 8.85
Youth Mental Health Tables – 9.1 to 9.15
Adult Mental Health Trend Tables – 10.1 to 10.41
Youth Mental Health Trend Tables – 11.1 to 11.6
Sample Size and Population Tables – 12.1 to 12.9

Introduction

Results from the 2016 National Survey on Drug Use and Health: Detailed Tables is a collection of tables presenting national estimates from the National Survey on Drug Use and Health (NSDUH).1 These tables present information for youths aged 12 to 17 and adults 18 or older (separately and combined) on drug, alcohol, and tobacco use, as well as substance use disorder (SUD) (also referred to as dependence or abuse), risk and availability of substance use, treatment, health topics, and alcohol consumption.2 For youths, additional topics include youth experiences and measures on mental health service utilization, major depressive episode (MDE), and treatment for depression (among youths with MDE). For adults, additional topics include measures on any mental illness (AMI), serious mental illness (SMI), AMI excluding SMI, mental health service utilization (i.e., treatment or counseling for mental health issues), suicidal thoughts and behaviors, MDE, treatment for depression (among adults with MDE), and serious psychological distress (SPD). Measures such as the co-occurrence of mental disorders with substance use or with SUDs also are presented for both adults and youths. Measures of these behaviors and characteristics are presented by a variety of demographic, geographic, and other variables. The estimates in the tables include prevalence rates of the behaviors, numbers of persons engaging in these behaviors, and other measures. A small number of measures are no longer comparable with measures from previous years, but the 2-year trend table format was retained in the detailed tables in order to help illustrate this lack of comparability.

A summary report, 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions, accompanies these detailed tables.3 In that report, information on key definitions (i.e., see the glossary in its Section D) can be found for many of the measures and terms used in these detailed tables and in other 2016 NSDUH documents, along with further analytic details on these measures (see its Section B in particular) and the survey. Where relevant, the glossary provides cross-references between terms and specific question wording for clarity.

In addition to these detailed tables, three first findings reports (FFRs) from the 2016 NSDUH that are focused on key substance use and mental health indicators, receipt of services for substance use and mental health issues among adults, and risk and protective factors and initiation of substance use are scheduled to be made available online in September 2017 at https://www.samhsa.gov/data/.

SURVEY DESIGN

A coordinated sample design was developed for the 2014 through 2017 NSDUHs. It is a state-based design with an independent, multistage area probability sample within each state and the District of Columbia. As a result, states are viewed as the first level of stratification. Each state is further stratified into approximately equally populated state sampling regions (SSRs). Creation of each year's multistage area probability sample then involves selecting census tracts within each SSR, census block groups within census tracts, and area segments (i.e., a collection of census blocks) within census block groups. Finally, dwelling units (DUs) are selected within segments, and within each selected DU, up to two residents who are at least 12 years old are selected for interviewing.

This partitioning of states divided the United States into a total of 750 SSRs, which results in 750 degrees of freedom for most national estimates presented in these detailed tables. Estimates for mean age of first use (AFU) and average number of days used are the exception. These estimates are treated differently because of the possibility of smaller sample sizes; therefore, they potentially belong to fewer variance estimation strata, and cell-specific degrees of freedom are used. For more information on degrees of freedom, see Section 6 of the 2015 NSDUH statistical inference report.4

The coordinated design for 2014 through 2017 includes a 50 percent overlap in third-stage units (area segments) within each successive 2-year period from 2014 through 2017. The designed overlap slightly increases the precision of estimates of year-to-year trends because of the expected small but positive correlation resulting from the overlapping area segments between successive survey years. The design also allocates more interviews to the largest 12 states (compared with the 1999 to 2013 design). Making the sample sizes more proportional to the state population sizes improves the precision of NSDUH estimates.

Starting in 2014, the allocation of the sample by age group changed. In the 2005 through 2013 NSDUHs, the sample was allocated equally between three age groups: 12 to 17, 18 to 25, and 26 or older. Starting in 2014, the allocation of the NSDUH sample became 25 percent for adolescents aged 12 to 17, 25 percent for adults aged 18 to 25, and 50 percent for adults aged 26 or older. The sample of adults aged 26 or older was further divided into three subgroups: aged 26 to 34 (15 percent), aged 35 to 49 (20 percent), and aged 50 or older (15 percent). These age allocation changes were designed to reflect more closely the actual population distributions by state and age group, so that the precision of estimates overall and for older age groups could be improved.

BREAKS IN TRENDS DUE TO QUESTIONNAIRE AND OTHER CHANGES

NSDUH has undergone changes over the years in order to improve the quality of its data and to address the changing needs of policymakers and researchers with regard to substance use and mental health issues. These changes affect the level of comparability across years, and many times cause breaks in trends. Information pertaining to some of the more major changes over the years as they pertain to the detailed tables are summarized below. For more detailed information on these revisions and revisions that do not pertain to the detailed tables, see Sections B and C of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.5

2016 Changes and Impact

Changes to Specific Prescription Drugs

To account for changing popularity and availability of specific prescription drugs, the survey has been designed to allow for the addition and removal of specific prescription drugs from year to year.6 These specific prescription drugs were further categorized into subtypes and presented as such in the detailed tables. The following specific prescription drugs from 2015 were removed because they had been discontinued or were reported infrequently in the 2015 data: Roxicet®, Actiq®, buspirone, hydroxyzine, meprobamate, and Ritalin® SR. Additionally, buprenorphine plus naloxone was added to the prescription pain relievers section. The impact of these changes was evaluated, and it was determined that the removal and addition of these drugs did not change the comparability of the subtype or overall pain reliever estimates presented in the detailed tables.

The any past year use of prescription pain reliever response option for Tylenol® with codeine 3 or 4 was modified to clarify that this drug was not the same as over-the-counter Tylenol® in order to reduce potential confusion between these two similarly sounding drug names. As expected, there was a reduction in reports of using Tylenol® with codeine 3 or 4. The impact assessment confirmed that codeine products were not comparable between 2015 and 2016, but the overall pain relievers category remained comparable. The lack of comparability for codeine products has been noted in the detailed tables that present estimates for prescription pain relievers, opioids, and prescription psychotherapeutics.

Changes to Education Measures

In 2016, the question about current school enrollment was reworded to clarify the question for younger respondents. Instead of asking "Are you now attending or are you currently enrolled in school?" the question was revised to say "Do you go to school?" The revised question also instructs respondents to answer "yes" if they were "on holiday or break from school, such as spring break or summer vacation, but plan to return when the break is over." A decrease in the percentage of adolescents aged 12 to 17 who reported currently being enrolled in school was seen between 2015 and 2016. The current school enrollment data are used in the creation of the college enrollment estimates, which for the 2016 detailed tables are considered comparable based on an impact assessment.

Additionally, text defining what is included in the term "school" was added for consistency to a different current school enrollment question asked specifically of youths. These current enrollment data are used to subset the student characteristic, adult involvement, and youth perceptions' tables in Section 3 of the detailed tables. After an assessment analysis, it was determined that the additional text had a negligible effect on the resulting data.

Changes to Driving Under the Influence Measures

Starting with the 2016 NSDUH, respondents who reported past year alcohol use or selected illicit drug use were asked individual questions about driving under the influence of each substance they indicated using. The selected illicit drugs include marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, and methamphetamine. Previously, questions about driving under the influence of illicit drugs did not specify individual drugs and were asked of past year users of illicit drugs including prescription psychotherapeutics. After analyzing the 2016 estimates for driving under the influence and comparing the results with the 2015 estimates, it was determined that breaks in trends occurred for all measures of driving under the influence, including the measure of driving under the influence of alcohol, only because of associated context effects from other changes in this section. (A context effect may be said to take place when the response to a question is affected by information that is not part of the question itself.)

Changes to OxyContin® and Oxycodone Product Estimates

Starting with the 2016 NSDUH, OxyContin® and Oxycodone estimates in the pain reliever subtype detailed tables are based on the imputation-revised OxyContin® use and misuse variables. In the 2015 detailed tables, these estimates were based on the edited OxyContin® use and misuse variables. As a result, the 2015 estimates in the 2016 detailed tables may not match those presented in the 2015 detailed tables. Although the estimates based on the edited OxyContin® use and misuse variables are not incorrect, the estimates based on the imputation revised OxyContin® use and misuse variables are recommended.

Changes to Standard Error Estimates

As with previous detailed tables, a "mixed" method approach for calculating standard errors was implemented in the 2016 detailed tables. Standard errors for controlled domains are calculated assuming no sampling error while standard errors for uncontrolled domains are calculated directly in SUDAAN®.7 Controlled domains are domains where the weight calibration process forces the domain size estimates to match their respective U.S. Census Bureau population estimates. For more information on calculating standard errors in the detailed tables and controlled domains, see Section 5 of the 2015 NSDUH statistical inference report.8 In the 2015 detailed tables numbered 1.28 to 1.87, some three-way interactions were inadvertently treated as controlled domains. Per NSDUH standard practices for detailed tables, three-way interactions should be treated as uncontrolled. These three-way interactions were treated as uncontrolled in the 2016 detailed tables numbered 1.29 to 1.66; therefore, the standard errors of the total estimates for the non-Hispanic white and non-Hispanic black categories may be different from those presented in the 2015 detailed tables.

2015 NSDUH Redesign Changes and Impact

The NSDUH questionnaire underwent a partial redesign in 2015. The prescription drug questions for pain relievers, tranquilizers, stimulants, and sedatives were redesigned to shift the focus from lifetime misuse to past year misuse. Additionally, questions were added about any past year prescription drug use, rather than just misuse. A separate section with methamphetamine questions was added, replacing the methamphetamine questions that were previously asked within the context of prescription stimulants. Substantial changes were also made to questions about smokeless tobacco, binge alcohol use, inhalants, and hallucinogens.

These changes led to breaks in the comparability of 2015 estimates with estimates from prior years. Consequently, these changes affected overall summary measures, such as any illicit drug use, and other measures, such as initiation, SUDs, and substance use treatment. Additionally, certain demographic items were changed as part of the partial redesign. Employment questions were moved from the computer-assisted personal interviewing (CAPI) section to the audio computer-assisted self-interviewing (ACASI) section of the questionnaire. Education questions were updated, and new questions were added on disability, English-language proficiency, sexual orientation of adults, and military families.

Due to the breaks in comparability, many estimates from years prior to 2015 have been noted in the detailed tables as not comparable due to methodological changes. These include measures of overall illicit drug use; use of hallucinogens, inhalants, and methamphetamine; misuse of psychotherapeutics; binge and heavy alcohol use overall and among females; smokeless tobacco use; and substance use treatment. Additionally, 2015 estimates by education and current employment have been noted as not comparable with prior years. Other topics, such as the mental health topics, did not undergo major changes and therefore are considered comparable.

Any use of prescription drugs includes both use as directed by a doctor and misuse. Misuse includes use in any way not directed by a doctor, including (a) use without a prescription of one's own; (b) use in greater amounts, more often, or longer than told to take a medication; or (c) use in any other way that was not directed by a doctor. Starting in 2015, the detailed tables no longer use the term "nonmedical use" and instead use the term "misuse." For more specific information about each of the 2015 NSDUH changes, see Section C of the 2015 National Survey on Drug Use and Health: Methodological Summary and Definitions.9

Starting with the 2015 NSDUH, there was a change in the focus of the questions for specific prescription psychotherapeutic drugs. The focus shifted from lifetime use of all respondents to use more than 12 months ago among respondents who last misused any prescription psychotherapeutic drug in any of the four categories (pain relievers, tranquilizers, stimulants, or sedatives). This shift appeared to cause an underreporting of lifetime prescription drug misuse compared with prior years. This underreporting might be because respondents are no longer presented with examples of drugs that formerly were available by prescription in the United States but are no longer available and because many fewer questions ask about lifetime use. These respondents who did not report misuse that occurred more than 12 months ago would be misclassified as still being "at risk" for initiation of misuse of prescription drugs in that psychotherapeutic category (i.e., individuals who initiated misuse more than 12 months ago are no longer at risk for initiation). For this reason, starting with the 2015 detailed tables, percentages for initiation of misuse of psychotherapeutic drugs among individuals who were at risk for initiation are not shown. The tables also do not show estimates for lifetime psychotherapeutic drug use. For more specific information about each of the 2015 changes, see Sections B.4.1 and B.4.2 in Section B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.10

In order to evaluate the changes from the 2015 redesign, a 12-month questionnaire redesign impact assessment was completed.11 Analyses were conducted on a subset of variables associated with the detailed tables to check for potential trend breaks, including the risk and availability measures. After significant differences between 2015 and previous years were found for 16 of 17 raw risk and availability variables during an initial analysis, logistic regression models were run on dichotomous recodes. All of the perceived great risk of harm associated with the substance use measures yielded a significant increase in 2015 compared with previous years. Extreme weights and missingness rates were investigated to ensure that these were not the cause of the difference. It was determined that these measures are not comparable for years prior to 2015.

Previous Mental Health Changes and Impact

Because of additional survey improvements and questionnaire changes to the mental health sections between 2002 and 2012, it is not possible to assess long-term trends for all of the mental health issues. A summary of the changes is described below, but for more detailed information on revisions, see Sections B.4.6 and B.4.7 in Section B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.12

In 2012, revisions were made to the 2008 to 2011 past year AMI and SMI estimates. Past year mental illness estimates for 2008 through 2011 found in mental health detailed tables and reports published prior to 2012 were based on a prediction model for mental illness developed using the 2008 clinical data from the Mental Health Surveillance Study (MHSS). An improved model was used for estimates starting in 2012. For the 2012, 2013, and 2014 mental health detailed tables and the 2015 and 2016 detailed tables, the 2012 to 2016 estimates and the previous 2008 to 2011 estimates are based on the 2012 model.

It is recommended that the mental illness variables derived from the 2012 model not be used when analyzing variables for past year suicidal thoughts, past year MDE, the Kessler-6 (K6) mental disorder scale, or the World Health Organization Disability Assessment Schedule (WHODAS) scale, and it is also recommended that the mental illness variables derived from the 2012 model not be used when analyzing other closely linked variables (including past year suicide attempts, past year suicide plans, medical treatment for suicide attempts, lifetime MDE, SPD, or components used in the K6 or WHODAS scales). For detailed information on model revisions to the mental illness items, see Section B.4.7 in Section B of 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.13 As with the mental illness estimates based on the 2008 model, the mental illness estimates based on the 2012 model are not comparable with SMI estimates produced from NSDUH data prior to 2004, and SMI estimates were not produced from 2004 to 2007; thus, long‑term trend estimates are not available for SMI.

Because of the 2008 questionnaire revisions to the mental health module, several estimates in 2008 (MDE and past 12-month SPD) were affected by context effects. However, an adjustment for the questionnaire changes was applied to estimates of MDE for 2005 to 2008. For more detailed information, see Section B.4.8 in Section B of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.14 Therefore, long-term trend estimates for these two measures are available from 2005 through 2016. No additional questionnaire changes from 2009 to 2016 have led to changes in these adult measures. Moreover, no questionnaire changes have been implemented that affected the adult mental health service utilization questions; therefore, estimates of mental health service utilization presented in these detailed tables reflect trends from 2002 to 2016. The only exceptions are estimates that combine mental health data with other topics that are considered not comparable.

No questionnaire revisions affected MDE for youths aged 12 to 17; thus, long-term trend estimates are available from 2004 through 2016. However, revisions to the youth mental health service utilization module of the 2009 NSDUH questionnaire resulted in new estimates and a discontinuation of trends for several items on the source of mental health services. New questions regarding the receipt of mental health services from juvenile justice sources were added in 2009, and questions regarding services from educational sources were revised and are not comparable with estimates prior to 2009.

Changes to Previously Published 2006 to 2010 Estimates

During regular data collection and processing checks for the 2011 NSDUH, data errors were identified. These errors affected the data for Pennsylvania (2006 to 2010) and Maryland (2008 and 2009). Cases with erroneous data were removed from the data files, and the remaining cases were reweighted to provide representative estimates. The errors had minimal impact on the national estimates and no effect on direct estimates for the other 48 states and the District of Columbia. In reports where model-based small area estimation (SAE) techniques are used, estimates for all states may be affected, even though the errors were concentrated in only two states. In reports that do not use model-based estimates, the only estimates appreciably affected are estimates for Pennsylvania, Maryland, the mid-Atlantic division, and the Northeast region.

The 2016 detailed tables and 2016 FFRs do not include state-level, model-based, or division-level estimates. However, the 2016 detailed tables do include estimates for the Northeast region. Estimates based on 2006 to 2010 data may differ from previously published estimates. Tables and estimates based only on data since 2011 are unaffected by these data errors. All affected tables (i.e., tables with estimates based on 2006 to 2010 data) contain a note to indicate this to the user.

Caution is advised when comparing data from older reports with data from more recent reports that are based on corrected data files. As discussed above, comparisons of estimates for Pennsylvania, Maryland, the mid-Atlantic division, and the Northeast region are of most concern, while comparisons of national data or data for other states and regions are essentially still valid. The Center for Behavioral Health Statistics and Quality (CBHSQ) within the Substance Abuse and Mental Health Services Administration (SAMHSA) does not recommend making comparisons between unrevised 2006 to 2010 estimates and estimates based on data for 2011 and subsequent years for the areas of greatest concern.

New 2002 Baseline

Methodological differences implemented in the 2002 NSDUH affected the comparability of the 2002 estimates with prior surveys. Some of the changes included the addition of a $30 incentive, a change in the survey name from the National Household Survey on Drug Abuse (NHSDA) to the current name, and updated population data from the 2000 decennial census being incorporated into the sample weights. Because of these improvements in the 2002 NSDUH, the 2002 data constitute a new baseline for tracking trends in substance use and other measures. Therefore, estimates from the 2002 through 2016 surveys should not be compared with estimates from the 2001 or earlier surveys to examine changes over time. In addition to the 2002 baseline change, the aforementioned 2015 and 2016 changes may also constitute a new baseline for various measures.

Methodology changes throughout NSDUH's history make it difficult to assess long-term trends from tables presenting data from 1971 to 2016. However, it is instructive to compare NSDUH estimates from 1971 to 2016 by "piecing together" the data from time periods for which data are comparable. Specifically, valid trend comparisons can be made for 1971 to 1998, 1999 to 2001, and 2002 to 2016. With this approach, comparisons between 1998 and 1999, and between 2001 and 2002, should be made with caution because they are potentially biased due to changes in methods. Nevertheless, when these data are combined in a single presentation, it often becomes clear that the effects of the changes in methods are small compared with the major shifts in substance use prevalence that have occurred over the past five decades.

TABLE PRESENTATION

Although the majority of the detailed tables present estimates from the 2015 and 2016 NSDUHs, some tables include only estimates from the 2016 NSDUH. Additionally, due to the 2016 questionnaire changes, two tables presenting estimates for driving under the influence of various substances are formatted to present 2 years of data, but all of the 2015 estimates are noted as being not comparable ("nc") or not reported ("nr"). The tables are formatted to allow the ability to present 2 years of estimates in subsequent years when more data are available. As more comparable years of data become available, multiyear trend tables for both measures that had a break in trend in 2015 due to the redesign and the driving under the influence measures mentioned earlier will be added. Also included are a number of tables that present data from prior surveys in the series, including a section of tables presenting data mainly from 2002 to 2016 or 2008 to 2016, with a few tables with data with various years starting from 2004 to 2009 and a couple of tables presenting data from 1971 to 2016. The following sections provide information on how the tables are organized, the types of tables that are available, information about specific indicators used for the 2016 detailed tables, information on missingness, information on the impact of rounding on estimates presented in the tables, and how totals are to be interpreted within the tables.

Table Numbering

The detailed tables are numbered using a three-part numbering scheme (e.g., 1.15A). The first part of the table number (1.15A) is the subject matter section to which a particular table belongs. The second part (1.15A) is the number of the table within a particular section. The third part (1.15A) is a table type indicator, an alphabetic letter appended to the table number. Each table number, as explained below, has multiple table types. Tables are numbered sequentially within each subject matter section. Identical tables across years may not be assigned the same table number each year.

In 2014, there were two sets of detailed tables—the detailed tables and the mental health detailed tables. The 2014 detailed tables included eight sections, and the 2014 mental health detailed tables contained three sections. A crosswalk has been included below that shows the detailed tables by section in the 2014 detailed tables and the sections within the 2015 and 2016 detailed tables.

2014 Table Section 2015 and 2016 Table Section
Detailed Tables  
Sections 1 to 7 Sections 1 to 7
Section 8 (Sample Size and Population Tables) Section 12
Mental Health Detailed Tables  
Section 1 (Adult Mental Health 2-Year Tables) Section 8
Section 1 (Adult Mental Health Multiyear Trend Tables) Section 10
Section 2 (Youth Mental Health 2-Year Tables) Section 9
Section 2 (Youth Mental Health Multiyear Trend Tables) Section 11
Section 3 (Sample Size and Population Tables) Section 12

The 12 subject matter sections and the number of tables per section in 2016 are as follows:

Section 1: Illicit Drug Use Tables – 1.1 to 1.116

Section 2: Tobacco Product and Alcohol Use Tables – 2.1 to 2.57

Section 3: Risk and Protective Factor Tables – 3.1 to 3.33

Section 4: Incidence Tables – 4.1 to 4.13

Section 5: Substance Use Disorder and Treatment Tables – 5.1 to 5.54

Section 6: Miscellaneous Tables – 6.1 to 6.90

Section 7: Trend Tables – 7.1 to 7.40

Section 8: Adult Mental Health Tables – 8.1 to 8.85

Section 9: Youth Mental Health Tables – 9.1 to 9.15

Section 10: Adult Mental Health Trend Tables – 10.1 to 10.41

Section 11: Youth Mental Health Trend Tables – 11.1 to 11.6

Section 12: Sample Size and Population Tables – 12.1 to 12.9

Table Types and Purpose

The table type indicators are primarily defined as follows; however, some exceptions do exist and are noted in subsequent text.

Table Type Purpose of the Table
A: Presents estimates of the numbers of persons exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings.
B: Presents estimates of the percentages of persons exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings.
C: Presents the standard error associated with each of the estimates in the "A" tables.
D: Presents the standard error associated with each of the estimates in the "B" tables.
N: Presents the number of cases in the specified NSDUH sample with the characteristics defined by the column and row headings.
P: Presents the p Values from tests of the statistical significance of differences between columns in the "B" tables.

The majority of tables within the detailed tables contain five table types (A, B, C, D, and P) as defined above. Note that table type N is used exclusively within Section 12 to display the sample size counts. Also, table type P is excluded from sets of tables where no significance testing is performed between 2016 and previous years. This includes tables that show only a single year of data and tables where all of the pre-2016 NSDUH estimates are deemed not comparable (i.e., estimates replaced with "nc" as defined below) or are not reported (i.e., estimates replaced with "nr" as defined below) within a table. Exceptions to this organization are noted as follows:

Table Indicators

Each 2016 detailed table, including those for all of the above table types, contains the following definitional footnote, regardless of whether any or all of the indicators were used in the table:

* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.

The "* = low precision" portion of the footnote indicates an estimate is being suppressed (i.e., not shown) due to low precision.

The "-- = not available" portion of the footnote indicates that for the given year, the questions used to produce the estimates were not available. For example, prior to 2016, respondents were not asked about specifically driving under the influence of marijuana. Thus, for 2015 and earlier years, those estimates are shown with the "--" notation.

The "da = does not apply" portion of the footnote indicates that the question or estimate does not apply to a certain group. For example, in pregnancy tables, the trimester estimates are shown as "da" for overall females and nonpregnant females, and in the incidence tables that show numbers in thousands and percentages in the same table, the p Values for the numbers in thousands are replaced with "da" because the detailed tables only show p Values of tests of differences of percentages.

The "nc = not comparable due to methodological changes" portion of the footnote indicates that estimates for the measure do exist for prior years, but they are no longer comparable with the current year estimate. For example, illicit drug use estimates are available for all years in the detailed tables, but the 2015 and 2016 estimates are not comparable with the 2002 through 2014 estimates due to questionnaire changes. Thus, the 2014 and prior year estimates are shown with the "nc" notation.

The "nr = not reported due to measurement issues" portion of the footnote indicates that the estimate could be calculated based on available data but is not calculated due to potential measurement issues. For example, lifetime use of prescription pain relievers for 2015 and 2016 is shown as "nr" because the questionnaire was changed to focus on past year misuse of pain relievers rather than lifetime past year use of pain relievers, and there appears to be an underestimate of lifetime pain reliever use compared with prior years.

For more information on how low precision is defined and further details on the changes noted above, see Section B.2.2 in Section B and Section C of the 2016 National Survey on Drug Use and Health: Methodological Summary and Definitions.15

Additionally, all type A and B detailed tables where significance testing was performed between years contain the following footnotes, regardless of whether any differences were significant:

a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.

b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.

Tables where significance testing was not performed between years, such as those with only a single year or single group of combined years or those with no comparable estimates for years prior to 2016, do not contain these footnotes.

Missingness

Some measures are not defined for all respondents and have missing data. In the detailed tables, a footnote or note is included to alert a user to the fact that missing data were excluded from the analysis. For the 2016 NSDUH, an investigation was completed to look at missing data rates in the 2016 detailed tables. The investigation was done for all new 2016 measures and existing measures where there was a break in a trend. For other measures, the results from the 2014 and 2015 investigations were assumed to still hold. That is, missing data were not a concern for most topics. Similar results were found in 2016. However, a few items did have a slightly higher rate of missing data (e.g., items on perceived availability of various illicit drugs and items on the source of prescription drugs obtained for most recent use). Specifically, less than 5 percent of the risk, availability, and protective factor subpopulations evaluated in 2016 had both weighted and unweighted missingness rates above 5 percent. The highest weighted rate of numerator missingness was 7.8 percent. These percentages were similar to the results for the risk, availability, and protective factor measures from the 2015 investigation. The exclusion of respondents with missing data induces a negative bias for estimates of population totals and may induce a bias in either direction for estimates of population means and proportions. For more information, see Chapter 4 of the 2015 NSDUH statistical inference report.16

Rounding and Effect on Significance Testing

Prevalence estimates in the form of percentages are presented rounded to the nearest tenth of a percent, and total estimates are rounded to the nearest thousand. Due to this rounding, prevalence estimates of 0.0 percent and total estimates of 0 are displayed in the tables. These estimates are rounded down from a percentage < 0.05 percent or < 50, respectively, and do not represent an absence of persons displaying a particular characteristic. Nonrounded estimates of zero are suppressed.

Testing between two prevalence estimates can indicate significant differences involving estimates that appear identical when rounded but are actually different. Note that similar results can be seen in the average age-at-first-use estimates and the estimates for the average number of days used, which are also rounded to the nearest tenth, and the total estimates. For example, in Table 1.14B, the estimate for past month heroin use among females aged 12 or older was 0.1 percent for both 2015 and 2016 and was indicated as significantly different. Although the rounded estimates appear the same, the unrounded estimates were 0.066 percent for 2015 and 0.129 percent for 2016. Another example in Table 7.3B, a trend table in the 2016 detailed tables, shows how seemingly identical estimates from previous years can differ in significance when each is compared against the current year estimate. The estimate for past month crack use among people aged 12 or older was 0.1 percent for 2008, 2010, 2011, 2013, 2014, and 2015, but only the 2011 estimate was significantly different from the 2016 estimate of 0.2 percent. Although the rounded estimates for 2008, 2010, 2011, 2013, 2014, and 2015 appeared to be the same, the unrounded estimates were 0.145 percent for 2008, 0.149 percent for 2010, 0.089 percent for 2011, 0.144 percent for 2013, 0.134 percent for 2014, and 0.147 percent for 2015; moreover, each of these estimates had varying standard errors that affected the testing. Note that differences in precision can also cause seemingly identical (or identical) previous year estimates to differ in significance when compared with the current year estimate.

Definitions of Totals

Totals are defined in different ways within the detailed tables. Totals can refer to the estimated number of persons with a specific characteristic, as shown in detailed table type A and displayed in number of thousands. For example, in Table 2.2, the total estimated population of persons aged 12 to 17 who used cigarettes in the past year in 2016 was approximately 1,785,000 and shown as 1,785. Totals can also be presented in the table rows or columns, either as a total of a subgroup category or listed as the "Total Population." If the estimate is a total of a subgroup category (e.g., total of gender), the estimate is the total number of both males and females combined. Instances where measures have missing data may cause the subcategories to not add up to a total and are noted in the tables. If the estimate is shown as the "Total Population" on the row, then that estimate is usually included as a reference for tables with a nonstandard denominator. This total population estimate is normally the number being used in the nonstandard denominator to allow users to easily see that estimate without having to switch tables. For example, in Table 8.53, the total population row for table type A shows the estimated number of persons who fit the criteria in the columns, which are the table denominators (i.e., 11,769,000 adults reported a perceived unmet need for mental health services in the past year for 2016), and this number is used as the denominator in all the reason estimates.

LOCATING A TABLE

The detailed tables are organized by table type into two categories:

Both categories are organized based on 12 subject matter sections as listed below. Clicking on the subject matter section of interest takes users to a list of tables for that section. Users can scroll through the list of table titles to find the table of interest, then click on the table title to go directly to that table. Users need to return to the table of contents to access tables from other sections or categories.

As mentioned earlier, the key definitions for the 2016 NSDUH (i.e., the glossary) appear in Section D of the 2016 methodological summary and definitions report and define and cross-reference many key measures used in the 2016 detailed tables and the 2016 FRRs.17 The glossary may be helpful when used in conjunction with the list of tables in identifying tables that contain information for selected measures. However, not all measures and terms listed in the glossary are specifically mentioned in the list of tables.

Note that the table numbers and Section Differ from previous years. The 2014 mental health detailed tables contained three sections. Section 1 of the 2014 mental health detailed tables is now equivalent to Sections 8 and 10 of the 2015 and 2016 detailed tables; 2014's Section 2 is equivalent to Sections 9 and 11 of the 2015 and 2016 detailed tables; and 2014's Section 3 (the sample size and population tables) is now included in Section 12 of the 2015 and 2016 detailed tables.

The 12 subject matter sections are as follows:

Index of Section 1: Illicit Drug Use Tables (1.1 to 1.116)

Index of Section 2: Tobacco Product and Alcohol Use Tables (2.1 to 2.57)

Index of Section 3: Risk and Protective Factor Tables (3.1 to 3.33)

Index of Section 4: Incidence Tables (4.1 to 4.13)

Index of Section 5: Substance Use Disorder and Treatment Tables (5.1 to 5.54)

Index of Section 6: Miscellaneous Tables (6.1 to 6.90)

Index of Section 7: Trend Tables (7.1 to 7.40)

Index of Section 8: Adult Mental Health Tables (8.1 to 8.85)

Index of Section 9: Youth Mental Health Tables (9.1 to 9.15)

Index of Section 10: Adult Mental Health Trend Tables (10.1 to 10.41)

Index of Section 11: Youth Mental Health Trend Tables (11.1 to 11.6)

Index of Section 12: Sample Size and Population Tables (12.1 to 12.9)

PRINTING A TABLE

For best printing results, use the PDF-Web file of this document located at https://www.samhsa.gov/data/.

General PDF Printing Instructions

Illicit Drug Use Tables – 1.1 to 1.116 (Numbers in Thousands and Percentages)

1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Numbers in Thousands, 2015 and 2016

1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Percentages, 2015 and 2016

1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Numbers in Thousands, 2015 and 2016

1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Percentages, 2015 and 2016

1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Numbers in Thousands, 2015 and 2016

1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Percentages, 2015 and 2016

1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Numbers in Thousands, 2015 and 2016

1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Percentages, 2015 and 2016

1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Numbers in Thousands, 2015 and 2016

1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Percentages, 2015 and 2016

1.6A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Numbers in Thousands, 2015 and 2016

1.6B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Percentages, 2015 and 2016

1.7A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Numbers in Thousands, 2015 and 2016

1.7B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Percentages, 2015 and 2016

1.8A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Numbers in Thousands, 2015 and 2016

1.8B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Percentages, 2015 and 2016

1.9A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Numbers in Thousands, 2015 and 2016

1.9B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Percentages, 2015 and 2016

1.10A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Numbers in Thousands, 2015 and 2016

1.10B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Percentages, 2015 and 2016

1.11A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Numbers in Thousands, 2015 and 2016

1.11B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Percentages, 2015 and 2016

1.12A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Numbers in Thousands, 2015 and 2016

1.12B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Percentages, 2015 and 2016

1.13A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Numbers in Thousands, 2015 and 2016

1.13B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Percentages, 2015 and 2016

1.14A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Numbers in Thousands, 2015 and 2016

1.14B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Percentages, 2015 and 2016

1.15A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.15B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.16A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.16B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.17A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.17B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.18A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.18B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.19A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.19B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.20A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.20B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.21A – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.21B – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.22A – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.22B – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.23A – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.23B – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.24A – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.24B – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.25A – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.25B – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.26A – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.26B – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.27A – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

1.27B – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

1.28A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

1.28B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

1.29A – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.29B – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.30A – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.30B – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.31A – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.31B – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.32A – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.32B – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.33A – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.33B – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.34A – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.34B – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.35A – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.35B – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.36A – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.36B – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.37A – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.37B – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.38A – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.38B – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.39A – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.39B – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.40A – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.40B – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.41A – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.41B – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.42A – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.42B – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.43A – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.43B – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.44A – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.44B – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.45A – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.45B – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.46A – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.46B – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.47A – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.47B – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.48A – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.48B – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.49A – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.49B – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.50A – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.50B – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.51A – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.51B – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.52A – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.52B – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.53A – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.53B – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.54A – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.54B – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.55A – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.55B – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.56A – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.56B – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.57A – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.57B – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.58A – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.58B – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.59A – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.59B – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.60A – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.60B – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.61A – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.61B – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.62A – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.62B – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.63A – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.63B – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.64A – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.64B – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.65A – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.65B – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.66A – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

1.66B – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

1.67A – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.67B – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.68A – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.68B – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.69A – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.69B – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.70A – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.70B – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.71A – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.71B – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.72A – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.72B – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.73A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.73B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.74A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.74B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.75A – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.75B – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.76A – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.76B – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.77A – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.77B – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.78A – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.78B – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.79A – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.79B – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.80A – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.80B – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.81A – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.81B – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.82A – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.82B – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.83A – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.83B – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.84A – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.84B – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.85A – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.85B – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.86A – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.86B – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.87A – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.87B – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.88A – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.88B – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.89A – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.89B – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.90A – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.90B – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.91A – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.91B – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.92A – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.92B – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.93A – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.93B – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.94A – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.94B – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.95A – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

1.95B – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

1.96A – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

1.96B – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

1.97A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016

1.97B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: Percentages, 2015 and 2016

1.98A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016

1.98B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: Percentages, 2015 and 2016

1.99A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016

1.99B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: Percentages, 2015 and 2016

1.100A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016

1.100B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: Percentages, 2015 and 2016

1.101A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016

1.101B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: Percentages, 2015 and 2016

1.102A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016

1.102B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: Percentages, 2015 and 2016

1.103A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016

1.103B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: Percentages, 2015 and 2016

1.104A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016

1.104B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: Percentages, 2015 and 2016

1.105A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016

1.105B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: Percentages, 2015 and 2016

1.106A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016

1.106B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: Percentages, 2015 and 2016

1.107A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016

1.107B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: Percentages, 2015 and 2016

1.108A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016

1.108B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: Percentages, 2015 and 2016

1.109A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016

1.109B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: Percentages, 2015 and 2016

1.110A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016

1.110B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: Percentages, 2015 and 2016

1.111A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016

1.111B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: Percentages, 2015 and 2016

1.112A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: Numbers in Thousands, 2015 and 2016

1.112B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: Percentages, 2015 and 2016

1.113A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: Numbers in Thousands, 2015 and 2016

1.113B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: Percentages, 2015 and 2016

1.114A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: Numbers in Thousands, 2015 and 2016

1.114B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: Percentages, 2015 and 2016

1.115A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: Numbers in Thousands, 2015 and 2016

1.115B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: Percentages, 2015 and 2016

1.116A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: Numbers in Thousands, 2015 and 2016

1.116B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: Percentages, 2015 and 2016

Illicit Drug Use Tables – 1.1 to 1.116 (Standard Errors and P Values)

1.1C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

1.1D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

1.1P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.2C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2015 and 2016

1.2D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Standard Errors of Percentages, 2015 and 2016

1.2P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.3C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Standard Errors of Numbers in Thousands, 2015 and 2016

1.3D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Standard Errors of Percentages, 2015 and 2016

1.3P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.4C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Standard Errors of Numbers in Thousands, 2015 and 2016

1.4D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Standard Errors of Percentages, 2015 and 2016

1.4P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.5C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Standard Errors of Numbers in Thousands, 2015 and 2016

1.5D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Standard Errors of Percentages, 2015 and 2016

1.5P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.6C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

1.6D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Standard Errors of Percentages, 2015 and 2016

1.6P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.7C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2015 and 2016

1.7D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Standard Errors of Percentages, 2015 and 2016

1.7P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.8C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Standard Errors of Numbers in Thousands, 2015 and 2016

1.8D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Standard Errors of Percentages, 2015 and 2016

1.8P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.9C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Standard Errors of Numbers in Thousands, 2015 and 2016

1.9D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Standard Errors of Percentages, 2015 and 2016

1.9P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.10C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

1.10D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Standard Errors of Percentages, 2015 and 2016

1.10P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.11C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Standard Errors of Numbers in Thousands, 2015 and 2016

1.11D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Standard Errors of Percentages, 2015 and 2016

1.11P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.12C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

1.12D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Standard Errors of Percentages, 2015 and 2016

1.12P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.13C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

1.13D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

1.13P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.14C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

1.14D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

1.14P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.15C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.15D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.15P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.16C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.16D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.16P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.17C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.17D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.17P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.18C – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.18D – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.18P – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.19C – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.19D – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.19P – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.20C – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.20D – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.20P – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.21C – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.21D – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.21P – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.22C – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.22D – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.22P – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.23C – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.23D – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.23P – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.24C – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.24D – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.24P – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.25C – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.25D – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.25P – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.26C – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.26D – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.26P – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.27C – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

1.27D – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

1.27P – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.28C – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

1.28D – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

1.28P – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.29C – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.29D – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.29P – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.30C – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.30D – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.30P – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.31C – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.31D – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.31P – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.32C – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.32D – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.32P – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.33C – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.33D – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.33P – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.34C – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.34D – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.34P – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.35C – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.35D – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.35P – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.36C – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.36D – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.36P – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.37C – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.37D – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.37P – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.38C – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.38D – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.38P – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.39C – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.39D – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.39P – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.40C – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.40D – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.40P – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.41C – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.41D – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.41P – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.42C – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.42D – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.42P – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.43C – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.43D – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.43P – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.44C – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.44D – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.44P – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.45C – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.45D – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.45P – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.46C – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.46D – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.46P – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.47C – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.47D – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.47P – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.48C – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.48D – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.48P – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.49C – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.49D – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.49P – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.50C – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.50D – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.50P – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.51C – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.51D – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.51P – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.52C – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.52D – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.52P – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.53C – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.53D – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.53P – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.54C – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.54D – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.54P – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.55C – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.55D – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.55P – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.56C – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.56D – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.56P – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.57C – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.57D – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.57P – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.58C – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.58D – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.58P – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.59C – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.59D – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.59P – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.60C – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.60D – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.60P – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.61C – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.61D – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.61P – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.62C – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.62D – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.62P – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.63C – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.63D – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.63P – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.64C – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.64D – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.64P – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.65C – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.65D – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.65P – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.66C – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.66D – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.66P – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.67C – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.67D – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.67P – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.68C – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.68D – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.68P – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.69C – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.69D – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.69P – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.70C – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.70D – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.70P – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.71C – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.71D – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.71P – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.72C – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.72D – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.72P – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.73C – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.73D – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.73P – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.74C – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.74D – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.74P – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.75C – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.75D – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.75P – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.76C – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.76D – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.76P – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.77C – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.77D – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.77P – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.78C – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.78D – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.78P – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.79C – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.79D – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.79P – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.80C – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.80D – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.80P – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.81C – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.81D – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.81P – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.82C – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.82D – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.82P – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.83C – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.83D – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.83P – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.84C – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.84D – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.84P – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.85C – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.85D – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.85P – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.86C – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.86D – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.86P – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.87C – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.87D – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.87P – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.88C – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.88D – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.88P – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.89C – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.89D – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.89P – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.90C – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.90D – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.90P – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.91C – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.91D – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.91P – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.92C – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.92D – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.92P – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.93C – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.93D – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.93P – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.94C – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.94D – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.94P – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.95C – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

1.95D – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

1.95P – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.96C – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

1.96D – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

1.96P – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.97C – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.97D – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: Standard Errors of Percentages, 2015 and 2016

1.97P – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.98C – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.98D – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: Standard Errors of Percentages, 2015 and 2016

1.98P – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.99C – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.99D – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: Standard Errors of Percentages, 2015 and 2016

1.99P – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.100C – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.100D – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: Standard Errors of Percentages, 2015 and 2016

1.100P – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.101C – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.101D – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: Standard Errors of Percentages, 2015 and 2016

1.101P – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.102C – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.102D – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: Standard Errors of Percentages, 2015 and 2016

1.102P – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.103C – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.103D – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: Standard Errors of Percentages, 2015 and 2016

1.103P – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.104C – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.104D – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: Standard Errors of Percentages, 2015 and 2016

1.104P – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.105C – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.105D – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: Standard Errors of Percentages, 2015 and 2016

1.105P – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.106C – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.106D – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: Standard Errors of Percentages, 2015 and 2016

1.106P – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.107C – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.107D – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: Standard Errors of Percentages, 2015 and 2016

1.107P – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.108C – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.108D – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: Standard Errors of Percentages, 2015 and 2016

1.108P – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.109C – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.109D – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: Standard Errors of Percentages, 2015 and 2016

1.109P – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.110C – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.110D – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: Standard Errors of Percentages, 2015 and 2016

1.110P – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.111C – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.111D – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: Standard Errors of Percentages, 2015 and 2016

1.111P – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.112C – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.112D – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: Standard Errors of Percentages, 2015 and 2016

1.112P – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.113C – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.113D – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: Standard Errors of Percentages, 2015 and 2016

1.113P – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.114C – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.114D – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: Standard Errors of Percentages, 2015 and 2016

1.114P – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.115C – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.115D – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: Standard Errors of Percentages, 2015 and 2016

1.115P – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

1.116C – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: Standard Errors of Numbers in Thousands, 2015 and 2016

1.116D – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: Standard Errors of Percentages, 2015 and 2016

1.116P – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: P Values from Tests of Differences of Percentages, 2016 Versus 2015

Tobacco Product and Alcohol Use Tables – 2.1 to 2.57 (Numbers in Thousands and Percentages)

2.1A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Numbers in Thousands, 2015 and 2016

2.1B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Percentages, 2015 and 2016

2.2A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Numbers in Thousands, 2015 and 2016

2.2B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Percentages, 2015 and 2016

2.3A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Numbers in Thousands, 2015 and 2016

2.3B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Percentages, 2015 and 2016

2.4A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Numbers in Thousands, 2015 and 2016

2.4B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Percentages, 2015 and 2016

2.5A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Numbers in Thousands, 2015 and 2016

2.5B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Percentages, 2015 and 2016

2.6A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Numbers in Thousands, 2015 and 2016

2.6B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Percentages, 2015 and 2016

2.7A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Numbers in Thousands, 2015 and 2016

2.7B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Percentages, 2015 and 2016

2.8A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Numbers in Thousands, 2015 and 2016

2.8B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Percentages, 2015 and 2016

2.9A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Numbers in Thousands, 2015 and 2016

2.9B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Percentages, 2015 and 2016

2.10A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Numbers in Thousands, 2015 and 2016

2.10B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Percentages, 2015 and 2016

2.11A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Numbers in Thousands, 2015 and 2016

2.11B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Percentages, 2015 and 2016

2.12A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Numbers in Thousands, 2015 and 2016

2.12B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Percentages, 2015 and 2016

2.13A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Numbers in Thousands, 2015 and 2016

2.13B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Percentages, 2015 and 2016

2.14A – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Numbers in Thousands, 2015 and 2016

2.14B – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Percentages, 2015 and 2016

2.15A – Tobacco Product Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

2.15B – Tobacco Product Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

2.16A – Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

2.16B – Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

2.17A – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

2.17B – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

2.18A – Cigar Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

2.18B – Cigar Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

2.19A – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

2.19B – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

2.20A – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

2.20B – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

2.21A – Tobacco Product Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.21B – Tobacco Product Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.22A – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.22B – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.23A – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.23B – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.24A – Cigarette Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.24B – Cigarette Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.25A – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.25B – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.26A – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.26B – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.27A – Smokeless Tobacco Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.27B – Smokeless Tobacco Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.28A – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.28B – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.29A – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.29B – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.30A – Cigar Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.30B – Cigar Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.31A – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.31B – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.32A – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.32B – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.33A – Alcohol Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.33B – Alcohol Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.34A – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.34B – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.35A – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.35B – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.36A – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.36B – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.37A – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.37B – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

2.38A – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.38B – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.39A – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.39B – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.40A – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.40B – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.41A – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.41B – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.42A – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.42B – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.43A – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.43B – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.44A – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.44B – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.45A – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.45B – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.46A – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.46B – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.47A – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.47B – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.48A – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.48B – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.49A – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.49B – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.50A – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.50B – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Percentages, 2015 and 2016

2.51A – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.51B – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

2.52A – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.52B – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Percentages, 2015 and 2016

2.53A – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

2.53B – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

2.54A – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.54B – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.55A – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.55B – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.56A – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.56B – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

2.57A – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

2.57B – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

Tobacco Product and Alcohol Use Tables – 2.1 to 2.57 (Standard Errors and P Values)

2.1C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

2.1D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

2.1P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.2C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2015 and 2016

2.2D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Standard Errors of Percentages, 2015 and 2016

2.2P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.3C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Standard Errors of Numbers in Thousands, 2015 and 2016

2.3D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Standard Errors of Percentages, 2015 and 2016

2.3P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.4C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Standard Errors of Numbers in Thousands, 2015 and 2016

2.4D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Standard Errors of Percentages, 2015 and 2016

2.4P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.5C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Standard Errors of Numbers in Thousands, 2015 and 2016

2.5D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Standard Errors of Percentages, 2015 and 2016

2.5P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.6C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

2.6D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Standard Errors of Percentages, 2015 and 2016

2.6P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.7C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2015 and 2016

2.7D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Standard Errors of Percentages, 2015 and 2016

2.7P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.8C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Standard Errors of Numbers in Thousands, 2015 and 2016

2.8D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Standard Errors of Percentages, 2015 and 2016

2.8P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.9C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Standard Errors of Numbers in Thousands, 2015 and 2016

2.9D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Standard Errors of Percentages, 2015 and 2016

2.9P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.10C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

2.10D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Standard Errors of Percentages, 2015 and 2016

2.10P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.11C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Standard Errors of Numbers in Thousands, 2015 and 2016

2.11D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Standard Errors of Percentages, 2015 and 2016

2.11P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.12C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

2.12D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Standard Errors of Percentages, 2015 and 2016

2.12P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.13C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

2.13D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

2.13P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.14C – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

2.14D – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

2.14P – Tobacco Product and Alcohol Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.15C – Tobacco Product Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

2.15D – Tobacco Product Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

2.15P – Tobacco Product Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.16C – Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

2.16D – Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

2.16P – Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.17C – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

2.17D – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

2.17P – Smokeless Tobacco Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.18C – Cigar Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

2.18D – Cigar Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

2.18P – Cigar Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.19C – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

2.19D – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

2.19P – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.20C – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

2.20D – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

2.20P – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.21C – Tobacco Product Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.21D – Tobacco Product Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.21P – Tobacco Product Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.22C – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.22D – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.22P – Tobacco Product Use in Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.23C – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.23D – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.23P – Tobacco Product Use in Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.24C – Cigarette Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.24D – Cigarette Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.24P – Cigarette Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.25C – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.25D – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.25P – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.26C – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.26D – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.26P – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.27C – Smokeless Tobacco Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.27D – Smokeless Tobacco Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.27P – Smokeless Tobacco Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.28C – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.28D – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.28P – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.29C – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.29D – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.29P – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.30C – Cigar Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.30D – Cigar Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.30P – Cigar Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.31C – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.31D – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.31P – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.32C – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.32D – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.32P – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.33C – Alcohol Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.33D – Alcohol Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.33P – Alcohol Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.34C – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.34D – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.34P – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.35C – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.35D – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.35P – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.36C – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.36D – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.36P – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.37C – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.37D – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.37P – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.38C – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.38D – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.38P – Tobacco Product Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.39C – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.39D – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.39P – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.40C – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.40D – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.40P – Cigarette Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.41C – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.41D – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.41P – Cigarette Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.42C – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.42D – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.42P – Smokeless Tobacco Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.43C – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.43D – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.43P – Smokeless Tobacco Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.44C – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.44D – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.44P – Cigar Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.45C – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.45D – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.45P – Cigar Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.46C – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.46D – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.46P – Alcohol Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.47C – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.47D – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.47P – Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.48C – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.48D – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.48P – Binge Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.49C – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.49D – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.49P – Heavy Alcohol Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.50C – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.50D – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.50P – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.51C – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.51D – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.51P – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.52C – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.52D – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.52P – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.53C – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.53D – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.53P – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.54C – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.54D – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.54P – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.55C – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.55D – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.55P – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.56C – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.56D – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.56P – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 12 to 20, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

2.57C – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

2.57D – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

2.57P – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Persons Aged 21 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

Risk and Protective Factor Tables – 3.1 to 3.33 (Numbers in Thousands and Percentages)

3.1A – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

3.1B – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

3.2A – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Past Year Initiates of Specific Substances Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

3.2B – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Past Year Initiates of Specific Substances Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

3.3A – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Specific Substance Use Initiation Status: Numbers in Thousands, 2015 and 2016

3.3B – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Specific Substance Use Initiation Status: Percentages, 2015 and 2016

3.4A – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.4B – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.5A – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 20, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.5B – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 20, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.6A – Perceived Great Risk of Harm Associated with Marijuana and Cocaine Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.6B – Perceived Great Risk of Harm Associated with Marijuana and Cocaine Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.7A – Perceived Great Risk of Harm Associated with Heroin and LSD Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.7B – Perceived Great Risk of Harm Associated with Heroin and LSD Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.8A – Perceived That Obtaining Specific Illicit Drugs Would Be Fairly or Very Easy among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.8B – Perceived That Obtaining Specific Illicit Drugs Would Be Fairly or Very Easy among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.9A – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.9B – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.10A – Youths Felt That Close Friends Would Strongly Disapprove or Somewhat Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.10B – Youths Felt That Close Friends Would Strongly Disapprove or Somewhat Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.11A – Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.11B – Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.12A – Participated in a Prevention Program or Group in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.12B – Participated in a Prevention Program or Group in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.13A – Participated in a Substance Use Program or Exposed to Substance Use Prevention Message in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.13B – Participated in a Substance Use Program or Exposed to Substance Use Prevention Message in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.14A – Participated in a Physical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.14B – Participated in a Physical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.15A – Participated in a Nonphysical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.15B – Participated in a Nonphysical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.16A – Selected Risk and Protective Factors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.16B – Selected Risk and Protective Factors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.17A – Youths Agreed or Strongly Agreed with Statements about Religious Beliefs among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.17B – Youths Agreed or Strongly Agreed with Statements about Religious Beliefs among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.18A – Parents Always or Sometimes Took Part in Specific Behaviors in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.18B – Parents Always or Sometimes Took Part in Specific Behaviors in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.19A – Measures of Student Characteristics in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.19B – Measures of Student Characteristics in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.20A – Adults Always or Sometimes Took Part in Specific School-Related Behaviors in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.20B – Adults Always or Sometimes Took Part in Specific School-Related Behaviors in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.21A – Youths Perceived That All or Most Students in Grade Level Use Specific Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Numbers in Thousands, 2015 and 2016

3.21B – Youths Perceived That All or Most Students in Grade Level Use Specific Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Percentages, 2015 and 2016

3.22A – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Risk of Harm Associated with Substance Use Behaviors: Numbers in Thousands, 2016

3.22B – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Risk of Harm Associated with Substance Use Behaviors: Percentages, 2016

3.23A – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Availability of Selected Illicit Drugs: Numbers in Thousands, 2016

3.23B – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Availability of Selected Illicit Drugs: Percentages, 2016

3.24A – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 or Older, by Past Month Substance Use Status: Numbers in Thousands, 2016

3.24B – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 or Older, by Past Month Substance Use Status: Percentages, 2016

3.25A – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 to 17, by Past Month Substance Use Status: Numbers in Thousands, 2016

3.25B – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 to 17, by Past Month Substance Use Status: Percentages, 2016

3.26A – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 or Older, by Past Month Substance Use Status: Numbers in Thousands, 2016

3.26B – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 or Older, by Past Month Substance Use Status: Percentages, 2016

3.27A – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 to 25, by Past Month Substance Use Status: Numbers in Thousands, 2016

3.27B – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 to 25, by Past Month Substance Use Status: Percentages, 2016

3.28A – Perceived Availability of Selected Illicit Drugs among Persons Aged 26 or Older, by Past Month Substance Use Status: Numbers in Thousands, 2016

3.28B – Perceived Availability of Selected Illicit Drugs among Persons Aged 26 or Older, by Past Month Substance Use Status: Percentages, 2016

3.29A – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Parents' Feelings about Substance Use Behaviors: Numbers in Thousands, 2016

3.29B – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Parents' Feelings about Substance Use Behaviors: Percentages, 2016

3.30A – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Close Friends' Feelings and Youth's Feelings about Peers' Substance Use Behaviors: Numbers in Thousands, 2016

3.30B – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Close Friends' Feelings and Youth's Feelings about Peers' Substance Use Behaviors: Percentages, 2016

3.31A – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Youth's Participation in Prevention or Substance Use Programs and Exposure to Substance Use Prevention Messages and Youth's Delinquency in Past Year: Numbers in Thousands, 2016

3.31B – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Youth's Participation in Prevention or Substance Use Programs and Exposure to Substance Use Prevention Messages and Youth's Delinquency in Past Year: Percentages, 2016

3.32A – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Risk and Protective Factors, Religious Beliefs, and Past Year Parental Involvement: Numbers in Thousands, 2016

3.32B – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Risk and Protective Factors, Religious Beliefs, and Past Year Parental Involvement: Percentages, 2016

3.33A – Past Month Use of Selected Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Measures of Scholastic Environment: Numbers in Thousands, 2016

3.33B – Past Month Use of Selected Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Measures of Scholastic Environment: Percentages, 2016

Risk and Protective Factor Tables – 3.1 to 3.33 (Standard Errors and P Values)

3.1C – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

3.1D – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

3.1P – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.2C – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Past Year Initiates of Specific Substances Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

3.2D – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Past Year Initiates of Specific Substances Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

3.2P – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Past Year Initiates of Specific Substances Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.3C – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Specific Substance Use Initiation Status: Standard Errors of Numbers in Thousands, 2015 and 2016

3.3D – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Specific Substance Use Initiation Status: Standard Errors of Percentages, 2015 and 2016

3.3P – Perceived Great Risk of Harm Associated with Substance Use and Perceived Availability of Substances among Persons Aged 12 or Older, by Specific Substance Use Initiation Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.4C – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.4D – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.4P – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.5C – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 20, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.5D – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 20, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.5P – Perceived Great Risk of Harm Associated with Cigarette and Alcohol Use among Persons Aged 12 to 20, by Demographic and Geographic Characteristics P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.6C – Perceived Great Risk of Harm Associated with Marijuana and Cocaine Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.6D – Perceived Great Risk of Harm Associated with Marijuana and Cocaine Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.6P – Perceived Great Risk of Harm Associated with Marijuana and Cocaine Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.7C – Perceived Great Risk of Harm Associated with Heroin and LSD Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.7D – Perceived Great Risk of Harm Associated with Heroin and LSD Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.7P – Perceived Great Risk of Harm Associated with Heroin and LSD Use among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.8C – Perceived That Obtaining Specific Illicit Drugs Would Be Fairly or Very Easy among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.8D – Perceived That Obtaining Specific Illicit Drugs Would Be Fairly or Very Easy among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.8P – Perceived That Obtaining Specific Illicit Drugs Would Be Fairly or Very Easy among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.9C – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.9D – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.9P – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.10C – Youths Felt That Close Friends Would Strongly Disapprove or Somewhat Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.10D – Youths Felt That Close Friends Would Strongly Disapprove or Somewhat Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.10P – Youths Felt That Close Friends Would Strongly Disapprove or Somewhat Disapprove of Youth's Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.11C – Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.11D – Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.11P – Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.12C – Participated in a Prevention Program or Group in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.12D – Participated in a Prevention Program or Group in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.12P – Participated in a Prevention Program or Group in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.13C – Participated in a Substance Use Program or Exposed to Substance Use Prevention Message in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.13D – Participated in a Substance Use Program or Exposed to Substance Use Prevention Message in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.13P – Participated in a Substance Use Program or Exposed to Substance Use Prevention Message in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.14C – Participated in a Physical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.14D – Participated in a Physical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.14P – Participated in a Physical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.15C – Participated in a Nonphysical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.15D – Participated in a Nonphysical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.15P – Participated in a Nonphysical Delinquent Behavior in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.16C – Selected Risk and Protective Factors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.16D – Selected Risk and Protective Factors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.16P – Selected Risk and Protective Factors among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.17C – Youths Agreed or Strongly Agreed with Statements about Religious Beliefs among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.17D – Youths Agreed or Strongly Agreed with Statements about Religious Beliefs among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.17P – Youths Agreed or Strongly Agreed with Statements about Religious Beliefs among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.18C – Parents Always or Sometimes Took Part in Specific Behaviors in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.18D – Parents Always or Sometimes Took Part in Specific Behaviors in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.18P – Parents Always or Sometimes Took Part in Specific Behaviors in Past Year among Persons Aged 12 to 17, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.19C – Measures of Student Characteristics in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.19D – Measures of Student Characteristics in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.19P – Measures of Student Characteristics in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.20C – Adults Always or Sometimes Took Part in Specific School-Related Behaviors in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.20D – Adults Always or Sometimes Took Part in Specific School-Related Behaviors in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.20P – Adults Always or Sometimes Took Part in Specific School-Related Behaviors in Past Year among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.21C – Youths Perceived That All or Most Students in Grade Level Use Specific Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

3.21D – Youths Perceived That All or Most Students in Grade Level Use Specific Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: Standard Errors of Percentages, 2015 and 2016

3.21P – Youths Perceived That All or Most Students in Grade Level Use Specific Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Demographic and Geographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

3.22C – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Risk of Harm Associated with Substance Use Behaviors: Standard Errors of Numbers in Thousands, 2016

3.22D – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Risk of Harm Associated with Substance Use Behaviors: Standard Errors of Percentages, 2016

3.23C – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Availability of Selected Illicit Drugs: Standard Errors of Numbers in Thousands, 2016

3.23D – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Perceived Availability of Selected Illicit Drugs: Standard Errors of Percentages, 2016

3.24C – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 or Older, by Past Month Substance Use Status: Standard Errors of Numbers in Thousands, 2016

3.24D – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 or Older, by Past Month Substance Use Status: Standard Errors of Percentages, 2016

3.25C – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 to 17, by Past Month Substance Use Status: Standard Errors of Numbers in Thousands, 2016

3.25D – Perceived Availability of Selected Illicit Drugs among Persons Aged 12 to 17, by Past Month Substance Use Status: Standard Errors of Percentages, 2016

3.26C – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 or Older, by Past Month Substance Use Status: Standard Errors of Numbers in Thousands, 2016

3.26D – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 or Older, by Past Month Substance Use Status: Standard Errors of Percentages, 2016

3.27C – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 to 25, by Past Month Substance Use Status: Standard Errors of Numbers in Thousands, 2016

3.27D – Perceived Availability of Selected Illicit Drugs among Persons Aged 18 to 25, by Past Month Substance Use Status: Standard Errors of Percentages, 2016

3.28C – Perceived Availability of Selected Illicit Drugs among Persons Aged 26 or Older, by Past Month Substance Use Status: Standard Errors of Numbers in Thousands, 2016

3.28D – Perceived Availability of Selected Illicit Drugs among Persons Aged 26 or Older, by Past Month Substance Use Status: Standard Errors of Percentages, 2016

3.29C – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Parents' Feelings about Substance Use Behaviors: Standard Errors of Numbers in Thousands, 2016

3.29D – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Parents' Feelings about Substance Use Behaviors: Standard Errors of Percentages, 2016

3.30C – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Close Friends' Feelings and Youth's Feelings about Peers' Substance Use Behaviors: Standard Errors of Numbers in Thousands, 2016

3.30D – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Youth's Perceptions of Close Friends' Feelings and Youth's Feelings about Peers' Substance Use Behaviors: Standard Errors of Percentages, 2016

3.31C – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Youth's Participation in Prevention or Substance Use Programs and Exposure to Substance Use Prevention Messages and Youth's Delinquency in Past Year: Standard Errors of Numbers in Thousands, 2016

3.31D – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Youth's Participation in Prevention or Substance Use Programs and Exposure to Substance Use Prevention Messages and Youth's Delinquency in Past Year: Standard Errors of Percentages, 2016

3.32C – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Risk and Protective Factors, Religious Beliefs, and Past Year Parental Involvement: Standard Errors of Numbers in Thousands, 2016

3.32D – Past Month Use of Selected Substances among Persons Aged 12 to 17, by Measures of Risk and Protective Factors, Religious Beliefs, and Past Year Parental Involvement: Standard Errors of Percentages, 2016

3.33C – Past Month Use of Selected Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Measures of Scholastic Environment: Standard Errors of Numbers in Thousands, 2016

3.33D – Past Month Use of Selected Substances among Persons Aged 12 to 17 Who Were Enrolled in School in Past Year, by Measures of Scholastic Environment: Standard Errors of Percentages, 2016

Incidence Tables – 4.1 to 4.13 (Numbers in Thousands and Percentages)

4.1B – Past Year Initiation of Marijuana Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Marijuana Use, and Past Year Marijuana Users Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

4.2B – Past Year Initiation of Cigarette Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Cigarette Use, and Past Year Cigarette Users Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

4.3B – Past Year Initiation of Alcohol Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Alcohol Use, and Past Year Alcohol Users Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

4.4B – Past Year Initiation of Substance Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 12 or Older: Numbers in Thousands and Percentages, 2015 and 2016

4.5B – Past Year Initiation of Substance Use among Persons Aged 12 to 17, Persons Aged 12 to 17 at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 12 to 17: Numbers in Thousands and Percentages, 2015 and 2016

4.6B – Past Year Initiation of Substance Use among Persons Aged 18 or Older, Persons Aged 18 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 18 or Older: Numbers in Thousands and Percentages, 2015 and 2016

4.7B – Past Year Initiation of Substance Use among Persons Aged 18 to 25, Persons Aged 18 to 25 at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 18 to 25: Numbers in Thousands and Percentages, 2015 and 2016

4.8B – Past Year Initiation of Substance Use among Persons Aged 26 or Older, Persons Aged 26 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 26 or Older: Numbers in Thousands and Percentages, 2015 and 2016

4.9A – Past Year Initiation of Substance Use among Persons Aged 12 or Older, by Gender: Numbers in Thousands, 2015 and 2016

4.10A – Past Year Initiation of Substance Use among Persons Aged 12 or Older Who Initiated Use Prior to Age 18, by Gender: Numbers in Thousands, 2015 and 2016

4.11A – Past Year Initiation of Substance Use among Persons Aged 12 or Older Who Initiated Use Prior to Age 21, by Gender: Numbers in Thousands, 2015 and 2016

4.12A – Past Year Initiation of Substance Use among Persons Aged 12 to 49, by Gender: Numbers in Thousands, 2015 and 2016

4.13B – Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49, by Gender: 2015 and 2016

Incidence Tables – 4.1 to 4.13 (Standard Errors and P Values)

4.1D – Past Year Initiation of Marijuana Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Marijuana Use, and Past Year Marijuana Users Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.1P – Past Year Initiation of Marijuana Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Marijuana Use, and Past Year Marijuana Users Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.2D – Past Year Initiation of Cigarette Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Cigarette Use, and Past Year Cigarette Users Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.2P – Past Year Initiation of Cigarette Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Cigarette Use, and Past Year Cigarette Users Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.3D – Past Year Initiation of Alcohol Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Alcohol Use, and Past Year Alcohol Users Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.3P – Past Year Initiation of Alcohol Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Alcohol Use, and Past Year Alcohol Users Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.4D – Past Year Initiation of Substance Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 12 or Older: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.4P – Past Year Initiation of Substance Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.5D – Past Year Initiation of Substance Use among Persons Aged 12 to 17, Persons Aged 12 to 17 at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 12 to 17: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.5P – Past Year Initiation of Substance Use among Persons Aged 12 to 17, Persons Aged 12 to 17 at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.6D – Past Year Initiation of Substance Use among Persons Aged 18 or Older, Persons Aged 18 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 18 or Older: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.6P – Past Year Initiation of Substance Use among Persons Aged 18 or Older, Persons Aged 18 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.7D – Past Year Initiation of Substance Use among Persons Aged 18 to 25, Persons Aged 18 to 25 at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 18 to 25: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.7P – Past Year Initiation of Substance Use among Persons Aged 18 to 25, Persons Aged 18 to 25 at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.8D – Past Year Initiation of Substance Use among Persons Aged 26 or Older, Persons Aged 26 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 26 or Older: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

4.8P – Past Year Initiation of Substance Use among Persons Aged 26 or Older, Persons Aged 26 or Older at Risk for Initiation of Substance Use, and Past Year Substance Users Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

4.9C – Past Year Initiation of Substance Use among Persons Aged 12 or Older, by Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

4.10C – Past Year Initiation of Substance Use among Persons Aged 12 or Older Who Initiated Use Prior to Age 18, by Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

4.11C – Past Year Initiation of Substance Use among Persons Aged 12 or Older Who Initiated Use Prior to Age 21, by Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

4.12C – Past Year Initiation of Substance Use among Persons Aged 12 to 49, by Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

4.13D – Standard Errors of Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49, by Gender: 2015 and 2016

4.13P – P Values from Tests of Differences of Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49, by Gender: 2016 Versus 2015

Substance Use Disorder and Treatment Tables – 5.1 to 5.54 (Numbers in Thousands and Percentages)

5.1A – Substance Use Disorder Status in Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2015 and 2016

5.1B – Substance Use Disorder Status in Past Year among Persons Aged 12 or Older: Percentages, 2015 and 2016

5.2A – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

5.2B – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

5.3A – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

5.3B – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

5.4A – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.4B – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.5A – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.5B – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.6A – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.6B – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.7A – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

5.7B – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

5.8A – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

5.8B – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

5.9A – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

5.9B – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

5.10A – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

5.10B – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

5.11A – Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.11B – Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.12A – Received Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.12B – Received Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.13A – Received Both Illicit Drug and Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.13B – Received Both Illicit Drug and Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.14A – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.14B – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

5.15A – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

5.15B – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

5.16A – Type of Substance Use Treatment Received at Any Location in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.16B – Type of Substance Use Treatment Received at Any Location in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use in Past Year, by Age Group: Percentages, 2015 and 2016

5.17A – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.17B – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.18A – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.18B – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.19A – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.19B – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.20A – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.20B – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.21A – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016

5.21B – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

5.22A – Received Illicit Drug Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.22B – Received Illicit Drug Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.23A – Received Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.23B – Received Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.24A – Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.24B – Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.25A – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.25B – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.26A – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

5.26B – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

5.27A – Type of Substance Use Treatment Received at a Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.27B – Type of Substance Use Treatment Received at a Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.28A – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.28B – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.29A – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.29B – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.30A – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.30B – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.31A – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.31B – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.32A – Source of Payment for Last or Current Illicit Drug Treatment among Persons Aged 12 or Older Who Received Their Last or Current Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.32B – Source of Payment for Last or Current Illicit Drug Treatment among Persons Aged 12 or Older Who Received Their Last or Current Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.33A – Source of Payment for Last or Current Alcohol Treatment among Persons Aged 12 or Older Who Received Their Last or Current Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.33B – Source of Payment for Last or Current Alcohol Treatment among Persons Aged 12 or Older Who Received Their Last or Current Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.34A – Source of Payment for Last or Current Substance Use Treatment among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.34B – Source of Payment for Last or Current Substance Use Treatment among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Percentages, 2015 and 2016

5.35A – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder of Specific Substances: Numbers in Thousands, 2015 and 2016

5.35B – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder of Specific Substances: Percentages, 2015 and 2016

5.36A – Type of Substance Use Treatment Received at Any Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

5.36B – Type of Substance Use Treatment Received at Any Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

5.37A – Receipt of Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility and Type of Substance Use Treatment Received in Past Year among Persons Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

5.37B – Receipt of Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility and Type of Substance Use Treatment Received in Past Year among Persons Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

5.38A – Received Illicit Drug Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.38B – Received Illicit Drug Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.39A – Received Alcohol Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.39B – Received Alcohol Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.40A – Received Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

5.40B – Received Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Percentages, 2015 and 2016

5.41A – Type of Substance Use Treatment Received at Any Treatment Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder Status: Numbers in Thousands, 2015 and 2016

5.41B – Type of Substance Use Treatment Received at Any Treatment Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder Status: Percentages, 2015 and 2016

5.42A – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands and Percentages, 2015 and 2016

5.42B – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

5.43A – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.43B – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.44A – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.44B – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.45A – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.45B – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

5.46A – Perceived Need for Illicit Drug Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug Problem, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.46B – Perceived Need for Illicit Drug Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug Problem, by Demographic Characteristics: Percentages, 2015 and 2016

5.47A – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.47B – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.48A – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.48B – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.49A – Perceived Need for Alcohol Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Alcohol Problem, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.49B – Perceived Need for Alcohol Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Alcohol Problem, by Demographic Characteristics: Percentages, 2015 and 2016

5.50A – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.50B – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.51A – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages, 2015 and 2016

5.51B – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

5.52A – Perceived Need for Substance Use Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for a Substance Use Problem, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

5.52B – Perceived Need for Substance Use Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for a Substance Use Problem, by Demographic Characteristics: Percentages, 2015 and 2016

5.53A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Numbers in Thousands, 2016

5.53B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Percentages, 2016

5.54A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 18 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Numbers in Thousands, 2016

5.54B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 18 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Percentages, 2016

Substance Use Disorder and Treatment Tables – 5.1 to 5.54 (Standard Errors and P Values)

5.1C – Substance Use Disorder Status in Past Year among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016

5.1D – Substance Use Disorder Status in Past Year among Persons Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016

5.1P – Substance Use Disorder Status in Past Year among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.2C – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.2D – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.2P – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.3C – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

5.3D – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

5.3P – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.4C – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.4D – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.4P – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.5C – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.5D – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.5P – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.6C – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.6D – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.6P – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.7C – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.7D – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.7P – Illicit Drug Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.8C – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.8D – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.8P – Alcohol Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.9C – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.9D – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.9P – Substance Use Disorder in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.10C – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

5.10D – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

5.10P – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.11C – Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.11D – Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.11P – Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.12C – Received Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.12D – Received Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.12P – Received Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.13C – Received Both Illicit Drug and Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.13D – Received Both Illicit Drug and Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.13P – Received Both Illicit Drug and Alcohol Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.14C – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.14D – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.14P – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.15C – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.15D – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.15P – Received Substance Use Treatment in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.16C – Type of Substance Use Treatment Received at Any Location in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.16D – Type of Substance Use Treatment Received at Any Location in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.16P – Type of Substance Use Treatment Received at Any Location in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.17C – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.17D – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.17P – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.18C – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.18D – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.18P – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.19C – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.19D – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.19P – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.20C – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.20D – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.20P – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.21C – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

5.21D – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

5.21P – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.22C – Received Illicit Drug Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.22D – Received Illicit Drug Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.22P – Received Illicit Drug Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.23C – Received Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.23D – Received Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.23P – Received Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.24C – Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.24D – Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.24P – Received Both Illicit Drug and Alcohol Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.25C – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.25D – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.25P – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.26C – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.26D – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.26P – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.27C – Type of Substance Use Treatment Received at a Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.27D – Type of Substance Use Treatment Received at a Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.27P – Type of Substance Use Treatment Received at a Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Treatment for Substance Use at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.28C – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.28D – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.28P – Substances for Which Last or Current Treatment Was Received among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.29C – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.29D – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.29P – Locations Received Illicit Drug Treatment in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.30C – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.30D – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.30P – Locations Received Alcohol Treatment in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.31C – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.31D – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.31P – Locations Received Substance Use Treatment in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.32C – Source of Payment for Last or Current Illicit Drug Treatment among Persons Aged 12 or Older Who Received Their Last or Current Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.32D – Source of Payment for Last or Current Illicit Drug Treatment among Persons Aged 12 or Older Who Received Their Last or Current Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.32P – Source of Payment for Last or Current Illicit Drug Treatment among Persons Aged 12 or Older Who Received Their Last or Current Illicit Drug Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.33C – Source of Payment for Last or Current Alcohol Treatment among Persons Aged 12 or Older Who Received Their Last or Current Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.33D – Source of Payment for Last or Current Alcohol Treatment among Persons Aged 12 or Older Who Received Their Last or Current Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.33P – Source of Payment for Last or Current Alcohol Treatment among Persons Aged 12 or Older Who Received Their Last or Current Alcohol Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.34C – Source of Payment for Last or Current Substance Use Treatment among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.34D – Source of Payment for Last or Current Substance Use Treatment among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.34P – Source of Payment for Last or Current Substance Use Treatment among Persons Aged 12 or Older Who Received Their Last or Current Substance Use Treatment at a Specialty Facility in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.35C – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder of Specific Substances: Standard Errors of Numbers in Thousands, 2015 and 2016

5.35D – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder of Specific Substances: Standard Errors of Percentages, 2015 and 2016

5.35P – Received Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder of Specific Substances: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.36C – Type of Substance Use Treatment Received at Any Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.36D – Type of Substance Use Treatment Received at Any Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.36P – Type of Substance Use Treatment Received at Any Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.37C – Receipt of Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility and Type of Substance Use Treatment Received in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.37D – Receipt of Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility and Type of Substance Use Treatment Received in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.37P – Receipt of Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility and Type of Substance Use Treatment Received in Past Year among Persons Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.38C – Received Illicit Drug Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.38D – Received Illicit Drug Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.38P – Received Illicit Drug Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Illicit Drug Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.39C – Received Alcohol Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.39D – Received Alcohol Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.39P – Received Alcohol Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Alcohol Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.40C – Received Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

5.40D – Received Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

5.40P – Received Substance Use Treatment at a Specialty Facility and/or a Non-Specialty Facility in Past Year among Persons Aged 12 or Older Who Received Substance Use Treatment in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.41C – Type of Substance Use Treatment Received at Any Treatment Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder Status: Standard Errors of Numbers in Thousands, 2015 and 2016

5.41D – Type of Substance Use Treatment Received at Any Treatment Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder Status: Standard Errors of Percentages, 2015 and 2016

5.41P – Type of Substance Use Treatment Received at Any Treatment Location or at a Specialty Facility in Past Year among Persons Aged 12 or Older, by Past Year Substance Use Disorder Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.42C – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.42D – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

5.42P – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.43C – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.43D – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.43P – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.44C – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.44D – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.44P – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.45C – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.45D – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.45P – Need for and Receipt of Treatment at a Specialty Facility for an Illicit Drug Problem in Past Year among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.46C – Perceived Need for Illicit Drug Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug Problem, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.46D – Perceived Need for Illicit Drug Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug Problem, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.46P – Perceived Need for Illicit Drug Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug Problem, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.47C – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.47D – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.47P – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.48C – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.48D – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.48P – Need for and Receipt of Treatment at a Specialty Facility for an Alcohol Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.49C – Perceived Need for Alcohol Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Alcohol Problem, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.49D – Perceived Need for Alcohol Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Alcohol Problem, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.49P – Perceived Need for Alcohol Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Alcohol Problem, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.50C – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.50D – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.50P – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.51C – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

5.51D – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.51P – Need for and Receipt of Treatment at a Specialty Facility for a Substance Use Problem in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.52C – Perceived Need for Substance Use Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for a Substance Use Problem, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

5.52D – Perceived Need for Substance Use Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for a Substance Use Problem, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

5.52P – Perceived Need for Substance Use Treatment and Whether Made an Effort to Get Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for a Substance Use Problem, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

5.53C – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Standard Errors of Numbers in Thousands, 2016

5.53D – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Standard Errors of Percentages, 2016

5.54C – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 18 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Standard Errors of Numbers in Thousands, 2016

5.54D – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year among Persons Aged 18 or Older Classified as Needing But Not Receiving Substance Use Treatment at a Specialty Facility and Who Felt a Need for Substance Use Treatment in Past Year: Standard Errors of Percentages, 2016

Miscellaneous Tables – 6.1 to 6.90 (Numbers in Thousands and Percentages)

6.1A – Number of Days Used Marijuana in Past Year among Past Year Users and Number of Days Used Marijuana in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.1B – Number of Days Used Marijuana in Past Year among Past Year Users and Number of Days Used Marijuana in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.2A – Number of Days Used Cocaine in Past Year among Past Year Users and Number of Days Used Cocaine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.2B – Number of Days Used Cocaine in Past Year among Past Year Users and Number of Days Used Cocaine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.3A – Number of Days Used Hallucinogens in Past Year among Past Year Users and Number of Days Used Hallucinogens in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.3B – Number of Days Used Hallucinogens in Past Year among Past Year Users and Number of Days Used Hallucinogens in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.4A – Number of Days Used Inhalants in Past Year among Past Year Users and Number of Days Used Inhalants in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.4B – Number of Days Used Inhalants in Past Year among Past Year Users and Number of Days Used Inhalants in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.5A – Number of Days Used Methamphetamine in Past Year among Past Year Users and Number of Days Used Methamphetamine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.5B – Number of Days Used Methamphetamine in Past Year among Past Year Users and Number of Days Used Methamphetamine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.6A – Number of Days Misused Prescription Psychotherapeutics in Past Month among Past Month Misusers Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.6B – Number of Days Misused Prescription Psychotherapeutics in Past Month among Past Month Misusers Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.7A – Number of Days Used Cigarettes in Past Month among Past Month Users and Number of Cigarettes Smoked Per Day among Daily Smokers Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.7B – Number of Days Used Cigarettes in Past Month among Past Month Users and Number of Cigarettes Smoked Per Day among Daily Smokers Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.8A – Number of Days Used Alcohol in Past Year among Past Year Users and Number of Days Used Alcohol in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2015 and 2016

6.8B – Number of Days Used Alcohol in Past Year among Past Year Users and Number of Days Used Alcohol in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2015 and 2016

6.9A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Numbers in Thousands, 2015 and 2016

6.9B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Percentages, 2015 and 2016

6.10A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Numbers in Thousands, 2015 and 2016

6.10B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Percentages, 2015 and 2016

6.11A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Numbers in Thousands, 2015 and 2016

6.11B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Percentages, 2015 and 2016

6.12A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Numbers in Thousands, 2015 and 2016

6.12B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Percentages, 2015 and 2016

6.13A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Numbers in Thousands, 2015 and 2016

6.13B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Percentages, 2015 and 2016

6.14A – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.14B – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.15A – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.15B – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.16A – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.16B – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.17A – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.17B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.18A – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.18B – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.19A – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.19B – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.20A – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.20B – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.21A – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.21B – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.22A – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.22B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.23A – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.23B – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.24A – Types of Illicit Drug Use in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Numbers in Thousands, 2015 and 2016

6.24B – Types of Illicit Drug Use in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Percentages, 2015 and 2016

6.25A – Drugs Used with Alcohol or within 2 Hours of Alcohol Use on Most Recent Use of Alcohol in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Numbers in Thousands, 2015 and 2016

6.25B – Drugs Used with Alcohol or within 2 Hours of Alcohol Use on Most Recent Use of Alcohol in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Percentages, 2015 and 2016

6.26A – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette and Alcohol Use: Numbers in Thousands, 2015 and 2016

6.26B – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette and Alcohol Use: Percentages, 2015 and 2016

6.27A – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette and Alcohol Use: Numbers in Thousands, 2015 and 2016

6.27B – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette and Alcohol Use: Percentages, 2015 and 2016

6.28A – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette and Alcohol Use: Numbers in Thousands, 2015 and 2016

6.28B – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette and Alcohol Use: Percentages, 2015 and 2016

6.29A – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette and Alcohol Use: Numbers in Thousands, 2015 and 2016

6.29B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette and Alcohol Use: Percentages, 2015 and 2016

6.30A – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette and Alcohol Use: Numbers in Thousands, 2015 and 2016

6.30B – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette and Alcohol Use: Percentages, 2015 and 2016

6.31A – Illicit Drug Use in Past Month, by Past Month Cigarette Use, Levels of Past Month Alcohol Use, and Age Group: Numbers in Thousands, 2015 and 2016

6.31B – Illicit Drug Use in Past Month, by Past Month Cigarette Use, Levels of Past Month Alcohol Use, and Age Group: Percentages, 2015 and 2016

6.32A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.32B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.33A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.33B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.34A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.34B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.35A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.35B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.36A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Numbers in Thousands, 2015 and 2016

6.36B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Percentages, 2015 and 2016

6.37A – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.37B – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.38A – Tobacco Product Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.38B – Tobacco Product Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.39A – Tobacco Product Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.39B – Tobacco Product Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.40A – Tobacco Product Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.40B – Tobacco Product Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.41A – Tobacco Product Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Numbers in Thousands, 2015 and 2016

6.41B – Tobacco Product Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Percentages, 2015 and 2016

6.42A – Illicit Drug or Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.42B – Illicit Drug or Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

6.43A – Opioid Use Disorder Status in Past Year among Persons Aged 12 or Older, by Age Group and Past Year Opioid Misuse Characteristics: Numbers in Thousands, 2015 and 2016

6.43B – Opioid Use Disorder Status in Past Year among Persons Aged 12 or Older, by Age Group and Past Year Opioid Misuse Characteristics: Percentages, 2015 and 2016

6.44A – Opioid Misuse Characteristics in Past Year among Past Year Opioid Misusers Aged 12 or Older and Opioid Disorder Characteristics in Past Year among Persons Aged 12 or Older with Past Year Opioid Use Disorder, by Age Group: Numbers in Thousands, 2015 and 2016

6.44B – Opioid Misuse Characteristics in Past Year among Past Year Opioid Misusers Aged 12 or Older and Opioid Disorder Characteristics in Past Year among Persons Aged 12 or Older with Past Year Opioid Use Disorder, by Age Group: Percentages, 2015 and 2016

6.45A – Marijuana Use in Prior Year and Past Year Marijuana Use Status among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.45B – Marijuana Use in Prior Year and Past Year Marijuana Use Status among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

6.46A – Cigarette Use and Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands and Percentages, 2015 and 2016

6.46B – Cigarette Use and Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016

6.47A – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.47B – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

6.48A – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

6.48B – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

6.49A – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.49B – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes and Demographic Characteristics: Percentages, 2015 and 2016

6.50A – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes Daily and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.50B – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes Daily and Demographic Characteristics: Percentages, 2015 and 2016

6.51A – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Marijuana and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.51B – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Marijuana and Demographic Characteristics: Percentages, 2015 and 2016

6.52A – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Alcohol and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.52B – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Alcohol and Demographic Characteristics: Percentages, 2015 and 2016

6.53A – Source Where Pain Relievers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

6.53B – Source Where Pain Relievers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

6.54A – Source Where Friend or Relative Obtained Pain Relievers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Pain Relievers from a Friend or Relative for Free in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

6.54B – Source Where Friend or Relative Obtained Pain Relievers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Pain Relievers from a Friend or Relative for Free in Past Year, by Age Group: Percentages, 2015 and 2016

6.55A – Source Where Tranquilizers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

6.55B – Source Where Tranquilizers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

6.56A – Source Where Friend or Relative Obtained Tranquilizers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Tranquilizers from a Friend or Relative for Free in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

6.56B – Source Where Friend or Relative Obtained Tranquilizers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Tranquilizers from a Friend or Relative for Free in Past Year, by Age Group: Percentages, 2015 and 2016

6.57A – Source Where Stimulants Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

6.57B – Source Where Stimulants Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

6.58A – Source Where Friend or Relative Obtained Stimulants among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Stimulants from a Friend or Relative for Free in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

6.58B – Source Where Friend or Relative Obtained Stimulants among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Stimulants from a Friend or Relative for Free in Past Year, by Age Group: Percentages, 2015 and 2016

6.59A – Source Where Sedatives Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016

6.59B – Source Where Sedatives Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Percentages, 2015 and 2016

6.60A – Source Where Friend or Relative Obtained Sedatives among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Sedatives from a Friend or Relative for Free in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

6.60B – Source Where Friend or Relative Obtained Sedatives among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Sedatives from a Friend or Relative for Free in Past Year, by Age Group: Percentages, 2015 and 2016

6.61A – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 12 or Older of Each Type of Prescription Psychotherapeutic: Numbers in Thousands, 2015 and 2016

6.61B – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 12 or Older of Each Type of Prescription Psychotherapeutic: Percentages, 2015 and 2016

6.62A – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 18 or Older of Each Type of Prescription Psychotherapeutic: Numbers in Thousands, 2015 and 2016

6.62B – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 18 or Older of Each Type of Prescription Psychotherapeutic: Percentages, 2015 and 2016

6.63A – Social Context and Location of Most Recent Alcohol Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Numbers in Thousands, 2015 and 2016

6.63B – Social Context and Location of Most Recent Alcohol Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Percentages, 2015 and 2016

6.64A – Source Where Alcohol Was Obtained for Most Recent Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Numbers in Thousands, 2015 and 2016

6.64B – Source Where Alcohol Was Obtained for Most Recent Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Percentages, 2015 and 2016

6.65A – Types of Illicit Drug Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Numbers in Thousands, 2015 and 2016

6.65B – Types of Illicit Drug Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Percentages, 2015 and 2016

6.66A – Illicit Drug Use, Marijuana Use, and Opioid Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Numbers in Thousands, 2015 and 2016

6.66B – Illicit Drug Use, Marijuana Use, and Opioid Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Percentages, 2015 and 2016

6.67A – Cigarette Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Numbers in Thousands, 2015 and 2016

6.67B – Cigarette Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Percentages, 2015 and 2016

6.68A – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Numbers in Thousands, 2015 and 2016

6.68B – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Percentages, 2015 and 2016

6.69A – Illicit Drug, Tobacco Product, and Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Numbers in Thousands, 2015 and 2016

6.69B – Illicit Drug, Tobacco Product, and Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Percentages, 2015 and 2016

6.70A – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status: Numbers in Thousands, 2015 and 2016

6.70B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status: Percentages, 2015 and 2016

6.71A – Types of Illicit Drug Use in Past Month among Males Aged 18 to 22, by College Enrollment Status: Numbers in Thousands, 2015 and 2016

6.71B – Types of Illicit Drug Use in Past Month among Males Aged 18 to 22, by College Enrollment Status: Percentages, 2015 and 2016

6.72A – Types of Illicit Drug Use in Past Month among Females Aged 18 to 22, by College Enrollment Status: Numbers in Thousands, 2015 and 2016

6.72B – Types of Illicit Drug Use in Past Month among Females Aged 18 to 22, by College Enrollment Status: Percentages, 2015 and 2016

6.73A – Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.73B – Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.74A – Marijuana Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.74B – Marijuana Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.75A – Opioid Misuse in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.75B – Opioid Misuse in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.76A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Gender: Numbers in Thousands, 2015 and 2016

6.76B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Gender: Percentages, 2015 and 2016

6.77A – Cigarette Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.77B – Cigarette Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.78A – Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.78B – Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.79A – Binge Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.79B – Binge Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.80A – Heavy Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.80B – Heavy Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.81A – Illicit Drug Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.81B – Illicit Drug Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.82A – Alcohol Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.82B – Alcohol Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.83A – Substance Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.83B – Substance Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Percentages, 2015 and 2016

6.84A – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.84B – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

6.85A – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

6.85B – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

6.86A – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses: Numbers in Thousands, 2015 and 2016

6.86B – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses: Percentages, 2015 and 2016

6.87A – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 49, by Past Year Probation and Parole/Supervised Release Statuses: Numbers in Thousands, 2015 and 2016

6.87B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 49, by Past Year Probation and Parole/Supervised Release Statuses: Percentages, 2015 and 2016

6.88A – Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.88B – Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Percentages, 2015 and 2016

6.89A – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.89B – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Percentages, 2015 and 2016

6.90A – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

6.90B – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Percentages, 2015 and 2016

Miscellaneous Tables – 6.1 to 6.90 (Standard Errors and P Values)

6.1C – Number of Days Used Marijuana in Past Year among Past Year Users and Number of Days Used Marijuana in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.1D – Number of Days Used Marijuana in Past Year among Past Year Users and Number of Days Used Marijuana in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.1P – Number of Days Used Marijuana in Past Year among Past Year Users and Number of Days Used Marijuana in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.2C – Number of Days Used Cocaine in Past Year among Past Year Users and Number of Days Used Cocaine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.2D – Number of Days Used Cocaine in Past Year among Past Year Users and Number of Days Used Cocaine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.2P – Number of Days Used Cocaine in Past Year among Past Year Users and Number of Days Used Cocaine in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.3C – Number of Days Used Hallucinogens in Past Year among Past Year Users and Number of Days Used Hallucinogens in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.3D – Number of Days Used Hallucinogens in Past Year among Past Year Users and Number of Days Used Hallucinogens in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.3P – Number of Days Used Hallucinogens in Past Year among Past Year Users and Number of Days Used Hallucinogens in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.4C – Number of Days Used Inhalants in Past Year among Past Year Users and Number of Days Used Inhalants in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.4D – Number of Days Used Inhalants in Past Year among Past Year Users and Number of Days Used Inhalants in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.4P – Number of Days Used Inhalants in Past Year among Past Year Users and Number of Days Used Inhalants in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.5C – Number of Days Used Methamphetamine in Past Year among Past Year Users and Number of Days Used Methamphetamine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.5D – Number of Days Used Methamphetamine in Past Year among Past Year Users and Number of Days Used Methamphetamine in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.5P – Number of Days Used Methamphetamine in Past Year among Past Year Users and Number of Days Used Methamphetamine in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.6C – Number of Days Misused Prescription Psychotherapeutics in Past Month among Past Month Misusers Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.6D – Number of Days Misused Prescription Psychotherapeutics in Past Month among Past Month Misusers Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.6P – Number of Days Misused Prescription Psychotherapeutics in Past Month among Past Month Misusers Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.7C – Number of Days Used Cigarettes in Past Month among Past Month Users and Number of Cigarettes Smoked Per Day among Daily Smokers Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.7D – Number of Days Used Cigarettes in Past Month among Past Month Users and Number of Cigarettes Smoked Per Day among Daily Smokers Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.7P – Number of Days Used Cigarettes in Past Month among Past Month Users and Number of Cigarettes Smoked Per Day among Daily Smokers Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.8C – Number of Days Used Alcohol in Past Year among Past Year Users and Number of Days Used Alcohol in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2015 and 2016

6.8D – Number of Days Used Alcohol in Past Year among Past Year Users and Number of Days Used Alcohol in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2015 and 2016

6.8P – Number of Days Used Alcohol in Past Year among Past Year Users and Number of Days Used Alcohol in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2015

6.9C – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

6.9D – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Percentages, 2015 and 2016

6.9P – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.10C – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

6.10D – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Percentages, 2015 and 2016

6.10P – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.11C – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

6.11D – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Percentages, 2015 and 2016

6.11P – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.12C – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

6.12D – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Percentages, 2015 and 2016

6.12P – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.13C – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

6.13D – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: Standard Errors of Percentages, 2015 and 2016

6.13P – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Substance Use Other Than Prescription Psychotherapeutic Use in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.14C – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.14D – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.14P – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.15C – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.15D – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.15P – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.16C – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.16D – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.16P – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.17C – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.17D – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.17P – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.18C – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.18D – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.18P – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.19C – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.19D – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.19P – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.20C – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.20D – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.20P – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.21C – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.21D – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.21P – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.22C – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.22D – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.22P – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.23C – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.23D – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.23P – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.24C – Types of Illicit Drug Use in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.24D – Types of Illicit Drug Use in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Standard Errors of Percentages, 2015 and 2016

6.24P – Types of Illicit Drug Use in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.25C – Drugs Used with Alcohol or within 2 Hours of Alcohol Use on Most Recent Use of Alcohol in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.25D – Drugs Used with Alcohol or within 2 Hours of Alcohol Use on Most Recent Use of Alcohol in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: Standard Errors of Percentages, 2015 and 2016

6.25P – Drugs Used with Alcohol or within 2 Hours of Alcohol Use on Most Recent Use of Alcohol in Past Month among Past Month Alcohol Users Aged 12 or Older, by Age Group and Underage and Legal Drinking Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.26C – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette and Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.26D – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette and Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.26P – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette and Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.27C – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette and Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.27D – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette and Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.27P – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette and Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.28C – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette and Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.28D – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette and Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.28P – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette and Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.29C – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette and Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.29D – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette and Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.29P – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette and Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.30C – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette and Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.30D – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette and Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.30P – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette and Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.31C – Illicit Drug Use in Past Month, by Past Month Cigarette Use, Levels of Past Month Alcohol Use, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.31D – Illicit Drug Use in Past Month, by Past Month Cigarette Use, Levels of Past Month Alcohol Use, and Age Group: Standard Errors of Percentages, 2015 and 2016

6.31P – Illicit Drug Use in Past Month, by Past Month Cigarette Use, Levels of Past Month Alcohol Use, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.32C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.32D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.32P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.33C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.33D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.33P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.34C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.34D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.34P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.35C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.35D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.35P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.36C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.36D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: Standard Errors of Percentages, 2015 and 2016

6.36P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Past Month Cigarette Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.37C – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.37D – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.37P – Tobacco Product Use in Past Month among Persons Aged 12 or Older, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.38C – Tobacco Product Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.38D – Tobacco Product Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.38P – Tobacco Product Use in Past Month among Persons Aged 12 to 17, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.39C – Tobacco Product Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.39D – Tobacco Product Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.39P – Tobacco Product Use in Past Month among Persons Aged 18 or Older, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.40C – Tobacco Product Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.40D – Tobacco Product Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.40P – Tobacco Product Use in Past Month among Persons Aged 18 to 25, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.41C – Tobacco Product Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Numbers in Thousands, 2015 and 2016

6.41D – Tobacco Product Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: Standard Errors of Percentages, 2015 and 2016

6.41P – Tobacco Product Use in Past Month among Persons Aged 26 or Older, by Levels of Past Month Alcohol Use: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.42C – Illicit Drug or Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.42D – Illicit Drug or Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.42P – Illicit Drug or Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.43C – Opioid Use Disorder Status in Past Year among Persons Aged 12 or Older, by Age Group and Past Year Opioid Misuse Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.43D – Opioid Use Disorder Status in Past Year among Persons Aged 12 or Older, by Age Group and Past Year Opioid Misuse Characteristics: Standard Errors of Percentages, 2015 and 2016

6.43P – Opioid Use Disorder Status in Past Year among Persons Aged 12 or Older, by Age Group and Past Year Opioid Misuse Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.44C – Opioid Misuse Characteristics in Past Year among Past Year Opioid Misusers Aged 12 or Older and Opioid Disorder Characteristics in Past Year among Persons Aged 12 or Older with Past Year Opioid Use Disorder, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.44D – Opioid Misuse Characteristics in Past Year among Past Year Opioid Misusers Aged 12 or Older and Opioid Disorder Characteristics in Past Year among Persons Aged 12 or Older with Past Year Opioid Use Disorder, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.44P – Opioid Misuse Characteristics in Past Year among Past Year Opioid Misusers Aged 12 or Older and Opioid Disorder Characteristics in Past Year among Persons Aged 12 or Older with Past Year Opioid Use Disorder, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.45C – Marijuana Use in Prior Year and Past Year Marijuana Use Status among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.45D – Marijuana Use in Prior Year and Past Year Marijuana Use Status among Persons Aged 12 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.45P – Marijuana Use in Prior Year and Past Year Marijuana Use Status among Persons Aged 12 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.46C – Cigarette Use and Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands and Standard Errors of Percentages, 2015 and 2016

6.46D – Cigarette Use and Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

6.46P – Cigarette Use and Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.47C – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.47D – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.47P – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.48C – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.48D – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.48P – Nicotine (Cigarette) Dependence in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.49C – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.49D – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.49P – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.50C – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes Daily and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.50D – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes Daily and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.50P – Nicotine (Cigarette) Dependence in Past Month among Past Month Cigarette Smokers Aged 18 or Older, by Age First Used Cigarettes Daily and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.51C – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Marijuana and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.51D – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Marijuana and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.51P – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Marijuana and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.52C – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Alcohol and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.52D – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Alcohol and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.52P – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Age First Used Alcohol and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.53C – Source Where Pain Relievers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.53D – Source Where Pain Relievers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.53P – Source Where Pain Relievers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.54C – Source Where Friend or Relative Obtained Pain Relievers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Pain Relievers from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.54D – Source Where Friend or Relative Obtained Pain Relievers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Pain Relievers from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.54P – Source Where Friend or Relative Obtained Pain Relievers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Pain Relievers from a Friend or Relative for Free in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.55C – Source Where Tranquilizers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.55D – Source Where Tranquilizers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.55P – Source Where Tranquilizers Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.56C – Source Where Friend or Relative Obtained Tranquilizers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Tranquilizers from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.56D – Source Where Friend or Relative Obtained Tranquilizers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Tranquilizers from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.56P – Source Where Friend or Relative Obtained Tranquilizers among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Tranquilizers from a Friend or Relative for Free in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.57C – Source Where Stimulants Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.57D – Source Where Stimulants Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.57P – Source Where Stimulants Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.58C – Source Where Friend or Relative Obtained Stimulants among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Stimulants from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.58D – Source Where Friend or Relative Obtained Stimulants among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Stimulants from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.58P – Source Where Friend or Relative Obtained Stimulants among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Stimulants from a Friend or Relative for Free in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.59C – Source Where Sedatives Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.59D – Source Where Sedatives Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.59P – Source Where Sedatives Were Obtained for Most Recent Misuse among Past Year Misusers Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.60C – Source Where Friend or Relative Obtained Sedatives among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Sedatives from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

6.60D – Source Where Friend or Relative Obtained Sedatives among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Sedatives from a Friend or Relative for Free in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

6.60P – Source Where Friend or Relative Obtained Sedatives among Past Year Misusers Aged 12 or Older Who Obtained Most Recently Misused Sedatives from a Friend or Relative for Free in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.61C – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 12 or Older of Each Type of Prescription Psychotherapeutic: Standard Errors of Numbers in Thousands, 2015 and 2016

6.61D – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 12 or Older of Each Type of Prescription Psychotherapeutic: Standard Errors of Percentages, 2015 and 2016

6.61P – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 12 or Older of Each Type of Prescription Psychotherapeutic: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.62C – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 18 or Older of Each Type of Prescription Psychotherapeutic: Standard Errors of Numbers in Thousands, 2015 and 2016

6.62D – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 18 or Older of Each Type of Prescription Psychotherapeutic: Standard Errors of Percentages, 2015 and 2016

6.62P – Main Reasons for Last Episode of Misuse of Prescription Psychotherapeutics among Past Year Misusers Aged 18 or Older of Each Type of Prescription Psychotherapeutic: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.63C – Social Context and Location of Most Recent Alcohol Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

6.63D – Social Context and Location of Most Recent Alcohol Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Standard Errors of Percentages, 2015 and 2016

6.63P – Social Context and Location of Most Recent Alcohol Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.64C – Source Where Alcohol Was Obtained for Most Recent Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

6.64D – Source Where Alcohol Was Obtained for Most Recent Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: Standard Errors of Percentages, 2015 and 2016

6.64P – Source Where Alcohol Was Obtained for Most Recent Use in Past Month among Past Month Alcohol Users Aged 12 to 20, by Age Group and Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.65C – Types of Illicit Drug Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Standard Errors of Numbers in Thousands, 2015 and 2016

6.65D – Types of Illicit Drug Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Standard Errors of Percentages, 2015 and 2016

6.65P – Types of Illicit Drug Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.66C – Illicit Drug Use, Marijuana Use, and Opioid Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.66D – Illicit Drug Use, Marijuana Use, and Opioid Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Standard Errors of Percentages, 2015 and 2016

6.66P – Illicit Drug Use, Marijuana Use, and Opioid Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.67C – Cigarette Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.67D – Cigarette Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Standard Errors of Percentages, 2015 and 2016

6.67P – Cigarette Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.68C – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.68D – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: Standard Errors of Percentages, 2015 and 2016

6.68P – Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.69C – Illicit Drug, Tobacco Product, and Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Standard Errors of Numbers in Thousands, 2015 and 2016

6.69D – Illicit Drug, Tobacco Product, and Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: Standard Errors of Percentages, 2015 and 2016

6.69P – Illicit Drug, Tobacco Product, and Alcohol Use in Past Month among Females Aged 15 to 44, by Pregnancy Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.70C – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status: Standard Errors of Numbers in Thousands, 2015 and 2016

6.70D – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status: Standard Errors of Percentages, 2015 and 2016

6.70P – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.71C – Types of Illicit Drug Use in Past Month among Males Aged 18 to 22, by College Enrollment Status: Standard Errors of Numbers in Thousands, 2015 and 2016

6.71D – Types of Illicit Drug Use in Past Month among Males Aged 18 to 22, by College Enrollment Status: Standard Errors of Percentages, 2015 and 2016

6.71P – Types of Illicit Drug Use in Past Month among Males Aged 18 to 22, by College Enrollment Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.72C – Types of Illicit Drug Use in Past Month among Females Aged 18 to 22, by College Enrollment Status: Standard Errors of Numbers in Thousands, 2015 and 2016

6.72D – Types of Illicit Drug Use in Past Month among Females Aged 18 to 22, by College Enrollment Status: Standard Errors of Percentages, 2015 and 2016

6.72P – Types of Illicit Drug Use in Past Month among Females Aged 18 to 22, by College Enrollment Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.73C – Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.73D – Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.73P – Illicit Drug Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.74C – Marijuana Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.74D – Marijuana Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.74P – Marijuana Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.75C – Opioid Misuse in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.75D – Opioid Misuse in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.75P – Opioid Misuse in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.76C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

6.76D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Gender: Standard Errors of Percentages, 2015 and 2016

6.76P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.77C – Cigarette Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.77D – Cigarette Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.77P – Cigarette Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.78C – Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.78D – Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.78P – Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.79C – Binge Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.79D – Binge Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.79P – Binge Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.80C – Heavy Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.80D – Heavy Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.80P – Heavy Alcohol Use in Past Month among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.81C – Illicit Drug Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.81D – Illicit Drug Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.81P – Illicit Drug Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.82C – Alcohol Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.82D – Alcohol Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.82P – Alcohol Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.83C – Substance Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.83D – Substance Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.83P – Substance Use Disorder in Past Year among Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.84C – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.84D – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.85C – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.85D – Drove Under Influence of Alcohol or Selected Illicit Drugs in Past Year among Persons Aged 16 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.86C – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses: Standard Errors of Numbers in Thousands, 2015 and 2016

6.86D – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses: Standard Errors of Percentages, 2015 and 2016

6.86P – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.87C – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 49, by Past Year Probation and Parole/Supervised Release Statuses: Standard Errors of Numbers in Thousands, 2015 and 2016

6.87D – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 49, by Past Year Probation and Parole/Supervised Release Statuses: Standard Errors of Percentages, 2015 and 2016

6.87P – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 49, by Past Year Probation and Parole/Supervised Release Statuses: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.88C – Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.88D – Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.88P – Illicit Drug Use in Past Month among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.89C – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.89D – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.89P – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

6.90C – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

6.90D – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

6.90P – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

Trend Tables – 7.1 to 7.40 (Numbers in Thousands and Percentages)

7.1A – Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Numbers in Thousands, 2002-2016

7.1B – Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Percentages, 2002-2016

7.2A – Types of Illicit Drug Use in Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2002-2016

7.2B – Types of Illicit Drug Use in Past Year among Persons Aged 12 or Older: Percentages, 2002-2016

7.3A – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older: Numbers in Thousands, 2002-2016

7.3B – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older: Percentages, 2002-2016

7.4A – Types of Illicit Drug Use in Lifetime among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.4B – Types of Illicit Drug Use in Lifetime among Persons Aged 12 to 17: Percentages, 2002-2016

7.5A – Types of Illicit Drug Use in Past Year among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.5B – Types of Illicit Drug Use in Past Year among Persons Aged 12 to 17: Percentages, 2002-2016

7.6A – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.6B – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17: Percentages, 2002-2016

7.7A – Types of Illicit Drug Use in Lifetime among Persons Aged 18 or Older: Numbers in Thousands, 2002-2016

7.7B – Types of Illicit Drug Use in Lifetime among Persons Aged 18 or Older: Percentages, 2002-2016

7.8A – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older: Numbers in Thousands, 2002-2016

7.8B – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older: Percentages, 2002-2016

7.9A – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older: Numbers in Thousands, 2002-2016

7.9B – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older: Percentages, 2002-2016

7.10A – Types of Illicit Drug Use in Lifetime among Persons Aged 18 to 25: Numbers in Thousands, 2002-2016

7.10B – Types of Illicit Drug Use in Lifetime among Persons Aged 18 to 25: Percentages, 2002-2016

7.11A – Types of Illicit Drug Use in Past Year among Persons Aged 18 to 25: Numbers in Thousands, 2002-2016

7.11B – Types of Illicit Drug Use in Past Year among Persons Aged 18 to 25: Percentages, 2002-2016

7.12A – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25: Numbers in Thousands, 2002-2016

7.12B – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25: Percentages, 2002-2016

7.13A – Types of Illicit Drug Use in Lifetime among Persons Aged 26 or Older: Numbers in Thousands, 2002-2016

7.13B – Types of Illicit Drug Use in Lifetime among Persons Aged 26 or Older: Percentages, 2002-2016

7.14A – Types of Illicit Drug Use in Past Year among Persons Aged 26 or Older: Numbers in Thousands, 2002-2016

7.14B – Types of Illicit Drug Use in Past Year among Persons Aged 26 or Older: Percentages, 2002-2016

7.15A – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older: Numbers in Thousands, 2002-2016

7.15B – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older: Percentages, 2002-2016

7.16A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Gender: Numbers in Thousands, 2002-2016

7.16B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Gender: Percentages, 2002-2016

7.17A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Gender: Numbers in Thousands, 2002-2016

7.17B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Gender: Percentages, 2002-2016

7.18A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Gender: Numbers in Thousands, 2002-2016

7.18B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Gender: Percentages, 2002-2016

7.19A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Gender: Numbers in Thousands, 2002-2016

7.19B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Gender: Percentages, 2002-2016

7.20A – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Gender: Numbers in Thousands, 2002-2016

7.20B – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Gender: Percentages, 2002-2016

7.21A – Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2002-2016

7.21B – Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2002-2016

7.22A – Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2002-2016

7.22B – Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2002-2016

7.23A – Daily Cigarette Use in Past Month among Past Month Users Aged 12 or Older and Smoked One or More Packs of Cigarettes Per Day among Daily Cigarette Users Aged 12 or Older, by Age Group: Numbers in Thousands, 2002-2016

7.23B – Daily Cigarette Use in Past Month among Past Month Users Aged 12 or Older and Smoked One or More Packs of Cigarettes Per Day among Daily Cigarette Users Aged 12 or Older, by Age Group: Percentages, 2002-2016

7.24A – Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Numbers in Thousands and Averages, 2002-2016

7.24B – Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Percentages and Averages, 2002-2016

7.25A – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Gender: Numbers in Thousands, 2002-2016

7.25B – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Gender: Percentages, 2002-2016

7.26A – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors and Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.26B – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors and Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17: Percentages, 2002-2016

7.27A – Exposed to Substance Use Prevention Program or Message in Past Year among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.27B – Exposed to Substance Use Prevention Program or Message in Past Year among Persons Aged 12 to 17: Percentages, 2002-2016

7.28A – Past Year Initiation of Substance Use among Persons Aged 12 or Older: Numbers in Thousands, 2002-2016

7.28B – Past Year Initiation of Substance Use among Persons Aged 12 or Older: Percentages, 2002-2016

7.29A – Past Year Initiation of Substance Use among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.29B – Past Year Initiation of Substance Use among Persons Aged 12 to 17: Percentages, 2002-2016

7.30A – Past Year Initiation of Substance Use among Persons Aged 18 or Older: Numbers in Thousands, 2002-2016

7.30B – Past Year Initiation of Substance Use among Persons Aged 18 or Older: Percentages, 2002-2016

7.31A – Past Year Initiation of Substance Use among Persons Aged 18 to 25: Numbers in Thousands, 2002-2016

7.31B – Past Year Initiation of Substance Use among Persons Aged 18 to 25: Percentages, 2002-2016

7.32A – Past Year Initiation of Substance Use among Persons Aged 26 or Older: Numbers in Thousands, 2002-2016

7.32B – Past Year Initiation of Substance Use among Persons Aged 26 or Older: Percentages, 2002-2016

7.33B – Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49: 2002-2016

7.34A – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2002-2016

7.34B – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older: Percentages, 2002-2016

7.35A – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

7.35B – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 to 17: Percentages, 2002-2016

7.36A – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 or Older: Numbers in Thousands, 2002-2016

7.36B – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 or Older: Percentages, 2002-2016

7.37A – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 to 25: Numbers in Thousands, 2002-2016

7.37B – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 to 25: Percentages, 2002-2016

7.38A – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 26 or Older: Numbers in Thousands, 2002-2016

7.38B – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 26 or Older: Percentages, 2002-2016

7.39B – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group: Percentages, 1971-2016

7.40B – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group: Percentages, 1971-2016

Trend Tables – 7.1 to 7.40 (Standard Errors and P Values)

7.1C – Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.1D – Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Standard Errors of Percentages, 2002-2016

7.1P – Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.2C – Types of Illicit Drug Use in Past Year among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.2D – Types of Illicit Drug Use in Past Year among Persons Aged 12 or Older: Standard Errors of Percentages, 2002-2016

7.2P – Types of Illicit Drug Use in Past Year among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.3C – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.3D – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older: Standard Errors of Percentages, 2002-2016

7.3P – Types of Illicit Drug Use in Past Month among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.4C – Types of Illicit Drug Use in Lifetime among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.4D – Types of Illicit Drug Use in Lifetime among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.4P – Types of Illicit Drug Use in Lifetime among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.5C – Types of Illicit Drug Use in Past Year among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.5D – Types of Illicit Drug Use in Past Year among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.5P – Types of Illicit Drug Use in Past Year among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.6C – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.6D – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.6P – Types of Illicit Drug Use in Past Month among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.7C – Types of Illicit Drug Use in Lifetime among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.7D – Types of Illicit Drug Use in Lifetime among Persons Aged 18 or Older: Standard Errors of Percentages, 2002-2016

7.7P – Types of Illicit Drug Use in Lifetime among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.8C – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.8D – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older: Standard Errors of Percentages, 2002-2016

7.8P – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.9C – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.9D – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older: Standard Errors of Percentages, 2002-2016

7.9P – Types of Illicit Drug Use in Past Month among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.10C – Types of Illicit Drug Use in Lifetime among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2002-2016

7.10D – Types of Illicit Drug Use in Lifetime among Persons Aged 18 to 25: Standard Errors of Percentages, 2002-2016

7.10P – Types of Illicit Drug Use in Lifetime among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.11C – Types of Illicit Drug Use in Past Year among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2002-2016

7.11D – Types of Illicit Drug Use in Past Year among Persons Aged 18 to 25: Standard Errors of Percentages, 2002-2016

7.11P – Types of Illicit Drug Use in Past Year among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.12C – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2002-2016

7.12D – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25: Standard Errors of Percentages, 2002-2016

7.12P – Types of Illicit Drug Use in Past Month among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.13C – Types of Illicit Drug Use in Lifetime among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.13D – Types of Illicit Drug Use in Lifetime among Persons Aged 26 or Older: Standard Errors of Percentages, 2002-2016

7.13P – Types of Illicit Drug Use in Lifetime among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.14C – Types of Illicit Drug Use in Past Year among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.14D – Types of Illicit Drug Use in Past Year among Persons Aged 26 or Older: Standard Errors of Percentages, 2002-2016

7.14P – Types of Illicit Drug Use in Past Year among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.15C – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.15D – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older: Standard Errors of Percentages, 2002-2016

7.15P – Types of Illicit Drug Use in Past Month among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.16C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Gender: Standard Errors of Numbers in Thousands, 2002-2016

7.16D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Gender: Standard Errors of Percentages, 2002-2016

7.16P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 or Older, by Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.17C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Gender: Standard Errors of Numbers in Thousands, 2002-2016

7.17D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Gender: Standard Errors of Percentages, 2002-2016

7.17P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 12 to 17, by Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.18C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Gender: Standard Errors of Numbers in Thousands, 2002-2016

7.18D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Gender: Standard Errors of Percentages, 2002-2016

7.18P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 or Older, by Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.19C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Gender: Standard Errors of Numbers in Thousands, 2002-2016

7.19D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Gender: Standard Errors of Percentages, 2002-2016

7.19P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 18 to 25, by Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.20C – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Gender: Standard Errors of Numbers in Thousands, 2002-2016

7.20D – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Gender: Standard Errors of Percentages, 2002-2016

7.20P – Tobacco Product and Alcohol Use in Past Month among Persons Aged 26 or Older, by Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.21C – Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2002-2016

7.21D – Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2002-2016

7.21P – Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Marijuana Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2002-2015

7.22C – Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2002-2016

7.22D – Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2002-2016

7.22P – Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Cocaine Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2002-2015

7.23C – Daily Cigarette Use in Past Month among Past Month Users Aged 12 or Older and Smoked One or More Packs of Cigarettes Per Day among Daily Cigarette Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2002-2016

7.23D – Daily Cigarette Use in Past Month among Past Month Users Aged 12 or Older and Smoked One or More Packs of Cigarettes Per Day among Daily Cigarette Users Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2002-2016

7.23P – Daily Cigarette Use in Past Month among Past Month Users Aged 12 or Older and Smoked One or More Packs of Cigarettes Per Day among Daily Cigarette Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.24C – Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands and Averages, 2002-2016

7.24D – Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: Standard Errors of Percentages and Averages, 2002-2016

7.24P – Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Year among Past Year Users Aged 12 or Older and Daily or Almost Daily Alcohol Use and Average Number of Days Used in Past Month among Past Month Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages and Averages, 2016 Versus 2002-2015

7.25C – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Gender: Standard Errors of Numbers in Thousands, 2002-2016

7.25D – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Gender: Standard Errors of Percentages, 2002-2016

7.25P – Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.26C – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors and Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.26D – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors and Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.26P – Youths Felt That Parents Would Strongly Disapprove of Youth's Substance Use Behaviors and Youths Strongly Disapproved or Somewhat Disapproved of Peers' Substance Use Behaviors among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.27C – Exposed to Substance Use Prevention Program or Message in Past Year among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.27D – Exposed to Substance Use Prevention Program or Message in Past Year among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.27P – Exposed to Substance Use Prevention Program or Message in Past Year among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.28C – Past Year Initiation of Substance Use among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.28D – Past Year Initiation of Substance Use among Persons Aged 12 or Older: Standard Errors of Percentages, 2002-2016

7.28P – Past Year Initiation of Substance Use among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.29C – Past Year Initiation of Substance Use among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.29D – Past Year Initiation of Substance Use among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.29P – Past Year Initiation of Substance Use among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.30C – Past Year Initiation of Substance Use among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.30D – Past Year Initiation of Substance Use among Persons Aged 18 or Older: Standard Errors of Percentages, 2002-2016

7.30P – Past Year Initiation of Substance Use among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.31C – Past Year Initiation of Substance Use among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2002-2016

7.31D – Past Year Initiation of Substance Use among Persons Aged 18 to 25: Standard Errors of Percentages, 2002-2016

7.31P – Past Year Initiation of Substance Use among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.32C – Past Year Initiation of Substance Use among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.32D – Past Year Initiation of Substance Use among Persons Aged 26 or Older: Standard Errors of Percentages, 2002-2016

7.32P – Past Year Initiation of Substance Use among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.33D – Standard Errors of Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49: 2002-2016

7.33P – P Values from Tests of Differences of Mean Age at First Substance Use among Past Year Initiates Aged 12 to 49: 2016 Versus 2002-2015

7.34C – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.34D – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older: Standard Errors of Percentages, 2002-2016

7.34P – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.35C – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

7.35D – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

7.35P – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.36C – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.36D – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 or Older: Standard Errors of Percentages, 2002-2016

7.36P – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.37C – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2002-2016

7.37D – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 to 25: Standard Errors of Percentages, 2002-2016

7.37P – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.38C – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2002-2016

7.38D – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 26 or Older: Standard Errors of Percentages, 2002-2016

7.38P – Substance Use Disorder for Specific Substances in Past Year among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

7.39D – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 1971-2016

7.40D – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group: Standard Errors of Percentages, 1971-2016

Adult Mental Health Tables – 8.1 to 8.85 (Numbers in Thousands and Percentages)

8.1A – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.1B – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.2A – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.2B – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.3A – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.3B – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.4A – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.4B – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.5A – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.5B – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.6A – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.6B – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.7A – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.7B – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2015 and 2016

8.8A – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.8B – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.9A – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.9B – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.10A – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.10B – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.11A – Any Use of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.11B – Any Use of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.12A – Any Use of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.12B – Any Use of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.13A – Any Use of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.13B – Any Use of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.14A – Any Use of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.14B – Any Use of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.15A – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.15B – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.16A – Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.16B – Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.17A – Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.17B – Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.18A – Misuse of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.18B – Misuse of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.19A – Misuse of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Numbers in Thousands, 2015 and 2016

8.19B – Misuse of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Percentages, 2015 and 2016

8.20A – Tobacco Product and Alcohol Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.20B – Tobacco Product and Alcohol Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.21A – Level of Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Age Group: Numbers in Thousands, 2015 and 2016

8.21B – Level of Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Age Group: Percentages, 2015 and 2016

8.22A – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Numbers in Thousands, 2015 and 2016

8.22B – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Percentages, 2015 and 2016

8.23A – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Numbers in Thousands, 2015 and 2016

8.23B – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Percentages, 2015 and 2016

8.24A – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Numbers in Thousands, 2015 and 2016

8.24B – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Percentages, 2015 and 2016

8.25A – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.25B – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.26A – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.26B – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.27A – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.27B – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.28A – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.28B – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.29A – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.29B – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.30A – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioecohljnomic Characteristics: Numbers in Thousands, 2015 and 2016

8.30B – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.31A – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.31B – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Percentages, 2015 and 2016

8.32A – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.32B – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Percentages, 2015 and 2016

8.33A – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.33B – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic Characteristics: Percentages, 2015 and 2016

8.34A – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.34B – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.35A – Received Inpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.35B – Received Inpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.36A – Received Outpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.36B – Received Outpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.37A – Received Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.37B – Received Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.38A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Substance Use Disorder, by Past Year Level of Mental Illness and Age Group: Numbers in Thousands, 2015 and 2016

8.38B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Substance Use Disorder, by Past Year Level of Mental Illness and Age Group: Percentages, 2015 and 2016

8.39A – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.39B – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.40A – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.40B – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.41A – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.41B – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.42A – Types and Locations of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.42B – Types and Locations of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.43A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Past Year Level of Mental Illness: Numbers in Thousands, 2015 and 2016

8.43B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Past Year Level of Mental Illness: Percentages, 2015 and 2016

8.44A – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

8.44B – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Percentages, 2015 and 2016

8.45A – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

8.45B – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Percentages, 2015 and 2016

8.46A – Sources of Payment for Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

8.46B – Sources of Payment for Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Percentages, 2015 and 2016

8.47A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.47B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Percentages, 2015 and 2016

8.48A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.48B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.49A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.49B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Percentages, 2015 and 2016

8.50A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.50B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.51A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.51B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Percentages, 2015 and 2016

8.52A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.52B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.53A – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Numbers in Thousands, 2015 and 2016

8.53B – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Percentages, 2015 and 2016

8.54A – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Numbers in Thousands, 2015 and 2016

8.54B – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Percentages, 2015 and 2016

8.55A – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Numbers in Thousands, 2015 and 2016

8.55B – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Percentages, 2015 and 2016

8.56A – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.56B – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.57A – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Gender and Age Group: Numbers in Thousands, 2015 and 2016

8.57B – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Gender and Age Group: Percentages, 2015 and 2016

8.58A – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.58B – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Percentages, 2015 and 2016

8.59A – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Numbers in Thousands, 2015 and 2016

8.59B – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Percentages, 2015 and 2016

8.60A – Substance Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Major Depressive Episode (MDE) Status: Numbers in Thousands, 2015 and 2016

8.60B – Substance Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Major Depressive Episode (MDE) Status: Percentages, 2015 and 2016

8.61A – Substance Use Disorder Status in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Past Year Major Depressive Episode (MDE) Status, and Past Year Status of Serious Thoughts of Suicide: Numbers in Thousands, 2015 and 2016

8.61B – Substance Use Disorder Status in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Past Year Major Depressive Episode (MDE) Status, and Past Year Status of Serious Thoughts of Suicide: Percentages, 2015 and 2016

8.62A – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

8.62B – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Percentages, 2015 and 2016

8.63A – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) with Severe Impairment Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Numbers in Thousands, 2015 and 2016

8.63B – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) with Severe Impairment Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Percentages, 2015 and 2016

8.64A – Type of Treatment Received in Past Year for Depression among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.64B – Type of Treatment Received in Past Year for Depression among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.65A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons 18 or Older, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Numbers in Thousands, 2015 and 2016

8.65B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons 18 or Older, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Percentages, 2015 and 2016

8.66A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.66B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.67A – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.67B – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.68A – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.68B – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.69A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.69B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.70A – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.70B – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.71A – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.71B – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016

8.72A – Made Any Suicide Plans or Attempted Suicide in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year, by Age Group and Gender: Numbers in Thousands, 2015 and 2016

8.72B – Made Any Suicide Plans or Attempted Suicide in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year, by Age Group and Gender: Percentages, 2015 and 2016

8.73A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.73B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.74A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.74B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.75A – Attempted Suicide in Past Year among Persons Aged 18 or Older, Received Medical Attention for Suicide Attempt, or Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year among Persons Aged 18 or Older Who Attempted Suicide in Past Year, by Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.75B – Attempted Suicide in Past Year among Persons Aged 18 or Older, Received Medical Attention for Suicide Attempt, or Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year among Persons Aged 18 or Older Who Attempted Suicide in Past Year, by Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

8.76A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Type of Illicit Drug Use in Past Year and Alcohol Use in Past Year and Past Month: Numbers in Thousands, 2015 and 2016

8.76B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Type of Illicit Drug Use in Past Year and Alcohol Use in Past Year and Past Month: Percentages, 2015 and 2016

8.77A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.77B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Percentages, 2015 and 2016

8.78A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

8.78B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Percentages, 2015 and 2016

8.79A – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Persons Aged 18 to 22, by College Enrollment Status: Numbers in Thousands, 2015 and 2016

8.79B – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Persons Aged 18 to 22, by College Enrollment Status: Percentages, 2015 and 2016

8.80A – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Males Aged 18 to 22, by College Enrollment Status: Numbers in Thousands, 2015 and 2016

8.80B – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Males Aged 18 to 22, by College Enrollment Status: Percentages, 2015 and 2016

8.81A – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Females Aged 18 to 22, by College Enrollment Status: Numbers in Thousands, 2015 and 2016

8.81B – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Females Aged 18 to 22, by College Enrollment Status: Percentages, 2015 and 2016

8.82A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Major Depressive Episode, Mental Health Services, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year: Numbers in Thousands, 2015 and 2016

8.82B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Major Depressive Episode, Mental Health Services, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year: Percentages, 2015 and 2016

8.83A – Major Depressive Episode, Mental Health Services and Perceived Need, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year: Numbers in Thousands, 2015 and 2016

8.83B – Major Depressive Episode, Mental Health Services and Perceived Need, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year: Percentages, 2015 and 2016

8.84A – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

8.84B – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Gender and Detailed Age Category: Percentages, 2015 and 2016

8.85A – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Age Group and Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

8.85B – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Age Group and Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

Adult Mental Health Tables – 8.1 to 8.85 (Standard Errors and P Values)

8.1C – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.1D – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.1P – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.2C – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.2D – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.2P – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.3C – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.3D – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.3P – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.4C – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.4D – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.4P – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.5C – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.5D – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.5P – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.6C – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.6D – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.6P – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.7C – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.7D – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.7P – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.8C – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.8D – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.8P – Levels of Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.9C – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.9D – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.9P – Types of Illicit Drug Use in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.10C – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.10D – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.10P – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.11C – Any Use of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.11D – Any Use of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.11P – Any Use of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.12C – Any Use of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.12D – Any Use of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.12P – Any Use of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.13C – Any Use of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.13D – Any Use of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.13P – Any Use of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.14C – Any Use of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.14D – Any Use of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.14P – Any Use of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.15C – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.15D – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.15P – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.16C – Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.16D – Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.16P – Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.17C – Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.17D – Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.17P – Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.18C – Misuse of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.18D – Misuse of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.18P – Misuse of Stimulants in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.19C – Misuse of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.19D – Misuse of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.19P – Misuse of Sedatives in Past Year among Persons Aged 18 or Older, by Level and Status of Mental Illness, Past Year Status of Major Depressive Episode, Past Year Status of Serious Thoughts of Suicide, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.20C – Tobacco Product and Alcohol Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.20D – Tobacco Product and Alcohol Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.20P – Tobacco Product and Alcohol Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.21C – Level of Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.21D – Level of Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Age Group: Standard Errors of Percentages, 2015 and 2016

8.21P – Level of Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.22C – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.22D – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.22P – Illicit Drug Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.23C – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.23D – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.23P – Alcohol Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.24C – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.24D – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: Standard Errors of Percentages, 2015 and 2016

8.24P – Substance Use Disorder in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Gender, and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.25C – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.25D – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.25P – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.26C – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.26D – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.26P – Co-Occurring Substance Use Disorder and Any Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.27C – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.27D – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.27P – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.28C – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.28D – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.28P – Co-Occurring Substance Use Disorder and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.29C – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.29D – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.29P – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.30C – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.30D – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.30P – Co-Occurring Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.31C – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.31D – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.31P – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.32C – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.32D – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.32P – Any Mental Illness and Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.33C – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.33D – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.33P – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.34C – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.34D – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.34P – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.35C – Received Inpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.35D – Received Inpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.35P – Received Inpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.36C – Received Outpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.36D – Received Outpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.36P – Received Outpatient Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.37C – Received Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.37D – Received Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.37P – Received Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.38C – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Substance Use Disorder, by Past Year Level of Mental Illness and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.38D – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Substance Use Disorder, by Past Year Level of Mental Illness and Age Group: Standard Errors of Percentages, 2015 and 2016

8.38P – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Substance Use Disorder, by Past Year Level of Mental Illness and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.39C – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.39D – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.39P – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.40C – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.40D – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.40P – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.41C – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.41D – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.41P – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.42C – Types and Locations of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.42D – Types and Locations of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.42P – Types and Locations of Mental Health Services Received in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.43C – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Past Year Level of Mental Illness: Standard Errors of Numbers in Thousands, 2015 and 2016

8.43D – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Past Year Level of Mental Illness: Standard Errors of Percentages, 2015 and 2016

8.43P – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Substance Use Disorder Status and Past Year Level of Mental Illness: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.44C – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.44D – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

8.44P – Types of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.45C – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.45D – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

8.45P – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.46C – Sources of Payment for Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.46D – Sources of Payment for Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

8.46P – Sources of Payment for Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.47C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.47D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.47P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.48C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.48D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.48P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.49C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.49D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.49P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.50C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.50D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.50P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.51C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.51D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.51P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.52C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.52D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.52P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Receipt of Past Year Mental Health Services and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.53C – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Standard Errors of Numbers in Thousands, 2015 and 2016

8.53D – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Standard Errors of Percentages, 2015 and 2016

8.53P – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.54C – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Standard Errors of Numbers in Thousands, 2015 and 2016

8.54D – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Standard Errors of Percentages, 2015 and 2016

8.54P – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.55C – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Standard Errors of Numbers in Thousands, 2015 and 2016

8.55D – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: Standard Errors of Percentages, 2015 and 2016

8.55P – Detailed Reasons for Not Receiving Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Receipt of Past Year Mental Health Services: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.56C – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.56D – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.56P – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.57C – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Gender and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.57D – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Gender and Age Group: Standard Errors of Percentages, 2015 and 2016

8.57P – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Gender and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.58C – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.58D – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.58P – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.59C – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.59D – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Standard Errors of Percentages, 2015 and 2016

8.59P – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 18 or Older, and Receipt of Treatment for Depression in Past Year among Persons Aged 18 or Older with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.60C – Substance Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Major Depressive Episode (MDE) Status: Standard Errors of Numbers in Thousands, 2015 and 2016

8.60D – Substance Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Major Depressive Episode (MDE) Status: Standard Errors of Percentages, 2015 and 2016

8.60P – Substance Use in Past Year and Past Month among Persons Aged 18 or Older, by Past Year Major Depressive Episode (MDE) Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.61C – Substance Use Disorder Status in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Past Year Major Depressive Episode (MDE) Status, and Past Year Status of Serious Thoughts of Suicide: Standard Errors of Numbers in Thousands, 2015 and 2016

8.61D – Substance Use Disorder Status in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Past Year Major Depressive Episode (MDE) Status, and Past Year Status of Serious Thoughts of Suicide: Standard Errors of Percentages, 2015 and 2016

8.61P – Substance Use Disorder Status in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness, Past Year Major Depressive Episode (MDE) Status, and Past Year Status of Serious Thoughts of Suicide: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.62C – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.62D – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

8.62P – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.63C – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) with Severe Impairment Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.63D – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) with Severe Impairment Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: Standard Errors of Percentages, 2015 and 2016

8.63P – Types of Professional Seen among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE) with Severe Impairment Who Saw or Talked to a Professional about Depression in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.64C – Type of Treatment Received in Past Year for Depression among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.64D – Type of Treatment Received in Past Year for Depression among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.64P – Type of Treatment Received in Past Year for Depression among Persons Aged 18 or Older with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.65C – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons 18 or Older, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

8.65D – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons 18 or Older, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Standard Errors of Percentages, 2015 and 2016

8.65P – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons 18 or Older, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.66C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.66D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.66P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.67C – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.67D – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.67P – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.68C – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.68D – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.68P – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.69C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.69D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.69P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.70C – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.70D – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.70P – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.71C – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.71D – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.71P – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.72C – Made Any Suicide Plans or Attempted Suicide in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year, by Age Group and Gender: Standard Errors of Numbers in Thousands, 2015 and 2016

8.72D – Made Any Suicide Plans or Attempted Suicide in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year, by Age Group and Gender: Standard Errors of Percentages, 2015 and 2016

8.72P – Made Any Suicide Plans or Attempted Suicide in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year, by Age Group and Gender: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.73C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.73D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.73P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.74C – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.74D – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.74P – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.75C – Attempted Suicide in Past Year among Persons Aged 18 or Older, Received Medical Attention for Suicide Attempt, or Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year among Persons Aged 18 or Older Who Attempted Suicide in Past Year, by Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.75D – Attempted Suicide in Past Year among Persons Aged 18 or Older, Received Medical Attention for Suicide Attempt, or Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year among Persons Aged 18 or Older Who Attempted Suicide in Past Year, by Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.75P – Attempted Suicide in Past Year among Persons Aged 18 or Older, Received Medical Attention for Suicide Attempt, or Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year among Persons Aged 18 or Older Who Attempted Suicide in Past Year, by Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.76C – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Type of Illicit Drug Use in Past Year and Alcohol Use in Past Year and Past Month: Standard Errors of Numbers in Thousands, 2015 and 2016

8.76D – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Type of Illicit Drug Use in Past Year and Alcohol Use in Past Year and Past Month: Standard Errors of Percentages, 2015 and 2016

8.76P – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Type of Illicit Drug Use in Past Year and Alcohol Use in Past Year and Past Month: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.77C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.77D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.77P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Probation Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.78C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.78D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.78P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Past Year Parole/Supervised Release Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.79C – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Persons Aged 18 to 22, by College Enrollment Status: Standard Errors of Numbers in Thousands, 2015 and 2016

8.79D – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Persons Aged 18 to 22, by College Enrollment Status: Standard Errors of Percentages, 2015 and 2016

8.79P – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Persons Aged 18 to 22, by College Enrollment Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.80C – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Males Aged 18 to 22, by College Enrollment Status: Standard Errors of Numbers in Thousands, 2015 and 2016

8.80D – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Males Aged 18 to 22, by College Enrollment Status: Standard Errors of Percentages, 2015 and 2016

8.80P – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Males Aged 18 to 22, by College Enrollment Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.81C – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Females Aged 18 to 22, by College Enrollment Status: Standard Errors of Numbers in Thousands, 2015 and 2016

8.81D – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Females Aged 18 to 22, by College Enrollment Status: Standard Errors of Percentages, 2015 and 2016

8.81P – Suicide Behavior and Treatment, Level of Mental Illness, Major Depressive Episode, and Mental Health Services among Females Aged 18 to 22, by College Enrollment Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.82C – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Major Depressive Episode, Mental Health Services, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

8.82D – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Major Depressive Episode, Mental Health Services, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year: Standard Errors of Percentages, 2015 and 2016

8.82P – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year among Persons Aged 18 or Older, by Major Depressive Episode, Mental Health Services, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.83C – Major Depressive Episode, Mental Health Services and Perceived Need, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

8.83D – Major Depressive Episode, Mental Health Services and Perceived Need, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year: Standard Errors of Percentages, 2015 and 2016

8.83P – Major Depressive Episode, Mental Health Services and Perceived Need, Substance Use Disorder, Serious Psychological Distress, and Substance Use Treatment at a Specialty Facility in Past Year among Persons Aged 18 or Older Who Had Serious Thoughts of Suicide in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.84C – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

8.84D – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

8.84P – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

8.85C – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Age Group and Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

8.85D – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Age Group and Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

8.85P – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Age Group and Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

Youth Mental Health Tables – 9.1 to 9.15 (Numbers in Thousands and Percentages)

9.1A – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Age Group: Numbers in Thousands, 2015 and 2016

9.1B – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Age Group: Percentages, 2015 and 2016

9.2A – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

9.2B – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2015 and 2016

9.3A – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

9.3B – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

9.4A – Reasons for Receiving Most Recent Mental Health Service in Past Year among Persons Aged 12 to 17 Who Received Respective Mental Health Services in Past Year: Numbers in Thousands, 2015 and 2016

9.4B – Reasons for Receiving Most Recent Mental Health Service in Past Year among Persons Aged 12 to 17 Who Received Respective Mental Health Services in Past Year: Percentages, 2015 and 2016

9.5A – Number of Visits or Overnight Stays in Past Year for Specialty Mental Health Services among Persons Aged 12 to 17 Who Received Respective Specialty Mental Health Services in Past Year: Numbers in Thousands, 2015 and 2016

9.5B – Number of Visits or Overnight Stays in Past Year for Specialty Mental Health Services among Persons Aged 12 to 17 Who Received Respective Specialty Mental Health Services in Past Year: Percentages, 2015 and 2016

9.6A – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Gender and Detailed Age Category: Numbers in Thousands, 2015 and 2016

9.6B – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Gender and Detailed Age Category: Percentages, 2015 and 2016

9.7A – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

9.7B – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Percentages, 2015 and 2016

9.8A – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Numbers in Thousands, 2015 and 2016

9.8B – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Percentages, 2015 and 2016

9.9A – Substance Use in Past Year and Past Month among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status: Numbers in Thousands, 2015 and 2016

9.9B – Substance Use in Past Year and Past Month among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status: Percentages, 2015 and 2016

9.10A – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

9.10B – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Demographic Characteristics: Percentages, 2015 and 2016

9.11A – Substance Use Disorder Status in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status and Demographic Characteristics: Numbers in Thousands, 2015 and 2016

9.11B – Substance Use Disorder Status in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status and Demographic Characteristics: Percentages, 2015 and 2016

9.12A – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) in Past Year and Co-Occurring Substance Use Disorder and MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2015 and 2016

9.12B – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) in Past Year and Co-Occurring Substance Use Disorder and MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2015 and 2016

9.13A – Types of Professional Seen among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year: Numbers in Thousands, 2015 and 2016

9.13B – Types of Professional Seen among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year: Percentages, 2015 and 2016

9.14A – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016

9.14B – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Percentages, 2015 and 2016

9.15A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Numbers in Thousands, 2015 and 2016

9.15B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Percentages, 2015 and 2016

Youth Mental Health Tables – 9.1 to 9.15 (Standard Errors and P Values)

9.1C – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

9.1D – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Age Group: Standard Errors of Percentages, 2015 and 2016

9.1P – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.2C – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.2D – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.2P – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.3C – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.3D – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.3P – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.4C – Reasons for Receiving Most Recent Mental Health Service in Past Year among Persons Aged 12 to 17 Who Received Respective Mental Health Services in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

9.4D – Reasons for Receiving Most Recent Mental Health Service in Past Year among Persons Aged 12 to 17 Who Received Respective Mental Health Services in Past Year: Standard Errors of Percentages, 2015 and 2016

9.4P – Reasons for Receiving Most Recent Mental Health Service in Past Year among Persons Aged 12 to 17 Who Received Respective Mental Health Services in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.5C – Number of Visits or Overnight Stays in Past Year for Specialty Mental Health Services among Persons Aged 12 to 17 Who Received Respective Specialty Mental Health Services in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

9.5D – Number of Visits or Overnight Stays in Past Year for Specialty Mental Health Services among Persons Aged 12 to 17 Who Received Respective Specialty Mental Health Services in Past Year: Standard Errors of Percentages, 2015 and 2016

9.5P – Number of Visits or Overnight Stays in Past Year for Specialty Mental Health Services among Persons Aged 12 to 17 Who Received Respective Specialty Mental Health Services in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.6C – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Gender and Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016

9.6D – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Gender and Detailed Age Category: Standard Errors of Percentages, 2015 and 2016

9.6P – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Gender and Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.7C – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.7D – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.7P – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.8C – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.8D – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: Standard Errors of Percentages, 2015 and 2016

9.8P – Had at Least One Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, and Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with MDE or MDE with Severe Impairment in Past Year, by Geographic, Socioeconomic, and Health Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.9C – Substance Use in Past Year and Past Month among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status: Standard Errors of Numbers in Thousands, 2015 and 2016

9.9D – Substance Use in Past Year and Past Month among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status: Standard Errors of Percentages, 2015 and 2016

9.9P – Substance Use in Past Year and Past Month among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.10C – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.10D – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.10P – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.11C – Substance Use Disorder Status in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.11D – Substance Use Disorder Status in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.11P – Substance Use Disorder Status in Past Year among Persons Aged 12 to 17, by Past Year Major Depressive Episode (MDE) Status and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.12C – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) in Past Year and Co-Occurring Substance Use Disorder and MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.12D – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) in Past Year and Co-Occurring Substance Use Disorder and MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.12P – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) in Past Year and Co-Occurring Substance Use Disorder and MDE with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.13C – Types of Professional Seen among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year: Standard Errors of Numbers in Thousands, 2015 and 2016

9.13D – Types of Professional Seen among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year: Standard Errors of Percentages, 2015 and 2016

9.13P – Types of Professional Seen among Persons Aged 12 to 17 with Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.14C – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016

9.14D – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016

9.14P – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015

9.15C – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016

9.15D – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: Standard Errors of Percentages, 2015 and 2016

9.15P – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services in Past Year among Persons Aged 12 to 17, by Past Year Substance Use Disorder and Major Depressive Episode (MDE) Status and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015

Adult Mental Health Trend Tables – 10.1 to 10.41 (Numbers in Thousands and Percentages)

10.1A – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.1B – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.2A – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2008-2016

10.2B – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2008-2016

10.3A – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.3B – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.4A – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2008-2016

10.4B – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2008-2016

10.5A – Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.5B – Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.6A – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2002-2016

10.6B – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2002-2016

10.7A – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2002-2016

10.7B – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2002-2016

10.8A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.8B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Demographic Characteristics: Percentages, 2008-2016

10.9A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2008-2016

10.9B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Geographic and Socioeconomic Characteristics: Percentages, 2008-2016

10.10A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.10B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Demographic Characteristics: Percentages, 2008-2016

10.11A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2008-2016

10.11B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Geographic and Socioeconomic Characteristics: Percentages, 2008-2016

10.12A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.12B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Demographic Characteristics: Percentages, 2008-2016

10.13A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2008-2016

10.13B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Geographic and Socioeconomic Characteristics: Percentages, 2008-2016

10.14A – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Excluding Serious Mental Illness, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.14B – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Excluding Serious Mental Illness, by Demographic Characteristics: Percentages, 2008-2016

10.15A – Received Only Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness and Age Group: Numbers in Thousands, 2008-2016

10.15B – Received Only Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness and Age Group: Percentages, 2008-2016

10.16A – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older, by Age Group: Numbers in Thousands, 2002-2016

10.16B – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older, by Age Group: Percentages, 2002-2016

10.17A – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Age Group: Numbers in Thousands, 2008-2016

10.17B – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Age Group: Percentages, 2008-2016

10.18A – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Age Group: Numbers in Thousands, 2008-2016

10.18B – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Age Group: Percentages, 2008-2016

10.19A – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year: Numbers in Thousands, 2002-2016

10.19B – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year: Percentages, 2002-2016

10.20A – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Outpatient Mental Health Services in Past Year: Numbers in Thousands, 2008-2016

10.20B – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Outpatient Mental Health Services in Past Year: Percentages, 2008-2016

10.21A – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Outpatient Mental Health Services in Past Year: Numbers in Thousands, 2008-2016

10.21B – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Outpatient Mental Health Services in Past Year: Percentages, 2008-2016

10.22A – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2002-2016

10.22B – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Percentages, 2002-2016

10.23A – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2008-2016

10.23B – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Percentages, 2008-2016

10.24A – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2008-2016

10.24B – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Percentages, 2008-2016

10.25A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2002-2016

10.25B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2002-2016

10.26A – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Age Group: Numbers in Thousands, 2008-2016

10.26B – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Age Group: Percentages, 2008-2016

10.27A – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2002-2016

10.27B – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Percentages, 2002-2016

10.28A – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2008-2016

10.28B – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Percentages, 2008-2016

10.29A – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Numbers in Thousands, 2008-2016

10.29B – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Percentages, 2008-2016

10.30A – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2005-2016

10.30B – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2005-2016

10.31A – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2009-2016

10.31B – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2009-2016

10.32A – Received Treatment for Depression in Past Year among Persons Aged 18 or Older with Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Numbers in Thousands, 2009-2016

10.32B – Received Treatment for Depression in Past Year among Persons Aged 18 or Older with Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Percentages, 2009-2016

10.33A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Numbers in Thousands, 2008-2016

10.33B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Percentages, 2008-2016

10.34A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.34B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.35A – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2008-2016

10.35B – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2008-2016

10.36A – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Numbers in Thousands, 2008-2016

10.36B – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Percentages, 2008-2016

10.37A – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.37B – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.38A – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Numbers in Thousands, 2008-2016

10.38B – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Percentages, 2008-2016

10.39A – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.39B – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.40A – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2008-2016

10.40B – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2008-2016

10.41A – Serious Psychological Distress (SPD) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2005-2016

10.41B – Serious Psychological Distress (SPD) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2005-2016

Adult Mental Health Trend Tables – 10.1 to 10.41 (Standard Errors and P Values)

10.1C – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.1D – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.1P – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.2C – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.2D – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2008-2016

10.2P – Any Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.3C – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.3D – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.3P – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.4C – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.4D – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2008-2016

10.4P – Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.5C – Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.5D – Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.5P – Any Mental Illness Excluding Serious Mental Illness in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.6C – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2002-2016

10.6D – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2002-2016

10.6P – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.7C – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2002-2016

10.7D – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2002-2016

10.7P – Received Mental Health Services in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.8C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.8D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.8P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.9C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.9D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2008-2016

10.9P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.10C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.10D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.10P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.11C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.11D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2008-2016

10.11P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.12C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.12D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.12P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.13C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.13D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2008-2016

10.13P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with No Past Year Mental Illness, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.14C – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Excluding Serious Mental Illness, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.14D – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Excluding Serious Mental Illness, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.14P – Received Mental Health Services in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Excluding Serious Mental Illness, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.15C – Received Only Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness and Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.15D – Received Only Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness and Age Group: Standard Errors of Percentages, 2008-2016

10.15P – Received Only Prescription Medication as a Type of Mental Health Service in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Past Year Level of Mental Illness and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.16C – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2002-2016

10.16D – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older, by Age Group: Standard Errors of Percentages, 2002-2016

10.16P – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.17C – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.17D – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Age Group: Standard Errors of Percentages, 2008-2016

10.17P – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.18C – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.18D – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Age Group: Standard Errors of Percentages, 2008-2016

10.18P – Type of Mental Health Service Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.19C – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year: Standard Errors of Numbers in Thousands, 2002-2016

10.19D – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year: Standard Errors of Percentages, 2002-2016

10.19P – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older Who Received Outpatient Mental Health Services in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.20C – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Outpatient Mental Health Services in Past Year: Standard Errors of Numbers in Thousands, 2008-2016

10.20D – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Outpatient Mental Health Services in Past Year: Standard Errors of Percentages, 2008-2016

10.20P – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Outpatient Mental Health Services in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.21C – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Outpatient Mental Health Services in Past Year: Standard Errors of Numbers in Thousands, 2008-2016

10.21D – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Outpatient Mental Health Services in Past Year: Standard Errors of Percentages, 2008-2016

10.21P – Locations of Outpatient Mental Health Services among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Outpatient Mental Health Services in Past Year: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.22C – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2002-2016

10.22D – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2002-2016

10.22P – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older Who Received Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.23C – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.23D – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2008-2016

10.23P – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Any Mental Illness Who Received Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.24C – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.24D – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2008-2016

10.24P – Number of Mental Health Services Received in Past Year among Persons Aged 18 or Older with Past Year Serious Mental Illness Who Received Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.25C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2002-2016

10.25D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2002-2016

10.25P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.26C – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.26D – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Age Group: Standard Errors of Percentages, 2008-2016

10.26P – Perceived Unmet Need for Mental Health Services in Past Year among Persons Aged 18 or Older, by Past Year Level of Mental Illness and Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.27C – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2002-2016

10.27D – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2002-2016

10.27P – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

10.28C – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.28D – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2008-2016

10.28P – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Any Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.29C – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Standard Errors of Numbers in Thousands, 2008-2016

10.29D – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: Standard Errors of Percentages, 2008-2016

10.29P – Receipt of Mental Health Services in Past Year among Persons Aged 18 or Older with a Past Year Serious Mental Illness and a Perceived Unmet Need for Mental Health Services in Past Year, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.30C – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2005-2016

10.30D – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2005-2016

10.30P – Major Depressive Episode (MDE) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2005-2015

10.31C – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2009-2016

10.31D – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2009-2016

10.31P – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2009-2015

10.32C – Received Treatment for Depression in Past Year among Persons Aged 18 or Older with Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2009-2016

10.32D – Received Treatment for Depression in Past Year among Persons Aged 18 or Older with Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Standard Errors of Percentages, 2009-2016

10.32P – Received Treatment for Depression in Past Year among Persons Aged 18 or Older with Past Year Major Depressive Episode (MDE), by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2009-2015

10.33C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2008-2016

10.33D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Standard Errors of Percentages, 2008-2016

10.33P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.34C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.34D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.34P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.35C – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.35D – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2008-2016

10.35P – Had Serious Thoughts of Suicide in Past Year among Persons Aged 18 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.36C – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2008-2016

10.36D – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Standard Errors of Percentages, 2008-2016

10.36P – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.37C – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.37D – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.37P – Made Any Suicide Plans in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.38C – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2008-2016

10.38D – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: Standard Errors of Percentages, 2008-2016

10.38P – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.39C – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.39D – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.39P – Attempted Suicide in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.40C – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2008-2016

10.40D – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2008-2016

10.40P – Serious Psychological Distress (SPD) in Past Month among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2008-2015

10.41C – Serious Psychological Distress (SPD) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2005-2016

10.41D – Serious Psychological Distress (SPD) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Standard Errors of Percentages, 2005-2016

10.41P – Serious Psychological Distress (SPD) in Past Year among Persons Aged 18 or Older, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2005-2015

Youth Mental Health Trend Tables – 11.1 to 11.6 (Numbers in Thousands and Percentages)

11.1A – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17: Numbers in Thousands, 2002-2016

11.1B – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17: Percentages, 2002-2016

11.2A – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2004-2016

11.2B – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2004-2016

11.3A – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Numbers in Thousands, 2004-2016

11.3B – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Percentages, 2004-2016

11.4A – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE): Numbers in Thousands, 2004-2016

11.4B – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE): Percentages, 2004-2016

11.5A – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2006-2016

11.5B – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2006-2016

11.6A – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE) with Severe Impairment, by Demographic Characteristics: Numbers in Thousands, 2006-2016

11.6B – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE) with Severe Impairment, by Demographic Characteristics: Percentages, 2006-2016

Youth Mental Health Trend Tables – 11.1 to 11.6 (Standard Errors and P Values)

11.1C – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2002-2016

11.1D – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17: Standard Errors of Percentages, 2002-2016

11.1P – Sources of Mental Health Services in Past Year among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2002-2015

11.2C – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2004-2016

11.2D – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Percentages, 2004-2016

11.2P – Had at Least One Major Depressive Episode (MDE) in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2004-2015

11.3C – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2004-2016

11.3D – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic Characteristics: Standard Errors of Percentages, 2004-2016

11.3P – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE), by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2004-2015

11.4C – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE): Standard Errors of Numbers in Thousands, 2004-2016

11.4D – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE): Standard Errors of Percentages, 2004-2016

11.4P – Type of Treatment Received in Past Year for Depression among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE): P Values from Tests of Differences of Percentages, 2016 Versus 2004-2015

11.5C – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2006-2016

11.5D – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Standard Errors of Percentages, 2006-2016

11.5P – Had at Least One Major Depressive Episode (MDE) with Severe Impairment in Past Year among Persons Aged 12 to 17, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2006-2015

11.6C – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE) with Severe Impairment, by Demographic Characteristics: Standard Errors of Numbers in Thousands, 2006-2016

11.6D – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE) with Severe Impairment, by Demographic Characteristics: Standard Errors of Percentages, 2006-2016

11.6P – Receipt of Treatment for Depression in Past Year among Persons Aged 12 to 17 with a Past Year Major Depressive Episode (MDE) with Severe Impairment, by Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2006-2015

Sample Size and Population Tables – 12.1 to 12.9 (Numbers in Thousands and Survey Sample Size)

12.1A – Numbers (in Thousands) of Persons Aged 12 or Older, by Gender and Detailed Age Category: 2015 and 2016

12.1N – Survey Sample Size for Respondents Aged 12 or Older, by Gender and Detailed Age Category: 2015 and 2016

12.2A – Numbers (in Thousands) of Persons Aged 12 or Older, by Age Group and Demographic Characteristics: 2015 and 2016

12.2N – Survey Sample Size for Respondents Aged 12 or Older, by Age Group and Demographic Characteristics: 2015 and 2016

12.3A – Numbers (in Thousands) of Persons Aged 12 or Older, by Underage and Legal Drinking Age Groups and Demographic Characteristics: 2015 and 2016

12.3N – Survey Sample Size for Respondents Aged 12 or Older, by Underage and Legal Drinking Age Groups and Demographic Characteristics: 2015 and 2016

12.4A – Numbers (in Thousands) of Persons Aged 12 or Older, by Age Group and Geographic, Socioeconomic, and Health Characteristics: 2015 and 2016

12.4N – Survey Sample Size for Respondents Aged 12 or Older, by Age Group and Geographic, Socioeconomic, and Health Characteristics: 2015 and 2016

12.5A – Numbers (in Thousands) of Persons Aged 12 or Older, by Underage and Legal Drinking Age Groups and Geographic and Socioeconomic Characteristics: 2015 and 2016

12.5N – Survey Sample Size for Respondents Aged 12 or Older, by Underage and Legal Drinking Age Groups and Geographic and Socioeconomic Characteristics: 2015 and 2016

12.6A – Numbers (in Thousands) of Persons Aged 12 or Older, by Youth and Adult Demographic Characteristics: 2002-2016

12.6N – Survey Sample Size for Respondents Aged 12 or Older, by Youth and Adult Demographic Characteristics: 2002-2016

12.7A – Numbers (in Thousands) of Females Aged 15 to 44, by Pregnancy Status and Demographic, Socioeconomic, and Pregnancy Characteristics: 2015 and 2016

12.7N – Survey Sample Size for Female Respondents Aged 15 to 44 by Pregnancy Status and Demographic, Socioeconomic, and Pregnancy Characteristics: 2015 and 2016

12.8A – Numbers (in Thousands) of Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: 2015 and 2016

12.8N – Survey Sample Size for Respondents Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: 2015 and 2016

12.9A – Numbers (in Thousands) of Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: 2015 and 2016

12.9N – Survey Sample Size for Respondents Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: 2015 and 2016

Sample Size and Population Tables – 12.1 to 12.9 (Standard Errors)

12.1C – Standard Errors of Numbers (in Thousands) of Persons Aged 12 or Older, by Gender and Detailed Age Category: 2015 and 2016

12.2C – Standard Errors of Numbers (in Thousands) of Persons Aged 12 or Older, by Age Group and Demographic Characteristics: 2015 and 2016

12.3C – Standard Errors of Numbers (in Thousands) of Persons Aged 12 or Older, by Underage and Legal Drinking Age Groups and Demographic Characteristics: 2015 and 2016

12.4C – Standard Errors of Numbers (in Thousands) of Persons Aged 12 or Older, by Age Group and Geographic, Socioeconomic, and Health Characteristics: 2015 and 2016

12.5C – Standard Errors of Numbers (in Thousands) of Persons Aged 12 or Older, by Underage and Legal Drinking Age Groups and Geographic and Socioeconomic Characteristics: 2015 and 2016

12.6C – Standard Errors of Numbers (in Thousands) of Persons Aged 12 or Older, by Youth and Adult Demographic Characteristics: 2002-2016

12.7C – Standard Errors of Numbers (in Thousands) of Females Aged 15 to 44, by Pregnancy Status and Demographic, Socioeconomic, and Pregnancy Characteristics: 2015 and 2016

12.8C – Standard Errors of Numbers (in Thousands) of Persons Aged 18 to 22, by College Enrollment Status and Demographic Characteristics: 2015 and 2016

12.9C – Standard Errors of Numbers (in Thousands) of Persons Aged 18 or Older, by Past Year Probation and Parole/Supervised Release Statuses and Demographic Characteristics: 2015 and 2016

170410
Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 130,610 130,628 47,730 48,501 27,080a 28,564
Marijuana 117,865 118,524 36,043a 37,570 22,226b 23,981
Cocaine 38,744 38,880 4,828 5,071 1,876 1,874
Crack 9,035 8,776 833 882 394 432
Heroin 5,099 4,981 828 948 329 475
Hallucinogens 40,915 41,490 4,692 4,903 1,240 1,390
LSD 25,324 25,861 1,535b 1,896 352 374
PCP 6,323 6,450 120 103 25 21
Ecstasy 18,328 18,459 2,560 2,485 557 619
Inhalants 25,765a 24,404 1,759 1,660 527 600
Methamphetamine 14,511 14,533 1,713a 1,391 897a 667
Misuse of Psychotherapeutics3,4 nr nr 18,942 18,671 6,365 6,207
Pain Relievers4 nr nr 12,462a 11,517 3,775 3,350
Tranquilizers nr nr 6,050 6,060 1,874 1,953
Stimulants nr nr 5,251 5,647 1,653 1,735
Sedatives nr nr 1,511 1,531 446 497
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 12,693a 11,824 3,963 3,649
170410
Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 48.8 48.5 17.8 18.0 10.1a 10.6
Marijuana 44.0 44.0 13.5 13.9 8.3b 8.9
Cocaine 14.5 14.4 1.8 1.9 0.7 0.7
Crack 3.4 3.3 0.3 0.3 0.1 0.2
Heroin 1.9 1.8 0.3 0.4 0.1 0.2
Hallucinogens 15.3 15.4 1.8 1.8 0.5 0.5
LSD 9.5 9.6 0.6b 0.7 0.1 0.1
PCP 2.4 2.4 0.0 0.0 0.0 0.0
Ecstasy 6.8 6.9 1.0 0.9 0.2 0.2
Inhalants 9.6a 9.1 0.7 0.6 0.2 0.2
Methamphetamine 5.4 5.4 0.6a 0.5 0.3a 0.2
Misuse of Psychotherapeutics3,4 nr nr 7.1 6.9 2.4 2.3
Pain Relievers4 nr nr 4.7a 4.3 1.4 1.2
Tranquilizers nr nr 2.3 2.2 0.7 0.7
Stimulants nr nr 2.0 2.1 0.6 0.6
Sedatives nr nr 0.6 0.6 0.2 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 4.7a 4.4 1.5 1.4
170410
Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 6,297b 5,737 4,346b 3,941 2,193a 1,959
Marijuana 3,912 3,676 3,137 2,982 1,752 1,609
Cocaine 208 212 153 136 53 28
Crack 12 17 5 11 1 3
Heroin 35 32 21 13 5 3
Hallucinogens 760 674 523 456 121 114
LSD 329 288 251 204 53 42
PCP 60 38 34 18 9 5
Ecstasy 357 288 201 177 33 29
Inhalants 2,271a 2,065 684a 554 175 149
Methamphetamine 71 69 40 32 13 9
Misuse of Psychotherapeutics3,4 nr nr 1,464 1,317 492a 389
Pain Relievers4 nr nr 969 881 276 239
Tranquilizers nr nr 394 434 162 121
Stimulants nr nr 491 427 117 92
Sedatives nr nr 102 100 21 23
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 980 891 277 241
170410
Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 25.3b 23.0 17.5b 15.8 8.8a 7.9
Marijuana 15.7 14.8 12.6 12.0 7.0 6.5
Cocaine 0.8 0.9 0.6 0.5 0.2 0.1
Crack 0.1 0.1 0.0 0.0 0.0 0.0
Heroin 0.1 0.1 0.1 0.1 0.0 0.0
Hallucinogens 3.1 2.7 2.1 1.8 0.5 0.5
LSD 1.3 1.2 1.0 0.8 0.2 0.2
PCP 0.2 0.2 0.1 0.1 0.0 0.0
Ecstasy 1.4 1.2 0.8 0.7 0.1 0.1
Inhalants 9.1a 8.3 2.7a 2.2 0.7 0.6
Methamphetamine 0.3 0.3 0.2 0.1 0.1 0.0
Misuse of Psychotherapeutics3,4 nr nr 5.9 5.3 2.0a 1.6
Pain Relievers4 nr nr 3.9 3.5 1.1 1.0
Tranquilizers nr nr 1.6 1.7 0.7 0.5
Stimulants nr nr 2.0 1.7 0.5 0.4
Sedatives nr nr 0.4 0.4 0.1 0.1
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 3.9 3.6 1.1 1.0
170410
Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 959a 820 536 443 206 158
Marijuana 196 160 134 132 66 59
Cocaine 9 5 6 3 4 *
Crack * 2 * 2 * *
Heroin 0 2 * 2 * *
Hallucinogens 89 65 69 37 21 11
LSD 37b 5 30b 2 9 2
PCP 18 2 13 1 5 *
Ecstasy 12 12 7 7 1 1
Inhalants 622 530 264 200 80 55
Methamphetamine 3 6 2 1 * *
Misuse of Psychotherapeutics3,4 nr nr 174 156 70 53
Pain Relievers4 nr nr 149 127 64 50
Tranquilizers nr nr 18 20 9 2
Stimulants nr nr 11 17 3 3
Sedatives nr nr 8 13 1 *
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 149 129 64 50
170410
Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 12.2a 10.5 6.8 5.7 2.6 2.0
Marijuana 2.5 2.0 1.7 1.7 0.8 0.8
Cocaine 0.1 0.1 0.1 0.0 0.1 *
Crack * 0.0 * 0.0 * *
Heroin 0.0 0.0 * 0.0 * *
Hallucinogens 1.1 0.8 0.9 0.5 0.3 0.1
LSD 0.5b 0.1 0.4b 0.0 0.1 0.0
PCP 0.2 0.0 0.2 0.0 0.1 *
Ecstasy 0.2 0.1 0.1 0.1 0.0 0.0
Inhalants 7.9 6.8 3.4 2.5 1.0 0.7
Methamphetamine 0.0 0.1 0.0 0.0 * *
Misuse of Psychotherapeutics3,4 nr nr 2.2 2.0 0.9 0.7
Pain Relievers4 nr nr 1.9 1.6 0.8 0.6
Tranquilizers nr nr 0.2 0.3 0.1 0.0
Stimulants nr nr 0.1 0.2 0.0 0.0
Sedatives nr nr 0.1 0.2 0.0 *
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 1.9 1.7 0.8 0.6
170410
Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 2,036 1,899 1,336 1,282 622 578
Marijuana 1,128 1,145 926 954 492 458
Cocaine 29 52 23 33 6 9
Crack 2 3 * 1 * 1
Heroin 6 10 6 2 2 *
Hallucinogens 176 166 129 118 29 36
LSD 67 62 46 48 9 12
PCP 18 10 8 5 * 2
Ecstasy 79 89 57 60 13 7
Inhalants 849 776 250 216 54 42
Methamphetamine 12 14 8 9 1 3
Misuse of Psychotherapeutics3,4 nr nr 425 413 143 133
Pain Relievers4 nr nr 304 303 85 76
Tranquilizers nr nr 98 129 33 38
Stimulants nr nr 115 121 37 34
Sedatives nr nr 29 34 11 13
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 306 305 85 76
170410
Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 23.6 22.1 15.5 14.9 7.2 6.7
Marijuana 13.1 13.3 10.7 11.1 5.7 5.3
Cocaine 0.3 0.6 0.3 0.4 0.1 0.1
Crack 0.0 0.0 * 0.0 * 0.0
Heroin 0.1 0.1 0.1 0.0 0.0 *
Hallucinogens 2.0 1.9 1.5 1.4 0.3 0.4
LSD 0.8 0.7 0.5 0.6 0.1 0.1
PCP 0.2 0.1 0.1 0.1 * 0.0
Ecstasy 0.9 1.0 0.7 0.7 0.1 0.1
Inhalants 9.8 9.0 2.9 2.5 0.6 0.5
Methamphetamine 0.1 0.2 0.1 0.1 0.0 0.0
Misuse of Psychotherapeutics3,4 nr nr 4.9 4.8 1.7 1.5
Pain Relievers4 nr nr 3.5 3.5 1.0 0.9
Tranquilizers nr nr 1.1 1.5 0.4 0.4
Stimulants nr nr 1.3 1.4 0.4 0.4
Sedatives nr nr 0.3 0.4 0.1 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 3.5 3.5 1.0 0.9
170410
Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 3,303a 3,018 2,474a 2,217 1,364 1,224
Marijuana 2,589a 2,372 2,077 1,895 1,194 1,092
Cocaine 171 154 123 100 43 19
Crack 11 12 5 7 1 2
Heroin 29 19 15 9 3 3
Hallucinogens 495 443 325 302 72 68
LSD 225 221 174 155 35 28
PCP 24 26 13 12 4 3
Ecstasy 265a 187 137 110 20 22
Inhalants 800 760 169 138 41 51
Methamphetamine 57 49 30 21 12 6
Misuse of Psychotherapeutics3,4 nr nr 865 748 279a 203
Pain Relievers4 nr nr 516 452 127 112
Tranquilizers nr nr 278 285 120 80
Stimulants nr nr 364 289 77 55
Sedatives nr nr 65 53 10 9
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 525 456 128 115
170410
Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 39.4b 35.7 29.5b 26.2 16.3a 14.5
Marijuana 30.9a 28.0 24.8a 22.4 14.2 12.9
Cocaine 2.0 1.8 1.5 1.2 0.5 0.2
Crack 0.1 0.1 0.1 0.1 0.0 0.0
Heroin 0.3 0.2 0.2 0.1 0.0 0.0
Hallucinogens 5.9 5.2 3.9 3.6 0.9 0.8
LSD 2.7 2.6 2.1 1.8 0.4 0.3
PCP 0.3 0.3 0.2 0.1 0.0 0.0
Ecstasy 3.2a 2.2 1.6 1.3 0.2 0.3
Inhalants 9.5 9.0 2.0 1.6 0.5 0.6
Methamphetamine 0.7 0.6 0.4 0.3 0.1 0.1
Misuse of Psychotherapeutics3,4 nr nr 10.3a 8.8 3.3a 2.4
Pain Relievers4 nr nr 6.2 5.3 1.5 1.3
Tranquilizers nr nr 3.3 3.4 1.4 0.9
Stimulants nr nr 4.3 3.4 0.9 0.7
Sedatives nr nr 0.8 0.6 0.1 0.1
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 6.3 5.4 1.5 1.4
170410
Table 1.6A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 124,313 124,891 43,384 44,559 24,887b 26,605
Marijuana 113,952 114,847 32,906a 34,588 20,474b 22,373
Cocaine 38,535 38,668 4,675 4,936 1,822 1,847
Crack 9,022 8,759 828 871 393 429
Heroin 5,064 4,950 807 934 325 471
Hallucinogens 40,155 40,816 4,169 4,447 1,118 1,276
LSD 24,994 25,573 1,284b 1,692 299 332
PCP 6,262 6,412 86 85 17 17
Ecstasy 17,971 18,171 2,359 2,308 524 590
Inhalants 23,494 22,339 1,076 1,106 352 451
Methamphetamine 14,440 14,464 1,673a 1,360 885a 658
Misuse of Psychotherapeutics3,4 nr nr 17,478 17,354 5,873 5,818
Pain Relievers4 nr nr 11,492a 10,635 3,499 3,111
Tranquilizers nr nr 5,656 5,626 1,712 1,832
Stimulants nr nr 4,760a 5,220 1,536 1,643
Sedatives nr nr 1,409 1,431 425 474
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 11,712 10,933 3,686 3,408
170410
Table 1.6B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 51.2 51.1 17.9 18.2 10.2a 10.9
Marijuana 46.9 47.0 13.6a 14.1 8.4b 9.1
Cocaine 15.9 15.8 1.9 2.0 0.8 0.8
Crack 3.7 3.6 0.3 0.4 0.2 0.2
Heroin 2.1 2.0 0.3 0.4 0.1 0.2
Hallucinogens 16.5 16.7 1.7 1.8 0.5 0.5
LSD 10.3 10.5 0.5b 0.7 0.1 0.1
PCP 2.6 2.6 0.0 0.0 0.0 0.0
Ecstasy 7.4 7.4 1.0 0.9 0.2 0.2
Inhalants 9.7a 9.1 0.4 0.5 0.1 0.2
Methamphetamine 5.9 5.9 0.7a 0.6 0.4a 0.3
Misuse of Psychotherapeutics3,4 nr nr 7.2 7.1 2.4 2.4
Pain Relievers4 nr nr 4.7a 4.3 1.4 1.3
Tranquilizers nr nr 2.3 2.3 0.7 0.7
Stimulants nr nr 2.0 2.1 0.6 0.7
Sedatives nr nr 0.6 0.6 0.2 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 4.8a 4.5 1.5 1.4
170410
Table 1.7A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 20,083a 19,469 13,102 13,034 7,797 8,012
Marijuana 18,392 17,897 11,246 11,401 6,921 7,184
Cocaine 4,074 3,901 1,876 1,919 580 552
Crack 531b 387 109 90 39 15
Heroin 616 539 217 227 88 88
Hallucinogens 6,486b 5,940 2,453 2,388 636 668
LSD 2,691 2,884 979a 1,161 219 209
PCP 267 235 32 15 2 *
Ecstasy 4,561b 4,018 1,422a 1,223 307 303
Inhalants 3,463 3,387 487 485 126 121
Methamphetamine 1,135b 836 329 265 128a 65
Misuse of Psychotherapeutics3,4 nr nr 5,330 5,026 1,766 1,600
Pain Relievers4 nr nr 2,979b 2,454 829b 631
Tranquilizers nr nr 1,874 1,844 582 536
Stimulants nr nr 2,537 2,578 757 767
Sedatives nr nr 265 256 86 50
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 3,029b 2,516 880b 688
170410
Table 1.7B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 57.5 56.3 37.5 37.7 22.3 23.2
Marijuana 52.7 51.8 32.2 33.0 19.8 20.8
Cocaine 11.7 11.3 5.4 5.6 1.7 1.6
Crack 1.5b 1.1 0.3 0.3 0.1 0.0
Heroin 1.8 1.6 0.6 0.7 0.3 0.3
Hallucinogens 18.6a 17.2 7.0 6.9 1.8 1.9
LSD 7.7 8.3 2.8a 3.4 0.6 0.6
PCP 0.8 0.7 0.1 0.0 0.0 *
Ecstasy 13.1b 11.6 4.1a 3.5 0.9 0.9
Inhalants 9.9 9.8 1.4 1.4 0.4 0.4
Methamphetamine 3.3b 2.4 0.9 0.8 0.4a 0.2
Misuse of Psychotherapeutics3,4 nr nr 15.3 14.5 5.1 4.6
Pain Relievers4 nr nr 8.5b 7.1 2.4b 1.8
Tranquilizers nr nr 5.4 5.3 1.7 1.5
Stimulants nr nr 7.3 7.5 2.2 2.2
Sedatives nr nr 0.8 0.7 0.2 0.1
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 8.7b 7.3 2.5b 2.0
170410
Table 1.8A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 6,717 6,441 4,916 4,969 2,921 3,032
Marijuana 6,029 5,787 4,378 4,423 2,661 2,762
Cocaine 887 874 563 608 166 150
Crack 93 70 29 30 9 2
Heroin 128 113 50 53 14 14
Hallucinogens 1,781 1,593 1,015 1,000 256 278
LSD 834 902 420a 548 109 86
PCP 70 45 15 5 1 *
Ecstasy 1,120b 883 541 455 106 108
Inhalants 1,123 1,029 218 227 59 57
Methamphetamine 255 192 104 91 41 19
Misuse of Psychotherapeutics3,4 nr nr 1,825 1,861 606 602
Pain Relievers4 nr nr 954 835 235 213
Tranquilizers nr nr 679 757 216 209
Stimulants nr nr 894 998 302 317
Sedatives nr nr 111 83 24 16
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 966 852 242 227
170410
Table 1.8B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 51.7 50.6 37.8 39.1 22.5 23.8
Marijuana 46.4 45.5 33.7 34.8 20.5 21.7
Cocaine 6.8 6.9 4.3 4.8 1.3 1.2
Crack 0.7 0.5 0.2 0.2 0.1 0.0
Heroin 1.0 0.9 0.4 0.4 0.1 0.1
Hallucinogens 13.7 12.5 7.8 7.9 2.0 2.2
LSD 6.4 7.1 3.2a 4.3 0.8 0.7
PCP 0.5 0.4 0.1 0.0 0.0 *
Ecstasy 8.6b 6.9 4.2 3.6 0.8 0.8
Inhalants 8.6 8.1 1.7 1.8 0.5 0.4
Methamphetamine 2.0 1.5 0.8 0.7 0.3 0.1
Misuse of Psychotherapeutics3,4 nr nr 14.0 14.6 4.7 4.7
Pain Relievers4 nr nr 7.3 6.6 1.8 1.7
Tranquilizers nr nr 5.2 6.0 1.7 1.6
Stimulants nr nr 6.9 7.8 2.3 2.5
Sedatives nr nr 0.9 0.7 0.2 0.1
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 7.4 6.7 1.9 1.8
170410
Table 1.9A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 13,366 13,028 8,186 8,065 4,877 4,980
Marijuana 12,363 12,111 6,868 6,979 4,260 4,422
Cocaine 3,186 3,027 1,313 1,311 414 402
Crack 438a 317 81 60 30 13
Heroin 488 425 167 173 74 74
Hallucinogens 4,705a 4,347 1,438 1,388 380 389
LSD 1,857 1,982 560 613 111 123
PCP 197 189 17 10 * 1
Ecstasy 3,440a 3,134 882 768 201 195
Inhalants 2,340 2,358 269 259 66 65
Methamphetamine 879b 643 226 173 87 46
Misuse of Psychotherapeutics3,4 nr nr 3,505a 3,166 1,160 998
Pain Relievers4 nr nr 2,026b 1,619 594b 417
Tranquilizers nr nr 1,195 1,087 366 327
Stimulants nr nr 1,643 1,580 455 450
Sedatives nr nr 155 172 61 33
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 2,063b 1,664 638b 461
170410
Table 1.9B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 61.0 59.6 37.4 36.9 22.3 22.8
Marijuana 56.4 55.4 31.3 31.9 19.4 20.2
Cocaine 14.5 13.9 6.0 6.0 1.9 1.8
Crack 2.0a 1.5 0.4 0.3 0.1 0.1
Heroin 2.2 1.9 0.8 0.8 0.3 0.3
Hallucinogens 21.5a 19.9 6.6 6.4 1.7 1.8
LSD 8.5 9.1 2.6 2.8 0.5 0.6
PCP 0.9 0.9 0.1 0.0 * 0.0
Ecstasy 15.7a 14.3 4.0 3.5 0.9 0.9
Inhalants 10.7 10.8 1.2 1.2 0.3 0.3
Methamphetamine 4.0b 2.9 1.0 0.8 0.4 0.2
Misuse of Psychotherapeutics3,4 nr nr 16.0a 14.5 5.3a 4.6
Pain Relievers4 nr nr 9.2b 7.4 2.7b 1.9
Tranquilizers nr nr 5.5 5.0 1.7 1.5
Stimulants nr nr 7.5 7.2 2.1 2.1
Sedatives nr nr 0.7 0.8 0.3 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 9.4b 7.6 2.9b 2.1
170410
Table 1.10A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 104,230 105,422 30,281 31,525 17,090a 18,593
Marijuana 95,561 96,950 21,660a 23,187 13,552b 15,188
Cocaine 34,462 34,767 2,799 3,017 1,243 1,295
Crack 8,491 8,372 718 781 354 414
Heroin 4,448 4,411 591 708 236a 383
Hallucinogens 33,669 34,876 1,716 2,059 482 608
LSD 22,304 22,689 305b 531 80 123
PCP 5,995 6,178 54 69 15 15
Ecstasy 13,411 14,154 937 1,084 217 286
Inhalants 20,031 18,952 588 620 226 329
Methamphetamine 13,305 13,628 1,344 1,095 757 594
Misuse of Psychotherapeutics3,4 nr nr 12,148 12,327 4,107 4,218
Pain Relievers4 nr nr 8,513 8,181 2,670 2,480
Tranquilizers nr nr 3,782 3,781 1,130 1,296
Stimulants nr nr 2,223a 2,643 779 876
Sedatives nr nr 1,143 1,176 340 425
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 8,683 8,417 2,806 2,720
170410
Table 1.10B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 50.1 50.2 14.6 15.0 8.2a 8.9
Marijuana 46.0 46.2 10.4 11.0 6.5b 7.2
Cocaine 16.6 16.6 1.3 1.4 0.6 0.6
Crack 4.1 4.0 0.3 0.4 0.2 0.2
Heroin 2.1 2.1 0.3 0.3 0.1 0.2
Hallucinogens 16.2 16.6 0.8 1.0 0.2 0.3
LSD 10.7 10.8 0.1b 0.3 0.0 0.1
PCP 2.9 2.9 0.0 0.0 0.0 0.0
Ecstasy 6.5 6.7 0.5 0.5 0.1 0.1
Inhalants 9.6a 9.0 0.3 0.3 0.1 0.2
Methamphetamine 6.4 6.5 0.6 0.5 0.4 0.3
Misuse of Psychotherapeutics3,4 nr nr 5.8 5.9 2.0 2.0
Pain Relievers4 nr nr 4.1 3.9 1.3 1.2
Tranquilizers nr nr 1.8 1.8 0.5 0.6
Stimulants nr nr 1.1a 1.3 0.4 0.4
Sedatives nr nr 0.5 0.6 0.2 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 4.2 4.0 1.3 1.3
170410
Table 1.11A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 23,098 23,423 10,174a 10,885 5,901a 6,520
Marijuana 21,187 21,770 7,902b 8,671 4,933b 5,629
Cocaine 6,873 6,960 1,221 1,457 464 507
Crack 1,426 1,394 92 147 45 49
Heroin 981a 1,214 293 331 116 151
Hallucinogens 8,514 8,913 1,146 1,383 327 415
LSD 3,702 3,942 231a 391 45 90
PCP 600 602 25 11 8 9
Ecstasy 6,030 6,457 741 834 195 261
Inhalants 4,902 4,533 278 315 90 161
Methamphetamine 2,738 2,618 406 361 174 139
Misuse of Psychotherapeutics3,4 nr nr 4,148 4,247 1,410 1,397
Pain Relievers4 nr nr 2,818 2,671 820 729
Tranquilizers nr nr 1,342 1,289 400 428
Stimulants nr nr 1,316 1,495 433 468
Sedatives nr nr 337 337 115 84
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 2,886 2,779 874 828
170410
Table 1.11B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 60.3 60.3 26.5 28.0 15.4a 16.8
Marijuana 55.3 56.1 20.6a 22.3 12.9b 14.5
Cocaine 17.9 17.9 3.2 3.8 1.2 1.3
Crack 3.7 3.6 0.2 0.4 0.1 0.1
Heroin 2.6a 3.1 0.8 0.9 0.3 0.4
Hallucinogens 22.2 23.0 3.0 3.6 0.9 1.1
LSD 9.7 10.2 0.6a 1.0 0.1 0.2
PCP 1.6 1.6 0.1 0.0 0.0 0.0
Ecstasy 15.7 16.6 1.9 2.1 0.5 0.7
Inhalants 12.8 11.7 0.7 0.8 0.2 0.4
Methamphetamine 7.1 6.7 1.1 0.9 0.5 0.4
Misuse of Psychotherapeutics3,4 nr nr 10.8 10.9 3.7 3.6
Pain Relievers4 nr nr 7.4 6.9 2.1 1.9
Tranquilizers nr nr 3.5 3.3 1.0 1.1
Stimulants nr nr 3.4 3.9 1.1 1.2
Sedatives nr nr 0.9 0.9 0.3 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 7.5 7.2 2.3 2.1
170410
Table 1.12A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 81,132 81,999 20,107 20,640 11,188 12,073
Marijuana 74,374 75,180 13,758 14,515 8,619a 9,560
Cocaine 27,588 27,807 1,579 1,560 779 788
Crack 7,066 6,978 626 634 309 365
Heroin 3,468 3,197 298 377 120 231
Hallucinogens 25,155 25,963 570 676 155 193
LSD 18,602 18,747 74 140 35 33
PCP 5,395 5,575 29 58 * *
Ecstasy 7,381 7,697 196 250 22 25
Inhalants 15,129 14,419 310 306 136 168
Methamphetamine 10,567 11,010 938 734 582 454
Misuse of Psychotherapeutics3,4 nr nr 8,000 8,080 2,697 2,820
Pain Relievers4 nr nr 5,696 5,510 1,850 1,752
Tranquilizers nr nr 2,440 2,493 730 868
Stimulants nr nr 907 1,148 346 409
Sedatives nr nr 806 839 224 341
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 5,797 5,637 1,932 1,892
170410
Table 1.12B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 47.8 47.9 11.9 12.1 6.6 7.1
Marijuana 43.9 43.9 8.1 8.5 5.1 5.6
Cocaine 16.3 16.2 0.9 0.9 0.5 0.5
Crack 4.2 4.1 0.4 0.4 0.2 0.2
Heroin 2.0 1.9 0.2 0.2 0.1 0.1
Hallucinogens 14.8 15.2 0.3 0.4 0.1 0.1
LSD 11.0 11.0 0.0 0.1 0.0 0.0
PCP 3.2 3.3 0.0 0.0 * *
Ecstasy 4.4 4.5 0.1 0.1 0.0 0.0
Inhalants 8.9 8.4 0.2 0.2 0.1 0.1
Methamphetamine 6.2 6.4 0.6 0.4 0.3 0.3
Misuse of Psychotherapeutics3,4 nr nr 4.7 4.7 1.6 1.6
Pain Relievers4 nr nr 3.4 3.2 1.1 1.0
Tranquilizers nr nr 1.4 1.5 0.4 0.5
Stimulants nr nr 0.5 0.7 0.2 0.2
Sedatives nr nr 0.5 0.5 0.1 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 3.4 3.3 1.1 1.1
170410
Table 1.13A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 69,822 68,325 26,576 27,032 16,164 16,779
Marijuana 63,490 62,697 20,934 21,839 13,715a 14,696
Cocaine 23,269 23,383 3,069 3,238 1,234 1,257
Crack 5,903 5,580 598 549 268 263
Heroin 3,540 3,281 548 596 238 295
Hallucinogens 24,410 24,401 3,039 3,061 885 863
LSD 15,830 16,098 1,047a 1,330 264 252
PCP 4,322 4,460 69 69 11 14
Ecstasy 10,526 10,388 1,651 1,479 390 366
Inhalants 16,103 15,090 997 988 328 378
Methamphetamine 8,856 8,498 1,166b 782 631a 387
Misuse of Psychotherapeutics3,4 nr nr 10,121 9,605 3,342 3,045
Pain Relievers4 nr nr 6,924a 6,226 2,110a 1,692
Tranquilizers nr nr 3,148 2,870 974 1,002
Stimulants nr nr 3,027 2,985 877 881
Sedatives nr nr 596 691 153 214
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 7,088a 6,420 2,246a 1,883
170410
Table 1.13B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 53.8a 52.3 20.5 20.7 12.5 12.8
Marijuana 48.9 48.0 16.1 16.7 10.6 11.3
Cocaine 17.9 17.9 2.4 2.5 1.0 1.0
Crack 4.5 4.3 0.5 0.4 0.2 0.2
Heroin 2.7 2.5 0.4 0.5 0.2 0.2
Hallucinogens 18.8 18.7 2.3 2.3 0.7 0.7
LSD 12.2 12.3 0.8a 1.0 0.2 0.2
PCP 3.3 3.4 0.1 0.1 0.0 0.0
Ecstasy 8.1 8.0 1.3 1.1 0.3 0.3
Inhalants 12.4a 11.6 0.8 0.8 0.3 0.3
Methamphetamine 6.8 6.5 0.9b 0.6 0.5a 0.3
Misuse of Psychotherapeutics3,4 nr nr 7.8 7.4 2.6 2.3
Pain Relievers4 nr nr 5.3a 4.8 1.6a 1.3
Tranquilizers nr nr 2.4 2.2 0.8 0.8
Stimulants nr nr 2.3 2.3 0.7 0.7
Sedatives nr nr 0.5 0.5 0.1 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 5.5a 4.9 1.7a 1.4
170410
Table 1.14A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 60,788 62,303 21,154 21,469 10,915a 11,786
Marijuana 54,375 55,827 15,109 15,731 8,511a 9,285
Cocaine 15,475 15,497 1,758 1,833 641 617
Crack 3,132 3,196 235 334 126 169
Heroin 1,559 1,700 280 352 91a 179
Hallucinogens 16,506 17,089 1,653 1,842 355b 527
LSD 9,494 9,763 487 566 88 122
PCP 2,001 1,990 51 33 14 7
Ecstasy 7,803 8,071 909 1,006 167a 253
Inhalants 9,662 9,314 762 671 199 222
Methamphetamine 5,655 6,035 547 609 266 280
Misuse of Psychotherapeutics3,4 nr nr 8,821 9,065 3,024 3,162
Pain Relievers4 nr nr 5,538 5,291 1,665 1,658
Tranquilizers nr nr 2,903 3,190 900 951
Stimulants nr nr 2,224b 2,662 776 854
Sedatives nr nr 915 840 293 283
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 5,605 5,403 1,718 1,766
170410
Table 1.14B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 44.1 44.9 15.3 15.5 7.9a 8.5
Marijuana 39.4 40.2 11.0 11.3 6.2a 6.7
Cocaine 11.2 11.2 1.3 1.3 0.5 0.4
Crack 2.3 2.3 0.2 0.2 0.1 0.1
Heroin 1.1 1.2 0.2 0.3 0.1a 0.1
Hallucinogens 12.0 12.3 1.2 1.3 0.3b 0.4
LSD 6.9 7.0 0.4 0.4 0.1 0.1
PCP 1.5 1.4 0.0 0.0 0.0 0.0
Ecstasy 5.7 5.8 0.7 0.7 0.1 0.2
Inhalants 7.0 6.7 0.6 0.5 0.1 0.2
Methamphetamine 4.1 4.3 0.4 0.4 0.2 0.2
Misuse of Psychotherapeutics3,4 nr nr 6.4 6.5 2.2 2.3
Pain Relievers4 nr nr 4.0 3.8 1.2 1.2
Tranquilizers nr nr 2.1 2.3 0.7 0.7
Stimulants nr nr 1.6b 1.9 0.6 0.6
Sedatives nr nr 0.7 0.6 0.2 0.2
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 4.1 3.9 1.2 1.3
170410
Table 1.15A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 130,610 130,628 47,730 48,501 27,080a 28,564
12-17 6,297b 5,737 4,346b 3,941 2,193a 1,959
12 374a 285 210 157 81 53
13 585 534 326 286 125 105
14 848 745 541 502 228 193
15 1,188 1,154 795 780 394 385
16 1,557b 1,331 1,162b 961 581 513
17 1,746 1,687 1,312 1,256 783 712
18 or Older 124,313 124,891 43,384 44,559 24,887b 26,605
18-25 20,083a 19,469 13,102 13,034 7,797 8,012
18 2,046 2,015 1,534 1,586 848 933
19 2,274 2,053 1,721 1,638 1,026 1,019
20 2,397 2,373 1,661 1,745 1,047 1,079
21 2,406 2,527 1,671 1,782 964 1,107
22 2,559 2,530 1,638 1,590 1,001 975
23 2,766 2,716 1,653 1,594 1,015 987
24 2,818 2,575 1,679 1,588 962 1,008
25 2,818 2,680 1,546 1,510 935 902
26 or Older 104,230 105,422 30,281 31,525 17,090a 18,593
26-29 10,620 10,647 5,166 5,475 3,038 3,272
30-34 12,478 12,776 5,008 5,410 2,863a 3,248
35-39 10,706b 11,829 3,705 3,905 2,067 2,393
40-44 10,335 9,973 2,964 2,904 1,714 1,636
45-49 11,497 11,119 3,051 3,025 1,790 1,869
50-54 13,847 12,754 3,556 3,073 1,917 1,701
55-59 12,832 13,164 2,976 3,291 1,681 2,039
60-64 9,987 10,436 1,888 1,922 1,152 1,029
65 or Older 11,928 12,725 1,967a 2,521 866b 1,405
170410
Table 1.15B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 48.8 48.5 17.8 18.0 10.1a 10.6
12-17 25.3b 23.0 17.5b 15.8 8.8a 7.9
12 9.7a 7.6 5.4 4.2 2.1 1.4
13 14.6 13.1 8.1 7.0 3.1 2.6
14 19.6 17.9 12.5 12.0 5.3 4.6
15 27.5 26.0 18.4 17.6 9.1 8.7
16 36.9b 31.0 27.5b 22.4 13.7 11.9
17 41.9 40.5 31.5 30.1 18.8 17.1
18 or Older 51.2 51.1 17.9 18.2 10.2a 10.9
18-25 57.5 56.3 37.5 37.7 22.3 23.2
18 44.9 44.1 33.7 34.7 18.6 20.4
19 53.4 52.1 40.4 41.6 24.1 25.9
20 57.4 56.3 39.8 41.4 25.1 25.6
21 58.3 58.4 40.5 41.2 23.3 25.6
22 60.1 59.3 38.5 37.3 23.5 22.9
23 61.7 60.5 36.9 35.5 22.6 22.0
24 62.7 59.6 37.4 36.8 21.4 23.3
25 61.8 60.2 33.9 33.9 20.5 20.2
26 or Older 50.1 50.2 14.6 15.0 8.2a 8.9
26-29 62.0 61.1 30.1 31.4 17.7 18.8
30-34 58.9 59.7 23.6 25.3 13.5a 15.2
35-39 55.0 57.5 19.0 19.0 10.6 11.6
40-44 51.5 51.1 14.8 14.9 8.5 8.4
45-49 55.3 55.0 14.7 15.0 8.6 9.2
50-54 60.1 58.4 15.4 14.1 8.3 7.8
55-59 60.9 60.2 14.1 15.0 8.0 9.3
60-64 53.6 54.5 10.1 10.0 6.2 5.4
65 or Older 25.6 26.5 4.2 5.3 1.9a 2.9
170410
Table 1.16A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 117,865 118,524 36,043a 37,570 22,226b 23,981
12-17 3,912 3,676 3,137 2,982 1,752 1,609
12 56a 29 32 19 11 9
13 140 131 102 114 56 50
14 375 392 302 338 153 143
15 752 753 624 616 339 316
16 1,166a 994 943a 804 503 443
17 1,423 1,378 1,134 1,091 690 649
18 or Older 113,952 114,847 32,906a 34,588 20,474b 22,373
18-25 18,392 17,897 11,246 11,401 6,921 7,184
18 1,801 1,763 1,381 1,403 764 876
19 2,044 1,840 1,501 1,458 924 917
20 2,185 2,184 1,496 1,562 973 969
21 2,222 2,342 1,432 1,580 862 1,008
22 2,364 2,301 1,399 1,396 896 830
23 2,561 2,532 1,398 1,374 907 885
24 2,626 2,427 1,392 1,375 814 900
25 2,590 2,508 1,247 1,254 780 799
26 or Older 95,561 96,950 21,660a 23,187 13,552b 15,188
26-29 9,777 9,957 4,059 4,466 2,574 2,869
30-34 11,410 11,813 3,843 4,206 2,359a 2,760
35-39 9,674b 10,992 2,705 3,031 1,645a 1,994
40-44 9,269 8,890 1,994 2,007 1,284 1,245
45-49 10,623 10,165 2,087 2,252 1,279 1,548
50-54 13,132a 11,611 2,408 1,980 1,433 1,267
55-59 12,056 12,383 2,058 2,307 1,426 1,570
60-64 9,424 9,921 1,371 1,351 917 838
65 or Older 10,196 11,218 1,135a 1,587 636a 1,097
170410
Table 1.16B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 44.0 44.0 13.5 13.9 8.3b 8.9
12-17 15.7 14.8 12.6 12.0 7.0 6.5
12 1.4a 0.8 0.8 0.5 0.3 0.2
13 3.5 3.2 2.6 2.8 1.4 1.2
14 8.7 9.4 7.0 8.1 3.5 3.4
15 17.4 17.0 14.4 13.9 7.9 7.1
16 27.6b 23.2 22.3b 18.7 11.9 10.3
17 34.2 33.0 27.2 26.2 16.6 15.5
18 or Older 46.9 47.0 13.6a 14.1 8.4b 9.1
18-25 52.7 51.8 32.2 33.0 19.8 20.8
18 39.5 38.6 30.3 30.7 16.8 19.2
19 48.0 46.7 35.2 37.0 21.7 23.3
20 52.3 51.8 35.8 37.1 23.3 23.0
21 53.8 54.1 34.7 36.5 20.9 23.3
22 55.5 54.0 32.9 32.7 21.0 19.5
23 57.1 56.4 31.2 30.6 20.2 19.7
24 58.5 56.2 31.0 31.8 18.1 20.8
25 56.9 56.3 27.4 28.2 17.1 17.9
26 or Older 46.0 46.2 10.4 11.0 6.5b 7.2
26-29 57.0 57.2 23.7 25.6 15.0 16.5
30-34 53.9 55.2 18.1 19.7 11.1a 12.9
35-39 49.7b 53.5 13.9 14.7 8.4 9.7
40-44 46.2 45.5 9.9 10.3 6.4 6.4
45-49 51.1 50.2 10.0 11.1 6.2a 7.7
50-54 57.0a 53.2 10.5 9.1 6.2 5.8
55-59 57.2 56.6 9.8 10.5 6.8 7.2
60-64 50.6 51.8 7.4 7.1 4.9 4.4
65 or Older 21.9 23.4 2.4 3.3 1.4a 2.3
170410
Table 1.17A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 38,744 38,880 4,828 5,071 1,876 1,874
12-17 208 212 153 136 53 28
12 3 * 3 * 2 *
13 6 5 3 3 2 *
14 11 12 8 11 2 6
15 18a 41 15 22 3 4
16 51 47 41 31 5 5
17 120 107 82 69 38 14
18 or Older 38,535 38,668 4,675 4,936 1,822 1,847
18-25 4,074 3,901 1,876 1,919 580 552
18 166 194 126 146 29 35
19 324 291 214 227 69 49
20 397 389 223 235 68 66
21 506 492 243 291 55 93
22 572 548 270 253 70 77
23 682 581 290 268 90 77
24 664 629 276 248 96 82
25 762 777 235 251 103 73
26 or Older 34,462 34,767 2,799 3,017 1,243 1,295
26-29 3,089 2,965 600a 800 208 277
30-34 3,785 3,995 621 657 256 229
35-39 3,296 3,637 397 318 180 116
40-44 2,997 2,718 273 241 135 129
45-49 4,139a 3,654 172 275 70a 151
50-54 6,228b 5,063 330 198 230 104
55-59 5,320 5,779 281 305 102 181
60-64 3,207a 3,880 80 130 42 70
65 or Older 2,402a 3,075 46 92 19 38
170410
Table 1.17B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14.5 14.4 1.8 1.9 0.7 0.7
12-17 0.8 0.9 0.6 0.5 0.2 0.1
12 0.1 * 0.1 * 0.0 *
13 0.1 0.1 0.1 0.1 0.1 *
14 0.2 0.3 0.2 0.3 0.1 0.1
15 0.4 0.9 0.3 0.5 0.1 0.1
16 1.2 1.1 1.0 0.7 0.1 0.1
17 2.9 2.6 2.0 1.7 0.9 0.3
18 or Older 15.9 15.8 1.9 2.0 0.8 0.8
18-25 11.7 11.3 5.4 5.6 1.7 1.6
18 3.6 4.3 2.8 3.2 0.6 0.8
19 7.6 7.4 5.0 5.8 1.6 1.2
20 9.5 9.2 5.3 5.6 1.6 1.6
21 12.3 11.4 5.9 6.7 1.3 2.1
22 13.4 12.9 6.3 5.9 1.7 1.8
23 15.2 13.0 6.5 6.0 2.0 1.7
24 14.8 14.6 6.1 5.7 2.1 1.9
25 16.7 17.4 5.2 5.6 2.3 1.6
26 or Older 16.6 16.6 1.3 1.4 0.6 0.6
26-29 18.0 17.0 3.5a 4.6 1.2 1.6
30-34 17.9 18.7 2.9 3.1 1.2 1.1
35-39 16.9 17.7 2.0 1.5 0.9 0.6
40-44 14.9 13.9 1.4 1.2 0.7 0.7
45-49 19.9 18.1 0.8a 1.4 0.3a 0.7
50-54 27.0a 23.2 1.4 0.9 1.0 0.5
55-59 25.2 26.4 1.3 1.4 0.5 0.8
60-64 17.2 20.3 0.4 0.7 0.2 0.4
65 or Older 5.2a 6.4 0.1 0.2 0.0 0.1
170410
Table 1.18A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 9,035 8,776 833 882 394 432
12-17 12 17 5 11 1 3
12 * * * * * *
13 * 2 * 2 * *
14 2 1 * 1 * 1
15 * 2 * * * *
16 3 7 * 4 * *
17 7 5 5 3 1 2
18 or Older 9,022 8,759 828 871 393 429
18-25 531b 387 109 90 39 15
18 13 7 2 1 0 1
19 32 31 16 16 5 *
20 48 31 11 13 3 1
21 54 45 12 12 3 10
22 80 48 18 10 5 *
23 95 59 14 14 1 *
24 85 63 12 12 9 2
25 124 103 25 13 12 1
26 or Older 8,491 8,372 718 781 354 414
26-29 568 505 43 57 26 15
30-34 858 889 49 90 19 33
35-39 1,007 901 99 56 48 31
40-44 926 760 107 71 64 37
45-49 1,334a 1,059 91 92 29 43
50-54 1,597 1,447 129 95 91 54
55-59 1,339 1,529 158 195 56 136
60-64 470 701 23 93 3 38
65 or Older 393 581 19 32 19 27
170410
Table 1.18B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3.4 3.3 0.3 0.3 0.1 0.2
12-17 0.1 0.1 0.0 0.0 0.0 0.0
12 * * * * * *
13 * 0.1 * 0.1 * *
14 0.0 0.0 * 0.0 * 0.0
15 * 0.0 * * * *
16 0.1 0.2 * 0.1 * *
17 0.2 0.1 0.1 0.1 0.0 0.0
18 or Older 3.7 3.6 0.3 0.4 0.2 0.2
18-25 1.5b 1.1 0.3 0.3 0.1 0.0
18 0.3 0.2 0.1 0.0 0.0 0.0
19 0.8 0.8 0.4 0.4 0.1 *
20 1.1 0.7 0.3 0.3 0.1 0.0
21 1.3 1.0 0.3 0.3 0.1 0.2
22 1.9 1.1 0.4 0.2 0.1 *
23 2.1 1.3 0.3 0.3 0.0 *
24 1.9 1.5 0.3 0.3 0.2 0.0
25 2.7 2.3 0.5 0.3 0.3 0.0
26 or Older 4.1 4.0 0.3 0.4 0.2 0.2
26-29 3.3 2.9 0.3 0.3 0.2 0.1
30-34 4.0 4.2 0.2 0.4 0.1 0.2
35-39 5.2 4.4 0.5 0.3 0.2 0.1
40-44 4.6 3.9 0.5 0.4 0.3 0.2
45-49 6.4 5.2 0.4 0.5 0.1 0.2
50-54 6.9 6.6 0.6 0.4 0.4 0.2
55-59 6.4 7.0 0.7 0.9 0.3 0.6
60-64 2.5 3.7 0.1 0.5 0.0 0.2
65 or Older 0.8 1.2 0.0 0.1 0.0 0.1
170410
Table 1.19A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 40,915 41,490 4,692 4,903 1,240 1,390
12-17 760 674 523 456 121 114
12 44 22 34 17 9 5
13 45 44 34 20 12 6
14 54 46 40 35 10 14
15 122 121 89 83 19 22
16 211 157 145 106 30 16
17 284 286 180 195 42 52
18 or Older 40,155 40,816 4,169 4,447 1,118 1,276
18-25 6,486b 5,940 2,453 2,388 636 668
18 377 421 264 276 71 83
19 651 552 379 357 84 98
20 753 620 372 366 102 97
21 763 721 284 323 80 91
22 869 809 279 292 84 66
23 1,025a 856 317 266 74 95
24 1,044 955 316 252 76 69
25 1,004 1,007 242 254 67 68
26 or Older 33,669 34,876 1,716 2,059 482 608
26-29 3,946 3,866 645 794 213 262
30-34 4,568 5,047 500 588 114 153
35-39 4,308 4,648 218 197 75 48
40-44 3,364 3,331 117 166 48 59
45-49 3,351 3,367 66 96 19 18
50-54 4,510b 3,499 34 131 5 42
55-59 4,270 4,403 70 56 2 9
60-64 3,263 3,669 66 26 6 17
65 or Older 2,089b 3,045 * 6 * *
170410
Table 1.19B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 15.3 15.4 1.8 1.8 0.5 0.5
12-17 3.1 2.7 2.1 1.8 0.5 0.5
12 1.1 0.6 0.9 0.5 0.2 0.1
13 1.1 1.1 0.9 0.5 0.3 0.1
14 1.2 1.1 0.9 0.8 0.2 0.3
15 2.8 2.7 2.1 1.9 0.4 0.5
16 5.0a 3.7 3.4 2.5 0.7 0.4
17 6.8 6.8 4.3 4.7 1.0 1.2
18 or Older 16.5 16.7 1.7 1.8 0.5 0.5
18-25 18.6a 17.2 7.0 6.9 1.8 1.9
18 8.3 9.2 5.8 6.0 1.5 1.8
19 15.3 14.0 8.9 9.1 2.0 2.5
20 18.0a 14.7 8.9 8.7 2.4 2.3
21 18.5 16.7 6.9 7.5 1.9 2.1
22 20.4 19.0 6.5 6.9 2.0 1.6
23 22.9a 19.1 7.1 5.9 1.6 2.1
24 23.2 22.1 7.0 5.8 1.7 1.6
25 22.0 22.6 5.3 5.7 1.5 1.5
26 or Older 16.2 16.6 0.8 1.0 0.2 0.3
26-29 23.0 22.2 3.8 4.6 1.2 1.5
30-34 21.6a 23.6 2.4 2.7 0.5 0.7
35-39 22.1 22.6 1.1 1.0 0.4 0.2
40-44 16.8 17.1 0.6 0.8 0.2 0.3
45-49 16.1 16.6 0.3 0.5 0.1 0.1
50-54 19.6a 16.0 0.1 0.6 0.0 0.2
55-59 20.3 20.1 0.3 0.3 0.0 0.0
60-64 17.5 19.2 0.4 0.1 0.0 0.1
65 or Older 4.5b 6.3 * 0.0 * *
170410
Table 1.20A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 25,765a 24,404 1,759 1,660 527 600
12-17 2,271a 2,065 684a 554 175 149
12 237 193 102 83 30 24
13 385 337 162 117 51 32
14 397 338 135 126 34 28
15 453 438 115 90 20 15
16 441 377 91 68 14 23
17 358 383 79 70 27 28
18 or Older 23,494 22,339 1,076 1,106 352 451
18-25 3,463 3,387 487 485 126 121
18 370 360 82 107 27 21
19 345 312 63 53 19 12
20 408 357 74 66 13 24
21 383 409 54 72 16 37
22 447 455 74 49 15 5
23 470 494 47 37 12 4
24 504 487 46 48 11 7
25 536 513 48 53 13 12
26 or Older 20,031 18,952 588 620 226 329
26-29 2,106a 1,783 155 191 36b 117
30-34 2,796 2,750 124 123 54 44
35-39 2,772 2,760 59 84 13 52
40-44 2,421 2,194 30 70 20 33
45-49 2,537 2,280 72 33 36 15
50-54 2,695 2,502 76 79 29 41
55-59 2,237 2,277 26 29 24 27
60-64 1,351 1,294 40 * 14 *
65 or Older 1,116 1,111 8 11 * *
170410
Table 1.20B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 9.6a 9.1 0.7 0.6 0.2 0.2
12-17 9.1a 8.3 2.7a 2.2 0.7 0.6
12 6.1 5.2 2.6 2.2 0.8 0.6
13 9.6 8.2 4.0a 2.9 1.3 0.8
14 9.2 8.1 3.1 3.0 0.8 0.7
15 10.5 9.9 2.7 2.0 0.5 0.3
16 10.4 8.8 2.1 1.6 0.3 0.5
17 8.6 9.2 1.9 1.7 0.7 0.7
18 or Older 9.7a 9.1 0.4 0.5 0.1 0.2
18-25 9.9 9.8 1.4 1.4 0.4 0.4
18 8.1 7.9 1.8 2.3 0.6 0.5
19 8.1 7.9 1.5 1.3 0.4 0.3
20 9.8 8.5 1.8 1.6 0.3 0.6
21 9.3 9.5 1.3 1.7 0.4 0.8
22 10.5 10.7 1.7 1.1 0.3 0.1
23 10.5 11.0 1.1 0.8 0.3 0.1
24 11.2 11.3 1.0 1.1 0.2 0.2
25 11.8 11.5 1.1 1.2 0.3 0.3
26 or Older 9.6a 9.0 0.3 0.3 0.1 0.2
26-29 12.3a 10.2 0.9 1.1 0.2a 0.7
30-34 13.2 12.8 0.6 0.6 0.3 0.2
35-39 14.2 13.4 0.3 0.4 0.1 0.3
40-44 12.1 11.2 0.1 0.4 0.1 0.2
45-49 12.2 11.3 0.3 0.2 0.2 0.1
50-54 11.7 11.5 0.3 0.4 0.1 0.2
55-59 10.6 10.4 0.1 0.1 0.1 0.1
60-64 7.3 6.8 0.2 * 0.1 *
65 or Older 2.4 2.3 0.0 0.0 * *
170410
Table 1.21A – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14,511 14,533 1,713a 1,391 897a 667
12-17 71 69 40 32 13 9
12 2 6 2 1 * *
13 1 0 * 0 * *
14 0 7 * 4 * 2
15 12 8 8 5 1 1
16 19 15 7 4 3 *
17 37 34 23 17 9 6
18 or Older 14,440 14,464 1,673a 1,360 885a 658
18-25 1,135b 836 329 265 128a 65
18 59 32 26 22 13 1
19 91 93 36 39 17 14
20 105 67 42 30 11 4
21 151 103 64 40 10 16
22 127 98 33 34 18 8
23 199a 127 50 29 14 2
24 187 136 28 23 13 12
25 215 180 51 47 32 7
26 or Older 13,305 13,628 1,344 1,095 757 594
26-29 1,092 919 188 138 67 51
30-34 1,646 1,699 218 224 107 88
35-39 1,608 1,725 223 160 113 101
40-44 1,440 1,410 156 148 107 78
45-49 1,654 1,445 205a 86 138 60
50-54 1,884 1,745 198 156 120 113
55-59 1,941 2,182 105 152 75 86
60-64 1,312 1,361 13 15 10 *
65 or Older 728a 1,142 38 17 19 17
170410
Table 1.21B – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 5.4 5.4 0.6a 0.5 0.3a 0.2
12-17 0.3 0.3 0.2 0.1 0.1 0.0
12 0.1 0.2 0.1 0.0 * *
13 0.0 0.0 * 0.0 * *
14 0.0 0.2 * 0.1 * 0.1
15 0.3 0.2 0.2 0.1 0.0 0.0
16 0.5 0.3 0.2 0.1 0.1 *
17 0.9 0.8 0.5 0.4 0.2 0.1
18 or Older 5.9 5.9 0.7a 0.6 0.4a 0.3
18-25 3.3b 2.4 0.9 0.8 0.4a 0.2
18 1.3 0.7 0.6 0.5 0.3 0.0
19 2.1 2.4 0.8 1.0 0.4 0.4
20 2.5 1.6 1.0 0.7 0.3 0.1
21 3.7 2.4 1.5 0.9 0.2 0.4
22 3.0 2.3 0.8 0.8 0.4 0.2
23 4.4a 2.8 1.1 0.6 0.3 0.0
24 4.2 3.1 0.6 0.5 0.3 0.3
25 4.7 4.0 1.1 1.1 0.7 0.2
26 or Older 6.4 6.5 0.6 0.5 0.4 0.3
26-29 6.4 5.3 1.1 0.8 0.4 0.3
30-34 7.8 7.9 1.0 1.0 0.5 0.4
35-39 8.3 8.4 1.1 0.8 0.6 0.5
40-44 7.2 7.2 0.8 0.8 0.5 0.4
45-49 8.0 7.1 1.0a 0.4 0.7 0.3
50-54 8.2 8.0 0.9 0.7 0.5 0.5
55-59 9.2 10.0 0.5 0.7 0.4 0.4
60-64 7.0 7.1 0.1 0.1 0.1 *
65 or Older 1.6a 2.4 0.1 0.0 0.0 0.0
170410
Table 1.22A – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 119,036b 115,351 18,942 18,671 6,365 6,207
12-17 7,006b 6,194 1,464 1,317 492a 389
12 660 614 77 66 34 20
13 890 776 96 90 37 32
14 1,121b 913 183 160 62 47
15 1,300 1,176 243 253 81 86
16 1,429a 1,273 402 322 128 100
17 1,606a 1,442 463 426 151 103
18 or Older 112,030a 109,157 17,478 17,354 5,873 5,818
18-25 15,469b 14,118 5,330 5,026 1,766 1,600
18 1,813a 1,574 522 537 185 161
19 1,947b 1,528 688 631 205 205
20 1,731 1,728 614 692 216 236
21 1,890 1,719 750 700 258 219
22 1,934 1,786 722 659 250 242
23 2,090 1,895 749b 581 244a 171
24 2,042 1,960 647 648 197 194
25 2,021 1,928 637 577 212 172
26 or Older 96,561 95,039 12,148 12,327 4,107 4,218
26-29 7,899 7,314 2,127 2,108 698 639
30-34 9,596 9,593 2,021 2,139 712 758
35-39 8,682a 9,429 1,504 1,514 451 540
40-44 8,614 8,378 1,255 1,225 477 439
45-49 9,371 9,002 1,209 1,104 551 408
50-54 11,075 10,141 1,365 1,367 419 513
55-59 10,167 10,741 1,157 1,146 319 392
60-64 9,173 8,861 602 670 226 178
65 or Older 21,985 21,581 908 1,054 253 351
170410
Table 1.22B – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 44.5b 42.8 7.1 6.9 2.4 2.3
12-17 28.1b 24.9 5.9 5.3 2.0a 1.6
12 17.1 16.4 2.0 1.8 0.9 0.5
13 22.2a 19.0 2.4 2.2 0.9 0.8
14 26.0b 21.9 4.2 3.8 1.4 1.1
15 30.1a 26.5 5.6 5.7 1.9 1.9
16 33.8b 29.7 9.5a 7.5 3.0 2.3
17 38.6a 34.6 11.1 10.2 3.6 2.5
18 or Older 46.1b 44.6 7.2 7.1 2.4 2.4
18-25 44.3b 40.8 15.3 14.5 5.1 4.6
18 39.8b 34.5 11.5 11.8 4.1 3.5
19 45.7b 38.8 16.2 16.0 4.8 5.2
20 41.5 41.0 14.7 16.4 5.2 5.6
21 45.8b 39.8 18.2 16.2 6.2 5.1
22 45.4 41.9 17.0 15.4 5.9 5.7
23 46.6a 42.2 16.7b 12.9 5.4a 3.8
24 45.5 45.3 14.4 15.0 4.4 4.5
25 44.4 43.3 14.0 13.0 4.6 3.9
26 or Older 46.4a 45.3 5.8 5.9 2.0 2.0
26-29 46.1b 42.0 12.4 12.1 4.1 3.7
30-34 45.3 44.8 9.5 10.0 3.4 3.5
35-39 44.6 45.9 7.7 7.4 2.3 2.6
40-44 42.9 42.9 6.3 6.3 2.4 2.2
45-49 45.1 44.5 5.8 5.5 2.7 2.0
50-54 48.1 46.4 5.9 6.3 1.8 2.4
55-59 48.2 49.1 5.5 5.2 1.5 1.8
60-64 49.3 46.3 3.2 3.5 1.2 0.9
65 or Older 47.3 45.0 2.0 2.2 0.5 0.7
170410
Table 1.23A – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 97,499b 91,846 12,462a 11,517 3,775 3,350
12-17 5,650b 4,732 969 881 276 239
12 521 456 66 49 29 20
13 740b 588 83 78 34 30
14 904b 710 138 111 45 24
15 1,053a 901 166 192 40 52
16 1,155b 960 235 196 60 59
17 1,277a 1,116 281 255 67 54
18 or Older 91,848b 87,114 11,492a 10,635 3,499 3,111
18-25 12,148b 10,407 2,979b 2,454 829b 631
18 1,487b 1,176 287 259 71 69
19 1,516b 1,092 348 272 77 64
20 1,292 1,195 319 303 87 80
21 1,466a 1,251 413 341 116 92
22 1,471 1,289 385 301 98 92
23 1,647a 1,417 413b 281 150b 74
24 1,594 1,506 399 369 126 89
25 1,674 1,481 415 327 104 70
26 or Older 79,701b 76,706 8,513 8,181 2,670 2,480
26-29 6,412a 5,731 1,405 1,301 411 341
30-34 7,974 7,781 1,412 1,370 409 388
35-39 7,245 7,612 1,065 1,100 298 339
40-44 7,120 7,015 979 842 341 271
45-49 7,803 7,297 941 756 387a 247
50-54 9,087 8,327 874 967 281 345
55-59 8,544 8,942 793 841 242 229
60-64 7,530 7,089 434 427 182 145
65 or Older 17,984 16,912 609 577 119 176
170410
Table 1.23B – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 36.4b 34.1 4.7a 4.3 1.4 1.2
12-17 22.7b 19.0 3.9 3.5 1.1 1.0
12 13.5 12.2 1.7 1.3 0.8 0.5
13 18.5b 14.4 2.1 1.9 0.9 0.7
14 20.9b 17.0 3.2 2.7 1.0 0.6
15 24.4b 20.3 3.8 4.3 0.9 1.2
16 27.3b 22.4 5.6 4.6 1.4 1.4
17 30.7b 26.8 6.8 6.1 1.6 1.3
18 or Older 37.8b 35.6 4.7a 4.3 1.4 1.3
18-25 34.8b 30.1 8.5b 7.1 2.4b 1.8
18 32.6b 25.7 6.3 5.7 1.6 1.5
19 35.6b 27.7 8.2 6.9 1.8 1.6
20 31.0 28.4 7.6 7.2 2.1 1.9
21 35.5b 28.9 10.0 7.9 2.8 2.1
22 34.5a 30.2 9.0 7.1 2.3 2.2
23 36.8b 31.6 9.2b 6.3 3.3b 1.7
24 35.5 34.8 8.9 8.5 2.8 2.1
25 36.7 33.2 9.1 7.3 2.3 1.6
26 or Older 38.3b 36.5 4.1 3.9 1.3 1.2
26-29 37.4b 32.9 8.2 7.5 2.4 2.0
30-34 37.6 36.4 6.7 6.4 1.9 1.8
35-39 37.2 37.0 5.5 5.3 1.5 1.6
40-44 35.5 35.9 4.9 4.3 1.7 1.4
45-49 37.6 36.1 4.5 3.7 1.9a 1.2
50-54 39.5 38.1 3.8 4.4 1.2 1.6
55-59 40.5 40.9 3.8 3.8 1.1 1.0
60-64 40.4 37.0 2.3 2.2 1.0 0.8
65 or Older 38.7a 35.2 1.3 1.2 0.3 0.4
170410
Table 1.24A – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 39,317 38,756 6,050 6,060 1,874 1,953
12-17 1,069 1,108 394 434 162 121
12 74 75 4 12 3 1
13 87 75 14 8 7 1
14 136 124 31 37 15 14
15 207 241 67 92 18 25
16 261 256 135 122 52 32
17 305 337 143 162 68 48
18 or Older 38,247 37,649 5,656 5,626 1,712 1,832
18-25 4,212 3,901 1,874 1,844 582 536
18 443 398 232 232 68 57
19 467 408 231 271 72 86
20 462 487 215 255 77 65
21 536 483 246 226 65 64
22 548 480 240 221 66 84
23 613 515 267 234 82 57
24 590 601 230 214 62 60
25 552 529 212 193 90 61
26 or Older 34,035 33,747 3,782 3,781 1,130 1,296
26-29 2,367 2,116 659 652 179 200
30-34 3,108 3,025 683 637 221 228
35-39 2,878 3,018 455 443 158 171
40-44 3,157 2,794 434 353 131 122
45-49 3,285 3,381 340 351 145 127
50-54 4,146 3,842 476 505 98 169
55-59 3,630 4,135 299 353 47a 152
60-64 3,643 3,134 180 145 57 16
65 or Older 7,820 8,303 256 343 93 111
170410
Table 1.24B – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14.7 14.4 2.3 2.2 0.7 0.7
12-17 4.3 4.4 1.6 1.7 0.7 0.5
12 1.9 2.0 0.1 0.3 0.1 0.0
13 2.2 1.8 0.4 0.2 0.2 0.0
14 3.1 3.0 0.7 0.9 0.3 0.3
15 4.8 5.4 1.5 2.1 0.4 0.6
16 6.2 6.0 3.2 2.9 1.2 0.7
17 7.3 8.1 3.4 3.9 1.6 1.2
18 or Older 15.8 15.4 2.3 2.3 0.7 0.7
18-25 12.1 11.3 5.4 5.3 1.7 1.5
18 9.7 8.7 5.1 5.1 1.5 1.3
19 11.0 10.4 5.4 6.9 1.7 2.2
20 11.1 11.6 5.2 6.1 1.8 1.5
21 13.0 11.2 6.0 5.2 1.6 1.5
22 12.9 11.3 5.6 5.2 1.6 2.0
23 13.7 11.5 6.0 5.2 1.8 1.3
24 13.1 13.9 5.1 5.0 1.4 1.4
25 12.1 11.9 4.7 4.3 2.0 1.4
26 or Older 16.4 16.1 1.8 1.8 0.5 0.6
26-29 13.8 12.1 3.8 3.7 1.0 1.1
30-34 14.7 14.1 3.2 3.0 1.0 1.1
35-39 14.8 14.7 2.3 2.2 0.8 0.8
40-44 15.7 14.3 2.2 1.8 0.7 0.6
45-49 15.8 16.7 1.6 1.7 0.7 0.6
50-54 18.0 17.6 2.1 2.3 0.4 0.8
55-59 17.2 18.9 1.4 1.6 0.2a 0.7
60-64 19.6a 16.4 1.0 0.8 0.3 0.1
65 or Older 16.8 17.3 0.6 0.7 0.2 0.2
170410
Table 1.25A – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 17,212a 18,420 5,251 5,647 1,653 1,735
12-17 1,820 1,799 491 427 117 92
12 129 164 8 6 3 0
13 200 212 3 11 0 2
14 242 237 25 47 6 15
15 311 330 90 74 31 20
16 431 381 169b 96 33 23
17 508 474 195 193 44 32
18 or Older 15,392a 16,621 4,760a 5,220 1,536 1,643
18-25 4,906 4,998 2,537 2,578 757 767
18 514 543 222 254 83 73
19 648 609 338 313 117 100
20 616 744 334 431 102 143
21 658 677 407 376 120 112
22 720 633 388 355 120 115
23 598 607 341 284 76 63
24 629 601 261 302 59 85
25 522 583 246 263 81 76
26 or Older 10,486a 11,623 2,223a 2,643 779 876
26-29 1,752 1,829 749 828 246 213
30-34 1,703 1,924 567 666 187 254
35-39 1,283 1,512 316 346 65 120
40-44 1,092 1,152 143 222 65 66
45-49 1,058 1,127 147 171 82 73
50-54 1,033 1,158 190 170 78 63
55-59 824 974 79 110 34 78
60-64 683 695 22 45 22 *
65 or Older 1,057 1,254 9a 83 * 8
170410
Table 1.25B – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6.4a 6.8 2.0 2.1 0.6 0.6
12-17 7.3 7.2 2.0 1.7 0.5 0.4
12 3.3 4.4 0.2 0.1 0.1 0.0
13 5.0 5.2 0.1 0.3 0.0 0.1
14 5.6 5.7 0.6 1.1 0.1 0.4
15 7.2 7.5 2.1 1.7 0.7 0.4
16 10.2 8.9 4.0b 2.2 0.8 0.5
17 12.2 11.4 4.7 4.6 1.1 0.8
18 or Older 6.3a 6.8 2.0 2.1 0.6 0.7
18-25 14.1 14.5 7.3 7.5 2.2 2.2
18 11.3 11.9 4.9 5.6 1.8 1.6
19 15.2 15.5 7.9 8.0 2.7 2.5
20 14.7 17.7 8.0 10.2 2.5 3.4
21 16.0 15.7 9.9 8.7 2.9 2.6
22 16.9 14.8 9.1 8.3 2.8 2.7
23 13.3 13.5 7.6 6.3 1.7 1.4
24 14.0 13.9 5.8 7.0 1.3 2.0
25 11.5 13.1 5.4 5.9 1.8 1.7
26 or Older 5.0a 5.5 1.1a 1.3 0.4 0.4
26-29 10.2 10.5 4.4 4.8 1.4 1.2
30-34 8.0 9.0 2.7 3.1 0.9 1.2
35-39 6.6 7.4 1.6 1.7 0.3 0.6
40-44 5.4 5.9 0.7 1.1 0.3 0.3
45-49 5.1 5.6 0.7 0.8 0.4 0.4
50-54 4.5 5.3 0.8 0.8 0.3 0.3
55-59 3.9 4.5 0.4 0.5 0.2 0.4
60-64 3.7 3.6 0.1 0.2 0.1 *
65 or Older 2.3 2.6 0.0a 0.2 * 0.0
170410
Table 1.26A – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 18,564 18,629 1,511 1,531 446 497
12-17 602 563 102 100 21 23
12 61 74 1 5 * *
13 71 70 7 8 1 *
14 68 84 10 15 2 5
15 113 99 19 19 9 8
16 147 104 34 25 5 3
17 142 132 31 28 5 6
18 or Older 17,962 18,067 1,409 1,431 425 474
18-25 1,339 1,278 265 256 86 50
18 143 126 31 21 10 5
19 149 118 38 40 8 8
20 134 114 42 22 7 3
21 163 164 32 42 6 2
22 160 131 30 16 13 7
23 229 189 48 37 24a 4
24 178 226 10b 43 5 11
25 183 210 34 34 13 9
26 or Older 16,623 16,789 1,143 1,176 340 425
26-29 855 842 181 141 43 26
30-34 1,165 1,375 156 196 72 58
35-39 1,267 1,281 134 92 23 23
40-44 1,345 1,241 107 152 52 75
45-49 1,754 1,501 106 66 57a 15
50-54 2,251 1,943 111 128 23 59
55-59 1,993 2,383 163 102 * 48
60-64 1,691 2,130 36 95 8 33
65 or Older 4,302 4,092 150 203 61 88
170410
Table 1.26B – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6.9 6.9 0.6 0.6 0.2 0.2
12-17 2.4 2.3 0.4 0.4 0.1 0.1
12 1.6 2.0 0.0 0.1 * *
13 1.8 1.7 0.2 0.2 0.0 *
14 1.6 2.0 0.2 0.4 0.0 0.1
15 2.6 2.2 0.4 0.4 0.2 0.2
16 3.5 2.4 0.8 0.6 0.1 0.1
17 3.4 3.2 0.7 0.7 0.1 0.1
18 or Older 7.4 7.4 0.6 0.6 0.2 0.2
18-25 3.8 3.7 0.8 0.7 0.2 0.1
18 3.1 2.8 0.7 0.5 0.2 0.1
19 3.5 3.0 0.9 1.0 0.2 0.2
20 3.2 2.7 1.0 0.5 0.2 0.1
21 3.9 3.8 0.8 1.0 0.1 0.1
22 3.8 3.1 0.7 0.4 0.3 0.2
23 5.1 4.2 1.1 0.8 0.5a 0.1
24 4.0 5.2 0.2b 1.0 0.1 0.3
25 4.0 4.7 0.7 0.8 0.3 0.2
26 or Older 8.0 8.0 0.5 0.6 0.2 0.2
26-29 5.0 4.8 1.1 0.8 0.3 0.1
30-34 5.5 6.4 0.7 0.9 0.3 0.3
35-39 6.5 6.2 0.7 0.4 0.1 0.1
40-44 6.7 6.4 0.5 0.8 0.3 0.4
45-49 8.4 7.4 0.5 0.3 0.3a 0.1
50-54 9.8 8.9 0.5 0.6 0.1 0.3
55-59 9.5 10.9 0.8 0.5 * 0.2
60-64 9.1 11.1 0.2 0.5 0.0 0.2
65 or Older 9.2 8.5 0.3 0.4 0.1 0.2
170412
Table 1.27A – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Numbers in Thousands, 2015 and 2016
Age Category Misuse in Past Year
(2015)
Misuse in Past Year
(2016)
Misuse in Past Month
(2015)
Misuse in Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 12,693a 11,824 3,963 3,649
12-17 980 891 277 241
12 66 49 29 20
13 83 81 34 30
14 138 112 45 24
15 169 193 40 53
16 236 201 60 61
17 289 255 68 54
18 or Older 11,712 10,933 3,686 3,408
18-25 3,029b 2,516 880b 688
18 293 263 72 76
19 349 279 79 72
20 325 309 92 80
21 413 346 116 100
22 393 315 104 98
23 413a 297 150a 86
24 421 373 158a 97
25 423 333 111 80
26 or Older 8,683 8,417 2,806 2,720
26-29 1,434 1,329 424 380
30-34 1,452 1,450 450 448
35-39 1,089 1,132 326 367
40-44 989 865 354 299
45-49 951 769 390 264
50-54 910 975 315 353
55-59 816 880 246 287
60-64 434 437 182 146
65 or Older 609 577 119 176
170412
Table 1.27B – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Percentages, 2015 and 2016
Age Category Misuse in Past Year
(2015)
Misuse in Past Year
(2016)
Misuse in Past Month
(2015)
Misuse in Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4.7a 4.4 1.5 1.4
12-17 3.9 3.6 1.1 1.0
12 1.7 1.3 0.8 0.5
13 2.1 2.0 0.9 0.7
14 3.2 2.7 1.0 0.6
15 3.9 4.4 0.9 1.2
16 5.6 4.7 1.4 1.4
17 6.9 6.1 1.6 1.3
18 or Older 4.8a 4.5 1.5 1.4
18-25 8.7b 7.3 2.5b 2.0
18 6.4 5.8 1.6 1.7
19 8.2 7.1 1.9 1.8
20 7.8 7.3 2.2 1.9
21 10.0 8.0 2.8 2.3
22 9.2 7.4 2.4 2.3
23 9.2a 6.6 3.3a 1.9
24 9.4 8.6 3.5 2.2
25 9.3 7.5 2.4 1.8
26 or Older 4.2 4.0 1.3 1.3
26-29 8.4 7.6 2.5 2.2
30-34 6.9 6.8 2.1 2.1
35-39 5.6 5.5 1.7 1.8
40-44 4.9 4.4 1.8 1.5
45-49 4.6 3.8 1.9 1.3
50-54 4.0 4.5 1.4 1.6
55-59 3.9 4.0 1.2 1.3
60-64 2.3 2.3 1.0 0.8
65 or Older 1.3 1.2 0.3 0.4
170410
Table 1.28A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016
Prescription Drug/Age Group Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
PSYCHOTHERAPEUTICS1 119,036b 115,351 18,942 18,671 18,942 18,671
12-17 7,006b 6,194 1,464 1,317 1,464 1,317
18 or Older 112,030a 109,157 17,478 17,354 17,478 17,354
18-25 15,469b 14,118 5,330 5,026 5,330 5,026
26 or Older 96,561 95,039 12,148 12,327 12,148 12,327
PAIN RELIEVERS1 97,499b 91,846 12,462a 11,517 12,462a 11,517
12-17 5,650b 4,732 969 881 969 881
18 or Older 91,848b 87,114 11,492a 10,635 11,492a 10,635
18-25 12,148b 10,407 2,979b 2,454 2,979b 2,454
26 or Older 79,701b 76,706 8,513 8,181 8,513 8,181
TRANQUILIZERS 39,317 38,756 6,050 6,060 6,050 6,060
12-17 1,069 1,108 394 434 394 434
18 or Older 38,247 37,649 5,656 5,626 5,656 5,626
18-25 4,212 3,901 1,874 1,844 1,874 1,844
26 or Older 34,035 33,747 3,782 3,781 3,782 3,781
STIMULANTS 17,212a 18,420 5,251 5,647 5,251 5,647
12-17 1,820 1,799 491 427 491 427
18 or Older 15,392a 16,621 4,760a 5,220 4,760a 5,220
18-25 4,906 4,998 2,537 2,578 2,537 2,578
26 or Older 10,486a 11,623 2,223a 2,643 2,223a 2,643
SEDATIVES 18,564 18,629 1,511 1,531 1,511 1,531
12-17 602 563 102 100 102 100
18 or Older 17,962 18,067 1,409 1,431 1,409 1,431
18-25 1,339 1,278 265 256 265 256
26 or Older 16,623 16,789 1,143 1,176 1,143 1,176
170410
Table 1.28B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Percentages, 2015 and 2016
Prescription Drug/Age Group Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
PSYCHOTHERAPEUTICS1 44.5b 42.8 7.1 6.9 15.9 16.2
12-17 28.1b 24.9 5.9 5.3 20.9 21.3
18 or Older 46.1b 44.6 7.2 7.1 15.6 15.9
18-25 44.3b 40.8 15.3 14.5 34.5 35.6
26 or Older 46.4a 45.3 5.8 5.9 12.6 13.0
PAIN RELIEVERS1 36.4b 34.1 4.7a 4.3 12.8 12.5
12-17 22.7b 19.0 3.9 3.5 17.2 18.6
18 or Older 37.8b 35.6 4.7a 4.3 12.5 12.2
18-25 34.8b 30.1 8.5b 7.1 24.5 23.6
26 or Older 38.3b 36.5 4.1 3.9 10.7 10.7
TRANQUILIZERS 14.7 14.4 2.3 2.2 15.4 15.6
12-17 4.3 4.4 1.6 1.7 36.9 39.2
18 or Older 15.8 15.4 2.3 2.3 14.8 14.9
18-25 12.1 11.3 5.4 5.3 44.5 47.3
26 or Older 16.4 16.1 1.8 1.8 11.1 11.2
STIMULANTS 6.4a 6.8 2.0 2.1 30.5 30.7
12-17 7.3 7.2 2.0 1.7 27.0 23.7
18 or Older 6.3a 6.8 2.0 2.1 30.9 31.4
18-25 14.1 14.5 7.3 7.5 51.7 51.6
26 or Older 5.0a 5.5 1.1a 1.3 21.2 22.7
SEDATIVES 6.9 6.9 0.6 0.6 8.1 8.2
12-17 2.4 2.3 0.4 0.4 17.0 17.8
18 or Older 7.4 7.4 0.6 0.6 7.8 7.9
18-25 3.8 3.7 0.8 0.7 19.8 20.0
26 or Older 8.0 8.0 0.5 0.6 6.9 7.0
170421
Table 1.29A – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 130,610 130,628 6,297b 5,737 124,313 124,891 20,083a 19,469 104,230 105,422
GENDER                    
Male 69,822 68,325 3,118a 2,882 66,705 65,443 10,577b 10,078 56,128 55,365
Female 60,788 62,303 3,180b 2,855 57,608a 59,448 9,506 9,391 48,102a 50,057
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 113,700 114,084 4,769b 4,382 108,931 109,702 16,047 15,647 92,884 94,056
White 91,038 91,690 3,261a 2,985 87,777 88,705 11,645 11,596 76,131 77,109
Black or African American 15,299 14,825 983a 847 14,316 13,979 2,863a 2,560 11,453 11,419
American Indian or Alaska Native 779 901 33 45 746 856 * 176 611 680
Native Hawaiian or Other Pacific Islander 348 493 * * 314 461 * * * *
Asian 3,544 3,391 209 230 3,336 3,161 732 712 2,604 2,449
Two or More Races 2,692 2,784 249 243 2,443 2,540 595 510 1,848 2,030
Hispanic or Latino 16,910 16,544 1,528a 1,355 15,382 15,189 4,036 3,822 11,347 11,366
EDUCATION                    
< High School da da da da 13,598b 11,903 2,889b 2,432 10,709a 9,471
High School Graduate da da da da 29,510 29,266 6,097a 5,641 23,413 23,625
Some College/Associate's Degree da da da da 42,860 43,598 8,439 8,548 34,421 35,050
College Graduate da da da da 38,345 40,123 2,658 2,848 35,687 37,276
CURRENT EMPLOYMENT                    
Full-Time da da da da 68,987 69,719 9,112 8,980 59,876 60,739
Part-Time da da da da 17,568 17,458 5,075 5,109 12,492 12,349
Unemployed da da da da 6,512 6,316 2,053 1,919 4,459 4,397
Other1 da da da da 31,246 31,398 3,843a 3,461 27,403 27,937
170421
Table 1.29B – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 48.8 48.5 25.3b 23.0 51.2 51.1 57.5 56.3 50.1 50.2
GENDER                    
Male 53.8a 52.3 24.6a 22.7 57.0a 55.5 60.3a 58.0 56.4 55.1
Female 44.1 44.9 26.0b 23.4 45.8 47.0 54.7 54.6 44.4 45.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 50.7 50.7 24.9b 23.0 53.1 53.2 58.5 57.7 52.3 52.6
White 53.4 53.7 24.4a 22.5 55.8 56.3 60.7 61.4 55.2 55.6
Black or African American 47.7 46.0 28.4a 24.9 50.0 48.5 57.1b 52.4 48.5 47.7
American Indian or Alaska Native 54.3 58.7 20.7 31.0 58.5 61.6 * 69.5 57.6 59.9
Native Hawaiian or Other Pacific Islander 48.1 41.3 * * 52.0 42.5 * * * *
Asian 24.1 23.3 16.7 17.4 24.8 23.9 36.1 33.1 22.8 22.1
Two or More Races 57.7 57.7 31.3 29.8 63.2 63.4 69.7 66.2 61.3 62.7
Hispanic or Latino 38.8 37.3 26.6b 23.2 40.7 39.5 54.1 51.1 37.4 36.6
EDUCATION                    
< High School da da da da 39.6a 36.9 53.5 50.9 37.0 34.5
High School Graduate da da da da 47.9 47.9 56.4 54.5 46.1 46.5
Some College/Associate's Degree da da da da 57.9 57.5 59.5 58.4 57.6 57.3
College Graduate da da da da 52.6 53.3 59.0 59.3 52.2 52.8
CURRENT EMPLOYMENT                    
Full-Time da da da da 58.2 57.9 62.6 62.0 57.6 57.4
Part-Time da da da da 54.2 54.4 56.9 56.3 53.1 53.7
Unemployed da da da da 56.9 56.9 58.6 58.1 56.2 56.4
Other1 da da da da 38.9 38.8 48.4a 44.9 37.8 38.1
170421
Table 1.30A – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 47,730 48,501 4,346b 3,941 43,384 44,559 13,102 13,034 30,281 31,525
GENDER                    
Male 26,576 27,032 2,134a 1,952 24,442 25,080 7,209 7,012 17,233 18,068
Female 21,154 21,469 2,212a 1,989 18,942 19,479 5,894 6,022 13,048 13,457
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 40,256 41,394 3,305b 3,020 36,951 38,375 10,514 10,550 26,437a 27,825
White 30,534 31,580 2,354b 2,080 28,180 29,500 7,560 7,708 20,620 21,792
Black or African American 6,625 6,466 608 579 6,017 5,888 1,922 1,857 4,094 4,031
American Indian or Alaska Native 328 362 27 31 302 331 91 * 211 218
Native Hawaiian or Other Pacific Islander 149 191 * * 118 180 * * * 116
Asian 1,355 1,340 107 134 1,249 1,205 457 434 791 772
Two or More Races 1,265 1,455 178 184 1,087 1,271 435 376 651a 896
Hispanic or Latino 7,474 7,107 1,041 922 6,433 6,185 2,589 2,485 3,844 3,700
EDUCATION                    
< High School da da da da 5,819a 5,205 1,892 1,690 3,927 3,514
High School Graduate da da da da 11,168 11,270 3,912 3,857 7,256 7,413
Some College/Associate's Degree da da da da 15,584 16,220 5,634 5,788 9,950 10,432
College Graduate da da da da 10,812a 11,865 1,664 1,699 9,148a 10,166
CURRENT EMPLOYMENT                    
Full-Time da da da da 22,378 23,048 5,694 5,626 16,684 17,422
Part-Time da da da da 7,308 7,580 3,500 3,708 3,808 3,872
Unemployed da da da da 3,450 3,463 1,439 1,420 2,011 2,043
Other1 da da da da 10,247 10,468 2,469 2,280 7,779 8,188
170421
Table 1.30B – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 17.8 18.0 17.5b 15.8 17.9 18.2 37.5 37.7 14.6 15.0
GENDER                    
Male 20.5 20.7 16.8a 15.4 20.9 21.3 41.1 40.4 17.3 18.0
Female 15.3 15.5 18.1a 16.3 15.1 15.4 33.9 35.0 12.0 12.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 18.0 18.4 17.3a 15.8 18.0 18.6 38.3 38.9 14.9 15.6
White 17.9 18.5 17.6b 15.7 17.9 18.7 39.4 40.8 14.9 15.7
Black or African American 20.7 20.1 17.6 17.0 21.0 20.4 38.4 38.0 17.4 16.8
American Indian or Alaska Native 22.9 23.6 16.6 21.0 23.7 23.8 42.5 * 19.9 19.2
Native Hawaiian or Other Pacific Islander 20.5 16.0 * * 19.5 16.5 * * * 12.5
Asian 9.2 9.2 8.6 10.2 9.3 9.1 22.5 20.1 6.9 7.0
Two or More Races 27.1 30.2 22.5 22.5 28.1 31.7 51.0 48.8 21.6 27.7
Hispanic or Latino 17.2 16.0 18.1a 15.8 17.0 16.1 34.7 33.2 12.7 11.9
EDUCATION                    
< High School da da da da 16.9 16.1 35.1 35.4 13.6 12.8
High School Graduate da da da da 18.1 18.4 36.2 37.3 14.3 14.6
Some College/Associate's Degree da da da da 21.1 21.4 39.7 39.5 16.6 17.0
College Graduate da da da da 14.8 15.7 36.9 35.4 13.4 14.4
CURRENT EMPLOYMENT                    
Full-Time da da da da 18.9 19.2 39.1 38.9 16.0 16.5
Part-Time da da da da 22.5 23.6 39.2 40.8 16.2 16.8
Unemployed da da da da 30.2 31.2 41.1 43.0 25.3 26.2
Other1 da da da da 12.7 12.9 31.1 29.6 10.7 11.2
170421
Table 1.31A – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 27,080a 28,564 2,193a 1,959 24,887b 26,605 7,797 8,012 17,090a 18,593
GENDER                    
Male 16,164 16,779 1,115 1,001 15,049 15,778 4,570 4,529 10,480 11,249
Female 10,915a 11,786 1,078 959 9,838b 10,827 3,227 3,483 6,610a 7,344
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 23,081a 24,465 1,667 1,513 21,414b 22,952 6,265 6,463 15,149a 16,489
White 17,396a 18,488 1,187a 1,019 16,209a 17,470 4,485 4,690 11,723a 12,780
Black or African American 4,023 4,040 305 295 3,718 3,745 1,232 1,219 2,486 2,526
American Indian or Alaska Native 204 240 13 16 191 224 39 56 152 168
Native Hawaiian or Other Pacific Islander 71 117 * * 52 113 * * 18 *
Asian 584 601 41 61 544 540 221 226 323 314
Two or More Races 803 977 102 118 701 860 254 230 447 630
Hispanic or Latino 3,999 4,100 526 447 3,473 3,653 1,532 1,549 1,941 2,103
EDUCATION                    
< High School da da da da 3,488 3,128 1,228 1,095 2,259 2,033
High School Graduate da da da da 6,722 7,145 2,326 2,427 4,396 4,717
Some College/Associate's Degree da da da da 9,293 9,994 3,417 3,585 5,876 6,410
College Graduate da da da da 5,385b 6,338 826 905 4,558a 5,433
CURRENT EMPLOYMENT                    
Full-Time da da da da 12,825 13,397 3,378 3,425 9,447 9,972
Part-Time da da da da 4,092a 4,630 2,038a 2,289 2,054 2,341
Unemployed da da da da 2,065 2,306 871 943 1,194 1,363
Other1 da da da da 5,905 6,272 1,510 1,354 4,395 4,917
170421
Table 1.31B – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 10.1a 10.6 8.8a 7.9 10.2a 10.9 22.3 23.2 8.2a 8.9
GENDER                    
Male 12.5 12.8 8.8 7.9 12.9 13.4 26.1 26.1 10.5 11.2
Female 7.9a 8.5 8.8 7.8 7.8a 8.6 18.6a 20.2 6.1 6.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 10.3a 10.9 8.7 7.9 10.4a 11.1 22.8 23.9 8.5a 9.2
White 10.2a 10.8 8.9a 7.7 10.3a 11.1 23.4 24.8 8.5a 9.2
Black or African American 12.5 12.5 8.8 8.7 13.0 13.0 24.6 24.9 10.5 10.5
American Indian or Alaska Native 14.2 15.7 8.3 11.2 15.0 16.1 18.1 22.3 14.3 14.7
Native Hawaiian or Other Pacific Islander 9.8 9.8 * * 8.6 10.4 * * 4.1 *
Asian 4.0 4.1 3.3 4.6 4.0 4.1 10.9 10.5 2.8 2.8
Two or More Races 17.2 20.2 12.8 14.4 18.1 21.4 29.8 29.8 14.8 19.5
Hispanic or Latino 9.2 9.2 9.2 7.6 9.2 9.5 20.6 20.7 6.4 6.8
EDUCATION                    
< High School da da da da 10.1 9.7 22.8 22.9 7.8 7.4
High School Graduate da da da da 10.9 11.7 21.5 23.4 8.7 9.3
Some College/Associate's Degree da da da da 12.6 13.2 24.1 24.5 9.8 10.5
College Graduate da da da da 7.4a 8.4 18.3 18.9 6.7a 7.7
CURRENT EMPLOYMENT                    
Full-Time da da da da 10.8 11.1 23.2 23.7 9.1 9.4
Part-Time da da da da 12.6a 14.4 22.8a 25.2 8.7 10.2
Unemployed da da da da 18.1 20.8 24.9 28.6 15.0 17.5
Other1 da da da da 7.3 7.7 19.0 17.6 6.1 6.7
170421
Table 1.32A – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 117,865 118,524 3,912 3,676 113,952 114,847 18,392 17,897 95,561 96,950
GENDER                    
Male 63,490 62,697 2,042 1,876 61,448 60,821 9,734b 9,279 51,714 51,542
Female 54,375 55,827 1,870 1,800 52,504 54,026 8,658 8,618 43,846a 45,408
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 103,781 104,468 2,931 2,772 100,850 101,697 14,729 14,372 86,121 87,325
White 83,700 84,639 2,064 1,949 81,636 82,690 10,723 10,708 70,913 71,982
Black or African American 13,901 13,445 579 512 13,322 12,934 2,672a 2,357 10,650 10,577
American Indian or Alaska Native 709 796 20 30 688 766 * 172 562 593
Native Hawaiian or Other Pacific Islander 297 369 * * 266 355 * * * 268
Asian 2,742 2,650 77 97 2,665 2,552 583 575 2,082 1,977
Two or More Races 2,432 2,569 159 168 2,273 2,401 557 474 1,717 1,927
Hispanic or Latino 14,084 14,055 982 905 13,103 13,150 3,663 3,525 9,439 9,625
EDUCATION                    
< High School da da da da 11,857b 10,521 2,611b 2,200 9,246a 8,322
High School Graduate da da da da 27,403 27,177 5,576 5,198 21,826 21,979
Some College/Associate's Degree da da da da 39,807 40,589 7,768 7,877 32,038 32,713
College Graduate da da da da 34,887 36,560 2,437 2,623 32,450 33,936
CURRENT EMPLOYMENT                    
Full-Time da da da da 64,177 64,809 8,542 8,370 55,634 56,440
Part-Time da da da da 16,059 16,112 4,609 4,694 11,449 11,419
Unemployed da da da da 5,966 5,793 1,863 1,769 4,103 4,024
Other1 da da da da 27,750 28,133 3,377a 3,065 24,374 25,068
170421
Table 1.32B – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 44.0 44.0 15.7 14.8 46.9 47.0 52.7 51.8 46.0 46.2
GENDER                    
Male 48.9 48.0 16.1 14.8 52.5 51.6 55.5a 53.4 52.0 51.3
Female 39.4 40.2 15.3 14.7 41.8 42.7 49.8 50.1 40.5 41.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 46.3 46.4 15.3 14.5 49.2 49.4 53.7 53.0 48.5 48.8
White 49.1 49.6 15.4 14.7 51.9 52.5 55.9 56.7 51.4 51.9
Black or African American 43.3 41.7 16.7 15.0 46.6 44.8 53.3b 48.2 45.1 44.2
American Indian or Alaska Native 49.4 51.8 12.8 20.7 54.0 55.1 * 68.1 53.0 52.2
Native Hawaiian or Other Pacific Islander 41.0 30.9 * * 44.1 32.7 * * * 28.9
Asian 18.6 18.2 6.2 7.4 19.8 19.3 28.8 26.7 18.2 17.8
Two or More Races 52.2 53.2 19.9 20.6 58.8 59.9 65.2 61.5 57.0 59.5
Hispanic or Latino 32.3 31.7 17.1 15.5 34.6 34.2 49.1 47.2 31.1 31.0
EDUCATION                    
< High School da da da da 34.5 32.6 48.4 46.0 31.9 30.3
High School Graduate da da da da 44.5 44.5 51.6 50.2 43.0 43.3
Some College/Associate's Degree da da da da 53.8 53.5 54.7 53.8 53.6 53.4
College Graduate da da da da 47.9 48.5 54.1 54.6 47.5 48.1
CURRENT EMPLOYMENT                    
Full-Time da da da da 54.1 53.9 58.7 57.8 53.5 53.3
Part-Time da da da da 49.5 50.2 51.7 51.7 48.7 49.7
Unemployed da da da da 52.2 52.2 53.2 53.6 51.7 51.6
Other1 da da da da 34.5 34.7 42.6 39.8 33.6 34.2
170421
Table 1.33A – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 36,043a 37,570 3,137 2,982 32,906a 34,588 11,246 11,401 21,660a 23,187
GENDER                    
Male 20,934 21,839 1,636 1,483 19,299 20,357 6,311 6,254 12,988a 14,103
Female 15,109 15,731 1,502 1,499 13,607 14,232 4,935 5,148 8,673 9,084
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 30,851a 32,303 2,412 2,300 28,439a 30,003 9,073 9,229 19,366a 20,774
White 23,248 24,298 1,736 1,625 21,512 22,673 6,457 6,723 15,056 15,950
Black or African American 5,403 5,341 437 416 4,966 4,925 1,756 1,669 3,210 3,256
American Indian or Alaska Native 260 298 18 24 242 273 84 * 158 178
Native Hawaiian or Other Pacific Islander 106 153 * * 77 146 * * 34 91
Asian 835 1,009 56 81 779 929 353 355 425 573
Two or More Races 1,000 1,204 136 148 863 1,057 379 331 484a 725
Hispanic or Latino 5,192 5,267 725 683 4,467 4,585 2,173 2,172 2,294 2,413
EDUCATION                    
< High School da da da da 4,161 3,979 1,634 1,472 2,527 2,507
High School Graduate da da da da 8,627 8,836 3,346 3,383 5,281 5,453
Some College/Associate's Degree da da da da 12,050a 12,978 4,885 5,118 7,164 7,860
College Graduate da da da da 8,069 8,795 1,380 1,429 6,689 7,367
CURRENT EMPLOYMENT                    
Full-Time da da da da 17,042 18,004 4,847 4,872 12,194 13,132
Part-Time da da da da 5,770 6,199 3,064 3,292 2,706 2,907
Unemployed da da da da 2,721 2,885 1,286 1,275 1,435 1,610
Other1 da da da da 7,373 7,500 2,048 1,962 5,325 5,538
170421
Table 1.33B – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 13.5 13.9 12.6 12.0 13.6a 14.1 32.2 33.0 10.4 11.0
GENDER                    
Male 16.1 16.7 12.9 11.7 16.5 17.3 36.0 36.0 13.1 14.0
Female 11.0 11.3 12.3 12.3 10.8 11.2 28.4 29.9 8.0 8.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 13.8 14.4 12.6 12.1 13.9a 14.6 33.1 34.1 10.9a 11.6
White 13.6 14.2 13.0 12.3 13.7 14.4 33.7a 35.6 10.9 11.5
Black or African American 16.8 16.6 12.6 12.2 17.4 17.1 35.0 34.1 13.6 13.6
American Indian or Alaska Native 18.1 19.4 11.5 16.5 19.0 19.7 39.3 * 14.9 15.6
Native Hawaiian or Other Pacific Islander 14.7 12.8 * * 12.8 13.5 * * 7.6 9.8
Asian 5.7 6.9 4.5 6.1 5.8 7.0 17.4 16.5 3.7 5.2
Two or More Races 21.4 25.0 17.2 18.0 22.3 26.4 44.4 43.1 16.1a 22.4
Hispanic or Latino 11.9 11.9 12.6 11.7 11.8 11.9 29.1 29.1 7.6 7.8
EDUCATION                    
< High School da da da da 12.1 12.3 30.3 30.8 8.7 9.1
High School Graduate da da da da 14.0 14.5 30.9 32.7 10.4 10.7
Some College/Associate's Degree da da da da 16.3 17.1 34.4 35.0 12.0 12.8
College Graduate da da da da 11.1 11.7 30.6 29.8 9.8 10.4
CURRENT EMPLOYMENT                    
Full-Time da da da da 14.4 15.0 33.3 33.6 11.7 12.4
Part-Time da da da da 17.8 19.3 34.4 36.2 11.5 12.6
Unemployed da da da da 23.8 26.0 36.7 38.6 18.1 20.6
Other1 da da da da 9.2 9.3 25.8 25.5 7.4 7.6
170421
Table 1.34A – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 22,226b 23,981 1,752 1,609 20,474b 22,373 6,921 7,184 13,552b 15,188
GENDER                    
Male 13,715a 14,696 956 867 12,758a 13,829 4,108 4,168 8,651a 9,661
Female 8,511a 9,285 796 741 7,715a 8,544 2,814 3,016 4,902a 5,528
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 19,075b 20,588 1,344 1,253 17,731b 19,334 5,580 5,786 12,151b 13,549
White 14,352a 15,358 974 871 13,378a 14,487 3,944 4,174 9,435 10,313
Black or African American 3,432 3,577 242 220 3,190 3,357 1,147 1,132 2,042 2,225
American Indian or Alaska Native 161 209 12 14 149 195 37 52 112 144
Native Hawaiian or Other Pacific Islander 67 103 * * 49 101 * * 16 *
Asian 438 486 26 47 412 440 189 188 223 252
Two or More Races 626a 854 72 99 554a 755 231 205 323b 550
Hispanic or Latino 3,151 3,394 408 355 2,743 3,038 1,341 1,398 1,402 1,640
EDUCATION                    
< High School da da da da 2,803 2,681 1,113 995 1,690 1,686
High School Graduate da da da da 5,613 6,112 2,065 2,202 3,548 3,910
Some College/Associate's Degree da da da da 7,788a 8,593 3,014 3,212 4,774a 5,382
College Graduate da da da da 4,270a 4,986 729 775 3,541a 4,211
CURRENT EMPLOYMENT                    
Full-Time da da da da 10,550a 11,404 2,964 3,085 7,586 8,319
Part-Time da da da da 3,430a 4,019 1,849 2,036 1,580a 1,983
Unemployed da da da da 1,686 1,984 794 858 892 1,127
Other1 da da da da 4,808 4,965 1,313 1,206 3,495 3,759
170421
Table 1.34B – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 8.3b 8.9 7.0 6.5 8.4b 9.1 19.8 20.8 6.5b 7.2
GENDER                    
Male 10.6 11.3 7.5 6.8 10.9a 11.7 23.4 24.0 8.7a 9.6
Female 6.2a 6.7 6.5 6.1 6.1a 6.7 16.2 17.5 4.5 5.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8.5b 9.1 7.0 6.6 8.7b 9.4 20.3 21.4 6.8a 7.6
White 8.4a 9.0 7.3 6.6 8.5a 9.2 20.6a 22.1 6.8 7.4
Black or African American 10.7 11.1 7.0 6.5 11.1 11.6 22.9 23.2 8.7 9.3
American Indian or Alaska Native 11.2 13.6 7.4 9.7 11.7 14.0 17.2 20.4 10.6 12.6
Native Hawaiian or Other Pacific Islander 9.2 8.6 * * 8.1 9.3 * * 3.7 *
Asian 3.0 3.3 2.1 3.5 3.1 3.3 9.3 8.7 1.9 2.3
Two or More Races 13.4a 17.7 9.1 12.1 14.3a 18.8 27.0 26.6 10.7a 17.0
Hispanic or Latino 7.2 7.7 7.1 6.1 7.3 7.9 18.0 18.7 4.6 5.3
EDUCATION                    
< High School da da da da 8.2 8.3 20.6 20.8 5.8 6.1
High School Graduate da da da da 9.1 10.0 19.1a 21.3 7.0 7.7
Some College/Associate's Degree da da da da 10.5 11.3 21.2 21.9 8.0 8.8
College Graduate da da da da 5.9 6.6 16.2 16.1 5.2a 6.0
CURRENT EMPLOYMENT                    
Full-Time da da da da 8.9 9.5 20.4 21.3 7.3 7.9
Part-Time da da da da 10.6b 12.5 20.7 22.4 6.7a 8.6
Unemployed da da da da 14.7a 17.9 22.7 26.0 11.2a 14.4
Other1 da da da da 6.0 6.1 16.6 15.6 4.8 5.1
170421
Table 1.35A – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 38,744 38,880 208 212 38,535 38,668 4,074 3,901 34,462 34,767
GENDER                    
Male 23,269 23,383 118 104 23,150 23,279 2,420 2,268 20,730 21,011
Female 15,475 15,497 90 108 15,385 15,389 1,653 1,633 13,732 13,756
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 33,681 34,145 152 160 33,529 33,985 3,188 3,137 30,341 30,848
White 28,603 29,006 124 139 28,479 28,867 2,734 2,738 25,745 26,129
Black or African American 3,297 3,134 6 4 3,292 3,130 178 145 3,114 2,985
American Indian or Alaska Native 250 236 1 3 249 234 36 25 213 208
Native Hawaiian or Other Pacific Islander 88 105 * * * 105 10 * * 92
Asian 572 632 7 4 565 628 99 77 466 552
Two or More Races 872 1,032 15 10 857 1,022 130 139 726 883
Hispanic or Latino 5,063 4,735 56 52 5,007 4,683 886 764 4,121 3,919
EDUCATION                    
< High School da da da da 4,583a 3,994 599b 428 3,984 3,566
High School Graduate da da da da 9,583 9,831 1,140 1,127 8,444 8,703
Some College/Associate's Degree da da da da 14,442 13,672 1,770 1,752 12,672 11,920
College Graduate da da da da 9,927a 11,171 565 594 9,362a 10,577
CURRENT EMPLOYMENT                    
Full-Time da da da da 22,067 21,540 2,072 2,037 19,995 19,503
Part-Time da da da da 5,076 5,121 859 936 4,217 4,185
Unemployed da da da da 2,158 2,246 372 411 1,786 1,835
Other1 da da da da 9,235 9,761 771b 517 8,464 9,244
170421
Table 1.35B – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14.5 14.4 0.8 0.9 15.9 15.8 11.7 11.3 16.6 16.6
GENDER                    
Male 17.9 17.9 0.9 0.8 19.8 19.7 13.8 13.1 20.8 20.9
Female 11.2 11.2 0.7 0.9 12.2 12.2 9.5 9.5 12.7 12.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15.0 15.2 0.8 0.8 16.4 16.5 11.6 11.6 17.1 17.2
White 16.8 17.0 0.9 1.0 18.1 18.3 14.2 14.5 18.7 18.9
Black or African American 10.3 9.7 0.2 0.1 11.5 10.9 3.6 3.0 13.2 12.5
American Indian or Alaska Native 17.4 15.4 0.5 1.9 19.5 16.8 16.9 10.0 20.1 18.3
Native Hawaiian or Other Pacific Islander 12.1 8.8 * * * 9.6 6.6 * * 9.9
Asian 3.9 4.3 0.5 0.3 4.2 4.7 4.9 3.6 4.1 5.0
Two or More Races 18.7 21.4 1.9 1.2 22.1 25.5 15.3 18.1 24.1 27.3
Hispanic or Latino 11.6 10.7 1.0 0.9 13.2 12.2 11.9 10.2 13.6 12.6
EDUCATION                    
< High School da da da da 13.3 12.4 11.1 9.0 13.7 13.0
High School Graduate da da da da 15.6 16.1 10.5 10.9 16.6 17.1
Some College/Associate's Degree da da da da 19.5a 18.0 12.5 12.0 21.2a 19.5
College Graduate da da da da 13.6 14.8 12.5 12.4 13.7a 15.0
CURRENT EMPLOYMENT                    
Full-Time da da da da 18.6 17.9 14.2 14.1 19.2 18.4
Part-Time da da da da 15.6 16.0 9.6 10.3 17.9 18.2
Unemployed da da da da 18.9 20.2 10.6 12.4 22.5 23.5
Other1 da da da da 11.5 12.0 9.7b 6.7 11.7 12.6
170421
Table 1.36A – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4,828 5,071 153 136 4,675 4,936 1,876 1,919 2,799 3,017
GENDER                    
Male 3,069 3,238 93 70 2,976 3,169 1,148 1,096 1,829 2,073
Female 1,758 1,833 60 66 1,699 1,767 728 823 970 944
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,084 4,303 109 96 3,975 4,207 1,495 1,595 2,480 2,612
White 3,090 3,362 86 85 3,003 3,277 1,282 1,397 1,721 1,880
Black or African American 760 612 6 3 755 609 101 81 653 528
American Indian or Alaska Native 38 31 1 2 37 29 * 11 16 18
Native Hawaiian or Other Pacific Islander 5 18 * * 5 18 * * * 12
Asian 74 101 7 2 67 98 34 46 33 52
Two or More Races 117 180 10 5 107 175 51 53 56a 122
Hispanic or Latino 744 768 44 39 700 729 381 324 319 405
EDUCATION                    
< High School da da da da 668 628 257 205 411 423
High School Graduate da da da da 1,186 1,150 459 441 727 709
Some College/Associate's Degree da da da da 1,783 1,789 852 949 930 841
College Graduate da da da da 1,038a 1,369 307 324 731a 1,045
CURRENT EMPLOYMENT                    
Full-Time da da da da 2,488 2,534 909 913 1,578 1,621
Part-Time da da da da 828 924 467 575 361 349
Unemployed da da da da 393 488 147 156 246 332
Other1 da da da da 966 990 352 275 614 715
170421
Table 1.36B – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.8 1.9 0.6 0.5 1.9 2.0 5.4 5.6 1.3 1.4
GENDER                    
Male 2.4 2.5 0.7 0.5 2.5 2.7 6.5 6.3 1.8 2.1
Female 1.3 1.3 0.5 0.5 1.4 1.4 4.2 4.8 0.9 0.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.8 1.9 0.6 0.5 1.9 2.0 5.4 5.9 1.4 1.5
White 1.8 2.0 0.6 0.6 1.9 2.1 6.7 7.4 1.2 1.4
Black or African American 2.4 1.9 0.2 0.1 2.6 2.1 2.0 1.7 2.8 2.2
American Indian or Alaska Native 2.7 2.0 0.5 1.1 2.9 2.1 * 4.2 1.5 1.6
Native Hawaiian or Other Pacific Islander 0.7 1.5 * * 0.9 1.7 * * * 1.3
Asian 0.5 0.7 0.5 0.2 0.5 0.7 1.7 2.1 0.3 0.5
Two or More Races 2.5 3.7 1.2 0.6 2.8 4.4 5.9 6.9 1.9 3.8
Hispanic or Latino 1.7 1.7 0.8 0.7 1.9 1.9 5.1 4.3 1.1 1.3
EDUCATION                    
< High School da da da da 1.9 1.9 4.8 4.3 1.4 1.5
High School Graduate da da da da 1.9 1.9 4.2 4.3 1.4 1.4
Some College/Associate's Degree da da da da 2.4 2.4 6.0 6.5 1.6 1.4
College Graduate da da da da 1.4a 1.8 6.8 6.7 1.1a 1.5
CURRENT EMPLOYMENT                    
Full-Time da da da da 2.1 2.1 6.2 6.3 1.5 1.5
Part-Time da da da da 2.6 2.9 5.2 6.3 1.5 1.5
Unemployed da da da da 3.4 4.4 4.2 4.7 3.1 4.2
Other1 da da da da 1.2 1.2 4.4 3.6 0.8 1.0
170421
Table 1.37A – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,876 1,874 53 28 1,822 1,847 580 552 1,243 1,295
GENDER                    
Male 1,234 1,257 39b 9 1,195 1,248 354 356 841 892
Female 641 617 14 18 627 599 226 196 401 403
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,620 1,559 39 22 1,582 1,537 463 439 1,119 1,098
White 1,096 1,076 26 16 1,070 1,059 387 355 683 704
Black or African American 439 315 1 * 437 315 40 24 397 290
American Indian or Alaska Native 6 20 0 1 5 18 2 * 3 *
Native Hawaiian or Other Pacific Islander * 16 * * * 16 * * * 11
Asian 30 51 6 2 24 49 14 28 11 22
Two or More Races 50 82 5 2 45 80 20 19 25 61
Hispanic or Latino 255 316 14 6 241 310 117 113 124 197
EDUCATION                    
< High School da da da da 321 353 79 81 242 272
High School Graduate da da da da 437 396 142 117 295 279
Some College/Associate's Degree da da da da 670 582 262 263 408 319
College Graduate da da da da 395 516 97 91 298 425
CURRENT EMPLOYMENT                    
Full-Time da da da da 862 886 257 279 605 607
Part-Time da da da da 272 299 139 157 133 142
Unemployed da da da da 201 206 48 37 153 169
Other1 da da da da 487 456 136a 79 351 377
170421
Table 1.37B – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7 0.7 0.2 0.1 0.8 0.8 1.7 1.6 0.6 0.6
GENDER                    
Male 1.0 1.0 0.3b 0.1 1.0 1.1 2.0 2.0 0.8 0.9
Female 0.5 0.4 0.1 0.1 0.5 0.5 1.3 1.1 0.4 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.7 0.2 0.1 0.8 0.7 1.7 1.6 0.6 0.6
White 0.6 0.6 0.2 0.1 0.7 0.7 2.0 1.9 0.5 0.5
Black or African American 1.4 1.0 0.0 * 1.5 1.1 0.8 0.5 1.7 1.2
American Indian or Alaska Native 0.4 1.3 0.2 0.8 0.4 1.3 0.9 * 0.3 *
Native Hawaiian or Other Pacific Islander * 1.3 * * * 1.4 * * * 1.2
Asian 0.2 0.4 0.5 0.2 0.2 0.4 0.7 1.3 0.1 0.2
Two or More Races 1.1 1.7 0.7 0.3 1.2 2.0 2.3 2.4 0.8 1.9
Hispanic or Latino 0.6 0.7 0.2 0.1 0.6 0.8 1.6 1.5 0.4 0.6
EDUCATION                    
< High School da da da da 0.9 1.1 1.5 1.7 0.8 1.0
High School Graduate da da da da 0.7 0.6 1.3 1.1 0.6 0.5
Some College/Associate's Degree da da da da 0.9 0.8 1.8 1.8 0.7 0.5
College Graduate da da da da 0.5 0.7 2.2 1.9 0.4 0.6
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.7 0.7 1.8 1.9 0.6 0.6
Part-Time da da da da 0.8 0.9 1.6 1.7 0.6 0.6
Unemployed da da da da 1.8 1.9 1.4 1.1 1.9 2.2
Other1 da da da da 0.6 0.6 1.7a 1.0 0.5 0.5
170421
Table 1.38A – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 9,035 8,776 12 17 9,022 8,759 531b 387 8,491 8,372
GENDER                    
Male 5,903 5,580 7 2 5,896 5,578 318a 215 5,578 5,363
Female 3,132 3,196 6 15 3,126 3,181 213 172 2,913 3,009
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7,971 7,942 9 13 7,961 7,929 396 322 7,566 7,607
White 6,024 5,797 8 10 6,016 5,787 366 286 5,650 5,501
Black or African American 1,586 1,564 1 * 1,584 1,564 10 3 1,574 1,561
American Indian or Alaska Native 60 76 * 0 60 76 4 10 56 65
Native Hawaiian or Other Pacific Islander 28 8 * * 28 8 0 * 27 8
Asian 63 205 * 2 63 204 4 7 59 197
Two or More Races 211 292 0 1 211 291 12 16 199 275
Hispanic or Latino 1,064 834 3 4 1,061 830 135a 65 926 765
EDUCATION                    
< High School da da da da 1,783 1,506 140b 71 1,642 1,435
High School Graduate da da da da 2,977 3,010 223 175 2,754 2,836
Some College/Associate's Degree da da da da 3,260 2,995 150 132 3,110 2,863
College Graduate da da da da 1,002 1,247 18 9 984 1,238
CURRENT EMPLOYMENT                    
Full-Time da da da da 4,430 4,199 263 187 4,167 4,012
Part-Time da da da da 910 1,013 90 62 820 952
Unemployed da da da da 691 756 69 62 622 693
Other1 da da da da 2,991 2,791 110 75 2,882 2,715
170421
Table 1.38B – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3.4 3.3 0.1 0.1 3.7 3.6 1.5b 1.1 4.1 4.0
GENDER                    
Male 4.5 4.3 0.1 0.0 5.0 4.7 1.8a 1.2 5.6 5.3
Female 2.3 2.3 0.0 0.1 2.5 2.5 1.2 1.0 2.7 2.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3.6 3.5 0.0 0.1 3.9 3.8 1.4 1.2 4.3 4.3
White 3.5 3.4 0.1 0.1 3.8 3.7 1.9 1.5 4.1 4.0
Black or African American 4.9 4.8 0.0 * 5.5 5.4 0.2 0.1 6.7 6.5
American Indian or Alaska Native 4.2 4.9 * 0.2 4.7 5.5 1.7 4.1 5.3 5.8
Native Hawaiian or Other Pacific Islander 3.8a 0.7 * * 4.6a 0.7 0.1 * 6.2a 0.9
Asian 0.4 1.4 * 0.1 0.5 1.5 0.2 0.3 0.5 1.8
Two or More Races 4.5 6.0 0.0 0.1 5.5 7.3 1.3 2.0 6.6 8.5
Hispanic or Latino 2.4 1.9 0.1 0.1 2.8 2.2 1.8a 0.9 3.0 2.5
EDUCATION                    
< High School da da da da 5.2 4.7 2.6a 1.5 5.7 5.2
High School Graduate da da da da 4.8 4.9 2.1 1.7 5.4 5.6
Some College/Associate's Degree da da da da 4.4 3.9 1.1 0.9 5.2 4.7
College Graduate da da da da 1.4 1.7 0.4 0.2 1.4 1.8
CURRENT EMPLOYMENT                    
Full-Time da da da da 3.7 3.5 1.8 1.3 4.0 3.8
Part-Time da da da da 2.8 3.2 1.0 0.7 3.5 4.1
Unemployed da da da da 6.0 6.8 2.0 1.9 7.8 8.9
Other1 da da da da 3.7 3.4 1.4 1.0 4.0 3.7
170421
Table 1.39A – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 833 882 5 11 828 871 109 90 718 781
GENDER                    
Male 598 549 3 * 595 549 79 54 516 494
Female 235 334 1a 11 233 323 31 36 203 287
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 751 801 3 8 748 793 72 79 676 714
White 401 500 1 8 399 493 65 77 334 416
Black or African American 317 277 1 * 315 277 5 * 310 277
American Indian or Alaska Native * 1 * * * 1 * 1 * 0
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian 8 * * * 8 1 * 1 8 *
Two or More Races 25 22 0 * 25 22 2 1 23 21
Hispanic or Latino 82 82 2 3 80 78 38 11 43 68
EDUCATION                    
< High School da da da da 201 247 37a 9 164 238
High School Graduate da da da da 294 236 32 49 262 188
Some College/Associate's Degree da da da da 276 238 38 33 238 205
College Graduate da da da da 56 150 2 * 54 150
CURRENT EMPLOYMENT                    
Full-Time da da da da 350 233 58 40 292 193
Part-Time da da da da 64 105 18 21 45 84
Unemployed da da da da 78a 171 12 15 66a 156
Other1 da da da da 336 363 21 14 315 349
170421
Table 1.39B – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.3 0.3 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.4
GENDER                    
Male 0.5 0.4 0.0 * 0.5 0.5 0.4 0.3 0.5 0.5
Female 0.2 0.2 0.0a 0.1 0.2 0.3 0.2 0.2 0.2 0.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3 0.4 0.0 0.0 0.4 0.4 0.3 0.3 0.4 0.4
White 0.2 0.3 0.0 0.1 0.3 0.3 0.3 0.4 0.2 0.3
Black or African American 1.0 0.9 0.0 * 1.1 1.0 0.1 * 1.3 1.2
American Indian or Alaska Native * 0.1 * * * 0.1 * 0.2 * 0.0
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian 0.1 * * * 0.1 0.0 * 0.0 0.1 *
Two or More Races 0.5 0.5 0.0 * 0.6 0.5 0.2 0.1 0.8 0.6
Hispanic or Latino 0.2 0.2 0.0 0.1 0.2 0.2 0.5 0.1 0.1 0.2
EDUCATION                    
< High School da da da da 0.6 0.8 0.7a 0.2 0.6 0.9
High School Graduate da da da da 0.5 0.4 0.3 0.5 0.5 0.4
Some College/Associate's Degree da da da da 0.4 0.3 0.3 0.2 0.4 0.3
College Graduate da da da da 0.1 0.2 0.1 * 0.1 0.2
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.3 0.2 0.4 0.3 0.3 0.2
Part-Time da da da da 0.2 0.3 0.2 0.2 0.2 0.4
Unemployed da da da da 0.7a 1.5 0.3 0.4 0.8a 2.0
Other1 da da da da 0.4 0.4 0.3 0.2 0.4 0.5
170421
Table 1.40A – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 394 432 1 3 393 429 39 15 354 414
GENDER                    
Male 268 263 * * 268 263 25 12 242 251
Female 126 169 1 3 125 166 13 3 112 163
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 352 388 1 3 351 384 16 10 335 374
White 175 216 * 3 175 212 15 10 160 202
Black or African American 171 156 1 * 169 156 * * 169 156
American Indian or Alaska Native * * * * * * * * * *
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian * * * * * * * * * *
Two or More Races 7 16 * * 7 16 2 * 5 16
Hispanic or Latino 42 45 * * 42 45 23 5 19 40
EDUCATION                    
< High School da da da da 98 121 22 3 76 118
High School Graduate da da da da 106 104 8 5 98 99
Some College/Associate's Degree da da da da 155 146 9 7 147 139
College Graduate da da da da 34 58 * * 34 58
CURRENT EMPLOYMENT                    
Full-Time da da da da 130 97 29 10 101 86
Part-Time da da da da 40 27 1 * 40 27
Unemployed da da da da 39 94 1 2 37 92
Other1 da da da da 184 211 8 2 176 209
170421
Table 1.40B – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.1 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.2
GENDER                    
Male 0.2 0.2 * * 0.2 0.2 0.1 0.1 0.2 0.2
Female 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.2
White 0.1 0.1 * 0.0 0.1 0.1 0.1 0.1 0.1 0.1
Black or African American 0.5 0.5 0.0 * 0.6 0.5 * * 0.7 0.7
American Indian or Alaska Native * * * * * * * * * *
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian * * * * * * * * * *
Two or More Races 0.1 0.3 * * 0.2 0.4 0.2 * 0.2 0.5
Hispanic or Latino 0.1 0.1 * * 0.1 0.1 0.3 0.1 0.1 0.1
EDUCATION                    
< High School da da da da 0.3 0.4 0.4 0.1 0.3 0.4
High School Graduate da da da da 0.2 0.2 0.1 0.0 0.2 0.2
Some College/Associate's Degree da da da da 0.2 0.2 0.1 0.0 0.2 0.2
College Graduate da da da da 0.0 0.1 * * 0.0 0.1
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.1 0.1 0.2 0.1 0.1 0.1
Part-Time da da da da 0.1 0.1 0.0 * 0.2 0.1
Unemployed da da da da 0.3 0.8 0.0 0.1 0.5 1.2
Other1 da da da da 0.2 0.3 0.1 0.0 0.2 0.3
170421
Table 1.41A – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 40,915 41,490 760 674 40,155 40,816 6,486b 5,940 33,669 34,876
GENDER                    
Male 24,410 24,401 410 390 23,999 24,011 3,917b 3,487 20,082 20,524
Female 16,506 17,089 350 284 16,156 16,805 2,569 2,453 13,587 14,352
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 36,420 37,010 575 493 35,845 36,516 5,200a 4,851 30,645 31,665
White 31,603 31,617 425 355 31,179 31,261 4,206 3,926 26,973 27,335
Black or African American 2,595 2,689 60 52 2,535 2,637 487 417 2,048 2,220
American Indian or Alaska Native 249a 374 6 12 243a 362 42 * 201 291
Native Hawaiian or Other Pacific Islander 61b 155 * * 49b 155 15 * 34a 119
Asian 846 1,052 24 35 822 1,017 210 202 612 815
Two or More Races 1,067 1,124 49 39 1,018 1,085 240 200 778 885
Hispanic or Latino 4,496 4,480 185 181 4,310 4,299 1,286a 1,089 3,024 3,210
EDUCATION                    
< High School da da da da 3,973b 3,225 837a 679 3,137a 2,546
High School Graduate da da da da 8,890 9,296 1,774 1,711 7,116 7,585
Some College/Associate's Degree da da da da 15,526 15,090 2,951a 2,606 12,574 12,484
College Graduate da da da da 11,766b 13,204 924 943 10,841b 12,261
CURRENT EMPLOYMENT                    
Full-Time da da da da 23,328 23,475 3,107 3,027 20,220 20,448
Part-Time da da da da 5,667 6,035 1,528 1,476 4,139 4,559
Unemployed da da da da 2,171 2,439 642 624 1,529 1,815
Other1 da da da da 8,990 8,867 1,209b 813 7,781 8,054
170421
Table 1.41B – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 15.3 15.4 3.1 2.7 16.5 16.7 18.6a 17.2 16.2 16.6
GENDER                    
Male 18.8 18.7 3.2 3.1 20.5 20.4 22.3b 20.1 20.2 20.4
Female 12.0 12.3 2.9 2.3 12.8 13.3 14.8 14.3 12.5 13.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 16.2 16.4 3.0 2.6 17.5 17.7 18.9 17.9 17.3 17.7
White 18.5 18.5 3.2 2.7 19.8 19.9 21.9 20.8 19.5 19.7
Black or African American 8.1 8.3 1.7 1.5 8.9 9.1 9.7 8.5 8.7 9.3
American Indian or Alaska Native 17.4a 24.3 3.7 8.2 19.1a 26.0 19.8 * 18.9 25.6
Native Hawaiian or Other Pacific Islander 8.4 12.9 * * 8.1 14.2 9.4 * 7.7 12.9
Asian 5.7 7.2 1.9 2.7 6.1 7.7 10.3 9.4 5.4 7.3
Two or More Races 22.9 23.3 6.1 4.7 26.3 27.1 28.1 26.0 25.8 27.3
Hispanic or Latino 10.3 10.1 3.2 3.1 11.4 11.2 17.3a 14.6 10.0 10.3
EDUCATION                    
< High School da da da da 11.6a 10.0 15.5 14.2 10.8 9.3
High School Graduate da da da da 14.4 15.2 16.4 16.5 14.0 14.9
Some College/Associate's Degree da da da da 21.0 19.9 20.8b 17.8 21.0 20.4
College Graduate da da da da 16.2a 17.5 20.5 19.6 15.9a 17.4
CURRENT EMPLOYMENT                    
Full-Time da da da da 19.7 19.5 21.4 20.9 19.4 19.3
Part-Time da da da da 17.5 18.8 17.1 16.2 17.6 19.8
Unemployed da da da da 19.0 22.0 18.3 18.9 19.3 23.3
Other1 da da da da 11.2 10.9 15.2b 10.6 10.7 11.0
170421
Table 1.42A – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4,692 4,903 523 456 4,169 4,447 2,453 2,388 1,716 2,059
GENDER                    
Male 3,039 3,061 287 274 2,752 2,787 1,536 1,502 1,216 1,285
Female 1,653 1,842 236 182 1,417 1,660 916 886 501a 774
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,893 4,139 397 347 3,496 3,792 1,977 1,957 1,519 1,834
White 3,000 3,265 286 262 2,714 3,004 1,547 1,587 1,167 1,417
Black or African American 430 373 33 28 397 345 211 176 186 170
American Indian or Alaska Native 19a 59 4 7 15a 52 8 12 7 40
Native Hawaiian or Other Pacific Islander 16 13 * * 5 13 5 * * 11
Asian 250 244 20 21 230 222 112 105 118 118
Two or More Races 179 185 44 30 135 156 94 77 41 79
Hispanic or Latino 798 764 125 109 673 655 476 430 197 225
EDUCATION                    
< High School da da da da 518 489 322 313 196 176
High School Graduate da da da da 939 914 648 581 291 333
Some College/Associate's Degree da da da da 1,649 1,919 1,170 1,177 479a 742
College Graduate da da da da 1,062 1,125 313 317 750 808
CURRENT EMPLOYMENT                    
Full-Time da da da da 2,179 2,307 1,017 1,066 1,162 1,242
Part-Time da da da da 942 1,037 719 745 223 293
Unemployed da da da da 335b 520 241 283 94b 238
Other1 da da da da 713 582 476b 295 237 287
170421
Table 1.42B – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.8 1.8 2.1 1.8 1.7 1.8 7.0 6.9 0.8 1.0
GENDER                    
Male 2.3 2.3 2.3 2.2 2.4 2.4 8.8 8.6 1.2 1.3
Female 1.2 1.3 1.9 1.5 1.1 1.3 5.3 5.1 0.5a 0.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.7 1.8 2.1 1.8 1.7 1.8 7.2 7.2 0.9 1.0
White 1.8 1.9 2.1 2.0 1.7 1.9 8.1 8.4 0.8 1.0
Black or African American 1.3 1.2 1.0 0.8 1.4 1.2 4.2 3.6 0.8 0.7
American Indian or Alaska Native 1.3a 3.8 2.4 4.7 1.2a 3.7 3.7 4.7 0.7a 3.5
Native Hawaiian or Other Pacific Islander 2.2 1.1 * * 0.8 1.2 3.1 * * 1.2
Asian 1.7 1.7 1.6 1.6 1.7 1.7 5.5 4.9 1.0 1.1
Two or More Races 3.8 3.8 5.6 3.7 3.5 3.9 11.0 10.0 1.4 2.4
Hispanic or Latino 1.8 1.7 2.2 1.9 1.8 1.7 6.4 5.8 0.6 0.7
EDUCATION                    
< High School da da da da 1.5 1.5 6.0 6.5 0.7 0.6
High School Graduate da da da da 1.5 1.5 6.0 5.6 0.6 0.7
Some College/Associate's Degree da da da da 2.2 2.5 8.2 8.0 0.8a 1.2
College Graduate da da da da 1.5 1.5 6.9 6.6 1.1 1.1
CURRENT EMPLOYMENT                    
Full-Time da da da da 1.8 1.9 7.0 7.4 1.1 1.2
Part-Time da da da da 2.9 3.2 8.1 8.2 0.9 1.3
Unemployed da da da da 2.9b 4.7 6.9 8.6 1.2b 3.0
Other1 da da da da 0.9 0.7 6.0b 3.8 0.3 0.4
170421
Table 1.43A – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,240 1,390 121 114 1,118 1,276 636 668 482 608
GENDER                    
Male 885 863 65 78 820 785 420 429 400 356
Female 355b 527 57 37 298b 491 216 239 83b 252
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 999 1,097 93 88 906 1,008 473 522 433 486
White 721 816 67 70 654 746 345 411 309 335
Black or African American 154 107 7 2 147 104 76 56 72 48
American Indian or Alaska Native 7 26 1 1 6 24 2 2 5 22
Native Hawaiian or Other Pacific Islander 6 1 * * 1 1 * * * *
Asian 51 90 4 6 47 84 23 31 25 53
Two or More Races 61 57 11 8 50 49 27 21 22 27
Hispanic or Latino 240 293 28 26 212 267 163 145 50 122
EDUCATION                    
< High School da da da da 178 189 91 103 87 86
High School Graduate da da da da 248 260 155 143 94 117
Some College/Associate's Degree da da da da 437 494 330 327 107 167
College Graduate da da da da 255 333 60 95 195 238
CURRENT EMPLOYMENT                    
Full-Time da da da da 536 606 245 290 290 317
Part-Time da da da da 258 349 177 238 81 111
Unemployed da da da da 109 163 77 82 32 81
Other1 da da da da 216 158 137b 59 79 99
170421
Table 1.43B – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.5 0.5 0.5 0.5 0.5 0.5 1.8 1.9 0.2 0.3
GENDER                    
Male 0.7 0.7 0.5 0.6 0.7 0.7 2.4 2.5 0.4 0.4
Female 0.3b 0.4 0.5 0.3 0.2b 0.4 1.2 1.4 0.1b 0.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4 0.5 0.5 0.5 0.4 0.5 1.7 1.9 0.2 0.3
White 0.4 0.5 0.5 0.5 0.4 0.5 1.8 2.2 0.2 0.2
Black or African American 0.5 0.3 0.2 0.1 0.5 0.4 1.5 1.1 0.3 0.2
American Indian or Alaska Native 0.5 1.7 0.3 0.9 0.5 1.7 0.7 0.8 0.4 2.0
Native Hawaiian or Other Pacific Islander 0.8 0.1 * * 0.2 0.1 * * * *
Asian 0.3 0.6 0.3 0.4 0.4 0.6 1.1 1.4 0.2 0.5
Two or More Races 1.3 1.2 1.4 1.0 1.3 1.2 3.2 2.8 0.7 0.8
Hispanic or Latino 0.6 0.7 0.5 0.4 0.6 0.7 2.2 1.9 0.2 0.4
EDUCATION                    
< High School da da da da 0.5 0.6 1.7 2.1 0.3 0.3
High School Graduate da da da da 0.4 0.4 1.4 1.4 0.2 0.2
Some College/Associate's Degree da da da da 0.6 0.7 2.3 2.2 0.2 0.3
College Graduate da da da da 0.3 0.4 1.3 2.0 0.3 0.3
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.5 0.5 1.7 2.0 0.3 0.3
Part-Time da da da da 0.8 1.1 2.0 2.6 0.3 0.5
Unemployed da da da da 1.0 1.5 2.2 2.5 0.4 1.0
Other1 da da da da 0.3 0.2 1.7b 0.8 0.1 0.1
170421
Table 1.44A – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 25,765a 24,404 2,271a 2,065 23,494 22,339 3,463 3,387 20,031 18,952
GENDER                    
Male 16,103 15,090 1,057 957 15,046 14,133 2,037 1,926 13,009 12,207
Female 9,662 9,314 1,213 1,108 8,449 8,205 1,427 1,461 7,022 6,744
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 22,574 21,595 1,764a 1,599 20,810 19,996 2,711 2,734 18,099 17,262
White 19,782 18,787 1,203 1,090 18,579 17,696 2,160 2,194 16,419 15,502
Black or African American 1,379 1,285 344 298 1,035 986 269 296 766 690
American Indian or Alaska Native 165 175 15 13 149 162 25 28 124 133
Native Hawaiian or Other Pacific Islander 44a 132 * * 35a 121 6 * 30 104
Asian 589 640 104 94 485 546 127 106 358 439
Two or More Races 615 577 88 92 527 485 124 92 403 393
Hispanic or Latino 3,191 2,809 507 466 2,684 2,343 752 653 1,932 1,690
EDUCATION                    
< High School da da da da 2,485b 1,861 538 469 1,947b 1,392
High School Graduate da da da da 4,827 4,568 1,042 961 3,785 3,607
Some College/Associate's Degree da da da da 8,623a 7,798 1,482 1,486 7,141a 6,312
College Graduate da da da da 7,560 8,112 401 471 7,158 7,641
CURRENT EMPLOYMENT                    
Full-Time da da da da 13,764 13,148 1,533 1,509 12,231 11,639
Part-Time da da da da 3,340 3,319 887 899 2,453 2,420
Unemployed da da da da 1,208 1,259 352 341 856 919
Other1 da da da da 5,182 4,612 691 637 4,491 3,975
170421
Table 1.44B – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 9.6a 9.1 9.1a 8.3 9.7a 9.1 9.9 9.8 9.6a 9.0
GENDER                    
Male 12.4a 11.6 8.3 7.5 12.9a 12.0 11.6 11.1 13.1 12.1
Female 7.0 6.7 9.9 9.1 6.7 6.5 8.2 8.5 6.5 6.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 10.1 9.6 9.2 8.4 10.2 9.7 9.9 10.1 10.2 9.6
White 11.6 11.0 9.0 8.2 11.8 11.2 11.3 11.6 11.9 11.2
Black or African American 4.3 4.0 9.9 8.8 3.6 3.4 5.4 6.1 3.2 2.9
American Indian or Alaska Native 11.5 11.4 9.6 9.1 11.7 11.6 11.7 11.2 11.7 11.7
Native Hawaiian or Other Pacific Islander 6.0 11.1 * * 5.9 11.2 3.5 * 6.7 11.2
Asian 4.0 4.4 8.4 7.1 3.6 4.1 6.3 4.9 3.1 4.0
Two or More Races 13.2 12.0 11.1 11.2 13.6 12.1 14.5 12.0 13.4 12.1
Hispanic or Latino 7.3a 6.3 8.8 8.0 7.1 6.1 10.1 8.7 6.4 5.4
EDUCATION                    
< High School da da da da 7.2a 5.8 10.0 9.8 6.7a 5.1
High School Graduate da da da da 7.8 7.5 9.6 9.3 7.5 7.1
Some College/Associate's Degree da da da da 11.7b 10.3 10.4 10.2 11.9b 10.3
College Graduate da da da da 10.4 10.8 8.9 9.8 10.5 10.8
CURRENT EMPLOYMENT                    
Full-Time da da da da 11.6 10.9 10.5 10.4 11.8 11.0
Part-Time da da da da 10.3 10.3 9.9 9.9 10.4 10.5
Unemployed da da da da 10.6 11.3 10.0 10.3 10.8 11.8
Other1 da da da da 6.4 5.7 8.7 8.3 6.2 5.4
170421
Table 1.45A – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,759 1,660 684a 554 1,076 1,106 487 485 588 620
GENDER                    
Male 997 988 293 238 704 750 300 281 404 469
Female 762 671 391 316 371 356 188 204 184 151
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,426 1,286 518a 410 908 876 381 370 527 506
White 1,016 1,007 354a 281 662 726 280 314 382 411
Black or African American 174 152 94 84 80 68 53 39 27 29
American Indian or Alaska Native 14 14 7 3 7 * 1 0 6 *
Native Hawaiian or Other Pacific Islander 3 6 * * 0 2 0 * * 2
Asian 149b 37 39a 11 111b 27 24 12 87a 15
Two or More Races 70 70 21 27 49 43 23a 3 26 40
Hispanic or Latino 333 374 166 144 167 229 106 115 61 114
EDUCATION                    
< High School da da da da 109 160 62 94 47 66
High School Graduate da da da da 300 249 167 128 133 120
Some College/Associate's Degree da da da da 343 369 194 208 149 161
College Graduate da da da da 324 328 64 55 259 273
CURRENT EMPLOYMENT                    
Full-Time da da da da 591 546 190 181 401 364
Part-Time da da da da 205 232 150 174 54 58
Unemployed da da da da 71a 153 42 56 30a 97
Other1 da da da da 208 175 106 74 103 101
170421
Table 1.45B – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7 0.6 2.7a 2.2 0.4 0.5 1.4 1.4 0.3 0.3
GENDER                    
Male 0.8 0.8 2.3 1.9 0.6 0.6 1.7 1.6 0.4 0.5
Female 0.6 0.5 3.2 2.6 0.3 0.3 1.1 1.2 0.2 0.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6 0.6 2.7a 2.1 0.4 0.4 1.4 1.4 0.3 0.3
White 0.6 0.6 2.6 2.1 0.4 0.5 1.5 1.7 0.3 0.3
Black or African American 0.5 0.5 2.7 2.5 0.3 0.2 1.1 0.8 0.1 0.1
American Indian or Alaska Native 1.0 0.9 4.6 2.3 0.5 * 0.2 0.2 0.6 *
Native Hawaiian or Other Pacific Islander 0.5 0.5 * * 0.1 0.2 0.2 * * 0.2
Asian 1.0b 0.3 3.1a 0.8 0.8b 0.2 1.2 0.6 0.8a 0.1
Two or More Races 1.5 1.5 2.6 3.3 1.3 1.1 2.7a 0.4 0.8 1.2
Hispanic or Latino 0.8 0.8 2.9 2.5 0.4 0.6 1.4 1.5 0.2 0.4
EDUCATION                    
< High School da da da da 0.3 0.5 1.1 2.0 0.2 0.2
High School Graduate da da da da 0.5 0.4 1.5 1.2 0.3 0.2
Some College/Associate's Degree da da da da 0.5 0.5 1.4 1.4 0.2 0.3
College Graduate da da da da 0.4 0.4 1.4 1.1 0.4 0.4
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.5 0.5 1.3 1.3 0.4 0.3
Part-Time da da da da 0.6 0.7 1.7 1.9 0.2 0.3
Unemployed da da da da 0.6a 1.4 1.2 1.7 0.4a 1.2
Other1 da da da da 0.3 0.2 1.3 1.0 0.1 0.1
170421
Table 1.46A – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 527 600 175 149 352 451 126 121 226 329
GENDER                    
Male 328 378 70 57 258 322 69 66 189 256
Female 199 222 105 93 94 129 57 55 37 74
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 406 446 122 112 284 334 92 97 193 237
White 259 308 71 49 188 259 55 72 133 187
Black or African American 63 86 32 43 31 43 11 24 19 19
American Indian or Alaska Native 7 12 1 2 7 * 1 0 6 *
Native Hawaiian or Other Pacific Islander 1 3 * * * 1 * * * *
Asian 35 19 9 7 25 12 10 * 15 12
Two or More Races 41 17 7 9 34a 8 15 * 20 8
Hispanic or Latino 121 154 53 38 67 117 34 24 33 93
EDUCATION                    
< High School da da da da 44 68 23 23 21 45
High School Graduate da da da da 93 70 51 26 43 45
Some College/Associate's Degree da da da da 98 138 38 61 60 76
College Graduate da da da da 117 174 14 11 103 163
CURRENT EMPLOYMENT                    
Full-Time da da da da 216 212 54 51 162 161
Part-Time da da da da 55 89 41 45 14 45
Unemployed da da da da 26 84 10 11 16 73
Other1 da da da da 55 65 21 15 34 50
170421
Table 1.46B – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.2 0.2 0.7 0.6 0.1 0.2 0.4 0.4 0.1 0.2
GENDER                    
Male 0.3 0.3 0.6 0.4 0.2 0.3 0.4 0.4 0.2 0.3
Female 0.1 0.2 0.9 0.8 0.1 0.1 0.3 0.3 0.0 0.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2 0.2 0.6 0.6 0.1 0.2 0.3 0.4 0.1 0.1
White 0.2 0.2 0.5 0.4 0.1 0.2 0.3 0.4 0.1 0.1
Black or African American 0.2 0.3 0.9 1.3 0.1 0.1 0.2 0.5 0.1 0.1
American Indian or Alaska Native 0.5 0.8 0.5 1.4 0.5 * 0.2 0.2 0.6 *
Native Hawaiian or Other Pacific Islander 0.2 0.2 * * * 0.1 * * * *
Asian 0.2 0.1 0.8 0.5 0.2 0.1 0.5 * 0.1 0.1
Two or More Races 0.9 0.4 0.9 1.1 0.9a 0.2 1.7 * 0.6 0.3
Hispanic or Latino 0.3 0.3 0.9 0.6 0.2 0.3 0.5 0.3 0.1 0.3
EDUCATION                    
< High School da da da da 0.1 0.2 0.4 0.5 0.1 0.2
High School Graduate da da da da 0.2 0.1 0.5 0.2 0.1 0.1
Some College/Associate's Degree da da da da 0.1 0.2 0.3 0.4 0.1 0.1
College Graduate da da da da 0.2 0.2 0.3 0.2 0.2 0.2
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.2 0.2 0.4 0.3 0.2 0.2
Part-Time da da da da 0.2 0.3 0.5 0.5 0.1 0.2
Unemployed da da da da 0.2 0.8 0.3 0.3 0.2 0.9
Other1 da da da da 0.1 0.1 0.3 0.2 0.0 0.1
170421
Table 1.47A – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14,511 14,533 71 69 14,440 14,464 1,135b 836 13,305 13,628
GENDER                    
Male 8,856 8,498 38 43 8,819 8,455 625b 427 8,193 8,028
Female 5,655 6,035 34 26 5,621 6,009 509 409 5,112 5,600
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 12,831 13,058 54 46 12,777 13,012 835a 671 11,942 12,341
White 11,550 11,653 38 37 11,511 11,616 708a 563 10,804 11,053
Black or African American 382 404 1 2 381 402 40 17 341 386
American Indian or Alaska Native 164 151 0 1 164 150 22 29 142 121
Native Hawaiian or Other Pacific Islander 46 50 * * 46 50 * * 40 45
Asian 235 359 8 1 227 358 21 21 206 338
Two or More Races 453 441 6 5 448 436 38 36 409 399
Hispanic or Latino 1,680 1,475 18 23 1,662 1,451 300b 164 1,362 1,287
EDUCATION                    
< High School da da da da 2,129 1,848 270b 169 1,859 1,679
High School Graduate da da da da 4,109 4,274 380 344 3,729 3,930
Some College/Associate's Degree da da da da 5,863 5,386 464b 302 5,399 5,084
College Graduate da da da da 2,339a 2,956 21 20 2,318a 2,936
CURRENT EMPLOYMENT                    
Full-Time da da da da 7,653 7,245 526a 386 7,127 6,858
Part-Time da da da da 1,794 1,976 199 137 1,595 1,839
Unemployed da da da da 828a 1,165 143 133 685b 1,032
Other1 da da da da 4,164 4,078 267a 179 3,897 3,899
170421
Table 1.47B – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 5.4 5.4 0.3 0.3 5.9 5.9 3.3b 2.4 6.4 6.5
GENDER                    
Male 6.8 6.5 0.3 0.3 7.5 7.2 3.6b 2.5 8.2 8.0
Female 4.1 4.3 0.3 0.2 4.5 4.7 2.9 2.4 4.7 5.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5.7 5.8 0.3 0.2 6.2 6.3 3.0a 2.5 6.7 6.9
White 6.8 6.8 0.3 0.3 7.3 7.4 3.7a 3.0 7.8 8.0
Black or African American 1.2 1.3 0.0 0.1 1.3 1.4 0.8 0.3 1.4 1.6
American Indian or Alaska Native 11.5 9.8 0.1 0.5 12.9 10.8 10.2 11.6 13.4 10.6
Native Hawaiian or Other Pacific Islander 6.4 4.2 * * 7.7 4.6 * * 9.1 4.8
Asian 1.6 2.5 0.6 0.1 1.7 2.7 1.0 1.0 1.8 3.0
Two or More Races 9.7 9.1 0.7 0.7 11.6 10.9 4.5 4.7 13.6 12.3
Hispanic or Latino 3.9 3.3 0.3 0.4 4.4 3.8 4.0b 2.2 4.5 4.1
EDUCATION                    
< High School da da da da 6.2 5.7 5.0a 3.5 6.4 6.1
High School Graduate da da da da 6.7 7.0 3.5 3.3 7.3 7.7
Some College/Associate's Degree da da da da 7.9 7.1 3.3b 2.1 9.0 8.3
College Graduate da da da da 3.2a 3.9 0.5 0.4 3.4a 4.2
CURRENT EMPLOYMENT                    
Full-Time da da da da 6.5 6.0 3.6a 2.7 6.9 6.5
Part-Time da da da da 5.5 6.2 2.2 1.5 6.8 8.0
Unemployed da da da da 7.2b 10.5 4.1 4.0 8.6b 13.2
Other1 da da da da 5.2 5.0 3.4a 2.3 5.4 5.3
170421
Table 1.48A – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,713a 1,391 40 32 1,673a 1,360 329 265 1,344 1,095
GENDER                    
Male 1,166b 782 20 18 1,146b 764 185 128 961a 636
Female 547 609 20 14 527 596 144 136 383 459
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,451 1,205 30 22 1,421 1,183 246 228 1,176 955
White 1,173 1,063 19 19 1,153 1,045 177 180 977 865
Black or African American 132 50 1 2 131 49 27 11 104 37
American Indian or Alaska Native 38 16 0 1 38 16 6 8 32a 7
Native Hawaiian or Other Pacific Islander 6 7 * * 6 7 * * 2 6
Asian 49 9 8 1 41 8 17 8 24 *
Two or More Races 53 59 2 0 51 59 14 20 37 39
Hispanic or Latino 262 187 10 10 252 177 84a 37 168 140
EDUCATION                    
< High School da da da da 422 357 91 53 332 304
High School Graduate da da da da 516 437 114 124 402 313
Some College/Associate's Degree da da da da 568a 405 122 85 446 320
College Graduate da da da da 167 160 3 2 164 158
CURRENT EMPLOYMENT                    
Full-Time da da da da 623 456 111 97 512 359
Part-Time da da da da 209 246 71 49 138 197
Unemployed da da da da 218 198 65 45 153 152
Other1 da da da da 623 459 83 73 540 386
170421
Table 1.48B – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6a 0.5 0.2 0.1 0.7a 0.6 0.9 0.8 0.6 0.5
GENDER                    
Male 0.9b 0.6 0.2 0.1 1.0b 0.6 1.1 0.7 1.0b 0.6
Female 0.4 0.4 0.2 0.1 0.4 0.5 0.8 0.8 0.4 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6 0.5 0.2 0.1 0.7 0.6 0.9 0.8 0.7 0.5
White 0.7 0.6 0.1 0.1 0.7 0.7 0.9 1.0 0.7 0.6
Black or African American 0.4 0.2 0.0 0.0 0.5 0.2 0.5 0.2 0.4 0.2
American Indian or Alaska Native 2.7 1.0 0.1 0.4 3.0 1.1 3.0 3.2 3.0a 0.6
Native Hawaiian or Other Pacific Islander 0.9 0.6 * * 1.0 0.6 * * 0.4 0.6
Asian 0.3 0.1 0.6 0.1 0.3 0.1 0.8 0.4 0.2 *
Two or More Races 1.1 1.2 0.3 0.0 1.3 1.5 1.6 2.6 1.2 1.2
Hispanic or Latino 0.6 0.4 0.2 0.2 0.7 0.5 1.1a 0.5 0.6 0.5
EDUCATION                    
< High School da da da da 1.2 1.1 1.7 1.1 1.1 1.1
High School Graduate da da da da 0.8 0.7 1.1 1.2 0.8 0.6
Some College/Associate's Degree da da da da 0.8a 0.5 0.9 0.6 0.7 0.5
College Graduate da da da da 0.2 0.2 0.1 0.0 0.2 0.2
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.5a 0.4 0.8 0.7 0.5 0.3
Part-Time da da da da 0.6 0.8 0.8 0.5 0.6 0.9
Unemployed da da da da 1.9 1.8 1.9 1.4 1.9 2.0
Other1 da da da da 0.8 0.6 1.0 0.9 0.7 0.5
170421
Table 1.49A – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 897a 667 13 9 885a 658 128a 65 757 594
GENDER                    
Male 631a 387 6 4 626a 383 74b 17 552 366
Female 266 280 7 5 259 275 54 48 205 228
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 741 572 9 6 732 566 90 50 642 516
White 592 536 7 5 585 530 69 49 516 481
Black or African American 85a 11 * * 85a 11 14 * 70 11
American Indian or Alaska Native 12 3 0 0 11 3 2 0 9 3
Native Hawaiian or Other Pacific Islander 4 3 * * 4 3 * * 1 3
Asian 19 * * * 19 * * * 19 *
Two or More Races 30 19 2 * 28 19 2 1 26 18
Hispanic or Latino 157 95 4 3 153 92 38 15 115 78
EDUCATION                    
< High School da da da da 193 152 42a 12 151 140
High School Graduate da da da da 279 207 46 31 233 177
Some College/Associate's Degree da da da da 291 204 37 22 254 182
College Graduate da da da da 121 95 3 * 119 95
CURRENT EMPLOYMENT                    
Full-Time da da da da 326a 178 54 20 272 158
Part-Time da da da da 92 129 14 9 78 120
Unemployed da da da da 107 99 24 6 82 93
Other1 da da da da 360 252 35 30 325 222
170421
Table 1.49B – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.3a 0.2 0.1 0.0 0.4a 0.3 0.4a 0.2 0.4 0.3
GENDER                    
Male 0.5a 0.3 0.0 0.0 0.5a 0.3 0.4b 0.1 0.6 0.4
Female 0.2 0.2 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3 0.3 0.0 0.0 0.4 0.3 0.3 0.2 0.4 0.3
White 0.3 0.3 0.1 0.0 0.4 0.3 0.4 0.3 0.4 0.3
Black or African American 0.3a 0.0 * * 0.3a 0.0 0.3 * 0.3 0.0
American Indian or Alaska Native 0.8 0.2 0.1 0.2 0.9 0.2 1.0 0.1 0.9 0.3
Native Hawaiian or Other Pacific Islander 0.6 0.3 * * 0.7 0.3 * * 0.2 0.3
Asian 0.1 * * * 0.1 * * * 0.2 *
Two or More Races 0.6 0.4 0.3 * 0.7 0.5 0.2 0.1 0.9 0.6
Hispanic or Latino 0.4 0.2 0.1 0.1 0.4 0.2 0.5 0.2 0.4 0.3
EDUCATION                    
< High School da da da da 0.6 0.5 0.8a 0.3 0.5 0.5
High School Graduate da da da da 0.5 0.3 0.4 0.3 0.5 0.3
Some College/Associate's Degree da da da da 0.4 0.3 0.3 0.1 0.4 0.3
College Graduate da da da da 0.2 0.1 0.1 * 0.2 0.1
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.3a 0.1 0.4 0.1 0.3 0.1
Part-Time da da da da 0.3 0.4 0.2 0.1 0.3 0.5
Unemployed da da da da 0.9 0.9 0.7 0.2 1.0 1.2
Other1 da da da da 0.4 0.3 0.4 0.4 0.4 0.3
170421
Table 1.50A – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 119,036b 115,351 7,006b 6,194 112,030a 109,157 15,469b 14,118 96,561 95,039
GENDER                    
Male 53,074 51,627 3,484b 3,152 49,590 48,476 7,104b 6,522 42,486 41,953
Female 65,962b 63,724 3,522b 3,043 62,440a 60,681 8,365b 7,595 54,075 53,086
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 103,215b 100,357 5,548b 4,899 97,666a 95,458 12,661b 11,406 85,005 84,052
White 82,226 80,618 4,042b 3,524 78,184 77,094 9,592b 8,651 68,592 68,443
Black or African American 13,685b 12,482 940 851 12,746a 11,631 1,911 1,737 10,835 9,894
American Indian or Alaska Native 637 713 27 31 610 682 115 94 496 588
Native Hawaiian or Other Pacific Islander 277b 546 * * 246b 518 61 * * *
Asian 3,925 3,656 243 244 3,682 3,412 528 507 3,154 2,904
Two or More Races 2,464 2,342 265 221 2,199 2,121 454a 346 1,745 1,775
Hispanic or Latino 15,821 14,994 1,458a 1,295 14,364 13,699 2,808 2,711 11,556 10,987
EDUCATION                    
< High School da da da da 14,625b 12,266 2,227b 1,725 12,398b 10,541
High School Graduate da da da da 28,109 27,342 4,636b 3,966 23,473 23,376
Some College/Associate's Degree da da da da 38,230 37,324 6,714 6,482 31,516 30,842
College Graduate da da da da 31,067 32,225 1,892 1,945 29,175 30,280
CURRENT EMPLOYMENT                    
Full-Time da da da da 51,011 50,813 6,473 6,149 44,537 44,664
Part-Time da da da da 14,934 14,273 3,971 3,753 10,962 10,520
Unemployed da da da da 5,384 4,871 1,578 1,422 3,805 3,449
Other1 da da da da 40,702 39,200 3,446b 2,794 37,256 36,406
170421
Table 1.50B – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 44.5b 42.8 28.1b 24.9 46.1b 44.6 44.3b 40.8 46.4a 45.3
GENDER                    
Male 40.9a 39.5 27.5b 24.9 42.4 41.1 40.5b 37.6 42.7 41.7
Female 47.8b 45.9 28.9b 24.9 49.7b 47.9 48.1b 44.1 49.9 48.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 46.1b 44.6 29.0b 25.7 47.6a 46.3 46.1b 42.1 47.9 47.0
White 48.2 47.2 30.2b 26.6 49.7 49.0 50.0b 45.8 49.7 49.4
Black or African American 42.7b 38.7 27.2 25.0 44.6b 40.3 38.1 35.5 45.9b 41.3
American Indian or Alaska Native 44.4 46.5 16.8 21.1 47.9 49.1 53.7a 37.3 46.8 51.8
Native Hawaiian or Other Pacific Islander 38.3 45.6 * * 40.8 47.7 38.5 * * *
Asian 26.7 25.1 19.5 18.5 27.4 25.8 26.1 23.6 27.6 26.2
Two or More Races 52.9 48.5 33.4a 27.0 56.9 52.9 53.2a 45.0 57.9 54.8
Hispanic or Latino 36.3a 33.8 25.4a 22.2 38.0a 35.6 37.7 36.3 38.1 35.4
EDUCATION                    
< High School da da da da 42.5b 38.0 41.3b 36.1 42.8b 38.4
High School Graduate da da da da 45.6 44.7 42.9b 38.3 46.2 46.1
Some College/Associate's Degree da da da da 51.7b 49.2 47.3b 44.3 52.7a 50.4
College Graduate da da da da 42.7 42.8 42.0 40.5 42.7 42.9
CURRENT EMPLOYMENT                    
Full-Time da da da da 43.0 42.2 44.5 42.5 42.8 42.2
Part-Time da da da da 46.0 44.5 44.5a 41.3 46.6 45.7
Unemployed da da da da 47.1 43.9 45.1 43.1 48.0 44.2
Other1 da da da da 50.6a 48.4 43.4b 36.3 51.4 49.7
170421
Table 1.51A – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 18,942 18,671 1,464 1,317 17,478 17,354 5,330 5,026 12,148 12,327
GENDER                    
Male 10,121 9,605 683 647 9,438 8,958 2,939a 2,632 6,499 6,326
Female 8,821 9,065 781a 670 8,040 8,395 2,391 2,394 5,649 6,001
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15,911 15,871 1,126 1,004 14,785 14,867 4,422 4,141 10,364 10,726
White 12,898 13,009 828a 682 12,069 12,327 3,579 3,313 8,490 9,014
Black or African American 1,861 1,689 179 173 1,682 1,516 494 492 1,187 1,025
American Indian or Alaska Native 98 78 6 7 92 72 33 25 59 47
Native Hawaiian or Other Pacific Islander 51 75 * * 45 73 9 * * 41
Asian 457 462 42 64 415 399 135 130 280 269
Two or More Races 546 558 65 78 482 480 171 151 311 329
Hispanic or Latino 3,031 2,799 339 313 2,692 2,486 908 885 1,784 1,601
EDUCATION                    
< High School da da da da 2,462b 1,937 682 578 1,780a 1,359
High School Graduate da da da da 4,115 4,267 1,472 1,376 2,642 2,891
Some College/Associate's Degree da da da da 6,585 6,166 2,479 2,374 4,106 3,792
College Graduate da da da da 4,316a 4,983 696 698 3,620a 4,285
CURRENT EMPLOYMENT                    
Full-Time da da da da 8,821 8,764 2,282 2,240 6,539 6,524
Part-Time da da da da 2,965 2,968 1,418 1,419 1,548 1,549
Unemployed da da da da 1,372 1,342 556 502 816 840
Other1 da da da da 4,320 4,279 1,074b 865 3,245 3,414
170421
Table 1.51B – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 7.1 6.9 5.9 5.3 7.2 7.1 15.3 14.5 5.8 5.9
GENDER                    
Male 7.8 7.4 5.4 5.1 8.1 7.6 16.8a 15.2 6.5 6.3
Female 6.4 6.5 6.4a 5.5 6.4 6.6 13.8 13.9 5.2 5.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7.1 7.1 5.9 5.3 7.2 7.2 16.1 15.3 5.8 6.0
White 7.6 7.6 6.2a 5.1 7.7 7.8 18.7 17.6 6.2 6.5
Black or African American 5.8 5.2 5.2 5.1 5.9 5.3 9.9 10.1 5.0 4.3
American Indian or Alaska Native 6.8 5.1 3.4 4.5 7.3 5.2 15.5 9.7 5.6 4.2
Native Hawaiian or Other Pacific Islander 7.0 6.3 * * 7.4 6.8 5.5 * * 4.4
Asian 3.1 3.2 3.4 4.8 3.1 3.0 6.7 6.0 2.4 2.4
Two or More Races 11.7 11.6 8.1 9.5 12.5 12.0 20.0 19.6 10.3 10.2
Hispanic or Latino 7.0 6.3 5.9 5.4 7.1 6.5 12.2 11.8 5.9 5.2
EDUCATION                    
< High School da da da da 7.2a 6.0 12.6 12.1 6.1 4.9
High School Graduate da da da da 6.7 7.0 13.6 13.3 5.2 5.7
Some College/Associate's Degree da da da da 8.9a 8.1 17.5 16.2 6.9 6.2
College Graduate da da da da 5.9 6.6 15.4 14.5 5.3a 6.1
CURRENT EMPLOYMENT                    
Full-Time da da da da 7.4 7.3 15.7 15.5 6.3 6.2
Part-Time da da da da 9.1 9.3 15.9 15.6 6.6 6.7
Unemployed da da da da 12.0 12.1 15.9 15.2 10.3 10.8
Other1 da da da da 5.4 5.3 13.5a 11.2 4.5 4.7
170421
Table 1.52A – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6,365 6,207 492a 389 5,873 5,818 1,766 1,600 4,107 4,218
GENDER                    
Male 3,342 3,045 210a 151 3,132 2,894 954a 801 2,178 2,093
Female 3,024 3,162 283 238 2,741 2,924 811 799 1,930 2,125
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5,365 5,402 374a 299 4,991 5,104 1,469 1,357 3,521 3,747
White 4,409 4,593 274 209 4,136 4,384 1,245 1,120 2,890 3,264
Black or African American 586 512 48 56 538 456 143 153 395 304
American Indian or Alaska Native 37 29 2 3 35 26 6 1 29 25
Native Hawaiian or Other Pacific Islander 13 18 * * 8 18 7 * 1 8
Asian 97 70 13 5 84 65 22 24 61 41
Two or More Races 223 180 33 26 191 155 46 49 145 105
Hispanic or Latino 1,001 805 118 91 882 714 296 243 586 471
EDUCATION                    
< High School da da da da 882a 629 259 210 623a 419
High School Graduate da da da da 1,505 1,508 527 466 978 1,043
Some College/Associate's Degree da da da da 2,226 1,979 815 727 1,411 1,252
College Graduate da da da da 1,260b 1,702 165 197 1,095a 1,505
CURRENT EMPLOYMENT                    
Full-Time da da da da 3,048 2,681 775 650 2,273 2,031
Part-Time da da da da 951 995 415 471 536 524
Unemployed da da da da 499 491 203 188 297 303
Other1 da da da da 1,375 1,651 373 291 1,003a 1,360
170421
Table 1.52B – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 2.4 2.3 2.0a 1.6 2.4 2.4 5.1 4.6 2.0 2.0
GENDER                    
Male 2.6 2.3 1.7a 1.2 2.7 2.5 5.4a 4.6 2.2 2.1
Female 2.2 2.3 2.3 2.0 2.2 2.3 4.7 4.6 1.8 1.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.4 2.4 2.0 1.6 2.4 2.5 5.4 5.0 2.0 2.1
White 2.6 2.7 2.0 1.6 2.6 2.8 6.5 5.9 2.1 2.4
Black or African American 1.8 1.6 1.4 1.7 1.9 1.6 2.8 3.1 1.7 1.3
American Indian or Alaska Native 2.6 1.9 1.1 2.1 2.8 1.9 2.7a 0.5 2.8 2.2
Native Hawaiian or Other Pacific Islander 1.7 1.5 * * 1.3 1.6 4.5 * 0.2 0.9
Asian 0.7 0.5 1.1 0.4 0.6 0.5 1.1 1.1 0.5 0.4
Two or More Races 4.8 3.7 4.1 3.2 4.9 3.9 5.3 6.4 4.8 3.2
Hispanic or Latino 2.3 1.8 2.1 1.5 2.3 1.9 4.0 3.2 1.9 1.5
EDUCATION                    
< High School da da da da 2.6a 2.0 4.8 4.4 2.2 1.5
High School Graduate da da da da 2.4 2.5 4.9 4.5 1.9 2.1
Some College/Associate's Degree da da da da 3.0 2.6 5.7 5.0 2.4 2.0
College Graduate da da da da 1.7a 2.3 3.7 4.1 1.6a 2.1
CURRENT EMPLOYMENT                    
Full-Time da da da da 2.6a 2.2 5.3 4.5 2.2 1.9
Part-Time da da da da 2.9 3.1 4.7 5.2 2.3 2.3
Unemployed da da da da 4.4 4.4 5.8 5.7 3.7 3.9
Other1 da da da da 1.7 2.0 4.7 3.8 1.4a 1.9
170421
Table 1.53A – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 97,499b 91,846 5,650b 4,732 91,848b 87,114 12,148b 10,407 79,701b 76,706
GENDER                    
Male 44,017b 41,422 2,684b 2,276 41,333b 39,146 5,388b 4,640 35,945 34,506
Female 53,482b 50,424 2,967b 2,456 50,515b 47,967 6,759b 5,767 43,756 42,200
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 84,357b 79,589 4,402b 3,674 79,955b 75,915 9,766b 8,310 70,189a 67,604
White 65,958b 62,347 3,125b 2,548 62,834a 59,799 7,164b 6,041 55,670 53,759
Black or African American 12,277b 11,142 822 736 11,455a 10,406 1,654 1,497 9,801 8,909
American Indian or Alaska Native 554 600 24 23 530 576 101 79 429 498
Native Hawaiian or Other Pacific Islander 237b 491 * * 214b 471 57 * * *
Asian 3,242 3,055 202 186 3,040 2,869 417 386 2,624 2,483
Two or More Races 2,089 1,954 207 162 1,882 1,792 374b 249 1,508 1,543
Hispanic or Latino 13,141a 12,257 1,248b 1,058 11,893 11,199 2,381a 2,097 9,512 9,102
EDUCATION                    
< High School da da da da 12,851b 10,380 1,861b 1,378 10,990b 9,002
High School Graduate da da da da 23,990 22,705 3,847b 3,126 20,143 19,579
Some College/Associate's Degree da da da da 31,634 30,199 5,153b 4,642 26,482 25,557
College Graduate da da da da 23,373 23,830 1,287 1,261 22,086 22,568
CURRENT EMPLOYMENT                    
Full-Time da da da da 41,344 40,345 5,139b 4,576 36,204 35,769
Part-Time da da da da 11,828a 10,784 2,957a 2,666 8,871 8,118
Unemployed da da da da 4,587a 4,008 1,325a 1,108 3,262 2,900
Other1 da da da da 34,090a 31,977 2,727b 2,057 31,363 29,920
170421
Table 1.53B – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 36.4b 34.1 22.7b 19.0 37.8b 35.6 34.8b 30.1 38.3b 36.5
GENDER                    
Male 33.9b 31.7 21.2b 17.9 35.3b 33.2 30.7b 26.7 36.1a 34.3
Female 38.8b 36.3 24.3b 20.1 40.2b 37.9 38.9b 33.5 40.4a 38.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 37.6b 35.4 23.0b 19.3 39.0b 36.8 35.6b 30.7 39.5b 37.8
White 38.7b 36.5 23.4b 19.2 40.0b 38.0 37.3b 32.0 40.3a 38.8
Black or African American 38.3b 34.6 23.8 21.6 40.0b 36.1 33.0 30.6 41.5b 37.2
American Indian or Alaska Native 38.7 39.1 15.2 15.9 41.6 41.5 47.2a 31.1 40.5 43.8
Native Hawaiian or Other Pacific Islander 32.7 41.1 * * 35.5 43.4 35.7 * * *
Asian 22.0 21.0 16.2 14.0 22.6 21.7 20.5 17.9 22.9 22.4
Two or More Races 44.8 40.5 26.0a 19.8 48.7 44.7 43.8b 32.4 50.1 47.6
Hispanic or Latino 30.2b 27.6 21.7b 18.1 31.4a 29.1 31.9a 28.0 31.3 29.3
EDUCATION                    
< High School da da da da 37.4b 32.2 34.5b 28.8 37.9b 32.8
High School Graduate da da da da 38.9a 37.2 35.6b 30.2 39.7 38.6
Some College/Associate's Degree da da da da 42.8b 39.8 36.3b 31.7 44.3b 41.8
College Graduate da da da da 32.1 31.6 28.6 26.3 32.3 32.0
CURRENT EMPLOYMENT                    
Full-Time da da da da 34.9a 33.5 35.3b 31.6 34.8 33.8
Part-Time da da da da 36.5a 33.6 33.1b 29.4 37.7 35.3
Unemployed da da da da 40.1a 36.1 37.8a 33.6 41.1 37.2
Other1 da da da da 42.4b 39.5 34.4b 26.7 43.3a 40.8
170421
Table 1.54A – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 12,462a 11,517 969 881 11,492a 10,635 2,979b 2,454 8,513 8,181
GENDER                    
Male 6,924a 6,226 451 413 6,473a 5,813 1,684b 1,328 4,789 4,486
Female 5,538 5,291 518 469 5,020 4,822 1,295a 1,126 3,725 3,696
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 10,305 9,650 734 672 9,572 8,978 2,436b 1,980 7,136 6,998
White 8,128 7,698 523 439 7,605 7,259 1,916b 1,500 5,689 5,759
Black or African American 1,400 1,257 141 144 1,259 1,113 309 320 951 793
American Indian or Alaska Native 80 60 3 4 77 56 27 16 49 40
Native Hawaiian or Other Pacific Islander 39 50 * * * 48 8 * * 31
Asian 266 269 24 36 242 233 67 51 175 182
Two or More Races 392 316 42 47 350 269 109 76 242 192
Hispanic or Latino 2,156 1,867 236 209 1,921 1,657 543 474 1,378 1,184
EDUCATION                    
< High School da da da da 1,976b 1,399 481b 318 1,495b 1,081
High School Graduate da da da da 2,988 3,017 928 825 2,060 2,192
Some College/Associate's Degree da da da da 4,248b 3,634 1,297b 1,064 2,950 2,570
College Graduate da da da da 2,281 2,586 273 247 2,008 2,339
CURRENT EMPLOYMENT                    
Full-Time da da da da 5,725 5,519 1,310 1,157 4,415 4,361
Part-Time da da da da 1,749 1,540 667 597 1,082 943
Unemployed da da da da 1,044 966 384 317 659 649
Other1 da da da da 2,975 2,611 618b 383 2,356 2,228
170421
Table 1.54B – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4.7a 4.3 3.9 3.5 4.7a 4.3 8.5b 7.1 4.1 3.9
GENDER                    
Male 5.3a 4.8 3.6 3.3 5.5a 4.9 9.6b 7.6 4.8 4.5
Female 4.0 3.8 4.2 3.8 4.0 3.8 7.5 6.5 3.4 3.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4.6 4.3 3.8 3.5 4.7 4.4 8.9b 7.3 4.0 3.9
White 4.8 4.5 3.9 3.3 4.8 4.6 10.0b 7.9 4.1 4.2
Black or African American 4.4 3.9 4.1 4.2 4.4 3.9 6.2 6.6 4.0 3.3
American Indian or Alaska Native 5.6 3.9 2.0 2.9 6.0 4.0 12.8 6.3 4.7 3.5
Native Hawaiian or Other Pacific Islander 5.4 4.2 * * * 4.4 5.0 * * 3.4
Asian 1.8 1.8 1.9 2.7 1.8 1.8 3.3 2.4 1.5 1.6
Two or More Races 8.4 6.5 5.2 5.7 9.1 6.7 12.7 9.9 8.0 5.9
Hispanic or Latino 5.0 4.2 4.1 3.6 5.1 4.3 7.3 6.3 4.5 3.8
EDUCATION                    
< High School da da da da 5.7b 4.3 8.9a 6.6 5.2a 3.9
High School Graduate da da da da 4.9 4.9 8.6 8.0 4.1 4.3
Some College/Associate's Degree da da da da 5.7b 4.8 9.1b 7.3 4.9a 4.2
College Graduate da da da da 3.1 3.4 6.1 5.1 2.9 3.3
CURRENT EMPLOYMENT                    
Full-Time da da da da 4.8 4.6 9.0 8.0 4.2 4.1
Part-Time da da da da 5.4 4.8 7.5 6.6 4.6 4.1
Unemployed da da da da 9.1 8.7 11.0 9.6 8.3 8.3
Other1 da da da da 3.7 3.2 7.8b 5.0 3.3 3.0
170421
Table 1.55A – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3,775 3,350 276 239 3,499 3,111 829b 631 2,670 2,480
GENDER                    
Male 2,110a 1,692 112 80 1,998a 1,612 458b 331 1,540 1,281
Female 1,665 1,658 164 159 1,501 1,499 371 300 1,130 1,200
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,087 2,847 207 182 2,880 2,665 676b 499 2,204 2,166
White 2,441 2,357 144 116 2,297 2,241 550b 403 1,747 1,838
Black or African American 432 367 41 47 391 320 82 69 309 251
American Indian or Alaska Native 16 18 1 3 15 16 6 1 10 15
Native Hawaiian or Other Pacific Islander 6 10 * * 6 10 * * * 5
Asian 52 11 4 * 48 11 4 1 44 10
Two or More Races 140 83 17 16 123 68 28 19 95 48
Hispanic or Latino 688 503 70 57 619 446 152 132 466 314
EDUCATION                    
< High School da da da da 636a 424 146a 86 490 338
High School Graduate da da da da 1,039 952 310 232 729 720
Some College/Associate's Degree da da da da 1,233 1,028 329 271 904 757
College Graduate da da da da 591 707 44 42 547 665
CURRENT EMPLOYMENT                    
Full-Time da da da da 1,847b 1,391 391b 276 1,456a 1,115
Part-Time da da da da 479 442 149 140 330 302
Unemployed da da da da 331 337 133 99 198 237
Other1 da da da da 842 941 156 115 685 826
170421
Table 1.55B – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.4 1.2 1.1 1.0 1.4 1.3 2.4b 1.8 1.3 1.2
GENDER                    
Male 1.6a 1.3 0.9 0.6 1.7a 1.4 2.6b 1.9 1.5 1.3
Female 1.2 1.2 1.3 1.3 1.2 1.2 2.1 1.7 1.0 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.4 1.3 1.1 1.0 1.4 1.3 2.5b 1.8 1.2 1.2
White 1.4 1.4 1.1 0.9 1.5 1.4 2.9b 2.1 1.3 1.3
Black or African American 1.3 1.1 1.2 1.4 1.4 1.1 1.6 1.4 1.3 1.0
American Indian or Alaska Native 1.1 1.2 0.4 1.7 1.2 1.1 2.6a 0.5 0.9 1.3
Native Hawaiian or Other Pacific Islander 0.9 0.8 * * 1.0 0.9 * * * 0.5
Asian 0.4 0.1 0.3 * 0.4 0.1 0.2 0.1 0.4 0.1
Two or More Races 3.0 1.7 2.1 1.9 3.2 1.7 3.3 2.5 3.1 1.5
Hispanic or Latino 1.6a 1.1 1.2 1.0 1.6 1.2 2.0 1.8 1.5 1.0
EDUCATION                    
< High School da da da da 1.9 1.3 2.7 1.8 1.7 1.2
High School Graduate da da da da 1.7 1.6 2.9 2.2 1.4 1.4
Some College/Associate's Degree da da da da 1.7 1.4 2.3 1.9 1.5 1.2
College Graduate da da da da 0.8 0.9 1.0 0.9 0.8 0.9
CURRENT EMPLOYMENT                    
Full-Time da da da da 1.6b 1.2 2.7b 1.9 1.4a 1.1
Part-Time da da da da 1.5 1.4 1.7 1.5 1.4 1.3
Unemployed da da da da 2.9 3.0 3.8 3.0 2.5 3.0
Other1 da da da da 1.0 1.2 2.0 1.5 0.9 1.1
170421
Table 1.56A – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 39,317 38,756 1,069 1,108 38,247 37,649 4,212 3,901 34,035 33,747
GENDER                    
Male 14,624 14,329 472 466 14,152 13,863 1,882 1,713 12,270 12,150
Female 24,693 24,427 598 641 24,095 23,786 2,330 2,188 21,765 21,598
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 34,844 34,753 863 863 33,981 33,890 3,515 3,265 30,467 30,625
White 30,271 29,782 656 663 29,615 29,119 2,960a 2,661 26,655 26,458
Black or African American 2,920 3,026 106 105 2,814 2,921 350 362 2,464 2,560
American Indian or Alaska Native 174 227 2 2 172 225 16 31 156 193
Native Hawaiian or Other Pacific Islander 34 84 * * 27 82 10 * 17a 74
Asian 682 875 35 47 647 828 75 98 572 729
Two or More Races 764 759 56 44 707 715 104 104 603 611
Hispanic or Latino 4,472 4,003 207 245 4,266 3,759 697 636 3,568 3,122
EDUCATION                    
< High School da da da da 4,567b 3,767 608 530 3,959a 3,236
High School Graduate da da da da 9,451 9,382 1,126 1,104 8,325 8,278
Some College/Associate's Degree da da da da 13,327 12,840 2,002a 1,739 11,325 11,101
College Graduate da da da da 10,903 11,660 477 528 10,426 11,132
CURRENT EMPLOYMENT                    
Full-Time da da da da 15,582 15,202 1,749 1,693 13,833 13,509
Part-Time da da da da 5,211 5,034 1,116 1,014 4,096 4,020
Unemployed da da da da 1,776 1,686 438 427 1,338 1,259
Other1 da da da da 15,677 15,727 910 767 14,768 14,960
170421
Table 1.56B – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14.7 14.4 4.3 4.4 15.8 15.4 12.1 11.3 16.4 16.1
GENDER                    
Male 11.3 11.0 3.7 3.7 12.1 11.8 10.7 9.9 12.3 12.1
Female 17.9 17.6 4.9 5.3 19.2 18.8 13.4 12.7 20.1 19.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15.5 15.4 4.5 4.5 16.6 16.4 12.8 12.0 17.2 17.1
White 17.8 17.4 4.9 5.0 18.8 18.5 15.4a 14.1 19.3 19.1
Black or African American 9.1 9.4 3.1 3.1 9.8 10.1 7.0 7.4 10.4 10.7
American Indian or Alaska Native 12.1 14.8 1.2 1.7 13.5 16.2 7.6 12.4 14.7 17.0
Native Hawaiian or Other Pacific Islander 4.7 7.0 * * 4.4 7.5 6.1 * 3.8 7.9
Asian 4.6 6.0 2.8 3.6 4.8 6.3 3.7 4.6 5.0 6.6
Two or More Races 16.4 15.7 7.1 5.3 18.3 17.8 12.2 13.5 20.0 18.9
Hispanic or Latino 10.3 9.0 3.6 4.2 11.3a 9.8 9.4 8.5 11.8 10.1
EDUCATION                    
< High School da da da da 13.3 11.7 11.3 11.1 13.7 11.8
High School Graduate da da da da 15.3 15.4 10.4 10.7 16.4 16.3
Some College/Associate's Degree da da da da 18.0 16.9 14.1b 11.9 18.9 18.1
College Graduate da da da da 15.0 15.5 10.6 11.0 15.3 15.8
CURRENT EMPLOYMENT                    
Full-Time da da da da 13.1 12.6 12.0 11.7 13.3 12.8
Part-Time da da da da 16.1 15.7 12.5 11.2 17.4 17.5
Unemployed da da da da 15.5 15.2 12.5 12.9 16.9 16.1
Other1 da da da da 19.5 19.4 11.5 10.0 20.4 20.4
170421
Table 1.57A – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6,050 6,060 394 434 5,656 5,626 1,874 1,844 3,782 3,781
GENDER                    
Male 3,148 2,870 184 203 2,964 2,667 1,021 914 1,943 1,752
Female 2,903 3,190 210 231 2,692 2,959 853 930 1,839 2,029
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5,173 5,281 305 325 4,868 4,955 1,583 1,516 3,285 3,439
White 4,381 4,445 227 232 4,154 4,213 1,325 1,219 2,829 2,994
Black or African American 484 495 39 43 445 452 163 193 282 260
American Indian or Alaska Native 28 22 1 1 27 22 8 8 19 14
Native Hawaiian or Other Pacific Islander 15 9 * * 14 9 7 * 7 *
Asian 96 102 10 16 86 85 32 30 54 55
Two or More Races 170 207 28 33 142 174 47 61 95 113
Hispanic or Latino 877 779 89 109 788 670 291 328 497 342
EDUCATION                    
< High School da da da da 733 622 271 276 462 346
High School Graduate da da da da 1,416 1,472 530 562 886 911
Some College/Associate's Degree da da da da 2,331a 1,994 902 823 1,429 1,171
College Graduate da da da da 1,177a 1,538 172 184 1,005a 1,355
CURRENT EMPLOYMENT                    
Full-Time da da da da 2,734 2,600 832 776 1,901 1,824
Part-Time da da da da 1,021 1,008 490 499 531 509
Unemployed da da da da 525 483 210 228 314 255
Other1 da da da da 1,377 1,534 342 341 1,035 1,193
170421
Table 1.57B – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 2.3 2.2 1.6 1.7 2.3 2.3 5.4 5.3 1.8 1.8
GENDER                    
Male 2.4 2.2 1.4 1.6 2.5 2.3 5.8 5.3 2.0 1.7
Female 2.1 2.3 1.7 1.9 2.1 2.3 4.9 5.4 1.7 1.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.3 2.3 1.6 1.7 2.4 2.4 5.8 5.6 1.9 1.9
White 2.6 2.6 1.7 1.8 2.6 2.7 6.9 6.5 2.1 2.2
Black or African American 1.5 1.5 1.1 1.3 1.6 1.6 3.3 3.9 1.2 1.1
American Indian or Alaska Native 2.0 1.5 0.5 0.6 2.1 1.6 3.9 3.0 1.8 1.2
Native Hawaiian or Other Pacific Islander 2.1 0.8 * * 2.3 0.9 4.5 * 1.5 *
Asian 0.7 0.7 0.8 1.2 0.6 0.6 1.6 1.4 0.5 0.5
Two or More Races 3.6 4.3 3.5 4.0 3.7 4.3 5.5 7.9 3.2 3.5
Hispanic or Latino 2.0 1.8 1.5 1.9 2.1 1.7 3.9 4.4 1.6 1.1
EDUCATION                    
< High School da da da da 2.1 1.9 5.0 5.8 1.6 1.3
High School Graduate da da da da 2.3 2.4 4.9 5.4 1.7 1.8
Some College/Associate's Degree da da da da 3.1a 2.6 6.4 5.6 2.4 1.9
College Graduate da da da da 1.6a 2.0 3.8 3.8 1.5a 1.9
CURRENT EMPLOYMENT                    
Full-Time da da da da 2.3 2.2 5.7 5.4 1.8 1.7
Part-Time da da da da 3.1 3.1 5.5 5.5 2.3 2.2
Unemployed da da da da 4.6 4.4 6.0 6.9 4.0 3.3
Other1 da da da da 1.7 1.9 4.3 4.4 1.4 1.6
170421
Table 1.58A – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,874 1,953 162 121 1,712 1,832 582 536 1,130 1,296
GENDER                    
Male 974 1,002 70 59 904 942 329 277 575 665
Female 900 951 92 61 808 890 253 259 555 631
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,635 1,748 122 94 1,513 1,654 489 455 1,024 1,199
White 1,405 1,468 93 71 1,312 1,397 418 341 894 1,056
Black or African American 136 199 9 9 127 190 53 83 74 107
American Indian or Alaska Native 6 6 1 * 6 6 0 * 5 6
Native Hawaiian or Other Pacific Islander * 8 * * * 8 * * * *
Asian 10 17 6 3 4 14 4 5 * 9
Two or More Races 75 50 13 11 62 38 11 21 51 18
Hispanic or Latino 239 205 40 27 199 178 93 81 106 97
EDUCATION                    
< High School da da da da 221 239 108 103 113 136
High School Graduate da da da da 447 476 166 170 281 306
Some College/Associate's Degree da da da da 735 586 261 214 475 372
College Graduate da da da da 309a 531 48 48 261a 483
CURRENT EMPLOYMENT                    
Full-Time da da da da 855 852 279 240 575 612
Part-Time da da da da 297 296 144 129 153 167
Unemployed da da da da 164 153 71 56 93 97
Other1 da da da da 397 531 89 111 309 421
170421
Table 1.58B – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7 0.7 0.7 0.5 0.7 0.7 1.7 1.5 0.5 0.6
GENDER                    
Male 0.8 0.8 0.6 0.5 0.8 0.8 1.9 1.6 0.6 0.7
Female 0.7 0.7 0.8 0.5 0.6 0.7 1.5 1.5 0.5 0.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.8 0.6 0.5 0.7 0.8 1.8 1.7 0.6 0.7
White 0.8 0.9 0.7 0.5 0.8 0.9 2.2 1.8 0.6 0.8
Black or African American 0.4 0.6 0.3 0.3 0.4 0.7 1.1 1.7 0.3 0.4
American Indian or Alaska Native 0.4 0.4 0.4 * 0.4 0.5 0.1 * 0.5 0.6
Native Hawaiian or Other Pacific Islander * 0.7 * * * 0.7 * * * *
Asian 0.1 0.1 0.5 0.2 0.0 0.1 0.2 0.2 * 0.1
Two or More Races 1.6 1.0 1.7 1.4 1.6 1.0 1.3 2.7 1.7 0.5
Hispanic or Latino 0.5 0.5 0.7 0.5 0.5 0.5 1.3 1.1 0.3 0.3
EDUCATION                    
< High School da da da da 0.6 0.7 2.0 2.2 0.4 0.5
High School Graduate da da da da 0.7 0.8 1.5 1.6 0.6 0.6
Some College/Associate's Degree da da da da 1.0 0.8 1.8 1.5 0.8 0.6
College Graduate da da da da 0.4a 0.7 1.1 1.0 0.4a 0.7
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.7 0.7 1.9 1.7 0.6 0.6
Part-Time da da da da 0.9 0.9 1.6 1.4 0.6 0.7
Unemployed da da da da 1.4 1.4 2.0 1.7 1.2 1.2
Other1 da da da da 0.5 0.7 1.1 1.4 0.4 0.6
170421
Table 1.59A – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 17,212a 18,420 1,820 1,799 15,392a 16,621 4,906 4,998 10,486a 11,623
GENDER                    
Male 8,461 8,626 1,082 1,117 7,380 7,509 2,690 2,597 4,690 4,912
Female 8,751b 9,795 739 682 8,012b 9,112 2,217 2,401 5,796b 6,711
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15,091a 16,249 1,571 1,515 13,520b 14,734 4,265 4,272 9,255b 10,462
White 12,815b 13,931 1,249 1,226 11,566a 12,705 3,664 3,656 7,903b 9,049
Black or African American 1,252 1,265 165 135 1,087 1,130 283 287 804 843
American Indian or Alaska Native 90 67 5 9 84 58 17 10 67 48
Native Hawaiian or Other Pacific Islander 36 58 * * 25 49 * * * 30
Asian 423 448 49 47 374 401 138 156 236 245
Two or More Races 474 479 91 88 383 391 150 145 233 246
Hispanic or Latino 2,121 2,171 249 284 1,872 1,888 641 726 1,231 1,162
EDUCATION                    
< High School da da da da 1,728 1,480 552 487 1,176 993
High School Graduate da da da da 3,189 3,231 1,165 1,123 2,024 2,107
Some College/Associate's Degree da da da da 6,103a 6,784 2,369 2,516 3,734a 4,268
College Graduate da da da da 4,372a 5,126 820 871 3,552a 4,255
CURRENT EMPLOYMENT                    
Full-Time da da da da 7,909 8,361 2,052 2,177 5,857 6,184
Part-Time da da da da 2,601 2,892 1,439 1,473 1,162 1,420
Unemployed da da da da 841 991 390 444 451 547
Other1 da da da da 4,041 4,376 1,025 904 3,016 3,472
170421
Table 1.59B – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6.4a 6.8 7.3 7.2 6.3a 6.8 14.1 14.5 5.0a 5.5
GENDER                    
Male 6.5 6.6 8.5 8.8 6.3 6.4 15.3 15.0 4.7 4.9
Female 6.3b 7.1 6.1 5.6 6.4b 7.2 12.8 14.0 5.3b 6.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6.7a 7.2 8.2 7.9 6.6a 7.2 15.5 15.8 5.2b 5.8
White 7.5a 8.2 9.3 9.2 7.4b 8.1 19.1 19.4 5.7b 6.5
Black or African American 3.9 3.9 4.8 4.0 3.8 3.9 5.6 5.9 3.4 3.5
American Indian or Alaska Native 6.3 4.4 3.4 6.0 6.6 4.2 8.0 4.0 6.4 4.2
Native Hawaiian or Other Pacific Islander 5.0 4.9 * * 4.2 4.5 * * * 3.3
Asian 2.9 3.1 3.9 3.6 2.8 3.0 6.8 7.2 2.1 2.2
Two or More Races 10.2 9.9 11.5 10.7 9.9 9.8 17.6 18.8 7.7 7.6
Hispanic or Latino 4.9 4.9 4.3 4.9 4.9 4.9 8.6 9.7 4.1 3.7
EDUCATION                    
< High School da da da da 5.0 4.6 10.2 10.2 4.1 3.6
High School Graduate da da da da 5.2 5.3 10.8 10.9 4.0 4.2
Some College/Associate's Degree da da da da 8.2 8.9 16.7 17.2 6.2 7.0
College Graduate da da da da 6.0a 6.8 18.2 18.1 5.2a 6.0
CURRENT EMPLOYMENT                    
Full-Time da da da da 6.7 6.9 14.1 15.0 5.6 5.8
Part-Time da da da da 8.0 9.0 16.1 16.2 4.9 6.2
Unemployed da da da da 7.4 8.9 11.1 13.4 5.7 7.0
Other1 da da da da 5.0 5.4 12.9 11.7 4.2 4.7
170421
Table 1.60A – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 5,251 5,647 491 427 4,760a 5,220 2,537 2,578 2,223a 2,643
GENDER                    
Male 3,027 2,985 259 243 2,768 2,742 1,482 1,377 1,286 1,365
Female 2,224b 2,662 232 184 1,992b 2,478 1,056 1,201 937b 1,277
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,600 4,953 413 348 4,187a 4,605 2,176 2,185 2,011a 2,419
White 4,019 4,306 350a 268 3,669 4,039 1,890 1,908 1,779a 2,130
Black or African American 212 245 18 17 194 228 130 105 64 122
American Indian or Alaska Native 25 12 2 4 23 8 4 6 * 2
Native Hawaiian or Other Pacific Islander 13 21 * * 8 21 * * 2 8
Asian 143 170 18 24 125 146 60 71 65 75
Two or More Races 189 198 21 35 168 163 86 81 82 82
Hispanic or Latino 651 694 77 79 573 615 362 392 212 223
EDUCATION                    
< High School da da da da 381 377 209 205 171 172
High School Graduate da da da da 961 945 566 528 396 417
Some College/Associate's Degree da da da da 2,042 2,226 1,287 1,362 755 863
College Graduate da da da da 1,376a 1,672 476 482 901a 1,191
CURRENT EMPLOYMENT                    
Full-Time da da da da 2,683 2,683 1,095 1,163 1,587 1,520
Part-Time da da da da 1,021 1,183 786 824 235 359
Unemployed da da da da 280 392 172 168 108a 224
Other1 da da da da 776 963 484 424 292b 539
170421
Table 1.60B – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 2.0 2.1 2.0 1.7 2.0 2.1 7.3 7.5 1.1a 1.3
GENDER                    
Male 2.3 2.3 2.0 1.9 2.4 2.3 8.5 7.9 1.3 1.4
Female 1.6b 1.9 1.9 1.5 1.6b 2.0 6.1 7.0 0.9b 1.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.1 2.2 2.2 1.8 2.0 2.2 7.9 8.1 1.1a 1.4
White 2.4 2.5 2.6a 2.0 2.3 2.6 9.9 10.1 1.3a 1.5
Black or African American 0.7 0.8 0.5 0.5 0.7 0.8 2.6 2.2 0.3 0.5
American Indian or Alaska Native 1.8 0.8 1.5 2.6 1.8 0.6 1.8 2.3 * 0.2
Native Hawaiian or Other Pacific Islander 1.8 1.8 * * 1.3 2.0 * * 0.4 0.9
Asian 1.0 1.2 1.4 1.8 0.9 1.1 3.0 3.3 0.6 0.7
Two or More Races 4.1 4.1 2.6 4.3 4.4 4.1 10.1 10.6 2.7 2.5
Hispanic or Latino 1.5 1.6 1.3 1.3 1.5 1.6 4.8 5.2 0.7 0.7
EDUCATION                    
< High School da da da da 1.1 1.2 3.9 4.3 0.6 0.6
High School Graduate da da da da 1.6 1.5 5.2 5.1 0.8 0.8
Some College/Associate's Degree da da da da 2.8 2.9 9.1 9.3 1.3 1.4
College Graduate da da da da 1.9 2.2 10.6 10.0 1.3a 1.7
CURRENT EMPLOYMENT                    
Full-Time da da da da 2.3 2.2 7.5 8.0 1.5 1.4
Part-Time da da da da 3.1 3.7 8.8 9.1 1.0 1.6
Unemployed da da da da 2.4a 3.5 4.9 5.1 1.4a 2.9
Other1 da da da da 1.0 1.2 6.1 5.5 0.4b 0.7
170421
Table 1.61A – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,653 1,735 117 92 1,536 1,643 757 767 779 876
GENDER                    
Male 877 881 61 46 816 836 403 394 413 441
Female 776 854 56 46 720 808 354 372 366 435
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,481 1,539 99 73 1,382 1,465 650 681 732 784
White 1,327 1,361 83 56 1,244 1,305 584 606 660 698
Black or African American 36a 80 1 6 35 74 27 33 8a 41
American Indian or Alaska Native * 3 1 1 * 2 1 * * 2
Native Hawaiian or Other Pacific Islander 9 2 * * 5 2 * * 1 2
Asian 42 27 5 2 36 25 19 19 18 6
Two or More Races 51 66 4 7 47 59 15 23 32 35
Hispanic or Latino 172 197 18 19 154 178 107 86 47 92
EDUCATION                    
< High School da da da da 166 140 87 71 79 70
High School Graduate da da da da 331 290 167 168 164 123
Some College/Associate's Degree da da da da 620 667 398 395 222 273
College Graduate da da da da 419 545 105 134 314 412
CURRENT EMPLOYMENT                    
Full-Time da da da da 833 811 303 287 530 524
Part-Time da da da da 305 401 211 278 94 123
Unemployed da da da da 94 96 59 57 34 40
Other1 da da da da 305 335 185 146 120 189
170421
Table 1.61B – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6 0.6 0.5 0.4 0.6 0.7 2.2 2.2 0.4 0.4
GENDER                    
Male 0.7 0.7 0.5 0.4 0.7 0.7 2.3 2.3 0.4 0.4
Female 0.6 0.6 0.5 0.4 0.6 0.6 2.0 2.2 0.3 0.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7 0.7 0.5 0.4 0.7 0.7 2.4 2.5 0.4 0.4
White 0.8 0.8 0.6 0.4 0.8 0.8 3.0 3.2 0.5 0.5
Black or African American 0.1a 0.2 0.0 0.2 0.1 0.3 0.5 0.7 0.0a 0.2
American Indian or Alaska Native * 0.2 0.6 0.6 * 0.1 0.3 * * 0.2
Native Hawaiian or Other Pacific Islander 1.3 0.1 * * 0.8 0.1 * * 0.2 0.2
Asian 0.3 0.2 0.4 0.2 0.3 0.2 0.9 0.9 0.2 0.1
Two or More Races 1.1 1.4 0.5 0.9 1.2 1.5 1.8 3.0 1.0 1.1
Hispanic or Latino 0.4 0.4 0.3 0.3 0.4 0.5 1.4 1.1 0.2 0.3
EDUCATION                    
< High School da da da da 0.5 0.4 1.6 1.5 0.3 0.3
High School Graduate da da da da 0.5 0.5 1.5 1.6 0.3 0.2
Some College/Associate's Degree da da da da 0.8 0.9 2.8 2.7 0.4 0.4
College Graduate da da da da 0.6 0.7 2.3 2.8 0.5 0.6
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.7 0.7 2.1 2.0 0.5 0.5
Part-Time da da da da 0.9 1.2 2.4 3.1 0.4 0.5
Unemployed da da da da 0.8 0.9 1.7 1.7 0.4 0.5
Other1 da da da da 0.4 0.4 2.3 1.9 0.2 0.3
170421
Table 1.62A – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 18,564 18,629 602 563 17,962 18,067 1,339 1,278 16,623 16,789
GENDER                    
Male 7,219 7,023 271 232 6,948 6,791 588 496 6,361 6,295
Female 11,345 11,607 331 331 11,014 11,276 751 782 10,263 10,493
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 16,739 16,683 503 455 16,236 16,228 1,135 1,044 15,101 15,184
White 14,192 14,435 379 345 13,813 14,090 922 873 12,891 13,217
Black or African American 1,576 1,411 66 61 1,509 1,350 115 99 1,395 1,252
American Indian or Alaska Native 75 107 4 3 72 104 * 6 63 98
Native Hawaiian or Other Pacific Islander 24 17 * * 23 16 * * 16 15
Asian 541 367 27 19 513 348 33 24 480 324
Two or More Races 332 346 26 26 306 320 50 42 256 278
Hispanic or Latino 1,825 1,946 99 108 1,726 1,838 203 234 1,523 1,604
EDUCATION                    
< High School da da da da 1,788 1,725 187 149 1,601 1,576
High School Graduate da da da da 4,113 4,151 353 307 3,761 3,845
Some College/Associate's Degree da da da da 6,131 6,064 621 632 5,510 5,431
College Graduate da da da da 5,930 6,126 178 190 5,752 5,936
CURRENT EMPLOYMENT                    
Full-Time da da da da 6,987 6,846 524 533 6,463 6,313
Part-Time da da da da 2,426 2,330 327 286 2,099 2,044
Unemployed da da da da 862 795 167 160 696 635
Other1 da da da da 7,686 8,096 321 299 7,365 7,797
170421
Table 1.62B – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6.9 6.9 2.4 2.3 7.4 7.4 3.8 3.7 8.0 8.0
GENDER                    
Male 5.6 5.4 2.1 1.8 5.9 5.8 3.4 2.9 6.4 6.3
Female 8.2 8.4 2.7 2.7 8.8 8.9 4.3 4.5 9.5 9.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 7.5 7.4 2.6 2.4 7.9 7.9 4.1 3.9 8.5 8.5
White 8.3 8.5 2.8 2.6 8.8 8.9 4.8 4.6 9.3 9.5
Black or African American 4.9 4.4 1.9 1.8 5.3 4.7 2.3 2.0 5.9 5.2
American Indian or Alaska Native 5.2 7.0 2.3 1.9 5.6 7.5 * 2.4 5.9 8.6
Native Hawaiian or Other Pacific Islander 3.3 1.5 * * 3.8 1.4 * * 3.7 1.6
Asian 3.7 2.5 2.2 1.4 3.8 2.6 1.6 1.1 4.2 2.9
Two or More Races 7.1 7.2 3.3 3.2 7.9 8.0 5.8 5.4 8.5 8.6
Hispanic or Latino 4.2 4.4 1.7 1.8 4.6 4.8 2.7 3.1 5.0 5.2
EDUCATION                    
< High School da da da da 5.2 5.4 3.5 3.1 5.5 5.7
High School Graduate da da da da 6.7 6.8 3.3 3.0 7.4 7.6
Some College/Associate's Degree da da da da 8.3 8.0 4.4 4.3 9.2 8.9
College Graduate da da da da 8.1 8.1 3.9 4.0 8.4 8.4
CURRENT EMPLOYMENT                    
Full-Time da da da da 5.9 5.7 3.6 3.7 6.2 6.0
Part-Time da da da da 7.5 7.3 3.7 3.2 8.9 8.9
Unemployed da da da da 7.5 7.2 4.8 4.8 8.8 8.1
Other1 da da da da 9.6 10.0 4.0 3.9 10.2 10.6
170421
Table 1.63A – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,511 1,531 102 100 1,409 1,431 265 256 1,143 1,176
GENDER                    
Male 596 691 44 39 552 652 122 114 430 538
Female 915 840 58 61 856 779 143 141 714 638
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1,344 1,328 79 78 1,265 1,249 232 196 1,033 1,053
White 1,183 1,130 60 66 1,123 1,064 204 164 919 900
Black or African American 76 102 6 2 69 100 9 17 60 82
American Indian or Alaska Native 0 5 0 0 * 4 * * * 2
Native Hawaiian or Other Pacific Islander 4 * * * 4 * * * 1 *
Asian 17 25 3 3 14 22 5 * 9 22
Two or More Races 65 66 9 7 56 59 12 12 44 47
Hispanic or Latino 166 204 23 22 144 182 33 59 110 123
EDUCATION                    
< High School da da da da 97 148 25 24 72 124
High School Graduate da da da da 320 263 81 60 239 204
Some College/Associate's Degree da da da da 514 478 130 117 384 361
College Graduate da da da da 478 542 29 55 448 487
CURRENT EMPLOYMENT                    
Full-Time da da da da 744 555 101 122 643a 433
Part-Time da da da da 227 263 86 61 141 202
Unemployed da da da da 74 97 26 38 49 58
Other1 da da da da 363 517 53 34 310 483
170421
Table 1.63B – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6 0.6 0.4 0.4 0.6 0.6 0.8 0.7 0.5 0.6
GENDER                    
Male 0.5 0.5 0.3 0.3 0.5 0.6 0.7 0.7 0.4 0.5
Female 0.7 0.6 0.5 0.5 0.7 0.6 0.8 0.8 0.7 0.6
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6 0.6 0.4 0.4 0.6 0.6 0.8 0.7 0.6 0.6
White 0.7 0.7 0.5 0.5 0.7 0.7 1.1 0.9 0.7 0.6
Black or African American 0.2 0.3 0.2 0.1 0.2 0.3 0.2 0.4 0.3 0.3
American Indian or Alaska Native 0.0 0.3 0.1 0.3 * 0.3 * * * 0.2
Native Hawaiian or Other Pacific Islander 0.5 * * * 0.6 * * * 0.2 *
Asian 0.1 0.2 0.3 0.2 0.1 0.2 0.2 * 0.1 0.2
Two or More Races 1.4 1.4 1.2 0.9 1.4 1.5 1.4 1.6 1.5 1.4
Hispanic or Latino 0.4 0.5 0.4 0.4 0.4 0.5 0.4 0.8 0.4 0.4
EDUCATION                    
< High School da da da da 0.3 0.5 0.5 0.5 0.2 0.5
High School Graduate da da da da 0.5 0.4 0.7 0.6 0.5 0.4
Some College/Associate's Degree da da da da 0.7 0.6 0.9 0.8 0.6 0.6
College Graduate da da da da 0.7 0.7 0.7 1.1 0.7 0.7
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.6a 0.5 0.7 0.8 0.6a 0.4
Part-Time da da da da 0.7 0.8 1.0 0.7 0.6 0.9
Unemployed da da da da 0.7 0.9 0.7 1.2 0.6 0.7
Other1 da da da da 0.5 0.6 0.7 0.4 0.4 0.7
170421
Table 1.64A – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 446 497 21 23 425 474 86 50 340 425
GENDER                    
Male 153 214 4 4 149 210 37 15 113 195
Female 293 283 17 19 276 264 49 35 227 230
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 405 457 13 18 392 439 70 40 322 399
White 345 382 10 17 335 365 59 36 276 328
Black or African American 50 23 1 1 48 22 6 2 42 20
American Indian or Alaska Native * 3 * 0 * 2 * * * 2
Native Hawaiian or Other Pacific Islander 4 * * * 4 * * * 1 *
Asian * 16 * * * 16 * * * 16
Two or More Races 7 34 2 0 5 33 1 1 3 32
Hispanic or Latino 41 40 8 5 33 35 16 10 17 26
EDUCATION                    
< High School da da da da 37 33 6 10 31 22
High School Graduate da da da da 141 91 19 5 122 86
Some College/Associate's Degree da da da da 109 128 52 31 57 98
College Graduate da da da da 139 223 9 4 129 219
CURRENT EMPLOYMENT                    
Full-Time da da da da 208 136 38 20 170 116
Part-Time da da da da 68 71 17 12 51 59
Unemployed da da da da 17 37 7 10 10 27
Other1 da da da da 132 231 24 7 108 224
170421
Table 1.64B – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2
GENDER                    
Male 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2
Female 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.2
White 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.2
Black or African American 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1
American Indian or Alaska Native * 0.2 * 0.2 * 0.2 * * * 0.2
Native Hawaiian or Other Pacific Islander 0.5 * * * 0.6 * * * 0.2 *
Asian * 0.1 * * * 0.1 * * * 0.1
Two or More Races 0.2 0.7 0.3 0.0 0.1 0.8 0.2 0.2 0.1 1.0
Hispanic or Latino 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1
EDUCATION                    
< High School da da da da 0.1 0.1 0.1 0.2 0.1 0.1
High School Graduate da da da da 0.2 0.1 0.2 0.0 0.2 0.2
Some College/Associate's Degree da da da da 0.1 0.2 0.4 0.2 0.1 0.2
College Graduate da da da da 0.2 0.3 0.2 0.1 0.2 0.3
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.2 0.1 0.3 0.1 0.2 0.1
Part-Time da da da da 0.2 0.2 0.2 0.1 0.2 0.3
Unemployed da da da da 0.1 0.3 0.2 0.3 0.1 0.3
Other1 da da da da 0.2 0.3 0.3 0.1 0.1 0.3
170421
Table 1.65A – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 12,693a 11,824 980 891 11,712 10,933 3,029b 2,516 8,683 8,417
GENDER                    
Male 7,088a 6,420 453 419 6,635a 6,001 1,725b 1,360 4,910 4,641
Female 5,605 5,403 528 471 5,077 4,932 1,304 1,156 3,773 3,776
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 10,486 9,909 742 679 9,744 9,230 2,459b 2,033 7,285 7,197
White 8,235 7,915 530 446 7,705 7,468 1,935b 1,549 5,770 5,919
Black or African American 1,466 1,295 143 144 1,324 1,151 309 320 1,015 831
American Indian or Alaska Native 80 63 3 5 77 59 27 19 49 40
Native Hawaiian or Other Pacific Islander 43 50 * * * 48 * * * 31
Asian 268 269 24 36 245 233 67 51 177 182
Two or More Races 394 317 42 47 353 270 109 76 244 194
Hispanic or Latino 2,206 1,915 238 212 1,968 1,703 570 483 1,398 1,220
EDUCATION                    
< High School da da da da 2,041b 1,473 499b 327 1,541a 1,146
High School Graduate da da da da 3,098 3,116 952 856 2,146 2,259
Some College/Associate's Degree da da da da 4,277a 3,740 1,305a 1,085 2,973 2,655
College Graduate da da da da 2,296 2,604 273 247 2,023 2,357
CURRENT EMPLOYMENT                    
Full-Time da da da da 5,817 5,658 1,335 1,185 4,483 4,473
Part-Time da da da da 1,764 1,581 678 616 1,086 965
Unemployed da da da da 1,074 1,011 395 329 679 682
Other1 da da da da 3,056 2,683 621b 386 2,435 2,297
170421
Table 1.65B – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4.7a 4.4 3.9 3.6 4.8a 4.5 8.7b 7.3 4.2 4.0
GENDER                    
Male 5.5a 4.9 3.6 3.3 5.7a 5.1 9.8b 7.8 4.9 4.6
Female 4.1 3.9 4.3 3.9 4.0 3.9 7.5 6.7 3.5 3.5
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4.7 4.4 3.9 3.6 4.8 4.5 9.0b 7.5 4.1 4.0
White 4.8 4.6 4.0 3.4 4.9 4.7 10.1b 8.2 4.2 4.3
Black or African American 4.6 4.0 4.1 4.2 4.6 4.0 6.2 6.6 4.3 3.5
American Indian or Alaska Native 5.6 4.1 2.0 3.1 6.0 4.2 12.8 7.4 4.7 3.5
Native Hawaiian or Other Pacific Islander 5.9 4.2 * * * 4.4 * * * 3.4
Asian 1.8 1.8 1.9 2.7 1.8 1.8 3.3 2.4 1.6 1.6
Two or More Races 8.5 6.6 5.2 5.7 9.1 6.7 12.8 9.9 8.1 6.0
Hispanic or Latino 5.1 4.3 4.1 3.6 5.2 4.4 7.6 6.5 4.6 3.9
EDUCATION                    
< High School da da da da 5.9b 4.6 9.3b 6.9 5.3a 4.2
High School Graduate da da da da 5.0 5.1 8.8 8.3 4.2 4.5
Some College/Associate's Degree da da da da 5.8b 4.9 9.2b 7.4 5.0 4.3
College Graduate da da da da 3.2 3.5 6.1 5.1 3.0 3.3
CURRENT EMPLOYMENT                    
Full-Time da da da da 4.9 4.7 9.2 8.2 4.3 4.2
Part-Time da da da da 5.4 4.9 7.6 6.8 4.6 4.2
Unemployed da da da da 9.4 9.1 11.3 10.0 8.6 8.7
Other1 da da da da 3.8 3.3 7.8b 5.0 3.4 3.1
170421
Table 1.66A – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3,963 3,649 277 241 3,686 3,408 880b 688 2,806 2,720
GENDER                    
Male 2,246a 1,883 113 82 2,133 1,801 490a 369 1,643 1,432
Female 1,718 1,766 164 159 1,553 1,607 390 319 1,163 1,288
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,245 3,089 207 182 3,038 2,907 698b 540 2,340 2,367
White 2,567 2,542 145 116 2,423 2,426 571a 434 1,851 1,992
Black or African American 462 419 41 47 421 372 83 74 339 298
American Indian or Alaska Native 16 22 1 3 15 20 6 5 10 15
Native Hawaiian or Other Pacific Islander 6 10 * * 6 10 * * * 5
Asian 52 11 4 * 48 11 4 1 44 10
Two or More Races 142 84 17 16 125 68 28 20 96 48
Hispanic or Latino 718 561 70 59 649 501 182 148 466 353
EDUCATION                    
< High School da da da da 670 486 161a 95 508 391
High School Graduate da da da da 1,149 1,049 332 260 817 789
Some College/Associate's Degree da da da da 1,272 1,128 341 290 931 838
College Graduate da da da da 596 745 46 43 550 702
CURRENT EMPLOYMENT                    
Full-Time da da da da 1,896b 1,483 424b 300 1,472 1,183
Part-Time da da da da 504 477 157 143 347 335
Unemployed da da da da 393 405 141 111 252 294
Other1 da da da da 893 1,042 159 134 735 908
170421
Table 1.66B – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.5 1.4 1.1 1.0 1.5 1.4 2.5b 2.0 1.3 1.3
GENDER                    
Male 1.7a 1.4 0.9 0.6 1.8 1.5 2.8a 2.1 1.7 1.4
Female 1.2 1.3 1.3 1.3 1.2 1.3 2.2 1.9 1.1 1.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.4 1.4 1.1 1.0 1.5 1.4 2.5a 2.0 1.3 1.3
White 1.5 1.5 1.1 0.9 1.5 1.5 3.0a 2.3 1.3 1.4
Black or African American 1.4 1.3 1.2 1.4 1.5 1.3 1.6 1.5 1.4 1.2
American Indian or Alaska Native 1.1 1.4 0.4 1.7 1.2 1.4 2.6 2.0 0.9 1.3
Native Hawaiian or Other Pacific Islander 0.9 0.8 * * 1.0 0.9 * * * 0.5
Asian 0.4 0.1 0.3 * 0.4 0.1 0.2 0.1 0.4 0.1
Two or More Races 3.0 1.7 2.1 1.9 3.2 1.7 3.3 2.6 3.2 1.5
Hispanic or Latino 1.6 1.3 1.2 1.0 1.7 1.3 2.4 2.0 1.5 1.1
EDUCATION                    
< High School da da da da 1.9 1.5 3.0 2.0 1.8 1.4
High School Graduate da da da da 1.9 1.7 3.1 2.5 1.6 1.6
Some College/Associate's Degree da da da da 1.7 1.5 2.4 2.0 1.6 1.4
College Graduate da da da da 0.8 1.0 1.0 0.9 0.8 1.0
CURRENT EMPLOYMENT                    
Full-Time da da da da 1.6b 1.2 2.9b 2.1 1.4a 1.1
Part-Time da da da da 1.6 1.5 1.8 1.6 1.5 1.5
Unemployed da da da da 3.4 3.7 4.0 3.4 3.2 3.8
Other1 da da da da 1.1 1.3 2.0 1.7 1.0 1.2
170420
Table 1.67A – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 47,730 48,501 4,346b 3,941 43,384 44,559 13,102 13,034 30,281 31,525
GEOGRAPHIC REGION                    
Northeast 8,914 9,171 741b 608 8,173 8,564 2,607 2,530 5,566 6,034
Midwest 9,530 9,665 958 893 8,572 8,772 2,750 2,784 5,822 5,987
South 16,096 15,932 1,571a 1,411 14,526 14,521 4,425 4,431 10,100 10,090
West 13,190 13,733 1,076 1,029 12,113 12,703 3,320 3,289 8,793 9,414
COUNTY TYPE1                    
Large Metro 28,398 29,084 2,518a 2,272 25,880 26,812 7,582 7,507 18,298 19,306
Small Metro 14,042 13,962 1,302a 1,152 12,740 12,810 4,046 4,116 8,694 8,694
Nonmetro 5,290 5,454 526 518 4,764 4,937 1,474 1,412 3,290 3,525
Urbanized 2,504 2,363 232 230 2,272 2,132 731 661 1,541 1,472
Less Urbanized 2,292 2,637 247 241 2,045 2,396 613 661 1,433 1,735
Completely Rural 494 455 48 46 446 408 131 90 316 318
POVERTY LEVEL2                    
Less Than 100% 9,635 9,326 969 840 8,666 8,486 3,537 3,432 5,129 5,054
100-199% 10,308 10,209 1,032 978 9,276 9,231 3,033 2,819 6,244 6,412
200% or More 27,533 28,669 2,345a 2,124 25,188 26,545 6,279 6,486 18,909 20,059
HEALTH INSURANCE3                    
Private 27,623 28,510 2,460b 2,166 25,164 26,344 7,746 8,043 17,417 18,301
Medicaid/CHIP4 9,988 10,636 1,652 1,602 8,335 9,033 2,480 2,602 5,855 6,432
Other5 6,655 7,011 215 196 6,440 6,815 1,053 1,081 5,387 5,735
No Coverage 6,930 6,405 185 168 6,744 6,236 2,187b 1,670 4,557 4,566
170420
Table 1.67B – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 17.8 18.0 17.5b 15.8 17.9 18.2 37.5 37.7 14.6 15.0
GEOGRAPHIC REGION                    
Northeast 18.6 19.2 18.0b 14.8 18.7 19.6 42.6 41.8 14.8 16.0
Midwest 16.8 17.0 17.9 16.8 16.7 17.1 37.1 37.8 13.3 13.6
South 16.1 15.7 16.6a 14.8 16.0 15.8 34.1 34.5 13.0 12.8
West 20.9 21.6 18.1 17.3 21.2 22.0 39.5 39.5 18.1 19.1
COUNTY TYPE1                    
Large Metro 19.0 19.4 17.9a 16.2 19.1 19.7 39.1 39.2 15.8 16.5
Small Metro 17.2 17.3 17.1 15.5 17.2 17.5 36.6 37.3 13.8 14.0
Nonmetro 14.4 14.2 16.2 15.2 14.2 14.1 33.1 32.4 11.3 11.5
Urbanized 16.5 15.4 16.2 16.2 16.6 15.3 35.6 34.2 13.2 12.3
Less Urbanized 13.5 13.6 17.1 14.4 13.1 13.6 31.4 32.0 10.5 11.1
Completely Rural 10.8 12.3 12.7 14.6 10.6 12.1 29.4 25.1 8.4 10.6
POVERTY LEVEL2                    
Less Than 100% 22.7 22.9 17.1 15.6 23.6 24.0 37.1 38.1 18.9 19.2
100-199% 18.9 18.6 18.2 17.3 19.0 18.7 36.2 36.0 15.4 15.5
200% or More 16.2 16.6 17.3b 15.3 16.1 16.7 38.4 38.1 13.5 14.1
HEALTH INSURANCE3                    
Private 15.7 15.9 17.1b 14.9 15.6 16.0 38.4 38.4 12.3 12.7
Medicaid/CHIP4 23.3 24.2 18.1 17.5 24.7 25.9 34.0 35.6 22.1 23.3
Other5 9.9 10.3 18.1 16.1 9.8 10.2 35.8 37.7 8.6 9.0
No Coverage 25.9 26.3 16.3 15.7 26.3 26.8 39.1 36.0 22.7 24.5
170420
Table 1.68A – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 27,080a 28,564 2,193a 1,959 24,887b 26,605 7,797 8,012 17,090a 18,593
GEOGRAPHIC REGION                    
Northeast 5,104 5,451 400a 301 4,704 5,150 1,579 1,658 3,124 3,492
Midwest 5,473 5,494 478 440 4,995 5,055 1,550 1,599 3,445 3,455
South 8,800 8,950 764 707 8,037 8,243 2,630 2,608 5,406 5,635
West 7,703a 8,670 551 512 7,151b 8,157 2,037 2,146 5,114a 6,011
COUNTY TYPE1                    
Large Metro 15,905 16,932 1,280a 1,103 14,625a 15,828 4,526 4,586 10,099a 11,242
Small Metro 8,071 8,407 664 614 7,407 7,793 2,447 2,577 4,960 5,217
Nonmetro 3,103 3,225 248 242 2,855 2,983 825 849 2,031 2,134
Urbanized 1,568 1,372 101 114 1,467 1,259 439 385 1,028 874
Less Urbanized 1,266a 1,600 121 104 1,145a 1,496 315 402 830a 1,094
Completely Rural 269 252 26 24 243 228 70 62 173 166
POVERTY LEVEL2                    
Less Than 100% 5,567 5,817 495 398 5,072 5,419 2,116 2,207 2,956 3,212
100-199% 6,045 6,348 499 495 5,546 5,853 1,862 1,734 3,684 4,119
200% or More 15,305 16,220 1,199 1,066 14,107a 15,154 3,657 3,891 10,449 11,263
HEALTH INSURANCE3                    
Private 15,104a 16,117 1,222 1,098 13,882a 15,019 4,577 4,860 9,306 10,159
Medicaid/CHIP4 5,888b 6,644 856 787 5,031b 5,857 1,411a 1,643 3,621a 4,214
Other5 3,745 4,042 98 77 3,647 3,965 608 648 3,039 3,317
No Coverage 4,352 4,054 94 90 4,258 3,964 1,433b 1,088 2,825 2,876
170420
Table 1.68B – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 10.1a 10.6 8.8a 7.9 10.2a 10.9 22.3 23.2 8.2a 8.9
GEOGRAPHIC REGION                    
Northeast 10.7 11.4 9.7a 7.3 10.8 11.8 25.8 27.4 8.3 9.3
Midwest 9.7 9.7 8.9 8.3 9.7 9.8 20.9 21.7 7.8 7.8
South 8.8 8.8 8.1 7.4 8.9 9.0 20.3 20.3 7.0 7.1
West 12.2a 13.6 9.3 8.6 12.5a 14.1 24.2 25.8 10.5a 12.2
COUNTY TYPE1                    
Large Metro 10.7 11.3 9.1a 7.8 10.8a 11.6 23.3 23.9 8.7a 9.6
Small Metro 9.9 10.4 8.7 8.3 10.0 10.6 22.1 23.3 7.9 8.4
Nonmetro 8.4 8.4 7.6 7.1 8.5 8.5 18.5 19.5 7.0 7.0
Urbanized 10.4 8.9 7.1 8.0 10.7 9.0 21.4 20.0 8.8 7.3
Less Urbanized 7.4 8.3 8.4 6.2 7.4 8.5 16.1 19.4 6.1 7.0
Completely Rural 5.9 6.8 6.8 7.7 5.8 6.8 15.8 17.2 4.6 5.5
POVERTY LEVEL2                    
Less Than 100% 13.1 14.3 8.7 7.4 13.8a 15.3 22.2a 24.5 10.9 12.2
100-199% 11.1 11.6 8.8 8.8 11.4 11.9 22.2 22.1 9.1 9.9
200% or More 9.0 9.4 8.8a 7.7 9.0 9.5 22.4 22.8 7.4 7.9
HEALTH INSURANCE3                    
Private 8.6 9.0 8.5 7.5 8.6 9.1 22.7 23.2 6.6 7.1
Medicaid/CHIP4 13.7a 15.1 9.4 8.6 14.9b 16.8 19.3a 22.5 13.7 15.3
Other5 5.6 6.0 8.3 6.3 5.6 6.0 20.7 22.6 4.8 5.2
No Coverage 16.2 16.6 8.3 8.4 16.6 17.0 25.6 23.4 14.1 15.4
170420
Table 1.69A – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 36,043a 37,570 3,137 2,982 32,906a 34,588 11,246 11,401 21,660a 23,187
GEOGRAPHIC REGION                    
Northeast 6,933 7,238 567a 478 6,366 6,760 2,323 2,267 4,042 4,493
Midwest 7,287 7,412 684 671 6,603 6,741 2,334 2,370 4,269 4,371
South 11,701 11,858 1,127 1,016 10,575 10,843 3,778 3,789 6,796 7,054
West 10,123a 11,062 759 817 9,364a 10,244 2,811 2,976 6,553 7,269
COUNTY TYPE1                    
Large Metro 21,541 22,587 1,796 1,749 19,744 20,838 6,543 6,655 13,201 14,183
Small Metro 10,614 10,693 962 864 9,652 9,828 3,484 3,546 6,168 6,283
Nonmetro 3,889 4,290 379 369 3,510 3,922 1,219 1,201 2,291a 2,721
Urbanized 1,875 1,838 170 175 1,705 1,663 605 563 1,100 1,100
Less Urbanized 1,641b 2,126 172 167 1,468b 1,960 505 561 964b 1,399
Completely Rural 373 326 36 27 337 299 109 77 228 222
POVERTY LEVEL2                    
Less Than 100% 7,330 7,496 679 608 6,651 6,889 3,025 3,043 3,626 3,845
100-199% 7,714 7,894 688 747 7,027 7,147 2,632 2,409 4,395 4,737
200% or More 20,781 21,901 1,770 1,627 19,011a 20,274 5,372 5,670 13,639 14,604
HEALTH INSURANCE3                    
Private 20,797a 22,000 1,818 1,651 18,979a 20,349 6,621 7,083 12,359 13,266
Medicaid/CHIP4 7,475a 8,272 1,130 1,197 6,344a 7,075 2,079 2,231 4,266a 4,844
Other5 4,699 4,977 146 134 4,553 4,843 922 931 3,631 3,911
No Coverage 5,321 5,107 142 132 5,179 4,975 1,916b 1,443 3,264 3,532
170420
Table 1.69B – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 13.5 13.9 12.6 12.0 13.6a 14.1 32.2 33.0 10.4 11.0
GEOGRAPHIC REGION                    
Northeast 14.5 15.1 13.8a 11.7 14.6 15.5 38.0 37.5 10.8 11.9
Midwest 12.9 13.1 12.8 12.6 12.9 13.1 31.5 32.2 9.7 9.9
South 11.7 11.7 11.9 10.7 11.7 11.8 29.2 29.5 8.7 8.9
West 16.1 17.4 12.8 13.8 16.4 17.8 33.4 35.8 13.5 14.7
COUNTY TYPE1                    
Large Metro 14.4 15.0 12.8 12.4 14.6 15.3 33.8 34.7 11.4 12.1
Small Metro 13.0 13.2 12.7 11.7 13.0 13.4 31.5 32.1 9.8 10.1
Nonmetro 10.6 11.2 11.7 10.8 10.5 11.2 27.4 27.5 7.9 8.9
Urbanized 12.4 12.0 11.9 12.3 12.4 11.9 29.5 29.1 9.4 9.2
Less Urbanized 9.6 11.0 11.9 10.0 9.4 11.1 25.8 27.1 7.1a 9.0
Completely Rural 8.1 8.8 9.7 8.4 8.0 8.9 24.5 21.4 6.1 7.4
POVERTY LEVEL2                    
Less Than 100% 17.3 18.4 12.0 11.3 18.1 19.5 31.8 33.8 13.3 14.6
100-199% 14.2 14.4 12.2 13.3 14.4 14.5 31.5 30.8 10.9 11.4
200% or More 12.2 12.7 13.0a 11.7 12.1 12.7 32.9 33.3 9.7 10.3
HEALTH INSURANCE3                    
Private 11.8 12.3 12.6a 11.3 11.7 12.4 32.8 33.9 8.7 9.2
Medicaid/CHIP4 17.4a 18.8 12.4 13.1 18.8 20.3 28.5 30.5 16.1 17.6
Other5 7.0 7.3 12.3 11.0 6.9 7.3 31.4 32.5 5.8 6.1
No Coverage 19.9 21.0 12.5 12.4 20.2 21.4 34.3 31.1 16.3a 18.9
170420
Table 1.70A – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 22,226b 23,981 1,752 1,609 20,474b 22,373 6,921 7,184 13,552b 15,188
GEOGRAPHIC REGION                    
Northeast 4,322 4,580 339 272 3,983 4,308 1,456 1,503 2,527 2,805
Midwest 4,571 4,668 387 353 4,183 4,315 1,364 1,427 2,819 2,889
South 6,857 7,263 593 540 6,265 6,723 2,307 2,285 3,958 4,437
West 6,476b 7,471 433 444 6,043b 7,027 1,794 1,969 4,248a 5,058
COUNTY TYPE1                    
Large Metro 13,072a 14,258 1,025 928 12,048a 13,330 4,048 4,143 8,000a 9,187
Small Metro 6,599 6,926 525 494 6,075 6,433 2,150 2,284 3,925 4,149
Nonmetro 2,554 2,797 203 187 2,352 2,610 723 757 1,628 1,853
Urbanized 1,313 1,193 81 92 1,231 1,101 383 350 848 750
Less Urbanized 1,038b 1,400 105 80 932b 1,320 272 359 660b 961
Completely Rural 204 203 16 14 188 189 68 48 120 142
POVERTY LEVEL2                    
Less Than 100% 4,664 4,910 393 313 4,271 4,598 1,901 1,996 2,370 2,601
100-199% 4,951 5,307 374 420 4,578 4,887 1,657 1,525 2,921 3,362
200% or More 12,479a 13,599 986 877 11,493a 12,723 3,231 3,498 8,262a 9,225
HEALTH INSURANCE3                    
Private 12,362a 13,501 999 911 11,363b 12,591 4,059 4,331 7,305a 8,260
Medicaid/CHIP4 4,858b 5,549 655 646 4,203b 4,903 1,233a 1,488 2,970 3,415
Other5 3,023 3,202 76 55 2,947 3,147 533 572 2,414 2,575
No Coverage 3,540 3,492 81 69 3,459 3,424 1,279b 969 2,180 2,455
170420
Table 1.70B – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 8.3b 8.9 7.0 6.5 8.4b 9.1 19.8 20.8 6.5b 7.2
GEOGRAPHIC REGION                    
Northeast 9.0 9.6 8.2 6.6 9.1 9.9 23.8 24.8 6.7 7.5
Midwest 8.1 8.2 7.2 6.6 8.2 8.4 18.4 19.4 6.4 6.6
South 6.8 7.2 6.3 5.7 6.9 7.3 17.8 17.8 5.1 5.6
West 10.3a 11.7 7.3 7.5 10.6a 12.2 21.3 23.7 8.7a 10.2
COUNTY TYPE1                    
Large Metro 8.8a 9.5 7.3 6.6 8.9a 9.8 20.9 21.6 6.9a 7.8
Small Metro 8.1 8.6 6.9 6.7 8.2 8.8 19.4 20.7 6.2 6.7
Nonmetro 7.0 7.3 6.2 5.5 7.0 7.5 16.3 17.4 5.6 6.1
Urbanized 8.7 7.8 5.7 6.5 9.0 7.9 18.7 18.1 7.3 6.3
Less Urbanized 6.1 7.2 7.3a 4.8 6.0a 7.5 13.9 17.4 4.8 6.2
Completely Rural 4.5 5.5 4.2 4.5 4.5 5.6 15.3 13.2 3.2 4.7
POVERTY LEVEL2                    
Less Than 100% 11.0a 12.1 6.9 5.8 11.6a 13.0 20.0a 22.2 8.7 9.9
100-199% 9.1 9.7 6.6 7.4 9.4 9.9 19.8 19.5 7.2 8.1
200% or More 7.3 7.9 7.3a 6.3 7.3a 8.0 19.8 20.5 5.9a 6.5
HEALTH INSURANCE3                    
Private 7.0a 7.5 6.9 6.3 7.0a 7.6 20.1 20.7 5.2a 5.7
Medicaid/CHIP4 11.3a 12.6 7.2 7.1 12.4a 14.1 16.9b 20.4 11.2 12.4
Other5 4.5 4.7 6.4 4.5 4.5 4.7 18.1 19.9 3.8 4.0
No Coverage 13.2 14.3 7.1 6.4 13.5 14.7 22.9 20.9 10.9a 13.2
170420
Table 1.71A – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4,828 5,071 153 136 4,675 4,936 1,876 1,919 2,799 3,017
GEOGRAPHIC REGION                    
Northeast 1,057 1,251 20 21 1,038 1,230 435 401 602a 829
Midwest 816 779 30 19 786 760 320 281 466 479
South 1,658 1,488 53 39 1,605 1,449 627 609 978 840
West 1,296 1,553 50 57 1,246 1,497 493 628 753 869
COUNTY TYPE1                    
Large Metro 3,023 3,218 75 68 2,948 3,150 1,098 1,134 1,850 2,017
Small Metro 1,319 1,430 64 51 1,256 1,378 575 618 680 761
Nonmetro 485 423 14 16 472 407 203 168 269 240
Urbanized 263 217 8 10 255 207 126a 79 129 128
Less Urbanized 185 187 4 5 180 182 68 74 112 108
Completely Rural 37 19 1 * 36 18 8 14 28 3
POVERTY LEVEL2                    
Less Than 100% 1,110 1,080 30 15 1,080 1,065 483 462 597 603
100-199% 1,147 1,124 39 38 1,107 1,087 435 378 672 709
200% or More 2,533 2,850 83 83 2,450 2,767 920 1,063 1,530 1,705
HEALTH INSURANCE3                    
Private 2,560 2,895 89 79 2,471 2,816 1,204 1,300 1,267 1,516
Medicaid/CHIP4 1,036 1,215 59 51 977 1,164 238 328 739 835
Other5 488 508 9 8 479 499 108 107 371 392
No Coverage 901 818 3 4 898 814 361b 225 537 589
170420
Table 1.71B – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.8 1.9 0.6 0.5 1.9 2.0 5.4 5.6 1.3 1.4
GEOGRAPHIC REGION                    
Northeast 2.2 2.6 0.5 0.5 2.4 2.8 7.1 6.6 1.6a 2.2
Midwest 1.4 1.4 0.6 0.4 1.5 1.5 4.3 3.8 1.1 1.1
South 1.7 1.5 0.6 0.4 1.8 1.6 4.8 4.7 1.3 1.1
West 2.1 2.4 0.8 1.0 2.2 2.6 5.9 7.5 1.5 1.8
COUNTY TYPE1                    
Large Metro 2.0 2.1 0.5 0.5 2.2 2.3 5.7 5.9 1.6 1.7
Small Metro 1.6 1.8 0.8 0.7 1.7 1.9 5.2 5.6 1.1 1.2
Nonmetro 1.3 1.1 0.4 0.5 1.4 1.2 4.6 3.8 0.9 0.8
Urbanized 1.7 1.4 0.6 0.7 1.9 1.5 6.1a 4.1 1.1 1.1
Less Urbanized 1.1 1.0 0.3 0.3 1.2 1.0 3.5 3.6 0.8 0.7
Completely Rural 0.8 0.5 0.4 * 0.9 0.5 1.8 4.0 0.7 0.1
POVERTY LEVEL2                    
Less Than 100% 2.6 2.7 0.5 0.3 2.9 3.0 5.1 5.1 2.2 2.3
100-199% 2.1 2.0 0.7 0.7 2.3 2.2 5.2 4.8 1.7 1.7
200% or More 1.5 1.6 0.6 0.6 1.6 1.7 5.6 6.2 1.1 1.2
HEALTH INSURANCE3                    
Private 1.5 1.6 0.6 0.5 1.5 1.7 6.0 6.2 0.9 1.1
Medicaid/CHIP4 2.4 2.8 0.6 0.6 2.9 3.3 3.3 4.5 2.8 3.0
Other5 0.7 0.7 0.7 0.7 0.7 0.7 3.7 3.7 0.6 0.6
No Coverage 3.4 3.4 0.3 0.4 3.5 3.5 6.5 4.8 2.7 3.2
170420
Table 1.72A – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,876 1,874 53 28 1,822 1,847 580 552 1,243 1,295
GEOGRAPHIC REGION                    
Northeast 411 417 2 5 409 412 124 111 284 301
Midwest 289 237 17 5 272 232 75 70 197 161
South 720 551 20 10 700 541 201 175 499 366
West 456a 669 14 8 441a 662 180 195 262a 466
COUNTY TYPE1                    
Large Metro 1,208 1,144 22 12 1,186 1,132 341 289 844 843
Small Metro 487 584 27 12 460 572 184 207 275 364
Nonmetro 181 147 3 4 177 143 55 55 123 87
Urbanized 98 87 3 3 96 84 37 28 58 56
Less Urbanized 79 48 1 1 78 47 17 16 61 31
Completely Rural 3 11 * * 3 11 * 11 3 1
POVERTY LEVEL2                    
Less Than 100% 469 529 11 2 458 526 161 149 297 378
100-199% 495 389 19 5 476 383 141 106 335 278
200% or More 897 954 23 20 874 934 263 295 611 639
HEALTH INSURANCE3                    
Private 824 958 30 17 794 941 345 351 449 590
Medicaid/CHIP4 461 565 20 9 441 556 69 98 372 458
Other5 233 215 * * 227 215 38 43 190 172
No Coverage 462 335 * 1 462 334 147b 72 316 262
170420
Table 1.72B – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7 0.7 0.2 0.1 0.8 0.8 1.7 1.6 0.6 0.6
GEOGRAPHIC REGION                    
Northeast 0.9 0.9 0.0 0.1 0.9 0.9 2.0 1.8 0.8 0.8
Midwest 0.5 0.4 0.3 0.1 0.5 0.5 1.0 1.0 0.4 0.4
South 0.7 0.5 0.2 0.1 0.8 0.6 1.6 1.4 0.6 0.5
West 0.7a 1.1 0.2 0.1 0.8a 1.1 2.1 2.3 0.5a 0.9
COUNTY TYPE1                    
Large Metro 0.8 0.8 0.2 0.1 0.9 0.8 1.8 1.5 0.7 0.7
Small Metro 0.6 0.7 0.4 0.2 0.6 0.8 1.7 1.9 0.4 0.6
Nonmetro 0.5 0.4 0.1 0.1 0.5 0.4 1.2 1.3 0.4 0.3
Urbanized 0.7 0.6 0.2 0.2 0.7 0.6 1.8 1.5 0.5 0.5
Less Urbanized 0.5 0.2 0.0 0.1 0.5 0.3 0.9 0.8 0.4 0.2
Completely Rural 0.1 0.3 * * 0.1 0.3 * 3.0 0.1 0.0
POVERTY LEVEL2                    
Less Than 100% 1.1 1.3 0.2 0.0 1.2 1.5 1.7 1.7 1.1 1.4
100-199% 0.9 0.7 0.3 0.1 1.0 0.8 1.7 1.3 0.8 0.7
200% or More 0.5 0.6 0.2 0.1 0.6 0.6 1.6 1.7 0.4 0.4
HEALTH INSURANCE3                    
Private 0.5 0.5 0.2 0.1 0.5 0.6 1.7 1.7 0.3 0.4
Medicaid/CHIP4 1.1 1.3 0.2 0.1 1.3 1.6 0.9 1.3 1.4 1.7
Other5 0.3 0.3 * * 0.3 0.3 1.3 1.5 0.3 0.3
No Coverage 1.7 1.4 * 0.1 1.8 1.4 2.6a 1.5 1.6 1.4
170412
Table 1.73A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 9,035 8,776 833 882 394 432
GEOGRAPHIC REGION            
Northeast 1,607 1,573 194 257 83 130
Midwest 1,733 1,838 214 163 78 89
South 3,376 2,961 371 337 200 142
West 2,318 2,404 55 125 33 71
COUNTY TYPE1            
Large Metro 4,772 4,787 467 537 235 282
Small Metro 2,847 2,562 266 266 121 137
Nonmetro 1,416 1,427 100 80 38 13
Urbanized 649 593 60 37 28 11
Less Urbanized 618 702 37 39 10 3
Completely Rural 148 132 3 4 * *
POVERTY LEVEL2            
Less Than 100% 2,159 2,192 300 324 150 204
100-199% 2,258 2,254 253 285 154 116
200% or More 4,618 4,330 280 272 90 112
HEALTH INSURANCE3            
Private 4,042 4,065 213 283 55 143
Medicaid/CHIP4 2,476 2,698 309 423 168 249
Other5 1,830 1,808 184 175 103 105
No Coverage 1,665 1,425 178 188 111 78
170412
Table 1.73B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3.4 3.3 0.3 0.3 0.1 0.2
GEOGRAPHIC REGION            
Northeast 3.4 3.3 0.4 0.5 0.2 0.3
Midwest 3.1 3.2 0.4 0.3 0.1 0.2
South 3.4 2.9 0.4 0.3 0.2 0.1
West 3.7 3.8 0.1 0.2 0.1 0.1
COUNTY TYPE1            
Large Metro 3.2 3.2 0.3 0.4 0.2 0.2
Small Metro 3.5 3.2 0.3 0.3 0.1 0.2
Nonmetro 3.9 3.7 0.3 0.2 0.1 0.0
Urbanized 4.3 3.9 0.4 0.2 0.2 0.1
Less Urbanized 3.6 3.6 0.2 0.2 0.1 0.0
Completely Rural 3.2 3.6 0.1 0.1 * *
POVERTY LEVEL2            
Less Than 100% 5.1 5.4 0.7 0.8 0.4 0.5
100-199% 4.1 4.1 0.5 0.5 0.3 0.2
200% or More 2.7 2.5 0.2 0.2 0.1 0.1
HEALTH INSURANCE3            
Private 2.3 2.3 0.1 0.2 0.0 0.1
Medicaid/CHIP4 5.8 6.1 0.7 1.0 0.4 0.6
Other5 2.7 2.7 0.3 0.3 0.2 0.2
No Coverage 6.2 5.8 0.7 0.8 0.4 0.3
170412
Table 1.74A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 40,915 41,490 4,692 4,903 1,240 1,390
GEOGRAPHIC REGION            
Northeast 7,559 7,941 885 892 209 254
Midwest 7,937 8,158 910a 713 259b 162
South 13,267 12,928 1,441 1,490 361 387
West 12,153 12,464 1,457a 1,808 410a 587
COUNTY TYPE1            
Large Metro 23,530 24,402 2,994 3,023 818 854
Small Metro 12,499 11,966 1,253 1,425 334 396
Nonmetro 4,887 5,122 445 455 88 140
Urbanized 2,367 2,290 222 233 45 68
Less Urbanized 2,059 2,414 192 170 40 58
Completely Rural 461 418 32 52 3 14
POVERTY LEVEL2            
Less Than 100% 5,741 5,299 909 1,013 255 281
100-199% 7,910 8,103 1,036 1,069 300 270
200% or More 27,189 28,023 2,693 2,774 667 832
HEALTH INSURANCE3            
Private 26,096 26,940 2,911 2,844 687 780
Medicaid/CHIP4 6,453 6,983 840 1,026 240 323
Other5 6,516 6,937 319a 464 117 130
No Coverage 5,363a 4,758 744 798 240 218
170412
Table 1.74B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 15.3 15.4 1.8 1.8 0.5 0.5
GEOGRAPHIC REGION            
Northeast 15.8 16.6 1.9 1.9 0.4 0.5
Midwest 14.0 14.4 1.6a 1.3 0.5b 0.3
South 13.2 12.8 1.4 1.5 0.4 0.4
West 19.3 19.6 2.3a 2.8 0.7a 0.9
COUNTY TYPE1            
Large Metro 15.8 16.2 2.0 2.0 0.5 0.6
Small Metro 15.3 14.8 1.5 1.8 0.4 0.5
Nonmetro 13.3 13.3 1.2 1.2 0.2 0.4
Urbanized 15.6 14.9 1.5 1.5 0.3 0.4
Less Urbanized 12.1 12.5 1.1 0.9 0.2 0.3
Completely Rural 10.1 11.3 0.7 1.4 0.1 0.4
POVERTY LEVEL2            
Less Than 100% 13.6 13.0 2.1 2.5 0.6 0.7
100-199% 14.5 14.8 1.9 1.9 0.6 0.5
200% or More 16.0 16.2 1.6 1.6 0.4 0.5
HEALTH INSURANCE3            
Private 14.8 15.0 1.7 1.6 0.4 0.4
Medicaid/CHIP4 15.0 15.9 2.0 2.3 0.6 0.7
Other5 9.7 10.2 0.5 0.7 0.2 0.2
No Coverage 20.0 19.5 2.8 3.3 0.9 0.9
170420
Table 1.75A – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,759 1,660 684a 554 1,076 1,106 487 485 588 620
GEOGRAPHIC REGION                    
Northeast 290 230 110 87 180 143 77 69 102 75
Midwest 377 326 137 151 240 175 109 81 131 94
South 587 571 249 196 338 374 152 189 185 185
West 505 534 187a 120 318 413 149 146 170 267
COUNTY TYPE1                    
Large Metro 1,123 970 401a 304 722 666 306 290 417 376
Small Metro 445 503 196 158 249 346 122 137 127 209
Nonmetro 191 187 86 93 105 94 60 58 45 36
Urbanized 95 70 35 33 60 37 30 24 30 14
Less Urbanized 79 96 42 49 37 47 22 25 15 22
Completely Rural 18 21 10 11 8 10 8 9 0 1
POVERTY LEVEL2                    
Less Than 100% 399 330 178b 113 221 217 159 115 62 101
100-199% 483a 352 191 143 291 208 122 97 169 111
200% or More 860 972 314 297 546 674 189 266 356 408
HEALTH INSURANCE3                    
Private 1,059 899 357 299 703 601 311 293 392 307
Medicaid/CHIP4 492 509 293 234 198 275 92 123 106 152
Other5 125 126 49 27 76 99 32 35 44 64
No Coverage 155 217 26 27 129 190 63 60 66 130
170420
Table 1.75B – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7 0.6 2.7a 2.2 0.4 0.5 1.4 1.4 0.3 0.3
GEOGRAPHIC REGION                    
Northeast 0.6 0.5 2.7 2.1 0.4 0.3 1.3 1.1 0.3 0.2
Midwest 0.7 0.6 2.6 2.8 0.5 0.3 1.5 1.1 0.3 0.2
South 0.6 0.6 2.6 2.1 0.4 0.4 1.2 1.5 0.2 0.2
West 0.8 0.8 3.1a 2.0 0.6 0.7 1.8 1.8 0.3 0.5
COUNTY TYPE1                    
Large Metro 0.8 0.6 2.9a 2.2 0.5 0.5 1.6 1.5 0.4 0.3
Small Metro 0.5 0.6 2.6 2.1 0.3 0.5 1.1 1.2 0.2 0.3
Nonmetro 0.5 0.5 2.7 2.7 0.3 0.3 1.3 1.3 0.2 0.1
Urbanized 0.6 0.5 2.4 2.3 0.4 0.3 1.5 1.2 0.3 0.1
Less Urbanized 0.5 0.5 2.9 2.9 0.2 0.3 1.1 1.2 0.1 0.1
Completely Rural 0.4 0.6 2.5 3.5 0.2 0.3 1.7 2.5 0.0 0.0
POVERTY LEVEL2                    
Less Than 100% 0.9 0.8 3.1a 2.1 0.6 0.6 1.7 1.3 0.2 0.4
100-199% 0.9a 0.6 3.4 2.5 0.6 0.4 1.5 1.2 0.4 0.3
200% or More 0.5 0.6 2.3 2.1 0.3 0.4 1.2 1.6 0.3 0.3
HEALTH INSURANCE3                    
Private 0.6 0.5 2.5 2.1 0.4 0.4 1.5 1.4 0.3 0.2
Medicaid/CHIP4 1.1 1.2 3.2 2.6 0.6 0.8 1.3 1.7 0.4 0.5
Other5 0.2 0.2 4.1 2.2 0.1 0.1 1.1 1.2 0.1 0.1
No Coverage 0.6 0.9 2.3 2.5 0.5 0.8 1.1 1.3 0.3 0.7
170420
Table 1.76A – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 527 600 175 149 352 451 126 121 226 329
GEOGRAPHIC REGION                    
Northeast 102 84 39a 16 63 67 14 17 49 50
Midwest 113 97 39 40 74 57 37 21 37 36
South 165 187 55 64 110 123 30 38 80 85
West 146 233 42 29 104 204 45 46 59a 158
COUNTY TYPE1                    
Large Metro 374 359 114 74 259 285 84 64 175 220
Small Metro 100a 180 44 44 56a 136 19a 49 37 87
Nonmetro 53 61 16 31 37 30 23 8 14 22
Urbanized 31 14 9 12 22b 2 11 1 11 1
Less Urbanized 18 38 3a 13 15 25 12 4 3 21
Completely Rural 5 9 5 5 * 4 * * * *
POVERTY LEVEL2                    
Less Than 100% 116 150 53 39 63 110 31 38 31 72
100-199% 109 108 43 32 66 76 36 28 30 48
200% or More 296 342 80 78 216 264 52 55 164 209
HEALTH INSURANCE3                    
Private 319 312 84 70 234 242 73 72 162 170
Medicaid/CHIP4 138 202 83 79 55 122 25 33 30 89
Other5 44 35 11 7 32 28 10 9 23 19
No Coverage 62 82 6 4 56 78 25 19 32 58
170420
Table 1.76B – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.2 0.2 0.7 0.6 0.1 0.2 0.4 0.4 0.1 0.2
GEOGRAPHIC REGION                    
Northeast 0.2 0.2 0.9a 0.4 0.1 0.2 0.2 0.3 0.1 0.1
Midwest 0.2 0.2 0.7 0.8 0.1 0.1 0.5 0.3 0.1 0.1
South 0.2 0.2 0.6 0.7 0.1 0.1 0.2 0.3 0.1 0.1
West 0.2 0.4 0.7 0.5 0.2 0.4 0.5 0.6 0.1a 0.3
COUNTY TYPE1                    
Large Metro 0.3 0.2 0.8 0.5 0.2 0.2 0.4 0.3 0.2 0.2
Small Metro 0.1a 0.2 0.6 0.6 0.1a 0.2 0.2a 0.4 0.1 0.1
Nonmetro 0.1 0.2 0.5 0.9 0.1 0.1 0.5 0.2 0.0 0.1
Urbanized 0.2 0.1 0.6 0.9 0.2b 0.0 0.5 0.0 0.1 0.0
Less Urbanized 0.1 0.2 0.2a 0.8 0.1 0.1 0.6 0.2 0.0 0.1
Completely Rural 0.1 0.2 1.3 1.6 * 0.1 * * * *
POVERTY LEVEL2                    
Less Than 100% 0.3 0.4 0.9 0.7 0.2 0.3 0.3 0.4 0.1 0.3
100-199% 0.2 0.2 0.8 0.6 0.1 0.2 0.4 0.4 0.1 0.1
200% or More 0.2 0.2 0.6 0.6 0.1 0.2 0.3 0.3 0.1 0.1
HEALTH INSURANCE3                    
Private 0.2 0.2 0.6 0.5 0.1 0.1 0.4 0.3 0.1 0.1
Medicaid/CHIP4 0.3 0.5 0.9 0.9 0.2 0.4 0.3 0.5 0.1 0.3
Other5 0.1 0.1 1.0 0.5 0.0 0.0 0.3 0.3 0.0 0.0
No Coverage 0.2 0.3 0.5 0.4 0.2 0.3 0.4 0.4 0.2 0.3
170420
Table 1.77A – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,713a 1,391 40 32 1,673a 1,360 329 265 1,344 1,095
GEOGRAPHIC REGION                    
Northeast 119 103 3 2 116 101 24 24 92 78
Midwest 234 245 9 5 225 240 40 52 185 188
South 632 508 10 9 622 499 138 115 483 384
West 728a 536 18 16 710a 520 127 74 583 445
COUNTY TYPE1                    
Large Metro 796 609 23 16 773 593 159 105 614 488
Small Metro 552 509 5 13 546 496 102 89 444 407
Nonmetro 365 273 11a 3 354 271 68 71 286 200
Urbanized 117 69 3 0 113 68 21 19 92 50
Less Urbanized 220 164 7 2 213 162 42 40 171 122
Completely Rural 28 41 1 0 28 41 5 12 23 29
POVERTY LEVEL2                    
Less Than 100% 548 526 12 5 536 521 99 112 437 410
100-199% 477 392 11 14 466 378 79 52 387 326
200% or More 681a 473 16 13 665a 460 145 101 520 359
HEALTH INSURANCE3                    
Private 538 375 17 12 521 363 142 112 378 250
Medicaid/CHIP4 570 606 23 20 547 586 80 114 467 472
Other5 225 198 * 0 225 197 27 10 199 187
No Coverage 521a 330 4 2 517a 328 96 48 421 280
170420
Table 1.77B – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6a 0.5 0.2 0.1 0.7a 0.6 0.9 0.8 0.6 0.5
GEOGRAPHIC REGION                    
Northeast 0.2 0.2 0.1 0.0 0.3 0.2 0.4 0.4 0.2 0.2
Midwest 0.4 0.4 0.2 0.1 0.4 0.5 0.5 0.7 0.4 0.4
South 0.6 0.5 0.1 0.1 0.7 0.5 1.1 0.9 0.6 0.5
West 1.2a 0.8 0.3 0.3 1.2a 0.9 1.5 0.9 1.2 0.9
COUNTY TYPE1                    
Large Metro 0.5 0.4 0.2 0.1 0.6 0.4 0.8 0.5 0.5 0.4
Small Metro 0.7 0.6 0.1 0.2 0.7 0.7 0.9 0.8 0.7 0.7
Nonmetro 1.0 0.7 0.4a 0.1 1.1 0.8 1.5 1.6 1.0 0.7
Urbanized 0.8 0.4 0.2 0.0 0.8 0.5 1.0 1.0 0.8 0.4
Less Urbanized 1.3 0.8 0.5 0.1 1.4 0.9 2.1 1.9 1.3 0.8
Completely Rural 0.6 1.1 0.2 0.0 0.7 1.2 1.1 3.4 0.6 0.9
POVERTY LEVEL2                    
Less Than 100% 1.3 1.3 0.2 0.1 1.5 1.5 1.0 1.2 1.6 1.6
100-199% 0.9 0.7 0.2 0.2 1.0 0.8 0.9 0.7 1.0 0.8
200% or More 0.4a 0.3 0.1 0.1 0.4a 0.3 0.9 0.6 0.4 0.3
HEALTH INSURANCE3                    
Private 0.3a 0.2 0.1 0.1 0.3 0.2 0.7 0.5 0.3 0.2
Medicaid/CHIP4 1.3 1.4 0.2 0.2 1.6 1.7 1.1 1.6 1.8 1.7
Other5 0.3 0.3 * 0.0 0.3 0.3 0.9 0.4 0.3 0.3
No Coverage 1.9a 1.4 0.3 0.2 2.0 1.4 1.7 1.0 2.1 1.5
170420
Table 1.78A – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 897a 667 13 9 885a 658 128a 65 757 594
GEOGRAPHIC REGION                    
Northeast 62 56 1 * 61 56 19 6 42 50
Midwest 102 112 4 3 99 108 11 8 88 100
South 375a 222 1 4 374a 218 55 23 319 195
West 358 277 7 2 350 275 43 27 308 248
COUNTY TYPE1                    
Large Metro 461a 262 8 4 452a 258 81a 22 372 236
Small Metro 276 268 * 4 276 264 33 25 244 239
Nonmetro 160 137 5 1 156 136 15 18 141 118
Urbanized 61 30 1 0 59 30 1 0 59 30
Less Urbanized 92 105 3 1 89 105 14 17 75 88
Completely Rural 8 1 1 0 7 1 0 0 7 1
POVERTY LEVEL2                    
Less Than 100% 289 272 1 1 288 271 40 33 248 239
100-199% 253 178 8 3 246 175 25 16 221 159
200% or More 349 217 4 5 345 212 58a 16 287 196
HEALTH INSURANCE3                    
Private 279 184 6 2 273 181 60 25 213 156
Medicaid/CHIP4 271 302 5 6 265 297 19 35 247 262
Other5 174 79 * * 174 79 13 2 161 77
No Coverage 278 163 2 1 277 162 39 16 238 146
170420
Table 1.78B – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.3a 0.2 0.1 0.0 0.4a 0.3 0.4a 0.2 0.4 0.3
GEOGRAPHIC REGION                    
Northeast 0.1 0.1 0.0 * 0.1 0.1 0.3 0.1 0.1 0.1
Midwest 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2
South 0.4a 0.2 0.0 0.0 0.4a 0.2 0.4 0.2 0.4a 0.2
West 0.6 0.4 0.1 0.0 0.6 0.5 0.5 0.3 0.6 0.5
COUNTY TYPE1                    
Large Metro 0.3a 0.2 0.1 0.0 0.3a 0.2 0.4a 0.1 0.3 0.2
Small Metro 0.3 0.3 * 0.1 0.4 0.4 0.3 0.2 0.4 0.4
Nonmetro 0.4 0.4 0.1 0.0 0.5 0.4 0.3 0.4 0.5 0.4
Urbanized 0.4 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.5 0.2
Less Urbanized 0.5 0.5 0.2 0.0 0.6 0.6 0.7 0.8 0.6 0.6
Completely Rural 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.2 0.0
POVERTY LEVEL2                    
Less Than 100% 0.7 0.7 0.0 0.0 0.8 0.8 0.4 0.4 0.9 0.9
100-199% 0.5 0.3 0.1 0.0 0.5 0.4 0.3 0.2 0.5 0.4
200% or More 0.2 0.1 0.0 0.0 0.2 0.1 0.4a 0.1 0.2 0.1
HEALTH INSURANCE3                    
Private 0.2 0.1 0.0 0.0 0.2 0.1 0.3a 0.1 0.2 0.1
Medicaid/CHIP4 0.6 0.7 0.1 0.1 0.8 0.9 0.3 0.5 0.9 0.9
Other5 0.3 0.1 * * 0.3 0.1 0.4 0.1 0.3 0.1
No Coverage 1.0 0.7 0.2 0.1 1.1 0.7 0.7 0.3 1.2 0.8
170420
Table 1.79A – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 119,036b 115,351 7,006b 6,194 112,030a 109,157 15,469b 14,118 96,561 95,039
GEOGRAPHIC REGION                    
Northeast 20,485a 19,312 1,035 943 19,450a 18,368 2,672b 2,330 16,778 16,038
Midwest 24,661 24,645 1,640b 1,401 23,021 23,244 3,450b 3,167 19,571 20,078
South 46,165 45,526 2,760b 2,477 43,405 43,049 5,798b 5,365 37,607 37,684
West 27,725b 25,869 1,571a 1,373 26,154b 24,495 3,549a 3,256 22,605a 21,239
COUNTY TYPE1                    
Large Metro 64,118 62,328 3,823b 3,364 60,296 58,965 8,292a 7,699 52,003 51,265
Small Metro 37,956 36,035 2,245b 1,927 35,711 34,108 5,031a 4,595 30,680 29,512
Nonmetro 16,962 16,988 939 903 16,023 16,085 2,146a 1,823 13,877 14,262
Urbanized 7,414 6,710 396 371 7,018 6,339 1,058a 817 5,960 5,522
Less Urbanized 7,539a 8,708 431 441 7,108a 8,266 889 865 6,219b 7,401
Completely Rural 2,009 1,570 111 91 1,897 1,479 198a 140 1,699 1,339
POVERTY LEVEL2                    
Less Than 100% 18,678b 17,010 1,444 1,309 17,234b 15,701 4,189b 3,656 13,046 12,045
100-199% 24,639 23,593 1,591a 1,384 23,048 22,209 3,624b 3,132 19,424 19,076
200% or More 75,458 74,454 3,971b 3,501 71,486 70,953 7,395 7,036 64,091 63,918
HEALTH INSURANCE3                    
Private 77,510 76,384 4,205b 3,611 73,305 72,773 9,259 8,806 64,047 63,967
Medicaid/CHIP4 20,572 19,940 2,504a 2,270 18,068 17,670 3,307 3,041 14,762 14,629
Other5 34,390 32,567 335 366 34,055 32,201 1,313a 1,104 32,742 31,097
No Coverage 9,890b 8,727 266 250 9,623b 8,477 2,170b 1,666 7,453 6,811
170420
Table 1.79B – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 44.5b 42.8 28.1b 24.9 46.1b 44.6 44.3b 40.8 46.4a 45.3
GEOGRAPHIC REGION                    
Northeast 42.8a 40.4 25.1 23.0 44.5a 42.0 43.7b 38.5 44.7 42.6
Midwest 43.5 43.4 30.6b 26.3 44.9 45.2 46.5a 43.0 44.6 45.6
South 46.1 45.0 29.1b 26.0 47.9 46.9 44.7a 41.8 48.4 47.8
West 44.0b 40.6 26.5a 23.1 45.8b 42.4 42.2 39.1 46.4b 43.0
COUNTY TYPE1                    
Large Metro 42.9a 41.5 27.2b 23.9 44.6 43.3 42.8a 40.2 44.9 43.8
Small Metro 46.5a 44.6 29.5b 26.0 48.3a 46.5 45.4b 41.6 48.7 47.4
Nonmetro 46.2 44.3 28.9 26.4 47.8 46.0 48.2b 41.8 47.8 46.6
Urbanized 48.9b 43.7 27.8 26.1 51.1b 45.5 51.6b 42.3 51.1b 46.1
Less Urbanized 44.3 45.0 29.8 26.3 45.6 46.8 45.5 41.9 45.7 47.4
Completely Rural 43.9 42.6 29.7 28.7 45.2 43.9 44.7 39.0 45.2 44.4
POVERTY LEVEL2                    
Less Than 100% 44.1a 41.8 25.5 24.4 47.0a 44.4 44.0b 40.6 48.0 45.7
100-199% 45.3a 43.0 28.1b 24.6 47.2a 45.1 43.3a 40.0 48.1 46.0
200% or More 44.3a 43.0 29.3b 25.2 45.6 44.6 45.2b 41.3 45.7 45.0
HEALTH INSURANCE3                    
Private 44.0b 42.6 29.2b 24.8 45.4a 44.2 45.8b 42.1 45.3 44.5
Medicaid/CHIP4 47.9b 45.3 27.4b 24.9 53.5a 50.7 45.3a 41.6 55.7 53.1
Other5 51.4b 48.0 28.2 30.2 51.8b 48.4 44.7b 38.5 52.2b 48.8
No Coverage 36.9 35.8 23.4 23.4 37.5 36.4 38.8 35.9 37.1 36.5
170420
Table 1.80A – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 18,942 18,671 1,464 1,317 17,478 17,354 5,330 5,026 12,148 12,327
GEOGRAPHIC REGION                    
Northeast 3,303 3,345 180 151 3,123 3,194 993 929 2,130 2,265
Midwest 3,769 3,894 357 331 3,412 3,562 1,212 1,222 2,200 2,340
South 7,084 6,642 554 494 6,529 6,148 1,893 1,781 4,636 4,367
West 4,786 4,790 373 341 4,413 4,449 1,231 1,094 3,182 3,355
COUNTY TYPE1                    
Large Metro 10,920 10,989 819 733 10,102 10,256 2,864 2,751 7,237 7,505
Small Metro 5,665 5,610 464 405 5,202 5,205 1,734 1,710 3,467 3,495
Nonmetro 2,357 2,071 182 179 2,175 1,893 731a 565 1,444 1,328
Urbanized 1,115 929 83 71 1,031 858 394a 289 637 569
Less Urbanized 1,055 952 82 83 973 869 291 226 681 643
Completely Rural 187 190 17 25 171 165 45 49 125 116
POVERTY LEVEL2                    
Less Than 100% 3,657 3,523 292 298 3,366 3,225 1,394 1,344 1,972 1,881
100-199% 4,231 3,834 364 323 3,866 3,511 1,217a 1,056 2,650 2,455
200% or More 10,944 11,213 808 696 10,136 10,517 2,609 2,526 7,526 7,991
HEALTH INSURANCE3                    
Private 11,238 11,297 888b 721 10,349 10,576 3,351 3,288 6,998 7,288
Medicaid/CHIP4 3,631 3,883 517 515 3,114 3,369 919 920 2,195 2,449
Other5 2,709 2,687 72 79 2,637 2,608 394 344 2,243 2,264
No Coverage 2,798a 2,405 51 66 2,747a 2,339 813b 617 1,934 1,722
170420
Table 1.80B – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 7.1 6.9 5.9 5.3 7.2 7.1 15.3 14.5 5.8 5.9
GEOGRAPHIC REGION                    
Northeast 6.9 7.0 4.4 3.7 7.1 7.3 16.2 15.3 5.7 6.0
Midwest 6.7 6.9 6.7 6.2 6.6 6.9 16.3 16.6 5.0 5.3
South 7.1 6.6 5.8 5.2 7.2 6.7 14.6 13.9 6.0 5.5
West 7.6 7.5 6.3 5.7 7.7 7.7 14.6 13.1 6.5 6.8
COUNTY TYPE1                    
Large Metro 7.3 7.3 5.8 5.2 7.5 7.5 14.8 14.3 6.2 6.4
Small Metro 6.9 6.9 6.1 5.5 7.0 7.1 15.7 15.5 5.5 5.6
Nonmetro 6.4a 5.4 5.6 5.2 6.5a 5.4 16.4b 13.0 5.0 4.3
Urbanized 7.4a 6.1 5.8 5.0 7.5 6.2 19.2a 15.0 5.5 4.7
Less Urbanized 6.2a 4.9 5.7 4.9 6.2 4.9 14.9a 10.9 5.0 4.1
Completely Rural 4.1 5.2 4.4 7.8 4.1 4.9 10.2 13.7 3.3 3.9
POVERTY LEVEL2                    
Less Than 100% 8.6 8.7 5.2 5.6 9.2 9.1 14.6 14.9 7.3 7.1
100-199% 7.8 7.0 6.4 5.7 7.9 7.1 14.5 13.5 6.6 5.9
200% or More 6.4 6.5 6.0a 5.0 6.5 6.6 16.0 14.8 5.4 5.6
HEALTH INSURANCE3                    
Private 6.4 6.3 6.2b 4.9 6.4 6.4 16.6 15.7 4.9 5.1
Medicaid/CHIP4 8.5 8.8 5.7 5.6 9.2 9.7 12.6 12.6 8.3 8.9
Other5 4.0 4.0 6.1 6.5 4.0 3.9 13.4 12.0 3.6 3.6
No Coverage 10.4 9.9 4.5 6.2 10.7 10.0 14.6 13.3 9.6 9.2
170420
Table 1.81A – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6,365 6,207 492a 389 5,873 5,818 1,766 1,600 4,107 4,218
GEOGRAPHIC REGION                    
Northeast 1,063 1,176 52 29 1,011 1,147 317 338 695 809
Midwest 1,285 1,204 112 90 1,173 1,114 396 357 777 758
South 2,611 2,244 206 177 2,406 2,067 701 575 1,705 1,492
West 1,406 1,583 123 93 1,283 1,490 352 330 931 1,160
COUNTY TYPE1                    
Large Metro 3,428 3,503 253 188 3,176 3,314 876 820 2,300 2,494
Small Metro 2,073 2,052 178 152 1,895 1,901 638 601 1,257 1,300
Nonmetro 864a 652 62 49 802a 603 251a 179 551 424
Urbanized 408a 270 26 21 382a 250 149a 84 233 166
Less Urbanized 378 324 28 19 349 305 91 81 258 224
Completely Rural 78 58 * 9 71 48 12 14 59 34
POVERTY LEVEL2                    
Less Than 100% 1,282 1,278 89 89 1,193 1,188 479 460 715 729
100-199% 1,392 1,280 131 94 1,260 1,186 427 358 834 828
200% or More 3,657 3,620 272 205 3,385 3,414 826 753 2,559 2,662
HEALTH INSURANCE3                    
Private 3,688 3,613 292a 207 3,397 3,406 1,096 1,032 2,301 2,373
Medicaid/CHIP4 1,182 1,402 177 149 1,006a 1,253 303 327 703a 926
Other5 809 936 31 25 779 911 110 104 669 807
No Coverage 1,120b 796 15 21 1,105b 775 314b 198 791a 577
170420
Table 1.81B – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 2.4 2.3 2.0a 1.6 2.4 2.4 5.1 4.6 2.0 2.0
GEOGRAPHIC REGION                    
Northeast 2.2 2.5 1.3 0.7 2.3 2.6 5.2 5.6 1.8 2.1
Midwest 2.3 2.1 2.1 1.7 2.3 2.2 5.3 4.8 1.8 1.7
South 2.6a 2.2 2.2 1.9 2.7 2.3 5.4 4.5 2.2 1.9
West 2.2 2.5 2.1 1.6 2.2 2.6 4.2 4.0 1.9 2.3
COUNTY TYPE1                    
Large Metro 2.3 2.3 1.8 1.3 2.3 2.4 4.5 4.3 2.0 2.1
Small Metro 2.5 2.5 2.3 2.0 2.6 2.6 5.8 5.4 2.0 2.1
Nonmetro 2.4b 1.7 1.9 1.4 2.4a 1.7 5.6a 4.1 1.9 1.4
Urbanized 2.7a 1.8 1.8 1.4 2.8a 1.8 7.2a 4.3 2.0 1.4
Less Urbanized 2.2 1.7 2.0 1.2 2.2 1.7 4.7 3.9 1.9 1.4
Completely Rural 1.7 1.6 * 2.9 1.7 1.4 2.6 3.9 1.6 1.1
POVERTY LEVEL2                    
Less Than 100% 3.0 3.1 1.6 1.7 3.3 3.4 5.0 5.1 2.6 2.8
100-199% 2.6 2.3 2.3 1.7 2.6 2.4 5.1 4.6 2.1 2.0
200% or More 2.1 2.1 2.0a 1.5 2.2 2.1 5.1 4.4 1.8 1.9
HEALTH INSURANCE3                    
Private 2.1 2.0 2.0a 1.4 2.1 2.1 5.4 4.9 1.6 1.7
Medicaid/CHIP4 2.8 3.2 1.9 1.6 3.0 3.6 4.1 4.5 2.7 3.4
Other5 1.2 1.4 2.6 2.1 1.2 1.4 3.7 3.6 1.1 1.3
No Coverage 4.2a 3.3 1.3 2.0 4.3a 3.3 5.6 4.3 3.9 3.1
170420
Table 1.82A – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 97,499b 91,846 5,650b 4,732 91,848b 87,114 12,148b 10,407 79,701b 76,706
GEOGRAPHIC REGION                    
Northeast 16,055b 14,204 806a 705 15,249b 13,498 1,959b 1,568 13,291b 11,931
Midwest 20,347 19,590 1,307b 1,037 19,040 18,553 2,663b 2,206 16,377 16,347
South 37,908 36,839 2,250b 1,886 35,658 34,953 4,588b 4,073 31,070 30,880
West 23,188b 21,213 1,288a 1,104 21,900b 20,109 2,937b 2,561 18,963a 17,549
COUNTY TYPE1                    
Large Metro 51,813a 49,208 3,087b 2,515 48,725 46,692 6,389b 5,638 42,336 41,054
Small Metro 31,532b 28,717 1,790b 1,515 29,742b 27,201 3,984b 3,371 25,759a 23,831
Nonmetro 14,154 13,921 773 701 13,381 13,220 1,775b 1,399 11,606 11,821
Urbanized 6,218 5,506 317 282 5,901 5,224 874b 623 5,027 4,600
Less Urbanized 6,245a 7,115 357 341 5,888a 6,774 732 658 5,156a 6,116
Completely Rural 1,690 1,301 99 78 1,591 1,222 169a 117 1,422 1,105
POVERTY LEVEL2                    
Less Than 100% 16,229b 14,329 1,250a 1,076 14,979b 13,254 3,396b 2,732 11,583a 10,522
100-199% 20,918 19,680 1,295 1,141 19,623 18,539 2,983b 2,444 16,640 16,095
200% or More 60,172 57,656 3,105b 2,515 57,067 55,140 5,589b 5,051 51,478 50,090
HEALTH INSURANCE3                    
Private 61,840a 59,007 3,336b 2,630 58,504 56,377 6,885b 6,127 51,619 50,250
Medicaid/CHIP4 18,227 17,151 2,043a 1,833 16,184 15,318 2,891b 2,536 13,292 12,783
Other5 28,719a 26,381 282 282 28,437a 26,099 1,029a 844 27,408a 25,255
No Coverage 8,346b 7,308 232 217 8,114b 7,091 1,817b 1,318 6,297 5,773
170420
Table 1.82B – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 36.4b 34.1 22.7b 19.0 37.8b 35.6 34.8b 30.1 38.3b 36.5
GEOGRAPHIC REGION                    
Northeast 33.6b 29.7 19.5 17.2 34.9b 30.9 32.0b 25.9 35.4b 31.7
Midwest 35.9 34.5 24.4b 19.5 37.1 36.1 35.9b 29.9 37.3 37.1
South 37.8a 36.4 23.7b 19.8 39.3 38.1 35.4b 31.7 40.0 39.1
West 36.8b 33.3 21.7a 18.6 38.4b 34.8 34.9b 30.8 38.9b 35.5
COUNTY TYPE1                    
Large Metro 34.7b 32.7 22.0b 17.9 36.0b 34.3 33.0b 29.4 36.5a 35.1
Small Metro 38.6b 35.6 23.5b 20.4 40.2b 37.1 36.0b 30.5 40.9b 38.2
Nonmetro 38.5a 36.3 23.8a 20.5 39.9 37.8 39.9b 32.1 40.0 38.6
Urbanized 41.0b 35.9 22.2 19.8 43.0b 37.5 42.6b 32.3 43.1a 38.4
Less Urbanized 36.7 36.8 24.7a 20.3 37.8 38.3 37.5a 31.8 37.9 39.2
Completely Rural 37.0 35.3 26.3 24.7 37.9 36.2 38.1 32.5 37.9 36.7
POVERTY LEVEL2                    
Less Than 100% 38.3b 35.2 22.1 20.0 40.8b 37.5 35.7b 30.3 42.6 39.9
100-199% 38.4b 35.8 22.9a 20.2 40.2b 37.6 35.7b 31.2 41.2a 38.8
200% or More 35.3b 33.3 22.9b 18.1 36.4b 34.6 34.2b 29.6 36.7a 35.2
HEALTH INSURANCE3                    
Private 35.1b 32.9 23.2b 18.1 36.2b 34.2 34.1b 29.3 36.5a 35.0
Medicaid/CHIP4 42.5b 39.0 22.4b 20.1 47.9b 43.9 39.6b 34.7 50.2b 46.4
Other5 42.9b 38.9 23.8 23.2 43.3b 39.2 35.0b 29.4 43.7b 39.6
No Coverage 31.1 30.0 20.4 20.3 31.6 30.5 32.5a 28.4 31.4 31.0
170420
Table 1.83A – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 12,462a 11,517 969 881 11,492a 10,635 2,979b 2,454 8,513 8,181
GEOGRAPHIC REGION                    
Northeast 2,007 1,797 104 86 1,903 1,711 472 403 1,431 1,308
Midwest 2,487 2,342 231 216 2,256 2,126 638 550 1,618 1,576
South 4,653 4,193 389 334 4,264 3,859 1,071a 876 3,193 2,983
West 3,315 3,185 245 246 3,069 2,939 798a 625 2,271 2,314
COUNTY TYPE1                    
Large Metro 7,021 6,567 524 468 6,497 6,099 1,488 1,286 5,009 4,813
Small Metro 3,767 3,459 306 281 3,461 3,178 1,025b 825 2,436 2,353
Nonmetro 1,674 1,491 139 133 1,534 1,358 466a 343 1,069 1,015
Urbanized 742 601 57 48 685 553 238a 154 448 399
Less Urbanized 786 756 67 64 720 692 203 153 517 539
Completely Rural 145 134 15 20 130 114 25 36 104 78
POVERTY LEVEL2                    
Less Than 100% 2,631 2,275 221 229 2,410a 2,047 765a 624 1,645 1,423
100-199% 2,962a 2,559 237 231 2,725a 2,328 795b 571 1,930 1,757
200% or More 6,835 6,645 512 422 6,323 6,223 1,385 1,221 4,938 5,001
HEALTH INSURANCE3                    
Private 6,691 6,497 555a 453 6,135 6,044 1,645 1,458 4,490 4,586
Medicaid/CHIP4 2,723 2,726 368 371 2,354 2,355 637 567 1,718 1,787
Other5 1,825 1,652 54 54 1,772 1,598 214 188 1,558 1,410
No Coverage 2,155b 1,710 36 51 2,119b 1,659 577b 332 1,543 1,328
170420
Table 1.83B – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4.7a 4.3 3.9 3.5 4.7a 4.3 8.5b 7.1 4.1 3.9
GEOGRAPHIC REGION                    
Northeast 4.2 3.8 2.5 2.1 4.4 3.9 7.7 6.7 3.8 3.5
Midwest 4.4 4.1 4.3 4.0 4.4 4.1 8.6 7.5 3.7 3.6
South 4.6a 4.1 4.1 3.5 4.7 4.2 8.3a 6.8 4.1 3.8
West 5.3 5.0 4.1 4.1 5.4 5.1 9.5a 7.5 4.7 4.7
COUNTY TYPE1                    
Large Metro 4.7 4.4 3.7 3.3 4.8 4.5 7.7 6.7 4.3 4.1
Small Metro 4.6 4.3 4.0 3.8 4.7 4.3 9.3b 7.5 3.9 3.8
Nonmetro 4.6 3.9 4.3 3.9 4.6 3.9 10.5a 7.9 3.7 3.3
Urbanized 4.9 3.9 4.0 3.4 5.0 4.0 11.6a 8.0 3.8 3.3
Less Urbanized 4.6 3.9 4.6 3.8 4.6 3.9 10.4 7.4 3.8 3.5
Completely Rural 3.2 3.6 4.1 6.4 3.1 3.4 5.7 10.0 2.8 2.6
POVERTY LEVEL2                    
Less Than 100% 6.2 5.6 3.9 4.3 6.6 5.8 8.0 6.9 6.1 5.4
100-199% 5.4a 4.7 4.2 4.1 5.6a 4.7 9.5b 7.3 4.8 4.2
200% or More 4.0 3.8 3.8a 3.0 4.0 3.9 8.5a 7.2 3.5 3.5
HEALTH INSURANCE3                    
Private 3.8 3.6 3.9a 3.1 3.8 3.7 8.1a 7.0 3.2 3.2
Medicaid/CHIP4 6.3 6.2 4.0 4.1 7.0 6.8 8.7 7.8 6.5 6.5
Other5 2.7 2.4 4.5 4.5 2.7 2.4 7.3 6.6 2.5 2.2
No Coverage 8.0 7.0 3.2 4.8 8.3 7.1 10.3b 7.1 7.7 7.1
170420
Table 1.84A – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3,775 3,350 276 239 3,499 3,111 829b 631 2,670 2,480
GEOGRAPHIC REGION                    
Northeast 605 556 29 19 576 537 121 100 455 438
Midwest 806 654 70 49 736 605 190 140 546 465
South 1,499a 1,223 114 119 1,385a 1,104 323a 224 1,061 879
West 865 917 63 52 802 865 194 167 608 698
COUNTY TYPE1                    
Large Metro 1,980 1,737 131 103 1,849 1,634 373a 278 1,476 1,356
Small Metro 1,246 1,164 106 96 1,140 1,068 302 243 838 825
Nonmetro 549 448 39 39 510 409 154 110 356 299
Urbanized 227 184 15 13 212 171 85a 42 127 129
Less Urbanized 260 235 18 16 242 219 61 58 181 161
Completely Rural 62 28 * 9 55 19 7 10 48 9
POVERTY LEVEL2                    
Less Than 100% 836 724 60 70 777 655 224a 146 552 508
100-199% 876 849 70 62 805 787 238 181 568 606
200% or More 2,059 1,768 146 107 1,913 1,661 363 295 1,550 1,366
HEALTH INSURANCE3                    
Private 1,946 1,722 142 115 1,804 1,607 439 353 1,365 1,254
Medicaid/CHIP4 823 913 120 99 703 814 191 169 513 645
Other5 496 533 13 16 483 517 47 43 436 474
No Coverage 766b 516 11 18 755b 498 190b 87 565 411
170420
Table 1.84B – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.4 1.2 1.1 1.0 1.4 1.3 2.4b 1.8 1.3 1.2
GEOGRAPHIC REGION                    
Northeast 1.3 1.2 0.7 0.5 1.3 1.2 2.0 1.6 1.2 1.2
Midwest 1.4 1.2 1.3 0.9 1.4 1.2 2.6 1.9 1.2 1.1
South 1.5a 1.2 1.2 1.2 1.5a 1.2 2.5a 1.7 1.4 1.1
West 1.4 1.4 1.1 0.9 1.4 1.5 2.3 2.0 1.2 1.4
COUNTY TYPE1                    
Large Metro 1.3 1.2 0.9 0.7 1.4 1.2 1.9 1.5 1.3 1.2
Small Metro 1.5 1.4 1.4 1.3 1.5 1.5 2.7 2.2 1.3 1.3
Nonmetro 1.5 1.2 1.2 1.1 1.5 1.2 3.5 2.5 1.2 1.0
Urbanized 1.5 1.2 1.0 0.9 1.5 1.2 4.2a 2.2 1.1 1.1
Less Urbanized 1.5 1.2 1.2 1.0 1.6 1.2 3.1 2.8 1.3 1.0
Completely Rural 1.3 0.8 * 2.9 1.3 0.6 1.7 2.8 1.3 0.3
POVERTY LEVEL2                    
Less Than 100% 2.0 1.8 1.1 1.3 2.1 1.9 2.4a 1.6 2.0 1.9
100-199% 1.6 1.5 1.2 1.1 1.7 1.6 2.8 2.3 1.4 1.5
200% or More 1.2 1.0 1.1 0.8 1.2 1.0 2.2 1.7 1.1 1.0
HEALTH INSURANCE3                    
Private 1.1 1.0 1.0 0.8 1.1 1.0 2.2a 1.7 1.0 0.9
Medicaid/CHIP4 1.9 2.1 1.3 1.1 2.1 2.3 2.6 2.3 1.9 2.3
Other5 0.7 0.8 1.1 1.3 0.7 0.8 1.6 1.5 0.7 0.7
No Coverage 2.9a 2.1 1.0 1.7 2.9a 2.1 3.4b 1.9 2.8 2.2
170420
Table 1.85A – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 39,317 38,756 1,069 1,108 38,247 37,649 4,212 3,901 34,035 33,747
GEOGRAPHIC REGION                    
Northeast 7,333 7,322 150 167 7,183 7,155 799 746 6,384 6,409
Midwest 7,796 7,833 241 255 7,556 7,578 884 817 6,672 6,761
South 16,129 15,622 426 438 15,703 15,185 1,609 1,463 14,094 13,721
West 8,058 7,979 253 248 7,805 7,731 920 875 6,885 6,856
COUNTY TYPE1                    
Large Metro 20,702 20,794 575 643 20,126 20,151 2,286 2,076 17,840 18,075
Small Metro 12,835 12,301 358 344 12,477 11,957 1,376 1,322 11,102 10,635
Nonmetro 5,780 5,662 136 121 5,644 5,541 551 503 5,093 5,038
Urbanized 2,444 2,130 58 59 2,386 2,071 289b 187 2,097 1,884
Less Urbanized 2,610 2,977 71 56 2,539 2,921 228 274 2,311 2,647
Completely Rural 726 555 8 6 718 549 33 43 685 506
POVERTY LEVEL2                    
Less Than 100% 5,896 5,745 202 227 5,693 5,519 1,072 969 4,622 4,550
100-199% 8,325 7,948 278 262 8,047 7,686 916 812 7,130 6,874
200% or More 25,030 24,994 589 619 24,441 24,375 2,158 2,052 22,283 22,323
HEALTH INSURANCE3                    
Private 25,524 25,076 629 616 24,896 24,461 2,579 2,347 22,317 22,114
Medicaid/CHIP4 6,571a 7,273 414 431 6,158a 6,842 830 845 5,328a 5,997
Other5 13,017 12,549 44 69 12,972 12,480 310 328 12,662 12,153
No Coverage 3,132a 2,619 35 49 3,098b 2,569 644a 500 2,454a 2,069
170420
Table 1.85B – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 14.7 14.4 4.3 4.4 15.8 15.4 12.1 11.3 16.4 16.1
GEOGRAPHIC REGION                    
Northeast 15.3 15.3 3.6 4.1 16.4 16.4 13.1 12.3 17.0 17.0
Midwest 13.8 13.8 4.5 4.8 14.7 14.7 11.9 11.1 15.2 15.3
South 16.1 15.4 4.5 4.6 17.3 16.6 12.4 11.4 18.1 17.4
West 12.8 12.5 4.3 4.2 13.7 13.4 10.9 10.5 14.1 13.9
COUNTY TYPE1                    
Large Metro 13.9 13.8 4.1 4.6 14.9 14.8 11.8 10.8 15.4 15.4
Small Metro 15.7 15.2 4.7 4.6 16.9 16.3 12.4 12.0 17.6 17.1
Nonmetro 15.7 14.8 4.2 3.5 16.9 15.8 12.4 11.6 17.5 16.5
Urbanized 16.1 13.9 4.0 4.2 17.4 14.9 14.1b 9.7 18.0 15.7
Less Urbanized 15.3 15.4 4.9 3.3 16.3 16.5 11.7 13.3 17.0 17.0
Completely Rural 15.9 15.0 2.0 1.8 17.1 16.3 7.5 11.8 18.2 16.8
POVERTY LEVEL2                    
Less Than 100% 13.9 14.1 3.6 4.2 15.5 15.6 11.3 10.8 17.0 17.3
100-199% 15.3 14.5 4.9 4.6 16.5 15.6 11.0 10.4 17.6 16.6
200% or More 14.7 14.4 4.3 4.5 15.6 15.3 13.2 12.0 15.9 15.7
HEALTH INSURANCE3                    
Private 14.5 14.0 4.4 4.2 15.4 14.9 12.8b 11.2 15.8 15.4
Medicaid/CHIP4 15.3 16.5 4.5 4.7 18.2 19.6 11.4 11.6 20.1 21.8
Other5 19.5 18.5 3.8 5.7 19.7 18.7 10.6 11.4 20.2 19.1
No Coverage 11.7 10.8 3.0 4.6 12.1 11.0 11.5 10.8 12.2 11.1
170420
Table 1.86A – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6,050 6,060 394 434 5,656 5,626 1,874 1,844 3,782 3,781
GEOGRAPHIC REGION                    
Northeast 1,099 1,206 30 45 1,069 1,161 317 369 752 792
Midwest 1,064 1,242 95 123 969 1,120 399 355 570 765
South 2,567 2,268 164 157 2,403 2,111 755 699 1,648 1,412
West 1,320 1,344 106 110 1,215 1,234 402 422 812 812
COUNTY TYPE1                    
Large Metro 3,281 3,481 240 266 3,041 3,215 968 999 2,073 2,216
Small Metro 1,953 1,942 117 131 1,836 1,811 639 642 1,197 1,169
Nonmetro 817 637 38 36 779 600 267 204 512 397
Urbanized 411a 278 14 20 397a 258 138 98 259 160
Less Urbanized 350 314 22 17 328 297 116 87 213 210
Completely Rural 56 45 2 0 53 45 13 19 40 26
POVERTY LEVEL2                    
Less Than 100% 1,186 1,197 75 79 1,111 1,118 481 522 630 596
100-199% 1,415 1,275 103 111 1,312 1,163 408 403 904 761
200% or More 3,429 3,562 216 243 3,213 3,318 965 894 2,248 2,425
HEALTH INSURANCE3                    
Private 3,392 3,486 251 235 3,141 3,251 1,149 1,100 1,992 2,151
Medicaid/CHIP4 1,231 1,371 135 174 1,097 1,197 353 379 744 818
Other5 872 870 17 35 855 835 112 133 743 702
No Coverage 1,070a 802 11 18 1,060a 784 308 275 752a 509
170420
Table 1.86B – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 2.3 2.2 1.6 1.7 2.3 2.3 5.4 5.3 1.8 1.8
GEOGRAPHIC REGION                    
Northeast 2.3 2.5 0.7 1.1 2.4 2.7 5.2 6.1 2.0 2.1
Midwest 1.9 2.2 1.8 2.3 1.9 2.2 5.4 4.8 1.3 1.7
South 2.6 2.2 1.7 1.6 2.6 2.3 5.8 5.4 2.1 1.8
West 2.1 2.1 1.8 1.8 2.1 2.1 4.8 5.1 1.7 1.6
COUNTY TYPE1                    
Large Metro 2.2 2.3 1.7 1.9 2.2 2.4 5.0 5.2 1.8 1.9
Small Metro 2.4 2.4 1.5 1.8 2.5 2.5 5.8 5.8 1.9 1.9
Nonmetro 2.2a 1.7 1.2 1.1 2.3a 1.7 6.0 4.7 1.8 1.3
Urbanized 2.7a 1.8 1.0 1.4 2.9a 1.9 6.7 5.1 2.2 1.3
Less Urbanized 2.1 1.6 1.5 1.0 2.1 1.7 5.9 4.2 1.6 1.3
Completely Rural 1.2 1.2 0.6 0.1 1.3 1.3 3.0 5.3 1.1 0.9
POVERTY LEVEL2                    
Less Than 100% 2.8 2.9 1.3 1.5 3.0 3.2 5.1 5.8 2.3 2.3
100-199% 2.6 2.3 1.8 2.0 2.7 2.4 4.9 5.1 2.2 1.8
200% or More 2.0 2.1 1.6 1.8 2.1 2.1 5.9 5.2 1.6 1.7
HEALTH INSURANCE3                    
Private 1.9 1.9 1.7 1.6 1.9 2.0 5.7 5.3 1.4 1.5
Medicaid/CHIP4 2.9 3.1 1.5 1.9 3.2 3.4 4.8 5.2 2.8 3.0
Other5 1.3 1.3 1.4 2.9 1.3 1.3 3.8 4.6 1.2 1.1
No Coverage 4.0 3.3 0.9 1.6 4.1 3.4 5.5 5.9 3.7a 2.7
170420
Table 1.87A – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,874 1,953 162 121 1,712 1,832 582 536 1,130 1,296
GEOGRAPHIC REGION                    
Northeast 312 410 8 11 304 399 96 114 207 286
Midwest 330 408 41 27 289 381 108 93 181 288
South 896 753 64 51 832 702 252 221 580 481
West 336 382 49 32 287 350 127 108 161 242
COUNTY TYPE1                    
Large Metro 955 1,106 92 68 863 1,038 295 294 568 744
Small Metro 663 639 54 47 610 592 231 185 378 407
Nonmetro 256 208 16 6 239 202 56 56 183 145
Urbanized 94 85 6 6 87 79 28 33 59 45
Less Urbanized 131 111 9a 0 122 111 24 20 98 92
Completely Rural 31 12 1 * 30 12 4 4 26 8
POVERTY LEVEL2                    
Less Than 100% 402 447 29 20 373 427 160 153 213 274
100-199% 401 361 47 28 354 333 136 111 218 222
200% or More 1,068 1,139 86 74 982 1,065 283 265 700 800
HEALTH INSURANCE3                    
Private 1,041 1,137 104a 60 937 1,077 322 306 615 771
Medicaid/CHIP4 392 449 56 50 336 398 103 116 233 282
Other5 231 234 10 10 222 224 45 47 176 177
No Coverage 349 278 1 4 347 274 128 89 219 185
170420
Table 1.87B – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7 0.7 0.7 0.5 0.7 0.7 1.7 1.5 0.5 0.6
GEOGRAPHIC REGION                    
Northeast 0.7 0.9 0.2 0.3 0.7 0.9 1.6 1.9 0.6 0.8
Midwest 0.6 0.7 0.8 0.5 0.6 0.7 1.5 1.3 0.4 0.7
South 0.9 0.7 0.7 0.5 0.9 0.8 1.9 1.7 0.7 0.6
West 0.5 0.6 0.8 0.5 0.5 0.6 1.5 1.3 0.3 0.5
COUNTY TYPE1                    
Large Metro 0.6 0.7 0.7 0.5 0.6 0.8 1.5 1.5 0.5 0.6
Small Metro 0.8 0.8 0.7 0.6 0.8 0.8 2.1 1.7 0.6 0.7
Nonmetro 0.7 0.5 0.5 0.2 0.7 0.6 1.3 1.3 0.6 0.5
Urbanized 0.6 0.6 0.4 0.4 0.6 0.6 1.4 1.7 0.5 0.4
Less Urbanized 0.8 0.6 0.6a 0.0 0.8 0.6 1.2 0.9 0.7 0.6
Completely Rural 0.7 0.3 0.3 * 0.7 0.4 0.9 1.0 0.7 0.3
POVERTY LEVEL2                    
Less Than 100% 0.9 1.1 0.5 0.4 1.0 1.2 1.7 1.7 0.8 1.0
100-199% 0.7 0.7 0.8 0.5 0.7 0.7 1.6 1.4 0.5 0.5
200% or More 0.6 0.7 0.6 0.5 0.6 0.7 1.7 1.6 0.5 0.6
HEALTH INSURANCE3                    
Private 0.6 0.6 0.7a 0.4 0.6 0.7 1.6 1.5 0.4 0.5
Medicaid/CHIP4 0.9 1.0 0.6 0.6 1.0 1.1 1.4 1.6 0.9 1.0
Other5 0.3 0.3 0.8 0.8 0.3 0.3 1.5 1.6 0.3 0.3
No Coverage 1.3 1.1 0.1 0.4 1.4 1.2 2.3 1.9 1.1 1.0
170420
Table 1.88A – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 17,212a 18,420 1,820 1,799 15,392a 16,621 4,906 4,998 10,486a 11,623
GEOGRAPHIC REGION                    
Northeast 2,894 3,206 281 264 2,614 2,942 941 1,033 1,673 1,909
Midwest 3,758 4,143 462 470 3,296 3,673 1,237 1,242 2,059a 2,431
South 7,072 7,586 709 769 6,362 6,817 1,814 1,807 4,549 5,010
West 3,488 3,485 368a 296 3,119 3,189 914 917 2,205 2,272
COUNTY TYPE1                    
Large Metro 9,546 10,343 1,005 1,003 8,541 9,340 2,749 2,822 5,792 6,518
Small Metro 5,544 5,829 619 529 4,925 5,300 1,578 1,619 3,347 3,681
Nonmetro 2,122 2,248 196a 267 1,926 1,981 580 557 1,347 1,424
Urbanized 988 920 86 120 902 800 319 262 583 538
Less Urbanized 887a 1,166 96 128 791 1,038 223 256 568 782
Completely Rural 248 162 14 19 233 143 37 39 196 104
POVERTY LEVEL2                    
Less Than 100% 2,934 2,930 273 273 2,660 2,657 1,174 1,251 1,486 1,406
100-199% 3,248 3,513 387 347 2,861 3,166 987 911 1,874 2,255
200% or More 10,918a 11,856 1,160 1,179 9,758a 10,677 2,633 2,715 7,125a 7,961
HEALTH INSURANCE3                    
Private 11,683a 12,608 1,166 1,152 10,517a 11,456 3,512 3,661 7,005 7,795
Medicaid/CHIP4 2,763 3,038 616 598 2,146 2,440 627 659 1,519 1,781
Other5 2,636 2,956 56a 106 2,580 2,850 370 337 2,209 2,513
No Coverage 1,713 1,654 48 39 1,665 1,615 533 468 1,131 1,147
170420
Table 1.88B – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6.4a 6.8 7.3 7.2 6.3a 6.8 14.1 14.5 5.0a 5.5
GEOGRAPHIC REGION                    
Northeast 6.1 6.7 6.8 6.4 6.0 6.7 15.4 17.1 4.5 5.1
Midwest 6.6 7.3 8.6 8.8 6.4 7.1 16.7 16.9 4.7a 5.5
South 7.1 7.5 7.5 8.1 7.0 7.4 14.0 14.1 5.9 6.4
West 5.5 5.5 6.2a 5.0 5.5 5.5 10.9 11.0 4.5 4.6
COUNTY TYPE1                    
Large Metro 6.4 6.9 7.2 7.1 6.3 6.9 14.2 14.7 5.0 5.6
Small Metro 6.8 7.2 8.1 7.1 6.7 7.2 14.3 14.7 5.3 5.9
Nonmetro 5.8 5.9 6.0a 7.8 5.8 5.7 13.0 12.8 4.6 4.7
Urbanized 6.5 6.0 6.0 8.5 6.6 5.7 15.6 13.6 5.0 4.5
Less Urbanized 5.2 6.0 6.6 7.6 5.1 5.9 11.4 12.4 4.2 5.0
Completely Rural 5.4 4.4 3.9 6.0 5.6 4.2 8.4 10.8 5.2 3.5
POVERTY LEVEL2                    
Less Than 100% 6.9 7.2 4.8 5.1 7.2 7.5 12.3 13.9 5.5 5.3
100-199% 6.0 6.4 6.8 6.2 5.9 6.4 11.8 11.6 4.6 5.4
200% or More 6.4 6.8 8.5 8.5 6.2 6.7 16.1 15.9 5.1 5.6
HEALTH INSURANCE3                    
Private 6.6 7.0 8.1 7.9 6.5 7.0 17.4 17.5 5.0 5.4
Medicaid/CHIP4 6.4 6.9 6.8 6.6 6.4 7.0 8.6 9.0 5.7 6.5
Other5 3.9 4.4 4.7a 8.7 3.9 4.3 12.6 11.8 3.5 3.9
No Coverage 6.4 6.8 4.3 3.6 6.5 6.9 9.5 10.1 5.6 6.2
170420
Table 1.89A – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 5,251 5,647 491 427 4,760a 5,220 2,537 2,578 2,223a 2,643
GEOGRAPHIC REGION                    
Northeast 986 1,168 83 58 903a 1,110 541 553 362a 557
Midwest 1,260 1,381 134 113 1,126 1,267 666 712 460 556
South 1,965 1,944 167 154 1,798 1,790 868 839 930 951
West 1,039 1,155 106 102 933 1,053 462 474 470 579
COUNTY TYPE1                    
Large Metro 2,991a 3,403 275 256 2,715a 3,147 1,394 1,450 1,321a 1,697
Small Metro 1,629 1,734 169 135 1,459 1,599 844 890 616 709
Nonmetro 632 509 46 35 586 474 300 237 286 237
Urbanized 349 281 19 20 330 261 188 138 142 123
Less Urbanized 250 192 23 11 228 181 93 85 135 96
Completely Rural 32 37 5 4 28 33 19 15 9 18
POVERTY LEVEL2                    
Less Than 100% 1,053 1,072 60 52 993 1,019 691 704 302 315
100-199% 954 968 99 80 856 888 444 443 412 445
200% or More 3,162 3,530 332 294 2,831a 3,236 1,322 1,353 1,509a 1,883
HEALTH INSURANCE3                    
Private 3,656 3,833 354 284 3,302 3,550 1,891 1,920 1,411 1,629
Medicaid/CHIP4 683a 890 117 122 566a 768 241 317 325 451
Other5 355a 548 13 11 343a 537 178 166 164b 372
No Coverage 694 629 15 20 679 609 281 236 399 373
170420
Table 1.89B – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 2.0 2.1 2.0 1.7 2.0 2.1 7.3 7.5 1.1a 1.3
GEOGRAPHIC REGION                    
Northeast 2.1 2.4 2.0 1.4 2.1a 2.5 8.8 9.1 1.0a 1.5
Midwest 2.2 2.4 2.5 2.1 2.2 2.5 9.0 9.7 1.0 1.3
South 2.0 1.9 1.8 1.6 2.0 2.0 6.7 6.5 1.2 1.2
West 1.6 1.8 1.8 1.7 1.6 1.8 5.5 5.7 1.0 1.2
COUNTY TYPE1                    
Large Metro 2.0a 2.3 2.0 1.8 2.0a 2.3 7.2 7.6 1.1a 1.4
Small Metro 2.0 2.1 2.2 1.8 2.0 2.2 7.6 8.1 1.0 1.1
Nonmetro 1.7 1.3 1.4 1.0 1.7 1.4 6.7 5.4 1.0 0.8
Urbanized 2.3 1.8 1.3 1.4 2.4 1.9 9.2 7.1 1.2 1.0
Less Urbanized 1.5 1.0 1.6 0.7 1.5 1.0 4.8 4.1 1.0 0.6
Completely Rural 0.7 1.0 1.3 1.3 0.7 1.0 4.2 4.1 0.2 0.6
POVERTY LEVEL2                    
Less Than 100% 2.5 2.6 1.1 1.0 2.7 2.9 7.3 7.8 1.1 1.2
100-199% 1.8 1.8 1.7 1.4 1.8 1.8 5.3 5.7 1.0 1.1
200% or More 1.9 2.0 2.4 2.1 1.8a 2.0 8.1 7.9 1.1a 1.3
HEALTH INSURANCE3                    
Private 2.1 2.1 2.5 1.9 2.0 2.2 9.4 9.2 1.0 1.1
Medicaid/CHIP4 1.6a 2.0 1.3 1.3 1.7a 2.2 3.3 4.3 1.2 1.6
Other5 0.5a 0.8 1.1 0.9 0.5a 0.8 6.1 5.8 0.3b 0.6
No Coverage 2.6 2.6 1.3 1.8 2.6 2.6 5.0 5.1 2.0 2.0
170420
Table 1.90A – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,653 1,735 117 92 1,536 1,643 757 767 779 876
GEOGRAPHIC REGION                    
Northeast 312 364 24a 5 288 359 156 194 132 165
Midwest 393 390 25 27 368 363 198 195 170 168
South 645 604 49 37 596 568 292 242 304 326
West 302 377 18 23 284 353 111 136 173 217
COUNTY TYPE1                    
Large Metro 890 1,033 64 56 826 977 381 406 445 571
Small Metro 530 564 42 29 488 535 279 292 210 243
Nonmetro 233a 138 11 7 222a 131 98 69 124 62
Urbanized 127a 63 5 4 122a 59 61 34 61 24
Less Urbanized 102 59 6 2 97 57 34 30 63 27
Completely Rural 4 17 0 1 3 16 3 5 * 11
POVERTY LEVEL2                    
Less Than 100% 349 380 16 15 333 365 205 256 129 109
100-199% 332 303 20 14 312 289 141 139 171 149
200% or More 944 1,029 81 63 862 966 383 348 479 618
HEALTH INSURANCE3                    
Private 1,114 1,181 92 61 1,022 1,119 551 567 471 552
Medicaid/CHIP4 220 314 15 30 205 284 72 122 134 162
Other5 116 146 8 3 108 143 48 38 60 105
No Coverage 244 171 5 3 239 169 99 62 140 107
170420
Table 1.90B – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6 0.6 0.5 0.4 0.6 0.7 2.2 2.2 0.4 0.4
GEOGRAPHIC REGION                    
Northeast 0.7 0.8 0.6a 0.1 0.7 0.8 2.6 3.2 0.4 0.4
Midwest 0.7 0.7 0.5 0.5 0.7 0.7 2.7 2.6 0.4 0.4
South 0.6 0.6 0.5 0.4 0.7 0.6 2.3 1.9 0.4 0.4
West 0.5 0.6 0.3 0.4 0.5 0.6 1.3 1.6 0.4 0.4
COUNTY TYPE1                    
Large Metro 0.6 0.7 0.5 0.4 0.6 0.7 2.0 2.1 0.4 0.5
Small Metro 0.6 0.7 0.5 0.4 0.7 0.7 2.5 2.6 0.3 0.4
Nonmetro 0.6a 0.4 0.3 0.2 0.7a 0.4 2.2 1.6 0.4 0.2
Urbanized 0.8a 0.4 0.3 0.3 0.9a 0.4 3.0 1.8 0.5 0.2
Less Urbanized 0.6 0.3 0.4 0.1 0.6 0.3 1.7 1.4 0.5 0.2
Completely Rural 0.1 0.4 0.1 0.2 0.1 0.5 0.7 1.3 * 0.4
POVERTY LEVEL2                    
Less Than 100% 0.8 0.9 0.3 0.3 0.9 1.0 2.1 2.8 0.5 0.4
100-199% 0.6 0.6 0.4 0.2 0.6 0.6 1.7 1.8 0.4 0.4
200% or More 0.6 0.6 0.6 0.5 0.6 0.6 2.3 2.0 0.3 0.4
HEALTH INSURANCE3                    
Private 0.6 0.7 0.6 0.4 0.6 0.7 2.7 2.7 0.3 0.4
Medicaid/CHIP4 0.5 0.7 0.2 0.3 0.6 0.8 1.0 1.7 0.5 0.6
Other5 0.2 0.2 0.6 0.2 0.2 0.2 1.6 1.3 0.1 0.2
No Coverage 0.9 0.7 0.4 0.2 0.9 0.7 1.8 1.3 0.7 0.6
170420
Table 1.91A – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 18,564 18,629 602 563 17,962 18,067 1,339 1,278 16,623 16,789
GEOGRAPHIC REGION                    
Northeast 3,181 3,203 74 79 3,107 3,124 207 244 2,900 2,880
Midwest 3,446 3,436 157 145 3,289 3,291 263 260 3,027 3,031
South 7,610 7,556 227 199 7,384 7,357 556 486 6,828 6,871
West 4,326 4,434 144 139 4,182 4,295 313 288 3,869 4,008
COUNTY TYPE1                    
Large Metro 9,863 9,785 308 290 9,555 9,495 742 637 8,814 8,858
Small Metro 6,034 6,087 204 181 5,830 5,906 418 492 5,412 5,414
Nonmetro 2,667 2,757 90 91 2,577 2,666 179 149 2,398 2,516
Urbanized 1,177 1,051 40 39 1,137 1,012 71 78 1,066 934
Less Urbanized 1,162a 1,505 41 43 1,122a 1,463 88 68 1,033a 1,395
Completely Rural 328 201 10 10 318 191 19 4 299 187
POVERTY LEVEL2                    
Less Than 100% 2,509 2,360 116 132 2,393 2,228 341 323 2,053 1,905
100-199% 3,802 3,632 152 127 3,650 3,506 329 263 3,320 3,243
200% or More 12,237 12,614 333 304 11,904 12,310 654 670 11,250 11,641
HEALTH INSURANCE3                    
Private 12,319 12,266 369 316 11,951 11,949 782 794 11,169 11,155
Medicaid/CHIP4 3,162 3,321 223 234 2,939 3,086 270 309 2,669 2,778
Other5 6,921 6,744 23 28 6,898 6,716 165 125 6,733 6,591
No Coverage 1,149 914 7 18 1,142 895 199a 125 943 770
170420
Table 1.91B – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 6.9 6.9 2.4 2.3 7.4 7.4 3.8 3.7 8.0 8.0
GEOGRAPHIC REGION                    
Northeast 6.7 6.7 1.8 1.9 7.1 7.1 3.4 4.0 7.7 7.6
Midwest 6.1 6.1 2.9 2.7 6.4 6.4 3.5 3.5 6.9 6.9
South 7.6 7.5 2.4 2.1 8.1 8.0 4.3 3.8 8.8 8.7
West 6.9 7.0 2.4 2.3 7.3 7.4 3.7 3.5 7.9 8.1
COUNTY TYPE1                    
Large Metro 6.6 6.5 2.2 2.1 7.1 7.0 3.8 3.3 7.6 7.6
Small Metro 7.4 7.5 2.7 2.4 7.9 8.1 3.8 4.5 8.6 8.7
Nonmetro 7.3 7.2 2.8 2.7 7.7 7.6 4.0 3.4 8.3 8.2
Urbanized 7.8 6.8 2.8 2.7 8.3 7.3 3.5 4.0 9.1 7.8
Less Urbanized 6.8 7.8 2.8 2.5 7.2 8.3 4.5 3.3 7.6 8.9
Completely Rural 7.2 5.4 2.6 3.0 7.6 5.7 4.4 1.1 7.9 6.2
POVERTY LEVEL2                    
Less Than 100% 5.9 5.8 2.0 2.5 6.5 6.3 3.6 3.6 7.6 7.2
100-199% 7.0 6.6 2.7 2.2 7.5 7.1 3.9 3.4 8.2 7.8
200% or More 7.2 7.3 2.5 2.2 7.6 7.7 4.0 3.9 8.0 8.2
HEALTH INSURANCE3                    
Private 7.0 6.8 2.6 2.2 7.4 7.3 3.9 3.8 7.9 7.8
Medicaid/CHIP4 7.4 7.5 2.4 2.6 8.7 8.8 3.7 4.2 10.1 10.1
Other5 10.3 9.9 1.9 2.3 10.5 10.1 5.6 4.4 10.7 10.3
No Coverage 4.3 3.8 0.6 1.7 4.5 3.8 3.6 2.7 4.7 4.1
170420
Table 1.92A – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1,511 1,531 102 100 1,409 1,431 265 256 1,143 1,176
GEOGRAPHIC REGION                    
Northeast 293 267 6 9 288 258 59 59 228 199
Midwest 250 196 39 26 211 170 51 42 160 128
South 568 583 32 33 536 550 88 105 448 445
West 399 486 26 33 373 453 67 49 306 404
COUNTY TYPE1                    
Large Metro 848 931 50 54 798 877 137 139 662 738
Small Metro 469 443 28 32 441 411 93 98 347 313
Nonmetro 193 157 24 14 169 143 35 18 134 124
Urbanized 122 70 9 5 113 65 25 15 88 51
Less Urbanized 67 69 14 8 53 61 7 3 46 58
Completely Rural 4 19 0 * 4 16 * 1 * 15
POVERTY LEVEL2                    
Less Than 100% 216 169 23 15 193 155 57 43 136 112
100-199% 278 300 25 18 253 282 35 50 218 232
200% or More 1,012 1,055 54 68 958 987 169 155 789 832
HEALTH INSURANCE3                    
Private 992 943 60 62 932 880 188 189 744 691
Medicaid/CHIP4 249 262 40 36 209 226 36 29 173 196
Other5 275 434 6 9 269 425 18 28 251 397
No Coverage 187 135 4 1 184 134 29 26 154 109
170420
Table 1.92B – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6 0.6 0.4 0.4 0.6 0.6 0.8 0.7 0.5 0.6
GEOGRAPHIC REGION                    
Northeast 0.6 0.6 0.1 0.2 0.7 0.6 1.0 1.0 0.6 0.5
Midwest 0.4 0.3 0.7 0.5 0.4 0.3 0.7 0.6 0.4 0.3
South 0.6 0.6 0.3 0.3 0.6 0.6 0.7 0.8 0.6 0.6
West 0.6 0.8 0.4 0.5 0.7 0.8 0.8 0.6 0.6 0.8
COUNTY TYPE1                    
Large Metro 0.6 0.6 0.4 0.4 0.6 0.6 0.7 0.7 0.6 0.6
Small Metro 0.6 0.5 0.4 0.4 0.6 0.6 0.8 0.9 0.6 0.5
Nonmetro 0.5 0.4 0.7 0.4 0.5 0.4 0.8 0.4 0.5 0.4
Urbanized 0.8 0.5 0.7 0.3 0.8 0.5 1.2 0.8 0.8 0.4
Less Urbanized 0.4 0.4 1.0 0.5 0.3 0.3 0.4 0.1 0.3 0.4
Completely Rural 0.1 0.5 0.1 * 0.1 0.5 * 0.2 * 0.5
POVERTY LEVEL2                    
Less Than 100% 0.5 0.4 0.4 0.3 0.5 0.4 0.6 0.5 0.5 0.4
100-199% 0.5 0.5 0.4 0.3 0.5 0.6 0.4 0.6 0.5 0.6
200% or More 0.6 0.6 0.4 0.5 0.6 0.6 1.0 0.9 0.6 0.6
HEALTH INSURANCE3                    
Private 0.6 0.5 0.4 0.4 0.6 0.5 0.9 0.9 0.5 0.5
Medicaid/CHIP4 0.6 0.6 0.4 0.4 0.6 0.6 0.5 0.4 0.7 0.7
Other5 0.4 0.6 0.5 0.7 0.4 0.6 0.6 1.0 0.4 0.6
No Coverage 0.7 0.6 0.3 0.1 0.7 0.6 0.5 0.6 0.8 0.6
170420
Table 1.93A – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 446 497 21 23 425 474 86 50 340 425
GEOGRAPHIC REGION                    
Northeast 100 86 2 1 98 85 29a 4 69 81
Midwest 80 36 4 6 76 30 10 12 66a 17
South 147 234 5 10 143 225 27 31 116 194
West 119 140 10 6 109 135 20a 2 89 133
COUNTY TYPE1                    
Large Metro 230 337 14 14 216 323 44 23 172 300
Small Metro 136 139 4 6 132 133 26 25 107 108
Nonmetro 80a 21 3 3 77a 19 16 2 61a 16
Urbanized 47a 3 * 1 47b 2 10 2 37 *
Less Urbanized 30 11 3 2 26 10 2 * 24 10
Completely Rural 3 7 * * 3 7 * * * 7
POVERTY LEVEL2                    
Less Than 100% 71 48 1 3 70 45 16 11 54 35
100-199% 41 95 6 5 35 90 12 8 23 82
200% or More 333 351 14 15 319 336 56 28 263 308
HEALTH INSURANCE3                    
Private 289 269 14 15 275 254 59 34 216 220
Medicaid/CHIP4 75 67 5 5 70 61 12 5 58 57
Other5 109 210 3 2 107 208 10 12 97 196
No Coverage 57 40 * * 57 40 8 5 49 35
170420
Table 1.93B – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2
GEOGRAPHIC REGION                    
Northeast 0.2 0.2 0.1 0.0 0.2 0.2 0.5a 0.1 0.2 0.2
Midwest 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2a 0.0
South 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.2
West 0.2 0.2 0.2 0.1 0.2 0.2 0.2a 0.0 0.2 0.3
COUNTY TYPE1                    
Large Metro 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.3
Small Metro 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2
Nonmetro 0.2b 0.1 0.1 0.1 0.2b 0.1 0.4 0.1 0.2a 0.1
Urbanized 0.3b 0.0 * 0.1 0.3b 0.0 0.5 0.1 0.3 *
Less Urbanized 0.2 0.1 0.2 0.1 0.2 0.1 0.1 * 0.2 0.1
Completely Rural 0.1 0.2 * * 0.1 0.2 * * * 0.2
POVERTY LEVEL2                    
Less Than 100% 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.2 0.1
100-199% 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2
200% or More 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.2
HEALTH INSURANCE3                    
Private 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.2
Medicaid/CHIP4 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2
Other5 0.2 0.3 0.2 0.2 0.2 0.3 0.3 0.4 0.2 0.3
No Coverage 0.2 0.2 * * 0.2 0.2 0.1 0.1 0.2 0.2
170420
Table 1.94A – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 12,693a 11,824 980 891 11,712 10,933 3,029b 2,516 8,683 8,417
GEOGRAPHIC REGION                    
Northeast 2,085 1,883 107 87 1,979 1,795 494 412 1,485 1,383
Midwest 2,533 2,399 235 216 2,298 2,183 648 558 1,650 1,626
South 4,718 4,294 392 341 4,326 3,954 1,076a 907 3,250 3,047
West 3,356 3,248 247 247 3,109 3,001 811a 640 2,298 2,361
COUNTY TYPE1                    
Large Metro 7,199 6,781 534 476 6,665 6,305 1,523 1,329 5,142 4,976
Small Metro 3,795 3,516 306 282 3,489 3,235 1,032b 838 2,458 2,397
Nonmetro 1,698 1,527 141 133 1,557 1,393 474b 349 1,083 1,044
Urbanized 763 603 59 48 705 555 243b 157 462 399
Less Urbanized 789 780 67 65 723 715 205 156 517 559
Completely Rural 145 143 15 20 130 123 26 37 104 86
POVERTY LEVEL2                    
Less Than 100% 2,723 2,388 228 231 2,495 2,158 775a 635 1,720 1,522
100-199% 3,003 2,640 237 231 2,766 2,409 807b 586 1,959 1,823
200% or More 6,932 6,757 515 429 6,417 6,328 1,413 1,256 5,004 5,072
HEALTH INSURANCE3                    
Private 6,755 6,569 558a 460 6,197 6,110 1,665 1,486 4,532 4,624
Medicaid/CHIP4 2,838 2,859 374 376 2,464 2,483 647 581 1,816 1,902
Other5 1,836 1,726 54 56 1,782 1,669 214 191 1,568 1,478
No Coverage 2,207a 1,802 39 51 2,168a 1,751 597b 350 1,571 1,401
170420
Table 1.94B – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 4.7a 4.4 3.9 3.6 4.8a 4.5 8.7b 7.3 4.2 4.0
GEOGRAPHIC REGION                    
Northeast 4.4 3.9 2.6 2.1 4.5 4.1 8.1 6.8 4.0 3.7
Midwest 4.5 4.2 4.4 4.0 4.5 4.2 8.7 7.6 3.8 3.7
South 4.7 4.2 4.1 3.6 4.8 4.3 8.3a 7.1 4.2 3.9
West 5.3 5.1 4.2 4.2 5.4 5.2 9.6a 7.7 4.7 4.8
COUNTY TYPE1                    
Large Metro 4.8 4.5 3.8 3.4 4.9 4.6 7.9 6.9 4.4 4.3
Small Metro 4.7 4.4 4.0 3.8 4.7 4.4 9.3b 7.6 3.9 3.8
Nonmetro 4.6 4.0 4.3 3.9 4.6 4.0 10.7a 8.0 3.7 3.4
Urbanized 5.0a 3.9 4.1 3.4 5.1a 4.0 11.8a 8.1 4.0 3.3
Less Urbanized 4.6 4.0 4.6 3.9 4.6 4.0 10.5 7.5 3.8 3.6
Completely Rural 3.2 3.9 4.1 6.4 3.1 3.6 5.8 10.2 2.8 2.9
POVERTY LEVEL2                    
Less Than 100% 6.4 5.9 4.0 4.3 6.8 6.1 8.1 7.1 6.3 5.8
100-199% 5.5a 4.8 4.2 4.1 5.7a 4.9 9.6b 7.5 4.8 4.4
200% or More 4.1 3.9 3.8a 3.1 4.1 4.0 8.6a 7.4 3.6 3.6
HEALTH INSURANCE3                    
Private 3.8 3.7 3.9a 3.2 3.8 3.7 8.2a 7.1 3.2 3.2
Medicaid/CHIP4 6.6 6.5 4.1 4.1 7.3 7.1 8.9 8.0 6.9 6.9
Other5 2.7 2.5 4.5 4.6 2.7 2.5 7.3 6.7 2.5 2.3
No Coverage 8.2 7.4 3.4 4.8 8.4 7.5 10.7b 7.5 7.8 7.5
170420
Table 1.95A – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 3,963 3,649 277 241 3,686 3,408 880b 688 2,806 2,720
GEOGRAPHIC REGION                    
Northeast 643 636 29 19 614 617 143 105 471 512
Midwest 849 707 70 49 779 658 205a 146 574 512
South 1,538 1,309 114 121 1,424 1,188 324 254 1,099 934
West 933 997 64 52 870 945 208 183 662 762
COUNTY TYPE1                    
Large Metro 2,091 1,941 131 105 1,960 1,835 404 311 1,556 1,524
Small Metro 1,300 1,239 106 97 1,193 1,142 317 254 877 889
Nonmetro 572 469 40 39 532 430 160 123 373 307
Urbanized 248 189 15 13 233 175 90a 46 143 129
Less Urbanized 262 249 18 16 244 233 62 64 182 169
Completely Rural 62 32 * 9 55 22 8 14 48 9
POVERTY LEVEL2                    
Less Than 100% 876 855 60 72 816 783 227 164 589 619
100-199% 928 941 70 62 858 879 253 182 606 696
200% or More 2,156 1,844 147 107 2,009 1,738 398 333 1,611 1,405
HEALTH INSURANCE3                    
Private 1,987 1,779 142 115 1,845 1,664 463 380 1,382 1,284
Medicaid/CHIP4 936 1,070 121 101 815 968 200 186 615 782
Other5 497 594 13 16 484 578 47 48 437 530
No Coverage 800a 597 11 18 789a 580 209b 104 580 476
170420
Table 1.95B – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 1.5 1.4 1.1 1.0 1.5 1.4 2.5b 2.0 1.3 1.3
GEOGRAPHIC REGION                    
Northeast 1.3 1.3 0.7 0.5 1.4 1.4 2.3 1.7 1.3 1.4
Midwest 1.5 1.2 1.3 0.9 1.5 1.3 2.8a 2.0 1.3 1.2
South 1.5 1.3 1.2 1.3 1.6 1.3 2.5 2.0 1.4 1.2
West 1.5 1.6 1.1 0.9 1.5 1.6 2.5 2.2 1.4 1.5
COUNTY TYPE1                    
Large Metro 1.4 1.3 0.9 0.7 1.4 1.3 2.1 1.6 1.3 1.3
Small Metro 1.6 1.5 1.4 1.3 1.6 1.6 2.9 2.3 1.4 1.4
Nonmetro 1.6 1.2 1.2 1.1 1.6 1.2 3.6 2.8 1.3 1.0
Urbanized 1.6 1.2 1.1 0.9 1.7 1.3 4.4a 2.4 1.2 1.1
Less Urbanized 1.5 1.3 1.2 1.0 1.6 1.3 3.2 3.1 1.3 1.1
Completely Rural 1.4 0.9 * 2.9 1.3 0.7 1.7 3.8 1.3 0.3
POVERTY LEVEL2                    
Less Than 100% 2.1 2.1 1.1 1.3 2.2 2.2 2.4 1.8 2.2 2.3
100-199% 1.7 1.7 1.2 1.1 1.8 1.8 3.0 2.3 1.5 1.7
200% or More 1.3a 1.1 1.1 0.8 1.3 1.1 2.4 2.0 1.1 1.0
HEALTH INSURANCE3                    
Private 1.1 1.0 1.0 0.8 1.1 1.0 2.3 1.8 1.0 0.9
Medicaid/CHIP4 2.2 2.4 1.3 1.1 2.4 2.8 2.7 2.5 2.3 2.8
Other5 0.7 0.9 1.1 1.3 0.7 0.9 1.6 1.7 0.7 0.8
No Coverage 3.0 2.5 1.0 1.7 3.1 2.5 3.7a 2.2 2.9 2.6
170511
Table 1.96A – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: Numbers in Thousands, 2015 and 2016
Drug or Method of Administration Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
HALLUCINOGENS 40,915 41,490 760 674 40,155 40,816 6,486b 5,940 33,669 34,876
PCP (Angel Dust, Phencyclidine) 6,323 6,450 60 38 6,262 6,412 267 235 5,995 6,178
LSD (Acid) 25,324 25,861 329 288 24,994 25,573 2,691 2,884 22,304 22,689
Peyote 5,473 5,687 15 18 5,458 5,669 238 220 5,221 5,449
Mescaline 8,044 8,126 27 17 8,017 8,109 243 226 7,775 7,883
Psilocybin (Mushrooms) 22,847 22,846 272 219 22,575 22,626 3,244 2,986 19,331 19,641
Ecstasy (MDMA) 18,328 18,459 357 288 17,971 18,171 4,561b 4,018 13,411 14,154
Ketamine 3,034 3,440 50 47 2,984 3,393 636 549 2,347a 2,844
DMT, AMT, or 5-MeO-DIPT ("Foxy") 2,150 2,238 37 50 2,113 2,188 834 748 1,279 1,440
Salvia divinorum 5,106 5,346 63 54 5,044 5,293 1,897b 1,472 3,147b 3,821
INHALANTS 25,765a 24,404 2,271a 2,065 23,494 22,339 3,463 3,387 20,031 18,952
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 7,446 7,209 147 130 7,299 7,079 471 508 6,828 6,571
Correction Fluid, Degreaser, or Cleaning Fluid 1,603 1,436 185 187 1,417 1,249 191 199 1,226 1,050
Gasoline or Lighter Fluid 3,183 2,948 397 428 2,786 2,519 407a 311 2,379 2,209
Glue, Shoe Polish, or Toluene 3,182 2,895 461 450 2,721 2,445 345 290 2,376 2,155
Halothane, Ether, or Other Anesthetics 809 908 23 24 786 884 110a 67 677 817
Lacquer Thinner or Other Paint Solvents 1,536 1,411 158 131 1,379 1,279 218 165 1,161 1,114
Lighter Gases (Butane, Propane) 767 728 110 114 657 615 90 108 567 507
Nitrous Oxide or Whippits 12,406 11,856 112 103 12,294 11,752 1,411 1,233 10,883 10,520
Felt-Tip Pens or Felt-Tip/Magic Markers 6,765 6,414 1,665 1,562 5,100 4,851 1,352 1,449 3,747 3,402
Spray Paints 1,901 1,673 415 364 1,486 1,310 360 307 1,126 1,003
Computer Cleaner/Air Duster 3,009a 2,586 248b 162 2,761 2,424 944a 774 1,818 1,650
Other Aerosol Sprays 1,492 1,259 158 119 1,334 1,141 231 227 1,103 914
NEEDLE USE1,2 4,419 4,519 23 31 4,396 4,488 397 370 4,000 4,117
Heroin Needle Use1,2 2,208 2,379 5 9 2,203 2,370 255 260 1,948 2,110
Cocaine Needle Use1,2 2,166 2,512 7 6 2,159 2,506 164 164 1,995 2,342
Methamphetamine Needle Use1,2 1,914 1,862 5 5 1,909 1,857 137 149 1,771 1,708
HEROIN 5,099 4,981 35 32 5,064 4,950 616 539 4,448 4,411
Smoke Heroin2 1,953 1,927 17 10 1,935 1,916 317 261 1,619 1,655
Sniff or Snort Heroin2 3,323 3,605 19 15 3,304 3,590 420 387 2,884 3,202
OTHER DRUGS                    
GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm,"
   "Liquid G,” and gamma hydroxybutyrate)
1,191 1,401 6a 25 1,185 1,376 100 95 1,085 1,281
Nonprescription Cough or Cold Medicine to Get High 10,381 10,088 639 656 9,742 9,432 2,087a 1,854 7,655 7,578
170511
Table 1.96B – Specific Hallucinogen, Inhalant, Needle, Heroin, and Other Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group: Percentages, 2015 and 2016
Drug or Method of Administration Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
HALLUCINOGENS 15.3 15.4 3.1 2.7 16.5 16.7 18.6a 17.2 16.2 16.6
PCP (Angel Dust, Phencyclidine) 2.4 2.4 0.2 0.2 2.6 2.6 0.8 0.7 2.9 2.9
LSD (Acid) 9.5 9.6 1.3 1.2 10.3 10.5 7.7 8.3 10.7 10.8
Peyote 2.0 2.1 0.1 0.1 2.2 2.3 0.7 0.6 2.5 2.6
Mescaline 3.0 3.0 0.1 0.1 3.3 3.3 0.7 0.7 3.7 3.8
Psilocybin (Mushrooms) 8.5 8.5 1.1 0.9 9.3 9.3 9.3 8.6 9.3 9.4
Ecstasy (MDMA) 6.8 6.9 1.4 1.2 7.4 7.4 13.1b 11.6 6.5 6.7
Ketamine 1.1 1.3 0.2 0.2 1.2 1.4 1.8 1.6 1.1a 1.4
DMT, AMT, or 5-MeO-DIPT ("Foxy") 0.8 0.8 0.1 0.2 0.9 0.9 2.4 2.2 0.6 0.7
Salvia divinorum 1.9 2.0 0.3 0.2 2.1 2.2 5.4b 4.3 1.5b 1.8
INHALANTS 9.6a 9.1 9.1a 8.3 9.7a 9.1 9.9 9.8 9.6a 9.0
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 2.8 2.7 0.6 0.5 3.0 2.9 1.3 1.5 3.3 3.1
Correction Fluid, Degreaser, or Cleaning Fluid 0.6 0.5 0.7 0.8 0.6 0.5 0.5 0.6 0.6 0.5
Gasoline or Lighter Fluid 1.2 1.1 1.6 1.7 1.1 1.0 1.2 0.9 1.1 1.1
Glue, Shoe Polish, or Toluene 1.2 1.1 1.9 1.8 1.1 1.0 1.0 0.8 1.1 1.0
Halothane, Ether, or Other Anesthetics 0.3 0.3 0.1 0.1 0.3 0.4 0.3a 0.2 0.3 0.4
Lacquer Thinner or Other Paint Solvents 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.5
Lighter Gases (Butane, Propane) 0.3 0.3 0.4 0.5 0.3 0.3 0.3 0.3 0.3 0.2
Nitrous Oxide or Whippits 4.6 4.4 0.4 0.4 5.1 4.8 4.0 3.6 5.2 5.0
Felt-Tip Pens or Felt-Tip/Magic Markers 2.5 2.4 6.7 6.3 2.1 2.0 3.9 4.2 1.8 1.6
Spray Paints 0.7 0.6 1.7 1.5 0.6 0.5 1.0 0.9 0.5 0.5
Computer Cleaner/Air Duster 1.1a 1.0 1.0b 0.6 1.1a 1.0 2.7a 2.2 0.9 0.8
Other Aerosol Sprays 0.6 0.5 0.6 0.5 0.5 0.5 0.7 0.7 0.5 0.4
NEEDLE USE1,2 1.7 1.7 0.1 0.1 1.8 1.8 1.1 1.1 1.9 2.0
Heroin Needle Use1,2 0.8 0.9 0.0 0.0 0.9 1.0 0.7 0.8 0.9 1.0
Cocaine Needle Use1,2 0.8 0.9 0.0 0.0 0.9 1.0 0.5 0.5 1.0 1.1
Methamphetamine Needle Use1,2 0.7 0.7 0.0 0.0 0.8 0.8 0.4 0.4 0.9 0.8
HEROIN 1.9 1.8 0.1 0.1 2.1 2.0 1.8 1.6 2.1 2.1
Smoke Heroin2 0.7 0.7 0.1 0.0 0.8 0.8 0.9 0.8 0.8 0.8
Sniff or Snort Heroin2 1.2 1.3 0.1 0.1 1.4 1.5 1.2 1.1 1.4 1.5
OTHER DRUGS                    
GHB ("G," "Georgia Home Boy," "Grievous Bodily Harm,"
   "Liquid G,” and gamma hydroxybutyrate)
0.4 0.5 0.0a 0.1 0.5 0.6 0.3 0.3 0.5 0.6
Nonprescription Cough or Cold Medicine to Get High 3.9 3.7 2.6 2.6 4.0 3.9 6.0 5.4 3.7 3.6
170525
Table 1.97A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 97,499b 91,846 12,462a 11,517 12,462a 11,517
Hydrocodone Products 58,261b 54,807 7,193 6,924 7,193 6,924
Zohydro® ER 395 407 35 46 * *
Oxycodone Products 27,940 27,622 4,260 3,905 4,260 3,905
OxyContin® 9,134 9,122 1,751a 1,443 1,751a 1,443
Tramadol Products 18,573 18,931 1,794 1,591 1,794 1,591
Codeine Products nc 26,544 nc 2,767 nc 2,767
Morphine Products 7,205 6,828 697 536 697 536
Fentanyl Products 1,997 1,837 299 228 299 228
Buprenorphine Products 2,349 2,253 688 712 688 712
Oxymorphone Products 1,329 1,094 384 302 384 302
Demerol® 1,434 1,387 106 95 106 95
Hydromorphone Products 2,484 2,118 261 239 261 239
Methadone 1,568 1,357 502a 346 502a 346
Any Other Prescription Pain Reliever2 23,882 23,253 917 793 917 793
170525
Table 1.97B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 or Older, by Pain Reliever Subtype: Percentages, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 36.4b 34.1 4.7a 4.3 12.8 12.5
Hydrocodone Products 21.8b 20.3 2.7 2.6 12.3 12.6
Zohydro® ER 0.1 0.2 0.0 0.0 * *
Oxycodone Products 10.4 10.3 1.6 1.4 15.2 14.1
OxyContin® 3.4 3.4 0.7a 0.5 19.2a 15.8
Tramadol Products 6.9 7.0 0.7 0.6 9.7 8.4
Codeine Products nc 9.9 nc 1.0 nc 10.4
Morphine Products 2.7 2.5 0.3 0.2 9.7 7.9
Fentanyl Products 0.7 0.7 0.1 0.1 15.0 12.4
Buprenorphine Products 0.9 0.8 0.3 0.3 29.3 31.6
Oxymorphone Products 0.5 0.4 0.1 0.1 28.9 27.6
Demerol® 0.5 0.5 0.0 0.0 7.4 6.9
Hydromorphone Products 0.9 0.8 0.1 0.1 10.5 11.3
Methadone 0.6 0.5 0.2a 0.1 32.0 25.5
Any Other Prescription Pain Reliever2 8.9 8.6 0.3 0.3 3.8 3.4
170525
Table 1.98A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 5,650b 4,732 969 881 969 881
Hydrocodone Products 1,471b 1,240 371 349 371 349
Zohydro® ER 46 52 4 12 * *
Oxycodone Products 891 943 197 254 197 254
OxyContin® 424 486 121 121 121 121
Tramadol Products 443 386 100a 64 100a 64
Codeine Products nc 1,614 nc 318 nc 318
Morphine Products 386 423 62 46 62 46
Fentanyl Products 58 46 8 8 * *
Buprenorphine Products 85 69 22 18 * *
Oxymorphone Products 83 96 26 28 * *
Demerol® 38 51 6 4 * *
Hydromorphone Products 35 37 7 5 * *
Methadone 63 45 23 22 * *
Any Other Prescription Pain Reliever2 2,267 2,260 150 163 150 163
170525
Table 1.98B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 12 to 17 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 12 to 17, by Pain Reliever Subtype: Percentages, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 22.7b 19.0 3.9 3.5 17.2 18.6
Hydrocodone Products 5.9b 5.0 1.5 1.4 25.2 28.1
Zohydro® ER 0.2 0.2 0.0 0.0 * *
Oxycodone Products 3.6 3.8 0.8 1.0 22.1 27.0
OxyContin® 1.7 2.0 0.5 0.5 28.6 24.9
Tramadol Products 1.8 1.6 0.4a 0.3 22.6 16.5
Codeine Products nc 6.5 nc 1.3 nc 19.7
Morphine Products 1.6 1.7 0.2 0.2 16.1 10.9
Fentanyl Products 0.2 0.2 0.0 0.0 * *
Buprenorphine Products 0.3 0.3 0.1 0.1 * *
Oxymorphone Products 0.3 0.4 0.1 0.1 * *
Demerol® 0.2 0.2 0.0 0.0 * *
Hydromorphone Products 0.1 0.2 0.0 0.0 * *
Methadone 0.3 0.2 0.1 0.1 * *
Any Other Prescription Pain Reliever2 9.1 9.1 0.6 0.7 6.6 7.2
170525
Table 1.99A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 91,848b 87,114 11,492a 10,635 11,492a 10,635
Hydrocodone Products 56,790b 53,567 6,822 6,575 6,822 6,575
Zohydro® ER 349 355 32 34 * *
Oxycodone Products 27,049 26,679 4,063 3,650 4,063 3,650
OxyContin® 8,710 8,636 1,630a 1,322 1,630a 1,322
Tramadol Products 18,130 18,544 1,694 1,527 1,694 1,527
Codeine Products nc 24,930 nc 2,449 nc 2,449
Morphine Products 6,818 6,404 635 490 635 490
Fentanyl Products 1,939 1,791 292 220 292 220
Buprenorphine Products 2,264 2,184 667 694 667 694
Oxymorphone Products 1,247 998 358 274 358 274
Demerol® 1,396 1,337 101 91 101 91
Hydromorphone Products 2,450 2,081 254 234 254 234
Methadone 1,506 1,311 479a 324 479a 324
Any Other Prescription Pain Reliever2 21,615 20,993 768 630 768 630
170525
Table 1.99B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 or Older, by Pain Reliever Subtype: Percentages, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 37.8b 35.6 4.7a 4.3 12.5 12.2
Hydrocodone Products 23.4b 21.9 2.8 2.7 12.0 12.3
Zohydro® ER 0.1 0.1 0.0 0.0 * *
Oxycodone Products 11.1 10.9 1.7 1.5 15.0 13.7
OxyContin® 3.6 3.5 0.7a 0.5 18.7a 15.3
Tramadol Products 7.5 7.6 0.7 0.6 9.3 8.2
Codeine Products nc 10.2 nc 1.0 nc 9.8
Morphine Products 2.8 2.6 0.3 0.2 9.3 7.6
Fentanyl Products 0.8 0.7 0.1 0.1 15.0 12.3
Buprenorphine Products 0.9 0.9 0.3 0.3 29.5 31.8
Oxymorphone Products 0.5 0.4 0.1 0.1 28.7 27.4
Demerol® 0.6 0.5 0.0 0.0 7.2 6.8
Hydromorphone Products 1.0 0.9 0.1 0.1 10.4 11.2
Methadone 0.6 0.5 0.2a 0.1 31.8 24.7
Any Other Prescription Pain Reliever2 8.9 8.6 0.3 0.3 3.6 3.0
170525
Table 1.100A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 12,148b 10,407 2,979b 2,454 2,979b 2,454
Hydrocodone Products 6,906b 5,923 1,888b 1,552 1,888b 1,552
Zohydro® ER 62 32 4 5 * *
Oxycodone Products 3,770b 3,233 1,230b 1,004 1,230b 1,004
OxyContin® 1,419b 1,175 534b 375 534b 375
Tramadol Products 1,754 1,657 385 343 385 343
Codeine Products nc 3,481 nc 550 nc 550
Morphine Products 1,066b 860 190a 124 190a 124
Fentanyl Products 233 175 81a 41 81a 41
Buprenorphine Products 453b 315 195 145 195 145
Oxymorphone Products 209 159 113a 62 * *
Demerol® 159a 96 28a 6 * *
Hydromorphone Products 237 187 48 39 48 *
Methadone 224 164 114 85 * *
Any Other Prescription Pain Reliever2 3,143 2,987 184 149 184 149
170525
Table 1.100B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 18 to 25 and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 18 to 25, by Pain Reliever Subtype: Percentages, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 34.8b 30.1 8.5b 7.1 24.5 23.6
Hydrocodone Products 19.8b 17.1 5.4b 4.5 27.3 26.2
Zohydro® ER 0.2 0.1 0.0 0.0 * *
Oxycodone Products 10.8b 9.4 3.5a 2.9 32.6 31.1
OxyContin® 4.1b 3.4 1.5b 1.1 37.7 31.9
Tramadol Products 5.0 4.8 1.1 1.0 21.9 20.7
Codeine Products nc 10.1 nc 1.6 nc 15.8
Morphine Products 3.1a 2.5 0.5a 0.4 17.8 14.4
Fentanyl Products 0.7 0.5 0.2a 0.1 34.8 23.4
Buprenorphine Products 1.3b 0.9 0.6 0.4 42.9 46.0
Oxymorphone Products 0.6 0.5 0.3a 0.2 * *
Demerol® 0.5a 0.3 0.1a 0.0 * *
Hydromorphone Products 0.7 0.5 0.1 0.1 20.1 *
Methadone 0.6 0.5 0.3 0.2 * *
Any Other Prescription Pain Reliever2 9.0 8.6 0.5 0.4 5.9 5.0
170525
Table 1.101A – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: Numbers in Thousands, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq®[2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 79,701b 76,706 8,513 8,181 8,513 8,181
Hydrocodone Products 49,884a 47,644 4,934 5,023 4,934 5,023
Zohydro® ER 288 322 27 29 * *
Oxycodone Products 23,280 23,446 2,834 2,646 2,834 2,646
OxyContin® 7,291 7,462 1,095 947 1,095 947
Tramadol Products 16,376 16,887 1,309 1,184 1,309 1,184
Codeine Products nc 21,449 nc 1,899 nc 1,899
Morphine Products 5,753 5,544 444 366 444 366
Fentanyl Products 1,706 1,616 211 179 211 179
Buprenorphine Products 1,810 1,868 472 549 472 549
Oxymorphone Products 1,038 840 245 212 245 212
Demerol® 1,237 1,240 72 84 72 84
Hydromorphone Products 2,213 1,894 207 195 207 195
Methadone 1,281 1,148 365 238 365 238
Any Other Prescription Pain Reliever2 18,472 18,006 583 481 583 481
170525
Table 1.101B – Any Use and Misuse of Pain Relievers in Past Year among Persons Aged 26 or Older and Misuse of Pain Relievers in Past Year among Past Year Any Users of Pain Relievers Aged 26 or Older, by Pain Reliever Subtype: Percentages, 2015 and 2016
Pain Reliever Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over—the—counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes hydrocodone products (Vicodin®, Lortab®, Norco®, Zohydro® ER, generic hydrocodone, or other similar products); oxycodone products (OxyContin®, Percocet®, Percodan®, Roxicet® [2015 only], Roxicodone®, generic oxycodone, or other similar products); tramadol products (Ultram®, Ultram® ER, Ultracet®, generic tramadol, generic extended-release tramadol, or other similar products); codeine products (Tylenol® with codeine 3 or 4, generic codeine pills, or other similar products); morphine products (Avinza®, Kadian®, MS Contin®, generic morphine, generic extended-release morphine, or other similar products); fentanyl products (Actiq® [2015 only], Duragesic®, Fentora®, generic fentanyl, or other similar products); buprenorphine products (Suboxone®, generic buprenorphine, generic buprenorphine plus naloxone [2016 only], or other similar products); oxymorphone products (Opana®, Opana® ER, generic oxymorphone, generic extended-release oxymorphone, or other similar products); meperidine products (Demerol® or other similar products); hydromorphone products (Dilaudid® or generic hydromorphone, Exalgo® or generic extended-release hydromorphone, or other similar products); methadone products (methadone or other similar products); or any other prescription pain reliever. Over-the-counter drugs are not included.
2 Includes use or misuse of pain relievers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription pain reliever" corresponding only to the specific pain reliever categories shown in the table are included in estimates for Any Other Prescription Pain Reliever and are also included in the relevant pain reliever category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION PAIN RELIEVER1 38.3b 36.5 4.1 3.9 10.7 10.7
Hydrocodone Products 24.0b 22.7 2.4 2.4 9.9 10.5
Zohydro® ER 0.1 0.2 0.0 0.0 * *
Oxycodone Products 11.2 11.2 1.4 1.3 12.2 11.3
OxyContin® 3.5 3.6 0.5 0.5 15.0 12.7
Tramadol Products 7.9 8.0 0.6 0.6 8.0 7.0
Codeine Products nc 10.2 nc 0.9 nc 8.9
Morphine Products 2.8 2.6 0.2 0.2 7.7 6.6
Fentanyl Products 0.8 0.8 0.1 0.1 12.4 11.1
Buprenorphine Products 0.9 0.9 0.2 0.3 26.1 29.4
Oxymorphone Products 0.5 0.4 0.1 0.1 23.6 25.3
Demerol® 0.6 0.6 0.0 0.0 5.8 6.8
Hydromorphone Products 1.1 0.9 0.1 0.1 9.3 10.3
Methadone 0.6 0.5 0.2 0.1 28.5 20.8
Any Other Prescription Pain Reliever2 8.9 8.6 0.3 0.2 3.2 2.7
170410
Table 1.102A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 39,317 38,756 6,050 6,060 6,050 6,060
Benzodiazepine Tranquilizers2 29,735 30,606 5,394 5,620 5,394 5,620
Alprazolam Products 17,568 18,380 4,098 4,322 4,098 4,322
Lorazepam Products 7,563 7,300 893 786 893 786
Clonazepam Products 6,752 6,738 1,212 1,012 1,212 1,012
Diazepam Products 7,411 7,033 1,332a 990 1,332a 990
Muscle Relaxants3 6,933 7,187 819 696 819 696
Cyclobenzaprine (Also Known as Flexeril®) 4,837 5,191 255 256 255 256
Soma® 2,429 2,158 596 442 596 442
Any Other Prescription Tranquilizer4 6,645 6,408 202 151 202 151
170410
Table 1.102B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 or Older, by Tranquilizer Subtype: Percentages, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 14.7 14.4 2.3 2.2 15.4 15.6
Benzodiazepine Tranquilizers2 11.1 11.4 2.0 2.1 18.1 18.4
Alprazolam Products 6.6 6.8 1.5 1.6 23.3 23.5
Lorazepam Products 2.8 2.7 0.3 0.3 11.8 10.8
Clonazepam Products 2.5 2.5 0.5 0.4 17.9 15.0
Diazepam Products 2.8 2.6 0.5a 0.4 18.0a 14.1
Muscle Relaxants3 2.6 2.7 0.3 0.3 11.8 9.7
Cyclobenzaprine (Also Known as Flexeril®) 1.8 1.9 0.1 0.1 5.3 4.9
Soma® 0.9 0.8 0.2 0.2 24.5 20.5
Any Other Prescription Tranquilizer4 2.5 2.4 0.1 0.1 3.0 2.4
170410
Table 1.103A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 1,069 1,108 394 434 394 434
Benzodiazepine Tranquilizers2 723 845 365 412 365 412
Alprazolam Products 606 678 343 382 343 382
Lorazepam Products 69a 117 11 27 * *
Clonazepam Products 98 112 50 32 * *
Diazepam Products 143 147 45 33 * *
Muscle Relaxants3 63 46 20 13 * *
Cyclobenzaprine (Also Known as Flexeril®) 38 22 13 7 * *
Soma® 27 23 9 6 * *
Any Other Prescription Tranquilizer4 290 331 23 26 23 26
170410
Table 1.103B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 12 to 17 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 12 to 17, by Tranquilizer Subtype: Percentages, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 4.3 4.4 1.6 1.7 36.9 39.2
Benzodiazepine Tranquilizers2 2.9 3.4 1.5 1.7 50.5 48.7
Alprazolam Products 2.4 2.7 1.4 1.5 56.6 56.4
Lorazepam Products 0.3a 0.5 0.0 0.1 * *
Clonazepam Products 0.4 0.5 0.2 0.1 * *
Diazepam Products 0.6 0.6 0.2 0.1 * *
Muscle Relaxants3 0.3 0.2 0.1 0.1 * *
Cyclobenzaprine (Also Known as Flexeril®) 0.2 0.1 0.1 0.0 * *
Soma® 0.1 0.1 0.0 0.0 * *
Any Other Prescription Tranquilizer4 1.2 1.3 0.1 0.1 7.9 7.8
170410
Table 1.104A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 38,247 37,649 5,656 5,626 5,656 5,626
Benzodiazepine Tranquilizers2 29,012 29,761 5,029 5,208 5,029 5,208
Alprazolam Products 16,962 17,702 3,755 3,939 3,755 3,939
Lorazepam Products 7,494 7,183 883 759 883 759
Clonazepam Products 6,654 6,625 1,162 980 1,162 980
Diazepam Products 7,269 6,885 1,287a 957 1,287a 957
Muscle Relaxants3 6,870 7,141 799 683 799 683
Cyclobenzaprine (Also Known as Flexeril®) 4,799 5,169 243 250 243 250
Soma® 2,402 2,135 587 436 587 436
Any Other Prescription Tranquilizer4 6,354 6,077 179 125 179 125
170410
Table 1.104B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 or Older, by Tranquilizer Subtype: Percentages, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 15.8 15.4 2.3 2.3 14.8 14.9
Benzodiazepine Tranquilizers2 11.9 12.2 2.1 2.1 17.3 17.5
Alprazolam Products 7.0 7.2 1.5 1.6 22.1 22.3
Lorazepam Products 3.1 2.9 0.4 0.3 11.8 10.6
Clonazepam Products 2.7 2.7 0.5 0.4 17.5 14.8
Diazepam Products 3.0 2.8 0.5a 0.4 17.7a 13.9
Muscle Relaxants3 2.8 2.9 0.3 0.3 11.6 9.6
Cyclobenzaprine (Also Known as Flexeril®) 2.0 2.1 0.1 0.1 5.1 4.8
Soma® 1.0 0.9 0.2 0.2 24.4 20.4
Any Other Prescription Tranquilizer4 2.6 2.5 0.1 0.1 2.8 2.1
170410
Table 1.105A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar; diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 4,212 3,901 1,874 1,844 1,874 1,844
Benzodiazepine Tranquilizers2 3,592 3,381 1,785 1,791 1,785 1,791
Alprazolam Products 2,800 2,680 1,518 1,559 1,518 1,559
Lorazepam Products 762b 569 210a 140 210a 140
Clonazepam Products 1,003b 775 464b 322 464b 322
Diazepam Products 860b 579 357b 175 357b 175
Muscle Relaxants3 581 514 174 113 174 113
Cyclobenzaprine (Also Known as Flexeril®) 326 311 55 36 55 36
Soma® 300 215 130 83 130 *
Any Other Prescription Tranquilizer4 494 490 42 29 42 29
170410
Table 1.105B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 18 to 25 and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 18 to 25, by Tranquilizer Subtype: Percentages, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 12.1 11.3 5.4 5.3 44.5 47.3
Benzodiazepine Tranquilizers2 10.3 9.8 5.1 5.2 49.7 53.0
Alprazolam Products 8.0 7.8 4.3 4.5 54.2 58.2
Lorazepam Products 2.2b 1.6 0.6a 0.4 27.6 24.6
Clonazepam Products 2.9b 2.2 1.3b 0.9 46.3 41.5
Diazepam Products 2.5b 1.7 1.0b 0.5 41.6a 30.2
Muscle Relaxants3 1.7 1.5 0.5 0.3 29.9 21.9
Cyclobenzaprine (Also Known as Flexeril®) 0.9 0.9 0.2 0.1 17.0 11.5
Soma® 0.9 0.6 0.4 0.2 43.5 *
Any Other Prescription Tranquilizer4 1.4 1.4 0.1 0.1 8.6 5.9
170410
Table 1.106A – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: Numbers in Thousands, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 34,035 33,747 3,782 3,781 3,782 3,781
Benzodiazepine Tranquilizers2 25,421 26,380 3,243 3,416 3,243 3,416
Alprazolam Products 14,162 15,023 2,237 2,380 2,237 2,380
Lorazepam Products 6,732 6,615 673 619 673 619
Clonazepam Products 5,651 5,850 698 658 698 658
Diazepam Products 6,409 6,306 930 783 930 783
Muscle Relaxants3 6,288 6,627 625 570 625 570
Cyclobenzaprine (Also Known as Flexeril®) 4,473 4,858 187 214 187 214
Soma® 2,102 1,920 456 353 456 353
Any Other Prescription Tranquilizer4 5,861 5,587 137 96 137 96
170410
Table 1.106B – Any Use and Misuse of Tranquilizers in Past Year among Persons Aged 26 or Older and Misuse of Tranquilizers in Past Year among Past Year Any Users of Tranquilizers Aged 26 or Older, by Tranquilizer Subtype: Percentages, 2015 and 2016
Tranquilizer Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes benzodiazepine tranquilizers (see footnote 2); muscle relaxants (see footnote 3); buspirone products (also known as BuSpar® or other similar products) [2015 only], hydroxyzine products (also known as Atarax® or Vistaril® or similar products) [2015 only], meprobamate products (also known as Equanil® or Miltown® or similar products) [2015 only], or any other prescription tranquilizer (see footnote 4).
2 Includes alprazolam products (Xanax®, Xanax® XR, generic alprazolam, generic extended-release alprazolam, or other similar products); lorazepam products (Ativan®, generic lorazepam, or other similar products); clonazepam products (Klonopin®, generic clonazepam, or other similar products); diazepam products (Valium®, generic diazepam, or other similar products); or other benzodiazepine tranquilizers that were specified for misuse of "any other prescription tranquilizer."
3 Includes cyclobenzaprine products (Flexeril®, generic cyclobenzaprine, or other similar products); carisoprodol products (Soma® or other similar products); or other muscle relaxants that were specified for misuse of "any other prescription tranquilizer."
4 Includes use or misuse of tranquilizers containing other active ingredients. A small number of respondents who reported misuse of "any other prescription tranquilizer" corresponding only to the specific tranquilizer categories shown in the table are included in estimates for Any Other Prescription Tranquilizer and are also included in the relevant tranquilizer category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION TRANQUILIZER1 16.4 16.1 1.8 1.8 11.1 11.2
Benzodiazepine Tranquilizers2 12.2 12.6 1.6 1.6 12.8 13.0
Alprazolam Products 6.8 7.2 1.1 1.1 15.8 15.8
Lorazepam Products 3.2 3.2 0.3 0.3 10.0 9.4
Clonazepam Products 2.7 2.8 0.3 0.3 12.3 11.3
Diazepam Products 3.1 3.0 0.4 0.4 14.5 12.4
Muscle Relaxants3 3.0 3.2 0.3 0.3 9.9 8.6
Cyclobenzaprine (Also Known as Flexeril®) 2.2 2.3 0.1 0.1 4.2 4.4
Soma® 1.0 0.9 0.2 0.2 21.7 18.4
Any Other Prescription Tranquilizer4 2.8 2.7 0.1 0.0 2.3 1.7
170410
Table 1.107A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 17,212a 18,420 5,251 5,647 5,251 5,647
Amphetamine or Methylphenidate Products2 12,834a 13,866 5,047 5,438 5,047 5,438
Amphetamine Products 11,315 12,041 4,778 5,111 4,778 5,111
Methylphenidate Products 3,457 3,710 979 875 979 875
Anorectic (Weight-Loss) Stimulants 2,315 2,553 121 207 121 207
Provigil® 574 558 103 74 * 74
Any Other Prescription Stimulant3 2,701 3,015 96 101 96 101
170410
Table 1.107B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 or Older, by Stimulant Subtype: Percentages, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 6.4a 6.8 2.0 2.1 30.5 30.7
Amphetamine or Methylphenidate Products2 4.8a 5.1 1.9 2.0 39.3 39.2
Amphetamine Products 4.2 4.5 1.8 1.9 42.2 42.4
Methylphenidate Products 1.3 1.4 0.4 0.3 28.3a 23.6
Anorectic (Weight-Loss) Stimulants 0.9 0.9 0.0 0.1 5.2 8.1
Provigil® 0.2 0.2 0.0 0.0 * 13.3
Any Other Prescription Stimulant3 1.0 1.1 0.0 0.0 3.6 3.4
170410
Table 1.108A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 1,820 1,799 491 427 491 427
Amphetamine or Methylphenidate Products2 1,622 1,610 468 413 468 413
Amphetamine Products 1,215 1,154 425 384 425 384
Methylphenidate Products 693 735 126a 82 126a 82
Anorectic (Weight-Loss) Stimulants 77 96 3a 18 * *
Provigil® 17 11 6 2 * *
Any Other Prescription Stimulant3 309 341 11 7 11 7
170410
Table 1.108B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 12 to 17 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 12 to 17, by Stimulant Subtype: Percentages, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 7.3 7.2 2.0 1.7 27.0 23.7
Amphetamine or Methylphenidate Products2 6.5 6.5 1.9 1.7 28.9 25.6
Amphetamine Products 4.9 4.6 1.7 1.5 35.0 33.3
Methylphenidate Products 2.8 3.0 0.5a 0.3 18.2a 11.1
Anorectic (Weight-Loss) Stimulants 0.3 0.4 0.0a 0.1 * *
Provigil® 0.1 0.0 0.0 0.0 * *
Any Other Prescription Stimulant3 1.2 1.4 0.0 0.0 3.6 1.9
170410
Table 1.109A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 15,392a 16,621 4,760a 5,220 4,760a 5,220
Amphetamine or Methylphenidate Products2 11,212a 12,256 4,579a 5,025 4,579 5,025
Amphetamine Products 10,101a 10,886 4,354 4,726 4,354 4,726
Methylphenidate Products 2,763 2,976 852 793 852 793
Anorectic (Weight-Loss) Stimulants 2,239 2,457 118 188 118 188
Provigil® 556 547 98 72 * 72
Any Other Prescription Stimulant3 2,392 2,673 85 95 85 95
170410
Table 1.109B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 or Older, by Stimulant Subtype: Percentages, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 6.3a 6.8 2.0 2.1 30.9 31.4
Amphetamine or Methylphenidate Products2 4.6a 5.0 1.9 2.1 40.8 41.0
Amphetamine Products 4.2 4.5 1.8 1.9 43.1 43.4
Methylphenidate Products 1.1 1.2 0.4 0.3 30.8 26.6
Anorectic (Weight-Loss) Stimulants 0.9 1.0 0.0 0.1 5.3 7.7
Provigil® 0.2 0.2 0.0 0.0 * 13.1
Any Other Prescription Stimulant3 1.0 1.1 0.0 0.0 3.6 3.5
170410
Table 1.110A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 4,906 4,998 2,537 2,578 2,537 2,578
Amphetamine or Methylphenidate Products2 4,537 4,703 2,507 2,555 2,507 2,555
Amphetamine Products 4,231 4,379 2,426 2,460 2,426 2,460
Methylphenidate Products 1,163 1,143 485 410 485 410
Anorectic (Weight-Loss) Stimulants 240 211 47 23 * *
Provigil® 33 34 10 4 * *
Any Other Prescription Stimulant3 439a 346 26 19 26 19
170410
Table 1.110B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 18 to 25 and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 18 to 25, by Stimulant Subtype: Percentages, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 14.1 14.5 7.3 7.5 51.7 51.6
Amphetamine or Methylphenidate Products2 13.0 13.6 7.2 7.4 55.3 54.3
Amphetamine Products 12.1 12.7 7.0 7.1 57.3 56.2
Methylphenidate Products 3.3 3.3 1.4 1.2 41.7 35.8
Anorectic (Weight-Loss) Stimulants 0.7 0.6 0.1 0.1 * *
Provigil® 0.1 0.1 0.0 0.0 * *
Any Other Prescription Stimulant3 1.3 1.0 0.1 0.1 6.0 5.4
170410
Table 1.111A – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: Numbers in Thousands, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 10,486a 11,623 2,223a 2,643 2,223a 2,643
Amphetamine or Methylphenidate Products2 6,676a 7,553 2,072a 2,470 2,072a 2,470
Amphetamine Products 5,870 6,508 1,927 2,266 1,927 2,266
Methylphenidate Products 1,601 1,833 367 383 367 383
Anorectic (Weight-Loss) Stimulants 1,999 2,246 71a 166 71a 166
Provigil® 524 513 88 68 * *
Any Other Prescription Stimulant3 1,952 2,328 59 76 59 76
170410
Table 1.111B – Any Use and Misuse of Stimulants in Past Year among Persons Aged 26 or Older and Misuse of Stimulants in Past Year among Past Year Any Users of Stimulants Aged 26 or Older, by Stimulant Subtype: Percentages, 2015 and 2016
Stimulant Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes amphetamine products (Adderall®, Adderall® XR, Dexedrine®, Vyvanse®, generic dextroamphetamine, generic amphetamine-dextroamphetamine combinations, generic extended-release amphetamine-dextroamphetamine combinations, or similar products); methylphenidate products (Ritalin®, Ritalin® SR [2015 only], Ritalin® LA, Concerta®, Daytrana®, Metadate CD, Metadate ER, Focalin, Focalin XR, generic methylphenidate, generic extended-release methylphenidate, generic dexmethylphenidate, generic extended-release dexmethylphenidate, or similar products); anorectic (weight-loss) stimulants (Didrex®, benzphetamine, Tenuate®, diethylpropion, phendimetrazine, phentermine or similar products); modafinil products (Provigil® or other similar products); or any other prescription stimulant.
2 Includes amphetamine and methylphenidate products that are primarily prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Vyvanse® is included with amphetamine products because its active ingredient (lisdexamfetamine) is metabolized to dextroamphetamine.
3 Includes use or misuse of stimulants containing other active ingredients. A small number of respondents who reported misuse of "any other prescription stimulant" corresponding only to the specific stimulant categories shown in the table are included in estimates for Any Other Prescription Stimulant and are also included in the relevant stimulant category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION STIMULANT1 5.0a 5.5 1.1a 1.3 21.2 22.7
Amphetamine or Methylphenidate Products2 3.2a 3.6 1.0a 1.2 31.0 32.7
Amphetamine Products 2.8 3.1 0.9 1.1 32.8 34.8
Methylphenidate Products 0.8 0.9 0.2 0.2 22.9 20.9
Anorectic (Weight-Loss) Stimulants 1.0 1.1 0.0a 0.1 3.6 7.4
Provigil® 0.3 0.2 0.0 0.0 * *
Any Other Prescription Stimulant3 0.9 1.1 0.0 0.0 3.0 3.3
170410
Table 1.112A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: Numbers in Thousands, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 18,564 18,629 1,511 1,531 1,511 1,531
Zolpidem Products 11,501 11,458 1,108 1,045 1,108 1,045
Eszopiclone Products 1,271 1,088 94 105 94 105
Zaleplon Products 353 413 34 15 * *
Benzodiazepine Sedatives2 2,523 2,123 205 124 205 124
Flurazepam (Also Known as Dalmane®) 156 126 * * * *
Temazepam Products 1,790a 1,340 100 99 100 99
Triazolam Products 636 728 101a 22 101a 22
Barbiturates 452 434 46 74 * *
Any Other Prescription Sedative3 5,399 5,521 191 238 191 238
170410
Table 1.112B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 or Older, by Sedative Subtype: Percentages, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 6.9 6.9 0.6 0.6 8.1 8.2
Zolpidem Products 4.3 4.3 0.4 0.4 9.6 9.1
Eszopiclone Products 0.5 0.4 0.0 0.0 7.4 9.7
Zaleplon Products 0.1 0.2 0.0 0.0 * *
Benzodiazepine Sedatives2 0.9 0.8 0.1 0.0 8.1 5.8
Flurazepam (Also Known as Dalmane®) 0.1 0.0 * * * *
Temazepam Products 0.7a 0.5 0.0 0.0 5.6 7.4
Triazolam Products 0.2 0.3 0.0a 0.0 15.9b 3.0
Barbiturates 0.2 0.2 0.0 0.0 * *
Any Other Prescription Sedative3 2.0 2.0 0.1 0.1 3.5 4.3
170410
Table 1.113A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: Numbers in Thousands, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 602 563 102 100 102 100
Zolpidem Products 207 181 73 48 73 48
Eszopiclone Products 27 29 3 7 * *
Zaleplon Products 19 11 2 * * *
Benzodiazepine Sedatives2 34 59 9 10 * *
Flurazepam (Also Known as Dalmane®) 1 6 * 3 * *
Temazepam Products 17 5 7 3 * *
Triazolam Products 16b 52 2 6 * *
Barbiturates 25 43 3 13 * *
Any Other Prescription Sedative3 354 347 20 24 20 24
170410
Table 1.113B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 12 to 17 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 12 to 17, by Sedative Subtype: Percentages, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 2.4 2.3 0.4 0.4 17.0 17.8
Zolpidem Products 0.8 0.7 0.3 0.2 35.5 26.5
Eszopiclone Products 0.1 0.1 0.0 0.0 * *
Zaleplon Products 0.1 0.0 0.0 * * *
Benzodiazepine Sedatives2 0.1 0.2 0.0 0.0 * *
Flurazepam (Also Known as Dalmane®) 0.0 0.0 * 0.0 * *
Temazepam Products 0.1 0.0 0.0 0.0 * *
Triazolam Products 0.1b 0.2 0.0 0.0 * *
Barbiturates 0.1 0.2 0.0 0.1 * *
Any Other Prescription Sedative3 1.4 1.4 0.1 0.1 5.7 6.9
170410
Table 1.114A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: Numbers in Thousands, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 17,962 18,067 1,409 1,431 1,409 1,431
Zolpidem Products 11,294 11,278 1,035 997 1,035 997
Eszopiclone Products 1,244 1,059 91 98 91 98
Zaleplon Products 334 402 32 15 * *
Benzodiazepine Sedatives2 2,489 2,064 197 114 197 114
Flurazepam (Also Known as Dalmane®) 154 120 * * * *
Temazepam Products 1,772a 1,336 93 96 93 96
Triazolam Products 620 677 99b 16 99b 16
Barbiturates 427 391 43 60 * *
Any Other Prescription Sedative3 5,045 5,175 171 214 171 214
170410
Table 1.114B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 or Older, by Sedative Subtype: Percentages, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 7.4 7.4 0.6 0.6 7.8 7.9
Zolpidem Products 4.7 4.6 0.4 0.4 9.2 8.8
Eszopiclone Products 0.5 0.4 0.0 0.0 7.3 9.3
Zaleplon Products 0.1 0.2 0.0 0.0 * *
Benzodiazepine Sedatives2 1.0 0.8 0.1 0.0 7.9 5.5
Flurazepam (Also Known as Dalmane®) 0.1 0.0 * * * *
Temazepam Products 0.7a 0.5 0.0 0.0 5.3 7.2
Triazolam Products 0.3 0.3 0.0b 0.0 16.0b 2.4
Barbiturates 0.2 0.2 0.0 0.0 * *
Any Other Prescription Sedative3 2.1 2.1 0.1 0.1 3.4 4.1
170410
Table 1.115A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: Numbers in Thousands, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 1,339 1,278 265 256 265 256
Zolpidem Products 723 663 207 187 207 187
Eszopiclone Products 56 79 19 15 * *
Zaleplon Products 22 11 5 2 * *
Benzodiazepine Sedatives2 148 108 27 9 * *
Flurazepam (Also Known as Dalmane®) 10 16 * * * *
Temazepam Products 76 47 14 4 * *
Triazolam Products 71 58 18 5 * *
Barbiturates 47 24 8 3 * *
Any Other Prescription Sedative3 542 574 38 44 38 44
170410
Table 1.115B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 18 to 25 and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 18 to 25, by Sedative Subtype: Percentages, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 3.8 3.7 0.8 0.7 19.8 20.0
Zolpidem Products 2.1 1.9 0.6 0.5 28.6 28.2
Eszopiclone Products 0.2 0.2 0.1 0.0 * *
Zaleplon Products 0.1 0.0 0.0 0.0 * *
Benzodiazepine Sedatives2 0.4 0.3 0.1 0.0 * *
Flurazepam (Also Known as Dalmane®) 0.0 0.0 * * * *
Temazepam Products 0.2 0.1 0.0 0.0 * *
Triazolam Products 0.2 0.2 0.1 0.0 * *
Barbiturates 0.1 0.1 0.0 0.0 * *
Any Other Prescription Sedative3 1.6 1.7 0.1 0.1 7.1 7.7
170410
Table 1.116A – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: Numbers in Thousands, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 16,623 16,789 1,143 1,176 1,143 1,176
Zolpidem Products 10,571 10,614 828 810 828 810
Eszopiclone Products 1,188 980 72 84 72 84
Zaleplon Products 312 391 28 13 * *
Benzodiazepine Sedatives2 2,340 1,956 170 104 170 104
Flurazepam (Also Known as Dalmane®) 144 104 * * * *
Temazepam Products 1,696a 1,289 79 92 79 92
Triazolam Products 549 619 82a 11 * *
Barbiturates 380 367 35 58 * *
Any Other Prescription Sedative3 4,503 4,600 133 170 133 170
170410
Table 1.116B – Any Use and Misuse of Sedatives in Past Year among Persons Aged 26 or Older and Misuse of Sedatives in Past Year among Past Year Any Users of Sedatives Aged 26 or Older, by Sedative Subtype: Percentages, 2015 and 2016
Sedative Subtype Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
a The difference between this estimate and the 2016 estimate is statistically significant at the .05 level. Rounding may make the estimates appear identical.
b The difference between this estimate and the 2016 estimate is statistically significant at the .01 level. Rounding may make the estimates appear identical.
1 Includes zolpidem products (Ambien®, Ambien® CR, generic zolpidem, generic extended-release zolpidem, or similar products); eszopiclone products (Lunesta®, generic eszopiclone, or similar products); zaleplon products (Sonata®, generic zaleplon, or similar products); benzodiazepine sedatives (see footnote 2); barbiturates (Butisol®, Seconal®, phenobarbital, or similar products); or any other prescription sedative.
2 Includes flurazepam products (flurazepam [also known as Dalmane®] or other similar products), temazepam products (Restoril®, generic temazepam, or other similar products); triazolam products (Halcion®, generic triazolam, or other similar products); or other benzodiazepine sedatives that were specified for misuse of "any other prescription sedative."
3 Includes use or misuse of sedatives containing other active ingredients. A small number of respondents who reported misuse of "any other prescription sedative" corresponding only to the specific sedative categories shown in the table are included in estimates for Any Other Prescription Sedative and are also included in the relevant sedative category.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ANY PRESCRIPTION SEDATIVE1 8.0 8.0 0.5 0.6 6.9 7.0
Zolpidem Products 5.1 5.1 0.4 0.4 7.8 7.6
Eszopiclone Products 0.6 0.5 0.0 0.0 6.1 8.5
Zaleplon Products 0.2 0.2 0.0 0.0 * *
Benzodiazepine Sedatives2 1.1 0.9 0.1 0.0 7.2 5.3
Flurazepam (Also Known as Dalmane®) 0.1 0.0 * * * *
Temazepam Products 0.8a 0.6 0.0 0.0 4.7 7.1
Triazolam Products 0.3 0.3 0.0a 0.0 * *
Barbiturates 0.2 0.2 0.0 0.0 * *
Any Other Prescription Sedative3 2.2 2.2 0.1 0.1 2.9 3.7
170410
Table 1.1C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 903 870 617 616 457 488
Marijuana 896 870 524 542 413 442
Cocaine 638 613 192 175 128 120
Crack 305 302 93 88 64 64
Heroin 234 234 79 83 44 63
Hallucinogens 635 642 175 185 83 94
LSD 521 526 83 98 39 41
PCP 270 288 30 28 11 9
Ecstasy 372 363 124 123 53 60
Inhalants 459 471 93 91 52 66
Methamphetamine 403 390 120 100 93 71
Misuse of Psychotherapeutics3,4 nr nr 380 374 206 211
Pain Relievers4 nr nr 307 286 157 159
Tranquilizers nr nr 209 206 109 120
Stimulants nr nr 174 192 97 103
Sedatives nr nr 113 117 57 74
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 312 291 164 171
170410
Table 1.1D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.34 0.32 0.23 0.23 0.17 0.18
Marijuana 0.33 0.32 0.20 0.20 0.15 0.16
Cocaine 0.24 0.23 0.07 0.07 0.05 0.04
Crack 0.11 0.11 0.03 0.03 0.02 0.02
Heroin 0.09 0.09 0.03 0.03 0.02 0.02
Hallucinogens 0.24 0.24 0.07 0.07 0.03 0.03
LSD 0.19 0.20 0.03 0.04 0.01 0.02
PCP 0.10 0.11 0.01 0.01 0.00 0.00
Ecstasy 0.14 0.13 0.05 0.05 0.02 0.02
Inhalants 0.17 0.17 0.03 0.03 0.02 0.02
Methamphetamine 0.15 0.14 0.04 0.04 0.03 0.03
Misuse of Psychotherapeutics3,4 nr nr 0.14 0.14 0.08 0.08
Pain Relievers4 nr nr 0.11 0.11 0.06 0.06
Tranquilizers nr nr 0.08 0.08 0.04 0.04
Stimulants nr nr 0.07 0.07 0.04 0.04
Sedatives nr nr 0.04 0.04 0.02 0.03
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.12 0.11 0.06 0.06
170410
Table 1.1P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.4923   0.5753   0.0417  
Marijuana 0.9305   0.0764   0.0069  
Cocaine 0.8928   0.4136   0.9381  
Crack 0.4518   0.7331   0.6982  
Heroin 0.6436   0.3229   0.0708  
Hallucinogens 0.7206   0.4537   0.2273  
LSD 0.6128   0.0061   0.7187  
PCP 0.8286   0.6634   0.7861  
Ecstasy 0.9806   0.5727   0.4600  
Inhalants 0.0216   0.4066   0.4082  
Methamphetamine 0.8983   0.0274   0.0361  
Misuse of Psychotherapeutics3,4 nr   0.4311   0.5042  
Pain Relievers4 nr   0.0137   0.0534  
Tranquilizers nr   0.9178   0.6794  
Stimulants nr   0.1269   0.6045  
Sedatives nr   0.9446   0.6167  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.0235   0.1638  
170410
Table 1.2C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 107 104 92 87 68 66
Marijuana 89 88 81 77 61 61
Cocaine 23 22 20 18 13 7
Crack 5 5 3 4 1 2
Heroin 8 8 7 5 3 2
Hallucinogens 44 38 37 31 17 16
LSD 28 24 26 20 12 9
PCP 13 8 11 5 6 3
Ecstasy 32 25 24 21 9 8
Inhalants 73 65 39 34 20 17
Methamphetamine 15 11 10 8 5 4
Misuse of Psychotherapeutics3,4 nr nr 58 53 37 29
Pain Relievers4 nr nr 47 42 27 22
Tranquilizers nr nr 32 32 21 17
Stimulants nr nr 35 34 17 14
Sedatives nr nr 16 14 7 6
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 48 43 27 22
170410
Table 1.2D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.43 0.42 0.37 0.35 0.27 0.26
Marijuana 0.36 0.35 0.32 0.31 0.24 0.24
Cocaine 0.09 0.09 0.08 0.07 0.05 0.03
Crack 0.02 0.02 0.01 0.02 0.01 0.01
Heroin 0.03 0.03 0.03 0.02 0.01 0.01
Hallucinogens 0.18 0.15 0.15 0.13 0.07 0.06
LSD 0.11 0.10 0.10 0.08 0.05 0.04
PCP 0.05 0.03 0.04 0.02 0.02 0.01
Ecstasy 0.13 0.10 0.09 0.08 0.04 0.03
Inhalants 0.29 0.26 0.16 0.14 0.08 0.07
Methamphetamine 0.06 0.04 0.04 0.03 0.02 0.01
Misuse of Psychotherapeutics3,4 nr nr 0.23 0.21 0.15 0.12
Pain Relievers4 nr nr 0.19 0.17 0.11 0.09
Tranquilizers nr nr 0.13 0.13 0.09 0.07
Stimulants nr nr 0.14 0.14 0.07 0.06
Sedatives nr nr 0.06 0.06 0.03 0.03
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.19 0.17 0.11 0.09
170410
Table 1.2P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.0002   0.0015   0.0152  
Marijuana 0.0570   0.1625   0.1029  
Cocaine 0.9096   0.5228   0.0847  
Crack 0.5057   0.2529   0.4399  
Heroin 0.7695   0.3338   0.7263  
Hallucinogens 0.1521   0.1849   0.7680  
LSD 0.2781   0.1763   0.4937  
PCP 0.1446   0.1752   0.5873  
Ecstasy 0.0949   0.4586   0.7462  
Inhalants 0.0326   0.0106   0.3091  
Methamphetamine 0.9054   0.5050   0.5313  
Misuse of Psychotherapeutics3,4 nr   0.0608   0.0226  
Pain Relievers4 nr   0.1721   0.2686  
Tranquilizers nr   0.3751   0.1199  
Stimulants nr   0.1890   0.2399  
Sedatives nr   0.9285   0.8791  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.1704   0.2907  
170410
Table 1.3C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 49 45 36 33 22 20
Marijuana 21 21 18 19 13 11
Cocaine 4 3 3 2 3 *
Crack * 2 * 2 * *
Heroin 0 2 * 2 * *
Hallucinogens 16 13 15 10 9 5
LSD 12 2 11 1 6 1
PCP 9 1 8 1 5 *
Ecstasy 7 4 6 4 1 1
Inhalants 38 35 25 21 14 11
Methamphetamine 2 3 2 1 * *
Misuse of Psychotherapeutics3,4 nr nr 19 19 12 11
Pain Relievers4 nr nr 18 17 11 11
Tranquilizers nr nr 7 8 6 2
Stimulants nr nr 4 5 2 2
Sedatives nr nr 4 5 1 *
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 18 17 11 11
170410
Table 1.3D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.58 0.55 0.44 0.41 0.28 0.25
Marijuana 0.26 0.26 0.23 0.25 0.17 0.15
Cocaine 0.05 0.04 0.04 0.03 0.04 *
Crack * 0.03 * 0.03 * *
Heroin 0.00 0.03 * 0.03 * *
Hallucinogens 0.21 0.17 0.19 0.12 0.11 0.06
LSD 0.15 0.03 0.14 0.01 0.08 0.01
PCP 0.11 0.02 0.10 0.01 0.06 *
Ecstasy 0.09 0.06 0.07 0.04 0.01 0.01
Inhalants 0.46 0.43 0.31 0.27 0.17 0.14
Methamphetamine 0.03 0.04 0.02 0.01 * *
Misuse of Psychotherapeutics3,4 nr nr 0.24 0.24 0.15 0.14
Pain Relievers4 nr nr 0.22 0.22 0.14 0.14
Tranquilizers nr nr 0.10 0.10 0.08 0.02
Stimulants nr nr 0.06 0.07 0.03 0.03
Sedatives nr nr 0.05 0.06 0.01 *
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.22 0.22 0.14 0.14
170410
Table 1.3P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.0334   0.0680   0.1116  
Marijuana 0.2276   0.9636   0.6909  
Cocaine 0.4564   0.3659   *  
Crack *   *   *  
Heroin 0.4155   *   *  
Hallucinogens 0.2548   0.0731   0.3210  
LSD 0.0054   0.0093   0.2576  
PCP 0.0711   0.1276   *  
Ecstasy 0.9434   0.9915   0.8590  
Inhalants 0.0737   0.0539   0.1526  
Methamphetamine 0.3596   0.8235   *  
Misuse of Psychotherapeutics3,4 nr   0.5198   0.2776  
Pain Relievers4 nr   0.3696   0.3837  
Tranquilizers nr   0.8496   0.2620  
Stimulants nr   0.3830   0.9118  
Sedatives nr   0.4576   *  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.4172   0.3837  
170410
Table 1.4C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 70 64 57 54 39 36
Marijuana 50 50 46 45 34 31
Cocaine 7 11 6 9 3 4
Crack 2 2 * 1 * 1
Heroin 3 5 3 2 2 *
Hallucinogens 20 19 18 16 8 8
LSD 11 11 9 10 4 4
PCP 6 4 4 2 * 2
Ecstasy 14 14 12 12 6 3
Inhalants 43 41 25 22 12 8
Methamphetamine 6 4 5 3 1 2
Misuse of Psychotherapeutics3,4 nr nr 32 32 19 19
Pain Relievers4 nr nr 27 28 14 14
Tranquilizers nr nr 15 17 8 10
Stimulants nr nr 17 18 10 10
Sedatives nr nr 8 9 5 5
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 27 28 14 14
170410
Table 1.4D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.72 0.69 0.61 0.60 0.43 0.41
Marijuana 0.54 0.56 0.51 0.51 0.38 0.36
Cocaine 0.08 0.13 0.07 0.10 0.04 0.05
Crack 0.02 0.02 * 0.02 * 0.02
Heroin 0.04 0.06 0.04 0.02 0.02 *
Hallucinogens 0.23 0.22 0.20 0.19 0.09 0.10
LSD 0.13 0.13 0.11 0.12 0.04 0.05
PCP 0.07 0.05 0.05 0.03 * 0.02
Ecstasy 0.16 0.16 0.14 0.13 0.07 0.04
Inhalants 0.47 0.47 0.28 0.25 0.14 0.10
Methamphetamine 0.07 0.05 0.06 0.04 0.01 0.03
Misuse of Psychotherapeutics3,4 nr nr 0.36 0.37 0.22 0.22
Pain Relievers4 nr nr 0.30 0.32 0.16 0.16
Tranquilizers nr nr 0.17 0.20 0.09 0.11
Stimulants nr nr 0.19 0.20 0.11 0.11
Sedatives nr nr 0.10 0.11 0.06 0.06
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.30 0.32 0.16 0.16
170410
Table 1.4P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.1430   0.5006   0.4035  
Marijuana 0.7368   0.5999   0.4635  
Cocaine 0.0667   0.3389   0.5090  
Crack 0.6227   *   *  
Heroin 0.5031   0.3848   *  
Hallucinogens 0.7586   0.6578   0.5050  
LSD 0.7994   0.9255   0.5505  
PCP 0.2806   0.4725   *  
Ecstasy 0.6047   0.8616   0.4021  
Inhalants 0.2139   0.3018   0.4070  
Methamphetamine 0.7266   0.9678   0.3468  
Misuse of Psychotherapeutics3,4 nr   0.8049   0.7218  
Pain Relievers4 nr   0.9907   0.6547  
Tranquilizers nr   0.1725   0.6571  
Stimulants nr   0.8048   0.8520  
Sedatives nr   0.6800   0.7330  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.9974   0.6617  
170410
Table 1.5C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 91 89 78 73 57 54
Marijuana 79 77 70 67 52 51
Cocaine 22 19 18 15 12 5
Crack 5 4 3 3 1 1
Heroin 8 6 6 4 2 2
Hallucinogens 37 30 29 25 12 12
LSD 23 21 21 17 9 8
PCP 7 7 6 5 4 2
Ecstasy 27 20 18 16 6 7
Inhalants 47 42 21 18 9 11
Methamphetamine 13 10 8 7 5 3
Misuse of Psychotherapeutics3,4 nr nr 49 44 29 20
Pain Relievers4 nr nr 37 31 19 14
Tranquilizers nr nr 27 26 18 14
Stimulants nr nr 31 29 14 10
Sedatives nr nr 13 11 5 4
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 38 32 19 15
170410
Table 1.5D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.85 0.80 0.80 0.72 0.62 0.59
Marijuana 0.81 0.75 0.74 0.68 0.57 0.56
Cocaine 0.26 0.22 0.22 0.18 0.14 0.06
Crack 0.06 0.05 0.03 0.04 0.02 0.02
Heroin 0.09 0.07 0.07 0.05 0.03 0.03
Hallucinogens 0.42 0.34 0.33 0.29 0.15 0.14
LSD 0.28 0.24 0.25 0.20 0.11 0.09
PCP 0.08 0.08 0.07 0.06 0.04 0.03
Ecstasy 0.32 0.23 0.22 0.19 0.08 0.08
Inhalants 0.53 0.46 0.24 0.21 0.10 0.13
Methamphetamine 0.16 0.11 0.10 0.08 0.06 0.04
Misuse of Psychotherapeutics3,4 nr nr 0.55 0.49 0.33 0.24
Pain Relievers4 nr nr 0.43 0.36 0.22 0.17
Tranquilizers nr nr 0.32 0.30 0.21 0.16
Stimulants nr nr 0.36 0.33 0.17 0.12
Sedatives nr nr 0.15 0.13 0.05 0.04
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.43 0.36 0.22 0.17
170410
Table 1.5P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.0018   0.0025   0.0414  
Marijuana 0.0101   0.0188   0.1079  
Cocaine 0.5387   0.3130   0.0601  
Crack 0.8582   0.5900   0.8227  
Heroin 0.3290   0.3299   0.9416  
Hallucinogens 0.2279   0.4906   0.7849  
LSD 0.8373   0.4486   0.5935  
PCP 0.8790   0.9388   0.8574  
Ecstasy 0.0197   0.2534   0.8548  
Inhalants 0.4323   0.2256   0.4527  
Methamphetamine 0.5991   0.4385   0.2990  
Misuse of Psychotherapeutics3,4 nr   0.0499   0.0210  
Pain Relievers4 nr   0.1526   0.4863  
Tranquilizers nr   0.9063   0.0651  
Stimulants nr   0.0646   0.1880  
Sedatives nr   0.4778   0.9331  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.1371   0.5275  
170410
Table 1.6C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 896 853 610 604 448 480
Marijuana 890 857 520 534 408 434
Cocaine 637 611 192 174 127 119
Crack 306 301 93 88 64 64
Heroin 234 233 79 83 44 63
Hallucinogens 630 632 171 181 81 92
LSD 519 520 81 96 38 40
PCP 269 288 29 28 9 8
Ecstasy 367 360 119 121 52 60
Inhalants 453 459 83 85 48 63
Methamphetamine 401 389 120 99 93 71
Misuse of Psychotherapeutics3,4 nr nr 375 365 201 208
Pain Relievers4 nr nr 303 280 156 158
Tranquilizers nr nr 205 203 107 118
Stimulants nr nr 171 185 96 103
Sedatives nr nr 111 116 57 74
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 307 286 162 170
170410
Table 1.6D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.37 0.35 0.25 0.25 0.18 0.20
Marijuana 0.37 0.35 0.21 0.22 0.17 0.18
Cocaine 0.26 0.25 0.08 0.07 0.05 0.05
Crack 0.13 0.12 0.04 0.04 0.03 0.03
Heroin 0.10 0.10 0.03 0.03 0.02 0.03
Hallucinogens 0.26 0.26 0.07 0.07 0.03 0.04
LSD 0.21 0.21 0.03 0.04 0.02 0.02
PCP 0.11 0.12 0.01 0.01 0.00 0.00
Ecstasy 0.15 0.15 0.05 0.05 0.02 0.02
Inhalants 0.19 0.19 0.03 0.03 0.02 0.03
Methamphetamine 0.17 0.16 0.05 0.04 0.04 0.03
Misuse of Psychotherapeutics3,4 nr nr 0.15 0.15 0.08 0.09
Pain Relievers4 nr nr 0.12 0.11 0.06 0.06
Tranquilizers nr nr 0.08 0.08 0.04 0.05
Stimulants nr nr 0.07 0.08 0.04 0.04
Sedatives nr nr 0.05 0.05 0.02 0.03
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.13 0.12 0.07 0.07
170410
Table 1.6P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.7957   0.2870   0.0144  
Marijuana 0.9457   0.0455   0.0028  
Cocaine 0.8674   0.3800   0.9472  
Crack 0.4376   0.7705   0.7153  
Heroin 0.6442   0.2893   0.0681  
Hallucinogens 0.6610   0.2917   0.2016  
LSD 0.5841   0.0014   0.5609  
PCP 0.7921   0.9607   0.9937  
Ecstasy 0.8843   0.6680   0.4321  
Inhalants 0.0425   0.8512   0.2247  
Methamphetamine 0.8883   0.0305   0.0387  
Misuse of Psychotherapeutics3,4 nr   0.6151   0.7397  
Pain Relievers4 nr   0.0223   0.0716  
Tranquilizers nr   0.8034   0.4975  
Stimulants nr   0.0653   0.4816  
Sedatives nr   0.9359   0.6273  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.0377   0.2047  
170410
Table 1.7C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 187 180 171 182 147 148
Marijuana 185 181 163 176 140 144
Cocaine 115 120 91 89 49 45
Crack 42 35 19 19 13 6
Heroin 48 43 28 28 19 16
Hallucinogens 139 143 99 98 51 50
LSD 95 104 61 68 28 25
PCP 30 28 13 7 1 *
Ecstasy 121 122 70 68 35 33
Inhalants 104 106 43 47 21 25
Methamphetamine 65 54 35 28 25 15
Misuse of Psychotherapeutics3,4 nr nr 127 131 73 74
Pain Relievers4 nr nr 92 92 46 46
Tranquilizers nr nr 78 79 44 41
Stimulants nr nr 96 104 51 58
Sedatives nr nr 26 30 16 12
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 94 94 50 48
170410
Table 1.7D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.53 0.52 0.49 0.53 0.42 0.43
Marijuana 0.53 0.52 0.47 0.51 0.40 0.42
Cocaine 0.33 0.35 0.26 0.26 0.14 0.13
Crack 0.12 0.10 0.05 0.05 0.04 0.02
Heroin 0.14 0.12 0.08 0.08 0.05 0.05
Hallucinogens 0.40 0.41 0.28 0.28 0.14 0.14
LSD 0.27 0.30 0.18 0.20 0.08 0.07
PCP 0.08 0.08 0.04 0.02 0.00 *
Ecstasy 0.35 0.35 0.20 0.20 0.10 0.10
Inhalants 0.30 0.31 0.12 0.14 0.06 0.07
Methamphetamine 0.19 0.16 0.10 0.08 0.07 0.04
Misuse of Psychotherapeutics3,4 nr nr 0.36 0.38 0.21 0.21
Pain Relievers4 nr nr 0.26 0.27 0.13 0.13
Tranquilizers nr nr 0.22 0.23 0.13 0.12
Stimulants nr nr 0.27 0.30 0.15 0.17
Sedatives nr nr 0.08 0.09 0.05 0.03
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.27 0.27 0.14 0.14
170410
Table 1.7P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.0974   0.8055   0.1335  
Marijuana 0.2092   0.2430   0.0828  
Cocaine 0.3913   0.6056   0.7310  
Crack 0.0086   0.4938   0.0929  
Heroin 0.2436   0.7464   0.9705  
Hallucinogens 0.0101   0.7504   0.5796  
LSD 0.1058   0.0303   0.8206  
PCP 0.4580   0.2553   *  
Ecstasy 0.0022   0.0420   0.9875  
Inhalants 0.7787   0.9665   0.9191  
Methamphetamine 0.0008   0.1789   0.0343  
Misuse of Psychotherapeutics3,4 nr   0.1432   0.1247  
Pain Relievers4 nr   0.0001   0.0026  
Tranquilizers nr   0.9178   0.4892  
Stimulants nr   0.6206   0.8208  
Sedatives nr   0.8547   0.0688  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.0002   0.0069  
170410
Table 1.8C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 179 188 147 169 111 125
Marijuana 167 182 139 162 105 115
Cocaine 62 58 51 51 26 23
Crack 18 16 9 11 5 2
Heroin 23 20 12 14 5 7
Hallucinogens 85 81 65 65 31 32
LSD 52 58 37 46 19 16
PCP 15 12 6 4 1 *
Ecstasy 65 58 45 42 20 20
Inhalants 65 61 30 31 14 16
Methamphetamine 32 26 18 19 13 10
Misuse of Psychotherapeutics3,4 nr nr 86 89 45 49
Pain Relievers4 nr nr 55 56 25 27
Tranquilizers nr nr 48 52 28 25
Stimulants nr nr 61 71 32 38
Sedatives nr nr 19 18 9 6
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 55 57 25 28
170410
Table 1.8D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.87 0.89 0.81 0.89 0.70 0.75
Marijuana 0.86 0.91 0.79 0.89 0.68 0.73
Cocaine 0.44 0.44 0.37 0.39 0.19 0.18
Crack 0.14 0.13 0.07 0.09 0.04 0.01
Heroin 0.17 0.15 0.09 0.11 0.04 0.05
Hallucinogens 0.57 0.58 0.46 0.47 0.24 0.25
LSD 0.38 0.43 0.28 0.35 0.14 0.13
PCP 0.11 0.09 0.05 0.03 0.01 *
Ecstasy 0.47 0.44 0.34 0.32 0.16 0.15
Inhalants 0.45 0.46 0.22 0.24 0.10 0.12
Methamphetamine 0.24 0.21 0.14 0.15 0.10 0.08
Misuse of Psychotherapeutics3,4 nr nr 0.58 0.61 0.33 0.37
Pain Relievers4 nr nr 0.40 0.42 0.19 0.21
Tranquilizers nr nr 0.36 0.39 0.21 0.20
Stimulants nr nr 0.42 0.51 0.23 0.29
Sedatives nr nr 0.15 0.14 0.07 0.05
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.40 0.43 0.19 0.22
170410
Table 1.8P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.3912   0.3141   0.1716  
Marijuana 0.4667   0.3725   0.2035  
Cocaine 0.9479   0.4078   0.7168  
Crack 0.3684   0.9074   0.2064  
Heroin 0.6838   0.7987   1.0000  
Hallucinogens 0.1470   0.9406   0.5338  
LSD 0.2259   0.0147   0.4180  
PCP 0.2064   0.2247   *  
Ecstasy 0.0086   0.1960   0.8758  
Inhalants 0.4034   0.7625   0.9482  
Methamphetamine 0.1646   0.6829   0.1815  
Misuse of Psychotherapeutics3,4 nr   0.4808   0.8809  
Pain Relievers4 nr   0.1807   0.6409  
Tranquilizers nr   0.1818   0.9330  
Stimulants nr   0.1350   0.6423  
Sedatives nr   0.3332   0.4945  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.2055   0.7884  
170410
Table 1.9C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 254 241 196 192 148 138
Marijuana 239 226 177 174 134 129
Cocaine 111 113 78 77 41 38
Crack 39 31 17 15 12 6
Heroin 41 37 24 25 19 15
Hallucinogens 139 136 78 79 38 40
LSD 81 92 48 52 22 19
PCP 25 25 11 6 * 1
Ecstasy 115 114 56 59 27 29
Inhalants 91 89 34 33 16 15
Methamphetamine 58 47 31 22 21 11
Misuse of Psychotherapeutics3,4 nr nr 113 115 61 60
Pain Relievers4 nr nr 81 75 40 38
Tranquilizers nr nr 62 62 34 32
Stimulants nr nr 80 82 40 42
Sedatives nr nr 19 24 13 10
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 82 76 44 39
170410
Table 1.9D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.64 0.61 0.62 0.62 0.53 0.51
Marijuana 0.65 0.62 0.59 0.59 0.50 0.49
Cocaine 0.44 0.46 0.33 0.34 0.18 0.17
Crack 0.18 0.14 0.08 0.07 0.05 0.03
Heroin 0.19 0.17 0.11 0.11 0.08 0.07
Hallucinogens 0.52 0.54 0.33 0.35 0.17 0.18
LSD 0.35 0.39 0.21 0.23 0.10 0.09
PCP 0.12 0.11 0.05 0.03 * 0.01
Ecstasy 0.46 0.48 0.25 0.26 0.12 0.13
Inhalants 0.37 0.38 0.15 0.15 0.07 0.07
Methamphetamine 0.26 0.21 0.14 0.10 0.09 0.05
Misuse of Psychotherapeutics3,4 nr nr 0.44 0.46 0.26 0.26
Pain Relievers4 nr nr 0.35 0.33 0.17 0.17
Tranquilizers nr nr 0.27 0.27 0.15 0.14
Stimulants nr nr 0.33 0.34 0.18 0.18
Sedatives nr nr 0.09 0.11 0.06 0.04
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.35 0.34 0.19 0.18
170410
Table 1.9P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.1113   0.6005   0.4525  
Marijuana 0.2584   0.4646   0.2476  
Cocaine 0.2577   0.9856   0.8466  
Crack 0.0133   0.3715   0.1861  
Heroin 0.2449   0.8351   0.9816  
Hallucinogens 0.0277   0.6441   0.8389  
LSD 0.2489   0.4097   0.6256  
PCP 0.8466   0.5660   *  
Ecstasy 0.0327   0.1378   0.8923  
Inhalants 0.8353   0.8440   0.9363  
Methamphetamine 0.0015   0.1722   0.0910  
Misuse of Psychotherapeutics3,4 nr   0.0147   0.0470  
Pain Relievers4 nr   0.0002   0.0011  
Tranquilizers nr   0.2134   0.4003  
Stimulants nr   0.5607   0.9453  
Sedatives nr   0.5466   0.0805  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.0003   0.0027  
170410
Table 1.10C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 862 825 550 549 405 435
Marijuana 858 829 460 479 361 391
Cocaine 615 592 167 152 117 110
Crack 302 297 93 86 62 64
Heroin 229 225 74 77 39 61
Hallucinogens 592 604 125 138 60 74
LSD 504 498 45 64 23 31
PCP 265 286 26 27 9 8
Ecstasy 335 332 92 96 39 46
Inhalants 438 439 75 73 45 57
Methamphetamine 392 377 115 95 89 70
Misuse of Psychotherapeutics3,4 nr nr 345 335 187 195
Pain Relievers4 nr nr 287 264 150 149
Tranquilizers nr nr 190 183 97 109
Stimulants nr nr 132 142 78 83
Sedatives nr nr 109 112 55 73
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 292 269 157 161
170410
Table 1.10D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.41 0.39 0.26 0.26 0.19 0.21
Marijuana 0.41 0.39 0.22 0.23 0.17 0.19
Cocaine 0.30 0.28 0.08 0.07 0.06 0.05
Crack 0.15 0.14 0.04 0.04 0.03 0.03
Heroin 0.11 0.11 0.04 0.04 0.02 0.03
Hallucinogens 0.28 0.29 0.06 0.07 0.03 0.04
LSD 0.24 0.24 0.02 0.03 0.01 0.01
PCP 0.13 0.14 0.01 0.01 0.00 0.00
Ecstasy 0.16 0.16 0.04 0.05 0.02 0.02
Inhalants 0.21 0.21 0.04 0.03 0.02 0.03
Methamphetamine 0.19 0.18 0.06 0.05 0.04 0.03
Misuse of Psychotherapeutics3,4 nr nr 0.17 0.16 0.09 0.09
Pain Relievers4 nr nr 0.14 0.13 0.07 0.07
Tranquilizers nr nr 0.09 0.09 0.05 0.05
Stimulants nr nr 0.06 0.07 0.04 0.04
Sedatives nr nr 0.05 0.05 0.03 0.03
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.14 0.13 0.08 0.08
170410
Table 1.10P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.8947   0.2157   0.0247  
Marijuana 0.7081   0.0514   0.0059  
Cocaine 0.9638   0.4108   0.7984  
Crack 0.6259   0.6642   0.5302  
Heroin 0.7979   0.3028   0.0528  
Hallucinogens 0.2839   0.0768   0.1847  
LSD 0.8177   0.0039   0.2361  
PCP 0.7565   0.6930   0.9669  
Ecstasy 0.1916   0.2870   0.2683  
Inhalants 0.0429   0.8036   0.1648  
Methamphetamine 0.7273   0.0705   0.1187  
Misuse of Psychotherapeutics3,4 nr   0.8991   0.8053  
Pain Relievers4 nr   0.2815   0.3264  
Tranquilizers nr   0.8860   0.2896  
Stimulants nr   0.0379   0.4310  
Sedatives nr   0.8890   0.3847  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.3691   0.6241  
170410
Table 1.11C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 246 256 229 240 181 193
Marijuana 251 263 212 207 165 180
Cocaine 191 190 93 92 60 59
Crack 92 89 23 28 17 18
Heroin 75 80 43 43 24 29
Hallucinogens 221 217 93 106 48 56
LSD 148 150 37 56 16 28
PCP 59 60 15 6 7 6
Ecstasy 189 196 78 79 36 45
Inhalants 167 161 43 43 19 34
Methamphetamine 126 125 49 44 32 28
Misuse of Psychotherapeutics3,4 nr nr 155 164 95 81
Pain Relievers4 nr nr 130 125 71 62
Tranquilizers nr nr 92 84 49 48
Stimulants nr nr 91 103 56 49
Sedatives nr nr 44 47 26 21
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 134 127 73 66
170410
Table 1.11D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.64 0.66 0.60 0.62 0.47 0.50
Marijuana 0.66 0.68 0.55 0.53 0.43 0.46
Cocaine 0.50 0.49 0.24 0.24 0.16 0.15
Crack 0.24 0.23 0.06 0.07 0.04 0.05
Heroin 0.19 0.21 0.11 0.11 0.06 0.08
Hallucinogens 0.58 0.56 0.24 0.27 0.13 0.14
LSD 0.39 0.39 0.10 0.14 0.04 0.07
PCP 0.15 0.15 0.04 0.02 0.02 0.01
Ecstasy 0.49 0.51 0.20 0.20 0.09 0.12
Inhalants 0.44 0.41 0.11 0.11 0.05 0.09
Methamphetamine 0.33 0.32 0.13 0.11 0.08 0.07
Misuse of Psychotherapeutics3,4 nr nr 0.40 0.42 0.25 0.21
Pain Relievers4 nr nr 0.34 0.32 0.19 0.16
Tranquilizers nr nr 0.24 0.22 0.13 0.12
Stimulants nr nr 0.24 0.26 0.15 0.13
Sedatives nr nr 0.12 0.12 0.07 0.05
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.35 0.33 0.19 0.17
170410
Table 1.11P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.9430   0.0720   0.0324  
Marijuana 0.3834   0.0219   0.0074  
Cocaine 0.9904   0.1072   0.6613  
Crack 0.6849   0.1400   0.9045  
Heroin 0.0434   0.5673   0.3835  
Hallucinogens 0.3509   0.1189   0.2482  
LSD 0.3592   0.0179   0.1223  
PCP 0.9450   0.3808   0.8545  
Ecstasy 0.2129   0.4461   0.2685  
Inhalants 0.0611   0.5897   0.0695  
Methamphetamine 0.3658   0.4414   0.3744  
Misuse of Psychotherapeutics3,4 nr   0.8424   0.8027  
Pain Relievers4 nr   0.3170   0.2672  
Tranquilizers nr   0.5728   0.7382  
Stimulants nr   0.2319   0.6910  
Sedatives nr   0.9513   0.3210  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.4364   0.5519  
170410
Table 1.12C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 812 776 479 465 354 363
Marijuana 799 780 407 407 317 325
Cocaine 567 544 133 124 98 92
Crack 285 282 90 81 60 62
Heroin 215 208 60 64 31 53
Hallucinogens 533 533 77 87 35 48
LSD 477 467 25 32 17 13
PCP 260 279 21 26 * *
Ecstasy 265 257 45 49 14 10
Inhalants 392 400 60 57 40 45
Methamphetamine 367 348 106 84 83 66
Misuse of Psychotherapeutics3,4 nr nr 300 296 164 178
Pain Relievers4 nr nr 249 236 137 135
Tranquilizers nr nr 161 164 84 98
Stimulants nr nr 92 103 55 63
Sedatives nr nr 98 103 45 71
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 253 240 142 145
170410
Table 1.12D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.48 0.45 0.28 0.27 0.21 0.21
Marijuana 0.47 0.46 0.24 0.24 0.19 0.19
Cocaine 0.33 0.32 0.08 0.07 0.06 0.05
Crack 0.17 0.16 0.05 0.05 0.04 0.04
Heroin 0.13 0.12 0.04 0.04 0.02 0.03
Hallucinogens 0.31 0.31 0.05 0.05 0.02 0.03
LSD 0.28 0.27 0.01 0.02 0.01 0.01
PCP 0.15 0.16 0.01 0.02 * *
Ecstasy 0.16 0.15 0.03 0.03 0.01 0.01
Inhalants 0.23 0.23 0.04 0.03 0.02 0.03
Methamphetamine 0.22 0.20 0.06 0.05 0.05 0.04
Misuse of Psychotherapeutics3,4 nr nr 0.18 0.17 0.10 0.10
Pain Relievers4 nr nr 0.15 0.14 0.08 0.08
Tranquilizers nr nr 0.10 0.10 0.05 0.06
Stimulants nr nr 0.05 0.06 0.03 0.04
Sedatives nr nr 0.06 0.06 0.03 0.04
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.15 0.14 0.08 0.08
170410
Table 1.12P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.9178   0.6029   0.1216  
Marijuana 0.9157   0.2842   0.0602  
Cocaine 0.9627   0.8565   0.9882  
Crack 0.6990   0.9860   0.5354  
Heroin 0.3026   0.3945   0.0828  
Hallucinogens 0.4411   0.3837   0.5433  
LSD 0.9670   0.1084   0.9113  
PCP 0.7378   0.3896   *  
Ecstasy 0.4978   0.4199   0.8879  
Inhalants 0.1328   0.9319   0.6059  
Methamphetamine 0.4987   0.1001   0.1859  
Misuse of Psychotherapeutics3,4 nr   0.9874   0.6964  
Pain Relievers4 nr   0.4832   0.5630  
Tranquilizers nr   0.8968   0.3068  
Stimulants nr   0.0908   0.4833  
Sedatives nr   0.8610   0.1788  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.5372   0.7850  
170410
Table 1.13C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 582 584 452 435 353 355
Marijuana 583 586 398 397 329 331
Cocaine 471 456 154 145 103 101
Crack 247 240 82 71 55 53
Heroin 191 187 60 66 40 47
Hallucinogens 451 468 137 139 70 73
LSD 388 401 70 83 36 35
PCP 226 237 21 24 7 7
Ecstasy 278 270 103 94 46 46
Inhalants 362 362 75 80 48 59
Methamphetamine 304 289 106 79 82 62
Misuse of Psychotherapeutics3,4 nr nr 277 268 152 144
Pain Relievers4 nr nr 225 208 127 113
Tranquilizers nr nr 156 144 81 92
Stimulants nr nr 130 130 67 68
Sedatives nr nr 68 81 29 56
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 228 210 133 122
170410
Table 1.13D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.45 0.45 0.35 0.33 0.27 0.27
Marijuana 0.45 0.45 0.31 0.30 0.25 0.25
Cocaine 0.36 0.35 0.12 0.11 0.08 0.08
Crack 0.19 0.18 0.06 0.05 0.04 0.04
Heroin 0.15 0.14 0.05 0.05 0.03 0.04
Hallucinogens 0.35 0.36 0.11 0.11 0.05 0.06
LSD 0.30 0.31 0.05 0.06 0.03 0.03
PCP 0.17 0.18 0.02 0.02 0.01 0.01
Ecstasy 0.21 0.21 0.08 0.07 0.04 0.04
Inhalants 0.28 0.28 0.06 0.06 0.04 0.05
Methamphetamine 0.23 0.22 0.08 0.06 0.06 0.05
Misuse of Psychotherapeutics3,4 nr nr 0.21 0.20 0.12 0.11
Pain Relievers4 nr nr 0.17 0.16 0.10 0.09
Tranquilizers nr nr 0.12 0.11 0.06 0.07
Stimulants nr nr 0.10 0.10 0.05 0.05
Sedatives nr nr 0.05 0.06 0.02 0.04
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.18 0.16 0.10 0.09
170410
Table 1.13P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.0165   0.6517   0.3039  
Marijuana 0.1389   0.1716   0.0602  
Cocaine 0.9466   0.4948   0.9217  
Crack 0.2957   0.6251   0.9321  
Heroin 0.2836   0.6253   0.3675  
Hallucinogens 0.7866   0.9946   0.7802  
LSD 0.7777   0.0124   0.7820  
PCP 0.7369   1.0000   0.7727  
Ecstasy 0.5848   0.1729   0.6825  
Inhalants 0.0310   0.8928   0.5344  
Methamphetamine 0.3258   0.0032   0.0142  
Misuse of Psychotherapeutics3,4 nr   0.1155   0.1292  
Pain Relievers4 nr   0.0137   0.0132  
Tranquilizers nr   0.1457   0.8622  
Stimulants nr   0.7158   0.9864  
Sedatives nr   0.3931   0.3550  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.0190   0.0381  
170410
Table 1.14C – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Standard Errors of Numbers in Thousands, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 613 592 362 397 262 301
Marijuana 607 569 309 333 228 263
Cocaine 386 378 103 104 69 67
Crack 165 181 43 55 32 40
Heroin 122 126 41 48 19 39
Hallucinogens 390 383 92 104 39 53
LSD 308 303 42 47 17 23
PCP 145 152 22 15 8 5
Ecstasy 214 225 57 72 26 36
Inhalants 262 260 58 49 24 30
Methamphetamine 229 244 55 62 42 40
Misuse of Psychotherapeutics3,4 nr nr 235 248 140 146
Pain Relievers4 nr nr 192 193 99 107
Tranquilizers nr nr 131 143 72 73
Stimulants nr nr 104 125 66 74
Sedatives nr nr 90 83 46 50
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 192 197 101 115
170410
Table 1.14D – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Standard Errors of Percentages, 2015 and 2016
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.44 0.43 0.26 0.29 0.19 0.22
Marijuana 0.44 0.41 0.22 0.24 0.17 0.19
Cocaine 0.28 0.27 0.07 0.08 0.05 0.05
Crack 0.12 0.13 0.03 0.04 0.02 0.03
Heroin 0.09 0.09 0.03 0.03 0.01 0.03
Hallucinogens 0.28 0.28 0.07 0.07 0.03 0.04
LSD 0.22 0.22 0.03 0.03 0.01 0.02
PCP 0.10 0.11 0.02 0.01 0.01 0.00
Ecstasy 0.16 0.16 0.04 0.05 0.02 0.03
Inhalants 0.19 0.19 0.04 0.04 0.02 0.02
Methamphetamine 0.17 0.18 0.04 0.04 0.03 0.03
Misuse of Psychotherapeutics3,4 nr nr 0.17 0.18 0.10 0.11
Pain Relievers4 nr nr 0.14 0.14 0.07 0.08
Tranquilizers nr nr 0.09 0.10 0.05 0.05
Stimulants nr nr 0.08 0.09 0.05 0.05
Sedatives nr nr 0.07 0.06 0.03 0.04
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr nr 0.14 0.14 0.07 0.08
170410
Table 1.14P – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Drug Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
2 Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting.
3 Prescription Psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
4 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
ILLICIT DRUGS1,2 0.1743   0.7231   0.0396  
Marijuana 0.1693   0.2316   0.0352  
Cocaine 0.8896   0.6578   0.7735  
Crack 0.8569   0.1659   0.4166  
Heroin 0.4632   0.2650   0.0443  
Hallucinogens 0.3699   0.1995   0.0066  
LSD 0.6250   0.2368   0.2550  
PCP 0.9125   0.4981   0.4704  
Ecstasy 0.4716   0.2961   0.0529  
Inhalants 0.2687   0.2210   0.5696  
Methamphetamine 0.2981   0.4795   0.8399  
Misuse of Psychotherapeutics3,4 nr   0.5721   0.5633  
Pain Relievers4 nr   0.3008   0.9063  
Tranquilizers nr   0.1591   0.6586  
Stimulants nr   0.0073   0.4586  
Sedatives nr   0.4974   0.8630  
OPIOIDS (HEROIN USE OR PAIN RELIEVER MISUSE)4 nr   0.3874   0.8109  
170410
Table 1.15C – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 903 870 617 616 457 488
12-17 107 104 92 87 68 66
12 30 24 22 18 15 10
13 37 38 27 28 16 16
14 45 41 37 34 23 21
15 53 51 43 42 30 29
16 61 53 55 44 37 33
17 65 68 57 58 45 41
18 or Older 896 853 610 604 448 480
18-25 187 180 171 182 147 148
18 90 87 74 81 53 59
19 94 100 80 91 63 69
20 103 102 82 87 62 65
21 99 105 82 88 62 66
22 96 97 81 78 63 58
23 100 102 77 75 60 58
24 101 86 80 69 62 56
25 108 100 79 77 60 56
26 or Older 862 825 550 549 405 435
26-29 279 282 195 206 143 158
30-34 293 307 177 188 127 149
35-39 273 275 162 163 122 122
40-44 273 260 143 141 106 111
45-49 295 276 155 146 117 109
50-54 469 431 238 216 175 159
55-59 436 486 216 239 161 189
60-64 401 390 175 156 134 120
65 or Older 399 416 191 204 141 151
170410
Table 1.15D – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.34 0.32 0.23 0.23 0.17 0.18
12-17 0.43 0.42 0.37 0.35 0.27 0.26
12 0.75 0.63 0.56 0.48 0.38 0.27
13 0.87 0.87 0.64 0.66 0.40 0.39
14 0.94 0.88 0.81 0.76 0.53 0.49
15 1.05 1.02 0.90 0.87 0.68 0.62
16 1.16 1.05 1.11 0.93 0.79 0.75
17 1.22 1.23 1.16 1.13 0.99 0.90
18 or Older 0.37 0.35 0.25 0.25 0.18 0.20
18-25 0.53 0.52 0.49 0.53 0.42 0.43
18 1.44 1.43 1.35 1.41 1.05 1.12
19 1.37 1.56 1.36 1.58 1.21 1.34
20 1.50 1.40 1.45 1.41 1.24 1.25
21 1.44 1.41 1.43 1.37 1.25 1.22
22 1.38 1.40 1.40 1.33 1.24 1.14
23 1.29 1.31 1.31 1.31 1.15 1.11
24 1.41 1.28 1.38 1.28 1.20 1.14
25 1.38 1.39 1.31 1.36 1.14 1.09
26 or Older 0.41 0.39 0.26 0.26 0.19 0.21
26-29 0.95 0.94 0.91 0.96 0.74 0.81
30-34 0.84 0.88 0.72 0.74 0.56 0.62
35-39 0.98 0.93 0.75 0.71 0.60 0.56
40-44 0.98 0.93 0.66 0.68 0.50 0.54
45-49 0.92 0.96 0.68 0.67 0.53 0.52
50-54 1.23 1.34 0.95 0.94 0.73 0.71
55-59 1.28 1.30 0.93 0.97 0.73 0.81
60-64 1.37 1.42 0.88 0.78 0.69 0.62
65 or Older 0.86 0.87 0.41 0.43 0.30 0.31
170410
Table 1.15P – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4923   0.5753   0.0417  
12-17 0.0002   0.0015   0.0152  
12 0.0343   0.0991   0.1368  
13 0.2114   0.2175   0.3289  
14 0.1756   0.6561   0.3667  
15 0.3196   0.5203   0.6258  
16 0.0003   0.0008   0.1037  
17 0.3856   0.3785   0.1990  
18 or Older 0.7957   0.2870   0.0144  
18-25 0.0974   0.8055   0.1335  
18 0.7006   0.5844   0.2160  
19 0.5562   0.5697   0.3175  
20 0.5840   0.4177   0.7580  
21 0.9529   0.7038   0.1850  
22 0.6860   0.5348   0.7007  
23 0.5105   0.4582   0.6836  
24 0.0981   0.7500   0.2224  
25 0.3888   0.9901   0.8643  
26 or Older 0.8947   0.2157   0.0247  
26-29 0.5266   0.3144   0.3220  
30-34 0.4989   0.1074   0.0415  
35-39 0.0511   0.9739   0.2130  
40-44 0.7321   0.9183   0.8221  
45-49 0.7913   0.7796   0.3925  
50-54 0.3457   0.3028   0.6089  
55-59 0.7108   0.4827   0.2219  
60-64 0.6480   0.9336   0.3836  
65 or Older 0.4612   0.0731   0.0127  
170410
Table 1.16C – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 896 870 524 542 413 442
12-17 89 88 81 77 61 61
12 11 6 8 5 4 4
13 18 20 17 19 12 11
14 28 28 26 26 19 18
15 41 41 38 37 27 26
16 52 45 47 39 33 31
17 59 61 53 53 41 39
18 or Older 890 857 520 534 408 434
18-25 185 181 163 176 140 144
18 82 82 69 78 49 57
19 89 95 76 85 60 64
20 95 99 78 82 59 61
21 93 100 78 80 58 62
22 93 93 76 73 61 53
23 95 96 71 68 57 55
24 97 86 73 65 56 54
25 101 96 69 73 54 53
26 or Older 858 829 460 479 361 391
26-29 267 275 172 184 129 148
30-34 280 303 155 166 115 134
35-39 264 266 134 145 102 112
40-44 256 253 114 119 90 96
45-49 279 264 129 125 95 100
50-54 456 412 202 185 151 140
55-59 424 473 184 210 148 173
60-64 386 383 143 139 118 108
65 or Older 375 395 158 153 130 129
170410
Table 1.16D – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.33 0.32 0.20 0.20 0.15 0.16
12-17 0.36 0.35 0.32 0.31 0.24 0.24
12 0.27 0.16 0.20 0.12 0.11 0.09
13 0.45 0.47 0.41 0.45 0.30 0.26
14 0.63 0.66 0.58 0.62 0.44 0.42
15 0.86 0.84 0.80 0.78 0.61 0.56
16 1.07 0.92 0.99 0.84 0.73 0.69
17 1.19 1.15 1.10 1.06 0.90 0.86
18 or Older 0.37 0.35 0.21 0.22 0.17 0.18
18-25 0.53 0.52 0.47 0.51 0.40 0.42
18 1.39 1.42 1.25 1.40 1.00 1.10
19 1.41 1.59 1.34 1.53 1.15 1.28
20 1.48 1.44 1.40 1.40 1.20 1.25
21 1.43 1.42 1.43 1.29 1.19 1.19
22 1.40 1.42 1.38 1.30 1.22 1.07
23 1.32 1.31 1.29 1.24 1.12 1.07
24 1.43 1.32 1.32 1.25 1.11 1.10
25 1.39 1.41 1.25 1.35 1.05 1.05
26 or Older 0.41 0.39 0.22 0.23 0.17 0.19
26-29 0.94 0.98 0.83 0.89 0.67 0.77
30-34 0.86 0.90 0.66 0.66 0.52 0.57
35-39 1.01 0.94 0.64 0.66 0.51 0.52
40-44 0.96 0.98 0.54 0.58 0.43 0.47
45-49 0.90 0.96 0.58 0.58 0.44 0.48
50-54 1.23 1.37 0.83 0.82 0.64 0.63
55-59 1.34 1.34 0.82 0.89 0.68 0.75
60-64 1.37 1.45 0.74 0.71 0.61 0.56
65 or Older 0.81 0.82 0.34 0.32 0.28 0.27
170410
Table 1.16P – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9305   0.0764   0.0069  
12-17 0.0570   0.1625   0.1029  
12 0.0320   0.1663   0.8494  
13 0.6651   0.7137   0.6762  
14 0.4356   0.2004   0.8348  
15 0.7158   0.6338   0.3655  
16 0.0020   0.0065   0.1227  
17 0.4826   0.4732   0.4155  
18 or Older 0.9457   0.0455   0.0028  
18-25 0.2092   0.2430   0.0828  
18 0.6381   0.8272   0.0923  
19 0.5745   0.3922   0.3575  
20 0.8059   0.5234   0.8485  
21 0.8734   0.3293   0.1406  
22 0.4377   0.9443   0.3311  
23 0.7003   0.7442   0.7338  
24 0.2352   0.6528   0.0786  
25 0.7786   0.6597   0.5739  
26 or Older 0.7081   0.0514   0.0059  
26-29 0.9303   0.1033   0.1519  
30-34 0.2764   0.0958   0.0164  
35-39 0.0052   0.3430   0.0876  
40-44 0.6145   0.6585   0.9675  
45-49 0.5200   0.1925   0.0195  
50-54 0.0372   0.2375   0.6486  
55-59 0.7678   0.5228   0.6812  
60-64 0.5374   0.7676   0.5145  
65 or Older 0.2039   0.0584   0.0182  
170410
Table 1.17C – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 638 613 192 175 128 120
12-17 23 22 20 18 13 7
12 2 * 2 * 2 *
13 3 3 2 2 2 *
14 4 5 4 5 2 3
15 6 10 5 8 2 3
16 11 10 10 8 3 3
17 19 16 16 13 12 5
18 or Older 637 611 192 174 127 119
18-25 115 120 91 89 49 45
18 23 26 21 22 9 11
19 37 32 29 30 15 14
20 38 38 31 29 18 14
21 39 48 28 35 12 20
22 46 44 36 30 15 15
23 49 44 35 31 19 16
24 45 47 30 30 21 18
25 57 59 32 38 23 16
26 or Older 615 592 167 152 117 110
26-29 148 133 65 70 40 44
30-34 151 162 65 66 46 40
35-39 152 162 59 44 40 26
40-44 148 140 49 44 32 38
45-49 186 153 29 46 19 34
50-54 316 255 71 56 61 43
55-59 267 312 74 63 38 46
60-64 214 248 32 42 22 27
65 or Older 199 205 25 35 19 23
170410
Table 1.17D – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.24 0.23 0.07 0.07 0.05 0.04
12-17 0.09 0.09 0.08 0.07 0.05 0.03
12 0.06 * 0.06 * 0.05 *
13 0.08 0.07 0.06 0.06 0.06 *
14 0.10 0.11 0.09 0.11 0.05 0.08
15 0.13 0.23 0.12 0.17 0.05 0.07
16 0.25 0.22 0.23 0.18 0.07 0.06
17 0.45 0.38 0.38 0.31 0.28 0.11
18 or Older 0.26 0.25 0.08 0.07 0.05 0.05
18-25 0.33 0.35 0.26 0.26 0.14 0.13
18 0.50 0.57 0.46 0.48 0.19 0.25
19 0.79 0.78 0.65 0.73 0.35 0.36
20 0.84 0.88 0.70 0.68 0.43 0.33
21 0.86 0.99 0.66 0.77 0.28 0.44
22 0.96 0.93 0.80 0.67 0.35 0.35
23 0.97 0.91 0.76 0.67 0.42 0.35
24 0.94 1.01 0.66 0.69 0.45 0.42
25 1.10 1.20 0.66 0.82 0.48 0.36
26 or Older 0.30 0.28 0.08 0.07 0.06 0.05
26-29 0.74 0.66 0.36 0.39 0.23 0.25
30-34 0.64 0.68 0.30 0.30 0.21 0.18
35-39 0.72 0.71 0.30 0.21 0.20 0.13
40-44 0.68 0.66 0.24 0.23 0.16 0.19
45-49 0.79 0.70 0.14 0.22 0.09 0.17
50-54 1.15 1.07 0.31 0.26 0.26 0.20
55-59 1.12 1.17 0.35 0.29 0.18 0.21
60-64 1.01 1.17 0.17 0.22 0.12 0.14
65 or Older 0.43 0.43 0.05 0.07 0.04 0.05
170410
Table 1.17P – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.8928   0.4136   0.9381  
12-17 0.9096   0.5228   0.0847  
12 *   *   *  
13 0.8611   0.8207   *  
14 0.8149   0.5934   0.3972  
15 0.0533   0.4438   0.9473  
16 0.7338   0.3984   0.9284  
17 0.6176   0.5127   0.0527  
18 or Older 0.8674   0.3800   0.9472  
18-25 0.3913   0.6056   0.7310  
18 0.4154   0.5221   0.6685  
19 0.8344   0.4388   0.4397  
20 0.8160   0.8071   0.9203  
21 0.5288   0.3911   0.1224  
22 0.6610   0.6702   0.7488  
23 0.0794   0.6257   0.5770  
24 0.8652   0.6666   0.7015  
25 0.6283   0.5984   0.2880  
26 or Older 0.9638   0.4108   0.7984  
26-29 0.3098   0.0398   0.2625  
30-34 0.3755   0.7399   0.6188  
35-39 0.4472   0.1788   0.1293  
40-44 0.2795   0.6970   0.9545  
45-49 0.0858   0.0431   0.0341  
50-54 0.0139   0.1927   0.1117  
55-59 0.4592   0.8943   0.1788  
60-64 0.0541   0.3643   0.4498  
65 or Older 0.0398   0.2983   0.5506  
170410
Table 1.18C – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 305 302 93 88 64 64
12-17 5 5 3 4 1 2
12 * * * * * *
13 * 2 * 2 * *
14 2 1 * 1 * 1
15 * 1 * * * *
16 3 3 * 3 * *
17 3 2 3 2 1 1
18 or Older 306 301 93 88 64 64
18-25 42 35 19 19 13 6
18 6 4 1 1 0 1
19 13 11 8 9 4 *
20 11 10 4 7 2 1
21 13 14 6 6 3 5
22 17 10 8 5 3 *
23 19 13 6 8 1 *
24 18 12 9 6 9 1
25 19 18 9 5 6 1
26 or Older 302 297 93 86 62 64
26-29 63 53 17 17 14 9
30-34 70 71 16 20 10 13
35-39 81 72 30 18 19 13
40-44 78 67 27 25 23 22
45-49 96 83 22 19 12 14
50-54 151 144 40 36 34 28
55-59 139 146 61 50 29 40
60-64 88 103 16 34 3 20
65 or Older 76 102 19 20 19 20
170410
Table 1.18D – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.11 0.11 0.03 0.03 0.02 0.02
12-17 0.02 0.02 0.01 0.02 0.01 0.01
12 * * * * * *
13 * 0.06 * 0.06 * *
14 0.04 0.03 * 0.03 * 0.03
15 * 0.03 * * * *
16 0.08 0.08 * 0.07 * *
17 0.08 0.05 0.06 0.04 0.03 0.03
18 or Older 0.13 0.12 0.04 0.04 0.03 0.03
18-25 0.12 0.10 0.05 0.05 0.04 0.02
18 0.12 0.09 0.03 0.02 0.01 0.01
19 0.31 0.27 0.18 0.23 0.10 *
20 0.27 0.25 0.10 0.16 0.04 0.03
21 0.32 0.32 0.14 0.13 0.08 0.13
22 0.38 0.24 0.18 0.13 0.08 *
23 0.43 0.29 0.13 0.18 0.02 *
24 0.39 0.28 0.21 0.14 0.21 0.03
25 0.40 0.41 0.19 0.12 0.13 0.01
26 or Older 0.15 0.14 0.04 0.04 0.03 0.03
26-29 0.36 0.30 0.10 0.10 0.08 0.05
30-34 0.32 0.32 0.07 0.09 0.05 0.06
35-39 0.41 0.34 0.15 0.09 0.10 0.06
40-44 0.38 0.34 0.13 0.13 0.11 0.11
45-49 0.44 0.39 0.10 0.09 0.06 0.07
50-54 0.64 0.65 0.17 0.17 0.15 0.13
55-59 0.65 0.63 0.29 0.23 0.14 0.18
60-64 0.46 0.53 0.08 0.18 0.01 0.10
65 or Older 0.16 0.21 0.04 0.04 0.04 0.04
170410
Table 1.18P – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4518   0.7331   0.6982  
12-17 0.5057   0.2529   0.4399  
12 *   *   *  
13 *   *   *  
14 0.8989   *   *  
15 *   *   *  
16 0.5037   *   *  
17 0.5676   0.5775   0.8181  
18 or Older 0.4376   0.7705   0.7153  
18-25 0.0086   0.4938   0.0929  
18 0.3848   0.4945   0.5453  
19 0.9075   0.9083   *  
20 0.2641   0.8098   0.4469  
21 0.5707   0.8896   0.2789  
22 0.0867   0.4178   *  
23 0.1168   0.9825   *  
24 0.3688   0.9776   0.4223  
25 0.4788   0.2318   0.0635  
26 or Older 0.6259   0.6642   0.5302  
26-29 0.3691   0.5806   0.5097  
30-34 0.8165   0.1197   0.3856  
35-39 0.1421   0.1872   0.4116  
40-44 0.1662   0.3601   0.4078  
45-49 0.0524   0.8990   0.4174  
50-54 0.7283   0.6115   0.4565  
55-59 0.4616   0.6986   0.1206  
60-64 0.1175   0.0682   0.0721  
65 or Older 0.1723   0.6835   0.8085  
170410
Table 1.19C – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 635 642 175 185 83 94
12-17 44 38 37 31 17 16
12 12 7 11 7 6 4
13 11 11 10 7 7 3
14 12 9 10 8 5 5
15 16 17 14 14 6 7
16 22 17 19 14 8 5
17 28 26 22 21 9 11
18 or Older 630 632 171 181 81 92
18-25 139 143 99 98 51 50
18 36 38 30 31 15 17
19 54 49 41 40 16 19
20 50 49 36 38 20 18
21 51 51 31 34 18 17
22 55 56 32 34 17 16
23 60 54 35 32 17 19
24 63 58 35 33 17 17
25 62 63 30 36 14 17
26 or Older 592 604 125 138 60 74
26-29 168 160 67 82 40 46
30-34 176 186 61 65 28 31
35-39 178 179 39 35 26 15
40-44 155 153 32 36 21 22
45-49 156 151 18 30 9 11
50-54 257 215 21 48 5 33
55-59 240 258 32 35 2 9
60-64 232 249 41 18 6 17
65 or Older 197 209 * 6 * *
170410
Table 1.19D – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.24 0.24 0.07 0.07 0.03 0.03
12-17 0.18 0.15 0.15 0.13 0.07 0.06
12 0.30 0.20 0.29 0.18 0.15 0.10
13 0.28 0.27 0.26 0.16 0.17 0.07
14 0.28 0.21 0.23 0.19 0.13 0.12
15 0.37 0.38 0.32 0.31 0.13 0.15
16 0.51 0.39 0.43 0.33 0.20 0.12
17 0.65 0.60 0.51 0.50 0.22 0.26
18 or Older 0.26 0.26 0.07 0.07 0.03 0.04
18-25 0.40 0.41 0.28 0.28 0.14 0.14
18 0.74 0.79 0.63 0.65 0.33 0.36
19 1.07 1.08 0.88 0.91 0.36 0.47
20 1.08 1.10 0.78 0.85 0.47 0.42
21 1.11 1.01 0.71 0.74 0.43 0.39
22 1.11 1.16 0.71 0.76 0.40 0.36
23 1.16 1.06 0.75 0.68 0.38 0.42
24 1.24 1.21 0.73 0.74 0.37 0.39
25 1.13 1.20 0.62 0.77 0.30 0.38
26 or Older 0.28 0.29 0.06 0.07 0.03 0.04
26-29 0.82 0.79 0.38 0.46 0.23 0.26
30-34 0.74 0.71 0.28 0.30 0.13 0.14
35-39 0.83 0.78 0.20 0.17 0.13 0.07
40-44 0.70 0.73 0.16 0.19 0.10 0.11
45-49 0.67 0.70 0.09 0.15 0.04 0.06
50-54 1.01 0.93 0.09 0.22 0.02 0.15
55-59 1.05 1.02 0.15 0.16 0.01 0.04
60-64 1.10 1.18 0.22 0.09 0.03 0.09
65 or Older 0.42 0.43 * 0.01 * *
170410
Table 1.19P – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7206   0.4537   0.2273  
12-17 0.1521   0.1849   0.7680  
12 0.1183   0.1996   0.6060  
13 0.8713   0.2087   0.3811  
14 0.6499   0.7579   0.5240  
15 0.8577   0.6767   0.7594  
16 0.0421   0.0788   0.1406  
17 0.9662   0.5975   0.5024  
18 or Older 0.6610   0.2917   0.2016  
18-25 0.0101   0.7504   0.5796  
18 0.3965   0.7815   0.5978  
19 0.4051   0.8842   0.3700  
20 0.0322   0.8526   0.8372  
21 0.2328   0.5707   0.7822  
22 0.3374   0.7635   0.4355  
23 0.0131   0.2454   0.4041  
24 0.4919   0.2545   0.8770  
25 0.7191   0.6724   0.9028  
26 or Older 0.2839   0.0768   0.1847  
26-29 0.4704   0.1831   0.4455  
30-34 0.0485   0.3460   0.3534  
35-39 0.6664   0.5330   0.3184  
40-44 0.7714   0.2806   0.6785  
45-49 0.5833   0.3666   0.9606  
50-54 0.0101   0.0577   0.2548  
55-59 0.9315   0.7246   0.4901  
60-64 0.3178   0.3598   0.5586  
65 or Older 0.0026   *   *  
170410
Table 1.20C – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 459 471 93 91 52 66
12-17 73 65 39 34 20 17
12 23 20 16 13 9 7
13 30 29 19 17 10 8
14 30 28 18 17 8 7
15 32 31 17 13 8 4
16 32 28 13 11 4 6
17 32 30 16 13 8 9
18 or Older 453 459 83 85 48 63
18-25 104 106 43 47 21 25
18 39 35 17 21 10 9
19 36 34 15 13 8 6
20 36 36 16 17 6 12
21 35 36 12 15 7 12
22 38 39 16 13 6 4
23 41 41 15 13 10 4
24 40 39 14 17 6 4
25 43 42 17 14 7 5
26 or Older 438 439 75 73 45 57
26-29 126 100 31 35 11 30
30-34 127 133 28 25 15 17
35-39 143 134 24 26 11 23
40-44 126 131 13 23 10 19
45-49 143 125 24 14 17 11
50-54 204 204 29 39 19 26
55-59 180 192 22 20 22 20
60-64 137 144 30 * 14 *
65 or Older 136 129 7 11 * *
170410
Table 1.20D – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.17 0.17 0.03 0.03 0.02 0.02
12-17 0.29 0.26 0.16 0.14 0.08 0.07
12 0.58 0.51 0.40 0.34 0.24 0.18
13 0.72 0.68 0.47 0.42 0.25 0.20
14 0.65 0.63 0.40 0.40 0.19 0.17
15 0.71 0.67 0.39 0.29 0.19 0.10
16 0.73 0.64 0.31 0.25 0.10 0.14
17 0.72 0.68 0.37 0.32 0.18 0.21
18 or Older 0.19 0.19 0.03 0.03 0.02 0.03
18-25 0.30 0.31 0.12 0.14 0.06 0.07
18 0.76 0.75 0.35 0.46 0.21 0.20
19 0.80 0.83 0.35 0.33 0.18 0.14
20 0.81 0.80 0.37 0.40 0.13 0.27
21 0.80 0.78 0.30 0.34 0.17 0.28
22 0.84 0.87 0.37 0.30 0.14 0.09
23 0.85 0.85 0.33 0.29 0.22 0.09
24 0.85 0.86 0.31 0.38 0.13 0.09
25 0.89 0.87 0.37 0.32 0.15 0.12
26 or Older 0.21 0.21 0.04 0.03 0.02 0.03
26-29 0.67 0.53 0.18 0.20 0.07 0.17
30-34 0.55 0.57 0.13 0.12 0.07 0.08
35-39 0.68 0.62 0.12 0.12 0.06 0.11
40-44 0.59 0.63 0.06 0.12 0.05 0.10
45-49 0.63 0.59 0.11 0.07 0.08 0.05
50-54 0.84 0.89 0.13 0.18 0.08 0.12
55-59 0.82 0.81 0.10 0.09 0.10 0.09
60-64 0.72 0.73 0.16 * 0.08 *
65 or Older 0.29 0.27 0.01 0.02 * *
170410
Table 1.20P – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0216   0.4066   0.4082  
12-17 0.0326   0.0106   0.3091  
12 0.1931   0.4150   0.6575  
13 0.1643   0.0495   0.1211  
14 0.2231   0.8530   0.6137  
15 0.5346   0.1739   0.5293  
16 0.0786   0.1619   0.1977  
17 0.5671   0.6762   0.9513  
18 or Older 0.0425   0.8512   0.2247  
18-25 0.7787   0.9665   0.9191  
18 0.8342   0.3448   0.6373  
19 0.8820   0.7927   0.5373  
20 0.2548   0.7390   0.4154  
21 0.8684   0.4245   0.1496  
22 0.8753   0.2080   0.1763  
23 0.6710   0.6078   0.4271  
24 0.9795   0.8499   0.6540  
25 0.8291   0.7856   0.8968  
26 or Older 0.0429   0.8036   0.1648  
26-29 0.0174   0.4639   0.0103  
30-34 0.6596   0.9644   0.6217  
35-39 0.3723   0.5353   0.1390  
40-44 0.3349   0.1189   0.5333  
45-49 0.2874   0.1722   0.3243  
50-54 0.8364   0.8865   0.6723  
55-59 0.8614   0.9342   0.9393  
60-64 0.6339   *   *  
65 or Older 0.8354   0.8453   *  
170410
Table 1.21C – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 403 390 120 100 93 71
12-17 15 11 10 8 5 4
12 2 3 2 1 * *
13 1 0 * 0 * *
14 0 4 * 3 * 2
15 6 3 5 2 1 1
16 7 5 3 3 2 *
17 11 8 7 6 5 3
18 or Older 401 389 120 99 93 71
18-25 65 54 35 28 25 15
18 16 10 9 9 8 1
19 20 19 10 14 8 10
20 19 15 12 10 6 2
21 23 21 15 13 5 7
22 23 15 10 9 8 5
23 28 22 15 9 9 1
24 25 20 10 7 7 6
25 28 24 16 11 15 3
26 or Older 392 377 115 95 89 70
26-29 84 70 34 26 21 16
30-34 103 107 34 35 25 21
35-39 116 108 44 28 31 23
40-44 101 102 35 31 30 24
45-49 116 95 45 19 37 16
50-54 169 166 52 49 41 44
55-59 169 200 35 49 30 34
60-64 149 142 10 11 10 *
65 or Older 114 131 27 17 19 17
170410
Table 1.21D – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.15 0.14 0.04 0.04 0.03 0.03
12-17 0.06 0.04 0.04 0.03 0.02 0.01
12 0.05 0.09 0.05 0.03 * *
13 0.01 0.01 * 0.01 * *
14 0.00 0.09 * 0.06 * 0.05
15 0.13 0.06 0.12 0.05 0.01 0.01
16 0.16 0.12 0.08 0.06 0.05 *
17 0.25 0.19 0.18 0.15 0.11 0.07
18 or Older 0.17 0.16 0.05 0.04 0.04 0.03
18-25 0.19 0.16 0.10 0.08 0.07 0.04
18 0.34 0.22 0.21 0.19 0.18 0.01
19 0.47 0.48 0.24 0.35 0.18 0.26
20 0.46 0.34 0.28 0.23 0.15 0.05
21 0.53 0.46 0.37 0.29 0.12 0.16
22 0.53 0.36 0.24 0.21 0.18 0.12
23 0.61 0.47 0.34 0.19 0.20 0.03
24 0.55 0.46 0.22 0.16 0.16 0.13
25 0.59 0.53 0.35 0.24 0.32 0.08
26 or Older 0.19 0.18 0.06 0.05 0.04 0.03
26-29 0.47 0.38 0.20 0.15 0.12 0.09
30-34 0.45 0.48 0.16 0.16 0.12 0.10
35-39 0.59 0.51 0.23 0.14 0.16 0.11
40-44 0.49 0.50 0.17 0.16 0.15 0.13
45-49 0.53 0.45 0.21 0.09 0.18 0.08
50-54 0.70 0.73 0.22 0.23 0.18 0.20
55-59 0.77 0.83 0.16 0.22 0.14 0.15
60-64 0.77 0.72 0.06 0.06 0.05 *
65 or Older 0.24 0.27 0.06 0.03 0.04 0.03
170410
Table 1.21P – Methamphetamine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.8983   0.0274   0.0361  
12-17 0.9054   0.5050   0.5313  
12 0.2985   0.7165   *  
13 0.5926   *   *  
14 0.0777   *   *  
15 0.5085   0.4721   0.7643  
16 0.5703   0.5681   *  
17 0.7907   0.5606   0.5562  
18 or Older 0.8883   0.0305   0.0387  
18-25 0.0008   0.1789   0.0343  
18 0.1555   0.7577   0.1169  
19 0.7530   0.6966   0.9218  
20 0.1025   0.4002   0.2496  
21 0.0733   0.1843   0.5067  
22 0.2848   0.9239   0.2731  
23 0.0316   0.2313   0.2039  
24 0.1659   0.7590   0.9813  
25 0.3926   0.8969   0.1132  
26 or Older 0.7273   0.0705   0.1187  
26-29 0.0672   0.2154   0.5132  
30-34 0.7927   0.9394   0.5418  
35-39 0.8622   0.1775   0.6429  
40-44 0.9496   0.9301   0.4988  
45-49 0.2421   0.0162   0.0608  
50-54 0.8494   0.6494   0.9919  
55-59 0.4981   0.4756   0.8555  
60-64 0.9480   0.8804   *  
65 or Older 0.0269   0.4880   0.8988  
170410
Table 1.22C – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 877 824 380 374 206 211
12-17 107 107 58 53 37 29
12 39 38 13 12 9 6
13 43 43 14 14 8 10
14 53 45 22 21 13 12
15 56 52 23 25 14 14
16 58 56 32 28 17 14
17 63 60 35 34 23 14
18 or Older 860 812 375 365 201 208
18-25 177 168 127 131 73 74
18 79 75 41 42 24 24
19 89 76 51 51 25 28
20 79 84 46 52 25 30
21 84 84 51 56 31 28
22 84 79 49 46 27 30
23 86 84 50 44 28 23
24 85 79 45 47 25 24
25 87 83 49 44 25 22
26 or Older 832 791 345 335 187 195
26-29 237 218 122 122 69 59
30-34 245 256 105 113 66 60
35-39 242 253 98 97 54 59
40-44 254 225 96 90 59 55
45-49 267 259 93 88 64 54
50-54 435 379 149 147 73 92
55-59 373 431 135 126 73 75
60-64 379 354 100 97 60 51
65 or Older 448 445 115 131 60 82
170410
Table 1.22D – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.33 0.31 0.14 0.14 0.08 0.08
12-17 0.43 0.43 0.23 0.21 0.15 0.12
12 0.91 0.93 0.32 0.33 0.23 0.16
13 0.94 0.96 0.35 0.35 0.19 0.23
14 1.06 0.93 0.49 0.50 0.29 0.29
15 1.06 1.00 0.51 0.53 0.31 0.32
16 1.09 1.07 0.73 0.62 0.40 0.33
17 1.17 1.13 0.79 0.78 0.54 0.33
18 or Older 0.35 0.33 0.15 0.15 0.08 0.09
18-25 0.51 0.49 0.36 0.38 0.21 0.21
18 1.42 1.29 0.85 0.84 0.51 0.52
19 1.45 1.36 1.05 1.11 0.58 0.67
20 1.36 1.43 0.95 1.12 0.59 0.68
21 1.40 1.37 1.09 1.11 0.70 0.62
22 1.42 1.38 1.03 0.97 0.62 0.68
23 1.27 1.37 0.99 0.88 0.60 0.51
24 1.40 1.41 0.93 1.00 0.55 0.55
25 1.33 1.41 0.94 0.91 0.53 0.47
26 or Older 0.40 0.38 0.17 0.16 0.09 0.09
26-29 0.94 0.95 0.65 0.67 0.39 0.33
30-34 0.85 0.82 0.47 0.50 0.31 0.27
35-39 0.97 0.88 0.49 0.45 0.28 0.28
40-44 0.97 0.88 0.47 0.45 0.29 0.28
45-49 0.94 0.94 0.44 0.42 0.30 0.26
50-54 1.32 1.32 0.62 0.65 0.32 0.41
55-59 1.30 1.34 0.62 0.56 0.34 0.34
60-64 1.36 1.40 0.52 0.50 0.32 0.26
65 or Older 0.96 0.93 0.25 0.27 0.13 0.17
170410
Table 1.22P – Any Use of Prescription Psychotherapeutics in Past Year and Misuse of Prescription Psychotherapeutics in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0002   0.4311   0.5042  
12-17 0.0000   0.0608   0.0226  
12 0.5797   0.6073   0.2146  
13 0.0170   0.6642   0.6936  
14 0.0045   0.5695   0.4644  
15 0.0137   0.8977   0.9006  
16 0.0064   0.0383   0.1825  
17 0.0128   0.4273   0.0546  
18 or Older 0.0021   0.6151   0.7397  
18-25 0.0000   0.1432   0.1247  
18 0.0076   0.7981   0.4532  
19 0.0004   0.9311   0.6522  
20 0.8147   0.2596   0.6145  
21 0.0021   0.1912   0.2007  
22 0.0672   0.2702   0.8148  
23 0.0208   0.0036   0.0344  
24 0.9517   0.6367   0.8716  
25 0.5750   0.4096   0.2584  
26 or Older 0.0322   0.8991   0.8053  
26-29 0.0024   0.7301   0.4298  
30-34 0.6800   0.5080   0.6644  
35-39 0.3293   0.5880   0.4237  
40-44 0.9756   0.9775   0.7431  
45-49 0.6609   0.5499   0.1125  
50-54 0.3724   0.7056   0.3078  
55-59 0.6372   0.7662   0.5871  
60-64 0.1378   0.7067   0.4920  
65 or Older 0.0974   0.4980   0.3609  
170410
Table 1.23C – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 861 771 307 286 157 159
12-17 101 97 47 42 27 22
12 34 33 12 11 8 6
13 39 39 13 14 8 9
14 47 41 19 18 11 10
15 51 44 18 22 9 10
16 52 49 24 21 11 11
17 57 51 27 23 15 9
18 or Older 848 762 303 280 156 158
18-25 165 153 92 92 46 46
18 71 65 30 30 14 15
19 75 63 33 31 14 14
20 65 67 31 34 15 19
21 70 64 36 35 20 19
22 72 62 34 30 16 18
23 76 74 37 32 23 14
24 72 69 35 35 21 17
25 78 69 39 33 17 12
26 or Older 818 742 287 264 150 149
26-29 208 188 99 89 52 47
30-34 227 226 89 88 46 43
35-39 219 225 85 82 44 49
40-44 231 203 88 73 52 44
45-49 240 229 80 71 54 39
50-54 384 331 113 124 60 68
55-59 347 383 109 109 63 57
60-64 338 313 77 79 56 45
65 or Older 435 425 96 98 37 54
170410
Table 1.23D – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.32 0.29 0.11 0.11 0.06 0.06
12-17 0.41 0.39 0.19 0.17 0.11 0.09
12 0.82 0.82 0.30 0.28 0.21 0.16
13 0.88 0.88 0.31 0.33 0.19 0.23
14 0.97 0.87 0.43 0.43 0.25 0.24
15 1.02 0.90 0.41 0.48 0.20 0.23
16 1.04 0.98 0.55 0.47 0.26 0.25
17 1.13 1.04 0.62 0.53 0.36 0.23
18 or Older 0.35 0.31 0.12 0.11 0.06 0.06
18-25 0.47 0.44 0.26 0.27 0.13 0.13
18 1.38 1.21 0.65 0.63 0.30 0.32
19 1.39 1.27 0.73 0.78 0.33 0.36
20 1.23 1.33 0.69 0.78 0.35 0.45
21 1.34 1.23 0.84 0.77 0.48 0.44
22 1.33 1.24 0.77 0.68 0.37 0.42
23 1.23 1.34 0.78 0.67 0.50 0.32
24 1.34 1.33 0.76 0.77 0.46 0.39
25 1.28 1.28 0.78 0.71 0.37 0.27
26 or Older 0.39 0.35 0.14 0.13 0.07 0.07
26-29 0.91 0.87 0.54 0.49 0.30 0.26
30-34 0.82 0.78 0.40 0.40 0.22 0.20
35-39 0.94 0.83 0.44 0.38 0.23 0.23
40-44 0.94 0.85 0.43 0.37 0.26 0.22
45-49 0.91 0.88 0.38 0.35 0.26 0.19
50-54 1.28 1.21 0.48 0.56 0.26 0.31
55-59 1.29 1.28 0.50 0.49 0.30 0.26
60-64 1.35 1.33 0.41 0.41 0.30 0.23
65 or Older 0.93 0.89 0.21 0.20 0.08 0.11
170410
Table 1.23P – Any Use of Pain Relievers in Past Year and Misuse of Pain Relievers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0000   0.0137   0.0534  
12-17 0.0000   0.1721   0.2686  
12 0.2590   0.3135   0.3751  
13 0.0011   0.7290   0.6805  
14 0.0027   0.3786   0.1680  
15 0.0019   0.4362   0.3954  
16 0.0005   0.1817   0.9056  
17 0.0093   0.4433   0.4024  
18 or Older 0.0000   0.0223   0.0716  
18-25 0.0000   0.0001   0.0026  
18 0.0002   0.4953   0.9215  
19 0.0000   0.2185   0.7249  
20 0.1601   0.6837   0.7189  
21 0.0002   0.0725   0.2984  
22 0.0175   0.0577   0.8070  
23 0.0048   0.0037   0.0047  
24 0.7447   0.7471   0.2086  
25 0.0535   0.0915   0.1127  
26 or Older 0.0009   0.2815   0.3264  
26-29 0.0004   0.3002   0.2611  
30-34 0.2406   0.6491   0.6918  
35-39 0.8905   0.8388   0.7139  
40-44 0.7411   0.3094   0.3473  
45-49 0.2523   0.1216   0.0422  
50-54 0.4398   0.3825   0.3752  
55-59 0.8469   0.9070   0.8150  
60-64 0.0851   0.8637   0.5652  
65 or Older 0.0117   0.7087   0.4053  
170410
Table 1.24C – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 623 592 209 206 109 120
12-17 50 53 32 32 21 17
12 14 13 3 7 2 1
13 14 12 7 3 6 1
14 18 16 9 9 6 6
15 22 24 12 15 6 8
16 25 25 18 17 12 8
17 27 30 19 19 14 10
18 or Older 617 587 205 203 107 118
18-25 115 111 78 79 44 41
18 39 35 29 29 16 14
19 39 37 27 31 16 16
20 38 41 25 29 15 14
21 43 42 30 27 15 15
22 41 40 27 27 14 17
23 44 41 30 28 16 14
24 44 44 28 26 13 14
25 47 44 28 24 17 13
26 or Older 599 573 190 183 97 109
26-29 124 110 69 60 33 35
30-34 132 129 60 60 36 32
35-39 131 140 54 51 30 31
40-44 150 129 58 46 28 27
45-49 150 150 47 46 31 28
50-54 254 232 87 93 35 46
55-59 222 256 64 68 27 44
60-64 241 200 60 43 28 13
65 or Older 299 332 62 77 39 52
170410
Table 1.24D – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.23 0.22 0.08 0.08 0.04 0.04
12-17 0.20 0.21 0.13 0.13 0.09 0.07
12 0.37 0.35 0.07 0.18 0.05 0.03
13 0.35 0.28 0.18 0.08 0.14 0.03
14 0.42 0.39 0.20 0.22 0.13 0.14
15 0.49 0.53 0.29 0.33 0.13 0.18
16 0.56 0.57 0.42 0.40 0.27 0.19
17 0.62 0.68 0.44 0.45 0.33 0.25
18 or Older 0.25 0.24 0.08 0.08 0.04 0.05
18-25 0.33 0.32 0.22 0.23 0.13 0.12
18 0.80 0.73 0.62 0.61 0.35 0.31
19 0.86 0.88 0.63 0.74 0.38 0.41
20 0.86 0.89 0.58 0.66 0.36 0.32
21 0.97 0.88 0.70 0.59 0.37 0.34
22 0.90 0.88 0.60 0.60 0.32 0.39
23 0.89 0.82 0.63 0.59 0.35 0.31
24 0.90 0.95 0.60 0.60 0.30 0.32
25 0.92 0.92 0.58 0.53 0.36 0.29
26 or Older 0.29 0.27 0.09 0.09 0.05 0.05
26-29 0.66 0.59 0.38 0.34 0.19 0.20
30-34 0.59 0.54 0.28 0.27 0.17 0.15
35-39 0.63 0.62 0.28 0.24 0.15 0.15
40-44 0.69 0.62 0.29 0.23 0.14 0.14
45-49 0.67 0.67 0.22 0.23 0.15 0.14
50-54 1.01 0.98 0.37 0.42 0.15 0.21
55-59 0.98 1.05 0.30 0.31 0.13 0.20
60-64 1.16 0.96 0.32 0.22 0.15 0.07
65 or Older 0.64 0.69 0.13 0.16 0.08 0.11
170410
Table 1.24P – Any Use of Tranquilizers in Past Year and Misuse of Tranquilizers in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.3384   0.9178   0.6794  
12-17 0.6071   0.3751   0.1199  
12 0.8816   0.2501   0.5646  
13 0.4205   0.4119   0.3293  
14 0.7731   0.5725   0.9759  
15 0.4035   0.2233   0.5614  
16 0.8003   0.5621   0.1506  
17 0.4200   0.4904   0.2494  
18 or Older 0.3029   0.8034   0.4975  
18-25 0.0902   0.9178   0.4892  
18 0.3691   0.9785   0.6170  
19 0.6255   0.1280   0.3580  
20 0.6966   0.3157   0.5412  
21 0.1732   0.4344   0.8467  
22 0.2113   0.5911   0.4340  
23 0.0605   0.3701   0.2279  
24 0.5479   0.8444   0.9568  
25 0.8574   0.6832   0.1807  
26 or Older 0.4498   0.8860   0.2896  
26-29 0.0606   0.8397   0.7026  
30-34 0.5015   0.5213   0.9237  
35-39 0.9085   0.6107   0.9279  
40-44 0.1154   0.3302   0.8797  
45-49 0.3519   0.7650   0.7385  
50-54 0.7761   0.6579   0.1806  
55-59 0.2445   0.6485   0.0477  
60-64 0.0383   0.5929   0.1730  
65 or Older 0.6100   0.4315   0.8179  
170410
Table 1.25C – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 356 368 174 192 97 103
12-17 62 61 35 34 17 14
12 15 20 4 3 2 0
13 22 22 2 4 0 2
14 23 23 8 11 5 6
15 25 29 15 14 9 8
16 33 29 22 14 9 6
17 37 35 23 25 11 7
18 or Older 351 358 171 185 96 103
18-25 130 139 96 104 51 58
18 40 44 24 30 14 17
19 51 50 38 39 20 22
20 48 57 34 44 17 23
21 47 54 38 40 20 21
22 49 48 37 35 20 21
23 42 47 33 30 14 13
24 46 43 29 31 13 16
25 40 46 29 30 15 15
26 or Older 314 327 132 142 78 83
26-29 107 109 69 76 44 34
30-34 103 106 60 62 35 33
35-39 94 101 50 45 22 26
40-44 84 96 31 36 21 19
45-49 85 87 30 38 24 28
50-54 127 132 52 50 31 31
55-59 109 113 34 37 22 32
60-64 94 101 17 24 17 *
65 or Older 136 136 9 35 * 8
170410
Table 1.25D – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.13 0.14 0.07 0.07 0.04 0.04
12-17 0.25 0.25 0.14 0.14 0.07 0.06
12 0.39 0.51 0.10 0.08 0.06 0.01
13 0.53 0.53 0.05 0.10 0.01 0.06
14 0.53 0.53 0.19 0.27 0.11 0.14
15 0.56 0.61 0.33 0.31 0.20 0.18
16 0.72 0.65 0.50 0.33 0.20 0.15
17 0.84 0.76 0.53 0.58 0.26 0.18
18 or Older 0.14 0.15 0.07 0.08 0.04 0.04
18-25 0.37 0.40 0.27 0.30 0.15 0.17
18 0.82 0.90 0.49 0.63 0.30 0.37
19 1.05 1.10 0.82 0.87 0.45 0.53
20 0.98 1.19 0.74 0.97 0.41 0.53
21 1.00 1.08 0.86 0.84 0.48 0.47
22 1.03 0.98 0.80 0.76 0.47 0.47
23 0.88 0.93 0.70 0.63 0.31 0.29
24 0.96 0.93 0.63 0.68 0.29 0.37
25 0.77 0.98 0.61 0.65 0.33 0.34
26 or Older 0.15 0.16 0.06 0.07 0.04 0.04
26-29 0.59 0.59 0.39 0.43 0.26 0.19
30-34 0.48 0.47 0.28 0.29 0.17 0.15
35-39 0.46 0.47 0.25 0.22 0.11 0.12
40-44 0.41 0.48 0.15 0.18 0.11 0.09
45-49 0.40 0.42 0.15 0.19 0.11 0.14
50-54 0.53 0.59 0.22 0.23 0.13 0.14
55-59 0.51 0.50 0.16 0.17 0.10 0.15
60-64 0.50 0.52 0.09 0.13 0.09 *
65 or Older 0.29 0.28 0.02 0.07 * 0.02
170410
Table 1.25P – Any Use of Stimulants in Past Year and Misuse of Stimulants in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0294   0.1269   0.6045  
12-17 0.7998   0.1890   0.2399  
12 0.1068   0.6020   0.3107  
13 0.8111   0.0737   0.3810  
14 0.9193   0.1004   0.2240  
15 0.7452   0.3569   0.3071  
16 0.1738   0.0031   0.3043  
17 0.4602   0.9394   0.3689  
18 or Older 0.0232   0.0653   0.4816  
18-25 0.4410   0.6206   0.8208  
18 0.6286   0.3785   0.6471  
19 0.8661   0.9864   0.7735  
20 0.0584   0.0787   0.1545  
21 0.8394   0.3237   0.6345  
22 0.1401   0.4653   0.8574  
23 0.8806   0.1766   0.4818  
24 0.9408   0.1951   0.1541  
25 0.1693   0.5539   0.8557  
26 or Older 0.0240   0.0379   0.4310  
26-29 0.7359   0.4899   0.5093  
30-34 0.1535   0.2806   0.1814  
35-39 0.2393   0.8552   0.1374  
40-44 0.4729   0.0781   0.9053  
45-49 0.4088   0.5519   0.8417  
50-54 0.2998   0.8864   0.8053  
55-59 0.4518   0.5835   0.2746  
60-64 0.9568   0.4547   *  
65 or Older 0.3890   0.0435   *  
170410
Table 1.26C – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 437 466 113 117 57 74
12-17 38 35 16 14 7 6
12 12 13 1 3 * *
13 13 12 4 4 1 *
14 11 13 5 6 1 3
15 17 15 6 8 5 5
16 20 15 10 8 3 2
17 18 18 8 8 3 3
18 or Older 434 464 111 116 57 74
18-25 63 65 26 30 16 12
18 21 20 9 7 5 4
19 21 20 10 13 4 5
20 20 18 13 8 7 3
21 23 23 10 12 4 2
22 22 18 8 7 6 4
23 26 24 11 12 9 4
24 24 28 5 12 4 5
25 22 26 8 9 5 6
26 or Older 426 457 109 112 55 73
26-29 72 72 33 30 14 12
30-34 82 90 30 35 21 17
35-39 94 89 32 22 14 11
40-44 101 82 31 32 21 25
45-49 116 98 27 18 18 8
50-54 193 174 41 48 13 40
55-59 160 225 49 35 * 22
60-64 167 171 22 37 8 24
65 or Older 251 241 47 59 29 41
170410
Table 1.26D – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.16 0.17 0.04 0.04 0.02 0.03
12-17 0.15 0.14 0.06 0.06 0.03 0.03
12 0.31 0.34 0.03 0.07 * *
13 0.32 0.28 0.10 0.09 0.02 *
14 0.26 0.30 0.12 0.14 0.03 0.08
15 0.38 0.33 0.15 0.18 0.12 0.12
16 0.46 0.35 0.23 0.18 0.07 0.04
17 0.44 0.42 0.19 0.20 0.08 0.07
18 or Older 0.18 0.19 0.05 0.05 0.02 0.03
18-25 0.18 0.19 0.08 0.09 0.05 0.03
18 0.46 0.44 0.20 0.15 0.11 0.08
19 0.48 0.51 0.24 0.34 0.10 0.11
20 0.49 0.42 0.32 0.18 0.16 0.06
21 0.55 0.52 0.24 0.28 0.11 0.05
22 0.50 0.41 0.20 0.15 0.14 0.10
23 0.57 0.52 0.25 0.27 0.19 0.08
24 0.52 0.63 0.10 0.27 0.08 0.12
25 0.48 0.56 0.17 0.20 0.12 0.13
26 or Older 0.20 0.22 0.05 0.05 0.03 0.03
26-29 0.40 0.40 0.19 0.17 0.08 0.07
30-34 0.37 0.40 0.14 0.16 0.10 0.08
35-39 0.46 0.41 0.16 0.11 0.07 0.05
40-44 0.48 0.41 0.15 0.16 0.10 0.13
45-49 0.52 0.47 0.13 0.09 0.09 0.04
50-54 0.77 0.76 0.18 0.22 0.05 0.18
55-59 0.74 0.92 0.23 0.16 * 0.10
60-64 0.83 0.83 0.12 0.19 0.04 0.13
65 or Older 0.54 0.50 0.10 0.12 0.06 0.08
170410
Table 1.26P – Any Use of Sedatives in Past Year and Misuse of Sedatives in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Any Use in Past
Year
(2015)
Any Use in Past
Year
(2016)
Misuse in Past
Year
(2015)
Misuse in Past
Year
(2016)
Misuse in Past
Month
(2015)
Misuse in Past
Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9320   0.9446   0.6167  
12-17 0.4462   0.9285   0.8791  
12 0.3811   0.2017   *  
13 0.8842   0.8908   *  
14 0.2777   0.5240   0.3452  
15 0.4342   1.0000   0.8979  
16 0.0714   0.4620   0.6124  
17 0.6898   0.7991   0.7634  
18 or Older 0.9705   0.9359   0.6273  
18-25 0.5936   0.8547   0.0688  
18 0.5516   0.3725   0.4196  
19 0.4802   0.7623   0.8655  
20 0.4307   0.1891   0.6038  
21 0.8353   0.5846   0.4280  
22 0.2638   0.1800   0.3962  
23 0.2499   0.4977   0.0368  
24 0.1295   0.0073   0.3545  
25 0.3486   0.9504   0.6103  
26 or Older 1.0000   0.8890   0.3847  
26-29 0.7814   0.3373   0.3291  
30-34 0.0922   0.4183   0.5885  
35-39 0.6657   0.2251   0.9504  
40-44 0.5930   0.2397   0.4474  
45-49 0.1457   0.2458   0.0383  
50-54 0.4316   0.7079   0.3722  
55-59 0.2095   0.2758   *  
60-64 0.0748   0.1604   0.3465  
65 or Older 0.3217   0.5181   0.6125  
170412
Table 1.27C – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Numbers in Thousands, 2015 and 2016
Age Category Misuse in Past Year
(2015)
Misuse in Past Year
(2016)
Misuse in Past Month
(2015)
Misuse in Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 312 291 164 171
12-17 48 43 27 22
12 12 11 8 6
13 13 14 8 9
14 19 18 11 10
15 19 22 9 10
16 24 21 11 11
17 28 23 15 9
18 or Older 307 286 162 170
18-25 94 94 50 48
18 29 30 14 15
19 33 32 14 15
20 31 34 15 19
21 36 35 20 20
22 35 31 16 19
23 37 33 23 16
24 37 35 26 17
25 39 33 18 13
26 or Older 292 269 157 161
26-29 101 89 53 48
30-34 91 92 49 47
35-39 86 83 46 52
40-44 88 76 52 50
45-49 80 71 54 39
50-54 117 125 64 69
55-59 110 112 64 67
60-64 77 79 56 45
65 or Older 96 98 37 54
170412
Table 1.27D – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: Standard Errors of Percentages, 2015 and 2016
Age Category Misuse in Past Year
(2015)
Misuse in Past Year
(2016)
Misuse in Past Month
(2015)
Misuse in Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.12 0.11 0.06 0.06
12-17 0.19 0.17 0.11 0.09
12 0.30 0.28 0.21 0.16
13 0.31 0.34 0.19 0.23
14 0.43 0.42 0.25 0.24
15 0.42 0.48 0.20 0.23
16 0.55 0.48 0.26 0.25
17 0.63 0.53 0.36 0.23
18 or Older 0.13 0.12 0.07 0.07
18-25 0.27 0.27 0.14 0.14
18 0.65 0.64 0.30 0.34
19 0.73 0.79 0.33 0.39
20 0.70 0.79 0.36 0.45
21 0.84 0.77 0.48 0.46
22 0.78 0.70 0.38 0.43
23 0.78 0.69 0.50 0.34
24 0.79 0.77 0.55 0.39
25 0.79 0.71 0.39 0.30
26 or Older 0.14 0.13 0.08 0.08
26-29 0.55 0.50 0.30 0.27
30-34 0.41 0.41 0.23 0.22
35-39 0.44 0.39 0.24 0.25
40-44 0.43 0.38 0.26 0.25
45-49 0.37 0.35 0.26 0.19
50-54 0.50 0.56 0.28 0.31
55-59 0.51 0.50 0.30 0.30
60-64 0.41 0.41 0.30 0.23
65 or Older 0.21 0.20 0.08 0.11
170412
Table 1.27P – Misuse of Opioids in Past Year and Past Month among Persons Aged 12 or Older, by Detailed Age Category: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Age Category Misuse in Past Year
(2015)
Misuse in Past Year
(2016)
Misuse in Past Month
(2015)
Misuse in Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0235   0.1638  
12-17 0.1704   0.2907  
12 0.3054   0.3751  
13 0.8238   0.6805  
14 0.4054   0.1680  
15 0.4784   0.3874  
16 0.2293   0.9895  
17 0.3330   0.3945  
18 or Older 0.0377   0.2047  
18-25 0.0002   0.0069  
18 0.4670   0.8502  
19 0.2911   0.9574  
20 0.6842   0.5876  
21 0.0898   0.4698  
22 0.0835   0.8130  
23 0.0116   0.0196  
24 0.4921   0.0590  
25 0.0851   0.1769  
26 or Older 0.3691   0.6241  
26-29 0.3046   0.4693  
30-34 0.8929   0.9187  
35-39 0.8915   0.7399  
40-44 0.3837   0.5153  
45-49 0.1300   0.0725  
50-54 0.4847   0.5509  
55-59 0.8291   0.7497  
60-64 0.9352   0.5729  
65 or Older 0.7087   0.4053  
170410
Table 1.28C – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Standard Errors of Numbers in Thousands, 2015 and 2016
Prescription Drug/Age Group Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
PSYCHOTHERAPEUTICS1 877 824 380 374 395 392
12-17 107 107 58 53 61 56
18 or Older 860 812 375 365 388 384
18-25 177 168 127 131 150 157
26 or Older 832 791 345 335 357 348
PAIN RELIEVERS1 861 771 307 286 316 295
12-17 101 97 47 42 49 44
18 or Older 848 762 303 280 310 291
18-25 165 153 92 92 99 98
26 or Older 818 742 287 264 293 271
TRANQUILIZERS 623 592 209 206 211 210
12-17 50 53 32 32 33 32
18 or Older 617 587 205 203 207 207
18-25 115 111 78 79 83 83
26 or Older 599 573 190 183 192 186
STIMULANTS 356 368 174 192 174 193
12-17 62 61 35 34 36 34
18 or Older 351 358 171 185 171 187
18-25 130 139 96 104 106 117
26 or Older 314 327 132 142 133 142
SEDATIVES 437 466 113 117 114 118
12-17 38 35 16 14 16 14
18 or Older 434 464 111 116 112 117
18-25 63 65 26 30 27 30
26 or Older 426 457 109 112 110 113
170410
Table 1.28D – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: Standard Errors of Percentages, 2015 and 2016
Prescription Drug/Age Group Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
PSYCHOTHERAPEUTICS1 0.33 0.31 0.14 0.14 0.31 0.32
12-17 0.43 0.43 0.23 0.21 0.76 0.76
18 or Older 0.35 0.33 0.15 0.15 0.33 0.33
18-25 0.51 0.49 0.36 0.38 0.68 0.82
26 or Older 0.40 0.38 0.17 0.16 0.35 0.34
PAIN RELIEVERS1 0.32 0.29 0.11 0.11 0.31 0.30
12-17 0.41 0.39 0.19 0.17 0.78 0.83
18 or Older 0.35 0.31 0.12 0.11 0.32 0.31
18-25 0.47 0.44 0.26 0.27 0.67 0.81
26 or Older 0.39 0.35 0.14 0.13 0.35 0.34
TRANQUILIZERS 0.23 0.22 0.08 0.08 0.50 0.52
12-17 0.20 0.21 0.13 0.13 2.33 2.27
18 or Older 0.25 0.24 0.08 0.08 0.50 0.53
18-25 0.33 0.32 0.22 0.23 1.36 1.53
26 or Older 0.29 0.27 0.09 0.09 0.53 0.53
STIMULANTS 0.13 0.14 0.07 0.07 0.86 0.88
12-17 0.25 0.25 0.14 0.14 1.63 1.56
18 or Older 0.14 0.15 0.07 0.08 0.95 0.95
18-25 0.37 0.40 0.27 0.30 1.36 1.40
26 or Older 0.15 0.16 0.06 0.07 1.12 1.09
SEDATIVES 0.16 0.17 0.04 0.04 0.59 0.61
12-17 0.15 0.14 0.06 0.06 2.43 2.23
18 or Older 0.18 0.19 0.05 0.05 0.60 0.62
18-25 0.18 0.19 0.08 0.09 1.77 2.08
26 or Older 0.20 0.22 0.05 0.05 0.64 0.65
170410
Table 1.28P – Any Use and Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older and Misuse of Prescription Psychotherapeutics in Past Year among Past Year Any Users Aged 12 or Older, by Age Group: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Prescription Drug/Age Group Any Use
in Past Year
(2015)
Any Use
in Past Year
(2016)
Misuse
in Past Year
among
Total Population
(2015)
Misuse
in Past Year
among
Total Population
(2016)
Misuse
in Past Year
among
Past Year
Any Users
(2015)
Misuse
in Past Year
among
Past Year
Any Users
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
PSYCHOTHERAPEUTICS1 0.0002   0.4311   0.5286  
12-17 0.0000   0.0608   0.7333  
18 or Older 0.0021   0.6151   0.5128  
18-25 0.0000   0.1432   0.2570  
26 or Older 0.0322   0.8991   0.4182  
PAIN RELIEVERS1 0.0000   0.0137   0.5792  
12-17 0.0000   0.1721   0.1946  
18 or Older 0.0000   0.0223   0.5048  
18-25 0.0000   0.0001   0.3610  
26 or Older 0.0009   0.2815   0.9744  
TRANQUILIZERS 0.3384   0.9178   0.7293  
12-17 0.6071   0.3751   0.4612  
18 or Older 0.3029   0.8034   0.8313  
18-25 0.0902   0.9178   0.1759  
26 or Older 0.4498   0.8860   0.9029  
STIMULANTS 0.0294   0.1269   0.8974  
12-17 0.7998   0.1890   0.1489  
18 or Older 0.0232   0.0653   0.7058  
18-25 0.4410   0.6206   0.9396  
26 or Older 0.0240   0.0379   0.3146  
SEDATIVES 0.9320   0.9446   0.9206  
12-17 0.4462   0.9285   0.7978  
18 or Older 0.9705   0.9359   0.9251  
18-25 0.5936   0.8547   0.9537  
26 or Older 1.0000   0.8890   0.8867  
170421
Table 1.29C – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 903 870 107 104 896 853 187 180 862 825
GENDER                    
Male 582 584 73 73 580 573 123 121 567 563
Female 613 592 77 68 604 584 124 121 588 562
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 811 802 93 91 804 792 162 152 780 778
White 699 674 94 88 1,192 1,130 248 251 1,142 1,088
Black or African American 277 269 51 45 446 430 108 103 411 400
American Indian or Alaska Native 68 81 6 9 66 77 * 27 60 70
Native Hawaiian or Other Pacific Islander 48 67 * * 47 65 * * * *
Asian 212 214 25 28 210 212 63 61 195 199
Two or More Races 135 147 20 21 133 144 39 35 130 138
Hispanic or Latino 325 341 52 51 322 335 87 90 301 317
EDUCATION                    
< High School da da da da 376 349 105 92 356 329
High School Graduate da da da da 568 572 157 141 534 545
Some College/Associate's Degree da da da da 713 675 211 228 666 628
College Graduate da da da da 802 805 111 118 786 788
CURRENT EMPLOYMENT                    
Full-Time da da da da 893 894 192 195 868 863
Part-Time da da da da 419 415 142 164 391 373
Unemployed da da da da 220 232 86 84 206 218
Other1 da da da da 688 656 138 123 663 644
170421
Table 1.29D – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.34 0.32 0.43 0.42 0.37 0.35 0.53 0.52 0.41 0.39
GENDER                    
Male 0.45 0.45 0.58 0.57 0.50 0.49 0.70 0.70 0.57 0.56
Female 0.44 0.43 0.63 0.55 0.48 0.46 0.71 0.70 0.54 0.51
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.36 0.36 0.48 0.48 0.39 0.38 0.59 0.56 0.44 0.43
White 0.41 0.39 0.58 0.55 0.44 0.42 0.68 0.65 0.49 0.48
Black or African American 0.86 0.83 1.09 1.05 0.95 0.92 1.20 1.19 1.11 1.10
American Indian or Alaska Native 3.42 3.08 3.46 4.36 3.92 3.31 * 4.43 4.63 3.76
Native Hawaiian or Other Pacific Islander 4.85 4.96 * * 5.59 5.51 * * * *
Asian 1.24 1.25 1.90 1.79 1.33 1.38 2.23 2.33 1.47 1.54
Two or More Races 2.14 1.96 2.11 2.12 2.60 2.27 2.33 2.53 3.24 2.69
Hispanic or Latino 0.75 0.77 0.90 0.87 0.85 0.87 1.17 1.20 0.99 1.02
EDUCATION                    
< High School da da da da 0.88 0.89 1.28 1.40 1.00 0.99
High School Graduate da da da da 0.66 0.67 0.87 0.89 0.77 0.78
Some College/Associate's Degree da da da da 0.60 0.54 0.80 0.84 0.70 0.64
College Graduate da da da da 0.66 0.64 1.36 1.35 0.70 0.68
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.47 0.44 0.76 0.70 0.52 0.49
Part-Time da da da da 0.86 0.85 0.96 1.05 1.13 1.11
Unemployed da da da da 1.34 1.37 1.63 1.57 1.82 1.83
Other1 da da da da 0.65 0.62 1.10 1.09 0.71 0.68
170421
Table 1.29P – Illicit Drug Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4923   0.0002   0.7957   0.0974   0.8947  
GENDER                    
Male 0.0165   0.0215   0.0292   0.0193   0.0885  
Female 0.1743   0.0021   0.0783   0.9037   0.0633  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.9263   0.0046   0.8454   0.3732   0.6869  
White 0.5633   0.0168   0.4223   0.4162   0.4983  
Black or African American 0.1390   0.0171   0.2243   0.0049   0.5667  
American Indian or Alaska Native 0.3202   0.0732   0.5328   *   0.6909  
Native Hawaiian or Other Pacific Islander 0.3152   *   0.2147   *   *  
Asian 0.6324   0.7993   0.6267   0.3300   0.7458  
Two or More Races 0.9831   0.6083   0.9550   0.2838   0.7541  
Hispanic or Latino 0.1476   0.0065   0.3043   0.0818   0.5932  
EDUCATION                    
< High School da   da   0.0357   0.1655   0.0806  
High School Graduate da   da   0.9894   0.1408   0.6776  
Some College/Associate's Degree da   da   0.5771   0.3486   0.7556  
College Graduate da   da   0.4882   0.8507   0.5108  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.6783   0.5473   0.7775  
Part-Time da   da   0.8210   0.6424   0.7061  
Unemployed da   da   0.9799   0.8338   0.9475  
Other1 da   da   0.8946   0.0216   0.7727  
170421
Table 1.30C – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 617 616 92 87 610 604 171 182 550 549
GENDER                    
Male 452 435 64 62 449 427 120 123 419 395
Female 362 397 68 57 353 394 114 120 316 358
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 580 553 80 75 573 542 153 155 516 496
White 497 480 82 68 549 536 202 203 496 497
Black or African American 214 188 37 38 254 226 87 90 225 193
American Indian or Alaska Native 37 44 5 7 35 41 17 * 30 35
Native Hawaiian or Other Pacific Islander 28 39 * * 26 38 * * * 36
Asian 113 124 19 21 110 122 46 46 99 109
Two or More Races 82 100 18 18 80 97 36 31 71 92
Hispanic or Latino 215 246 46 45 212 241 79 88 194 214
EDUCATION                    
< High School da da da da 215 209 85 75 199 190
High School Graduate da da da da 308 312 120 118 276 279
Some College/Associate's Degree da da da da 373 374 174 191 323 312
College Graduate da da da da 358 392 87 92 338 367
CURRENT EMPLOYMENT                    
Full-Time da da da da 432 456 150 153 402 413
Part-Time da da da da 242 255 121 143 208 214
Unemployed da da da da 154 152 72 74 134 131
Other1 da da da da 346 341 101 102 324 327
170421
Table 1.30D – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.23 0.23 0.37 0.35 0.25 0.25 0.49 0.53 0.26 0.26
GENDER                    
Male 0.35 0.33 0.51 0.49 0.38 0.36 0.69 0.71 0.42 0.39
Female 0.26 0.29 0.55 0.47 0.28 0.31 0.66 0.70 0.29 0.33
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.26 0.25 0.42 0.40 0.28 0.26 0.56 0.57 0.29 0.28
White 0.29 0.28 0.53 0.45 0.31 0.30 0.68 0.67 0.33 0.32
Black or African American 0.67 0.58 0.90 0.97 0.73 0.63 1.22 1.22 0.81 0.68
American Indian or Alaska Native 2.16 2.40 3.18 3.87 2.42 2.57 5.50 * 2.73 2.64
Native Hawaiian or Other Pacific Islander 3.56 3.06 * * 3.97 3.45 * * * 3.71
Asian 0.75 0.78 1.42 1.47 0.80 0.85 1.93 1.84 0.83 0.91
Two or More Races 1.67 1.73 2.01 1.95 2.00 2.03 2.80 2.89 2.22 2.42
Hispanic or Latino 0.49 0.55 0.81 0.77 0.56 0.62 1.06 1.17 0.64 0.69
EDUCATION                    
< High School da da da da 0.58 0.61 1.26 1.27 0.63 0.65
High School Graduate da da da da 0.46 0.47 0.83 0.90 0.51 0.51
Some College/Associate's Degree da da da da 0.44 0.43 0.79 0.79 0.49 0.47
College Graduate da da da da 0.44 0.45 1.38 1.37 0.45 0.46
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.33 0.32 0.75 0.73 0.35 0.34
Part-Time da da da da 0.65 0.68 0.94 1.09 0.80 0.85
Unemployed da da da da 1.21 1.17 1.53 1.59 1.53 1.46
Other1 da da da da 0.40 0.39 0.95 1.00 0.42 0.41
170421
Table 1.30P – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.5753   0.0015   0.2870   0.8055   0.2157  
GENDER                    
Male 0.6517   0.0441   0.4511   0.4245   0.2590  
Female 0.7231   0.0153   0.4183   0.2528   0.5308  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2063   0.0130   0.1022   0.4057   0.0946  
White 0.1244   0.0049   0.0514   0.1094   0.0799  
Black or African American 0.4978   0.6745   0.5252   0.8327   0.6273  
American Indian or Alaska Native 0.8313   0.4005   0.9644   *   0.8570  
Native Hawaiian or Other Pacific Islander 0.3222   *   0.5579   *   *  
Asian 0.9874   0.4370   0.8803   0.3382   0.9758  
Two or More Races 0.1984   0.9838   0.1960   0.5589   0.0613  
Hispanic or Latino 0.1074   0.0368   0.2359   0.3371   0.4097  
EDUCATION                    
< High School da   da   0.3485   0.8598   0.4065  
High School Graduate da   da   0.6317   0.3833   0.6548  
Some College/Associate's Degree da   da   0.5846   0.8737   0.5371  
College Graduate da   da   0.1306   0.4175   0.0962  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.5505   0.7825   0.4018  
Part-Time da   da   0.2338   0.2352   0.5832  
Unemployed da   da   0.5352   0.3728   0.6851  
Other1 da   da   0.7515   0.2556   0.4587  
170421
Table 1.31C – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 457 488 68 66 448 480 147 148 405 435
GENDER                    
Male 353 355 48 46 348 350 108 106 321 323
Female 262 301 49 44 258 296 94 100 227 268
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 437 444 60 57 430 436 129 126 392 398
White 376 385 57 48 396 407 150 143 361 379
Black or African American 179 154 28 25 197 174 67 70 177 149
American Indian or Alaska Native 30 34 3 4 30 33 8 11 28 31
Native Hawaiian or Other Pacific Islander 16 34 * * 13 34 * * 9 *
Asian 79 63 11 15 77 61 32 33 69 50
Two or More Races 64 85 15 15 62 82 26 23 56 79
Hispanic or Latino 171 193 35 33 166 190 68 75 149 172
EDUCATION                    
< High School da da da da 157 153 67 59 146 140
High School Graduate da da da da 238 250 92 93 223 226
Some College/Associate's Degree da da da da 274 294 132 137 235 249
College Graduate da da da da 237 266 60 59 229 253
CURRENT EMPLOYMENT                    
Full-Time da da da da 315 334 117 111 294 309
Part-Time da da da da 169 202 88 104 139 175
Unemployed da da da da 120 125 54 60 103 109
Other1 da da da da 265 256 80 75 249 247
170421
Table 1.31D – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.17 0.18 0.27 0.26 0.18 0.20 0.42 0.43 0.19 0.21
GENDER                    
Male 0.27 0.27 0.38 0.36 0.30 0.30 0.62 0.61 0.32 0.32
Female 0.19 0.22 0.40 0.36 0.21 0.23 0.54 0.58 0.21 0.25
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.20 0.20 0.31 0.30 0.21 0.21 0.47 0.46 0.22 0.22
White 0.22 0.23 0.40 0.34 0.23 0.24 0.60 0.56 0.25 0.26
Black or African American 0.56 0.48 0.73 0.69 0.61 0.53 1.05 1.13 0.68 0.57
American Indian or Alaska Native 1.88 1.89 1.78 2.69 2.16 2.05 3.14 4.12 2.51 2.36
Native Hawaiian or Other Pacific Islander 2.22 2.69 * * 2.24 3.01 * * 2.11 *
Asian 0.54 0.45 0.83 1.07 0.57 0.48 1.50 1.44 0.60 0.46
Two or More Races 1.31 1.55 1.76 1.71 1.57 1.82 2.47 2.54 1.83 2.18
Hispanic or Latino 0.39 0.44 0.61 0.56 0.44 0.49 0.91 1.00 0.49 0.55
EDUCATION                    
< High School da da da da 0.44 0.46 1.09 1.08 0.48 0.50
High School Graduate da da da da 0.36 0.38 0.74 0.75 0.42 0.42
Some College/Associate's Degree da da da da 0.34 0.35 0.71 0.68 0.37 0.38
College Graduate da da da da 0.31 0.33 1.11 1.03 0.33 0.33
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.25 0.25 0.67 0.63 0.27 0.27
Part-Time da da da da 0.47 0.57 0.80 0.94 0.55 0.71
Unemployed da da da da 0.98 1.03 1.28 1.47 1.24 1.29
Other1 da da da da 0.31 0.30 0.82 0.84 0.33 0.32
170421
Table 1.31P – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0417   0.0152   0.0144   0.1335   0.0247  
GENDER                    
Male 0.3039   0.0894   0.2031   0.9885   0.1499  
Female 0.0396   0.0687   0.0161   0.0315   0.0517  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0321   0.0759   0.0153   0.0959   0.0278  
White 0.0413   0.0245   0.0174   0.0557   0.0419  
Black or African American 0.9842   0.8966   0.9878   0.8232   0.9901  
American Indian or Alaska Native 0.5775   0.3712   0.6864   0.4305   0.8965  
Native Hawaiian or Other Pacific Islander 1.0000   *   0.6346   *   *  
Asian 0.8236   0.3188   0.9555   0.8510   0.9911  
Two or More Races 0.1331   0.5293   0.1660   0.9803   0.1013  
Hispanic or Latino 0.9067   0.0709   0.6293   0.8937   0.5915  
EDUCATION                    
< High School da   da   0.4847   0.9231   0.5742  
High School Graduate da   da   0.1365   0.0718   0.2755  
Some College/Associate's Degree da   da   0.1977   0.6529   0.2173  
College Graduate da   da   0.0201   0.7233   0.0238  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.3787   0.6350   0.3857  
Part-Time da   da   0.0109   0.0467   0.1042  
Unemployed da   da   0.0638   0.0528   0.1902  
Other1 da   da   0.3465   0.2148   0.1564  
170421
Table 1.32C – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 896 870 89 88 890 857 185 181 858 829
GENDER                    
Male 583 586 63 65 581 577 124 122 569 566
Female 607 569 63 56 597 563 118 121 579 542
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 806 802 75 77 798 792 162 153 775 774
White 696 676 73 70 1,134 1,073 236 238 1,087 1,034
Black or African American 273 261 36 35 427 398 105 99 391 369
American Indian or Alaska Native 65 71 4 7 64 69 * 27 58 62
Native Hawaiian or Other Pacific Islander 44 54 * * 42 53 * * * 49
Asian 183 186 15 19 181 184 54 52 172 173
Two or More Races 132 143 16 17 131 141 38 34 128 135
Hispanic or Latino 314 334 44 43 311 331 89 89 292 311
EDUCATION                    
< High School da da da da 352 320 99 87 335 298
High School Graduate da da da da 543 547 150 135 509 521
Some College/Associate's Degree da da da da 686 649 199 218 644 606
College Graduate da da da da 771 750 105 111 754 737
CURRENT EMPLOYMENT                    
Full-Time da da da da 868 872 183 184 842 843
Part-Time da da da da 400 399 134 157 376 361
Unemployed da da da da 209 225 82 80 194 209
Other1 da da da da 639 609 125 112 619 598
170421
Table 1.32D – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.33 0.32 0.36 0.35 0.37 0.35 0.53 0.52 0.41 0.39
GENDER                    
Male 0.45 0.45 0.49 0.51 0.50 0.49 0.71 0.71 0.57 0.56
Female 0.44 0.41 0.51 0.46 0.47 0.44 0.68 0.70 0.53 0.50
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.36 0.36 0.39 0.40 0.39 0.38 0.59 0.56 0.44 0.43
White 0.41 0.40 0.48 0.47 0.44 0.43 0.70 0.65 0.49 0.48
Black or African American 0.85 0.81 0.92 0.91 0.93 0.89 1.22 1.24 1.08 1.05
American Indian or Alaska Native 3.30 3.31 2.62 4.14 3.81 3.48 * 4.40 4.48 3.90
Native Hawaiian or Other Pacific Islander 4.72 4.20 * * 5.47 4.72 * * * 5.15
Asian 1.18 1.14 1.13 1.30 1.28 1.25 2.14 2.14 1.42 1.39
Two or More Races 2.16 1.98 1.87 1.80 2.66 2.30 2.43 2.57 3.32 2.70
Hispanic or Latino 0.72 0.75 0.77 0.74 0.82 0.86 1.19 1.19 0.96 1.00
EDUCATION                    
< High School da da da da 0.89 0.85 1.28 1.37 1.00 0.93
High School Graduate da da da da 0.66 0.67 0.90 0.90 0.76 0.77
Some College/Associate's Degree da da da da 0.60 0.55 0.79 0.84 0.71 0.65
College Graduate da da da da 0.67 0.64 1.40 1.34 0.70 0.68
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.47 0.45 0.78 0.73 0.52 0.50
Part-Time da da da da 0.85 0.84 0.96 1.06 1.12 1.09
Unemployed da da da da 1.33 1.40 1.60 1.61 1.80 1.84
Other1 da da da da 0.64 0.60 1.10 1.03 0.69 0.66
170421
Table 1.32P – Marijuana Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9305   0.0570   0.9457   0.2092   0.7081  
GENDER                    
Male 0.1389   0.0674   0.1822   0.0341   0.3708  
Female 0.1693   0.4066   0.1454   0.7877   0.1432  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8243   0.1721   0.7631   0.4509   0.6288  
White 0.3773   0.2667   0.3470   0.3658   0.4251  
Black or African American 0.1464   0.1899   0.1690   0.0035   0.4999  
American Indian or Alaska Native 0.5744   0.1064   0.8201   *   0.8937  
Native Hawaiian or Other Pacific Islander 0.1108   *   0.1119   *   *  
Asian 0.7733   0.5077   0.7573   0.4760   0.8438  
Two or More Races 0.7205   0.8091   0.7576   0.2629   0.5642  
Hispanic or Latino 0.5379   0.1415   0.6788   0.2468   0.9637  
EDUCATION                    
< High School da   da   0.1292   0.2139   0.2430  
High School Graduate da   da   0.9922   0.2917   0.7583  
Some College/Associate's Degree da   da   0.7226   0.4163   0.8926  
College Graduate da   da   0.4810   0.7645   0.5114  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.6586   0.3906   0.7992  
Part-Time da   da   0.5352   0.9961   0.5225  
Unemployed da   da   0.9942   0.8625   0.9582  
Other1 da   da   0.8197   0.0677   0.5648  
170421
Table 1.33C – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 524 542 81 77 520 534 163 176 460 479
GENDER                    
Male 398 397 58 57 395 390 117 120 365 357
Female 309 333 56 50 304 330 107 115 266 294
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 500 497 69 68 494 487 145 151 442 437
White 442 433 68 61 472 457 186 187 423 420
Black or African American 182 170 32 32 216 196 83 84 187 166
American Indian or Alaska Native 32 40 4 6 30 39 17 * 25 31
Native Hawaiian or Other Pacific Islander 20 37 * * 16 37 * * 13 34
Asian 83 108 12 17 81 107 41 42 68 96
Two or More Races 71 88 16 16 69 85 35 29 60 81
Hispanic or Latino 180 204 41 39 178 201 75 83 154 180
EDUCATION                    
< High School da da da da 174 178 78 70 159 159
High School Graduate da da da da 265 271 113 111 232 239
Some College/Associate's Degree da da da da 310 330 161 177 262 268
College Graduate da da da da 301 326 79 85 283 304
CURRENT EMPLOYMENT                    
Full-Time da da da da 368 392 137 140 338 356
Part-Time da da da da 207 225 114 132 169 189
Unemployed da da da da 130 141 67 71 107 119
Other1 da da da da 290 272 91 95 268 258
170421
Table 1.33D – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.20 0.20 0.32 0.31 0.21 0.22 0.47 0.51 0.22 0.23
GENDER                    
Male 0.31 0.30 0.46 0.45 0.34 0.33 0.67 0.69 0.37 0.36
Female 0.22 0.24 0.46 0.41 0.24 0.26 0.61 0.67 0.25 0.27
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.22 0.22 0.36 0.36 0.24 0.24 0.53 0.56 0.25 0.24
White 0.26 0.25 0.46 0.42 0.28 0.27 0.66 0.65 0.29 0.28
Black or African American 0.57 0.53 0.82 0.86 0.62 0.57 1.19 1.23 0.68 0.61
American Indian or Alaska Native 1.96 2.25 2.51 3.87 2.13 2.41 5.56 * 2.29 2.31
Native Hawaiian or Other Pacific Islander 2.70 2.94 * * 2.76 3.31 * * 2.97 3.56
Asian 0.58 0.69 0.91 1.22 0.62 0.75 1.77 1.77 0.60 0.81
Two or More Races 1.45 1.57 1.90 1.76 1.74 1.84 2.83 2.84 1.91 2.18
Hispanic or Latino 0.41 0.46 0.71 0.66 0.47 0.52 1.01 1.11 0.51 0.58
EDUCATION                    
< High School da da da da 0.50 0.53 1.19 1.21 0.54 0.56
High School Graduate da da da da 0.40 0.42 0.82 0.86 0.43 0.45
Some College/Associate's Degree da da da da 0.38 0.40 0.77 0.76 0.41 0.42
College Graduate da da da da 0.38 0.39 1.28 1.35 0.39 0.39
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.29 0.28 0.72 0.72 0.31 0.30
Part-Time da da da da 0.57 0.61 0.93 1.05 0.66 0.76
Unemployed da da da da 1.05 1.14 1.45 1.61 1.27 1.38
Other1 da da da da 0.34 0.32 0.87 0.97 0.35 0.34
170421
Table 1.33P – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0764   0.1625   0.0455   0.2430   0.0514  
GENDER                    
Male 0.1716   0.0592   0.0969   0.9912   0.0595  
Female 0.2316   0.9677   0.2210   0.0910   0.3984  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0543   0.2939   0.0360   0.1652   0.0460  
White 0.0844   0.2337   0.0549   0.0225   0.1324  
Black or African American 0.7195   0.7428   0.7415   0.6085   0.9902  
American Indian or Alaska Native 0.6790   0.2724   0.8266   *   0.8124  
Native Hawaiian or Other Pacific Islander 0.6384   *   0.8687   *   0.6138  
Asian 0.1519   0.3043   0.1949   0.7011   0.1441  
Two or More Races 0.0989   0.7430   0.1117   0.7189   0.0284  
Hispanic or Latino 0.9456   0.3294   0.8863   0.9489   0.7698  
EDUCATION                    
< High School da   da   0.7473   0.7634   0.6024  
High School Graduate da   da   0.4329   0.1543   0.5703  
Some College/Associate's Degree da   da   0.1179   0.6034   0.1384  
College Graduate da   da   0.2619   0.6359   0.2292  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.1513   0.7440   0.1197  
Part-Time da   da   0.0641   0.1497   0.2664  
Unemployed da   da   0.1630   0.3642   0.1821  
Other1 da   da   0.8549   0.7834   0.6745  
170421
Table 1.34C – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 413 442 61 61 408 434 140 144 361 391
GENDER                    
Male 329 331 45 44 324 325 105 103 297 296
Female 228 263 42 39 226 259 88 94 195 233
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 395 403 53 52 390 394 124 123 349 357
White 346 349 49 44 363 363 138 132 326 336
Black or African American 153 143 25 22 167 159 64 67 146 136
American Indian or Alaska Native 25 31 3 3 24 31 8 11 22 29
Native Hawaiian or Other Pacific Islander 16 33 * * 13 33 * * 9 *
Asian 67 56 9 14 64 55 29 29 56 46
Two or More Races 50 78 11 14 48 76 25 21 42 73
Hispanic or Latino 147 176 32 29 144 173 65 73 124 157
EDUCATION                    
< High School da da da da 134 140 62 57 121 129
High School Graduate da da da da 213 227 86 89 195 205
Some College/Associate's Degree da da da da 248 262 123 124 211 222
College Graduate da da da da 212 230 57 56 203 216
CURRENT EMPLOYMENT                    
Full-Time da da da da 283 305 106 107 259 280
Part-Time da da da da 149 185 84 92 118 162
Unemployed da da da da 101 118 51 57 83 99
Other1 da da da da 246 226 73 71 227 215
170421
Table 1.34D – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.15 0.16 0.24 0.24 0.17 0.18 0.40 0.42 0.17 0.19
GENDER                    
Male 0.25 0.25 0.36 0.35 0.28 0.28 0.60 0.59 0.30 0.29
Female 0.17 0.19 0.34 0.32 0.18 0.20 0.50 0.55 0.18 0.21
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.18 0.18 0.28 0.27 0.19 0.19 0.45 0.45 0.20 0.20
White 0.20 0.20 0.35 0.32 0.22 0.22 0.56 0.55 0.22 0.23
Black or African American 0.48 0.44 0.67 0.61 0.52 0.49 1.04 1.11 0.57 0.52
American Indian or Alaska Native 1.60 1.76 1.76 2.37 1.79 1.93 3.09 3.91 2.03 2.17
Native Hawaiian or Other Pacific Islander 2.20 2.67 * * 2.21 2.99 * * 2.08 *
Asian 0.46 0.40 0.68 0.98 0.48 0.42 1.36 1.31 0.49 0.42
Two or More Races 1.07 1.44 1.38 1.54 1.28 1.69 2.40 2.36 1.40 2.02
Hispanic or Latino 0.34 0.40 0.55 0.50 0.38 0.45 0.87 0.98 0.41 0.51
EDUCATION                    
< High School da da da da 0.39 0.43 1.02 1.05 0.41 0.46
High School Graduate da da da da 0.33 0.36 0.71 0.73 0.37 0.39
Some College/Associate's Degree da da da da 0.31 0.33 0.68 0.65 0.33 0.35
College Graduate da da da da 0.28 0.29 1.07 1.02 0.29 0.29
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.23 0.23 0.63 0.62 0.24 0.25
Part-Time da da da da 0.43 0.53 0.77 0.87 0.48 0.67
Unemployed da da da da 0.84 0.99 1.23 1.46 1.01 1.20
Other1 da da da da 0.29 0.27 0.77 0.81 0.30 0.28
170421
Table 1.34P – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0069   0.1029   0.0028   0.0828   0.0059  
GENDER                    
Male 0.0602   0.1656   0.0357   0.4720   0.0340  
Female 0.0352   0.3389   0.0210   0.0687   0.0518  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0097   0.2607   0.0054   0.0916   0.0104  
White 0.0389   0.1327   0.0217   0.0349   0.0604  
Black or African American 0.5489   0.5573   0.4920   0.8630   0.4253  
American Indian or Alaska Native 0.3007   0.4444   0.3592   0.5310   0.4679  
Native Hawaiian or Other Pacific Islander 0.8712   *   0.7585   *   *  
Asian 0.5508   0.2297   0.6853   0.7446   0.6115  
Two or More Races 0.0185   0.1532   0.0359   0.8968   0.0123  
Hispanic or Latino 0.4001   0.1804   0.2595   0.5725   0.2969  
EDUCATION                    
< High School da   da   0.7815   0.8961   0.6271  
High School Graduate da   da   0.0702   0.0396   0.1821  
Some College/Associate's Degree da   da   0.0702   0.4336   0.0922  
College Graduate da   da   0.0540   0.9826   0.0498  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0795   0.2908   0.1080  
Part-Time da   da   0.0030   0.1272   0.0193  
Unemployed da   da   0.0184   0.0716   0.0458  
Other1 da   da   0.7020   0.4269   0.4552  
170421
Table 1.35C – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 638 613 23 22 637 611 115 120 615 592
GENDER                    
Male 471 456 16 15 470 456 85 86 460 444
Female 386 378 16 16 384 377 73 73 371 366
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 582 567 19 19 581 564 100 105 566 548
White 519 509 17 19 617 582 107 108 600 564
Black or African American 203 175 3 3 223 195 25 22 220 193
American Indian or Alaska Native 33 37 1 1 33 37 10 8 31 36
Native Hawaiian or Other Pacific Islander 31 23 * * * 23 5 * * 23
Asian 75 109 4 3 73 109 22 17 70 107
Two or More Races 90 98 6 4 90 97 21 20 87 95
Hispanic or Latino 217 233 13 11 217 232 54 50 208 228
EDUCATION                    
< High School da da da da 222 194 46 38 212 191
High School Graduate da da da da 315 338 65 65 311 327
Some College/Associate's Degree da da da da 436 382 93 86 422 363
College Graduate da da da da 365 373 47 51 360 366
CURRENT EMPLOYMENT                    
Full-Time da da da da 501 467 91 80 484 459
Part-Time da da da da 232 248 55 66 226 235
Unemployed da da da da 142 147 35 41 137 139
Other1 da da da da 339 349 57 40 331 344
170421
Table 1.35D – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.24 0.23 0.09 0.09 0.26 0.25 0.33 0.35 0.30 0.28
GENDER                    
Male 0.36 0.35 0.13 0.12 0.40 0.39 0.49 0.49 0.46 0.44
Female 0.28 0.27 0.13 0.13 0.31 0.30 0.42 0.42 0.34 0.33
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.26 0.25 0.10 0.10 0.28 0.27 0.37 0.39 0.32 0.31
White 0.30 0.30 0.13 0.14 0.33 0.32 0.47 0.50 0.37 0.36
Black or African American 0.63 0.54 0.08 0.08 0.70 0.60 0.48 0.45 0.84 0.71
American Indian or Alaska Native 2.08 2.07 0.37 0.86 2.39 2.27 4.18 3.02 2.76 2.76
Native Hawaiian or Other Pacific Islander 3.94 1.95 * * * 2.18 3.01 * * 2.50
Asian 0.52 0.72 0.35 0.20 0.56 0.79 1.04 0.78 0.63 0.93
Two or More Races 1.69 1.70 0.77 0.49 2.02 2.00 2.17 2.33 2.52 2.39
Hispanic or Latino 0.50 0.53 0.23 0.19 0.57 0.60 0.73 0.67 0.68 0.74
EDUCATION                    
< High School da da da da 0.59 0.57 0.80 0.77 0.68 0.66
High School Graduate da da da da 0.47 0.47 0.56 0.58 0.56 0.55
Some College/Associate's Degree da da da da 0.51 0.45 0.56 0.54 0.61 0.53
College Graduate da da da da 0.44 0.45 0.92 0.97 0.47 0.47
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.38 0.33 0.57 0.49 0.41 0.37
Part-Time da da da da 0.64 0.68 0.56 0.67 0.85 0.91
Unemployed da da da da 1.12 1.14 0.96 1.14 1.52 1.49
Other1 da da da da 0.39 0.40 0.65 0.48 0.43 0.44
170421
Table 1.35P – Cocaine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.8928   0.9096   0.8674   0.3913   0.9638  
GENDER                    
Male 0.9466   0.5314   0.9432   0.2616   0.9198  
Female 0.8896   0.4285   0.8517   0.9662   0.8410  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6825   0.7531   0.7158   0.9470   0.7283  
White 0.6017   0.5168   0.6388   0.6898   0.7033  
Black or African American 0.5093   0.7026   0.4902   0.3779   0.5151  
American Indian or Alaska Native 0.4977   0.1480   0.4138   0.1901   0.6606  
Native Hawaiian or Other Pacific Islander 0.4480   *   *   *   *  
Asian 0.5921   0.5906   0.5538   0.2989   0.4041  
Two or More Races 0.2570   0.4483   0.2356   0.3644   0.3595  
Hispanic or Latino 0.1898   0.7769   0.1942   0.0848   0.3444  
EDUCATION                    
< High School da   da   0.2615   0.0522   0.4293  
High School Graduate da   da   0.4254   0.6562   0.5073  
Some College/Associate's Degree da   da   0.0207   0.5176   0.0251  
College Graduate da   da   0.0516   0.8856   0.0464  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.1395   0.8161   0.1338  
Part-Time da   da   0.7312   0.4332   0.8271  
Unemployed da   da   0.3900   0.2336   0.6338  
Other1 da   da   0.3230   0.0002   0.1324  
170421
Table 1.36C – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 192 175 20 18 192 174 91 89 167 152
GENDER                    
Male 154 145 14 13 153 145 71 63 136 131
Female 103 104 13 12 103 104 51 55 93 88
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 175 162 16 15 175 161 80 80 157 141
White 142 143 14 14 144 142 82 80 123 120
Black or African American 102 74 3 3 105 75 19 17 101 73
American Indian or Alaska Native 11 12 1 1 11 12 * 6 7 11
Native Hawaiian or Other Pacific Islander 4 8 * * 4 8 * * * 7
Asian 21 25 4 2 20 25 13 14 16 18
Two or More Races 20 31 5 3 19 31 11 11 16 29
Hispanic or Latino 69 71 11 10 68 70 37 34 53 60
EDUCATION                    
< High School da da da da 76 71 31 27 69 66
High School Graduate da da da da 97 92 43 41 89 80
Some College/Associate's Degree da da da da 114 102 67 67 91 79
College Graduate da da da da 93 101 36 38 85 91
CURRENT EMPLOYMENT                    
Full-Time da da da da 136 122 59 55 123 107
Part-Time da da da da 74 78 44 51 61 61
Unemployed da da da da 55 57 21 29 51 50
Other1 da da da da 85 89 40 30 76 84
170421
Table 1.36D – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.07 0.07 0.08 0.07 0.08 0.07 0.26 0.26 0.08 0.07
GENDER                    
Male 0.12 0.11 0.11 0.10 0.13 0.12 0.40 0.36 0.14 0.13
Female 0.07 0.08 0.11 0.09 0.08 0.08 0.29 0.32 0.09 0.08
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.08 0.07 0.08 0.08 0.09 0.08 0.29 0.29 0.09 0.08
White 0.08 0.08 0.11 0.11 0.09 0.09 0.39 0.39 0.09 0.09
Black or African American 0.32 0.23 0.08 0.08 0.36 0.26 0.38 0.35 0.42 0.30
American Indian or Alaska Native 0.76 0.73 0.37 0.68 0.85 0.82 * 2.23 0.63 0.87
Native Hawaiian or Other Pacific Islander 0.53 0.70 * * 0.65 0.77 * * * 0.77
Asian 0.14 0.17 0.35 0.16 0.15 0.19 0.63 0.62 0.14 0.16
Two or More Races 0.43 0.64 0.60 0.38 0.50 0.76 1.23 1.42 0.52 0.88
Hispanic or Latino 0.16 0.16 0.19 0.16 0.18 0.18 0.50 0.45 0.17 0.19
EDUCATION                    
< High School da da da da 0.22 0.21 0.57 0.55 0.24 0.24
High School Graduate da da da da 0.16 0.15 0.39 0.39 0.17 0.16
Some College/Associate's Degree da da da da 0.15 0.13 0.43 0.42 0.15 0.13
College Graduate da da da da 0.12 0.13 0.74 0.75 0.12 0.13
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.11 0.10 0.39 0.37 0.12 0.10
Part-Time da da da da 0.23 0.24 0.47 0.53 0.26 0.26
Unemployed da da da da 0.46 0.50 0.58 0.84 0.63 0.62
Other1 da da da da 0.10 0.11 0.47 0.37 0.10 0.11
170421
Table 1.36P – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4136   0.5228   0.3800   0.6056   0.4108  
GENDER                    
Male 0.4948   0.2405   0.4340   0.6423   0.2557  
Female 0.6578   0.7184   0.6916   0.1593   0.7800  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3959   0.5750   0.3735   0.2587   0.6003  
White 0.1759   0.9769   0.1755   0.1653   0.3823  
Black or African American 0.2214   0.4428   0.2235   0.4779   0.2712  
American Indian or Alaska Native 0.5114   0.4749   0.4595   *   0.9028  
Native Hawaiian or Other Pacific Islander 0.3720   *   0.4318   *   *  
Asian 0.3913   0.3821   0.3137   0.5855   0.4035  
Two or More Races 0.0967   0.3721   0.0694   0.6009   0.0541  
Hispanic or Latino 0.9096   0.7272   0.8671   0.2265   0.3313  
EDUCATION                    
< High School da   da   0.9928   0.5564   0.7153  
High School Graduate da   da   0.8451   0.9799   0.8869  
Some College/Associate's Degree da   da   0.8084   0.4195   0.3655  
College Graduate da   da   0.0342   0.9438   0.0224  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.9617   0.9171   0.9293  
Part-Time da   da   0.3114   0.1068   0.9603  
Unemployed da   da   0.1640   0.6000   0.2022  
Other1 da   da   0.8955   0.1318   0.4072  
170421
Table 1.37C – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 128 120 13 7 127 119 49 45 117 110
GENDER                    
Male 103 101 10 4 103 101 38 37 95 93
Female 69 67 8 6 69 67 27 26 65 62
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 121 109 9 6 121 108 43 41 112 99
White 89 89 7 5 90 89 42 36 80 79
Black or African American 80 53 1 * 81 54 13 9 78 53
American Indian or Alaska Native 3 11 0 1 3 11 1 * 3 *
Native Hawaiian or Other Pacific Islander * 8 * * * 8 * * * 7
Asian 12 19 4 2 11 19 6 11 9 12
Two or More Races 12 25 3 2 12 25 7 8 9 23
Hispanic or Latino 39 51 8 3 38 51 20 19 33 46
EDUCATION                    
< High School da da da da 56 60 17 18 53 57
High School Graduate da da da da 55 57 22 18 53 53
Some College/Associate's Degree da da da da 73 63 33 34 65 53
College Graduate da da da da 56 62 22 16 52 59
CURRENT EMPLOYMENT                    
Full-Time da da da da 77 75 33 29 72 69
Part-Time da da da da 46 51 21 27 41 43
Unemployed da da da da 45 37 12 10 44 36
Other1 da da da da 66 69 22 16 62 66
170421
Table 1.37D – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.05 0.04 0.05 0.03 0.05 0.05 0.14 0.13 0.06 0.05
GENDER                    
Male 0.08 0.08 0.08 0.03 0.09 0.09 0.22 0.21 0.10 0.09
Female 0.05 0.05 0.07 0.05 0.05 0.05 0.16 0.15 0.06 0.06
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.05 0.05 0.03 0.06 0.05 0.16 0.15 0.06 0.06
White 0.05 0.05 0.06 0.04 0.06 0.06 0.21 0.19 0.06 0.06
Black or African American 0.25 0.17 0.04 * 0.28 0.18 0.25 0.19 0.32 0.22
American Indian or Alaska Native 0.20 0.69 0.25 0.63 0.22 0.77 0.52 * 0.24 *
Native Hawaiian or Other Pacific Islander * 0.68 * * * 0.75 * * * 0.76
Asian 0.08 0.13 0.35 0.15 0.08 0.15 0.31 0.51 0.08 0.11
Two or More Races 0.26 0.50 0.39 0.24 0.30 0.60 0.80 0.99 0.31 0.71
Hispanic or Latino 0.09 0.11 0.14 0.06 0.10 0.13 0.27 0.26 0.11 0.15
EDUCATION                    
< High School da da da da 0.16 0.18 0.32 0.37 0.18 0.21
High School Graduate da da da da 0.09 0.09 0.20 0.17 0.10 0.10
Some College/Associate's Degree da da da da 0.10 0.08 0.22 0.22 0.11 0.09
College Graduate da da da da 0.08 0.08 0.48 0.34 0.08 0.08
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.07 0.06 0.22 0.20 0.07 0.06
Part-Time da da da da 0.14 0.16 0.23 0.29 0.17 0.19
Unemployed da da da da 0.39 0.33 0.35 0.29 0.55 0.46
Other1 da da da da 0.08 0.09 0.27 0.20 0.09 0.09
170421
Table 1.37P – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9381   0.0847   0.9472   0.7310   0.7984  
GENDER                    
Male 0.9217   0.0054   0.7687   0.9212   0.7615  
Female 0.7735   0.6850   0.7381   0.4406   0.9811  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6662   0.1294   0.7395   0.7636   0.8367  
White 0.8675   0.3117   0.9209   0.6269   0.8665  
Black or African American 0.1732   *   0.1741   0.3509   0.2085  
American Indian or Alaska Native 0.2184   0.4125   0.2515   *   *  
Native Hawaiian or Other Pacific Islander *   *   *   *   *  
Asian 0.3431   0.4055   0.2520   0.3063   0.4455  
Two or More Races 0.2693   0.3823   0.2166   0.9443   0.1735  
Hispanic or Latino 0.3940   0.3263   0.3225   0.8685   0.2177  
EDUCATION                    
< High School da   da   0.5024   0.6300   0.5671  
High School Graduate da   da   0.6287   0.4855   0.8273  
Some College/Associate's Degree da   da   0.2737   0.8544   0.2431  
College Graduate da   da   0.1994   0.6748   0.1348  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.9184   0.5962   0.9235  
Part-Time da   da   0.6637   0.6352   0.8433  
Unemployed da   da   0.8565   0.5883   0.7501  
Other1 da   da   0.6989   0.0388   0.7917  
170421
Table 1.38C – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 305 302 5 5 306 301 42 35 302 297
GENDER                    
Male 247 240 4 1 246 240 34 27 245 235
Female 165 181 3 5 165 181 24 21 163 180
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 288 285 4 4 288 284 34 32 286 280
White 229 234 4 4 234 241 33 30 231 238
Black or African American 153 133 1 * 162 142 5 1 162 142
American Indian or Alaska Native 13 21 * 0 13 21 2 5 13 20
Native Hawaiian or Other Pacific Islander 10 3 * * 10 3 0 * 10 3
Asian 19 72 * 2 19 72 4 6 19 72
Two or More Races 39 47 0 1 39 47 5 10 38 46
Hispanic or Latino 95 105 2 2 96 105 25 14 94 104
EDUCATION                    
< High School da da da da 137 125 23 14 132 124
High School Graduate da da da da 172 183 29 25 170 179
Some College/Associate's Degree da da da da 185 176 21 20 185 174
College Graduate da da da da 101 128 6 4 101 128
CURRENT EMPLOYMENT                    
Full-Time da da da da 203 196 31 24 200 194
Part-Time da da da da 94 113 19 16 90 112
Unemployed da da da da 86 75 14 13 86 75
Other1 da da da da 178 184 19 14 177 184
170421
Table 1.38D – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.11 0.11 0.02 0.02 0.13 0.12 0.12 0.10 0.15 0.14
GENDER                    
Male 0.19 0.18 0.03 0.01 0.21 0.20 0.19 0.16 0.25 0.23
Female 0.12 0.13 0.02 0.04 0.13 0.14 0.14 0.12 0.15 0.16
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.13 0.13 0.02 0.02 0.14 0.14 0.12 0.12 0.16 0.16
White 0.13 0.14 0.03 0.03 0.15 0.15 0.17 0.16 0.16 0.17
Black or African American 0.48 0.41 0.04 * 0.53 0.46 0.10 0.03 0.64 0.55
American Indian or Alaska Native 0.90 1.29 * 0.19 1.01 1.42 0.81 1.87 1.20 1.71
Native Hawaiian or Other Pacific Islander 1.40 0.28 * * 1.68 0.31 0.08 * 2.32 0.37
Asian 0.13 0.49 * 0.12 0.14 0.53 0.18 0.26 0.17 0.63
Two or More Races 0.82 0.94 0.01 0.09 0.99 1.13 0.54 1.24 1.27 1.36
Hispanic or Latino 0.22 0.24 0.04 0.04 0.25 0.27 0.34 0.18 0.31 0.34
EDUCATION                    
< High School da da da da 0.38 0.38 0.42 0.29 0.44 0.45
High School Graduate da da da da 0.27 0.29 0.26 0.24 0.32 0.34
Some College/Associate's Degree da da da da 0.25 0.23 0.15 0.14 0.30 0.28
College Graduate da da da da 0.14 0.17 0.14 0.09 0.15 0.18
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.17 0.16 0.21 0.16 0.19 0.18
Part-Time da da da da 0.29 0.34 0.21 0.18 0.38 0.47
Unemployed da da da da 0.72 0.65 0.40 0.39 1.02 0.91
Other1 da da da da 0.22 0.22 0.23 0.18 0.24 0.25
170421
Table 1.38P – Crack Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4518   0.5057   0.4376   0.0086   0.6259  
GENDER                    
Male 0.2957   0.2957   0.2955   0.0208   0.4237  
Female 0.8569   0.0958   0.8923   0.2236   0.7801  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8730   0.5203   0.8516   0.1352   0.9615  
White 0.4741   0.6603   0.4610   0.0876   0.5935  
Black or African American 0.8805   *   0.8690   0.1476   0.8552  
American Indian or Alaska Native 0.6148   *   0.6570   0.2651   0.8182  
Native Hawaiian or Other Pacific Islander 0.0272   *   0.0247   *   0.0229  
Asian 0.0509   *   0.0523   0.6567   0.0545  
Two or More Races 0.2347   0.1793   0.2441   0.6093   0.3294  
Hispanic or Latino 0.0780   0.8311   0.0774   0.0142   0.1965  
EDUCATION                    
< High School da   da   0.3550   0.0265   0.4900  
High School Graduate da   da   0.8099   0.2676   0.7209  
Some College/Associate's Degree da   da   0.1783   0.4413   0.2096  
College Graduate da   da   0.1974   0.2349   0.1750  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.2775   0.0650   0.3944  
Part-Time da   da   0.4281   0.2447   0.2804  
Unemployed da   da   0.4194   0.8912   0.4376  
Other1 da   da   0.3875   0.1522   0.4384  
170421
Table 1.39C – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 93 88 3 4 93 88 19 19 93 86
GENDER                    
Male 82 71 2 * 82 71 17 14 82 70
Female 43 55 1 4 43 55 9 12 42 54
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 91 83 2 4 91 83 14 18 91 82
White 51 66 1 4 51 66 13 18 49 64
Black or African American 75 52 1 * 76 53 4 * 76 53
American Indian or Alaska Native * 1 * * * 1 * 0 * 0
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian 8 * * * 8 1 * 1 8 *
Two or More Races 11 15 0 * 11 15 1 1 11 15
Hispanic or Latino 23 29 2 2 23 28 13 6 18 28
EDUCATION                    
< High School da da da da 40 47 13 4 37 47
High School Graduate da da da da 61 43 8 13 60 41
Some College/Associate's Degree da da da da 52 47 11 11 51 46
College Graduate da da da da 27 45 2 * 27 45
CURRENT EMPLOYMENT                    
Full-Time da da da da 65 42 15 11 65 41
Part-Time da da da da 23 37 7 11 22 35
Unemployed da da da da 26 34 5 6 25 34
Other1 da da da da 56 60 9 7 55 60
170421
Table 1.39D – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.03 0.03 0.01 0.02 0.04 0.04 0.05 0.05 0.04 0.04
GENDER                    
Male 0.06 0.05 0.02 * 0.07 0.06 0.10 0.08 0.08 0.07
Female 0.03 0.04 0.01 0.04 0.03 0.04 0.05 0.07 0.04 0.05
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.04 0.04 0.01 0.02 0.04 0.04 0.05 0.07 0.05 0.05
White 0.03 0.04 0.01 0.03 0.03 0.04 0.07 0.09 0.04 0.05
Black or African American 0.23 0.16 0.04 * 0.26 0.18 0.07 * 0.32 0.22
American Indian or Alaska Native * 0.04 * * * 0.04 * 0.15 * 0.04
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian 0.05 * * * 0.06 0.01 * 0.03 0.07 *
Two or More Races 0.24 0.31 0.01 * 0.29 0.38 0.15 0.12 0.37 0.47
Hispanic or Latino 0.05 0.06 0.03 0.04 0.06 0.07 0.18 0.07 0.06 0.09
EDUCATION                    
< High School da da da da 0.11 0.14 0.24 0.08 0.13 0.17
High School Graduate da da da da 0.10 0.07 0.08 0.13 0.12 0.08
Some College/Associate's Degree da da da da 0.07 0.06 0.08 0.08 0.09 0.07
College Graduate da da da da 0.04 0.06 0.05 * 0.04 0.06
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.06 0.03 0.10 0.07 0.06 0.04
Part-Time da da da da 0.07 0.11 0.08 0.12 0.09 0.15
Unemployed da da da da 0.23 0.31 0.13 0.18 0.32 0.43
Other1 da da da da 0.07 0.07 0.11 0.10 0.08 0.08
170421
Table 1.39P – Crack Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7331   0.2529   0.7705   0.4938   0.6642  
GENDER                    
Male 0.6251   *   0.6449   0.2902   0.8058  
Female 0.1659   0.0422   0.2115   0.7136   0.2350  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7065   0.2530   0.7384   0.7049   0.7933  
White 0.2439   0.1074   0.2766   0.5396   0.3328  
Black or African American 0.6419   *   0.6467   *   0.6708  
American Indian or Alaska Native *   *   *   *   *  
Native Hawaiian or Other Pacific Islander *   *   *   *   *  
Asian *   *   0.3641   *   *  
Two or More Races 0.8281   *   0.8288   0.5812   0.8381  
Hispanic or Latino 0.9542   0.7039   0.9287   0.0656   0.4743  
EDUCATION                    
< High School da   da   0.3243   0.0479   0.1529  
High School Graduate da   da   0.4505   0.2554   0.2993  
Some College/Associate's Degree da   da   0.5337   0.7106   0.5784  
College Graduate da   da   0.0814   *   0.0732  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.1219   0.3246   0.1831  
Part-Time da   da   0.3352   0.8421   0.3375  
Unemployed da   da   0.0249   0.6552   0.0304  
Other1 da   da   0.7696   0.5805   0.7143  
170421
Table 1.40C – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 64 64 1 2 64 64 13 6 62 64
GENDER                    
Male 55 53 * * 55 53 11 6 54 53
Female 32 40 1 2 32 40 6 2 32 40
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 61 60 1 2 61 60 6 5 61 59
White 39 47 * 2 39 47 6 5 38 47
Black or African American 49 38 1 * 50 38 * * 50 38
American Indian or Alaska Native * * * * * * * * * *
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian * * * * * * * * * *
Two or More Races 3 15 * * 3 15 1 * 3 15
Hispanic or Latino 18 25 * * 18 25 11 3 14 24
EDUCATION                    
< High School da da da da 26 35 11 2 24 35
High School Graduate da da da da 29 34 4 2 29 34
Some College/Associate's Degree da da da da 42 41 5 5 42 41
College Graduate da da da da 24 22 * * 24 22
CURRENT EMPLOYMENT                    
Full-Time da da da da 34 31 12 5 32 31
Part-Time da da da da 21 19 1 * 21 19
Unemployed da da da da 21 27 1 2 21 27
Other1 da da da da 43 48 5 1 42 48
170421
Table 1.40D – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.02 0.02 0.01 0.01 0.03 0.03 0.04 0.02 0.03 0.03
GENDER                    
Male 0.04 0.04 * * 0.05 0.05 0.06 0.03 0.05 0.05
Female 0.02 0.03 0.01 0.02 0.03 0.03 0.03 0.01 0.03 0.04
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.03 0.03 0.01 0.01 0.03 0.03 0.02 0.02 0.03 0.03
White 0.02 0.03 * 0.01 0.02 0.03 0.03 0.03 0.03 0.03
Black or African American 0.15 0.12 0.04 * 0.17 0.13 * * 0.21 0.16
American Indian or Alaska Native * * * * * * * * * *
Native Hawaiian or Other Pacific Islander * * * * * * * * * *
Asian * * * * * * * * * *
Two or More Races 0.07 0.30 * * 0.09 0.36 0.14 * 0.11 0.45
Hispanic or Latino 0.04 0.06 * * 0.05 0.06 0.15 0.04 0.05 0.08
EDUCATION                    
< High School da da da da 0.08 0.11 0.21 0.04 0.08 0.13
High School Graduate da da da da 0.05 0.06 0.03 0.02 0.06 0.07
Some College/Associate's Degree da da da da 0.06 0.05 0.03 0.03 0.07 0.07
College Graduate da da da da 0.03 0.03 * * 0.03 0.03
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.03 0.03 0.08 0.04 0.03 0.03
Part-Time da da da da 0.07 0.06 0.01 * 0.09 0.08
Unemployed da da da da 0.18 0.24 0.03 0.05 0.26 0.34
Other1 da da da da 0.05 0.06 0.07 0.02 0.06 0.07
170421
Table 1.40P – Crack Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6982   0.4399   0.7153   0.0929   0.5302  
GENDER                    
Male 0.9321   *   0.9300   0.2898   0.9346  
Female 0.4166   0.4403   0.4377   0.0953   0.3285  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6939   0.4373   0.7125   0.4796   0.6680  
White 0.5029   *   0.5392   0.6111   0.4943  
Black or African American 0.7959   *   0.8083   *   0.7942  
American Indian or Alaska Native *   *   *   *   *  
Native Hawaiian or Other Pacific Islander *   *   *   *   *  
Asian *   *   *   *   *  
Two or More Races 0.5651   *   0.5654   *   0.4993  
Hispanic or Latino 0.9453   *   0.9454   0.1192   0.4705  
EDUCATION                    
< High School da   da   0.4850   0.1092   0.2611  
High School Graduate da   da   0.9857   0.5237   0.9732  
Some College/Associate's Degree da   da   0.8208   0.7552   0.8506  
College Graduate da   da   0.4803   *   0.4785  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.4420   0.1446   0.7060  
Part-Time da   da   0.6577   *   0.6839  
Unemployed da   da   0.0892   0.5130   0.1028  
Other1 da   da   0.6842   0.3121   0.6251  
170421
Table 1.41C – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 635 642 44 38 630 632 139 143 592 604
GENDER                    
Male 451 468 32 29 450 461 104 102 430 443
Female 390 383 29 25 387 380 90 83 371 369
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 588 606 38 31 585 598 121 122 556 576
White 533 543 34 26 641 634 132 133 609 603
Black or African American 151 146 12 11 163 157 40 37 153 150
American Indian or Alaska Native 30 51 2 5 30 49 8 * 27 47
Native Hawaiian or Other Pacific Islander 16 33 * * 14 33 6 * 13 31
Asian 86 126 8 10 86 126 31 31 75 118
Two or More Races 92 95 9 8 91 94 27 23 87 91
Hispanic or Latino 205 191 23 22 203 190 67 68 182 179
EDUCATION                    
< High School da da da da 192 169 55 48 182 161
High School Graduate da da da da 290 320 84 75 271 306
Some College/Associate's Degree da da da da 434 387 114 110 406 362
College Graduate da da da da 402 409 61 67 394 398
CURRENT EMPLOYMENT                    
Full-Time da da da da 500 486 110 104 479 468
Part-Time da da da da 227 258 70 85 212 237
Unemployed da da da da 129 150 47 49 120 143
Other1 da da da da 344 322 71 50 329 313
170421
Table 1.41D – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.24 0.24 0.18 0.15 0.26 0.26 0.40 0.41 0.28 0.29
GENDER                    
Male 0.35 0.36 0.25 0.23 0.38 0.39 0.59 0.59 0.43 0.44
Female 0.28 0.28 0.24 0.20 0.31 0.30 0.52 0.48 0.34 0.34
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.26 0.27 0.20 0.16 0.29 0.29 0.44 0.45 0.31 0.32
White 0.31 0.32 0.25 0.19 0.34 0.34 0.54 0.57 0.37 0.37
Black or African American 0.47 0.45 0.34 0.33 0.52 0.51 0.72 0.71 0.60 0.59
American Indian or Alaska Native 1.95 2.44 1.18 2.68 2.21 2.62 3.35 * 2.51 3.06
Native Hawaiian or Other Pacific Islander 2.17 2.72 * * 2.40 3.03 3.54 * 2.99 3.42
Asian 0.60 0.81 0.64 0.75 0.66 0.89 1.39 1.37 0.68 1.00
Two or More Races 1.79 1.65 1.14 0.91 2.15 1.95 2.57 2.49 2.65 2.32
Hispanic or Latino 0.47 0.43 0.40 0.38 0.54 0.49 0.90 0.92 0.60 0.58
EDUCATION                    
< High School da da da da 0.54 0.52 0.90 0.90 0.60 0.58
High School Graduate da da da da 0.43 0.46 0.70 0.66 0.49 0.53
Some College/Associate's Degree da da da da 0.49 0.45 0.64 0.64 0.58 0.52
College Graduate da da da da 0.49 0.46 1.15 1.17 0.51 0.48
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.37 0.34 0.65 0.62 0.40 0.37
Part-Time da da da da 0.63 0.70 0.69 0.80 0.82 0.91
Unemployed da da da da 1.05 1.18 1.17 1.28 1.41 1.58
Other1 da da da da 0.39 0.38 0.77 0.60 0.42 0.41
170421
Table 1.41P – Hallucinogen Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7206   0.1521   0.6610   0.0101   0.2839  
GENDER                    
Male 0.7866   0.6492   0.7892   0.0044   0.7062  
Female 0.3699   0.1018   0.3087   0.4507   0.2131  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.5925   0.1046   0.5438   0.0913   0.3144  
White 0.9768   0.1056   0.9736   0.1343   0.7302  
Black or African American 0.7096   0.6710   0.7040   0.2541   0.5006  
American Indian or Alaska Native 0.0236   0.1244   0.0411   *   0.0917  
Native Hawaiian or Other Pacific Islander 0.1758   *   0.0981   *   0.2309  
Asian 0.1312   0.4754   0.1406   0.6031   0.0906  
Two or More Races 0.8676   0.3534   0.7973   0.5283   0.6678  
Hispanic or Latino 0.7214   0.8310   0.7393   0.0266   0.6342  
EDUCATION                    
< High School da   da   0.0373   0.3250   0.0639  
High School Graduate da   da   0.2036   0.8953   0.1806  
Some College/Associate's Degree da   da   0.0962   0.0007   0.4120  
College Graduate da   da   0.0300   0.5994   0.0215  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.7231   0.6164   0.8095  
Part-Time da   da   0.1401   0.3886   0.0591  
Unemployed da   da   0.0530   0.7344   0.0593  
Other1 da   da   0.6537   0.0000   0.6676  
170421
Table 1.42C – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 175 185 37 31 171 181 99 98 125 138
GENDER                    
Male 137 139 27 25 134 134 76 74 98 108
Female 92 104 25 19 90 102 55 58 66 83
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 156 165 31 26 154 162 83 85 116 128
White 133 146 27 22 134 143 80 82 103 114
Black or African American 49 38 9 9 48 37 27 24 37 28
American Indian or Alaska Native 5 19 2 4 5 17 3 4 4 17
Native Hawaiian or Other Pacific Islander 7 7 * * 3 7 3 * * 6
Asian 51 45 7 8 50 44 22 23 44 37
Two or More Races 23 24 9 7 21 23 16 11 13 21
Hispanic or Latino 71 67 19 17 68 65 51 46 41 44
EDUCATION                    
< High School da da da da 51 55 34 31 39 45
High School Graduate da da da da 68 66 52 40 45 49
Some College/Associate's Degree da da da da 102 111 69 77 69 78
College Graduate da da da da 90 94 36 40 81 82
CURRENT EMPLOYMENT                    
Full-Time da da da da 117 129 61 59 99 111
Part-Time da da da da 72 82 54 61 44 53
Unemployed da da da da 38 54 29 34 26 42
Other1 da da da da 62 62 40 34 45 51
170421
Table 1.42D – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.07 0.07 0.15 0.13 0.07 0.07 0.28 0.28 0.06 0.07
GENDER                    
Male 0.11 0.11 0.21 0.20 0.11 0.11 0.43 0.43 0.10 0.11
Female 0.07 0.07 0.20 0.15 0.07 0.08 0.32 0.34 0.06 0.08
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.07 0.16 0.14 0.07 0.08 0.30 0.31 0.07 0.07
White 0.08 0.09 0.20 0.16 0.08 0.09 0.37 0.40 0.07 0.08
Black or African American 0.15 0.12 0.25 0.26 0.16 0.13 0.52 0.47 0.15 0.12
American Indian or Alaska Native 0.35 1.12 1.02 2.23 0.38 1.11 1.23 1.65 0.37 1.35
Native Hawaiian or Other Pacific Islander 1.01 0.56 * * 0.42 0.62 1.58 * * 0.71
Asian 0.35 0.31 0.59 0.60 0.37 0.34 1.00 1.03 0.38 0.34
Two or More Races 0.50 0.51 1.12 0.78 0.54 0.59 1.73 1.42 0.44 0.64
Hispanic or Latino 0.16 0.15 0.34 0.29 0.18 0.17 0.68 0.61 0.14 0.14
EDUCATION                    
< High School da da da da 0.15 0.17 0.59 0.62 0.13 0.16
High School Graduate da da da da 0.11 0.11 0.47 0.38 0.09 0.10
Some College/Associate's Degree da da da da 0.14 0.14 0.44 0.47 0.11 0.13
College Graduate da da da da 0.12 0.12 0.73 0.78 0.12 0.12
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.10 0.11 0.40 0.39 0.09 0.10
Part-Time da da da da 0.21 0.25 0.56 0.62 0.18 0.23
Unemployed da da da da 0.34 0.49 0.78 0.97 0.33 0.54
Other1 da da da da 0.08 0.08 0.47 0.42 0.06 0.07
170421
Table 1.42P – Hallucinogen Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4537   0.1849   0.2917   0.7504   0.0768  
GENDER                    
Male 0.9946   0.7249   0.9372   0.8432   0.6879  
Female 0.1995   0.0987   0.0885   0.7912   0.0123  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2897   0.2319   0.1922   0.9558   0.0753  
White 0.1628   0.5148   0.1248   0.5184   0.1075  
Black or African American 0.3334   0.7032   0.3528   0.3876   0.6711  
American Indian or Alaska Native 0.0300   0.3457   0.0274   0.6234   0.0402  
Native Hawaiian or Other Pacific Islander 0.3347   *   0.6506   *   *  
Asian 0.9518   0.9944   0.9514   0.6406   0.9517  
Two or More Races 0.9939   0.1709   0.6128   0.6389   0.1677  
Hispanic or Latino 0.6076   0.4855   0.7448   0.4581   0.6998  
EDUCATION                    
< High School da   da   0.9681   0.5019   0.8678  
High School Graduate da   da   0.8531   0.5298   0.5270  
Some College/Associate's Degree da   da   0.1137   0.7400   0.0176  
College Graduate da   da   0.8373   0.7394   0.7669  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.5731   0.4863   0.6908  
Part-Time da   da   0.2921   0.8665   0.2670  
Unemployed da   da   0.0028   0.1866   0.0033  
Other1 da   da   0.1198   0.0004   0.4911  
170421
Table 1.43C – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 83 94 17 16 81 92 51 50 60 74
GENDER                    
Male 70 73 12 13 69 72 43 41 54 58
Female 39 53 12 9 38 52 28 28 21 45
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 74 81 14 13 74 79 42 43 57 64
White 65 70 11 12 65 69 34 39 52 55
Black or African American 27 18 4 2 26 18 16 13 21 14
American Indian or Alaska Native 4 15 0 1 4 15 1 1 4 15
Native Hawaiian or Other Pacific Islander 5 1 * * 1 1 * * * *
Asian 16 29 4 4 15 29 9 13 13 26
Two or More Races 15 15 5 3 14 15 9 6 10 13
Hispanic or Latino 35 44 10 7 33 44 27 24 18 36
EDUCATION                    
< High School da da da da 28 40 18 19 24 36
High School Graduate da da da da 35 41 23 22 26 34
Some College/Associate's Degree da da da da 44 47 36 35 25 32
College Graduate da da da da 43 49 13 17 40 46
CURRENT EMPLOYMENT                    
Full-Time da da da da 57 63 30 31 47 52
Part-Time da da da da 37 51 26 31 26 38
Unemployed da da da da 22 31 15 19 16 25
Other1 da da da da 34 31 24 13 25 28
170421
Table 1.43D – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.03 0.03 0.07 0.06 0.03 0.04 0.14 0.14 0.03 0.04
GENDER                    
Male 0.05 0.06 0.10 0.10 0.06 0.06 0.24 0.24 0.05 0.06
Female 0.03 0.04 0.10 0.07 0.03 0.04 0.16 0.16 0.02 0.04
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.03 0.04 0.07 0.07 0.04 0.04 0.15 0.16 0.03 0.04
White 0.04 0.04 0.08 0.09 0.04 0.04 0.17 0.20 0.04 0.04
Black or African American 0.08 0.06 0.11 0.05 0.09 0.06 0.31 0.25 0.09 0.06
American Indian or Alaska Native 0.26 0.92 0.26 0.56 0.29 1.02 0.43 0.51 0.34 1.23
Native Hawaiian or Other Pacific Islander 0.66 0.10 * * 0.20 0.11 * * * *
Asian 0.11 0.20 0.29 0.30 0.12 0.22 0.43 0.59 0.11 0.23
Two or More Races 0.32 0.31 0.61 0.42 0.36 0.37 1.04 0.80 0.34 0.41
Hispanic or Latino 0.08 0.10 0.17 0.13 0.09 0.11 0.36 0.32 0.06 0.11
EDUCATION                    
< High School da da da da 0.08 0.12 0.33 0.38 0.08 0.13
High School Graduate da da da da 0.06 0.07 0.21 0.21 0.05 0.07
Some College/Associate's Degree da da da da 0.06 0.06 0.25 0.23 0.04 0.05
College Graduate da da da da 0.06 0.06 0.29 0.36 0.06 0.06
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.05 0.05 0.20 0.21 0.04 0.05
Part-Time da da da da 0.11 0.16 0.29 0.33 0.11 0.16
Unemployed da da da da 0.19 0.27 0.43 0.55 0.21 0.32
Other1 da da da da 0.04 0.04 0.29 0.16 0.03 0.04
170421
Table 1.43P – Hallucinogen Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.2273   0.7680   0.2016   0.5796   0.1847  
GENDER                    
Male 0.7802   0.4504   0.6746   0.8400   0.5368  
Female 0.0066   0.2045   0.0017   0.5094   0.0004  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.3748   0.8236   0.3465   0.3487   0.5451  
White 0.3032   0.7852   0.3158   0.1451   0.7399  
Black or African American 0.1440   0.2581   0.1763   0.3595   0.3451  
American Indian or Alaska Native 0.2075   0.3609   0.2315   0.9642   0.2275  
Native Hawaiian or Other Pacific Islander 0.2938   *   0.7099   *   *  
Asian 0.2339   0.7005   0.2526   0.6544   0.3114  
Two or More Races 0.7766   0.6296   0.8854   0.7468   0.8553  
Hispanic or Latino 0.3888   0.8409   0.3568   0.6164   0.0756  
EDUCATION                    
< High School da   da   0.6527   0.3729   0.9259  
High School Graduate da   da   0.7975   0.8651   0.5839  
Some College/Associate's Degree da   da   0.4506   0.7638   0.1458  
College Graduate da   da   0.2670   0.1719   0.5376  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.4523   0.2811   0.7629  
Part-Time da   da   0.1308   0.1420   0.4824  
Unemployed da   da   0.1349   0.7112   0.0931  
Other1 da   da   0.1861   0.0021   0.6002  
170421
Table 1.44C – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 459 471 73 65 453 459 104 106 438 439
GENDER                    
Male 362 362 50 46 357 355 80 80 345 340
Female 262 260 51 46 260 256 64 66 248 245
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 430 435 62 58 424 427 88 90 411 412
White 404 400 54 51 437 427 87 85 425 414
Black or African American 98 91 28 23 95 92 30 31 90 86
American Indian or Alaska Native 24 38 4 4 22 37 7 7 21 35
Native Hawaiian or Other Pacific Islander 15 37 * * 14 37 3 * 14 36
Asian 66 101 17 19 63 99 24 22 55 96
Two or More Races 62 54 11 12 61 53 19 15 58 50
Hispanic or Latino 155 143 35 32 152 138 52 53 145 127
EDUCATION                    
< High School da da da da 157 112 42 39 149 108
High School Graduate da da da da 198 201 61 56 189 193
Some College/Associate's Degree da da da da 300 267 74 75 288 252
College Graduate da da da da 287 313 38 42 282 306
CURRENT EMPLOYMENT                    
Full-Time da da da da 357 364 72 71 347 353
Part-Time da da da da 178 177 56 62 166 167
Unemployed da da da da 88 99 33 33 85 92
Other1 da da da da 242 229 52 49 233 222
170421
Table 1.44D – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.17 0.17 0.29 0.26 0.19 0.19 0.30 0.31 0.21 0.21
GENDER                    
Male 0.28 0.28 0.39 0.36 0.30 0.30 0.45 0.46 0.35 0.34
Female 0.19 0.19 0.42 0.38 0.21 0.20 0.37 0.39 0.23 0.22
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.19 0.19 0.32 0.30 0.21 0.21 0.32 0.33 0.23 0.23
White 0.24 0.23 0.38 0.36 0.25 0.25 0.40 0.42 0.28 0.28
Black or African American 0.30 0.28 0.72 0.62 0.33 0.31 0.59 0.61 0.38 0.35
American Indian or Alaska Native 1.57 2.13 2.59 2.38 1.70 2.33 3.35 2.81 1.93 2.70
Native Hawaiian or Other Pacific Islander 2.01 2.93 * * 2.26 3.19 1.89 * 3.00 3.71
Asian 0.42 0.65 1.38 1.32 0.44 0.70 1.10 0.99 0.47 0.81
Two or More Races 1.28 1.06 1.43 1.34 1.51 1.26 2.03 1.80 1.83 1.48
Hispanic or Latino 0.35 0.32 0.60 0.55 0.40 0.36 0.70 0.70 0.48 0.41
EDUCATION                    
< High School da da da da 0.44 0.35 0.72 0.78 0.50 0.40
High School Graduate da da da da 0.32 0.31 0.52 0.51 0.36 0.36
Some College/Associate's Degree da da da da 0.38 0.33 0.47 0.48 0.45 0.39
College Graduate da da da da 0.35 0.39 0.76 0.80 0.37 0.41
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.28 0.28 0.45 0.46 0.31 0.31
Part-Time da da da da 0.52 0.51 0.58 0.63 0.67 0.68
Unemployed da da da da 0.75 0.84 0.90 0.97 1.03 1.09
Other1 da da da da 0.29 0.28 0.58 0.60 0.31 0.30
170421
Table 1.44P – Inhalant Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0216   0.0326   0.0425   0.7787   0.0429  
GENDER                    
Male 0.0310   0.1375   0.0448   0.4289   0.0573  
Female 0.2687   0.1215   0.4142   0.6061   0.3327  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0786   0.0623   0.1255   0.6459   0.0930  
White 0.0728   0.1341   0.1015   0.5326   0.0698  
Black or African American 0.4491   0.2133   0.6521   0.4149   0.4750  
American Indian or Alaska Native 0.9764   0.8858   0.9806   0.9010   0.9899  
Native Hawaiian or Other Pacific Islander 0.1587   *   0.1747   *   0.3417  
Asian 0.6239   0.5154   0.5414   0.3624   0.3900  
Two or More Races 0.4554   0.9419   0.4398   0.3579   0.5954  
Hispanic or Latino 0.0387   0.2857   0.0594   0.2027   0.1442  
EDUCATION                    
< High School da   da   0.0114   0.8859   0.0109  
High School Graduate da   da   0.4245   0.6343   0.5089  
Some College/Associate's Degree da   da   0.0064   0.6716   0.0065  
College Graduate da   da   0.4559   0.4152   0.5145  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0874   0.8632   0.0850  
Part-Time da   da   0.9465   0.9594   0.9239  
Unemployed da   da   0.4908   0.8289   0.5161  
Other1 da   da   0.0611   0.5964   0.0717  
170421
Table 1.45C – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 93 91 39 34 83 85 43 47 75 73
GENDER                    
Male 75 80 26 25 69 75 35 38 63 67
Female 58 49 30 26 49 44 24 28 43 34
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 85 81 33 29 78 75 36 42 69 65
White 69 74 29 25 64 72 31 40 58 61
Black or African American 24 22 13 13 21 18 17 12 11 14
American Indian or Alaska Native 5 10 4 1 4 * 1 0 4 *
Native Hawaiian or Other Pacific Islander 2 3 * * 0 2 0 * * 2
Asian 32 12 11 5 30 11 9 7 28 9
Two or More Races 14 17 5 6 13 16 8 2 10 16
Hispanic or Latino 35 44 20 18 28 40 20 22 19 31
EDUCATION                    
< High School da da da da 21 30 15 18 14 24
High School Graduate da da da da 46 43 25 22 43 37
Some College/Associate's Degree da da da da 41 45 26 33 31 31
College Graduate da da da da 55 50 18 16 50 50
CURRENT EMPLOYMENT                    
Full-Time da da da da 69 64 26 25 63 57
Part-Time da da da da 32 42 28 33 17 27
Unemployed da da da da 19 32 11 12 15 30
Other1 da da da da 35 33 18 17 30 28
170421
Table 1.45D – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.03 0.03 0.16 0.14 0.03 0.03 0.12 0.14 0.04 0.03
GENDER                    
Male 0.06 0.06 0.20 0.19 0.06 0.06 0.20 0.22 0.06 0.07
Female 0.04 0.04 0.24 0.21 0.04 0.03 0.14 0.16 0.04 0.03
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.04 0.04 0.17 0.15 0.04 0.04 0.13 0.15 0.04 0.04
White 0.04 0.04 0.21 0.19 0.04 0.04 0.16 0.21 0.04 0.04
Black or African American 0.08 0.07 0.38 0.38 0.07 0.06 0.34 0.24 0.05 0.06
American Indian or Alaska Native 0.38 0.61 2.18 0.89 0.32 * 0.25 0.19 0.38 *
Native Hawaiian or Other Pacific Islander 0.27 0.26 * * 0.06 0.17 0.22 * * 0.18
Asian 0.21 0.09 0.89 0.40 0.22 0.09 0.44 0.32 0.24 0.08
Two or More Races 0.31 0.35 0.69 0.71 0.33 0.40 0.93 0.21 0.33 0.49
Hispanic or Latino 0.08 0.10 0.35 0.31 0.07 0.10 0.27 0.30 0.06 0.10
EDUCATION                    
< High School da da da da 0.06 0.09 0.28 0.38 0.05 0.09
High School Graduate da da da da 0.08 0.07 0.23 0.21 0.08 0.07
Some College/Associate's Degree da da da da 0.06 0.06 0.18 0.22 0.05 0.05
College Graduate da da da da 0.08 0.07 0.40 0.33 0.07 0.07
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.06 0.05 0.17 0.17 0.06 0.05
Part-Time da da da da 0.10 0.13 0.30 0.35 0.07 0.12
Unemployed da da da da 0.17 0.29 0.32 0.37 0.19 0.38
Other1 da da da da 0.04 0.04 0.22 0.21 0.04 0.04
170421
Table 1.45P – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4066   0.0106   0.8512   0.9665   0.8036  
GENDER                    
Male 0.8928   0.1284   0.6939   0.7681   0.5195  
Female 0.2210   0.0521   0.7842   0.6183   0.5417  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2201   0.0131   0.7378   0.9145   0.7953  
White 0.9235   0.0518   0.5158   0.4548   0.7427  
Black or African American 0.4930   0.6392   0.6444   0.5365   0.9376  
American Indian or Alaska Native 0.8974   0.3220   *   0.8614   *  
Native Hawaiian or Other Pacific Islander 0.9635   *   0.3663   *   *  
Asian 0.0012   0.0192   0.0075   0.2538   0.0140  
Two or More Races 0.9400   0.5178   0.7602   0.0173   0.5588  
Hispanic or Latino 0.5373   0.3699   0.2244   0.7705   0.1759  
EDUCATION                    
< High School da   da   0.1125   0.0929   0.4387  
High School Graduate da   da   0.4463   0.3380   0.8324  
Some College/Associate's Degree da   da   0.7802   0.8455   0.8620  
College Graduate da   da   0.9280   0.5783   0.9374  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.5680   0.8267   0.6081  
Part-Time da   da   0.5777   0.6347   0.8760  
Unemployed da   da   0.0252   0.3101   0.0408  
Other1 da   da   0.4710   0.2442   0.9387  
170421
Table 1.46C – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 52 66 20 17 48 63 21 25 45 57
GENDER                    
Male 48 59 13 11 46 57 17 20 44 52
Female 24 30 15 13 18 29 13 13 12 26
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 48 57 16 15 45 54 17 23 42 49
White 41 50 12 10 40 49 13 21 38 44
Black or African American 13 18 7 10 11 16 6 9 9 13
American Indian or Alaska Native 4 10 1 1 4 * 1 0 4 *
Native Hawaiian or Other Pacific Islander 1 2 * * * 1 * * * *
Asian 12 10 5 5 11 9 6 * 9 9
Two or More Races 12 7 3 4 12 6 7 * 9 6
Hispanic or Latino 23 33 12 9 19 32 12 8 15 29
EDUCATION                    
< High School da da da da 13 22 9 9 9 19
High School Graduate da da da da 30 23 15 11 26 21
Some College/Associate's Degree da da da da 22 32 11 20 19 24
College Graduate da da da da 31 43 7 6 30 43
CURRENT EMPLOYMENT                    
Full-Time da da da da 41 43 14 13 39 40
Part-Time da da da da 15 32 14 19 7 26
Unemployed da da da da 13 28 5 5 12 28
Other1 da da da da 17 20 7 5 16 19
170421
Table 1.46D – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.02 0.02 0.08 0.07 0.02 0.03 0.06 0.07 0.02 0.03
GENDER                    
Male 0.04 0.05 0.10 0.09 0.04 0.05 0.09 0.12 0.04 0.05
Female 0.02 0.02 0.13 0.11 0.01 0.02 0.08 0.08 0.01 0.02
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.02 0.03 0.08 0.08 0.02 0.03 0.06 0.08 0.02 0.03
White 0.02 0.03 0.09 0.07 0.03 0.03 0.07 0.11 0.03 0.03
Black or African American 0.04 0.06 0.21 0.28 0.04 0.05 0.12 0.18 0.04 0.05
American Indian or Alaska Native 0.28 0.61 0.33 0.70 0.32 * 0.25 0.19 0.38 *
Native Hawaiian or Other Pacific Islander 0.20 0.16 * * * 0.07 * * * *
Asian 0.08 0.07 0.41 0.34 0.08 0.07 0.32 * 0.08 0.08
Two or More Races 0.26 0.15 0.35 0.43 0.30 0.16 0.84 * 0.30 0.20
Hispanic or Latino 0.05 0.07 0.21 0.15 0.05 0.08 0.17 0.11 0.05 0.09
EDUCATION                    
< High School da da da da 0.04 0.07 0.16 0.20 0.03 0.07
High School Graduate da da da da 0.05 0.04 0.13 0.10 0.05 0.04
Some College/Associate's Degree da da da da 0.03 0.04 0.08 0.13 0.03 0.04
College Graduate da da da da 0.04 0.06 0.15 0.12 0.04 0.06
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.03 0.04 0.09 0.09 0.04 0.04
Part-Time da da da da 0.05 0.10 0.15 0.21 0.03 0.11
Unemployed da da da da 0.12 0.25 0.14 0.14 0.16 0.35
Other1 da da da da 0.02 0.02 0.09 0.07 0.02 0.03
170421
Table 1.46P – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4082   0.3091   0.2247   0.9191   0.1648  
GENDER                    
Male 0.5344   0.4480   0.4023   0.9406   0.3471  
Female 0.5696   0.5153   0.3124   0.9427   0.1962  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6142   0.6412   0.4955   0.8045   0.5169  
White 0.4461   0.1516   0.2643   0.4496   0.3673  
Black or African American 0.3108   0.3309   0.5204   0.2210   0.9793  
American Indian or Alaska Native 0.6726   0.2818   *   0.8614   *  
Native Hawaiian or Other Pacific Islander 0.9855   *   *   *   *  
Asian 0.3250   0.6459   0.3679   *   0.8708  
Two or More Races 0.0782   0.6606   0.0460   *   0.2691  
Hispanic or Latino 0.4352   0.2570   0.1993   0.4796   0.0725  
EDUCATION                    
< High School da   da   0.2641   0.7955   0.2353  
High School Graduate da   da   0.5540   0.1856   0.9465  
Some College/Associate's Degree da   da   0.3501   0.3282   0.6458  
College Graduate da   da   0.3253   0.6552   0.2863  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.9061   0.8739   0.9493  
Part-Time da   da   0.3278   0.8982   0.2499  
Unemployed da   da   0.0532   0.8024   0.0538  
Other1 da   da   0.7283   0.5324   0.5330  
170421
Table 1.47C – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 403 390 15 11 401 389 65 54 392 377
GENDER                    
Male 304 289 10 9 301 288 51 39 295 282
Female 229 244 10 6 228 244 40 34 223 237
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 372 359 12 9 371 357 52 46 360 349
White 348 335 10 8 367 361 49 44 358 353
Black or African American 71 66 1 2 72 67 15 7 69 66
American Indian or Alaska Native 27 26 0 0 27 26 6 8 26 24
Native Hawaiian or Other Pacific Islander 14 17 * * 14 17 * * 13 17
Asian 59 89 6 1 58 89 11 10 57 90
Two or More Races 66 62 4 3 66 62 8 12 65 61
Hispanic or Latino 137 139 7 7 136 138 38 25 132 135
EDUCATION                    
< High School da da da da 139 130 32 22 133 128
High School Graduate da da da da 217 224 35 34 212 220
Some College/Associate's Degree da da da da 263 224 45 32 259 219
College Graduate da da da da 168 188 6 9 168 187
CURRENT EMPLOYMENT                    
Full-Time da da da da 295 264 47 37 288 261
Part-Time da da da da 131 150 27 22 128 149
Unemployed da da da da 89 106 22 21 86 104
Other1 da da da da 229 222 33 23 225 219
170421
Table 1.47D – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.15 0.14 0.06 0.04 0.17 0.16 0.19 0.16 0.19 0.18
GENDER                    
Male 0.23 0.22 0.08 0.07 0.26 0.24 0.29 0.23 0.30 0.28
Female 0.17 0.18 0.08 0.05 0.18 0.19 0.23 0.20 0.21 0.22
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.17 0.16 0.06 0.05 0.18 0.17 0.19 0.17 0.20 0.20
White 0.20 0.20 0.07 0.06 0.22 0.21 0.25 0.23 0.25 0.24
Black or African American 0.22 0.21 0.04 0.05 0.25 0.23 0.29 0.14 0.29 0.27
American Indian or Alaska Native 1.70 1.66 0.09 0.33 1.96 1.82 2.46 3.11 2.29 2.14
Native Hawaiian or Other Pacific Islander 1.86 1.43 * * 2.26 1.59 * * 2.97 1.82
Asian 0.40 0.60 0.44 0.07 0.43 0.66 0.54 0.48 0.50 0.79
Two or More Races 1.34 1.20 0.54 0.35 1.61 1.44 0.92 1.52 2.05 1.75
Hispanic or Latino 0.31 0.31 0.12 0.12 0.36 0.36 0.51 0.33 0.44 0.43
EDUCATION                    
< High School da da da da 0.39 0.40 0.57 0.46 0.44 0.46
High School Graduate da da da da 0.34 0.34 0.32 0.32 0.40 0.40
Some College/Associate's Degree da da da da 0.33 0.28 0.31 0.22 0.40 0.34
College Graduate da da da da 0.22 0.24 0.13 0.18 0.24 0.25
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.24 0.20 0.32 0.25 0.26 0.23
Part-Time da da da da 0.40 0.43 0.30 0.24 0.53 0.60
Unemployed da da da da 0.75 0.89 0.60 0.62 1.03 1.23
Other1 da da da da 0.28 0.27 0.40 0.30 0.30 0.29
170421
Table 1.47P – Methamphetamine Use in Lifetime among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.8983   0.9054   0.8883   0.0008   0.7273  
GENDER                    
Male 0.3258   0.6544   0.3090   0.0030   0.5429  
Female 0.2981   0.4951   0.2898   0.0686   0.1721  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7392   0.6252   0.7425   0.0282   0.5480  
White 0.8521   0.9202   0.8638   0.0366   0.6713  
Black or African American 0.8389   0.7988   0.8515   0.1547   0.6762  
American Indian or Alaska Native 0.5001   0.1714   0.4425   0.7283   0.3803  
Native Hawaiian or Other Pacific Islander 0.3468   *   0.2679   *   0.2183  
Asian 0.2206   0.2116   0.1912   0.9304   0.1812  
Two or More Races 0.7278   0.9144   0.7284   0.9159   0.6283  
Hispanic or Latino 0.2143   0.5930   0.2038   0.0024   0.5712  
EDUCATION                    
< High School da   da   0.4006   0.0387   0.6340  
High School Graduate da   da   0.5005   0.6743   0.4861  
Some College/Associate's Degree da   da   0.0511   0.0013   0.1605  
College Graduate da   da   0.0325   0.8717   0.0302  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.1750   0.0199   0.2946  
Part-Time da   da   0.2882   0.0644   0.1343  
Unemployed da   da   0.0047   0.9452   0.0037  
Other1 da   da   0.7051   0.0354   0.8852  
170421
Table 1.48C – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 120 100 10 8 120 99 35 28 115 95
GENDER                    
Male 106 79 7 6 106 79 27 21 103 76
Female 55 62 7 4 55 61 22 19 51 58
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 109 94 8 6 109 94 30 27 103 90
White 95 88 5 6 95 88 24 24 90 85
Black or African American 39 20 1 2 39 20 14 6 37 19
American Indian or Alaska Native 11 6 0 0 11 6 2 5 11 4
Native Hawaiian or Other Pacific Islander 4 3 * * 4 3 * * 1 3
Asian 20 5 6 1 20 5 10 5 17 *
Two or More Races 14 18 2 0 14 18 4 11 14 14
Hispanic or Latino 45 32 5 4 45 31 20 10 44 29
EDUCATION                    
< High School da da da da 60 58 17 12 56 56
High School Graduate da da da da 65 51 22 21 61 46
Some College/Associate's Degree da da da da 60 55 22 16 58 52
College Graduate da da da da 47 41 2 2 47 41
CURRENT EMPLOYMENT                    
Full-Time da da da da 70 56 20 17 67 53
Part-Time da da da da 43 50 17 15 35 48
Unemployed da da da da 40 33 16 11 36 31
Other1 da da da da 77 59 17 16 76 57
170421
Table 1.48D – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.04 0.04 0.04 0.03 0.05 0.04 0.10 0.08 0.06 0.05
GENDER                    
Male 0.08 0.06 0.05 0.05 0.09 0.07 0.15 0.12 0.10 0.08
Female 0.04 0.04 0.06 0.03 0.04 0.05 0.12 0.11 0.05 0.05
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.04 0.04 0.03 0.05 0.05 0.11 0.10 0.06 0.05
White 0.06 0.05 0.04 0.05 0.06 0.06 0.12 0.12 0.07 0.06
Black or African American 0.12 0.06 0.04 0.05 0.14 0.07 0.27 0.12 0.15 0.08
American Indian or Alaska Native 0.78 0.38 0.09 0.26 0.88 0.42 1.13 1.85 1.02 0.32
Native Hawaiian or Other Pacific Islander 0.53 0.27 * * 0.64 0.30 * * 0.31 0.32
Asian 0.14 0.04 0.44 0.07 0.15 0.04 0.51 0.24 0.15 *
Two or More Races 0.31 0.36 0.25 0.01 0.37 0.44 0.47 1.34 0.45 0.44
Hispanic or Latino 0.10 0.07 0.10 0.08 0.12 0.08 0.27 0.14 0.15 0.09
EDUCATION                    
< High School da da da da 0.17 0.18 0.31 0.24 0.19 0.20
High School Graduate da da da da 0.10 0.08 0.20 0.20 0.12 0.09
Some College/Associate's Degree da da da da 0.08 0.07 0.16 0.11 0.10 0.08
College Graduate da da da da 0.07 0.05 0.05 0.04 0.07 0.06
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.06 0.05 0.14 0.12 0.06 0.05
Part-Time da da da da 0.13 0.15 0.19 0.17 0.15 0.20
Unemployed da da da da 0.35 0.29 0.45 0.32 0.46 0.40
Other1 da da da da 0.10 0.07 0.21 0.20 0.10 0.08
170421
Table 1.48P – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0274   0.5050   0.0305   0.1789   0.0705  
GENDER                    
Male 0.0032   0.8308   0.0032   0.1157   0.0089  
Female 0.4795   0.4395   0.4318   0.8175   0.3457  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0750   0.4041   0.0840   0.7213   0.0906  
White 0.3915   0.9675   0.3885   0.8705   0.3489  
Black or African American 0.0573   0.9418   0.0558   0.3104   0.1041  
American Indian or Alaska Native 0.0627   0.3210   0.0548   0.9004   0.0287  
Native Hawaiian or Other Pacific Islander 0.6443   *   0.5838   *   0.6588  
Asian 0.0561   0.2116   0.1004   0.3958   *  
Two or More Races 0.8619   0.3408   0.7979   0.5126   0.9692  
Hispanic or Latino 0.1446   0.9746   0.1431   0.0350   0.5490  
EDUCATION                    
< High School da   da   0.6135   0.1445   0.8864  
High School Graduate da   da   0.3608   0.5929   0.2415  
Some College/Associate's Degree da   da   0.0326   0.1382   0.0839  
College Graduate da   da   0.8442   0.6991   0.8608  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0483   0.6022   0.0630  
Part-Time da   da   0.5411   0.3316   0.2893  
Unemployed da   da   0.7762   0.3760   0.9723  
Other1 da   da   0.0748   0.7513   0.0854  
170421
Table 1.49C – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 93 71 5 4 93 71 25 15 89 70
GENDER                    
Male 82 62 2 3 82 62 19 7 79 61
Female 42 40 5 3 42 40 15 13 39 38
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 81 68 3 3 81 68 21 14 78 66
White 71 67 3 3 71 67 17 14 69 65
Black or African American 32 6 * * 33 6 12 * 30 6
American Indian or Alaska Native 5 3 0 0 5 3 1 0 5 3
Native Hawaiian or Other Pacific Islander 4 2 * * 4 2 * * 1 2
Asian 16 * * * 16 * * * 16 *
Two or More Races 13 10 2 * 12 10 1 0 12 10
Hispanic or Latino 41 24 4 2 41 24 14 6 39 24
EDUCATION                    
< High School da da da da 41 42 12 6 39 42
High School Graduate da da da da 51 39 18 12 47 38
Some College/Associate's Degree da da da da 50 36 12 8 49 35
College Graduate da da da da 39 33 2 * 39 33
CURRENT EMPLOYMENT                    
Full-Time da da da da 57 35 16 7 55 34
Part-Time da da da da 29 41 8 4 28 40
Unemployed da da da da 29 26 11 4 27 26
Other1 da da da da 59 45 12 12 57 43
170421
Table 1.49D – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.03 0.03 0.02 0.01 0.04 0.03 0.07 0.04 0.04 0.03
GENDER                    
Male 0.06 0.05 0.02 0.02 0.07 0.05 0.11 0.04 0.08 0.06
Female 0.03 0.03 0.04 0.02 0.03 0.03 0.09 0.08 0.04 0.03
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.04 0.03 0.02 0.02 0.04 0.03 0.08 0.05 0.04 0.04
White 0.04 0.04 0.02 0.02 0.05 0.04 0.09 0.07 0.05 0.05
Black or African American 0.10 0.02 * * 0.11 0.02 0.23 * 0.13 0.03
American Indian or Alaska Native 0.37 0.17 0.09 0.21 0.41 0.18 0.52 0.07 0.48 0.22
Native Hawaiian or Other Pacific Islander 0.50 0.18 * * 0.60 0.20 * * 0.23 0.24
Asian 0.11 * * * 0.12 * * * 0.14 *
Two or More Races 0.27 0.20 0.25 * 0.32 0.24 0.14 0.06 0.41 0.30
Hispanic or Latino 0.09 0.06 0.07 0.04 0.11 0.06 0.18 0.08 0.13 0.08
EDUCATION                    
< High School da da da da 0.12 0.13 0.23 0.12 0.13 0.15
High School Graduate da da da da 0.08 0.06 0.16 0.11 0.09 0.07
Some College/Associate's Degree da da da da 0.07 0.05 0.09 0.05 0.08 0.06
College Graduate da da da da 0.05 0.04 0.05 * 0.06 0.05
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.05 0.03 0.11 0.05 0.05 0.03
Part-Time da da da da 0.09 0.13 0.09 0.04 0.12 0.17
Unemployed da da da da 0.26 0.24 0.30 0.11 0.34 0.34
Other1 da da da da 0.07 0.06 0.15 0.16 0.08 0.06
170421
Table 1.49P – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0361   0.5313   0.0387   0.0343   0.1187  
GENDER                    
Male 0.0142   0.6783   0.0146   0.0060   0.0536  
Female 0.8399   0.6357   0.8083   0.7594   0.7072  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1021   0.4999   0.1069   0.1197   0.2024  
White 0.5626   0.7672   0.5679   0.4007   0.6960  
Black or African American 0.0253   *   0.0252   *   0.0534  
American Indian or Alaska Native 0.1460   0.5862   0.1346   0.0724   0.2469  
Native Hawaiian or Other Pacific Islander 0.4937   *   0.4681   *   0.7483  
Asian *   *   *   *   *  
Two or More Races 0.4510   *   0.5248   0.4924   0.5348  
Hispanic or Latino 0.1712   0.8282   0.1766   0.1235   0.3739  
EDUCATION                    
< High School da   da   0.6148   0.0437   0.9624  
High School Graduate da   da   0.2562   0.5118   0.3336  
Some College/Associate's Degree da   da   0.1384   0.2647   0.2067  
College Graduate da   da   0.5529   *   0.5945  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0232   0.0602   0.0689  
Part-Time da   da   0.4411   0.5051   0.3600  
Unemployed da   da   0.9172   0.1106   0.7394  
Other1 da   da   0.1460   0.8023   0.1493  
170421
Table 1.50C – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 877 824 107 107 860 812 177 168 832 791
GENDER                    
Male 560 550 77 75 552 546 117 119 544 529
Female 628 572 76 73 612 569 123 115 587 557
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 794 741 94 92 779 732 149 150 756 713
White 669 647 108 103 1,123 1,075 213 200 1,085 1,048
Black or African American 281 267 54 44 446 400 87 87 416 376
American Indian or Alaska Native 67 77 5 6 66 76 22 15 59 71
Native Hawaiian or Other Pacific Islander 45 73 * * 43 74 12 * * *
Asian 284 227 32 29 282 223 52 53 273 220
Two or More Races 155 143 22 19 154 140 35 28 151 135
Hispanic or Latino 326 325 57 53 320 319 88 84 302 313
EDUCATION                    
< High School da da da da 416 359 85 77 402 348
High School Graduate da da da da 570 596 128 120 554 575
Some College/Associate's Degree da da da da 651 668 176 183 625 637
College Graduate da da da da 717 699 87 95 712 683
CURRENT EMPLOYMENT                    
Full-Time da da da da 736 724 156 156 714 701
Part-Time da da da da 361 363 124 136 343 340
Unemployed da da da da 201 194 73 75 191 178
Other1 da da da da 815 802 119 109 802 786
170421
Table 1.50D – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.33 0.31 0.43 0.43 0.35 0.33 0.51 0.49 0.40 0.38
GENDER                    
Male 0.43 0.42 0.61 0.59 0.47 0.46 0.67 0.69 0.55 0.53
Female 0.45 0.41 0.63 0.59 0.49 0.45 0.71 0.67 0.54 0.51
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.35 0.33 0.49 0.48 0.38 0.36 0.54 0.55 0.43 0.40
White 0.39 0.38 0.59 0.57 0.42 0.41 0.62 0.67 0.47 0.45
Black or African American 0.88 0.83 1.11 1.05 0.96 0.90 1.14 1.21 1.11 1.04
American Indian or Alaska Native 3.24 3.78 3.15 4.17 3.66 4.00 5.41 4.73 4.14 4.68
Native Hawaiian or Other Pacific Islander 4.70 4.90 * * 5.43 5.41 5.90 * * *
Asian 1.52 1.36 2.11 1.90 1.64 1.50 2.05 1.93 1.88 1.75
Two or More Races 2.05 1.96 2.14 1.97 2.42 2.27 2.76 2.70 3.02 2.71
Hispanic or Latino 0.75 0.73 0.99 0.90 0.85 0.83 1.18 1.13 0.99 1.01
EDUCATION                    
< High School da da da da 0.94 0.89 1.23 1.23 1.06 1.04
High School Graduate da da da da 0.66 0.67 0.86 0.86 0.78 0.78
Some College/Associate's Degree da da da da 0.55 0.57 0.76 0.75 0.65 0.68
College Graduate da da da da 0.64 0.60 1.43 1.38 0.68 0.63
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.45 0.43 0.73 0.73 0.50 0.48
Part-Time da da da da 0.80 0.80 0.98 1.01 1.06 1.05
Unemployed da da da da 1.28 1.36 1.44 1.64 1.77 1.78
Other1 da da da da 0.63 0.64 1.09 1.05 0.69 0.70
170421
Table 1.50P – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0002   0.0000   0.0021   0.0000   0.0322  
GENDER                    
Male 0.0225   0.0018   0.0572   0.0016   0.2003  
Female 0.0021   0.0000   0.0100   0.0001   0.0676  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0023   0.0000   0.0111   0.0000   0.1194  
White 0.0735   0.0000   0.1869   0.0000   0.6250  
Black or African American 0.0006   0.1447   0.0008   0.1254   0.0015  
American Indian or Alaska Native 0.6939   0.3909   0.8301   0.0243   0.4476  
Native Hawaiian or Other Pacific Islander 0.2698   *   0.3633   *   *  
Asian 0.4159   0.7388   0.4529   0.3915   0.5735  
Two or More Races 0.1272   0.0286   0.2387   0.0296   0.4491  
Hispanic or Latino 0.0159   0.0154   0.0422   0.4065   0.0602  
EDUCATION                    
< High School da   da   0.0004   0.0029   0.0031  
High School Graduate da   da   0.3569   0.0001   0.8865  
Some College/Associate's Degree da   da   0.0016   0.0045   0.0145  
College Graduate da   da   0.8910   0.4631   0.8019  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.2046   0.0538   0.3705  
Part-Time da   da   0.1791   0.0222   0.5655  
Unemployed da   da   0.0884   0.3533   0.1381  
Other1 da   da   0.0119   0.0000   0.0699  
170421
Table 1.51C – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 380 374 58 53 375 365 127 131 345 335
GENDER                    
Male 277 268 40 39 275 260 93 92 255 238
Female 235 248 41 37 232 247 84 90 208 230
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 347 334 49 46 343 325 113 115 312 309
White 308 297 46 38 316 317 122 121 287 298
Black or African American 125 103 20 20 129 107 40 41 116 97
American Indian or Alaska Native 21 14 2 2 21 14 9 7 19 12
Native Hawaiian or Other Pacific Islander 20 20 * * 20 20 4 * * 16
Asian 68 73 11 14 66 72 24 23 62 68
Two or More Races 59 58 11 13 56 54 21 19 52 50
Hispanic or Latino 153 150 31 28 148 146 58 61 135 122
EDUCATION                    
< High School da da da da 148 127 48 42 138 120
High School Graduate da da da da 169 181 70 70 156 160
Some College/Associate's Degree da da da da 223 205 101 110 197 182
College Graduate da da da da 199 229 48 52 193 220
CURRENT EMPLOYMENT                    
Full-Time da da da da 247 247 88 92 232 229
Part-Time da da da da 148 153 77 87 127 126
Unemployed da da da da 95 94 43 43 84 84
Other1 da da da da 209 213 62 59 197 205
170421
Table 1.51D – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.14 0.14 0.23 0.21 0.15 0.15 0.36 0.38 0.17 0.16
GENDER                    
Male 0.21 0.20 0.32 0.31 0.23 0.22 0.53 0.53 0.26 0.24
Female 0.17 0.18 0.34 0.30 0.18 0.20 0.49 0.52 0.19 0.21
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.15 0.15 0.26 0.24 0.17 0.16 0.41 0.42 0.18 0.17
White 0.18 0.17 0.32 0.27 0.19 0.18 0.51 0.52 0.20 0.20
Black or African American 0.39 0.32 0.53 0.57 0.43 0.34 0.75 0.73 0.47 0.38
American Indian or Alaska Native 1.36 0.95 1.16 1.39 1.55 1.03 3.64 2.65 1.72 1.10
Native Hawaiian or Other Pacific Islander 2.71 1.62 * * 3.15 1.78 2.55 * * 1.74
Asian 0.45 0.50 0.87 1.03 0.48 0.55 1.14 1.04 0.52 0.62
Two or More Races 1.21 1.10 1.35 1.51 1.43 1.26 2.16 2.22 1.69 1.43
Hispanic or Latino 0.35 0.34 0.54 0.49 0.39 0.38 0.77 0.81 0.45 0.39
EDUCATION                    
< High School da da da da 0.41 0.38 0.83 0.82 0.45 0.43
High School Graduate da da da da 0.27 0.29 0.62 0.63 0.30 0.30
Some College/Associate's Degree da da da da 0.28 0.25 0.58 0.62 0.31 0.28
College Graduate da da da da 0.26 0.28 0.97 0.93 0.27 0.30
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.20 0.19 0.55 0.55 0.21 0.21
Part-Time da da da da 0.43 0.45 0.74 0.83 0.52 0.53
Unemployed da da da da 0.80 0.81 1.13 1.18 1.00 1.02
Other1 da da da da 0.25 0.25 0.70 0.71 0.27 0.27
170421
Table 1.51P – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4311   0.0608   0.6151   0.1432   0.8991  
GENDER                    
Male 0.1155   0.5258   0.1320   0.0210   0.4785  
Female 0.5721   0.0465   0.3684   0.8230   0.3260  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8139   0.0846   0.9896   0.1462   0.5090  
White 0.8153   0.0124   0.5665   0.1190   0.2054  
Black or African American 0.2566   0.9067   0.2556   0.8502   0.2147  
American Indian or Alaska Native 0.2821   0.5626   0.2444   0.1995   0.4769  
Native Hawaiian or Other Pacific Islander 0.8152   *   0.8620   *   *  
Asian 0.9242   0.2759   0.9153   0.6669   0.9781  
Two or More Races 0.9213   0.4925   0.7967   0.8754   0.9482  
Hispanic or Latino 0.1943   0.4563   0.2312   0.7544   0.2249  
EDUCATION                    
< High School da   da   0.0421   0.6244   0.0571  
High School Graduate da   da   0.4271   0.7054   0.2449  
Some College/Associate's Degree da   da   0.0445   0.1257   0.1202  
College Graduate da   da   0.0666   0.5026   0.0465  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.5584   0.7800   0.6669  
Part-Time da   da   0.8544   0.8020   0.8328  
Unemployed da   da   0.9339   0.6758   0.7336  
Other1 da   da   0.7974   0.0182   0.6405  
170421
Table 1.52C – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 206 211 37 29 201 208 73 74 187 195
GENDER                    
Male 152 144 23 18 150 142 53 50 138 135
Female 140 146 28 23 136 145 48 53 126 135
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 190 200 31 25 187 197 67 67 172 185
White 174 192 27 21 173 193 67 65 159 182
Black or African American 68 51 9 11 68 52 19 21 64 47
American Indian or Alaska Native 16 9 1 2 16 9 2 1 16 9
Native Hawaiian or Other Pacific Islander 6 8 * * 4 8 4 * 1 4
Asian 35 18 6 3 35 18 9 9 34 15
Two or More Races 41 31 9 7 40 30 10 10 39 28
Hispanic or Latino 85 76 19 15 83 75 31 30 77 67
EDUCATION                    
< High School da da da da 84 62 28 28 80 57
High School Graduate da da da da 105 109 41 42 96 100
Some College/Associate's Degree da da da da 117 115 53 54 103 105
College Graduate da da da da 103 130 22 24 101 128
CURRENT EMPLOYMENT                    
Full-Time da da da da 148 130 50 44 143 124
Part-Time da da da da 76 88 37 46 66 74
Unemployed da da da da 52 52 24 26 47 46
Other1 da da da da 110 129 38 32 102 126
170421
Table 1.52D – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.08 0.08 0.15 0.12 0.08 0.09 0.21 0.21 0.09 0.09
GENDER                    
Male 0.12 0.11 0.18 0.14 0.13 0.12 0.30 0.29 0.14 0.13
Female 0.10 0.11 0.23 0.19 0.11 0.11 0.27 0.31 0.12 0.12
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.08 0.09 0.16 0.13 0.09 0.10 0.25 0.25 0.10 0.10
White 0.10 0.11 0.20 0.16 0.11 0.12 0.32 0.32 0.11 0.13
Black or African American 0.21 0.16 0.27 0.32 0.23 0.17 0.38 0.42 0.27 0.19
American Indian or Alaska Native 1.11 0.59 0.47 1.03 1.25 0.64 0.96 0.37 1.49 0.78
Native Hawaiian or Other Pacific Islander 0.85 0.64 * * 0.67 0.71 2.43 * 0.19 0.47
Asian 0.24 0.13 0.46 0.24 0.26 0.14 0.44 0.43 0.29 0.14
Two or More Races 0.87 0.62 1.08 0.89 1.02 0.72 1.12 1.28 1.28 0.85
Hispanic or Latino 0.20 0.17 0.33 0.25 0.22 0.19 0.42 0.40 0.25 0.22
EDUCATION                    
< High School da da da da 0.24 0.19 0.50 0.57 0.27 0.21
High School Graduate da da da da 0.17 0.17 0.37 0.40 0.19 0.19
Some College/Associate's Degree da da da da 0.15 0.15 0.34 0.33 0.17 0.17
College Graduate da da da da 0.14 0.17 0.49 0.48 0.15 0.18
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.12 0.11 0.33 0.29 0.13 0.12
Part-Time da da da da 0.23 0.27 0.39 0.48 0.28 0.32
Unemployed da da da da 0.45 0.46 0.67 0.76 0.59 0.57
Other1 da da da da 0.13 0.16 0.46 0.39 0.14 0.17
170421
Table 1.52P – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.5042   0.0226   0.7397   0.1247   0.8053  
GENDER                    
Male 0.1292   0.0420   0.2066   0.0417   0.5850  
Female 0.5633   0.2075   0.4211   0.9518   0.3557  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.9580   0.0532   0.7502   0.2942   0.4567  
White 0.5022   0.0579   0.3575   0.1951   0.1480  
Black or African American 0.3649   0.5161   0.3082   0.6246   0.2215  
American Indian or Alaska Native 0.5999   0.3565   0.5363   0.0406   0.7280  
Native Hawaiian or Other Pacific Islander 0.8060   *   0.7543   *   0.1792  
Asian 0.5162   0.1901   0.6580   0.9720   0.6065  
Two or More Races 0.3227   0.4939   0.3919   0.5282   0.2954  
Hispanic or Latino 0.0654   0.2240   0.1059   0.1912   0.2175  
EDUCATION                    
< High School da   da   0.0413   0.5965   0.0599  
High School Graduate da   da   0.9180   0.4689   0.6348  
Some College/Associate's Degree da   da   0.0651   0.0987   0.1986  
College Graduate da   da   0.0186   0.5274   0.0242  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0326   0.0567   0.1397  
Part-Time da   da   0.6238   0.4006   0.9967  
Unemployed da   da   0.9289   0.9205   0.8543  
Other1 da   da   0.1158   0.1367   0.0333  
170421
Table 1.53C – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 861 771 101 97 848 762 165 153 818 742
GENDER                    
Male 552 537 69 69 543 534 108 108 530 525
Female 618 556 72 64 608 551 120 108 582 531
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 788 713 88 82 778 709 141 140 755 683
White 676 623 94 81 990 928 172 155 958 906
Black or African American 273 256 49 42 418 373 78 80 392 352
American Indian or Alaska Native 64 69 5 6 63 68 21 14 55 64
Native Hawaiian or Other Pacific Islander 42 73 * * 41 71 11 * * *
Asian 262 216 29 25 261 213 44 47 253 210
Two or More Races 142 133 19 16 141 131 31 25 137 127
Hispanic or Latino 310 303 54 51 304 295 83 77 285 293
EDUCATION                    
< High School da da da da 395 334 78 68 384 322
High School Graduate da da da da 531 532 113 104 514 517
Some College/Associate's Degree da da da da 581 605 143 139 558 581
College Graduate da da da da 591 584 70 69 589 576
CURRENT EMPLOYMENT                    
Full-Time da da da da 659 632 137 133 638 616
Part-Time da da da da 330 304 102 103 315 288
Unemployed da da da da 192 169 67 64 179 157
Other1 da da da da 733 708 101 86 722 696
170421
Table 1.53D – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.32 0.29 0.41 0.39 0.35 0.31 0.47 0.44 0.39 0.35
GENDER                    
Male 0.43 0.41 0.54 0.54 0.46 0.45 0.61 0.62 0.53 0.52
Female 0.45 0.40 0.59 0.52 0.48 0.43 0.69 0.63 0.54 0.49
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.35 0.32 0.46 0.43 0.38 0.34 0.51 0.52 0.43 0.38
White 0.40 0.36 0.55 0.50 0.43 0.39 0.62 0.64 0.47 0.43
Black or African American 0.85 0.80 1.06 1.02 0.94 0.86 1.08 1.16 1.10 1.00
American Indian or Alaska Native 3.25 3.56 3.07 3.73 3.65 3.78 5.67 4.44 4.10 4.41
Native Hawaiian or Other Pacific Islander 4.62 4.88 * * 5.33 5.24 5.76 * * *
Asian 1.45 1.33 2.04 1.71 1.56 1.46 1.83 1.79 1.79 1.72
Two or More Races 2.11 1.95 2.02 1.70 2.48 2.29 2.66 2.62 3.07 2.71
Hispanic or Latino 0.71 0.68 0.94 0.87 0.80 0.77 1.11 1.03 0.94 0.94
EDUCATION                    
< High School da da da da 0.92 0.86 1.21 1.16 1.05 0.99
High School Graduate da da da da 0.65 0.63 0.81 0.80 0.77 0.74
Some College/Associate's Degree da da da da 0.55 0.57 0.72 0.68 0.65 0.67
College Graduate da da da da 0.60 0.58 1.24 1.18 0.64 0.62
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.43 0.41 0.71 0.70 0.48 0.45
Part-Time da da da da 0.81 0.75 0.91 0.89 1.07 0.97
Unemployed da da da da 1.29 1.26 1.42 1.51 1.78 1.68
Other1 da da da da 0.63 0.64 1.02 0.92 0.69 0.69
170421
Table 1.53P – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0000   0.0000   0.0000   0.0000   0.0009  
GENDER                    
Male 0.0002   0.0000   0.0013   0.0000   0.0167  
Female 0.0001   0.0000   0.0006   0.0000   0.0153  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0000   0.0000   0.0000   0.0000   0.0025  
White 0.0001   0.0000   0.0008   0.0000   0.0181  
Black or African American 0.0011   0.1429   0.0015   0.1352   0.0027  
American Indian or Alaska Native 0.9357   0.8819   0.9830   0.0295   0.5920  
Native Hawaiian or Other Pacific Islander 0.2030   *   0.2862   *   *  
Asian 0.5767   0.4442   0.6586   0.3102   0.8193  
Two or More Races 0.1284   0.0164   0.2394   0.0039   0.5546  
Hispanic or Latino 0.0087   0.0033   0.0302   0.0107   0.1285  
EDUCATION                    
< High School da   da   0.0000   0.0006   0.0004  
High School Graduate da   da   0.0499   0.0000   0.3122  
Some College/Associate's Degree da   da   0.0003   0.0000   0.0079  
College Graduate da   da   0.5844   0.1830   0.7099  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0237   0.0002   0.1216  
Part-Time da   da   0.0104   0.0029   0.0979  
Unemployed da   da   0.0256   0.0360   0.1042  
Other1 da   da   0.0014   0.0000   0.0136  
170421
Table 1.54C – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 307 286 47 42 303 280 92 92 287 264
GENDER                    
Male 225 208 33 31 224 205 72 67 213 195
Female 192 193 33 32 188 190 61 60 174 177
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 279 258 40 36 274 252 82 80 256 242
White 247 227 36 30 249 235 79 72 231 224
Black or African American 117 93 18 19 118 95 29 33 110 89
American Indian or Alaska Native 20 12 2 2 20 12 9 4 18 11
Native Hawaiian or Other Pacific Islander 19 17 * * * 16 4 * * 15
Asian 58 63 9 11 57 62 17 15 54 60
Two or More Races 51 38 8 9 49 36 17 15 47 31
Hispanic or Latino 124 122 25 24 120 119 45 43 114 106
EDUCATION                    
< High School da da da da 129 108 38 32 122 102
High School Graduate da da da da 147 156 53 54 138 143
Some College/Associate's Degree da da da da 177 151 65 61 162 143
College Graduate da da da da 139 168 31 30 137 165
CURRENT EMPLOYMENT                    
Full-Time da da da da 198 202 67 63 189 190
Part-Time da da da da 112 108 49 52 103 94
Unemployed da da da da 85 81 36 34 76 73
Other1 da da da da 171 161 44 34 165 158
170421
Table 1.54D – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.11 0.11 0.19 0.17 0.12 0.11 0.26 0.27 0.14 0.13
GENDER                    
Male 0.17 0.16 0.26 0.24 0.19 0.17 0.41 0.39 0.21 0.19
Female 0.14 0.14 0.27 0.26 0.15 0.15 0.35 0.35 0.16 0.16
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.12 0.11 0.21 0.19 0.13 0.12 0.30 0.30 0.14 0.14
White 0.14 0.13 0.26 0.22 0.15 0.14 0.37 0.35 0.16 0.15
Black or African American 0.36 0.29 0.48 0.53 0.40 0.31 0.57 0.62 0.45 0.36
American Indian or Alaska Native 1.31 0.81 1.01 1.12 1.49 0.88 3.52 1.83 1.66 1.01
Native Hawaiian or Other Pacific Islander 2.58 1.37 * * * 1.51 2.49 * * 1.57
Asian 0.39 0.43 0.68 0.82 0.41 0.47 0.84 0.72 0.46 0.54
Two or More Races 1.05 0.75 1.01 1.12 1.25 0.86 1.87 1.83 1.51 0.93
Hispanic or Latino 0.28 0.28 0.44 0.41 0.32 0.31 0.60 0.58 0.37 0.34
EDUCATION                    
< High School da da da da 0.36 0.33 0.68 0.65 0.40 0.36
High School Graduate da da da da 0.23 0.25 0.48 0.50 0.27 0.27
Some College/Associate's Degree da da da da 0.23 0.19 0.42 0.39 0.26 0.23
College Graduate da da da da 0.19 0.22 0.67 0.60 0.19 0.23
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.16 0.16 0.44 0.41 0.18 0.17
Part-Time da da da da 0.33 0.32 0.52 0.54 0.43 0.40
Unemployed da da da da 0.71 0.71 0.98 0.98 0.91 0.90
Other1 da da da da 0.21 0.19 0.55 0.44 0.22 0.21
170421
Table 1.54P – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0137   0.1721   0.0223   0.0001   0.2815  
GENDER                    
Male 0.0137   0.3978   0.0185   0.0004   0.2103  
Female 0.3008   0.2827   0.3884   0.0647   0.7966  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0688   0.2790   0.0894   0.0003   0.5793  
White 0.1956   0.0822   0.2791   0.0001   0.8847  
Black or African American 0.3129   0.8378   0.2878   0.6309   0.2180  
American Indian or Alaska Native 0.2747   0.5573   0.2413   0.1058   0.5526  
Native Hawaiian or Other Pacific Islander 0.6783   *   *   *   *  
Asian 0.9436   0.4410   0.9536   0.3973   0.8734  
Two or More Races 0.1504   0.7415   0.1254   0.2811   0.2444  
Hispanic or Latino 0.0625   0.3983   0.0785   0.2185   0.1507  
EDUCATION                    
< High School da   da   0.0039   0.0106   0.0243  
High School Graduate da   da   0.8017   0.3629   0.4968  
Some College/Associate's Degree da   da   0.0021   0.0012   0.0408  
College Graduate da   da   0.2870   0.3017   0.2049  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.2775   0.0950   0.6037  
Part-Time da   da   0.2136   0.2222   0.3978  
Unemployed da   da   0.6781   0.3051   0.9935  
Other1 da   da   0.0981   0.0001   0.4929  
170421
Table 1.55C – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 157 159 27 22 156 158 46 46 150 149
GENDER                    
Male 127 113 16 12 127 112 34 33 123 106
Female 99 107 21 19 97 107 32 31 90 103
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 142 143 22 19 141 143 43 40 134 135
White 125 139 20 16 126 139 41 38 118 131
Black or African American 61 47 9 10 61 47 14 14 58 44
American Indian or Alaska Native 6 7 0 1 6 7 2 1 6 7
Native Hawaiian or Other Pacific Islander 4 5 * * 4 5 * * * 3
Asian 32 6 2 * 32 6 4 1 31 6
Two or More Races 36 14 5 5 36 14 9 6 35 12
Hispanic or Latino 72 61 14 12 71 60 23 22 69 56
EDUCATION                    
< High School da da da da 74 55 20 17 72 53
High School Graduate da da da da 93 87 30 28 87 82
Some College/Associate's Degree da da da da 89 86 32 31 84 81
College Graduate da da da da 64 85 10 12 63 83
CURRENT EMPLOYMENT                    
Full-Time da da da da 120 100 33 29 121 97
Part-Time da da da da 54 62 22 24 49 57
Unemployed da da da da 43 45 20 19 38 41
Other1 da da da da 85 94 22 19 82 92
170421
Table 1.55D – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.06 0.06 0.11 0.09 0.06 0.06 0.13 0.13 0.07 0.07
GENDER                    
Male 0.10 0.09 0.12 0.09 0.11 0.09 0.20 0.19 0.12 0.11
Female 0.07 0.08 0.17 0.16 0.08 0.08 0.18 0.18 0.08 0.09
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.06 0.06 0.12 0.10 0.07 0.07 0.16 0.15 0.08 0.08
White 0.07 0.08 0.15 0.12 0.08 0.09 0.21 0.20 0.09 0.09
Black or African American 0.19 0.14 0.25 0.29 0.21 0.16 0.28 0.27 0.24 0.18
American Indian or Alaska Native 0.42 0.46 0.25 0.98 0.47 0.49 0.96 0.37 0.54 0.60
Native Hawaiian or Other Pacific Islander 0.53 0.43 * * 0.64 0.48 * * * 0.31
Asian 0.22 0.04 0.19 * 0.23 0.04 0.18 0.04 0.27 0.05
Two or More Races 0.76 0.30 0.68 0.56 0.91 0.34 0.99 0.78 1.14 0.37
Hispanic or Latino 0.17 0.14 0.24 0.20 0.19 0.16 0.30 0.29 0.23 0.18
EDUCATION                    
< High School da da da da 0.21 0.17 0.37 0.35 0.24 0.19
High School Graduate da da da da 0.15 0.14 0.27 0.27 0.17 0.16
Some College/Associate's Degree da da da da 0.12 0.11 0.22 0.21 0.14 0.13
College Graduate da da da da 0.09 0.11 0.22 0.24 0.09 0.12
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.10 0.08 0.22 0.20 0.11 0.09
Part-Time da da da da 0.16 0.19 0.24 0.26 0.21 0.25
Unemployed da da da da 0.37 0.40 0.56 0.56 0.48 0.52
Other1 da da da da 0.10 0.11 0.27 0.24 0.11 0.13
170421
Table 1.55P – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0534   0.2686   0.0716   0.0026   0.3264  
GENDER                    
Male 0.0132   0.1043   0.0206   0.0090   0.0982  
Female 0.9063   0.8424   0.9356   0.1151   0.6769  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.2239   0.4039   0.2658   0.0033   0.7790  
White 0.6538   0.2847   0.7537   0.0079   0.6399  
Black or African American 0.3887   0.5749   0.3345   0.5719   0.3984  
American Indian or Alaska Native 0.8969   0.1953   0.9244   0.0448   0.6597  
Native Hawaiian or Other Pacific Islander 0.9287   *   0.8482   *   *  
Asian 0.2088   *   0.2580   0.4312   0.2961  
Two or More Races 0.1147   0.8112   0.1195   0.5343   0.1453  
Hispanic or Latino 0.0432   0.4517   0.0559   0.4934   0.0733  
EDUCATION                    
< High School da   da   0.0512   0.0701   0.1391  
High School Graduate da   da   0.5381   0.0974   0.9464  
Some College/Associate's Degree da   da   0.0641   0.1252   0.1604  
College Graduate da   da   0.3747   0.7964   0.3410  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0020   0.0078   0.0178  
Part-Time da   da   0.6944   0.7252   0.7744  
Unemployed da   da   0.8037   0.3196   0.4494  
Other1 da   da   0.4791   0.1912   0.3059  
170421
Table 1.56C – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 623 592 50 53 617 587 115 111 599 573
GENDER                    
Male 362 338 34 32 361 337 79 74 352 330
Female 474 467 36 39 467 465 84 78 454 452
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 571 541 44 45 566 537 98 98 552 526
White 528 496 40 43 617 587 103 98 608 575
Black or African American 163 163 16 14 178 180 31 33 168 173
American Indian or Alaska Native 30 40 1 1 30 40 5 8 29 38
Native Hawaiian or Other Pacific Islander 10 29 * * 9 29 5 * 7 28
Asian 103 111 11 11 103 109 19 23 100 108
Two or More Races 83 72 11 8 81 71 17 13 80 70
Hispanic or Latino 197 209 24 25 193 205 53 50 184 201
EDUCATION                    
< High School da da da da 226 202 46 39 218 199
High School Graduate da da da da 319 343 60 62 314 335
Some College/Associate's Degree da da da da 371 369 86 77 359 358
College Graduate da da da da 393 387 40 47 391 383
CURRENT EMPLOYMENT                    
Full-Time da da da da 387 376 74 72 380 371
Part-Time da da da da 225 223 62 65 216 213
Unemployed da da da da 120 121 37 38 114 116
Other1 da da da da 429 491 58 52 425 487
170421
Table 1.56D – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.23 0.22 0.20 0.21 0.25 0.24 0.33 0.32 0.29 0.27
GENDER                    
Male 0.28 0.26 0.27 0.25 0.31 0.29 0.45 0.43 0.35 0.33
Female 0.34 0.34 0.30 0.32 0.37 0.37 0.48 0.45 0.42 0.41
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.25 0.24 0.23 0.24 0.28 0.26 0.36 0.36 0.31 0.29
White 0.31 0.29 0.28 0.31 0.33 0.31 0.46 0.47 0.37 0.35
Black or African American 0.51 0.51 0.42 0.40 0.57 0.56 0.60 0.63 0.66 0.65
American Indian or Alaska Native 1.88 2.39 0.47 0.78 2.12 2.63 2.21 3.13 2.56 3.01
Native Hawaiian or Other Pacific Islander 1.41 2.29 * * 1.43 2.52 2.85 * 1.63 2.93
Asian 0.68 0.73 0.87 0.86 0.73 0.79 0.90 1.04 0.84 0.93
Two or More Races 1.63 1.38 1.30 0.96 1.91 1.62 1.82 1.65 2.42 1.98
Hispanic or Latino 0.45 0.47 0.41 0.42 0.51 0.53 0.71 0.67 0.61 0.65
EDUCATION                    
< High School da da da da 0.62 0.58 0.79 0.77 0.72 0.67
High School Graduate da da da da 0.47 0.50 0.52 0.57 0.56 0.59
Some College/Associate's Degree da da da da 0.43 0.42 0.54 0.48 0.51 0.51
College Graduate da da da da 0.48 0.45 0.85 0.89 0.50 0.47
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.30 0.28 0.48 0.46 0.33 0.32
Part-Time da da da da 0.63 0.62 0.64 0.65 0.84 0.84
Unemployed da da da da 0.96 1.03 0.99 1.07 1.31 1.38
Other1 da da da da 0.48 0.51 0.68 0.64 0.52 0.56
170421
Table 1.56P – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.3384   0.6071   0.3029   0.0902   0.4498  
GENDER                    
Male 0.4177   0.9100   0.4157   0.1542   0.6003  
Female 0.5306   0.4190   0.4754   0.3150   0.5623  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7566   0.9480   0.7302   0.1367   0.9131  
White 0.4630   0.8294   0.4352   0.0420   0.6552  
Black or African American 0.6933   0.9657   0.7116   0.6339   0.7916  
American Indian or Alaska Native 0.3739   0.5833   0.4266   0.1960   0.5602  
Native Hawaiian or Other Pacific Islander 0.3760   *   0.2696   *   0.2108  
Asian 0.1807   0.5863   0.1896   0.5465   0.2144  
Two or More Races 0.7585   0.2792   0.8587   0.5973   0.7165  
Hispanic or Latino 0.0605   0.3035   0.0420   0.3985   0.0585  
EDUCATION                    
< High School da   da   0.0615   0.8823   0.0596  
High School Graduate da   da   0.9869   0.7441   0.9223  
Some College/Associate's Degree da   da   0.0722   0.0014   0.2757  
College Graduate da   da   0.4299   0.7304   0.4424  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.2145   0.6247   0.2458  
Part-Time da   da   0.6795   0.1411   0.9561  
Unemployed da   da   0.7997   0.7666   0.6913  
Other1 da   da   0.8927   0.0970   0.9770  
170421
Table 1.57C – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 209 206 32 32 205 203 78 79 190 183
GENDER                    
Male 156 144 22 22 155 141 60 56 141 127
Female 131 143 22 22 129 142 52 54 118 130
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 190 188 27 26 187 185 70 71 172 170
White 178 178 24 23 179 182 70 65 165 168
Black or African American 51 49 10 10 51 49 22 25 46 40
American Indian or Alaska Native 8 7 1 0 8 7 3 4 7 6
Native Hawaiian or Other Pacific Islander 6 6 * * 6 6 4 * 5 *
Asian 24 24 6 7 23 23 13 11 20 20
Two or More Races 27 34 9 8 25 33 10 9 23 31
Hispanic or Latino 90 72 17 16 87 70 33 37 80 56
EDUCATION                    
< High School da da da da 81 69 30 30 75 63
High School Graduate da da da da 98 107 42 44 89 91
Some College/Associate's Degree da da da da 126 106 56 55 111 93
College Graduate da da da da 95 124 24 23 92 120
CURRENT EMPLOYMENT                    
Full-Time da da da da 129 127 52 50 119 116
Part-Time da da da da 82 87 43 46 72 73
Unemployed da da da da 64 50 28 28 58 42
Other1 da da da da 119 124 33 35 114 119
170421
Table 1.57D – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.08 0.08 0.13 0.13 0.08 0.08 0.22 0.23 0.09 0.09
GENDER                    
Male 0.12 0.11 0.17 0.17 0.13 0.12 0.34 0.32 0.14 0.13
Female 0.09 0.10 0.18 0.18 0.10 0.11 0.30 0.31 0.11 0.12
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.08 0.08 0.14 0.14 0.09 0.09 0.26 0.26 0.10 0.09
White 0.10 0.10 0.17 0.17 0.11 0.11 0.34 0.33 0.12 0.12
Black or African American 0.16 0.15 0.28 0.28 0.17 0.16 0.43 0.49 0.19 0.16
American Indian or Alaska Native 0.56 0.48 0.33 0.34 0.62 0.53 1.46 1.48 0.68 0.54
Native Hawaiian or Other Pacific Islander 0.85 0.49 * * 1.01 0.54 2.44 * 1.04 *
Asian 0.17 0.16 0.47 0.51 0.18 0.17 0.61 0.50 0.17 0.18
Two or More Races 0.57 0.69 1.05 0.90 0.65 0.80 1.18 1.21 0.76 0.95
Hispanic or Latino 0.21 0.16 0.29 0.27 0.23 0.18 0.44 0.50 0.26 0.18
EDUCATION                    
< High School da da da da 0.23 0.21 0.54 0.61 0.26 0.23
High School Graduate da da da da 0.16 0.17 0.38 0.41 0.18 0.18
Some College/Associate's Degree da da da da 0.16 0.14 0.36 0.34 0.18 0.15
College Graduate da da da da 0.13 0.16 0.53 0.47 0.13 0.17
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.11 0.10 0.35 0.32 0.11 0.11
Part-Time da da da da 0.25 0.26 0.46 0.48 0.30 0.31
Unemployed da da da da 0.54 0.45 0.76 0.81 0.72 0.54
Other1 da da da da 0.15 0.15 0.40 0.44 0.16 0.16
170421
Table 1.57P – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9178   0.3751   0.8034   0.9178   0.8860  
GENDER                    
Male 0.1457   0.5377   0.1167   0.2289   0.2625  
Female 0.1591   0.5159   0.1905   0.2701   0.3223  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.7460   0.5589   0.8116   0.6451   0.6050  
White 0.8089   0.8142   0.8356   0.3496   0.5144  
Black or African American 0.9066   0.7210   0.9632   0.2958   0.6596  
American Indian or Alaska Native 0.4484   0.7839   0.4177   0.6520   0.5248  
Native Hawaiian or Other Pacific Islander 0.1898   *   0.2148   *   *  
Asian 0.8381   0.5030   0.9779   0.8003   0.9006  
Two or More Races 0.4718   0.7338   0.5188   0.1501   0.7808  
Hispanic or Latino 0.3253   0.4409   0.2369   0.4645   0.0938  
EDUCATION                    
< High School da   da   0.5270   0.3537   0.3335  
High School Graduate da   da   0.6239   0.3404   0.8428  
Some College/Associate's Degree da   da   0.0187   0.1389   0.0501  
College Graduate da   da   0.0362   0.9868   0.0331  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.3331   0.4570   0.5105  
Part-Time da   da   0.9919   0.9935   0.9196  
Unemployed da   da   0.7338   0.4192   0.4319  
Other1 da   da   0.4090   0.8397   0.3991  
170421
Table 1.58C – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 109 120 21 17 107 118 44 41 97 109
GENDER                    
Male 81 92 14 12 79 91 34 31 70 83
Female 72 73 16 11 70 72 27 27 65 67
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 102 115 17 15 99 113 39 39 91 105
White 95 109 14 13 93 107 37 35 86 101
Black or African American 30 31 4 5 30 32 12 16 27 27
American Indian or Alaska Native 4 4 1 * 4 4 0 * 4 4
Native Hawaiian or Other Pacific Islander * 6 * * * 6 * * * *
Asian 6 10 4 2 4 10 4 4 * 9
Two or More Races 18 11 7 4 16 11 4 7 16 8
Hispanic or Latino 40 34 13 8 38 33 20 15 31 29
EDUCATION                    
< High School da da da da 35 35 20 19 29 30
High School Graduate da da da da 52 54 23 24 45 48
Some College/Associate's Degree da da da da 69 56 29 25 63 50
College Graduate da da da da 49 79 12 10 47 78
CURRENT EMPLOYMENT                    
Full-Time da da da da 70 72 31 26 63 68
Part-Time da da da da 41 45 21 22 35 40
Unemployed da da da da 29 29 14 12 24 26
Other1 da da da da 61 72 19 20 58 69
170421
Table 1.58D – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.04 0.04 0.09 0.07 0.04 0.05 0.13 0.12 0.05 0.05
GENDER                    
Male 0.06 0.07 0.11 0.09 0.07 0.08 0.20 0.18 0.07 0.08
Female 0.05 0.05 0.13 0.09 0.06 0.06 0.16 0.15 0.06 0.06
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.05 0.09 0.08 0.05 0.05 0.14 0.14 0.05 0.06
White 0.06 0.06 0.11 0.10 0.06 0.07 0.19 0.18 0.06 0.07
Black or African American 0.09 0.10 0.11 0.14 0.10 0.11 0.24 0.33 0.11 0.11
American Indian or Alaska Native 0.31 0.29 0.31 * 0.35 0.32 0.10 * 0.42 0.39
Native Hawaiian or Other Pacific Islander * 0.48 * * * 0.53 * * * *
Asian 0.04 0.07 0.35 0.16 0.03 0.07 0.18 0.19 * 0.08
Two or More Races 0.39 0.23 0.85 0.53 0.42 0.26 0.44 0.86 0.53 0.25
Hispanic or Latino 0.09 0.08 0.23 0.14 0.10 0.09 0.26 0.20 0.10 0.09
EDUCATION                    
< High School da da da da 0.10 0.11 0.37 0.38 0.10 0.11
High School Graduate da da da da 0.08 0.09 0.22 0.23 0.09 0.10
Some College/Associate's Degree da da da da 0.09 0.07 0.20 0.16 0.10 0.08
College Graduate da da da da 0.07 0.10 0.26 0.21 0.07 0.11
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.06 0.06 0.21 0.18 0.06 0.06
Part-Time da da da da 0.13 0.14 0.23 0.24 0.15 0.17
Unemployed da da da da 0.25 0.26 0.40 0.37 0.31 0.33
Other1 da da da da 0.08 0.09 0.24 0.25 0.08 0.09
170421
Table 1.58P – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6794   0.1199   0.4975   0.4892   0.2896  
GENDER                    
Male 0.8622   0.5535   0.7903   0.2870   0.4311  
Female 0.6586   0.1212   0.4550   0.8262   0.4575  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4832   0.2051   0.3734   0.5999   0.2307  
White 0.6674   0.2513   0.5578   0.1379   0.2351  
Black or African American 0.1531   0.9548   0.1558   0.1245   0.4068  
American Indian or Alaska Native 0.9761   *   0.9525   *   0.9019  
Native Hawaiian or Other Pacific Islander *   *   *   *   *  
Asian 0.5258   0.4731   0.3116   0.7998   *  
Two or More Races 0.1999   0.7989   0.1936   0.1408   0.0501  
Hispanic or Latino 0.4832   0.3953   0.6378   0.6132   0.8026  
EDUCATION                    
< High School da   da   0.5070   0.7658   0.4717  
High School Graduate da   da   0.6360   0.7088   0.6888  
Some College/Associate's Degree da   da   0.0604   0.1467   0.1614  
College Graduate da   da   0.0246   0.8595   0.0201  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.8791   0.3372   0.7793  
Part-Time da   da   0.9584   0.5796   0.7369  
Unemployed da   da   0.8739   0.5500   0.8833  
Other1 da   da   0.1596   0.3477   0.2239  
170421
Table 1.59C – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 356 368 62 61 351 358 130 139 314 327
GENDER                    
Male 236 236 46 47 231 229 87 92 212 209
Female 244 246 40 38 239 243 82 87 218 227
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 331 343 56 56 325 335 118 122 291 311
White 292 317 54 55 306 331 127 134 273 306
Black or African American 103 89 20 17 104 90 29 29 97 86
American Indian or Alaska Native 22 19 2 3 22 19 5 4 21 18
Native Hawaiian or Other Pacific Islander 12 17 * * 11 15 * * * 13
Asian 62 59 13 11 60 58 24 26 56 52
Two or More Races 53 43 13 14 51 41 20 18 46 36
Hispanic or Latino 127 113 26 26 125 112 48 55 115 99
EDUCATION                    
< High School da da da da 127 111 41 39 118 103
High School Graduate da da da da 154 157 61 67 143 141
Some College/Associate's Degree da da da da 214 227 107 115 182 202
College Graduate da da da da 206 226 55 63 196 210
CURRENT EMPLOYMENT                    
Full-Time da da da da 252 253 84 85 235 236
Part-Time da da da da 130 140 76 87 106 111
Unemployed da da da da 74 76 32 41 68 64
Other1 da da da da 197 208 65 62 186 198
170421
Table 1.59D – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.13 0.14 0.25 0.25 0.14 0.15 0.37 0.40 0.15 0.16
GENDER                    
Male 0.18 0.18 0.36 0.37 0.20 0.19 0.50 0.53 0.21 0.21
Female 0.18 0.18 0.33 0.31 0.19 0.19 0.47 0.51 0.20 0.21
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.15 0.15 0.29 0.29 0.16 0.16 0.43 0.45 0.16 0.17
White 0.17 0.19 0.37 0.37 0.18 0.20 0.52 0.58 0.19 0.21
Black or African American 0.32 0.28 0.56 0.48 0.35 0.31 0.56 0.57 0.40 0.35
American Indian or Alaska Native 1.50 1.20 1.02 1.95 1.71 1.30 2.44 1.66 1.99 1.56
Native Hawaiian or Other Pacific Islander 1.69 1.48 * * 1.76 1.47 * * * 1.39
Asian 0.42 0.39 0.92 0.83 0.45 0.42 1.12 1.12 0.49 0.45
Two or More Races 1.08 0.86 1.53 1.55 1.26 1.00 2.07 2.14 1.46 1.10
Hispanic or Latino 0.29 0.26 0.46 0.45 0.33 0.29 0.64 0.74 0.38 0.32
EDUCATION                    
< High School da da da da 0.36 0.34 0.73 0.78 0.40 0.37
High School Graduate da da da da 0.24 0.25 0.54 0.61 0.28 0.27
Some College/Associate's Degree da da da da 0.28 0.28 0.61 0.64 0.29 0.31
College Graduate da da da da 0.27 0.27 1.09 1.10 0.28 0.28
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.21 0.20 0.53 0.52 0.22 0.21
Part-Time da da da da 0.39 0.41 0.73 0.83 0.44 0.47
Unemployed da da da da 0.63 0.66 0.89 1.12 0.83 0.79
Other1 da da da da 0.24 0.25 0.72 0.72 0.25 0.26
170421
Table 1.59P – Any Use of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0294   0.7998   0.0232   0.4410   0.0240  
GENDER                    
Male 0.7476   0.5882   0.8197   0.5632   0.5630  
Female 0.0040   0.3176   0.0018   0.0813   0.0058  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.0193   0.5350   0.0132   0.6964   0.0083  
White 0.0105   0.8535   0.0084   0.7060   0.0052  
Black or African American 0.9655   0.2675   0.7946   0.7687   0.8323  
American Indian or Alaska Native 0.3260   0.2475   0.2628   0.1744   0.4037  
Native Hawaiian or Other Pacific Islander 0.9719   *   0.8958   *   *  
Asian 0.7271   0.7678   0.6842   0.7892   0.8296  
Two or More Races 0.8510   0.7242   0.9243   0.6452   0.9375  
Hispanic or Latino 0.9421   0.4165   0.9134   0.2566   0.5271  
EDUCATION                    
< High School da   da   0.3699   0.9706   0.4074  
High School Graduate da   da   0.7448   0.9225   0.6526  
Some College/Associate's Degree da   da   0.0582   0.5422   0.0870  
College Graduate da   da   0.0468   0.9660   0.0383  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.3293   0.2000   0.4935  
Part-Time da   da   0.0765   0.9369   0.0597  
Unemployed da   da   0.0884   0.1238   0.2451  
Other1 da   da   0.2705   0.2308   0.1072  
170421
Table 1.60C – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 174 192 35 34 171 185 96 104 132 142
GENDER                    
Male 130 130 24 26 127 125 71 71 100 99
Female 104 125 25 21 102 123 54 68 82 98
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 161 178 31 30 156 171 85 93 123 135
White 152 165 29 25 148 162 87 97 121 128
Black or African American 29 33 6 6 28 33 22 17 18 29
American Indian or Alaska Native 15 4 1 2 15 4 2 4 * 2
Native Hawaiian or Other Pacific Islander 6 10 * * 4 10 * * 1 6
Asian 28 30 8 8 27 29 14 17 23 24
Two or More Races 27 26 6 11 26 24 15 13 21 20
Hispanic or Latino 58 60 16 15 57 59 35 41 44 39
EDUCATION                    
< High School da da da da 42 45 25 26 35 37
High School Graduate da da da da 73 72 45 44 56 57
Some College/Associate's Degree da da da da 104 120 75 87 68 80
College Graduate da da da da 96 107 39 46 91 93
CURRENT EMPLOYMENT                    
Full-Time da da da da 122 122 61 65 109 98
Part-Time da da da da 72 83 57 64 44 55
Unemployed da da da da 35 48 22 24 27 42
Other1 da da da da 65 88 43 44 47 74
170421
Table 1.60D – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.07 0.07 0.14 0.14 0.07 0.08 0.27 0.30 0.06 0.07
GENDER                    
Male 0.10 0.10 0.19 0.21 0.11 0.11 0.40 0.41 0.10 0.10
Female 0.08 0.09 0.20 0.17 0.08 0.10 0.31 0.40 0.08 0.09
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.08 0.16 0.16 0.08 0.08 0.31 0.34 0.07 0.08
White 0.09 0.10 0.21 0.19 0.09 0.10 0.39 0.45 0.09 0.09
Black or African American 0.09 0.10 0.17 0.18 0.10 0.11 0.42 0.34 0.08 0.12
American Indian or Alaska Native 1.02 0.29 0.62 1.08 1.16 0.29 0.77 1.46 * 0.14
Native Hawaiian or Other Pacific Islander 0.85 0.82 * * 0.67 0.90 * * 0.31 0.62
Asian 0.19 0.21 0.58 0.64 0.20 0.22 0.68 0.75 0.20 0.22
Two or More Races 0.58 0.54 0.79 1.26 0.68 0.60 1.61 1.59 0.69 0.62
Hispanic or Latino 0.13 0.13 0.27 0.27 0.15 0.15 0.48 0.55 0.15 0.13
EDUCATION                    
< High School da da da da 0.12 0.14 0.45 0.54 0.12 0.13
High School Graduate da da da da 0.12 0.12 0.41 0.42 0.11 0.11
Some College/Associate's Degree da da da da 0.14 0.15 0.45 0.51 0.11 0.13
College Graduate da da da da 0.13 0.14 0.83 0.84 0.13 0.13
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.10 0.10 0.40 0.42 0.10 0.09
Part-Time da da da da 0.22 0.25 0.58 0.64 0.19 0.24
Unemployed da da da da 0.31 0.43 0.63 0.69 0.34 0.53
Other1 da da da da 0.08 0.11 0.49 0.54 0.06 0.10
170421
Table 1.60P – Misuse of Stimulants in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.1269   0.1890   0.0653   0.6206   0.0379  
GENDER                    
Male 0.7158   0.6462   0.7806   0.3377   0.6265  
Female 0.0073   0.1462   0.0024   0.0651   0.0099  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1278   0.1438   0.0616   0.7451   0.0276  
White 0.1718   0.0357   0.0729   0.6308   0.0459  
Black or African American 0.4613   0.9858   0.4534   0.4079   0.0946  
American Indian or Alaska Native 0.3532   0.3693   0.3092   0.7655   *  
Native Hawaiian or Other Pacific Islander 0.9860   *   0.5649   *   0.5221  
Asian 0.4904   0.6098   0.5629   0.7489   0.7218  
Two or More Races 0.9529   0.2634   0.7546   0.8167   0.8250  
Hispanic or Latino 0.7061   0.9960   0.7020   0.5783   0.9083  
EDUCATION                    
< High School da   da   0.7355   0.5492   0.8470  
High School Graduate da   da   0.9307   0.8252   0.7882  
Some College/Associate's Degree da   da   0.3558   0.7071   0.3791  
College Graduate da   da   0.0832   0.6568   0.0452  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.8080   0.3792   0.5044  
Part-Time da   da   0.0842   0.7496   0.0639  
Unemployed da   da   0.0427   0.8633   0.0173  
Other1 da   da   0.1010   0.3992   0.0069  
170421
Table 1.61C – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 97 103 17 14 96 103 51 58 78 83
GENDER                    
Male 67 68 11 10 66 67 37 38 52 56
Female 66 74 12 10 65 74 32 41 56 59
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 92 98 15 12 91 98 48 53 76 82
White 89 95 14 10 87 95 47 53 74 79
Black or African American 11 19 1 5 11 19 9 10 5 16
American Indian or Alaska Native * 2 1 1 * 2 1 * * 2
Native Hawaiian or Other Pacific Islander 6 2 * * 3 2 * * 1 2
Asian 15 10 4 2 15 10 8 8 12 5
Two or More Races 18 16 2 5 18 15 5 7 17 14
Hispanic or Latino 25 31 8 7 23 30 18 18 15 24
EDUCATION                    
< High School da da da da 32 29 16 16 28 25
High School Graduate da da da da 42 40 23 27 34 30
Some College/Associate's Degree da da da da 54 60 37 43 38 44
College Graduate da da da da 54 61 18 21 50 56
CURRENT EMPLOYMENT                    
Full-Time da da da da 72 62 31 28 65 55
Part-Time da da da da 40 53 25 39 31 37
Unemployed da da da da 17 21 13 15 12 15
Other1 da da da da 43 48 28 23 31 43
170421
Table 1.61D – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.04 0.04 0.07 0.06 0.04 0.04 0.15 0.17 0.04 0.04
GENDER                    
Male 0.05 0.05 0.09 0.08 0.06 0.06 0.21 0.22 0.05 0.06
Female 0.05 0.05 0.10 0.08 0.05 0.06 0.18 0.24 0.05 0.05
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.04 0.04 0.08 0.06 0.04 0.05 0.18 0.19 0.04 0.05
White 0.05 0.06 0.11 0.08 0.06 0.06 0.23 0.26 0.05 0.06
Black or African American 0.03 0.06 0.04 0.14 0.04 0.06 0.18 0.20 0.02 0.07
American Indian or Alaska Native * 0.11 0.39 0.42 * 0.11 0.32 * * 0.14
Native Hawaiian or Other Pacific Islander 0.77 0.13 * * 0.53 0.14 * * 0.19 0.17
Asian 0.10 0.07 0.30 0.18 0.11 0.07 0.40 0.39 0.11 0.04
Two or More Races 0.38 0.33 0.29 0.64 0.45 0.38 0.63 0.87 0.55 0.42
Hispanic or Latino 0.06 0.07 0.14 0.12 0.06 0.08 0.24 0.24 0.05 0.08
EDUCATION                    
< High School da da da da 0.09 0.09 0.29 0.34 0.10 0.09
High School Graduate da da da da 0.07 0.06 0.21 0.26 0.07 0.06
Some College/Associate's Degree da da da da 0.07 0.08 0.25 0.27 0.06 0.07
College Graduate da da da da 0.07 0.08 0.39 0.42 0.07 0.08
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.06 0.05 0.21 0.19 0.06 0.05
Part-Time da da da da 0.12 0.16 0.27 0.41 0.13 0.16
Unemployed da da da da 0.15 0.19 0.36 0.44 0.15 0.19
Other1 da da da da 0.05 0.06 0.34 0.28 0.04 0.06
170421
Table 1.61P – Misuse of Stimulants in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6045   0.2399   0.4816   0.8208   0.4310  
GENDER                    
Male 0.9864   0.3221   0.8888   0.9252   0.7557  
Female 0.4586   0.4998   0.3963   0.6602   0.4217  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.6965   0.1675   0.5569   0.5612   0.6794  
White 0.7965   0.1190   0.6427   0.6231   0.7433  
Black or African American 0.0498   0.2915   0.0744   0.6561   0.0462  
American Indian or Alaska Native *   0.9825   *   *   *  
Native Hawaiian or Other Pacific Islander 0.1432   *   0.2521   *   0.9261  
Asian 0.4426   0.4757   0.5359   0.9492   0.3817  
Two or More Races 0.5891   0.6192   0.6659   0.2523   0.9506  
Hispanic or Latino 0.5783   0.9491   0.5755   0.3665   0.1173  
EDUCATION                    
< High School da   da   0.7202   0.7606   0.8941  
High School Graduate da   da   0.5011   0.8251   0.3609  
Some College/Associate's Degree da   da   0.6940   0.7673   0.4418  
College Graduate da   da   0.1552   0.4162   0.2369  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.7166   0.7190   0.8564  
Part-Time da   da   0.1204   0.1551   0.5046  
Unemployed da   da   0.8350   0.9537   0.7580  
Other1 da   da   0.6675   0.3409   0.1955  
170421
Table 1.62C – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 437 466 38 35 434 464 63 65 426 457
GENDER                    
Male 280 258 26 23 277 256 43 42 272 255
Female 324 376 28 26 322 374 48 47 317 369
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 417 418 35 31 414 415 56 56 408 408
White 371 387 30 27 409 435 53 51 404 430
Black or African American 122 115 11 11 130 121 19 17 126 119
American Indian or Alaska Native 19 27 2 1 19 27 * 3 18 27
Native Hawaiian or Other Pacific Islander 11 8 * * 10 8 * * 9 8
Asian 97 75 9 7 96 74 10 9 96 74
Two or More Races 54 48 8 6 54 48 11 9 53 47
Hispanic or Latino 140 183 16 17 139 182 27 31 136 181
EDUCATION                    
< High School da da da da 147 142 25 21 146 140
High School Graduate da da da da 206 251 30 32 203 249
Some College/Associate's Degree da da da da 262 265 45 46 257 260
College Graduate da da da da 282 294 22 25 280 293
CURRENT EMPLOYMENT                    
Full-Time da da da da 266 258 39 39 261 254
Part-Time da da da da 160 166 33 31 157 165
Unemployed da da da da 89 85 23 24 89 82
Other1 da da da da 330 362 34 32 328 359
170421
Table 1.62D – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.16 0.17 0.15 0.14 0.18 0.19 0.18 0.19 0.20 0.22
GENDER                    
Male 0.22 0.20 0.20 0.18 0.24 0.22 0.25 0.24 0.27 0.25
Female 0.23 0.27 0.23 0.21 0.26 0.30 0.28 0.27 0.29 0.34
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.19 0.19 0.18 0.16 0.20 0.20 0.21 0.21 0.23 0.23
White 0.22 0.23 0.22 0.20 0.23 0.24 0.27 0.27 0.26 0.27
Black or African American 0.38 0.36 0.33 0.31 0.42 0.40 0.37 0.34 0.49 0.47
American Indian or Alaska Native 1.28 1.73 1.25 0.93 1.44 1.89 * 1.28 1.62 2.30
Native Hawaiian or Other Pacific Islander 1.43 0.69 * * 1.72 0.75 * * 2.10 0.87
Asian 0.64 0.50 0.74 0.55 0.69 0.55 0.50 0.43 0.81 0.64
Two or More Races 1.14 0.95 0.94 0.77 1.36 1.13 1.30 1.08 1.71 1.37
Hispanic or Latino 0.32 0.41 0.28 0.29 0.37 0.47 0.36 0.41 0.45 0.58
EDUCATION                    
< High School da da da da 0.41 0.42 0.46 0.44 0.49 0.49
High School Graduate da da da da 0.32 0.39 0.27 0.31 0.38 0.46
Some College/Associate's Degree da da da da 0.34 0.32 0.31 0.31 0.41 0.39
College Graduate da da da da 0.35 0.35 0.49 0.51 0.37 0.37
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.21 0.20 0.26 0.26 0.24 0.23
Part-Time da da da da 0.46 0.50 0.36 0.34 0.62 0.68
Unemployed da da da da 0.74 0.74 0.64 0.72 1.07 1.00
Other1 da da da da 0.38 0.40 0.42 0.40 0.42 0.44
170421
Table 1.62P – Any Use of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9320   0.4462   0.9705   0.5936   1.0000  
GENDER                    
Male 0.5292   0.2552   0.5873   0.1464   0.7303  
Female 0.7012   1.0000   0.7071   0.5730   0.7853  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8273   0.3225   0.8751   0.3386   0.9495  
White 0.6627   0.4229   0.6270   0.6363   0.5987  
Black or African American 0.3037   0.7874   0.3045   0.5981   0.3171  
American Indian or Alaska Native 0.4214   0.8258   0.4270   *   0.3319  
Native Hawaiian or Other Pacific Islander 0.2414   *   0.2084   *   0.3555  
Asian 0.1510   0.4014   0.1762   0.4259   0.2153  
Two or More Races 0.9799   0.9595   0.9771   0.7926   0.9730  
Hispanic or Latino 0.7012   0.7519   0.7244   0.4486   0.8310  
EDUCATION                    
< High School da   da   0.8026   0.5890   0.7594  
High School Graduate da   da   0.8183   0.4665   0.7763  
Some College/Associate's Degree da   da   0.5262   0.8858   0.5457  
College Graduate da   da   0.9834   0.9831   0.9950  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.4973   0.8264   0.4608  
Part-Time da   da   0.7437   0.2987   0.9661  
Unemployed da   da   0.7160   0.9342   0.6708  
Other1 da   da   0.4350   0.7706   0.4391  
170421
Table 1.63C – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 113 117 16 14 111 116 26 30 109 112
GENDER                    
Male 68 81 9 10 68 80 19 22 65 78
Female 90 83 12 10 89 82 20 20 88 80
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 103 112 14 12 102 110 24 25 100 107
White 99 104 12 11 99 104 23 23 97 101
Black or African American 21 29 4 1 21 29 4 7 20 28
American Indian or Alaska Native 0 3 0 0 * 3 * * * 2
Native Hawaiian or Other Pacific Islander 3 * * * 3 * * * 1 *
Asian 9 11 2 3 9 11 4 * 8 11
Two or More Races 23 25 4 4 23 25 5 5 22 24
Hispanic or Latino 37 37 8 9 36 36 11 18 35 31
EDUCATION                    
< High School da da da da 28 34 9 8 27 33
High School Graduate da da da da 49 55 15 12 47 54
Some College/Associate's Degree da da da da 66 62 19 22 63 60
College Graduate da da da da 70 76 9 14 70 75
CURRENT EMPLOYMENT                    
Full-Time da da da da 82 58 16 19 81 54
Part-Time da da da da 39 51 16 16 35 48
Unemployed da da da da 23 25 8 13 21 21
Other1 da da da da 62 82 14 10 60 81
170421
Table 1.63D – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.04 0.04 0.06 0.06 0.05 0.05 0.08 0.09 0.05 0.05
GENDER                    
Male 0.05 0.06 0.07 0.08 0.06 0.07 0.11 0.13 0.07 0.08
Female 0.07 0.06 0.10 0.08 0.07 0.06 0.11 0.12 0.08 0.07
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.05 0.05 0.07 0.06 0.05 0.05 0.09 0.09 0.06 0.06
White 0.06 0.06 0.09 0.08 0.06 0.07 0.12 0.12 0.07 0.07
Black or African American 0.07 0.09 0.10 0.04 0.07 0.10 0.09 0.15 0.09 0.12
American Indian or Alaska Native 0.01 0.21 0.10 0.23 * 0.23 * * * 0.22
Native Hawaiian or Other Pacific Islander 0.42 * * * 0.51 * * * 0.19 *
Asian 0.06 0.08 0.19 0.21 0.07 0.08 0.18 * 0.07 0.10
Two or More Races 0.49 0.51 0.44 0.45 0.59 0.61 0.61 0.70 0.73 0.73
Hispanic or Latino 0.09 0.08 0.14 0.15 0.10 0.09 0.14 0.24 0.11 0.10
EDUCATION                    
< High School da da da da 0.08 0.10 0.16 0.17 0.09 0.12
High School Graduate da da da da 0.08 0.09 0.14 0.12 0.09 0.10
Some College/Associate's Degree da da da da 0.09 0.08 0.14 0.15 0.10 0.10
College Graduate da da da da 0.10 0.10 0.19 0.29 0.10 0.10
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.07 0.05 0.11 0.13 0.08 0.05
Part-Time da da da da 0.12 0.16 0.18 0.17 0.15 0.21
Unemployed da da da da 0.20 0.22 0.24 0.38 0.27 0.27
Other1 da da da da 0.08 0.10 0.17 0.12 0.08 0.11
170421
Table 1.63P – Misuse of Sedatives in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9446   0.9285   0.9359   0.8547   0.8890  
GENDER                    
Male 0.3931   0.7085   0.3616   0.8037   0.3079  
Female 0.4974   0.8308   0.4766   0.9908   0.4682  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.8828   0.9685   0.8830   0.3404   0.9342  
White 0.7068   0.6925   0.6687   0.2571   0.8658  
Black or African American 0.4072   0.2304   0.3275   0.2909   0.4791  
American Indian or Alaska Native 0.1312   0.3799   *   *   *  
Native Hawaiian or Other Pacific Islander *   *   *   *   *  
Asian 0.5713   0.8805   0.5382   *   0.3239  
Two or More Races 0.9773   0.6309   0.9648   0.8150   0.9945  
Hispanic or Latino 0.5166   0.9222   0.4916   0.2233   0.8302  
EDUCATION                    
< High School da   da   0.1812   0.8998   0.1759  
High School Graduate da   da   0.4577   0.3472   0.6147  
Some College/Associate's Degree da   da   0.5897   0.5695   0.7107  
College Graduate da   da   0.6392   0.1594   0.8093  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0499   0.3642   0.0258  
Part-Time da   da   0.5403   0.2503   0.2809  
Unemployed da   da   0.4501   0.3538   0.7204  
Other1 da   da   0.1270   0.2839   0.0843  
170421
Table 1.64C – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 57 74 7 6 57 74 16 12 55 73
GENDER                    
Male 29 56 3 2 29 55 10 6 27 55
Female 46 50 7 6 45 50 12 10 44 49
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 55 73 5 6 55 73 14 10 54 72
White 53 66 5 6 53 67 13 10 52 66
Black or African American 18 14 1 1 18 14 4 2 17 14
American Indian or Alaska Native * 2 * 0 * 2 * * * 2
Native Hawaiian or Other Pacific Islander 3 * * * 3 * * * 1 *
Asian * 10 * * * 10 * * * 10
Two or More Races 3 22 1 0 3 22 1 1 2 22
Hispanic or Latino 14 15 5 3 13 15 8 6 10 14
EDUCATION                    
< High School da da da da 14 14 3 5 14 14
High School Graduate da da da da 31 42 7 4 30 41
Some College/Associate's Degree da da da da 23 32 13 9 19 31
College Graduate da da da da 39 51 6 3 38 51
CURRENT EMPLOYMENT                    
Full-Time da da da da 42 33 10 8 40 32
Part-Time da da da da 20 24 7 6 18 24
Unemployed da da da da 8 16 4 5 6 15
Other1 da da da da 34 61 10 3 32 61
170421
Table 1.64D – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.02 0.03 0.03 0.03 0.02 0.03 0.05 0.03 0.03 0.03
GENDER                    
Male 0.02 0.04 0.02 0.02 0.02 0.05 0.06 0.04 0.03 0.05
Female 0.03 0.04 0.05 0.05 0.04 0.04 0.07 0.06 0.04 0.04
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.02 0.03 0.03 0.03 0.03 0.04 0.05 0.04 0.03 0.04
White 0.03 0.04 0.04 0.05 0.03 0.04 0.07 0.05 0.04 0.05
Black or African American 0.06 0.04 0.04 0.03 0.06 0.05 0.07 0.04 0.07 0.06
American Indian or Alaska Native * 0.16 * 0.18 * 0.18 * * * 0.22
Native Hawaiian or Other Pacific Islander 0.42 * * * 0.51 * * * 0.19 *
Asian * 0.07 * * * 0.08 * * * 0.09
Two or More Races 0.06 0.46 0.16 0.01 0.07 0.56 0.12 0.13 0.08 0.69
Hispanic or Latino 0.03 0.03 0.09 0.05 0.03 0.04 0.11 0.08 0.03 0.04
EDUCATION                    
< High School da da da da 0.04 0.04 0.06 0.10 0.05 0.05
High School Graduate da da da da 0.05 0.07 0.06 0.03 0.06 0.08
Some College/Associate's Degree da da da da 0.03 0.04 0.09 0.06 0.03 0.05
College Graduate da da da da 0.05 0.07 0.12 0.07 0.06 0.07
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.03 0.03 0.07 0.05 0.04 0.03
Part-Time da da da da 0.06 0.08 0.08 0.06 0.08 0.10
Unemployed da da da da 0.07 0.14 0.11 0.16 0.08 0.19
Other1 da da da da 0.04 0.08 0.12 0.04 0.04 0.08
170421
Table 1.64P – Misuse of Sedatives in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.6167   0.8791   0.6273   0.0688   0.3847  
GENDER                    
Male 0.3550   1.0000   0.3550   0.0714   0.1964  
Female 0.8630   0.8709   0.8431   0.3848   0.9939  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.5933   0.5147   0.6318   0.0769   0.4219  
White 0.6772   0.3114   0.7397   0.1615   0.5524  
Black or African American 0.2404   0.8144   0.2444   0.2784   0.3194  
American Indian or Alaska Native *   *   *   *   *  
Native Hawaiian or Other Pacific Islander *   *   *   *   *  
Asian *   *   *   *   *  
Two or More Races 0.2442   0.0938   0.2056   0.8889   0.2058  
Hispanic or Latino 0.9352   0.5451   0.9258   0.5514   0.6427  
EDUCATION                    
< High School da   da   0.9112   0.3605   0.6939  
High School Graduate da   da   0.3463   0.0711   0.4841  
Some College/Associate's Degree da   da   0.6668   0.1477   0.2708  
College Graduate da   da   0.2227   0.3717   0.1868  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.1862   0.1609   0.2956  
Part-Time da   da   0.9041   0.5317   0.7508  
Unemployed da   da   0.2509   0.6282   0.2948  
Other1 da   da   0.1591   0.1180   0.1003  
170421
Table 1.65C – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 312 291 48 43 307 286 94 94 292 269
GENDER                    
Male 228 210 33 31 228 207 73 69 217 196
Female 192 197 34 32 188 195 61 62 174 181
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 285 262 40 36 280 257 83 81 262 246
White 248 232 37 30 251 241 79 73 234 229
Black or African American 126 94 18 19 127 97 29 33 120 90
American Indian or Alaska Native 20 13 2 2 20 12 9 5 18 11
Native Hawaiian or Other Pacific Islander 20 17 * * * 16 * * * 15
Asian 58 63 9 11 57 62 17 15 54 60
Two or More Races 51 38 8 9 49 36 17 15 47 31
Hispanic or Latino 125 124 25 24 122 120 47 43 114 108
EDUCATION                    
< High School da da da da 132 111 41 32 124 105
High School Graduate da da da da 153 155 54 55 143 141
Some College/Associate's Degree da da da da 177 155 66 61 163 146
College Graduate da da da da 140 168 31 30 138 165
CURRENT EMPLOYMENT                    
Full-Time da da da da 199 204 69 64 191 192
Part-Time da da da da 111 110 49 52 103 95
Unemployed da da da da 91 82 37 35 82 74
Other1 da da da da 172 164 44 35 166 161
170421
Table 1.65D – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.12 0.11 0.19 0.17 0.13 0.12 0.27 0.27 0.14 0.13
GENDER                    
Male 0.18 0.16 0.26 0.24 0.19 0.18 0.42 0.40 0.22 0.20
Female 0.14 0.14 0.28 0.26 0.15 0.15 0.35 0.36 0.16 0.17
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.13 0.12 0.21 0.19 0.14 0.12 0.30 0.30 0.15 0.14
White 0.15 0.14 0.26 0.22 0.16 0.14 0.38 0.35 0.17 0.16
Black or African American 0.39 0.29 0.48 0.53 0.43 0.32 0.57 0.62 0.49 0.36
American Indian or Alaska Native 1.31 0.83 1.01 1.14 1.49 0.89 3.52 2.06 1.66 1.01
Native Hawaiian or Other Pacific Islander 2.61 1.37 * * * 1.51 * * * 1.57
Asian 0.39 0.43 0.68 0.82 0.41 0.47 0.84 0.72 0.46 0.54
Two or More Races 1.05 0.75 1.01 1.12 1.25 0.86 1.87 1.83 1.51 0.93
Hispanic or Latino 0.29 0.28 0.44 0.41 0.32 0.31 0.63 0.58 0.38 0.35
EDUCATION                    
< High School da da da da 0.36 0.34 0.73 0.66 0.41 0.38
High School Graduate da da da da 0.24 0.25 0.49 0.51 0.28 0.27
Some College/Associate's Degree da da da da 0.23 0.20 0.43 0.40 0.27 0.23
College Graduate da da da da 0.19 0.22 0.67 0.60 0.20 0.23
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.16 0.16 0.45 0.41 0.18 0.18
Part-Time da da da da 0.33 0.33 0.52 0.55 0.43 0.41
Unemployed da da da da 0.76 0.72 1.01 0.98 0.99 0.91
Other1 da da da da 0.21 0.20 0.55 0.44 0.22 0.21
170421
Table 1.65P – Misuse of Opioids in Past Year among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0235   0.1704   0.0377   0.0002   0.3691  
GENDER                    
Male 0.0190   0.4656   0.0240   0.0004   0.2608  
Female 0.3874   0.2283   0.5067   0.1118   0.8958  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.1093   0.2730   0.1407   0.0008   0.6821  
White 0.3363   0.0866   0.4559   0.0003   0.6942  
Black or African American 0.2512   0.8910   0.2340   0.6309   0.1746  
American Indian or Alaska Native 0.3377   0.4733   0.2921   0.1896   0.5526  
Native Hawaiian or Other Pacific Islander 0.5667   *   *   *   *  
Asian 0.9696   0.4410   0.9276   0.3973   0.9001  
Two or More Races 0.1455   0.7415   0.1212   0.2721   0.2396  
Hispanic or Latino 0.0639   0.3936   0.0807   0.1386   0.1874  
EDUCATION                    
< High School da   da   0.0065   0.0100   0.0395  
High School Graduate da   da   0.8383   0.4394   0.5569  
Some College/Associate's Degree da   da   0.0065   0.0022   0.0817  
College Graduate da   da   0.2849   0.3017   0.2036  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.3643   0.1093   0.7292  
Part-Time da   da   0.2871   0.2749   0.4770  
Unemployed da   da   0.7875   0.3210   0.8902  
Other1 da   da   0.0895   0.0001   0.4633  
170421
Table 1.66C – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 164 171 27 22 162 170 50 48 157 161
GENDER                    
Male 133 122 16 12 133 121 36 35 129 114
Female 101 115 21 19 99 115 34 32 92 111
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 148 155 22 19 147 154 43 42 141 146
White 128 148 20 16 129 148 41 39 121 140
Black or African American 68 53 9 10 69 53 14 14 67 50
American Indian or Alaska Native 6 8 0 1 6 7 2 3 6 7
Native Hawaiian or Other Pacific Islander 4 5 * * 4 5 * * * 3
Asian 32 6 2 * 32 6 4 1 31 6
Two or More Races 36 14 5 5 36 14 9 6 35 12
Hispanic or Latino 72 65 14 12 70 64 27 23 69 60
EDUCATION                    
< High School da da da da 75 61 23 18 72 58
High School Graduate da da da da 103 91 31 30 97 85
Some College/Associate's Degree da da da da 92 92 36 32 85 87
College Graduate da da da da 64 88 11 12 63 86
CURRENT EMPLOYMENT                    
Full-Time da da da da 120 105 37 30 121 101
Part-Time da da da da 55 63 23 24 50 59
Unemployed da da da da 50 51 21 20 45 47
Other1 da da da da 86 98 22 20 83 97
170421
Table 1.66D – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: Standard Errors of Percentages, 2015 and 2016
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.06 0.06 0.11 0.09 0.07 0.07 0.14 0.14 0.08 0.08
GENDER                    
Male 0.10 0.09 0.12 0.10 0.11 0.10 0.20 0.20 0.13 0.11
Female 0.07 0.08 0.17 0.16 0.08 0.09 0.19 0.18 0.08 0.10
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.07 0.07 0.12 0.10 0.07 0.07 0.16 0.16 0.08 0.08
White 0.08 0.09 0.15 0.12 0.08 0.09 0.21 0.20 0.09 0.10
Black or African American 0.21 0.16 0.25 0.29 0.24 0.18 0.28 0.29 0.28 0.21
American Indian or Alaska Native 0.42 0.49 0.25 0.98 0.47 0.53 0.96 1.14 0.54 0.60
Native Hawaiian or Other Pacific Islander 0.53 0.43 * * 0.64 0.48 * * * 0.31
Asian 0.22 0.04 0.19 * 0.23 0.04 0.18 0.04 0.27 0.05
Two or More Races 0.76 0.30 0.68 0.56 0.91 0.34 0.99 0.79 1.14 0.37
Hispanic or Latino 0.16 0.15 0.24 0.20 0.19 0.17 0.36 0.31 0.23 0.19
EDUCATION                    
< High School da da da da 0.22 0.19 0.42 0.37 0.25 0.21
High School Graduate da da da da 0.16 0.15 0.28 0.29 0.19 0.17
Some College/Associate's Degree da da da da 0.12 0.12 0.24 0.22 0.14 0.14
College Graduate da da da da 0.09 0.12 0.24 0.24 0.09 0.12
CURRENT EMPLOYMENT                    
Full-Time da da da da 0.10 0.09 0.25 0.21 0.11 0.10
Part-Time da da da da 0.17 0.20 0.25 0.26 0.21 0.25
Unemployed da da da da 0.43 0.45 0.57 0.59 0.56 0.59
Other1 da da da da 0.11 0.12 0.27 0.26 0.11 0.13
170421
Table 1.66P – Misuse of Opioids in Past Month among Persons Aged 12 or Older, by Age Group and Demographic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Demographic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Opioid misuse refers to the use of heroin or the misuse of prescription pain relievers. Misuse of prescription pain relievers is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription pain relievers do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.1638   0.2907   0.2047   0.0069   0.6241  
GENDER                    
Male 0.0381   0.1256   0.0541   0.0179   0.1939  
Female 0.8109   0.8424   0.7796   0.1346   0.4424  
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 0.4376   0.3926   0.5008   0.0116   0.9664  
White 0.8890   0.2746   0.9960   0.0168   0.4818  
Black or African American 0.6073   0.5749   0.5471   0.7464   0.5892  
American Indian or Alaska Native 0.6206   0.1953   0.7815   0.6661   0.6597  
Native Hawaiian or Other Pacific Islander 0.9287   *   0.8482   *   *  
Asian 0.2088   *   0.2580   0.4312   0.2961  
Two or More Races 0.1090   0.8112   0.1135   0.6036   0.1306  
Hispanic or Latino 0.0852   0.5288   0.1027   0.3157   0.1822  
EDUCATION                    
< High School da   da   0.1279   0.0689   0.3115  
High School Graduate da   da   0.5101   0.1614   0.8316  
Some College/Associate's Degree da   da   0.1828   0.1934   0.3556  
College Graduate da   da   0.2413   0.7472   0.2097  
CURRENT EMPLOYMENT                    
Full-Time da   da   0.0053   0.0085   0.0465  
Part-Time da   da   0.7989   0.6049   0.9478  
Unemployed da   da   0.7336   0.4093   0.4789  
Other1 da   da   0.2977   0.4966   0.2205  
170420
Table 1.67C – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 617 616 92 87 610 604 171 182 550 549
GEOGRAPHIC REGION                    
Northeast 257 266 38 30 255 264 71 71 221 239
Midwest 247 229 38 38 244 224 77 67 218 194
South 377 348 56 55 370 341 105 111 334 306
West 338 371 46 48 334 370 94 103 314 336
COUNTY TYPE1                    
Large Metro 537 579 85 81 524 574 194 224 490 507
Small Metro 390 375 56 48 381 366 152 157 319 320
Nonmetro 205 231 33 34 196 217 84 82 166 182
Urbanized 166 170 22 24 159 158 62 66 137 126
Less Urbanized 148 164 24 23 139 157 56 55 113 133
Completely Rural 63 62 9 9 62 58 24 18 52 49
POVERTY LEVEL2                    
Less Than 100% 276 285 52 48 267 277 146 154 217 224
100-199% 281 287 50 48 273 278 103 98 253 255
200% or More 523 533 82 75 511 517 151 168 480 476
HEALTH INSURANCE3                    
Private 518 527 84 75 507 517 205 222 449 456
Medicaid/CHIP4 276 290 64 63 264 277 93 99 241 249
Other5 277 304 22 22 278 301 62 67 274 289
No Coverage 224 215 20 20 222 214 91 76 199 194
170420
Table 1.67D – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.23 0.23 0.37 0.35 0.25 0.25 0.49 0.53 0.26 0.26
GEOGRAPHIC REGION                    
Northeast 0.54 0.56 0.91 0.73 0.58 0.60 1.16 1.17 0.59 0.63
Midwest 0.44 0.40 0.72 0.71 0.48 0.44 1.04 0.91 0.50 0.44
South 0.38 0.34 0.59 0.58 0.41 0.37 0.81 0.86 0.43 0.39
West 0.54 0.58 0.78 0.81 0.58 0.64 1.11 1.24 0.64 0.68
COUNTY TYPE1                    
Large Metro 0.32 0.34 0.51 0.50 0.35 0.37 0.68 0.74 0.38 0.39
Small Metro 0.40 0.40 0.68 0.53 0.44 0.44 0.86 0.89 0.45 0.45
Nonmetro 0.47 0.47 0.87 0.83 0.50 0.49 1.30 1.28 0.52 0.49
Urbanized 0.86 0.83 1.24 1.38 0.93 0.86 1.93 1.98 1.01 0.86
Less Urbanized 0.64 0.61 1.41 1.15 0.68 0.66 1.98 1.86 0.68 0.69
Completely Rural 1.20 1.30 2.24 2.14 1.30 1.37 4.31 3.53 1.19 1.37
POVERTY LEVEL2                    
Less Than 100% 0.53 0.61 0.81 0.78 0.59 0.68 0.98 1.05 0.68 0.77
100-199% 0.46 0.47 0.77 0.74 0.51 0.52 0.93 1.00 0.57 0.57
200% or More 0.28 0.27 0.51 0.47 0.30 0.29 0.69 0.68 0.32 0.31
HEALTH INSURANCE3                    
Private 0.28 0.26 0.50 0.45 0.30 0.28 0.67 0.67 0.30 0.29
Medicaid/CHIP4 0.53 0.55 0.61 0.58 0.66 0.68 1.00 1.09 0.79 0.79
Other5 0.41 0.43 1.65 1.61 0.42 0.43 1.58 1.78 0.42 0.44
No Coverage 0.74 0.76 1.60 1.69 0.76 0.79 1.22 1.32 0.90 0.90
170420
Table 1.67P – Illicit Drug Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.5753   0.0015   0.2870   0.8055   0.2157  
GEOGRAPHIC REGION                    
Northeast 0.4668   0.0067   0.2767   0.6089   0.1521  
Midwest 0.7133   0.2662   0.5751   0.5927   0.6231  
South 0.5033   0.0322   0.7357   0.7335   0.7304  
West 0.3789   0.4729   0.3244   0.9686   0.2671  
COUNTY TYPE1                    
Large Metro 0.4482   0.0124   0.2541   0.9642   0.1844  
Small Metro 0.8799   0.0706   0.6641   0.5304   0.8174  
Nonmetro 0.7805   0.3937   0.8842   0.6922   0.7876  
Urbanized 0.3364   0.9837   0.3162   0.6040   0.4714  
Less Urbanized 0.8569   0.1375   0.6625   0.8225   0.5514  
Completely Rural 0.4032   0.5616   0.4506   0.4996   0.2255  
POVERTY LEVEL2                    
Less Than 100% 0.8381   0.1955   0.6459   0.4612   0.7620  
100-199% 0.5921   0.4011   0.6869   0.8531   0.9809  
200% or More 0.3019   0.0054   0.1369   0.7046   0.1370  
HEALTH INSURANCE3                    
Private 0.5620   0.0013   0.2718   0.9162   0.3115  
Medicaid/CHIP4 0.2333   0.5179   0.1859   0.2665   0.2686  
Other5 0.5004   0.4019   0.4634   0.4470   0.4875  
No Coverage 0.6841   0.8108   0.6571   0.0710   0.1725  
170420
Table 1.68C – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 457 488 68 66 448 480 147 148 405 435
GEOGRAPHIC REGION                    
Northeast 188 200 31 24 185 199 63 66 159 175
Midwest 181 175 30 27 175 172 64 58 158 157
South 276 270 41 40 272 267 90 88 249 237
West 259 311 35 36 254 307 78 86 237 283
COUNTY TYPE1                    
Large Metro 384 420 60 55 373 415 144 158 343 368
Small Metro 269 279 39 36 264 274 108 110 232 245
Nonmetro 155 168 22 21 149 163 59 62 125 138
Urbanized 128 114 13 16 125 109 48 45 105 89
Less Urbanized 103 119 16 13 97 116 35 41 80 102
Completely Rural 39 44 8 6 39 41 14 15 33 33
POVERTY LEVEL2                    
Less Than 100% 201 212 38 32 197 207 106 109 157 172
100-199% 211 218 33 33 206 214 83 76 184 194
200% or More 364 400 56 52 354 393 116 125 330 359
HEALTH INSURANCE3                    
Private 363 384 57 54 355 376 154 154 310 333
Medicaid/CHIP4 207 228 46 41 199 221 71 78 185 203
Other5 213 214 15 13 213 215 45 51 209 204
No Coverage 175 166 14 15 174 165 74 62 157 151
170420
Table 1.68D – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.17 0.18 0.27 0.26 0.18 0.20 0.42 0.43 0.19 0.21
GEOGRAPHIC REGION                    
Northeast 0.39 0.42 0.76 0.59 0.42 0.45 1.03 1.09 0.42 0.46
Midwest 0.32 0.31 0.56 0.52 0.34 0.33 0.86 0.78 0.36 0.36
South 0.28 0.27 0.43 0.42 0.30 0.29 0.70 0.69 0.32 0.30
West 0.41 0.49 0.58 0.61 0.45 0.53 0.92 1.04 0.49 0.57
COUNTY TYPE1                    
Large Metro 0.24 0.26 0.39 0.37 0.26 0.28 0.60 0.61 0.28 0.30
Small Metro 0.30 0.33 0.48 0.44 0.32 0.36 0.72 0.71 0.34 0.38
Nonmetro 0.37 0.36 0.64 0.56 0.39 0.39 1.07 1.12 0.39 0.38
Urbanized 0.67 0.60 0.87 0.98 0.72 0.65 1.81 1.63 0.76 0.64
Less Urbanized 0.50 0.49 0.99 0.73 0.53 0.53 1.39 1.62 0.53 0.56
Completely Rural 0.74 0.97 2.15 1.66 0.81 1.02 2.72 3.43 0.78 0.98
POVERTY LEVEL2                    
Less Than 100% 0.42 0.48 0.63 0.55 0.48 0.54 0.83 0.89 0.53 0.62
100-199% 0.36 0.37 0.55 0.55 0.39 0.41 0.86 0.85 0.42 0.45
200% or More 0.21 0.21 0.37 0.35 0.22 0.23 0.62 0.58 0.23 0.24
HEALTH INSURANCE3                    
Private 0.20 0.20 0.36 0.34 0.21 0.21 0.59 0.54 0.22 0.22
Medicaid/CHIP4 0.42 0.46 0.48 0.43 0.53 0.57 0.85 0.93 0.64 0.67
Other5 0.31 0.31 1.23 1.00 0.32 0.31 1.28 1.52 0.33 0.31
No Coverage 0.60 0.62 1.20 1.34 0.62 0.65 1.12 1.16 0.73 0.75
170420
Table 1.68P – Illicit Drug Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Illicit Drug Use includes the misuse of prescription psychotherapeutics or the use of marijuana, cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0417   0.0152   0.0144   0.1335   0.0247  
GEOGRAPHIC REGION                    
Northeast 0.2206   0.0167   0.1165   0.2882   0.1442  
Midwest 0.9554   0.3703   0.8333   0.4310   0.9938  
South 0.8817   0.2737   0.7541   0.9734   0.6662  
West 0.0215   0.4267   0.0144   0.2278   0.0252  
COUNTY TYPE1                    
Large Metro 0.0749   0.0161   0.0304   0.4745   0.0283  
Small Metro 0.2099   0.4789   0.1724   0.1920   0.3194  
Nonmetro 0.9331   0.5201   0.9879   0.5446   0.9739  
Urbanized 0.1012   0.5080   0.0709   0.5508   0.1089  
Less Urbanized 0.2359   0.0728   0.1412   0.1257   0.2394  
Completely Rural 0.4667   0.7751   0.4907   0.7746   0.4766  
POVERTY LEVEL2                    
Less Than 100% 0.0597   0.1217   0.0279   0.0489   0.0940  
100-199% 0.3781   0.9665   0.3690   0.9304   0.1796  
200% or More 0.2014   0.0280   0.1054   0.5628   0.1574  
HEALTH INSURANCE3                    
Private 0.1382   0.0642   0.0731   0.4524   0.1188  
Medicaid/CHIP4 0.0214   0.2418   0.0097   0.0131   0.0717  
Other5 0.3979   0.2070   0.3554   0.3455   0.4133  
No Coverage 0.6336   0.9257   0.6289   0.1524   0.2071  
170420
Table 1.69C – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 524 542 81 77 520 534 163 176 460 479
GEOGRAPHIC REGION                    
Northeast 217 236 32 27 215 230 69 68 179 206
Midwest 209 199 33 33 206 194 76 67 178 167
South 310 302 51 48 305 298 101 109 270 255
West 309 337 42 44 308 336 85 100 287 308
COUNTY TYPE1                    
Large Metro 433 488 69 69 426 482 177 209 393 422
Small Metro 327 319 48 41 320 313 138 142 265 271
Nonmetro 172 203 28 28 162 193 75 76 132 160
Urbanized 127 142 19 21 122 132 55 60 101 102
Less Urbanized 128 149 19 19 120 143 51 50 94 121
Completely Rural 49 47 8 6 48 45 22 17 39 38
POVERTY LEVEL2                    
Less Than 100% 234 249 45 39 226 243 135 143 178 192
100-199% 232 242 38 42 228 235 97 91 204 212
200% or More 430 467 67 65 423 454 136 156 390 409
HEALTH INSURANCE3                    
Private 445 450 69 65 437 441 188 204 375 383
Medicaid/CHIP4 228 243 52 53 218 230 87 93 197 203
Other5 234 236 19 18 235 235 58 63 230 223
No Coverage 190 188 18 18 188 188 85 70 163 170
170420
Table 1.69D – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.20 0.20 0.32 0.31 0.21 0.22 0.47 0.51 0.22 0.23
GEOGRAPHIC REGION                    
Northeast 0.45 0.49 0.78 0.67 0.49 0.53 1.13 1.13 0.48 0.55
Midwest 0.37 0.35 0.61 0.62 0.40 0.38 1.02 0.91 0.41 0.38
South 0.31 0.30 0.54 0.50 0.34 0.32 0.78 0.85 0.35 0.32
West 0.49 0.53 0.70 0.74 0.54 0.58 1.01 1.20 0.59 0.62
COUNTY TYPE1                    
Large Metro 0.27 0.30 0.44 0.43 0.30 0.32 0.66 0.73 0.32 0.33
Small Metro 0.35 0.36 0.60 0.49 0.39 0.39 0.81 0.84 0.39 0.40
Nonmetro 0.40 0.43 0.77 0.75 0.43 0.45 1.25 1.23 0.42 0.44
Urbanized 0.67 0.72 1.16 1.28 0.72 0.75 1.83 1.87 0.74 0.73
Less Urbanized 0.59 0.59 1.18 1.04 0.61 0.63 1.89 1.78 0.59 0.65
Completely Rural 1.05 1.05 2.15 1.75 1.12 1.10 4.22 3.57 1.01 1.13
POVERTY LEVEL2                    
Less Than 100% 0.47 0.54 0.72 0.66 0.53 0.61 0.95 0.99 0.59 0.68
100-199% 0.40 0.41 0.63 0.67 0.44 0.45 0.92 0.96 0.47 0.48
200% or More 0.24 0.24 0.43 0.42 0.26 0.26 0.65 0.67 0.26 0.27
HEALTH INSURANCE3                    
Private 0.24 0.23 0.43 0.41 0.26 0.25 0.65 0.65 0.26 0.25
Medicaid/CHIP4 0.45 0.48 0.51 0.52 0.56 0.58 0.95 1.06 0.66 0.66
Other5 0.35 0.34 1.52 1.35 0.35 0.35 1.53 1.72 0.36 0.34
No Coverage 0.64 0.70 1.45 1.51 0.66 0.73 1.18 1.28 0.75 0.83
170420
Table 1.69P – Marijuana Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0764   0.1625   0.0455   0.2430   0.0514  
GEOGRAPHIC REGION                    
Northeast 0.3124   0.0398   0.1913   0.7311   0.0901  
Midwest 0.6749   0.8350   0.6394   0.5933   0.7103  
South 0.9378   0.0939   0.7237   0.7351   0.6782  
West 0.0580   0.3503   0.0754   0.1306   0.1381  
COUNTY TYPE1                    
Large Metro 0.1244   0.5632   0.1028   0.2981   0.1227  
Small Metro 0.6119   0.2023   0.4776   0.5641   0.5822  
Nonmetro 0.3133   0.4216   0.2365   0.9278   0.0995  
Urbanized 0.6851   0.8369   0.6445   0.8910   0.8152  
Less Urbanized 0.1039   0.1834   0.0598   0.6145   0.0335  
Completely Rural 0.6447   0.6415   0.5896   0.6238   0.3760  
POVERTY LEVEL2                    
Less Than 100% 0.0981   0.4943   0.0687   0.1114   0.1575  
100-199% 0.7188   0.2382   0.8762   0.6032   0.4062  
200% or More 0.1833   0.0305   0.0939   0.6497   0.1399  
HEALTH INSURANCE3                    
Private 0.1537   0.0337   0.0736   0.2095   0.1653  
Medicaid/CHIP4 0.0373   0.3307   0.0601   0.1423   0.1178  
Other5 0.5165   0.5295   0.4864   0.6361   0.4816  
No Coverage 0.2491   0.9624   0.2432   0.0629   0.0211  
170420
Table 1.70C – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 413 442 61 61 408 434 140 144 361 391
GEOGRAPHIC REGION                    
Northeast 165 178 28 23 160 174 63 66 133 148
Midwest 163 156 26 24 159 152 59 56 143 140
South 238 238 37 34 234 236 86 86 206 204
West 246 286 32 35 244 284 71 86 223 261
COUNTY TYPE1                    
Large Metro 339 377 52 49 332 371 134 147 297 324
Small Metro 247 248 34 33 244 243 98 100 210 220
Nonmetro 140 157 21 19 132 152 57 59 110 129
Urbanized 113 109 12 14 110 104 47 44 91 85
Less Urbanized 95 110 15 11 88 107 32 38 74 93
Completely Rural 27 35 6 4 26 34 14 14 22 30
POVERTY LEVEL2                    
Less Than 100% 175 182 33 27 172 179 99 101 134 146
100-199% 188 195 28 31 184 191 79 71 161 174
200% or More 329 365 49 47 320 359 108 120 294 325
HEALTH INSURANCE3                    
Private 330 345 51 49 324 338 142 138 279 296
Medicaid/CHIP4 182 199 38 38 175 192 65 77 162 173
Other5 195 182 14 10 195 182 42 48 192 173
No Coverage 151 149 13 13 150 148 69 58 132 137
170420
Table 1.70D – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.15 0.16 0.24 0.24 0.17 0.18 0.40 0.42 0.17 0.19
GEOGRAPHIC REGION                    
Northeast 0.34 0.37 0.69 0.56 0.37 0.40 1.03 1.09 0.36 0.39
Midwest 0.29 0.28 0.49 0.46 0.31 0.30 0.80 0.75 0.33 0.32
South 0.24 0.23 0.39 0.35 0.26 0.26 0.67 0.67 0.26 0.26
West 0.39 0.45 0.53 0.59 0.43 0.49 0.85 1.04 0.46 0.53
COUNTY TYPE1                    
Large Metro 0.22 0.24 0.35 0.33 0.24 0.26 0.57 0.61 0.24 0.26
Small Metro 0.28 0.29 0.43 0.42 0.31 0.32 0.67 0.69 0.32 0.34
Nonmetro 0.34 0.34 0.60 0.50 0.36 0.37 1.04 1.07 0.36 0.37
Urbanized 0.63 0.58 0.81 0.90 0.67 0.62 1.79 1.59 0.69 0.62
Less Urbanized 0.47 0.47 0.96 0.64 0.49 0.51 1.30 1.54 0.49 0.52
Completely Rural 0.60 0.80 1.58 1.30 0.64 0.86 2.71 3.33 0.59 0.92
POVERTY LEVEL2                    
Less Than 100% 0.37 0.42 0.55 0.48 0.42 0.47 0.78 0.86 0.45 0.53
100-199% 0.33 0.34 0.47 0.52 0.36 0.37 0.84 0.81 0.38 0.40
200% or More 0.19 0.20 0.34 0.32 0.20 0.21 0.58 0.57 0.21 0.22
HEALTH INSURANCE3                    
Private 0.18 0.18 0.33 0.32 0.20 0.19 0.55 0.52 0.20 0.20
Medicaid/CHIP4 0.38 0.41 0.40 0.40 0.47 0.50 0.80 0.92 0.56 0.58
Other5 0.29 0.27 1.12 0.85 0.29 0.27 1.21 1.46 0.30 0.27
No Coverage 0.53 0.57 1.13 1.17 0.55 0.59 1.05 1.11 0.63 0.68
170420
Table 1.70P – Marijuana Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0069   0.1029   0.0028   0.0828   0.0059  
GEOGRAPHIC REGION                    
Northeast 0.2881   0.0875   0.1805   0.4849   0.1859  
Midwest 0.6702   0.3567   0.5496   0.3234   0.7580  
South 0.3200   0.2546   0.2388   0.9878   0.1515  
West 0.0117   0.8281   0.0111   0.0684   0.0323  
COUNTY TYPE1                    
Large Metro 0.0230   0.1477   0.0119   0.3546   0.0115  
Small Metro 0.1953   0.6849   0.1757   0.1728   0.3473  
Nonmetro 0.4879   0.3275   0.3868   0.4669   0.3788  
Urbanized 0.2984   0.5266   0.2400   0.8217   0.2773  
Less Urbanized 0.0816   0.0231   0.0341   0.0894   0.0655  
Completely Rural 0.2976   0.9087   0.2946   0.6711   0.1614  
POVERTY LEVEL2                    
Less Than 100% 0.0488   0.1386   0.0239   0.0485   0.0937  
100-199% 0.2215   0.2389   0.2955   0.7827   0.1066  
200% or More 0.0515   0.0424   0.0235   0.3224   0.0481  
HEALTH INSURANCE3                    
Private 0.0447   0.1510   0.0235   0.4034   0.0382  
Medicaid/CHIP4 0.0187   0.8634   0.0153   0.0047   0.1443  
Other5 0.6020   0.1881   0.5465   0.3484   0.6339  
No Coverage 0.1411   0.6736   0.1278   0.1762   0.0152  
170420
Table 1.71C – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 192 175 20 18 192 174 91 89 167 152
GEOGRAPHIC REGION                    
Northeast 80 95 7 7 80 94 39 39 66 82
Midwest 83 63 7 5 83 63 39 29 76 56
South 113 102 12 10 113 101 52 46 102 87
West 101 107 11 11 100 108 47 58 85 90
COUNTY TYPE1                    
Large Metro 169 154 13 14 169 153 81 74 148 130
Small Metro 85 96 13 10 84 96 48 55 70 78
Nonmetro 55 45 5 5 55 45 26 22 48 40
Urbanized 38 35 4 4 38 35 20 15 34 32
Less Urbanized 36 27 2 2 36 27 17 16 29 23
Completely Rural 18 7 1 * 18 7 4 6 18 2
POVERTY LEVEL2                    
Less Than 100% 94 88 9 6 94 88 52 44 76 75
100-199% 85 92 10 9 85 91 42 36 75 83
200% or More 146 133 14 14 145 133 62 70 128 110
HEALTH INSURANCE3                    
Private 142 129 14 13 141 128 82 77 113 106
Medicaid/CHIP4 87 97 12 11 86 96 29 38 82 89
Other5 64 66 6 5 63 66 18 18 61 64
No Coverage 83 78 2 3 83 78 37 28 72 71
170420
Table 1.71D – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.07 0.07 0.08 0.07 0.08 0.07 0.26 0.26 0.08 0.07
GEOGRAPHIC REGION                    
Northeast 0.17 0.20 0.17 0.17 0.18 0.22 0.64 0.64 0.18 0.22
Midwest 0.15 0.11 0.14 0.09 0.16 0.12 0.53 0.39 0.17 0.13
South 0.11 0.10 0.13 0.11 0.12 0.11 0.40 0.36 0.13 0.11
West 0.16 0.17 0.18 0.19 0.18 0.19 0.56 0.70 0.17 0.18
COUNTY TYPE1                    
Large Metro 0.11 0.10 0.09 0.10 0.12 0.11 0.39 0.37 0.12 0.11
Small Metro 0.10 0.12 0.17 0.13 0.11 0.13 0.39 0.46 0.11 0.12
Nonmetro 0.14 0.11 0.15 0.14 0.16 0.13 0.56 0.47 0.16 0.13
Urbanized 0.23 0.22 0.31 0.30 0.25 0.24 0.84 0.64 0.27 0.26
Less Urbanized 0.21 0.14 0.14 0.13 0.23 0.15 0.84 0.74 0.21 0.15
Completely Rural 0.40 0.17 0.23 * 0.43 0.19 0.94 1.64 0.47 0.06
POVERTY LEVEL2                    
Less Than 100% 0.21 0.21 0.15 0.11 0.25 0.24 0.50 0.45 0.27 0.28
100-199% 0.15 0.17 0.18 0.15 0.17 0.18 0.49 0.44 0.18 0.20
200% or More 0.08 0.08 0.10 0.10 0.09 0.08 0.37 0.39 0.09 0.08
HEALTH INSURANCE3                    
Private 0.08 0.07 0.10 0.09 0.09 0.08 0.37 0.34 0.08 0.07
Medicaid/CHIP4 0.20 0.22 0.13 0.12 0.25 0.27 0.39 0.52 0.30 0.32
Other5 0.10 0.10 0.54 0.40 0.10 0.10 0.59 0.60 0.10 0.10
No Coverage 0.31 0.31 0.21 0.27 0.32 0.32 0.63 0.58 0.35 0.37
170420
Table 1.71P – Cocaine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4136   0.5228   0.3800   0.6056   0.4108  
GEOGRAPHIC REGION                    
Northeast 0.1298   0.8845   0.1319   0.5680   0.0421  
Midwest 0.7104   0.2199   0.7858   0.4424   0.9064  
South 0.1961   0.3615   0.2299   0.8625   0.2489  
West 0.0958   0.6734   0.1043   0.0535   0.4070  
COUNTY TYPE1                    
Large Metro 0.4375   0.7139   0.4190   0.6319   0.4522  
Small Metro 0.3035   0.4932   0.2697   0.4723   0.4094  
Nonmetro 0.2151   0.8207   0.1997   0.3120   0.4761  
Urbanized 0.2816   0.7672   0.2452   0.0433   0.9206  
Less Urbanized 0.6229   0.9518   0.6287   0.9368   0.6105  
Completely Rural 0.4883   *   0.4740   0.2593   0.1831  
POVERTY LEVEL2                    
Less Than 100% 0.9176   0.1678   0.8371   0.9308   0.8073  
100-199% 0.7925   0.9167   0.7945   0.5609   0.8602  
200% or More 0.1665   0.9233   0.1597   0.2355   0.3678  
HEALTH INSURANCE3                    
Private 0.1255   0.5733   0.1110   0.5847   0.1543  
Medicaid/CHIP4 0.2475   0.6575   0.2371   0.0614   0.5916  
Other5 0.8823   0.9318   0.8757   0.9357   0.8582  
No Coverage 0.9882   0.8694   0.9922   0.0509   0.3453  
170420
Table 1.72C – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 128 120 13 7 127 119 49 45 117 110
GEOGRAPHIC REGION                    
Northeast 57 53 2 3 57 53 21 19 52 51
Midwest 45 35 6 2 45 34 14 13 42 31
South 83 64 9 5 83 64 29 24 79 58
West 60 78 6 3 59 78 27 29 49 72
COUNTY TYPE1                    
Large Metro 110 96 7 5 110 96 41 34 102 89
Small Metro 54 62 10 5 53 62 27 27 47 56
Nonmetro 35 31 2 2 35 31 12 11 31 28
Urbanized 25 25 2 2 25 25 9 8 21 24
Less Urbanized 25 17 0 1 25 17 7 7 22 15
Completely Rural 3 6 * * 3 6 * 6 3 1
POVERTY LEVEL2                    
Less Than 100% 65 72 5 2 65 72 27 24 58 66
100-199% 60 58 8 3 59 58 23 19 57 54
200% or More 88 81 7 6 87 81 33 34 77 71
HEALTH INSURANCE3                    
Private 79 82 8 5 78 82 39 37 63 73
Medicaid/CHIP4 65 76 7 4 64 75 15 20 62 72
Other5 48 44 * * 48 44 11 12 46 42
No Coverage 64 51 * 1 64 51 25 14 58 49
170420
Table 1.72D – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.05 0.04 0.05 0.03 0.05 0.05 0.14 0.13 0.06 0.05
GEOGRAPHIC REGION                    
Northeast 0.12 0.11 0.04 0.07 0.13 0.12 0.35 0.32 0.14 0.13
Midwest 0.08 0.06 0.11 0.04 0.09 0.07 0.19 0.18 0.09 0.07
South 0.08 0.06 0.09 0.05 0.09 0.07 0.23 0.19 0.10 0.07
West 0.10 0.12 0.10 0.06 0.10 0.14 0.32 0.35 0.10 0.15
COUNTY TYPE1                    
Large Metro 0.07 0.06 0.05 0.03 0.08 0.07 0.20 0.17 0.09 0.08
Small Metro 0.07 0.08 0.13 0.06 0.07 0.08 0.24 0.24 0.08 0.09
Nonmetro 0.09 0.08 0.07 0.06 0.10 0.09 0.26 0.26 0.10 0.09
Urbanized 0.16 0.16 0.16 0.14 0.17 0.18 0.45 0.37 0.18 0.20
Less Urbanized 0.14 0.09 0.03 0.05 0.16 0.09 0.37 0.31 0.16 0.10
Completely Rural 0.06 0.15 * * 0.07 0.16 * 1.52 0.08 0.02
POVERTY LEVEL2                    
Less Than 100% 0.15 0.17 0.09 0.03 0.17 0.20 0.27 0.25 0.21 0.25
100-199% 0.11 0.10 0.14 0.06 0.12 0.12 0.27 0.24 0.14 0.13
200% or More 0.05 0.05 0.05 0.04 0.06 0.05 0.20 0.19 0.06 0.05
HEALTH INSURANCE3                    
Private 0.04 0.05 0.06 0.04 0.05 0.05 0.18 0.17 0.04 0.05
Medicaid/CHIP4 0.15 0.17 0.08 0.05 0.19 0.21 0.20 0.28 0.23 0.26
Other5 0.07 0.06 * * 0.07 0.07 0.36 0.40 0.07 0.07
No Coverage 0.24 0.21 * 0.12 0.25 0.21 0.44 0.30 0.28 0.26
170420
Table 1.72P – Cocaine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Cocaine use includes the use of crack.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9381   0.0847   0.9472   0.7310   0.7984  
GEOGRAPHIC REGION                    
Northeast 0.9335   0.3828   0.9652   0.6857   0.8216  
Midwest 0.3531   0.0770   0.4630   0.8298   0.4770  
South 0.0767   0.2933   0.0957   0.5088   0.1391  
West 0.0355   0.3453   0.0299   0.6527   0.0225  
COUNTY TYPE1                    
Large Metro 0.6182   0.2114   0.6701   0.3527   0.9423  
Small Metro 0.1955   0.1656   0.1388   0.4899   0.2016  
Nonmetro 0.3616   0.9099   0.3560   0.9049   0.3226  
Urbanized 0.7015   0.9501   0.6924   0.5579   0.8959  
Less Urbanized 0.2039   0.7979   0.2013   0.8386   0.1846  
Completely Rural 0.1536   *   0.1535   *   0.3426  
POVERTY LEVEL2                    
Less Than 100% 0.3850   0.1269   0.3423   0.9156   0.2768  
100-199% 0.1743   0.1113   0.2312   0.3545   0.4019  
200% or More 0.7222   0.7445   0.7002   0.6801   0.8455  
HEALTH INSURANCE3                    
Private 0.2892   0.1896   0.2396   0.9073   0.1702  
Medicaid/CHIP4 0.3489   0.1822   0.3000   0.2591   0.4512  
Other5 0.7318   *   0.8073   0.6697   0.7321  
No Coverage 0.2559   *   0.2516   0.0411   0.6547  
170412
Table 1.73C – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 305 302 93 88 64 64
GEOGRAPHIC REGION            
Northeast 121 137 35 54 27 38
Midwest 120 123 57 32 26 24
South 199 166 64 56 50 39
West 160 171 22 36 19 31
COUNTY TYPE1            
Large Metro 255 250 78 71 52 55
Small Metro 157 148 45 49 33 33
Nonmetro 104 117 24 24 17 8
Urbanized 69 80 20 18 16 8
Less Urbanized 71 80 11 14 5 1
Completely Rural 40 30 3 3 * *
POVERTY LEVEL2            
Less Than 100% 145 164 51 55 37 47
100-199% 150 148 48 54 40 35
200% or More 220 221 63 49 29 35
HEALTH INSURANCE3            
Private 201 216 55 56 22 42
Medicaid/CHIP4 166 169 47 64 36 51
Other5 142 149 44 43 36 36
No Coverage 126 105 41 39 34 29
170412
Table 1.73D – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.11 0.11 0.03 0.03 0.02 0.02
GEOGRAPHIC REGION            
Northeast 0.25 0.29 0.07 0.11 0.06 0.08
Midwest 0.21 0.22 0.10 0.06 0.05 0.04
South 0.20 0.16 0.06 0.06 0.05 0.04
West 0.25 0.27 0.03 0.06 0.03 0.05
COUNTY TYPE1            
Large Metro 0.17 0.16 0.05 0.05 0.03 0.04
Small Metro 0.19 0.18 0.06 0.06 0.04 0.04
Nonmetro 0.27 0.29 0.06 0.06 0.05 0.02
Urbanized 0.44 0.50 0.13 0.12 0.11 0.05
Less Urbanized 0.38 0.39 0.07 0.07 0.03 0.01
Completely Rural 0.81 0.74 0.06 0.09 * *
POVERTY LEVEL2            
Less Than 100% 0.33 0.39 0.12 0.13 0.09 0.11
100-199% 0.26 0.26 0.09 0.10 0.07 0.06
200% or More 0.13 0.13 0.04 0.03 0.02 0.02
HEALTH INSURANCE3            
Private 0.12 0.12 0.03 0.03 0.01 0.02
Medicaid/CHIP4 0.37 0.37 0.11 0.14 0.08 0.12
Other5 0.21 0.22 0.07 0.06 0.05 0.05
No Coverage 0.45 0.41 0.15 0.16 0.13 0.12
170412
Table 1.73P – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4518   0.7331   0.6982  
GEOGRAPHIC REGION            
Northeast 0.8536   0.2979   0.2914  
Midwest 0.5362   0.4387   0.7588  
South 0.0803   0.6648   0.3505  
West 0.7758   0.0977   0.3041  
COUNTY TYPE1            
Large Metro 0.9647   0.5264   0.5514  
Small Metro 0.2446   0.9674   0.7043  
Nonmetro 0.7187   0.4556   0.1687  
Urbanized 0.4858   0.3622   0.3253  
Less Urbanized 0.9910   0.8621   0.1450  
Completely Rural 0.7475   0.6992   *  
POVERTY LEVEL2            
Less Than 100% 0.5684   0.6138   0.2961  
100-199% 0.9075   0.6760   0.4668  
200% or More 0.2280   0.8764   0.6549  
HEALTH INSURANCE3            
Private 0.8634   0.4075   0.0671  
Medicaid/CHIP4 0.5031   0.1865   0.2103  
Other5 0.8240   0.8491   0.9790  
No Coverage 0.5468   0.6291   0.5951  
170412
Table 1.74C – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 635 642 175 185 83 94
GEOGRAPHIC REGION            
Northeast 258 281 63 69 32 34
Midwest 248 238 73 48 30 21
South 375 353 96 92 44 41
West 364 356 105 132 53 75
COUNTY TYPE1            
Large Metro 566 595 148 147 73 76
Small Metro 405 365 86 99 36 45
Nonmetro 243 258 42 48 16 27
Urbanized 189 187 33 37 11 19
Less Urbanized 152 176 25 26 11 17
Completely Rural 81 74 8 14 1 8
POVERTY LEVEL2            
Less Than 100% 216 212 67 86 34 46
100-199% 286 275 73 79 39 39
200% or More 584 607 132 130 60 69
HEALTH INSURANCE3            
Private 580 584 138 134 59 65
Medicaid/CHIP4 248 253 65 83 35 49
Other5 295 307 37 63 23 30
No Coverage 208 200 67 67 36 36
170412
Table 1.74D – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.24 0.24 0.07 0.07 0.03 0.03
GEOGRAPHIC REGION            
Northeast 0.54 0.59 0.13 0.14 0.07 0.07
Midwest 0.44 0.42 0.13 0.08 0.05 0.04
South 0.37 0.35 0.10 0.09 0.04 0.04
West 0.58 0.56 0.17 0.21 0.08 0.12
COUNTY TYPE1            
Large Metro 0.33 0.34 0.10 0.10 0.05 0.05
Small Metro 0.41 0.40 0.10 0.12 0.04 0.05
Nonmetro 0.55 0.54 0.11 0.12 0.04 0.07
Urbanized 0.97 0.97 0.20 0.23 0.07 0.12
Less Urbanized 0.67 0.70 0.14 0.13 0.06 0.09
Completely Rural 1.62 1.54 0.17 0.35 0.03 0.22
POVERTY LEVEL2            
Less Than 100% 0.47 0.49 0.15 0.21 0.08 0.11
100-199% 0.47 0.45 0.13 0.14 0.07 0.07
200% or More 0.30 0.30 0.08 0.07 0.04 0.04
HEALTH INSURANCE3            
Private 0.29 0.29 0.08 0.07 0.03 0.04
Medicaid/CHIP4 0.50 0.53 0.15 0.19 0.08 0.11
Other5 0.42 0.43 0.05 0.09 0.03 0.04
No Coverage 0.70 0.73 0.25 0.27 0.13 0.15
170412
Table 1.74P – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Lifetime
(2015)
Lifetime
(2016)
Past Year
(2015)
Past Year
(2016)
Past Month
(2015)
Past Month
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.7206   0.4537   0.2273  
GEOGRAPHIC REGION            
Northeast 0.2963   0.9397   0.3352  
Midwest 0.5121   0.0244   0.0057  
South 0.3220   0.7885   0.7191  
West 0.7001   0.0277   0.0413  
COUNTY TYPE1            
Large Metro 0.2875   0.9574   0.7533  
Small Metro 0.3629   0.1153   0.2347  
Nonmetro 0.9543   0.8730   0.1100  
Urbanized 0.6222   0.8517   0.2854  
Less Urbanized 0.6983   0.1954   0.5426  
Completely Rural 0.5907   0.0548   0.1400  
POVERTY LEVEL2            
Less Than 100% 0.4202   0.1558   0.5112  
100-199% 0.7268   0.8202   0.5549  
200% or More 0.5912   0.8415   0.0806  
HEALTH INSURANCE3            
Private 0.6093   0.5039   0.3398  
Medicaid/CHIP4 0.2536   0.1374   0.2080  
Other5 0.4066   0.0546   0.7575  
No Coverage 0.6324   0.1562   1.0000  
170420
Table 1.75C – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 93 91 39 34 83 85 43 47 75 73
GEOGRAPHIC REGION                    
Northeast 39 31 15 12 36 27 15 17 32 27
Midwest 48 32 16 18 44 27 18 16 40 21
South 56 54 24 20 50 51 27 32 40 40
West 49 58 22 16 42 55 24 26 35 50
COUNTY TYPE1                    
Large Metro 84 74 32 27 76 70 37 41 70 60
Small Metro 40 46 21 17 34 44 20 21 28 37
Nonmetro 24 27 12 13 20 23 13 15 15 17
Urbanized 18 18 7 8 16 14 9 11 13 9
Less Urbanized 15 18 9 9 11 17 8 9 8 14
Completely Rural 7 7 3 4 5 6 5 6 0 1
POVERTY LEVEL2                    
Less Than 100% 40 36 19 15 35 32 27 18 22 29
100-199% 52 39 23 17 46 35 21 22 41 27
200% or More 66 75 28 27 60 72 24 36 54 63
HEALTH INSURANCE3                    
Private 72 65 30 26 65 61 36 38 57 47
Medicaid/CHIP4 50 48 26 22 43 43 17 24 40 36
Other5 24 25 11 8 21 25 11 15 18 19
No Coverage 26 44 7 7 25 43 19 14 17 41
170420
Table 1.75D – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.03 0.03 0.16 0.14 0.03 0.03 0.12 0.14 0.04 0.03
GEOGRAPHIC REGION                    
Northeast 0.08 0.06 0.35 0.28 0.08 0.06 0.24 0.28 0.09 0.07
Midwest 0.09 0.06 0.30 0.33 0.09 0.05 0.24 0.22 0.09 0.05
South 0.06 0.05 0.25 0.21 0.06 0.06 0.20 0.25 0.05 0.05
West 0.08 0.09 0.38 0.28 0.07 0.10 0.29 0.31 0.07 0.10
COUNTY TYPE1                    
Large Metro 0.06 0.05 0.23 0.19 0.06 0.05 0.19 0.21 0.06 0.05
Small Metro 0.05 0.06 0.27 0.22 0.05 0.06 0.17 0.19 0.04 0.06
Nonmetro 0.06 0.07 0.35 0.36 0.06 0.06 0.28 0.34 0.05 0.05
Urbanized 0.12 0.11 0.45 0.55 0.12 0.10 0.40 0.56 0.11 0.07
Less Urbanized 0.09 0.09 0.61 0.51 0.07 0.10 0.40 0.42 0.06 0.09
Completely Rural 0.15 0.19 0.88 1.21 0.12 0.17 1.11 1.58 0.01 0.02
POVERTY LEVEL2                    
Less Than 100% 0.09 0.09 0.34 0.28 0.10 0.09 0.28 0.18 0.08 0.11
100-199% 0.10 0.07 0.39 0.29 0.10 0.07 0.25 0.28 0.10 0.06
200% or More 0.04 0.04 0.20 0.20 0.04 0.04 0.15 0.21 0.04 0.04
HEALTH INSURANCE3                    
Private 0.04 0.04 0.20 0.18 0.04 0.04 0.17 0.18 0.04 0.03
Medicaid/CHIP4 0.12 0.11 0.27 0.24 0.13 0.12 0.23 0.32 0.15 0.13
Other5 0.04 0.04 0.90 0.62 0.03 0.04 0.37 0.53 0.03 0.03
No Coverage 0.10 0.18 0.64 0.67 0.10 0.19 0.34 0.29 0.08 0.22
170420
Table 1.75P – Inhalant Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4066   0.0106   0.8512   0.9665   0.8036  
GEOGRAPHIC REGION                    
Northeast 0.2363   0.2404   0.4169   0.7231   0.5111  
Midwest 0.3789   0.5422   0.2201   0.2805   0.4111  
South 0.7752   0.0755   0.6508   0.3566   0.9603  
West 0.7577   0.0174   0.1866   0.9785   0.1207  
COUNTY TYPE1                    
Large Metro 0.1600   0.0183   0.5561   0.8301   0.6284  
Small Metro 0.2916   0.1676   0.0741   0.5802   0.0859  
Nonmetro 0.7202   0.9163   0.6256   0.9638   0.6295  
Urbanized 0.3122   0.8562   0.2772   0.7164   0.2908  
Less Urbanized 0.8111   0.9931   0.8125   0.8936   0.7706  
Completely Rural 0.4627   0.5034   0.6609   0.6937   0.6621  
POVERTY LEVEL2                    
Less Than 100% 0.2940   0.0182   0.9393   0.2611   0.2586  
100-199% 0.0388   0.0721   0.1430   0.5693   0.2156  
200% or More 0.3432   0.5440   0.2049   0.1236   0.5761  
HEALTH INSURANCE3                    
Private 0.0740   0.1026   0.2082   0.5936   0.2345  
Medicaid/CHIP4 0.9465   0.0756   0.2607   0.2877   0.4563  
Other5 0.9952   0.0947   0.4977   0.8542   0.4555  
No Coverage 0.1347   0.8215   0.1399   0.7000   0.1266  
170420
Table 1.76C – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 52 66 20 17 48 63 21 25 45 57
GEOGRAPHIC REGION                    
Northeast 21 26 10 5 19 26 5 7 19 25
Midwest 25 18 9 9 23 17 11 8 20 15
South 33 29 10 12 31 28 10 17 29 21
West 25 48 11 8 23 47 14 15 18 44
COUNTY TYPE1                    
Large Metro 49 55 17 12 46 53 19 21 43 48
Small Metro 16 31 9 9 13 31 6 13 11 26
Nonmetro 12 17 5 8 10 15 8 4 6 14
Urbanized 9 5 4 5 8 1 5 1 6 1
Less Urbanized 8 15 1 4 7 15 7 3 2 14
Completely Rural 2 5 2 3 * 3 * * * *
POVERTY LEVEL2                    
Less Than 100% 20 30 10 9 17 28 9 12 14 26
100-199% 20 23 11 7 17 22 13 11 11 19
200% or More 45 53 13 13 43 51 14 15 41 48
HEALTH INSURANCE3                    
Private 44 48 13 12 42 46 15 21 40 40
Medicaid/CHIP4 21 35 14 12 17 32 8 11 15 30
Other5 16 9 5 4 15 11 6 5 14 10
No Coverage 17 28 3 3 16 28 12 9 11 27
170420
Table 1.76D – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.02 0.02 0.08 0.07 0.02 0.03 0.06 0.07 0.02 0.03
GEOGRAPHIC REGION                    
Northeast 0.04 0.06 0.24 0.12 0.04 0.06 0.08 0.11 0.05 0.07
Midwest 0.04 0.03 0.16 0.17 0.04 0.03 0.15 0.10 0.05 0.03
South 0.03 0.03 0.10 0.12 0.03 0.03 0.08 0.13 0.04 0.03
West 0.04 0.08 0.18 0.13 0.04 0.08 0.17 0.18 0.04 0.09
COUNTY TYPE1                    
Large Metro 0.03 0.04 0.12 0.09 0.03 0.04 0.10 0.11 0.04 0.04
Small Metro 0.02 0.04 0.11 0.12 0.02 0.04 0.05 0.12 0.02 0.04
Nonmetro 0.03 0.04 0.14 0.22 0.03 0.04 0.19 0.09 0.02 0.05
Urbanized 0.06 0.03 0.26 0.36 0.06 0.01 0.24 0.04 0.05 0.01
Less Urbanized 0.04 0.08 0.10 0.26 0.05 0.08 0.35 0.13 0.02 0.09
Completely Rural 0.05 0.12 0.62 1.02 * 0.09 * * * *
POVERTY LEVEL2                    
Less Than 100% 0.05 0.07 0.18 0.16 0.05 0.08 0.09 0.13 0.05 0.10
100-199% 0.04 0.04 0.19 0.13 0.03 0.04 0.15 0.14 0.03 0.04
200% or More 0.03 0.03 0.10 0.09 0.03 0.03 0.09 0.09 0.03 0.03
HEALTH INSURANCE3                    
Private 0.02 0.03 0.09 0.08 0.03 0.03 0.08 0.10 0.03 0.03
Medicaid/CHIP4 0.05 0.08 0.15 0.13 0.05 0.09 0.11 0.16 0.06 0.11
Other5 0.02 0.01 0.43 0.32 0.02 0.02 0.21 0.16 0.02 0.02
No Coverage 0.06 0.12 0.30 0.24 0.06 0.12 0.21 0.18 0.06 0.14
170420
Table 1.76P – Inhalant Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4082   0.3091   0.2247   0.9191   0.1648  
GEOGRAPHIC REGION                    
Northeast 0.5844   0.0370   0.9051   0.7335   0.9738  
Midwest 0.5947   0.9003   0.5379   0.2346   0.9501  
South 0.6654   0.5638   0.7929   0.6715   0.9312  
West 0.1212   0.3383   0.0531   0.9590   0.0380  
COUNTY TYPE1                    
Large Metro 0.8168   0.0610   0.7382   0.4878   0.5042  
Small Metro 0.0200   0.9350   0.0145   0.0398   0.0723  
Nonmetro 0.8042   0.1531   0.6592   0.1235   0.6407  
Urbanized 0.1331   0.6256   0.0097   0.0576   0.0801  
Less Urbanized 0.3023   0.0255   0.6435   0.2243   0.2207  
Completely Rural 0.3457   0.8027   *   *   *  
POVERTY LEVEL2                    
Less Than 100% 0.2693   0.3846   0.1243   0.5535   0.1509  
100-199% 0.9467   0.3994   0.7337   0.7269   0.4307  
200% or More 0.5566   0.8625   0.5121   0.9696   0.5069  
HEALTH INSURANCE3                    
Private 0.8414   0.3853   0.9662   0.8942   0.9265  
Medicaid/CHIP4 0.1400   0.8290   0.0757   0.5388   0.0925  
Other5 0.6114   0.4345   0.8070   0.9270   0.8347  
No Coverage 0.4231   0.7698   0.4004   0.9431   0.3175  
170420
Table 1.77C – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 120 100 10 8 120 99 35 28 115 95
GEOGRAPHIC REGION                    
Northeast 35 28 2 2 35 28 9 9 34 26
Midwest 36 39 4 3 35 39 10 11 35 37
South 72 57 5 4 72 57 24 20 65 54
West 80 65 7 6 80 65 24 15 79 63
COUNTY TYPE1                    
Large Metro 89 75 8 6 89 74 29 20 88 72
Small Metro 65 61 4 4 64 61 17 16 62 58
Nonmetro 50 36 4 1 50 36 14 14 45 33
Urbanized 28 16 2 0 28 16 7 6 26 15
Less Urbanized 39 29 4 1 39 29 12 12 35 26
Completely Rural 11 14 1 0 11 14 3 5 11 13
POVERTY LEVEL2                    
Less Than 100% 65 66 6 2 64 66 21 18 60 64
100-199% 62 52 5 5 63 52 16 10 60 51
200% or More 77 56 6 5 77 56 22 21 74 52
HEALTH INSURANCE3                    
Private 66 51 7 5 66 51 22 21 62 46
Medicaid/CHIP4 67 74 7 6 67 73 16 17 66 70
Other5 47 46 * 0 47 46 9 6 46 46
No Coverage 63 43 3 1 63 43 22 13 59 41
170420
Table 1.77D – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.04 0.04 0.04 0.03 0.05 0.04 0.10 0.08 0.06 0.05
GEOGRAPHIC REGION                    
Northeast 0.07 0.06 0.04 0.04 0.08 0.06 0.14 0.15 0.09 0.07
Midwest 0.06 0.07 0.07 0.05 0.07 0.08 0.13 0.14 0.08 0.08
South 0.07 0.06 0.05 0.04 0.08 0.06 0.18 0.16 0.08 0.07
West 0.13 0.10 0.13 0.10 0.14 0.11 0.28 0.19 0.16 0.13
COUNTY TYPE1                    
Large Metro 0.06 0.05 0.06 0.05 0.07 0.05 0.15 0.11 0.08 0.06
Small Metro 0.08 0.08 0.05 0.06 0.09 0.08 0.15 0.14 0.10 0.09
Nonmetro 0.13 0.09 0.13 0.04 0.15 0.10 0.31 0.33 0.15 0.11
Urbanized 0.19 0.11 0.13 0.02 0.21 0.12 0.32 0.31 0.22 0.13
Less Urbanized 0.22 0.14 0.26 0.07 0.24 0.16 0.61 0.56 0.25 0.16
Completely Rural 0.25 0.37 0.17 0.04 0.27 0.40 0.68 1.48 0.29 0.42
POVERTY LEVEL2                    
Less Than 100% 0.15 0.16 0.10 0.04 0.17 0.19 0.22 0.20 0.22 0.24
100-199% 0.11 0.10 0.09 0.09 0.13 0.11 0.19 0.13 0.15 0.12
200% or More 0.05 0.03 0.05 0.04 0.05 0.03 0.14 0.12 0.05 0.04
HEALTH INSURANCE3                    
Private 0.04 0.03 0.05 0.03 0.04 0.03 0.11 0.10 0.04 0.03
Medicaid/CHIP4 0.16 0.17 0.08 0.06 0.20 0.21 0.22 0.23 0.25 0.25
Other5 0.07 0.07 * 0.02 0.07 0.07 0.32 0.21 0.07 0.07
No Coverage 0.23 0.18 0.24 0.14 0.24 0.19 0.38 0.28 0.29 0.22
170420
Table 1.77P – Methamphetamine Use in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0274   0.5050   0.0305   0.1789   0.0705  
GEOGRAPHIC REGION                    
Northeast 0.7174   0.6522   0.7337   0.9913   0.7287  
Midwest 0.8536   0.4009   0.8006   0.4067   0.9655  
South 0.1453   0.8244   0.1473   0.4849   0.2071  
West 0.0406   0.8257   0.0424   0.0736   0.1244  
COUNTY TYPE1                    
Large Metro 0.0964   0.4871   0.1079   0.1347   0.2503  
Small Metro 0.6720   0.1471   0.6015   0.5817   0.6961  
Nonmetro 0.0759   0.0433   0.1046   0.8237   0.0686  
Urbanized 0.1386   0.1395   0.1615   0.9162   0.1445  
Less Urbanized 0.0860   0.1480   0.1116   0.8031   0.1010  
Completely Rural 0.2763   0.3235   0.2595   0.1748   0.4982  
POVERTY LEVEL2                    
Less Than 100% 0.9909   0.2438   0.9565   0.4918   0.8663  
100-199% 0.2762   0.7083   0.2594   0.2163   0.3810  
200% or More 0.0270   0.6216   0.0291   0.1122   0.0765  
HEALTH INSURANCE3                    
Private 0.0467   0.5399   0.0517   0.2625   0.0936  
Medicaid/CHIP4 0.8227   0.7484   0.8257   0.1549   0.8809  
Other5 0.6438   *   0.6402   0.1565   0.8208  
No Coverage 0.0486   0.5829   0.0517   0.1449   0.1118  
170420
Table 1.78C – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 93 71 5 4 93 71 25 15 89 70
GEOGRAPHIC REGION                    
Northeast 24 25 1 * 24 25 8 6 23 24
Midwest 25 30 2 2 25 30 5 4 24 29
South 57 38 1 3 57 38 17 10 54 37
West 64 48 5 1 64 48 15 9 62 47
COUNTY TYPE1                    
Large Metro 73 53 5 3 73 53 21 9 70 52
Small Metro 46 46 * 2 46 46 10 8 45 45
Nonmetro 34 29 2 1 34 29 8 10 33 27
Urbanized 23 11 1 0 23 11 0 0 23 11
Less Urbanized 24 27 2 0 24 27 8 9 23 25
Completely Rural 5 1 1 0 5 1 0 0 5 1
POVERTY LEVEL2                    
Less Than 100% 49 52 1 1 49 52 16 10 46 51
100-199% 46 31 5 2 46 31 10 6 45 30
200% or More 62 43 2 3 62 42 14 10 60 41
HEALTH INSURANCE3                    
Private 52 40 4 2 52 40 16 10 49 39
Medicaid/CHIP4 51 56 3 3 51 56 9 10 50 55
Other5 45 24 * * 45 24 7 2 44 24
No Coverage 49 32 2 1 49 32 15 9 47 31
170420
Table 1.78D – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.03 0.03 0.02 0.01 0.04 0.03 0.07 0.04 0.04 0.03
GEOGRAPHIC REGION                    
Northeast 0.05 0.05 0.02 * 0.06 0.06 0.13 0.10 0.06 0.06
Midwest 0.04 0.05 0.04 0.05 0.05 0.06 0.07 0.05 0.05 0.07
South 0.06 0.04 0.01 0.03 0.06 0.04 0.13 0.08 0.07 0.05
West 0.10 0.08 0.08 0.01 0.11 0.08 0.18 0.10 0.13 0.09
COUNTY TYPE1                    
Large Metro 0.05 0.04 0.03 0.02 0.05 0.04 0.11 0.05 0.06 0.04
Small Metro 0.06 0.06 * 0.03 0.06 0.06 0.09 0.07 0.07 0.07
Nonmetro 0.09 0.07 0.07 0.01 0.10 0.08 0.18 0.22 0.11 0.09
Urbanized 0.15 0.07 0.08 0.02 0.16 0.08 0.02 0.02 0.19 0.09
Less Urbanized 0.14 0.13 0.13 0.03 0.15 0.15 0.41 0.45 0.16 0.16
Completely Rural 0.10 0.02 0.16 0.04 0.11 0.02 0.10 0.09 0.13 0.02
POVERTY LEVEL2                    
Less Than 100% 0.11 0.13 0.01 0.02 0.13 0.15 0.17 0.11 0.17 0.19
100-199% 0.08 0.06 0.08 0.04 0.09 0.06 0.12 0.07 0.11 0.07
200% or More 0.04 0.02 0.02 0.02 0.04 0.03 0.09 0.06 0.04 0.03
HEALTH INSURANCE3                    
Private 0.03 0.02 0.03 0.01 0.03 0.02 0.08 0.05 0.03 0.03
Medicaid/CHIP4 0.12 0.13 0.03 0.03 0.15 0.16 0.13 0.14 0.19 0.20
Other5 0.07 0.04 * * 0.07 0.04 0.24 0.05 0.07 0.04
No Coverage 0.18 0.13 0.16 0.12 0.19 0.14 0.27 0.19 0.23 0.17
170420
Table 1.78P – Methamphetamine Use in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0361   0.5313   0.0387   0.0343   0.1187  
GEOGRAPHIC REGION                    
Northeast 0.8680   *   0.8890   0.2091   0.8086  
Midwest 0.8137   0.9854   0.8130   0.6881   0.7609  
South 0.0210   0.3171   0.0186   0.1231   0.0481  
West 0.2619   0.2118   0.2937   0.3787   0.3816  
COUNTY TYPE1                    
Large Metro 0.0238   0.4075   0.0266   0.0114   0.1064  
Small Metro 0.9305   *   0.8753   0.5539   0.9740  
Nonmetro 0.4923   0.1153   0.5476   0.7826   0.4810  
Urbanized 0.2216   0.3857   0.2355   0.7141   0.2315  
Less Urbanized 0.9749   0.2401   0.9165   0.8344   0.9667  
Completely Rural 0.1775   0.4925   0.2036   0.9384   0.2035  
POVERTY LEVEL2                    
Less Than 100% 0.9372   0.9710   0.9305   0.7942   0.9748  
100-199% 0.1636   0.3084   0.1901   0.5487   0.2184  
200% or More 0.0790   0.7569   0.0765   0.0132   0.2117  
HEALTH INSURANCE3                    
Private 0.1342   0.4355   0.1471   0.0465   0.3490  
Medicaid/CHIP4 0.7404   0.9585   0.7598   0.2356   0.9455  
Other5 0.0581   *   0.0582   0.1138   0.0912  
No Coverage 0.1062   0.8481   0.1085   0.2989   0.1641  
170420
Table 1.79C – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 877 824 107 107 860 812 177 168 832 791
GEOGRAPHIC REGION                    
Northeast 329 316 39 35 323 313 69 73 314 298
Midwest 332 378 48 46 327 374 75 72 324 361
South 560 507 69 68 553 498 104 105 536 489
West 474 429 60 55 460 425 104 88 439 420
COUNTY TYPE1                    
Large Metro 1,039 1,037 113 105 1,010 1,022 204 219 986 980
Small Metro 816 792 75 71 795 773 163 141 759 745
Nonmetro 542 568 46 52 528 545 103 86 492 516
Urbanized 418 367 33 32 405 351 80 72 363 323
Less Urbanized 402 466 32 38 387 450 71 61 357 419
Completely Rural 236 196 15 15 231 188 28 22 220 175
POVERTY LEVEL2                    
Less Than 100% 442 436 65 59 425 428 152 148 391 389
100-199% 543 510 66 59 533 500 115 101 523 485
200% or More 1,105 1,094 109 100 1,076 1,074 168 176 1,051 1,038
HEALTH INSURANCE3                    
Private 1,041 1,077 114 103 1,015 1,056 213 217 997 1,024
Medicaid/CHIP4 482 463 80 80 466 447 113 99 439 419
Other5 763 755 30 31 762 755 68 65 764 751
No Coverage 289 272 26 26 287 270 89 78 267 257
170420
Table 1.79D – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.33 0.31 0.43 0.43 0.35 0.33 0.51 0.49 0.40 0.38
GEOGRAPHIC REGION                    
Northeast 0.69 0.66 0.95 0.86 0.74 0.72 1.12 1.20 0.84 0.79
Midwest 0.59 0.67 0.91 0.86 0.64 0.73 1.01 0.98 0.74 0.82
South 0.56 0.50 0.73 0.72 0.61 0.54 0.80 0.82 0.69 0.62
West 0.75 0.67 1.00 0.92 0.80 0.74 1.23 1.05 0.90 0.85
COUNTY TYPE1                    
Large Metro 0.44 0.44 0.60 0.59 0.47 0.48 0.72 0.70 0.53 0.54
Small Metro 0.59 0.53 0.76 0.70 0.64 0.58 0.81 0.77 0.74 0.66
Nonmetro 0.76 0.72 1.09 1.09 0.82 0.78 1.25 1.17 0.93 0.88
Urbanized 1.14 1.02 1.71 1.74 1.21 1.09 1.68 1.85 1.35 1.28
Less Urbanized 1.13 1.02 1.56 1.59 1.22 1.10 1.98 1.80 1.38 1.23
Completely Rural 2.25 2.36 3.26 2.74 2.43 2.59 4.33 3.36 2.76 2.85
POVERTY LEVEL2                    
Less Than 100% 0.69 0.71 0.93 0.89 0.77 0.80 0.97 0.95 0.98 1.01
100-199% 0.66 0.63 0.92 0.85 0.72 0.69 0.99 0.97 0.85 0.80
200% or More 0.41 0.39 0.58 0.56 0.44 0.42 0.71 0.71 0.48 0.47
HEALTH INSURANCE3                    
Private 0.38 0.38 0.58 0.54 0.41 0.41 0.65 0.65 0.46 0.46
Medicaid/CHIP4 0.69 0.70 0.71 0.69 0.83 0.85 1.16 1.05 1.01 1.04
Other5 0.73 0.73 2.15 2.35 0.74 0.74 1.63 1.64 0.77 0.78
No Coverage 0.86 0.90 1.94 2.08 0.90 0.94 1.16 1.29 1.10 1.14
170420
Table 1.79P – Any Use of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0002   0.0000   0.0021   0.0000   0.0322  
GEOGRAPHIC REGION                    
Northeast 0.0114   0.1079   0.0172   0.0022   0.0783  
Midwest 0.9176   0.0007   0.7228   0.0127   0.3630  
South 0.1330   0.0022   0.2576   0.0108   0.5099  
West 0.0012   0.0122   0.0024   0.0592   0.0066  
COUNTY TYPE1                    
Large Metro 0.0196   0.0001   0.0571   0.0111   0.1653  
Small Metro 0.0177   0.0004   0.0469   0.0007   0.1672  
Nonmetro 0.0745   0.1172   0.1122   0.0001   0.3684  
Urbanized 0.0005   0.4826   0.0006   0.0001   0.0068  
Less Urbanized 0.6459   0.1403   0.5027   0.1624   0.3509  
Completely Rural 0.6767   0.8148   0.7041   0.2168   0.8379  
POVERTY LEVEL2                    
Less Than 100% 0.0191   0.3650   0.0220   0.0098   0.1113  
100-199% 0.0119   0.0044   0.0310   0.0162   0.0840  
200% or More 0.0230   0.0000   0.0840   0.0001   0.2894  
HEALTH INSURANCE3                    
Private 0.0097   0.0000   0.0465   0.0000   0.2248  
Medicaid/CHIP4 0.0078   0.0080   0.0176   0.0168   0.0623  
Other5 0.0014   0.5741   0.0013   0.0074   0.0028  
No Coverage 0.3750   0.9908   0.3845   0.0848   0.7018  
170420
Table 1.80C – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 380 374 58 53 375 365 127 131 345 335
GEOGRAPHIC REGION                    
Northeast 161 150 20 16 159 149 54 58 138 135
Midwest 158 147 25 23 157 144 59 57 143 122
South 244 224 37 34 244 217 77 77 224 198
West 187 206 32 30 182 202 67 63 177 192
COUNTY TYPE1                    
Large Metro 327 326 51 45 322 318 113 119 298 291
Small Metro 202 203 31 28 198 198 86 91 175 174
Nonmetro 132 109 18 18 130 105 54 41 108 94
Urbanized 92 70 13 10 91 69 39 33 77 59
Less Urbanized 100 79 13 13 98 76 38 25 77 70
Completely Rural 38 37 4 7 38 35 11 13 33 29
POVERTY LEVEL2                    
Less Than 100% 160 154 25 28 159 151 85 84 131 126
100-199% 183 167 29 27 178 163 60 59 170 150
200% or More 307 310 47 41 301 302 97 101 286 286
HEALTH INSURANCE3                    
Private 299 311 50 41 293 305 124 127 267 280
Medicaid/CHIP4 159 161 34 33 153 155 57 53 138 145
Other5 169 187 13 14 168 187 34 34 166 184
No Coverage 144 127 9 13 144 126 50 46 132 115
170420
Table 1.80D – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.14 0.14 0.23 0.21 0.15 0.15 0.36 0.38 0.17 0.16
GEOGRAPHIC REGION                    
Northeast 0.34 0.31 0.48 0.40 0.36 0.34 0.88 0.96 0.37 0.36
Midwest 0.28 0.26 0.46 0.43 0.31 0.28 0.79 0.77 0.32 0.28
South 0.24 0.22 0.39 0.36 0.27 0.24 0.59 0.60 0.29 0.25
West 0.30 0.32 0.54 0.50 0.32 0.35 0.79 0.76 0.36 0.39
COUNTY TYPE1                    
Large Metro 0.21 0.20 0.34 0.30 0.23 0.22 0.52 0.51 0.25 0.24
Small Metro 0.22 0.23 0.39 0.34 0.24 0.25 0.62 0.66 0.26 0.26
Nonmetro 0.32 0.24 0.50 0.49 0.35 0.26 0.99 0.86 0.35 0.28
Urbanized 0.54 0.38 0.80 0.70 0.59 0.41 1.45 1.29 0.62 0.43
Less Urbanized 0.50 0.35 0.81 0.72 0.54 0.37 1.63 1.14 0.49 0.41
Completely Rural 0.67 0.87 1.23 1.70 0.73 0.92 2.20 3.11 0.74 0.89
POVERTY LEVEL2                    
Less Than 100% 0.35 0.36 0.42 0.50 0.40 0.41 0.74 0.78 0.46 0.46
100-199% 0.32 0.29 0.49 0.46 0.35 0.32 0.66 0.67 0.41 0.35
200% or More 0.17 0.17 0.32 0.28 0.19 0.18 0.53 0.52 0.20 0.19
HEALTH INSURANCE3                    
Private 0.16 0.17 0.32 0.26 0.17 0.18 0.50 0.49 0.18 0.19
Medicaid/CHIP4 0.35 0.35 0.36 0.35 0.43 0.43 0.73 0.70 0.50 0.51
Other5 0.25 0.27 1.08 1.11 0.26 0.27 1.06 1.08 0.26 0.28
No Coverage 0.51 0.49 0.79 1.16 0.53 0.51 0.83 0.92 0.62 0.59
170420
Table 1.80P – Misuse of Prescription Psychotherapeutics in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.4311   0.0608   0.6151   0.1432   0.8991  
GEOGRAPHIC REGION                    
Northeast 0.8325   0.2539   0.7249   0.4959   0.4510  
Midwest 0.5731   0.4747   0.4918   0.8178   0.4847  
South 0.1063   0.2188   0.1546   0.3549   0.2560  
West 0.8768   0.4615   0.9690   0.1606   0.6178  
COUNTY TYPE1                    
Large Metro 1.0000   0.1638   0.8373   0.5580   0.6125  
Small Metro 0.9909   0.2319   0.8412   0.8315   0.7827  
Nonmetro 0.0136   0.5828   0.0164   0.0070   0.1577  
Urbanized 0.0425   0.4137   0.0570   0.0357   0.3237  
Less Urbanized 0.0423   0.5122   0.0520   0.0477   0.1834  
Completely Rural 0.3198   0.1211   0.4538   0.3041   0.6389  
POVERTY LEVEL2                    
Less Than 100% 0.9700   0.5221   0.9330   0.7634   0.8619  
100-199% 0.0704   0.2921   0.0943   0.2509   0.2399  
200% or More 0.8310   0.0310   0.5789   0.1215   0.3259  
HEALTH INSURANCE3                    
Private 0.7071   0.0037   0.9420   0.1811   0.6333  
Medicaid/CHIP4 0.4662   0.9484   0.4794   0.9903   0.4151  
Other5 0.8105   0.8021   0.7938   0.3788   0.9581  
No Coverage 0.4265   0.2259   0.3754   0.2879   0.6486  
170420
Table 1.81C – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 206 211 37 29 201 208 73 74 187 195
GEOGRAPHIC REGION                    
Northeast 81 96 11 7 81 95 29 33 72 91
Midwest 91 80 15 13 90 78 33 31 82 70
South 142 126 24 22 139 125 48 44 130 115
West 100 124 20 14 95 121 35 33 90 117
COUNTY TYPE1                    
Large Metro 163 174 30 21 159 172 57 57 148 163
Small Metro 113 116 21 19 111 114 49 46 101 103
Nonmetro 76 58 10 9 75 56 27 22 65 49
Urbanized 53 37 6 5 53 36 22 15 44 31
Less Urbanized 50 39 7 5 49 39 17 16 43 36
Completely Rural 28 17 * 4 28 16 5 5 26 15
POVERTY LEVEL2                    
Less Than 100% 87 86 13 14 85 85 41 43 75 73
100-199% 99 97 19 14 97 96 35 33 91 89
200% or More 161 167 28 21 158 165 54 51 148 158
HEALTH INSURANCE3                    
Private 160 167 29 22 156 165 64 65 144 153
Medicaid/CHIP4 86 89 21 17 83 88 31 33 77 82
Other5 87 107 10 7 86 106 17 17 85 105
No Coverage 90 70 5 8 90 70 32 26 83 65
170420
Table 1.81D – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.08 0.08 0.15 0.12 0.08 0.09 0.21 0.21 0.09 0.09
GEOGRAPHIC REGION                    
Northeast 0.17 0.20 0.26 0.16 0.19 0.22 0.48 0.54 0.19 0.24
Midwest 0.16 0.14 0.28 0.25 0.18 0.15 0.45 0.42 0.19 0.16
South 0.14 0.12 0.25 0.23 0.15 0.14 0.37 0.35 0.17 0.15
West 0.16 0.19 0.33 0.23 0.17 0.21 0.42 0.40 0.18 0.24
COUNTY TYPE1                    
Large Metro 0.11 0.11 0.21 0.15 0.12 0.12 0.29 0.28 0.13 0.14
Small Metro 0.14 0.14 0.27 0.24 0.15 0.16 0.40 0.38 0.16 0.17
Nonmetro 0.19 0.14 0.30 0.24 0.21 0.15 0.56 0.50 0.21 0.16
Urbanized 0.31 0.23 0.43 0.35 0.34 0.25 0.92 0.69 0.34 0.26
Less Urbanized 0.27 0.20 0.45 0.32 0.29 0.22 0.81 0.76 0.30 0.23
Completely Rural 0.57 0.43 * 1.19 0.60 0.46 1.00 1.33 0.63 0.47
POVERTY LEVEL2                    
Less Than 100% 0.20 0.21 0.24 0.26 0.23 0.24 0.40 0.44 0.27 0.28
100-199% 0.18 0.17 0.32 0.25 0.20 0.19 0.40 0.41 0.22 0.21
200% or More 0.09 0.09 0.20 0.15 0.10 0.10 0.32 0.29 0.11 0.11
HEALTH INSURANCE3                    
Private 0.09 0.09 0.20 0.15 0.10 0.10 0.30 0.29 0.10 0.10
Medicaid/CHIP4 0.20 0.20 0.23 0.18 0.24 0.25 0.42 0.45 0.29 0.29
Other5 0.13 0.16 0.81 0.60 0.13 0.16 0.56 0.58 0.14 0.16
No Coverage 0.32 0.28 0.45 0.72 0.34 0.29 0.56 0.54 0.41 0.34
170420
Table 1.81P – Misuse of Prescription Psychotherapeutics in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Prescription psychotherapeutics include pain relievers, tranquilizers, stimulants, or sedatives and do not include over-the-counter drugs.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.5042   0.0226   0.7397   0.1247   0.8053  
GEOGRAPHIC REGION                    
Northeast 0.3809   0.0650   0.2855   0.5611   0.3472  
Midwest 0.4813   0.2638   0.5957   0.3542   0.8421  
South 0.0468   0.3276   0.0627   0.0698   0.2003  
West 0.3092   0.2181   0.2109   0.6790   0.1571  
COUNTY TYPE1                    
Large Metro 0.8221   0.0585   0.6079   0.5441   0.4379  
Small Metro 1.0000   0.4029   0.8887   0.4981   0.7056  
Nonmetro 0.0074   0.2328   0.0106   0.0369   0.0621  
Urbanized 0.0124   0.4853   0.0151   0.0124   0.1454  
Less Urbanized 0.1099   0.1492   0.1571   0.5187   0.2223  
Completely Rural 0.8490   *   0.7446   0.4255   0.5908  
POVERTY LEVEL2                    
Less Than 100% 0.6960   0.7653   0.7343   0.8847   0.7287  
100-199% 0.3704   0.1105   0.5217   0.3514   0.8297  
200% or More 0.6810   0.0348   0.9138   0.1323   0.7630  
HEALTH INSURANCE3                    
Private 0.5352   0.0107   0.8043   0.2207   0.8756  
Medicaid/CHIP4 0.1243   0.2621   0.0757   0.6038   0.0878  
Other5 0.3842   0.6159   0.3603   0.8925   0.3283  
No Coverage 0.0308   0.4461   0.0260   0.0693   0.1091  
170420
Table 1.82C – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 861 771 101 97 848 762 165 153 818 742
GEOGRAPHIC REGION                    
Northeast 325 329 36 34 321 323 61 68 314 310
Midwest 331 360 45 42 332 358 69 65 326 351
South 547 448 67 60 538 444 95 95 518 440
West 447 410 55 51 435 406 94 80 417 395
COUNTY TYPE1                    
Large Metro 913 894 99 88 891 884 169 173 867 852
Small Metro 719 680 66 63 704 665 133 104 670 647
Nonmetro 486 487 41 42 476 471 85 67 445 449
Urbanized 378 321 29 27 368 310 66 52 334 289
Less Urbanized 348 392 29 30 335 380 60 47 308 358
Completely Rural 204 164 15 14 200 157 25 19 191 145
POVERTY LEVEL2                    
Less Than 100% 414 395 58 52 402 388 124 116 374 355
100-199% 512 445 60 53 505 435 104 86 495 425
200% or More 950 936 95 83 929 923 144 144 908 899
HEALTH INSURANCE3                    
Private 912 926 99 84 895 912 168 166 876 889
Medicaid/CHIP4 459 419 73 70 450 406 105 91 424 380
Other5 691 663 28 27 692 663 61 55 694 659
No Coverage 267 244 24 25 266 243 82 72 249 229
170420
Table 1.82D – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.32 0.29 0.41 0.39 0.35 0.31 0.47 0.44 0.39 0.35
GEOGRAPHIC REGION                    
Northeast 0.68 0.69 0.87 0.83 0.74 0.74 1.00 1.12 0.84 0.82
Midwest 0.58 0.63 0.83 0.78 0.65 0.70 0.93 0.88 0.74 0.80
South 0.55 0.44 0.71 0.63 0.59 0.48 0.73 0.74 0.67 0.56
West 0.71 0.64 0.93 0.86 0.76 0.70 1.12 0.96 0.86 0.80
COUNTY TYPE1                    
Large Metro 0.42 0.41 0.55 0.54 0.45 0.45 0.65 0.65 0.51 0.51
Small Metro 0.60 0.52 0.72 0.65 0.65 0.57 0.78 0.70 0.73 0.66
Nonmetro 0.75 0.71 1.06 0.94 0.81 0.77 1.22 1.11 0.92 0.87
Urbanized 1.26 1.04 1.63 1.52 1.35 1.12 1.79 1.66 1.53 1.29
Less Urbanized 1.06 1.01 1.54 1.29 1.14 1.10 1.86 1.68 1.28 1.21
Completely Rural 2.05 2.28 3.33 2.80 2.23 2.50 4.00 3.09 2.52 2.73
POVERTY LEVEL2                    
Less Than 100% 0.69 0.67 0.85 0.82 0.77 0.76 0.89 0.86 0.98 0.96
100-199% 0.66 0.60 0.88 0.80 0.73 0.66 0.96 0.91 0.86 0.76
200% or More 0.40 0.37 0.55 0.51 0.43 0.40 0.68 0.65 0.47 0.44
HEALTH INSURANCE3                    
Private 0.38 0.36 0.54 0.48 0.41 0.39 0.58 0.60 0.46 0.44
Medicaid/CHIP4 0.70 0.66 0.68 0.62 0.85 0.81 1.15 1.00 1.03 0.99
Other5 0.72 0.71 2.06 2.06 0.74 0.72 1.60 1.48 0.77 0.75
No Coverage 0.84 0.81 1.83 2.03 0.87 0.85 1.15 1.22 1.08 1.02
170420
Table 1.82P – Any Use of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0000   0.0000   0.0000   0.0000   0.0009  
GEOGRAPHIC REGION                    
Northeast 0.0001   0.0531   0.0002   0.0001   0.0022  
Midwest 0.1135   0.0000   0.2879   0.0000   0.8572  
South 0.0408   0.0000   0.1197   0.0005   0.3495  
West 0.0004   0.0108   0.0008   0.0042   0.0038  
COUNTY TYPE1                    
Large Metro 0.0011   0.0000   0.0067   0.0001   0.0473  
Small Metro 0.0001   0.0009   0.0004   0.0000   0.0073  
Nonmetro 0.0298   0.0256   0.0587   0.0000   0.2985  
Urbanized 0.0009   0.2621   0.0012   0.0000   0.0143  
Less Urbanized 0.9550   0.0377   0.7470   0.0242   0.4585  
Completely Rural 0.5819   0.7137   0.6180   0.1650   0.7521  
POVERTY LEVEL2                    
Less Than 100% 0.0015   0.0707   0.0027   0.0000   0.0579  
100-199% 0.0041   0.0261   0.0091   0.0008   0.0442  
200% or More 0.0003   0.0000   0.0030   0.0000   0.0284  
HEALTH INSURANCE3                    
Private 0.0000   0.0000   0.0006   0.0000   0.0152  
Medicaid/CHIP4 0.0003   0.0092   0.0007   0.0008   0.0072  
Other5 0.0001   0.8421   0.0001   0.0097   0.0003  
No Coverage 0.3111   0.9693   0.3223   0.0138   0.7814  
170420
Table 1.83C – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 307 286 47 42 303 280 92 92 287 264
GEOGRAPHIC REGION                    
Northeast 122 115 15 12 120 114 37 43 109 104
Midwest 127 115 19 19 127 112 37 36 119 102
South 196 170 32 28 194 168 56 56 181 159
West 163 169 26 25 160 165 53 48 157 157
COUNTY TYPE1                    
Large Metro 261 250 39 35 256 245 75 79 243 228
Small Metro 158 150 25 25 155 147 59 51 143 138
Nonmetro 108 93 16 15 108 90 39 32 92 84
Urbanized 69 55 12 8 68 54 26 21 58 48
Less Urbanized 87 72 11 12 86 69 31 20 69 66
Completely Rural 32 26 4 6 32 25 7 12 30 21
POVERTY LEVEL2                    
Less Than 100% 137 123 22 25 136 120 52 46 122 108
100-199% 150 130 23 23 147 127 51 42 139 120
200% or More 241 232 37 30 237 228 70 71 224 218
HEALTH INSURANCE3                    
Private 222 233 39 30 218 229 77 74 206 216
Medicaid/CHIP4 141 136 29 29 136 132 46 43 127 123
Other5 139 143 12 11 139 143 25 26 137 140
No Coverage 133 109 8 12 132 109 42 34 124 103
170420
Table 1.83D – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.11 0.11 0.19 0.17 0.12 0.11 0.26 0.27 0.14 0.13
GEOGRAPHIC REGION                    
Northeast 0.26 0.24 0.36 0.29 0.28 0.26 0.60 0.71 0.29 0.27
Midwest 0.22 0.20 0.36 0.36 0.25 0.22 0.50 0.49 0.27 0.23
South 0.20 0.17 0.34 0.29 0.21 0.18 0.43 0.44 0.23 0.20
West 0.26 0.26 0.44 0.41 0.28 0.29 0.63 0.58 0.32 0.32
COUNTY TYPE1                    
Large Metro 0.17 0.16 0.27 0.24 0.18 0.17 0.36 0.38 0.20 0.19
Small Metro 0.19 0.18 0.33 0.31 0.20 0.19 0.49 0.43 0.22 0.22
Nonmetro 0.27 0.22 0.45 0.43 0.29 0.23 0.80 0.71 0.30 0.25
Urbanized 0.40 0.32 0.75 0.52 0.45 0.34 1.14 1.02 0.47 0.37
Less Urbanized 0.45 0.33 0.70 0.67 0.49 0.35 1.38 0.95 0.46 0.39
Completely Rural 0.59 0.64 1.21 1.62 0.65 0.67 1.50 2.98 0.69 0.66
POVERTY LEVEL2                    
Less Than 100% 0.31 0.29 0.38 0.45 0.35 0.33 0.51 0.49 0.43 0.40
100-199% 0.27 0.23 0.39 0.40 0.29 0.25 0.58 0.52 0.33 0.28
200% or More 0.14 0.13 0.26 0.21 0.15 0.14 0.40 0.39 0.16 0.15
HEALTH INSURANCE3                    
Private 0.12 0.13 0.26 0.20 0.13 0.13 0.35 0.33 0.14 0.15
Medicaid/CHIP4 0.31 0.30 0.31 0.30 0.39 0.37 0.60 0.57 0.46 0.43
Other5 0.21 0.21 0.96 0.92 0.21 0.21 0.81 0.85 0.22 0.22
No Coverage 0.48 0.42 0.70 1.05 0.50 0.44 0.71 0.70 0.60 0.53
170420
Table 1.83P – Misuse of Pain Relievers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0137   0.1721   0.0223   0.0001   0.2815  
GEOGRAPHIC REGION                    
Northeast 0.1960   0.3414   0.2247   0.2600   0.3816  
Midwest 0.3838   0.6082   0.4248   0.1067   0.7538  
South 0.0496   0.1851   0.0778   0.0162   0.2835  
West 0.5055   1.0000   0.4960   0.0199   0.9621  
COUNTY TYPE1                    
Large Metro 0.1553   0.2427   0.1988   0.0676   0.4522  
Small Metro 0.1950   0.6115   0.2204   0.0059   0.7600  
Nonmetro 0.0515   0.5347   0.0648   0.0147   0.3464  
Urbanized 0.0519   0.5074   0.0688   0.0261   0.3905  
Less Urbanized 0.2036   0.4317   0.2463   0.0739   0.5717  
Completely Rural 0.5921   0.2599   0.7520   0.1269   0.8391  
POVERTY LEVEL2                    
Less Than 100% 0.1515   0.5320   0.1165   0.1223   0.2801  
100-199% 0.0261   0.8681   0.0263   0.0041   0.2172  
200% or More 0.3450   0.0344   0.5213   0.0184   0.9957  
HEALTH INSURANCE3                    
Private 0.3128   0.0212   0.5000   0.0121   0.9429  
Medicaid/CHIP4 0.7300   0.9512   0.6911   0.2474   0.9970  
Other5 0.3225   0.9651   0.3246   0.5555   0.3835  
No Coverage 0.1144   0.2069   0.0930   0.0010   0.4893  
170420
Table 1.84C – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 157 159 27 22 156 158 46 46 150 149
GEOGRAPHIC REGION                    
Northeast 58 70 7 6 58 69 14 19 56 64
Midwest 74 64 12 9 75 62 21 19 73 58
South 104 90 17 18 102 90 29 25 98 86
West 80 94 14 10 78 93 27 27 78 88
COUNTY TYPE1                    
Large Metro 125 127 19 15 123 127 35 34 119 121
Small Metro 90 85 17 16 89 84 30 26 86 80
Nonmetro 52 46 9 8 52 45 19 17 48 40
Urbanized 31 30 5 4 31 29 14 9 28 26
Less Urbanized 37 34 5 5 37 34 13 14 34 30
Completely Rural 23 8 * 4 23 6 3 4 22 4
POVERTY LEVEL2                    
Less Than 100% 72 68 11 13 70 68 27 21 65 65
100-199% 83 83 14 11 82 82 27 23 77 78
200% or More 116 118 20 14 116 118 33 34 110 111
HEALTH INSURANCE3                    
Private 111 120 20 15 110 120 38 35 109 112
Medicaid/CHIP4 74 77 17 14 72 76 23 24 67 72
Other5 68 77 5 6 68 77 10 10 67 76
No Coverage 75 60 4 8 75 59 23 17 71 57
170420
Table 1.84D – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.06 0.06 0.11 0.09 0.06 0.06 0.13 0.13 0.07 0.07
GEOGRAPHIC REGION                    
Northeast 0.12 0.15 0.17 0.14 0.13 0.16 0.23 0.31 0.15 0.17
Midwest 0.13 0.11 0.23 0.17 0.15 0.12 0.28 0.25 0.17 0.13
South 0.10 0.09 0.18 0.19 0.11 0.10 0.22 0.20 0.13 0.11
West 0.13 0.15 0.24 0.16 0.14 0.16 0.32 0.32 0.16 0.18
COUNTY TYPE1                    
Large Metro 0.08 0.08 0.13 0.11 0.09 0.09 0.17 0.18 0.10 0.10
Small Metro 0.11 0.11 0.22 0.21 0.12 0.12 0.26 0.23 0.13 0.13
Nonmetro 0.14 0.12 0.26 0.22 0.15 0.13 0.41 0.39 0.16 0.13
Urbanized 0.19 0.19 0.32 0.29 0.21 0.21 0.67 0.45 0.23 0.22
Less Urbanized 0.20 0.17 0.35 0.31 0.22 0.19 0.62 0.67 0.24 0.19
Completely Rural 0.47 0.20 * 1.19 0.50 0.18 0.77 1.11 0.56 0.13
POVERTY LEVEL2                    
Less Than 100% 0.17 0.17 0.19 0.24 0.19 0.19 0.28 0.22 0.24 0.24
100-199% 0.15 0.15 0.25 0.19 0.17 0.17 0.32 0.29 0.19 0.19
200% or More 0.07 0.07 0.15 0.10 0.07 0.07 0.20 0.20 0.08 0.08
HEALTH INSURANCE3                    
Private 0.06 0.07 0.14 0.10 0.07 0.07 0.18 0.16 0.08 0.08
Medicaid/CHIP4 0.17 0.17 0.19 0.15 0.21 0.22 0.31 0.33 0.25 0.26
Other5 0.10 0.11 0.43 0.46 0.10 0.11 0.36 0.34 0.11 0.12
No Coverage 0.27 0.24 0.39 0.70 0.29 0.25 0.41 0.37 0.35 0.30
170420
Table 1.84P – Misuse of Pain Relievers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
NOTE: Prescription psychotherapeutic subtypes were revised in 2016; one effect was the comparability of codeine products between 2015 and 2016.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.0534   0.2686   0.0716   0.0026   0.3264  
GEOGRAPHIC REGION                    
Northeast 0.5996   0.2583   0.6721   0.3673   0.8396  
Midwest 0.1223   0.1749   0.1807   0.0670   0.3816  
South 0.0362   0.8655   0.0310   0.0139   0.1344  
West 0.7359   0.5031   0.6622   0.5070   0.5080  
COUNTY TYPE1                    
Large Metro 0.1646   0.2297   0.2071   0.0556   0.4406  
Small Metro 0.5824   0.7472   0.6155   0.1211   0.9671  
Nonmetro 0.0687   0.8567   0.0691   0.0949   0.2317  
Urbanized 0.2513   0.8148   0.2590   0.0165   0.9678  
Less Urbanized 0.2404   0.5851   0.2727   0.7285   0.3297  
Completely Rural 0.2552   *   0.1537   0.3441   0.0875  
POVERTY LEVEL2                    
Less Than 100% 0.4091   0.4103   0.3252   0.0464   0.7631  
100-199% 0.7672   0.6582   0.8158   0.2139   0.8296  
200% or More 0.0596   0.0888   0.0995   0.0793   0.2109  
HEALTH INSURANCE3                    
Private 0.1195   0.2189   0.1627   0.0445   0.4014  
Medicaid/CHIP4 0.5239   0.2971   0.4031   0.5233   0.2697  
Other5 0.7736   0.7872   0.7887   0.8648   0.7583  
No Coverage 0.0426   0.3887   0.0343   0.0055   0.1884  
170420
Table 1.85C – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 623 592 50 53 617 587 115 111 599 573
GEOGRAPHIC REGION                    
Northeast 258 232 17 20 254 229 48 50 246 221
Midwest 226 247 23 21 223 246 49 45 219 240
South 405 363 31 38 401 357 69 65 389 348
West 315 316 27 23 311 314 61 59 302 309
COUNTY TYPE1                    
Large Metro 543 525 42 44 537 521 100 94 524 507
Small Metro 394 395 28 28 390 390 69 72 377 381
Nonmetro 265 270 16 16 265 268 45 38 257 257
Urbanized 190 161 10 9 189 160 33 23 177 153
Less Urbanized 173 209 12 12 174 207 32 30 167 199
Completely Rural 109 97 3 2 108 96 10 12 106 90
POVERTY LEVEL2                    
Less Than 100% 216 234 23 23 214 232 64 58 205 225
100-199% 312 303 23 25 311 300 56 49 309 295
200% or More 570 543 40 40 565 540 87 89 557 529
HEALTH INSURANCE3                    
Private 559 539 41 40 555 537 100 93 545 528
Medicaid/CHIP4 238 276 32 32 235 272 52 49 229 265
Other5 419 460 11 13 419 460 30 33 418 460
No Coverage 155 138 7 11 154 137 46 40 143 133
170420
Table 1.85D – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.23 0.22 0.20 0.21 0.25 0.24 0.33 0.32 0.29 0.27
GEOGRAPHIC REGION                    
Northeast 0.54 0.48 0.40 0.48 0.58 0.52 0.78 0.82 0.65 0.59
Midwest 0.40 0.43 0.42 0.38 0.43 0.48 0.67 0.61 0.50 0.54
South 0.40 0.36 0.33 0.40 0.44 0.39 0.54 0.51 0.50 0.44
West 0.50 0.50 0.45 0.39 0.54 0.54 0.73 0.71 0.62 0.63
COUNTY TYPE1                    
Large Metro 0.32 0.29 0.28 0.30 0.35 0.32 0.47 0.44 0.40 0.36
Small Metro 0.40 0.40 0.34 0.36 0.43 0.43 0.54 0.57 0.50 0.50
Nonmetro 0.60 0.53 0.45 0.43 0.66 0.58 0.87 0.76 0.74 0.65
Urbanized 0.93 0.74 0.68 0.65 1.02 0.82 1.32 0.98 1.13 0.94
Less Urbanized 0.84 0.81 0.75 0.69 0.94 0.88 1.40 1.27 1.05 0.99
Completely Rural 1.81 1.83 0.78 0.71 1.96 1.99 1.96 2.82 2.19 2.09
POVERTY LEVEL2                    
Less Than 100% 0.47 0.52 0.39 0.41 0.53 0.59 0.61 0.59 0.68 0.75
100-199% 0.52 0.46 0.40 0.44 0.58 0.51 0.61 0.58 0.69 0.60
200% or More 0.29 0.27 0.28 0.28 0.31 0.29 0.48 0.48 0.34 0.32
HEALTH INSURANCE3                    
Private 0.28 0.26 0.27 0.26 0.31 0.28 0.43 0.40 0.34 0.32
Medicaid/CHIP4 0.49 0.54 0.33 0.33 0.61 0.67 0.66 0.64 0.77 0.83
Other5 0.55 0.59 0.93 1.06 0.56 0.60 0.94 1.05 0.58 0.63
No Coverage 0.54 0.54 0.66 1.03 0.56 0.56 0.77 0.80 0.66 0.68
170420
Table 1.85P – Any Use of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Any Use of prescription psychotherapeutics is defined as (a) the use of one's own prescription medication as directed by a doctor or (b) misuse of prescription psychotherapeutics. Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.3384   0.6071   0.3029   0.0902   0.4498  
GEOGRAPHIC REGION                    
Northeast 0.9788   0.4551   0.9297   0.5424   0.9733  
Midwest 0.9395   0.6117   0.9849   0.3421   0.8386  
South 0.2028   0.8458   0.1869   0.1510   0.2599  
West 0.7159   0.8930   0.7158   0.6684   0.7636  
COUNTY TYPE1                    
Large Metro 0.9543   0.2434   0.8608   0.1369   0.9210  
Small Metro 0.3810   0.8782   0.3688   0.5604   0.4236  
Nonmetro 0.2129   0.3095   0.2486   0.4749   0.2741  
Urbanized 0.0656   0.8996   0.0642   0.0068   0.1456  
Less Urbanized 0.9652   0.1461   0.8618   0.4122   0.9973  
Completely Rural 0.7060   0.8281   0.7336   0.1195   0.5926  
POVERTY LEVEL2                    
Less Than 100% 0.7754   0.2536   0.8980   0.5515   0.7912  
100-199% 0.2322   0.6206   0.2380   0.4917   0.2413  
200% or More 0.5119   0.7630   0.5013   0.0901   0.7089  
HEALTH INSURANCE3                    
Private 0.1910   0.7172   0.1935   0.0098   0.4001  
Medicaid/CHIP4 0.0835   0.6870   0.1129   0.8385   0.1334  
Other5 0.2334   0.1835   0.2180   0.5310   0.1939  
No Coverage 0.2120   0.2026   0.1839   0.4943   0.2259  
170420
Table 1.86C – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 209 206 32 32 205 203 78 79 190 183
GEOGRAPHIC REGION                    
Northeast 87 98 7 10 87 97 32 37 80 87
Midwest 83 81 13 16 80 79 34 30 71 71
South 144 126 23 20 142 125 48 48 132 113
West 92 101 16 15 90 100 39 39 84 91
COUNTY TYPE1                    
Large Metro 162 166 28 26 158 164 60 61 146 150
Small Metro 116 114 15 16 114 112 47 49 103 98
Nonmetro 79 60 9 8 78 60 33 24 66 52
Urbanized 57 41 5 5 57 40 22 18 52 35
Less Urbanized 51 43 7 6 51 43 25 16 36 37
Completely Rural 20 13 1 0 20 13 5 6 19 10
POVERTY LEVEL2                    
Less Than 100% 86 81 13 13 85 80 44 42 72 69
100-199% 109 93 16 16 107 90 37 35 101 82
200% or More 158 170 25 24 155 168 58 56 147 156
HEALTH INSURANCE3                    
Private 153 165 27 24 150 162 66 63 138 154
Medicaid/CHIP4 90 95 17 20 87 93 34 35 80 83
Other5 102 98 7 9 102 97 18 19 101 95
No Coverage 87 69 4 6 87 68 32 30 80 59
170420
Table 1.86D – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.08 0.08 0.13 0.13 0.08 0.08 0.22 0.23 0.09 0.09
GEOGRAPHIC REGION                    
Northeast 0.18 0.20 0.17 0.24 0.20 0.22 0.53 0.60 0.21 0.23
Midwest 0.15 0.14 0.25 0.30 0.16 0.15 0.46 0.41 0.16 0.16
South 0.14 0.12 0.24 0.21 0.16 0.14 0.37 0.37 0.17 0.14
West 0.15 0.16 0.28 0.25 0.16 0.17 0.46 0.47 0.17 0.18
COUNTY TYPE1                    
Large Metro 0.11 0.11 0.19 0.18 0.12 0.12 0.30 0.30 0.12 0.13
Small Metro 0.14 0.14 0.20 0.21 0.15 0.15 0.40 0.40 0.16 0.15
Nonmetro 0.21 0.15 0.26 0.22 0.22 0.16 0.70 0.54 0.22 0.17
Urbanized 0.36 0.25 0.34 0.35 0.39 0.28 0.99 0.83 0.42 0.29
Less Urbanized 0.29 0.21 0.47 0.34 0.31 0.23 1.20 0.77 0.26 0.23
Completely Rural 0.42 0.33 0.29 0.07 0.45 0.36 1.10 1.62 0.50 0.32
POVERTY LEVEL2                    
Less Than 100% 0.20 0.20 0.22 0.24 0.23 0.23 0.43 0.44 0.26 0.26
100-199% 0.20 0.17 0.28 0.28 0.22 0.18 0.42 0.43 0.25 0.20
200% or More 0.09 0.10 0.18 0.17 0.10 0.10 0.35 0.32 0.10 0.11
HEALTH INSURANCE3                    
Private 0.09 0.09 0.18 0.16 0.09 0.10 0.31 0.28 0.10 0.10
Medicaid/CHIP4 0.21 0.21 0.18 0.21 0.25 0.26 0.45 0.47 0.30 0.30
Other5 0.15 0.14 0.62 0.77 0.15 0.15 0.59 0.66 0.16 0.15
No Coverage 0.32 0.28 0.35 0.54 0.33 0.29 0.55 0.63 0.39 0.31
170420
Table 1.86P – Misuse of Tranquilizers in Past Year among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: P Values from Tests of Differences of Percentages, 2016 Versus 2015
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.9178   0.3751   0.8034   0.9178   0.8860  
GEOGRAPHIC REGION                    
Northeast 0.3786   0.1868   0.4468   0.2639   0.7335  
Midwest 0.1317   0.1459   0.1934   0.3496   0.0648  
South 0.0780   0.7952   0.0841   0.4679   0.1344  
West 0.9366   0.8692   0.9592   0.6478   0.9224  
COUNTY TYPE1                    
Large Metro 0.4223   0.4598   0.4876   0.6181   0.5570  
Small Metro 0.9506   0.4146   0.9515   0.9425   0.9051  
Nonmetro 0.0270   0.7516   0.0297   0.1242   0.1047  
Urbanized 0.0356   0.3780   0.0299   0.2088   0.0875  
Less Urbanized 0.2148   0.3867   0.2628   0.2212   0.5423  
Completely Rural 0.9797   0.0552   0.8984   0.2248   0.7371  
POVERTY LEVEL2                    
Less Than 100% 0.6174   0.6497   0.6709   0.2174   0.8826  
100-199% 0.2823   0.6821   0.2435   0.6623   0.2033  
200% or More 0.7283   0.5103   0.8042   0.1640   0.4788  
HEALTH INSURANCE3                    
Private 0.8875   0.5792   0.8152   0.3015   0.5358  
Medicaid/CHIP4 0.4027   0.1189   0.6125   0.5861   0.7116  
Other5 0.9246   0.1371   0.8201   0.3646   0.7052  
No Coverage 0.0922   0.2653   0.0801   0.6145   0.0404  
170420
Table 1.87C – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Numbers in Thousands, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 109 120 21 17 107 118 44 41 97 109
GEOGRAPHIC REGION                    
Northeast 43 64 3 4 43 64 17 17 41 61
Midwest 38 48 9 7 36 47 17 16 32 43
South 83 72 14 12 82 71 28 28 77 64
West 37 53 13 9 35 52 21 20 27 48
COUNTY TYPE1                    
Large Metro 81 93 18 12 80 92 33 32 72 86
Small Metro 60 67 11 11 58 65 27 23 52 59
Nonmetro 38 33 5 3 39 32 14 12 36 30
Urbanized 23 20 3 3 24 20 10 10 21 17
Less Urbanized 24 25 4 0 24 25 9 7 22 24
Completely Rural 19 7 1 * 19 7 3 3 19 6
POVERTY LEVEL2                    
Less Than 100% 48 50 8 6 47 49 25 21 40 45
100-199% 47 43 12 8 45 43 22 18 40 38
200% or More 83 95 15 13 82 94 29 29 76 89
HEALTH INSURANCE3                    
Private 80 99 17 12 78 98 31 32 71 91
Medicaid/CHIP4 47 49 12 11 45 48 20 19 40 44
Other5 50 44 7 5 49 43 11 11 48 42
No Coverage 42 38 1 3 42 38 22 17 37 34
170420
Table 1.87D – Misuse of Tranquilizers in Past Month among Persons Aged 12 or Older, by Age Group and Geographic and Socioeconomic Characteristics: Standard Errors of Percentages, 2015 and 2016
Geographic/Socioeconomic Characteristic Aged 12+
(2015)
Aged 12+
(2016)
Aged 12-17
(2015)
Aged 12-17
(2016)
Aged 18+
(2015)
Aged 18+
(2016)
Aged 18-25
(2015)
Aged 18-25
(2016)
Aged 26+
(2015)
Aged 26+
(2016)
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Misuse of prescription psychotherapeutics is defined as use in any way not directed by a doctor, including use without a prescription of one's own; use in greater amounts, more often, or longer than told; or use in any other way not directed by a doctor. Prescription psychotherapeutics do not include over-the-counter drugs.
1 County Type is based on the 2013 Rural-Urban Continuum Codes.
2 Estimates are based on a definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 CHIP is the Children's Health Insurance Program. Individuals aged 19 or younger are eligible for the plan.
5 Other Health Insurance is defined as having Medicare, CHAMPUS, TRICARE, CHAMPVA, the VA, military health care, or any other type of health insurance.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2015 and 2016.
TOTAL 0.04 0.04 0.09 0.07 0.04 0.05 0.13 0.12 0.05 0.05
GEOGRAPHIC REGION                    
Northeast 0.09 0.13 0.07 0.11 0.10 0.15 0.28 0.29 0.11 0.16
Midwest 0.07 0.08 0.17 0.14 0.07 0.09 0.23 0.21 0.07 0.10
South 0.08 0.07 0.15 0.12 0.09 0.08 0.22 0.22 0.10 0.08
West 0.06 0.08 0.21 0.14 0.06 0.09 0.25 0.24 0.06 0.10
COUNTY TYPE1                    
Large Metro 0.05 0.06 0.12 0.09 0.06 0.07 0.17 0.16 0.06 0.07
Small Metro 0.07 0.08 0.14 0.14 0.08 0.09 0.23 0.20 0.08 0.09
Nonmetro 0.10 0.08 0.16 0.08 0.11 0.09 0.31 0.28 0.12 0.10
Urbanized 0.14 0.13 0.23 0.18 0.16 0.14 0.49 0.47 0.17 0.14
Less Urbanized 0.14 0.13 0.28 0.01 0.15 0.14 0.44 0.35 0.16 0.15
Completely Rural 0.40 0.18 0.18 * 0.43 0.20 0.66 0.69 0.48 0.20
POVERTY LEVEL2                    
Less Than 100% 0.11 0.12 0.14 0.11 0.13 0.14 0.26 0.22 0.15 0.17
100-199% 0.09 0.08 0.22 0.14 0.09 0.09 0.26 0.23 0.10 0.09
200% or More 0.05 0.05 0.11 0.09 0.05 0.06 0.18 0.17 0.05 0.06
HEALTH INSURANCE3                    
Private 0.05 0.05 0.12 0.08 0.05 0.06 0.15 0.15 0.05 0.06
Medicaid/CHIP4 0.11 0.11 0.13 0.12 0.13 0.14 0.27 0.25 0.15 0.16
Other5 0.07 0.06 0.55 0.39 0.07 0.07 0.38 0.38 0.08 0.07
No Coverage 0.15 0.15 0.13 0.27 0.16 0.16 0.38 0.36 0.18 0.18
170420